smiles,assay_id,activity_type,pActivity,molecule_chembl_id,document_year,document_chembl_id,journal,source,assay_description,round_id,assay_context,scaffold,program_id,target_chembl_id,target_name,target_type
Brc1ccc(CNCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,CHEMBL3626473,Ki,5.28,CHEMBL3622101,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,108,0,c1ccc(CNCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Brc1ccc(N2CCN(Cc3ccccc3)CC2)c2cc[nH]c12,CHEMBL884862,Ki,7.33,CHEMBL90476,1998,CHEMBL1130595,Bioorg Med Chem Lett,Scientific Literature,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,13,1,c1ccc(CN2CCN(c3cccc4[nH]ccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Brc1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1,CHEMBL3626473,Ki,7.28,CHEMBL3622097,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,108,0,c1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Brc1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1,CHEMBL3626475,Ki,7.32,CHEMBL3622097,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,108,2,c1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Brc1ccc(NCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,CHEMBL3626473,Ki,6.04,CHEMBL3622093,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,108,0,c1ccc(NCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Brc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2,CHEMBL670398,Ki,6.8,CHEMBL418321,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,16,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Brc1cccc(N2CCN(Cc3cc4ccccn4n3)CC2)n1,CHEMBL934518,Ki,6.06,CHEMBL272396,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,58,4,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Brc1cccc(N2CCN(Cc3cc4ccccn4n3)CC2)n1,CHEMBL934519,Ki,6.26,CHEMBL272396,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,58,5,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Brc1cccc(N2CCN(Cc3cnn4ccccc34)CC2)n1,CHEMBL934518,Ki,6.68,CHEMBL272395,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,58,4,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Brc1cccc(N2CCN(Cc3cnn4ccccc34)CC2)n1,CHEMBL934519,Ki,6.82,CHEMBL272395,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,58,5,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC(C#C)=C1CCC(N(CCC)CCC)CC1,CHEMBL672527,Ki,4.92,CHEMBL165022,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding affinity on High Affinity Site of Dopamine receptor D2L,20,6,C=C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCC)CC1,CHEMBL670556,Ki,4.92,CHEMBL162762,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity of Compound of Dopamine receptor D2S,20,7,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCC)CC1,CHEMBL670557,Ki,4.77,CHEMBL162762,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2S,20,8,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCC)CC1,CHEMBL670558,Ki,6.6,CHEMBL162762,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity on High Affinity Site of Dopamine receptor D2S,20,9,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCC)CC1,CHEMBL672526,Ki,4.72,CHEMBL162762,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2L,20,10,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCC)CC1,CHEMBL672527,Ki,6.57,CHEMBL162762,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding affinity on High Affinity Site of Dopamine receptor D2L,20,6,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCC)CC1,CHEMBL672528,Ki,4.85,CHEMBL162762,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was tested on low Affinity Site of Dopamine receptor D2L,20,11,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCC)CC1,CHEMBL672529,Ki,7.42,CHEMBL162762,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2L,20,12,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCC)CC1,CHEMBL672581,Ki,5.54,CHEMBL162762,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Dissociation constant of compound on one-site model Dopamine receptor D2S,20,13,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCC)CC1,CHEMBL673075,Ki,5.55,CHEMBL162762,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Dissociation constant of compound on one-site model Dopamine receptor D2L,20,14,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCC)CC1,CHEMBL872880,Ki,7.47,CHEMBL162762,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2S,20,15,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL995087,Ki,7.4,CHEMBL484358,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,58,16,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL995088,Ki,7.37,CHEMBL484358,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,58,17,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1,CHEMBL995087,Ki,6.21,CHEMBL484202,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,58,16,C1=CCC(NCCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CCC(N(CCC)CCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1,CHEMBL995088,Ki,6.77,CHEMBL484202,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,58,17,C1=CCC(NCCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL2400820,Ki,7.8,CHEMBL2397480,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,86,18,O=C(NCCCCNC1CC=CCC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL2400821,Ki,8.7,CHEMBL2397480,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,87,19,O=C(NCCCCNC1CC=CCC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL2400822,Ki,7.66,CHEMBL2397480,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,87,20,O=C(NCCCCNC1CC=CCC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL2400820,Ki,6.55,CHEMBL2397391,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,87,18,O=C(NCCCCNC1CC=CCC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL2400821,Ki,8.41,CHEMBL2397391,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,87,19,O=C(NCCCCNC1CC=CCC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL2400822,Ki,7.18,CHEMBL2397391,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,87,20,O=C(NCCCCNC1CC=CCC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL2400820,Ki,7.68,CHEMBL2396663,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,87,18,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL2400821,Ki,8.92,CHEMBL2396663,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,87,19,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL2400822,Ki,7.85,CHEMBL2396663,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,87,20,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL3578854,Ki,8.03,CHEMBL2396663,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,21,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL3578855,Ki,8.41,CHEMBL2396663,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,22,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,CHEMBL3578854,Ki,8.8,CHEMBL3577342,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,21,O=C(NCCCCNC1CC=COC1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,CHEMBL3578855,Ki,8.54,CHEMBL3577342,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,22,O=C(NCCCCNC1CC=COC1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1,CHEMBL2400820,Ki,8.41,CHEMBL2397478,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,87,18,O=C(NCCCCNC1CC=CCC1)c1ccc(OCCCc2cn[nH]n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1,CHEMBL2400821,Ki,9.28,CHEMBL2397478,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,87,19,O=C(NCCCCNC1CC=CCC1)c1ccc(OCCCc2cn[nH]n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1,CHEMBL2400822,Ki,8.22,CHEMBL2397478,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,87,20,O=C(NCCCCNC1CC=CCC1)c1ccc(OCCCc2cn[nH]n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL2400820,Ki,7.85,CHEMBL2397476,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,87,18,O=C(NCCCCNC1CC=CCC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL2400821,Ki,8.96,CHEMBL2397476,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,87,19,O=C(NCCCCNC1CC=CCC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL2400822,Ki,8.11,CHEMBL2397476,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,87,20,O=C(NCCCCNC1CC=CCC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL2400820,Ki,7.48,CHEMBL2397479,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,87,18,O=C(NCCCCNC1CC=CCC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL2400821,Ki,8.51,CHEMBL2397479,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,87,19,O=C(NCCCCNC1CC=CCC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL2400822,Ki,7.5,CHEMBL2397479,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,87,20,O=C(NCCCCNC1CC=CCC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL2400820,Ki,6.64,CHEMBL2397390,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,87,18,O=C(NCCCCNC1CC=CCC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL2400821,Ki,8.26,CHEMBL2397390,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,87,19,O=C(NCCCCNC1CC=CCC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL2400822,Ki,7.2,CHEMBL2397390,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,87,20,O=C(NCCCCNC1CC=CCC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL2400820,Ki,7.75,CHEMBL2397389,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,87,18,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL2400821,Ki,9.22,CHEMBL2397389,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,87,19,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL2400822,Ki,7.96,CHEMBL2397389,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,87,20,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL3578854,Ki,7.85,CHEMBL2397389,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,21,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL3578855,Ki,8.06,CHEMBL2397389,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,22,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,CHEMBL3578854,Ki,8.31,CHEMBL3577343,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,21,O=C(NCCCCNC1CC=COC1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1,CHEMBL3578855,Ki,8.0,CHEMBL3577343,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,22,O=C(NCCCCNC1CC=COC1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1,CHEMBL2400820,Ki,8.06,CHEMBL2397477,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,87,18,O=C(NCCCCNC1CC=CCC1)c1ccc(OCCCc2cn[nH]n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1,CHEMBL2400821,Ki,8.38,CHEMBL2397477,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,87,19,O=C(NCCCCNC1CC=CCC1)c1ccc(OCCCc2cn[nH]n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cnn(CCCC)n3)c(OC)c2)CC1,CHEMBL2400822,Ki,8.1,CHEMBL2397477,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,87,20,O=C(NCCCCNC1CC=CCC1)c1ccc(OCCCc2cn[nH]n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL2400820,Ki,8.03,CHEMBL2397392,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,87,18,O=C(NCCCCNC1CC=CCC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL2400821,Ki,9.26,CHEMBL2397392,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,87,19,O=C(NCCCCNC1CC=CCC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL2400822,Ki,8.15,CHEMBL2397392,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,87,20,O=C(NCCCCNC1CC=CCC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCCC(=O)Nc1ccc(CCN(CCC)C2CCc3c(O)cccc3C2)cc1,CHEMBL4236717,Ki,7.77,CHEMBL4242192,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,129,23,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCCC(=O)Nc1ccc(CCN(CCC)C2CCc3c(O)cccc3C2)cc1,CHEMBL4236718,Ki,7.72,CHEMBL4242192,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,129,24,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCCCCN(CCC)C1Cc2ccccc2C1,CHEMBL4736183,Ki,6.72,CHEMBL4781480,2021,CHEMBL4732144,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,146,25,c1ccc2c(c1)CCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCN(C)Cc1ccc(OCCCCCN2CCN(c3cccc4c3ccn4S(=O)(=O)c3ccccc3)CC2)cc1,CHEMBL4711041,Ki,6.09,CHEMBL4741978,2020,CHEMBL4706587,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta plate reader analysis,141,26,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCCOc4ccccc4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCN(CCCCN1CCN(c2cccc(Cl)c2Cl)CC1)C1CCc2ccc(O)cc2C1,CHEMBL670524,Ki,8.13,CHEMBL157035,2002,CHEMBL1135449,Bioorg Med Chem Lett,Scientific Literature,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,27,27,c1ccc(N2CCN(CCCCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1,CHEMBL670524,Ki,7.17,CHEMBL157293,2002,CHEMBL1135449,Bioorg Med Chem Lett,Scientific Literature,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,27,27,c1ccc(N2CCN(CCCCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1,CHEMBL926379,Ki,7.54,CHEMBL157293,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,58,28,c1ccc(N2CCN(CCCCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1,CHEMBL670524,Ki,6.61,CHEMBL158013,2002,CHEMBL1135449,Bioorg Med Chem Lett,Scientific Literature,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,27,27,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCN1CCC2(CC1)OC=C(c1ccccc1)C2=O,CHEMBL671745,Ki,4.62,CHEMBL553666,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,1,29,O=C1C(c2ccccc2)=COC12CCNCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCN1CCC[C@@H](c2cccc(C#N)c2)C1,CHEMBL679938,Ki,5.93,CHEMBL91228,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",2,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCOc1c(OC)cc2c3c1-c1cc(N)ccc1CC3N(C)CC2,CHEMBL4628381,Ki,6.37,CHEMBL4636589,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,141,31,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCOc1c(OC)cc2c3c1-c1cc(NC(C)=O)ccc1CC3N(C)CC2,CHEMBL4628381,Ki,6.07,CHEMBL4633772,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,141,31,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCOc1c(OC)cc2c3c1-c1cc([N+](=O)[O-])ccc1CC3N(C)CC2,CHEMBL4628381,Ki,5.69,CHEMBL4638749,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,141,31,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCOc1ccc(-c2ccc(C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)cc2)cc1,CHEMBL4736183,Ki,6.01,CHEMBL4794870,2021,CHEMBL4732144,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,146,25,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCOc1ccc(CN2CCN(c3ccccc3OC)CC2)cc1OC,CHEMBL4236717,Ki,7.11,CHEMBL4250062,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,129,23,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCOc1ccc(CN2CCN(c3ccccc3OC)CC2)cc1OC,CHEMBL4236718,Ki,7.16,CHEMBL4250062,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,129,24,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCOc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1,CHEMBL5351445,Ki,7.07,CHEMBL5399833,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,155,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#CCOc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1,CHEMBL5351446,Ki,7.34,CHEMBL5399833,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,155,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1,CHEMBL671363,Ki,6.11,CHEMBL57176,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,27,34,c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1,CHEMBL671365,Ki,6.24,CHEMBL57176,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,27,35,c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cc(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)c(OC)c2ccccc12,CHEMBL671368,Ki,6.51,CHEMBL112833,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cc(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)c(OC)c2ccccc12,CHEMBL872881,Ki,6.845,CHEMBL112833,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cc(CN2CCN(c3ccccc3OC)CC2)c2cccccc1-2,CHEMBL2214282,Ki,7.12,CHEMBL2207632,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,80,38,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cc(CN2CCN(c3ccccc3OC)CC2)c2cccccc1-2,CHEMBL2214283,Ki,7.02,CHEMBL2207632,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,80,39,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL898785,Ki,7.64,CHEMBL393365,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,50,40,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL898786,Ki,7.96,CHEMBL393365,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,50,41,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL898785,Ki,7.82,CHEMBL394292,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,50,40,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL898786,Ki,7.57,CHEMBL394292,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,50,41,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL898785,Ki,6.6,CHEMBL241212,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,50,40,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL898786,Ki,6.8,CHEMBL241212,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,50,41,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL898785,Ki,7.16,CHEMBL241631,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,50,40,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL898786,Ki,7.32,CHEMBL241631,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,50,41,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc2c(c1)CCN(CCCCN1CCN(c3ccccc3OC)CC1)C2=O,CHEMBL1771855,Ki,7.62,CHEMBL1771114,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,76,42,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc2c(c1)CCN(CCCCN1CCN(c3ccccc3OC)CC1)C2=O,CHEMBL1771856,Ki,8.06,CHEMBL1771114,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,76,43,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc2cc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)sc2c1,CHEMBL913685,Ki,6.7,CHEMBL218368,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,50,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1ccc2sc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)cc2c1,CHEMBL913685,Ki,6.39,CHEMBL221397,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,50,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL898785,Ki,7.29,CHEMBL239733,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,50,40,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL898786,Ki,7.64,CHEMBL239733,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,50,41,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL898785,Ki,7.82,CHEMBL392437,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,50,40,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL898786,Ki,7.62,CHEMBL392437,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,50,41,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL898785,Ki,6.85,CHEMBL391256,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,50,40,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL898786,Ki,7.11,CHEMBL391256,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,50,41,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL898785,Ki,6.92,CHEMBL394473,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,50,40,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL898786,Ki,7.08,CHEMBL394473,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,50,41,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)c(C)nn12,CHEMBL671731,Ki,4.68,CHEMBL156851,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,27,45,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)c(C)nn12,CHEMBL671732,Ki,4.6,CHEMBL156851,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,27,46,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL671731,Ki,5.43,CHEMBL160952,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,27,45,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL671732,Ki,5.21,CHEMBL160952,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,27,46,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL913685,Ki,5.43,CHEMBL160952,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,50,44,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccn1C1CCN(Cc2ccccc2)CC1,CHEMBL672580,Ki,5.2,CHEMBL325104,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,16,47,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C#Cc1cccn1C1CCN(Cc2ccccc2)CC1,CHEMBL673074,Ki,5.18,CHEMBL325104,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,16,48,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1)c1ccccc1,CHEMBL671363,Ki,6.12,CHEMBL58662,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,27,34,C(#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1)c1ccccc1,CHEMBL671365,Ki,6.26,CHEMBL58662,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,27,35,C(#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(#Cc1ccccc1)CN(c1ccccc1)C1CCN(Cc2ccccc2)CC1,CHEMBL667743,IC50,6.05,CHEMBL113282,1994,CHEMBL1127992,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from dopamine D2 receptor,3,49,C(#Cc1ccccc1)CN(c1ccccc1)C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(#Cc1ccccc1)COC1CCN(CCc2ccccc2)CC1,CHEMBL878132,Ki,5.87,CHEMBL311508,1994,CHEMBL1127981,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,3,50,C(#Cc1ccccc1)COC1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(#Cc1ccccc1)COCCC1CCN(CCc2ccccc2)CC1,CHEMBL878132,Ki,6.88,CHEMBL78067,1994,CHEMBL1127981,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,3,50,C(#Cc1ccccc1)COCCC1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(#Cc1cccn1C1CCN(Cc2ccccc2)CC1)c1ccccc1,CHEMBL672580,Ki,5.08,CHEMBL104092,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,16,47,C(#Cc1cccn1C1CCN(Cc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(#Cc1cccn1C1CCN(Cc2ccccc2)CC1)c1ccccc1,CHEMBL673074,Ki,5.0,CHEMBL104092,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,16,48,C(#Cc1cccn1C1CCN(Cc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(=C/Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc21)\Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc21,CHEMBL670392,Ki,7.25,CHEMBL314663,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,4,51,C(=CCn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc21)Cn1c(-c2ccc(OCCCN3CCCC3)cc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(=C/Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc21)\Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc21,CHEMBL670392,Ki,6.29,CHEMBL86129,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,4,51,C(=CCn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc21)Cn1c(-c2ccc(OCCCN3CCCCC3)cc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(=C/Cn1c(-c2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2)nc2ccccc21)\Cn1c(-c2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2)nc2ccccc21,CHEMBL670392,Ki,5.4,CHEMBL83722,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,4,51,C(=CCn1c(-c2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2)nc2ccccc21)Cn1c(-c2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(=C/c1cc(CCCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)on1)\c1ccccc1,CHEMBL672182,Ki,6.31,CHEMBL543041,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,27,52,C(=Cc1cc(CCCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)on1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(=C/c1cc(CCCCN2CCN(c3ccccc3)CC2)on1)\c1ccccc1,CHEMBL672182,Ki,5.01,CHEMBL543277,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,27,52,C(=Cc1cc(CCCCN2CCN(c3ccccc3)CC2)on1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(=C/c1ccccc1)\COCC1CCN(CCCc2ccccc2)CC1,CHEMBL878132,Ki,6.02,CHEMBL308980,1994,CHEMBL1127981,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,3,50,C(=Cc1ccccc1)COCC1CCN(CCCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(=C/c1ccccc1)\COCC1CCN(CCc2ccccc2)CC1,CHEMBL878132,Ki,6.62,CHEMBL77206,1994,CHEMBL1127981,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,3,50,C(=Cc1ccccc1)COCC1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C(COCC1CCN(Cc2ccccc2)CC1)=C(c1ccccc1)c1ccccc1,CHEMBL878132,Ki,6.21,CHEMBL75860,1994,CHEMBL1127981,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,3,50,C(COCC1CCN(Cc2ccccc2)CC1)=C(c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C/C(=C\CN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1)CN1C(=O)CCc2ccccc21,CHEMBL853595,Ki,6.17,CHEMBL201400,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,53,O=C1CCc2ccccc2N1CC=CCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C/C=C/CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.36,CHEMBL3695438,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C/C=C/CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.24,CHEMBL3676899,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C/C=C/CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.02,CHEMBL3642758,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C/C=C1/c2ccccc2C=C(N2CCN(C)CC2)c2ccccc21,CHEMBL675960,Ki,6.14,CHEMBL90977,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,3,57,C=C1c2ccccc2C=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(/C=C/c2ccccc2)CCN(CCc2c[nH]c3ncccc23)C1,CHEMBL671652,Ki,6.55,CHEMBL2112913,1999,CHEMBL1132519,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,16,58,C(=Cc1ccccc1)C1=CCN(CCc2c[nH]c3ncccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(/C=C/c2ccccc2)CCN(CCc2cc3ccc[nH]c-3n2)C1,CHEMBL671652,Ki,5.89,CHEMBL154482,1999,CHEMBL1132519,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,16,58,C(=Cc1ccccc1)C1=CCN(CCc2cc3ccc[nH]c-3n2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(CCN2CCc3ccccc3C2)CCc2ccccc21,CHEMBL3863657,Ki,5.25,CHEMBL3970994,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,114,59,C1=C(CCN2CCc3ccccc3C2)CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,CHEMBL4368222,Ki,7.59,CHEMBL285157,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,133,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccco2)C1,CHEMBL4368222,Ki,6.59,CHEMBL4521477,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,133,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccco2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2c[nH]c3ccccc23)CCN(Cc2cccs2)C1,CHEMBL4368222,Ki,7.14,CHEMBL4554558,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,133,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2cccs2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2c[nH]c3ccccc23)CCNC1,CHEMBL671418,Ki,6.7,CHEMBL27811,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,33,61,C1=C(c2c[nH]c3ccccc23)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2ccccc2)CCN(CC[C@H]2CC[C@H](Nc3ncccn3)CC2)C1,CHEMBL672206,Ki,8.33,CHEMBL164604,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,13,62,C1=C(c2ccccc2)CCN(CCC2CCC(Nc3ncccn3)CC2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2ccccc2)CCN(CCc2c[nH]c3ncccc23)C1,CHEMBL671652,Ki,7.68,CHEMBL2112912,1999,CHEMBL1132519,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,16,58,C1=C(c2ccccc2)CCN(CCc2c[nH]c3ncccc23)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2ccccc2)CCN(C[C@@H]2CCC=C(c3ccccc3)C2)C1,CHEMBL672910,Ki,8.08,CHEMBL335545,1995,CHEMBL1128721,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,4,63,C1=C(c2ccccc2)CCN(CC2CCC=C(c3ccccc3)C2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2ccccc2)CCN(C[C@@H]2CCC=C(c3ccccc3)C2)C1,CHEMBL672911,Ki,7.59,CHEMBL335545,1995,CHEMBL1128721,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,4,64,C1=C(c2ccccc2)CCN(CC2CCC=C(c3ccccc3)C2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2ccccc2)CCN(C[C@@H]2CCC=C(c3ccccc3)C2)C1,CHEMBL673248,Ki,7.59,CHEMBL335545,1994,CHEMBL1127372,J Med Chem,Scientific Literature,Tested for binding affinity towards human D2L receptor using [3H]spiperone as radioligand,3,65,C1=C(c2ccccc2)CCN(CC2CCC=C(c3ccccc3)C2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2ccccc2)CCN(Cc2cn(-c3ccccc3)nn2)C1,CHEMBL871242,Ki,6.66,CHEMBL379177,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,44,66,C1=C(c2ccccc2)CCN(Cc2cn(-c3ccccc3)nn2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2ccccc2)CCN(Cc2cn(-c3ccccc3)nn2)C1,CHEMBL871243,Ki,6.96,CHEMBL379177,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,44,67,C1=C(c2ccccc2)CCN(Cc2cn(-c3ccccc3)nn2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,CHEMBL871242,Ki,7.42,CHEMBL378455,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,44,66,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,CHEMBL871243,Ki,7.55,CHEMBL378455,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,44,67,C1=C(c2ccccc2)CCN(Cc2cnn(-c3ccccc3)c2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2nc3ccccc3[nH]2)CCN(Cc2ccccc2)C1,CHEMBL670393,Ki,5.85,CHEMBL71173,1997,CHEMBL1130515,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,9,68,C1=C(c2nc3ccccc3[nH]2)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2nc3ccccc3o2)CCN(Cc2ccccc2)C1,CHEMBL670393,Ki,6.62,CHEMBL70267,1997,CHEMBL1130515,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,9,68,C1=C(c2nc3ccccc3o2)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1=C(c2nc3ccccc3s2)CCN(Cc2ccccc2)C1,CHEMBL670393,Ki,6.22,CHEMBL69355,1997,CHEMBL1130515,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,9,68,C1=C(c2nc3ccccc3s2)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C1C2C3CC4C2C2C1C3[C@H](NCC13C5C6C7C5C1C7C63)C42,CHEMBL2432454,Ki,5.25,CHEMBL2432039,2013,CHEMBL2429832,Bioorg Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,87,69,C1C2C3CC4C2C(NCC25C6C7C8C6C2C8C75)C2C1C3C42,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=C(C)CN(NC(=O)NCCCN1CCN(c2ccccc2OC)CC1)c1ccc(OC)cc1,CHEMBL4323478,Ki,6.68,CHEMBL4472580,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,133,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NNc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=C(C)CN(NC(=O)NCCCN1CCN(c2ccccc2OC)CC1)c1ccc(OC)cc1,CHEMBL4323479,Ki,6.52,CHEMBL4472580,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,133,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NNc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=C1/C(=C\C=C2/CCC[C@]3(C)[C@@H]([C@H](C)C[C@@H]4OC(=O)C(=C)[C@H]4CCCC)CC[C@@H]23)C[C@@H](O)[C@H](C)[C@@H]1O,CHEMBL907725,Ki,5.3,CHEMBL384538,2006,CHEMBL1137322,J Med Chem,Scientific Literature,Binding affinity to D2 receptor,44,72,C=C1CC(CCC2CCC3C(=CC=C4CCCCC4=C)CCCC23)OC1=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=C1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21,CHEMBL671374,Ki,6.6,CHEMBL327713,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,3,73,C=C1c2ccccc2C=C(C2=CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=C1c2ccccc2C=C(N2CCN(C)CC2)c2ccccc21,CHEMBL675960,Ki,7.24,CHEMBL91310,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,3,57,C=C1c2ccccc2C=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN(CC=C)CCc1c[nH]c2ccc(Br)cc12,CHEMBL3756490,Ki,5.36,CHEMBL3754166,2016,CHEMBL3751848,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,114,74,c1ccc2[nH]ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN(CC=C)CCc1c[nH]c2ccc(C)cc12,CHEMBL3756490,Ki,5.29,CHEMBL3753318,2016,CHEMBL3751848,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,114,74,c1ccc2[nH]ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN(CC=C)CCc1c[nH]c2ccc(Cl)cc12,CHEMBL3756490,Ki,5.73,CHEMBL3752900,2016,CHEMBL3751848,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,114,74,c1ccc2[nH]ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN(CC=C)CCc1c[nH]c2ccc(F)cc12,CHEMBL3756490,Ki,5.61,CHEMBL3754496,2016,CHEMBL3751848,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 dopamine receptor (unknown origin) by competition binding assay,114,74,c1ccc2[nH]ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN(NC(=O)NCCCN1CCN(c2ccccc2OC)CC1)c1ccc(OC)cc1,CHEMBL4323478,Ki,6.75,CHEMBL4475978,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,133,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NNc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN(NC(=O)NCCCN1CCN(c2ccccc2OC)CC1)c1ccc(OC)cc1,CHEMBL4323479,Ki,6.47,CHEMBL4475978,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,133,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NNc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC=C(C2=Cc3ccccc3Cc3ccccc32)CC1,CHEMBL672525,Ki,7.08,CHEMBL555362,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,4,75,C1=C(C2=Cc3ccccc3Cc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC=C(C2=Cc3ccccc3Oc3ccccc32)CC1,CHEMBL672525,Ki,6.96,CHEMBL544418,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,4,75,C1=C(C2=Cc3ccccc3Oc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2(CC1)OC=C(c1ccccc1)C2=O,CHEMBL671745,Ki,5.31,CHEMBL555614,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,1,29,O=C1C(c2ccccc2)=COC12CCNCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2C=C(O)C(O)=C3C(c4ccccc4)CC1C32,CHEMBL5231713,Ki,7.8,CHEMBL5285185,2020,CHEMBL5230125,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from D2DR (unknown origin),141,76,C1=CC2CCNC3CC(c4ccccc4)C(=C1)C23,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2Cc3c(O)cccc3C[C@H]21,CHEMBL673016,Ki,8.85,CHEMBL278285,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2c3c(cccc3OC)CCC21,CHEMBL673016,Ki,8.07,CHEMBL273412,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2c3c(cccc3OC)CC[C@@H]21,CHEMBL672485,Ki,7.11,CHEMBL418705,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2c3c(cccc3OC)CC[C@H]21,CHEMBL672485,Ki,8.17,CHEMBL10270,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2c3cccc(C#N)c3CCC21,CHEMBL679938,Ki,6.01,CHEMBL92939,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2c3cccc(O)c3CCC21,CHEMBL673016,Ki,7.755000000000001,CHEMBL10289,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2c3cccc(O)c3CC[C@@H]21,CHEMBL672485,Ki,7.23,CHEMBL275543,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2c3cccc(O)c3CC[C@H]21,CHEMBL672485,Ki,6.97,CHEMBL10408,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2c3cccc(OC)c3CC[C@@H]21,CHEMBL673016,Ki,7.3,CHEMBL276825,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2c3cccc(OC)c3CC[C@H]21,CHEMBL672485,Ki,7.11,CHEMBL10570,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC2c3cccc(OC)c3CC[C@H]21,CHEMBL673016,Ki,7.11,CHEMBL10570,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@@H](c2cccc(C#N)c2)C1,CHEMBL679938,Ki,6.59,CHEMBL93212,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(Br)cc(OC)c1OC,CHEMBL941849,Ki,9.06,CHEMBL240106,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,50,79,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(Br)cc(OC)c1OC,CHEMBL941850,Ki,9.07,CHEMBL240106,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,50,80,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(Br)ccc1OC,CHEMBL941849,Ki,7.57,CHEMBL397592,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,50,79,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(Br)ccc1OC,CHEMBL941850,Ki,7.64,CHEMBL397592,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,50,80,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCCl)cc(OC)c1OC,CHEMBL1005621,IC50,7.77,CHEMBL502017,2008,CHEMBL1156607,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor,58,81,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC,CHEMBL1005621,IC50,8.3,CHEMBL392158,2008,CHEMBL1156607,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor,58,81,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC,CHEMBL3265956,Ki,10.01,CHEMBL392158,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC,CHEMBL941849,Ki,8.68,CHEMBL392158,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,50,79,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)cc(OC)c1OC,CHEMBL941850,Ki,8.66,CHEMBL392158,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,50,80,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)ccc1OC,CHEMBL941849,Ki,7.52,CHEMBL428561,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,50,79,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCF)ccc1OC,CHEMBL941850,Ki,7.52,CHEMBL428561,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,50,80,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3CCC[C@H]3C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCC(N)=O)C(=O)O)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.67,CHEMBL3265038,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N1CCCC1C(=O)N1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCC(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.91,CHEMBL3265042,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.55,CHEMBL3265046,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCCC(=O)NC(Cc1cnc[nH]1)C(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NCCc1cnc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCCOCCOCCOCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.62,CHEMBL3265048,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCCOCCOCCOCCC(=O)NC(Cc1cnc[nH]1)C(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NCCc1cnc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.52,CHEMBL3265047,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCOCCOCC(=O)NC(Cc1cnc[nH]1)C(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NCCc1cnc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.28,CHEMBL3265322,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCOCCOCCOCCOCCC(=O)NC(CCCCNC(=O)CN1CCNCCNCCNCC1)C(=O)NC(Cc1cnc[nH]1)C(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NCCc1cnc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(=O)N[C@@H](CCCCNC(=O)O/N=C/c3ccc([Si](F)(C(C)(C)C)C(C)(C)C)cc3)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,8.22,CHEMBL3265321,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCOCCOCCOCCOCCC(=O)NC(CCCCNC(=O)ON=Cc1ccccc1)C(=O)NC(Cc1cnc[nH]1)C(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NCCc1cnc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,8.83,CHEMBL3265049,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCOCCOCCOCCOCCC(=O)NC(Cc1cnc[nH]1)C(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NCCc1cnc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.58,CHEMBL3265317,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCOCCOCCOCCOCCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NC(CCCCNC(=O)CN1CCNCCNCCNCC1)C(=O)NCC(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCC(N)=O)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,8.14,CHEMBL3265324,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C1CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C(=O)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.56,CHEMBL3265314,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCOCCOCCOCCOCCOCCOCCC(=O)NC(Cc1cnc[nH]1)C(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NCCc1cnc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.45,CHEMBL3265318,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCOCCOCCOCCOCCOCCOCCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NC(CCCCNC(=O)CN1CCNCCNCCNCC1)C(=O)NCC(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.27,CHEMBL3265315,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NC(Cc1cnc[nH]1)C(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NCCc1cnc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.37,CHEMBL3265319,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NC(CCCCNC(=O)CN1CCNCCNCCNCC1)C(=O)NCC(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.35,CHEMBL3265320,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NC(CCCCNC(=O)CN1CCNCCNCCNCC1)C(=O)NCC(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.6,CHEMBL3265316,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(=O)NC(Cc1cnc[nH]1)C(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NCCc1cnc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)[C@@H](C)CC)[C@@H](C)CC)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,8.09,CHEMBL3265043,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCCc1c[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,8.01,CHEMBL3265039,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C1CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C(=O)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)O)[C@@H](C)CC)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.99,CHEMBL3265040,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CNC(=O)C(Cc1cnc[nH]1)NC(=O)CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCC(=O)NC(Cc1ccccc1)C(=O)N1CCCC1C(=O)NCC(=O)NCCc1cnc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N3CCC[C@H]3C(=O)O)C(C)C)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.89,CHEMBL3265044,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,8.1,CHEMBL3265045,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NC(CCCCNC(=O)CN1CCNCCNCCNCC1)C(=O)NCC(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@H](C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCNC(=O)CN3CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCC[n+]3c(C)cc(/C=C/C=C/c4ccc(N(C)C)cc4)cc3C)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)O)[C@@H](C)O)[C@@H](C)O)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.19,CHEMBL3265323,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NC(Cc1ccccc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NC(CCCCNC(=O)CN1CCNCCNCCNCC1)C(=O)NCC(=O)NCC(=O)NCC(=O)NC(Cc1ccccc1)C(=O)NC(CCCC[n+]1ccc(C=CC=Cc2ccccc2)cc1)C(=O)NCC(=O)NCC(=O)NCC(=O)NCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(CCCSC2CC(=O)N(CCCCCC(=O)N[C@H](C(=O)N[C@@H](Cc3cnc[nH]3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3CCC[C@H]3C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CO)C(=O)N3CCC[C@H]3C(=O)N[C@H](C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C(=O)N3CCC[C@H]3C(=O)O)C(C)C)[C@@H](C)O)C2=O)cc(OC)c1OC,CHEMBL3265956,Ki,7.56,CHEMBL3265041,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(CCCCCN1C(=O)CC(SCCCc2cccc(C(=O)NCC3CCCN3)c2)C1=O)NCC(=O)NC(Cc1cnc[nH]1)C(=O)NCC(=O)N1CCCC1C(=O)N1CCCC1C(=O)NCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N1CCCC1C(=O)NCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)N1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(I)cc(OC)c1OC,CHEMBL941849,Ki,9.13,CHEMBL241169,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,50,79,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(I)cc(OC)c1OC,CHEMBL941850,Ki,9.17,CHEMBL241169,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,50,80,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(I)ccc1OC,CHEMBL941849,Ki,7.82,CHEMBL397103,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,50,79,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cc(I)ccc1OC,CHEMBL941850,Ki,7.85,CHEMBL397103,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,50,80,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCC[C@H]1CNC(=O)c1cccc(CCCF)c1,CHEMBL3265956,Ki,9.2,CHEMBL3265329,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21,CHEMBL672486,Ki,8.075,CHEMBL11363,1993,CHEMBL1126639,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,83,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21,CHEMBL673016,Ki,9.52,CHEMBL11363,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@@H]2c3c(O)cccc3CC[C@H]21,CHEMBL672485,Ki,7.6,CHEMBL283738,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@@H]2c3c(cccc3OC)CC[C@H]21,CHEMBL672485,Ki,8.07,CHEMBL286205,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@@H]2c3cccc(O)c3CC[C@@H]21,CHEMBL673016,Ki,7.23,CHEMBL566133,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@@H]2c3cccc(O)c3CC[C@H]21,CHEMBL672485,Ki,8.39,CHEMBL25483,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@@H]2c3cccc(OC)c3CC[C@H]21,CHEMBL672488,Ki,7.3,CHEMBL24222,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in rat striatum",1,84,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@@H]2c3cccc(OC)c3CC[C@H]21,CHEMBL679938,Ki,7.3,CHEMBL24222,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@H]2Cc3c(O)cccc3C[C@@H]21,CHEMBL672486,Ki,6.63,CHEMBL267557,1993,CHEMBL1126639,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,83,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@H]2Cc3c(O)cccc3C[C@H]21,CHEMBL673016,Ki,6.63,CHEMBL24050,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@H]2c3c(O)cccc3CC[C@H]21,CHEMBL673016,Ki,6.82,CHEMBL287134,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@H]2c3c(cccc3OC)CC[C@H]21,CHEMBL673016,Ki,8.15,CHEMBL26118,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@H]2c3cccc(O)c3CC[C@H]21,CHEMBL672485,Ki,7.12,CHEMBL285873,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@H]2c3cccc(O)c3CC[C@H]21,CHEMBL673016,Ki,6.97,CHEMBL285873,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@H]2c3cccc(OC)c3CC[C@H]21,CHEMBL672485,Ki,7.75,CHEMBL280955,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@H]2c3cccc(OC)c3CC[C@H]21,CHEMBL673016,Ki,7.75,CHEMBL280955,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CC[C@H]2c3cccc(OC)c3CC[C@H]21,CHEMBL679938,Ki,7.75,CHEMBL280955,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCc2c(cc(O)c(O)c2Br)C(c2ccccc2)C1,CHEMBL669945,Ki,7.72,CHEMBL544114,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,0,85,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCc2c(cc(O)c(O)c2Br)C(c2ccccc2)C1,CHEMBL669946,Ki,4.68,CHEMBL544114,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,0,86,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCc2c(cc(O)c(O)c2Br)[C@@H](c2ccccc2)C1,CHEMBL672210,Ki,6.46,CHEMBL34095,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,13,87,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1,CHEMBL669942,Ki,7.26,CHEMBL544115,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at high affinity state.,0,88,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1,CHEMBL669943,Ki,5.89,CHEMBL544115,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at low affinity state,0,89,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCc2c(cc(O)c(O)c2Cl)[C@@H](c2ccccc2)C1,CHEMBL672210,Ki,6.29,CHEMBL317741,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,13,87,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCc2cc(Br)c(O)cc2C(c2ccccc2)C1,CHEMBL672777,Ki,6.2,CHEMBL543473,1992,CHEMBL1126025,J Med Chem,Scientific Literature,In vitro ability to inhibit [3H]spiperone binding to Dopamine receptor D2,0,90,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCc2cc(OC)c(O)cc2C(c2c(Cl)cccc2Cl)C1,CHEMBL4625240,Ki,5.82,CHEMBL4645139,2020,CHEMBL4622940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),141,91,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1CCc2nc(N)sc2CC1,CHEMBL4334861,Ki,6.21,CHEMBL279085,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [125I]iodosupride from human recombinant dopamine D2S receptor expressed in CHO cells incubated for 30 mins by competitive radioligand binding analysis,133,92,c1nc2c(s1)CCNCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCN1C[C@H]2C[C@@]2(c2ccc(NS(=O)(=O)c3ccc(C(C)C)cc3)cc2)C1,CHEMBL1225698,Ki,7.2,CHEMBL1224698,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,67,93,O=S(=O)(Nc1ccc(C23CNCC2C3)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCOC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.78,CHEMBL400826,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,50,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCOc1c(OC)cc2c3c1-c1cc(N)ccc1CC3N(C)CC2,CHEMBL4628381,Ki,6.12,CHEMBL4649785,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,141,31,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=CCOc1cc(F)c(F)cc1C1CC1CN,CHEMBL3774018,Ki,5.31,CHEMBL3769968,2016,CHEMBL3769385,J Med Chem,Scientific Literature,Binding affinity to human dopamine D2 receptor by radioligand binding assay,114,95,c1ccc(C2CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL675680,Ki,6.57,CHEMBL431640,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,27,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=Cc1ccc(C(=O)NCCCCN2CCCN(c3ccccc3OC)CC2)cc1,CHEMBL2388819,Ki,6.89,CHEMBL2386609,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,87,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=Cc1ccc2c(c1OC)-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670886,Ki,5.76,CHEMBL331100,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,6,98,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C=Cc1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670880,Ki,6.75,CHEMBL119656,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,6,99,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC#CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.93,CHEMBL3695439,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC#CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.59,CHEMBL3676900,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC#CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.37,CHEMBL3642759,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC#CC1=CCC(N(CCC)CCCCn2cc(C)nn2)CC1,CHEMBL995087,Ki,5.39,CHEMBL484203,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,58,16,C1=CCC(NCCCCn2ccnn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC#CC1=CCC(N(CCC)CCCCn2cc(C)nn2)CC1,CHEMBL995088,Ki,5.68,CHEMBL484203,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,58,17,C1=CCC(NCCCCn2ccnn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N(C)c1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1,CHEMBL4729778,Ki,7.69,CHEMBL4792709,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),141,100,c1ccc(OCCCN2CCC(c3noc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N(CCC(=O)N[C@@H](CN[C@@H]1CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)Cc1ccc(O)cc1)C[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,CHEMBL3705539,Ki,6.56,CHEMBL3647702,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",108,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NC(=O)CCNCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N(CCCN(C(C)=O)[C@@H]1CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)C[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,CHEMBL3705539,Ki,7.4,CHEMBL3647703,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",108,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCCNCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N(CCCNC[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1)[C@@H]1CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O,CHEMBL3705539,Ki,6.7,CHEMBL3647697,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",108,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCCNCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N(CCCN[C@@H](CN[C@@H]1CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)Cc1ccc(O)cc1)C[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,CHEMBL3705539,Ki,7.85,CHEMBL3647704,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",108,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NCCCNCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N(CCCN[C@@H]1CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC1=O)C[C@@H]1C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,CHEMBL3705539,Ki,7.33,CHEMBL3647706,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",108,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCCNCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N(Cc1ccc([C@H]2CN(C)CCc3cc(Cl)c(O)cc32)cc1)C1CCC1,CHEMBL1073809,Ki,6.8,CHEMBL596824,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,67,102,c1ccc2c(c1)CCNCC2c1ccc(CNC2CCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N1CCC(C)c2c(C)ccc(CCN3CCN(c4noc5ccccc45)CC3)c21,CHEMBL872392,Ki,7.77,CHEMBL197663,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,c1cc2c(c(CCN3CCN(c4noc5ccccc45)CC3)c1)NCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N1CCC(C)c2c(C)ccc(CCN3CCN(c4nsc5ccccc45)CC3)c21,CHEMBL872392,Ki,7.92,CHEMBL197990,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,c1cc2c(c(CCN3CCN(c4nsc5ccccc45)CC3)c1)NCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N1CCC(C)c2cc(F)cc(CCN3CCN(c4noc5ccccc45)CC3)c21,CHEMBL872392,Ki,7.54,CHEMBL370659,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,c1cc2c(c(CCN3CCN(c4noc5ccccc45)CC3)c1)NCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N1CCC(C)c2cc(F)cc(CCN3CCN(c4nsc5ccccc45)CC3)c21,CHEMBL872392,Ki,7.75,CHEMBL372811,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,c1cc2c(c(CCN3CCN(c4nsc5ccccc45)CC3)c1)NCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N1CCC(C)c2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c21,CHEMBL872392,Ki,7.77,CHEMBL369913,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,c1cc2c(c(CCN3CCN(c4nsc5ccccc45)CC3)c1)NCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N1CCC(c2ccccc2)c2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c21,CHEMBL872392,Ki,7.92,CHEMBL439680,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,c1ccc(C2CCNc3c(CCN4CCN(c5nsc6ccccc56)CC4)cccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N1CCN([C@H]2CCC[C@@H](NC(=O)c3cc4c(F)ccc(C)c4[nH]3)C2)CC1,CHEMBL5125561,IC50,4.89,CHEMBL5095235,2022,CHEMBL5120931,ACS Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin),153,104,O=C(NC1CCCC(N2CCNCC2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)NC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,7.08,CHEMBL246021,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,50,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)NC1CCC(c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)CC1,CHEMBL3855278,Ki,6.34,CHEMBL3912801,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,114,105,c1ccc(C2CC23CCN(CCCSc2nnc(C4CCCCC4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21,CHEMBL945767,Ki,7.82,CHEMBL252030,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,58,106,c1ccc2c(N3CCN(CCc4ccc5c(c4)CCC5)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21,CHEMBL945767,Ki,7.66,CHEMBL252818,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,58,106,c1ccc2c(N3CCN(CCc4ccc5c(c4)CCC5)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)NCC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,5.7,CHEMBL399601,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,50,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)NCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL670172,Ki,5.8,CHEMBL21252,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)NCc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1,CHEMBL4729778,Ki,5.8,CHEMBL4764639,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),141,100,c1ccc(OCCCN2CCC(c3noc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2,CHEMBL1261591,Ki,8.15,CHEMBL1259144,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,67,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2,CHEMBL1261591,Ki,8.48,CHEMBL1259174,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,67,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2,CHEMBL1261591,Ki,7.57,CHEMBL1259173,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,67,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1,CHEMBL1261591,Ki,8.51,CHEMBL1259187,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,67,108,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@@H]1CC2(CCN(Cc3ccc4[nH]c5ccc(Cl)cc5c4c3)CC2)c2ccccc21,CHEMBL1936809,IC50,6.3,CHEMBL1934127,2012,CHEMBL1932960,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,80,109,c1ccc2c(c1)CCC21CCN(Cc2ccc3[nH]c4ccccc4c3c2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@@H]1CC2(CCN(Cc3ccc4c(c3)c3ccccc3n4C(N)=O)CC2)c2ccccc21,CHEMBL1936809,IC50,5.82,CHEMBL1934130,2012,CHEMBL1932960,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,80,109,c1ccc2c(c1)CCC21CCN(Cc2ccc3[nH]c4ccccc4c3c2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@@H]1c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1,CHEMBL670677,Ki,5.44,CHEMBL282375,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,20,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3ccc(F)c4occc34)CC2)CC1,CHEMBL3705383,Ki,6.39,CHEMBL3695417,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,54,c1cc(C2CCN(CCC3CCCCC3)CC2)c2ccoc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.53,CHEMBL3695358,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.6,CHEMBL3664814,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1,CHEMBL3705383,Ki,6.73,CHEMBL3695354,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,54,c1cc(C2CCN(CCC3CCCCC3)CC2)c2ccoc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.3,CHEMBL3676846,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.17,CHEMBL3697951,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",96,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1,CHEMBL671651,Ki,8.0,CHEMBL78916,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,9,113,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nc(C)cc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.04,CHEMBL3642777,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nc(C)cc4occc34)CC2)CC1,CHEMBL3705135,Ki,6.6,CHEMBL3642773,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3ncc(C)c4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.64,CHEMBL3642784,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3ncc(C)c4occc34)CC2)CC1,CHEMBL3705135,Ki,5.83,CHEMBL3642780,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.11,CHEMBL3642709,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,6.31,CHEMBL3639415,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1,CHEMBL3705135,Ki,6.92,CHEMBL3642693,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,c1cc2sccc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,7.6,CHEMBL3973487,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,114,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(C#N)cc3C2)CC1,CHEMBL3089794,Ki,7.63,CHEMBL3085819,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,CHEMBL3089794,Ki,5.22,CHEMBL3088210,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)N[C@H]1c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1,CHEMBL670677,Ki,5.1,CHEMBL27247,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,20,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,8.47,CHEMBL162768,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,33,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1C,CHEMBL3887359,Ki,7.14,CHEMBL3899117,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",108,117,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(C(=O)CCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL4815619,Ki,5.96,CHEMBL4875079,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,146,118,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL4815619,Ki,5.71,CHEMBL4859988,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,146,118,c1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(CCN(C)CC2Cc3ccc4c(ccn4S(=O)(=O)c4ccccc4)c32)cc1,CHEMBL3872136,Ki,6.6,CHEMBL3910287,2017,CHEMBL3871306,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,123,119,O=S(=O)(c1ccccc1)n1ccc2c3c(ccc21)CC3CNCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(CCN2CC3COc4ccc(C#N)cc4C3C2)cc1,CHEMBL670398,Ki,7.4,CHEMBL61565,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,16,3,c1ccc(CCN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(CCN2C[C@@H]3COc4ccc(C#N)cc4[C@H]3C2)cc1,CHEMBL670398,Ki,7.5,CHEMBL418671,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,16,3,c1ccc(CCN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(CCN2C[C@H]3COc4ccc(C#N)cc4[C@@H]3C2)cc1,CHEMBL670398,Ki,7.4,CHEMBL62823,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,16,3,c1ccc(CCN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(CN2CC3COc4ccc(C#N)cc4C3C2)cc1,CHEMBL670398,Ki,7.6,CHEMBL65071,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,16,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(CN2C[C@@H]3COc4ccc(C#N)cc4[C@H]3C2)cc1,CHEMBL670398,Ki,7.9,CHEMBL62416,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,16,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(CN2C[C@H]3COc4ccc(C#N)cc4[C@@H]3C2)cc1,CHEMBL670398,Ki,7.5,CHEMBL413275,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,16,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(OCC(O)CN2CCC(c3noc4cc(F)ccc34)CC2)cc1,CHEMBL4729778,Ki,6.92,CHEMBL4799934,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),141,100,c1ccc(OCCCN2CCC(c3noc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1,CHEMBL4729778,Ki,5.94,CHEMBL4794963,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),141,100,c1ccc(OCCCCN2CCC(c3noc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1,CHEMBL4729778,Ki,8.68,CHEMBL4784373,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),141,100,c1ccc(OCCCN2CCC(c3noc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1C,CHEMBL4729778,Ki,6.82,CHEMBL4760689,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),141,100,c1ccc(OCCCN2CCC(c3noc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)cc1F,CHEMBL4729778,Ki,6.83,CHEMBL4790699,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),141,100,c1ccc(OCCCN2CCC(c3noc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(OCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL4729778,Ki,6.78,CHEMBL4779364,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),141,100,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(OCCCN2CCN(c3cccc4ccsc34)CC2)cc1,CHEMBL4729778,Ki,7.79,CHEMBL4764692,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),141,100,c1ccc(OCCCN2CCN(c3cccc4ccsc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(OCCCN2CCN(c3ncccn3)CC2)cc1,CHEMBL4729778,Ki,6.3,CHEMBL4798631,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),141,100,c1ccc(OCCCN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(OCCCN2CCN(c3nsc4ccccc34)CC2)cc1,CHEMBL4729778,Ki,7.1,CHEMBL4777055,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),141,100,c1ccc(OCCCN2CCN(c3nsc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1,CHEMBL670394,Ki,6.02,CHEMBL161899,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,13,120,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(C#N)cc4CC3)CC2)c1,CHEMBL674940,Ki,6.3,CHEMBL313255,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,21,121,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(C#N)cc4CC3)CC2)c1F,CHEMBL674940,Ki,6.3,CHEMBL86183,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,21,121,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1cccc(C2CCN(CCCC(=O)c3ccc(C)c(C)c3)CC2)c1,CHEMBL894444,Ki,5.21,CHEMBL244004,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,50,122,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1cccc(C2CCN(CCCC(=O)c3ccc(Cl)cc3)CC2)c1,CHEMBL894444,Ki,5.85,CHEMBL243794,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,50,122,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1cccc(CCN2CCN(c3cccc4nc(C)ccc34)CC2)c1,CHEMBL1635455,Ki,6.4,CHEMBL1632206,2010,CHEMBL1629528,J Med Chem,Scientific Literature,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,67,123,c1ccc(CCN2CCN(c3cccc4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL3806800,IC50,7.01,CHEMBL3805600,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,114,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)Nc1nc(C)c(-c2ccc3ccn(S(=O)(=O)c4ccccc4)c3c2)[nH]1,CHEMBL4354013,Ki,5.28,CHEMBL4469147,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,133,125,O=S(=O)(c1ccccc1)n1ccc2ccc(-c3cnc[nH]3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)OC(CCNC(=O)c1ccc(-c2ccccn2)cc1)CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL895648,Ki,6.87,CHEMBL242434,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,50,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.35,CHEMBL3318845,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,96,127,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.35,CHEMBL3318845,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,96,128,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)OC1CCCc2ccc(/N=C/N3CCc4ccccc4C3)cc21,CHEMBL886705,Ki,5.62,CHEMBL241281,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,50,129,C(=Nc1ccc2c(c1)CCCC2)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)OC1CCc2ccc(/N=C/N(C)Cc3ccccc3)cc21,CHEMBL886705,Ki,5.8,CHEMBL240025,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,50,129,C(=Nc1ccc2c(c1)CCC2)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)OC1CCc2ccc(/N=C/N3CCc4ccccc4C3)cc21,CHEMBL886705,Ki,5.77,CHEMBL241103,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,50,129,C(=Nc1ccc2c(c1)CCC2)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)O[C@@H]1[C@@H]2C[C@H]([C@@H]1OC(C)=O)[C@H]1C(=O)N(CCCCN3CCN(c4cccc5sccc45)CC3)C(=O)[C@@H]21,CHEMBL4254801,IC50,7.35,CHEMBL4290309,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,129,130,O=C1C2C3CCC(C3)C2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1ccc(-c2ccc(C(=O)NCCCCN3CCc4ccc(OS(=O)(=O)C(F)(F)F)cc4C3)cc2)cc1,CHEMBL672227,Ki,6.7,CHEMBL367129,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,16,131,O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1ccc(-c2nnc(SCCCN3CCOC(c4ccc(C(F)(F)F)cc4)C3)n2C)cc1,CHEMBL3768209,Ki,4.7,CHEMBL3765267,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,114,132,c1ccc(-c2nnc(SCCCN3CCOC(c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1ccc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)cc1,CHEMBL3855278,Ki,6.35,CHEMBL3979523,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,114,105,c1ccc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1ccc(/C=C/C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)cc1,CHEMBL672227,Ki,6.6,CHEMBL293347,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,16,131,O=C(C=Cc1ccccc1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1ccc(C(=O)Nc2ccc(CCN3CC4COc5ccc(C#N)cc5C4C3)cc2)cc1,CHEMBL670398,Ki,7.7,CHEMBL434403,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,16,3,O=C(Nc1ccc(CCN2CC3COc4ccccc4C3C2)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,6.52,CHEMBL108698,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1ccc2c(c1)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)CC2=O,CHEMBL3106891,Ki,7.49,CHEMBL3102875,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,96,134,O=C1CC(CN2CCC(C(=O)c3ccccc3)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1ccc2c(c1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O,CHEMBL3106891,Ki,7.3,CHEMBL3104516,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,96,134,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1ccc2c(c1O)-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670885,Ki,5.56,CHEMBL326159,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,6,135,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1cccc(/C=C/C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)c1,CHEMBL672227,Ki,6.4,CHEMBL52135,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,16,131,O=C(C=Cc1ccccc1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(C#N)cc4CC3)CC2)c1,CHEMBL674940,Ki,6.7,CHEMBL419487,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,21,121,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1,CHEMBL925073,IC50,6.0,CHEMBL250689,2007,CHEMBL1140623,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,50,136,O=C(Nc1ccccc1)NC1CCCCC1CN1CCCC(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670881,Ki,6.51,CHEMBL333134,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride fromd human Dopamine receptor D2A expressed in LtK- cells,6,137,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1,CHEMBL894060,Ki,7.17,CHEMBL389718,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,50,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C,CHEMBL925073,IC50,6.19,CHEMBL249854,2007,CHEMBL1140623,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,50,136,O=C(Nc1nccs1)NC1CNCCC1CN1CCCC(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1,CHEMBL5442215,Ki,5.05,CHEMBL1200618,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,c1ccc(CCCCN2CCC(C(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)N1CCC(NCCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4711026,Ki,5.22,CHEMBL4765081,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,141,140,c1ccc(C(SCCNC2CCNCC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)NCCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL670172,Ki,6.4,CHEMBL278288,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)NCCCCN1CCN(c2ccc(Br)cc2)CC1,CHEMBL670172,Ki,5.8,CHEMBL277669,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)NCCCCN1CCN(c2ccc(C(F)(F)F)cc2)CC1,CHEMBL670172,Ki,5.4,CHEMBL21059,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)NCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL670172,Ki,5.6,CHEMBL20493,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)NCCCCN1CCN(c2ccc(F)cc2)CC1,CHEMBL670172,Ki,5.7,CHEMBL277937,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)NCCCCN1CCN(c2cccc(Cl)c2)CC1,CHEMBL670172,Ki,6.6,CHEMBL20729,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)NCCCCN1CCN(c2ccccc2)CC1,CHEMBL670172,Ki,6.1,CHEMBL21035,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)NCCCCN1CCN(c2ccccc2Cl)CC1,CHEMBL670172,Ki,7.2,CHEMBL283142,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)NCCCCN1CCN2c3ccc(Cl)cc3CCC2C1,CHEMBL670172,Ki,6.4,CHEMBL20204,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc2c(c1)CCC1CNCCN21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)NCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL670172,Ki,5.6,CHEMBL282008,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.42,CHEMBL3695411,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.42,CHEMBL3676873,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.28,CHEMBL3642747,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)C1CCC(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)CC1,CHEMBL3706129,Ki,6.46,CHEMBL3676922,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.4,CHEMBL3695412,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.28,CHEMBL3676885,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.35,CHEMBL3642749,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)CNC(=O)NCCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1,CHEMBL862319,Ki,7.04,CHEMBL381514,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,c1cc(N2CCNCC2)ncn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)N1C=CN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1=O,CHEMBL5236927,IC50,5.76,CHEMBL5290330,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,146,142,O=C1CN(C(=O)CCCN2CCN(c3ccccc3)CC2)C=CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)NC(=O)C1C(=O)NCCN1C(=O)CCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL5236927,IC50,8.42,CHEMBL5266508,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,146,142,O=C1CN(C(=O)CCCN2CCN(c3ccccc3)CC2)CCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)NC(=O)Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2cc(Br)c(Br)cc21,CHEMBL5236927,IC50,6.35,CHEMBL5282604,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,146,142,c1ccc(N2CCN(CCCc3nc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)NC(=O)Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2ccccc21,CHEMBL5236927,IC50,6.43,CHEMBL5273880,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,146,142,c1ccc(N2CCN(CCCc3nc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)NC(=O)NCCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1,CHEMBL862319,Ki,7.18,CHEMBL205264,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,c1cc(N2CCNCC2)ncn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)NC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,CHEMBL3089794,Ki,6.61,CHEMBL3088215,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12,CHEMBL4121476,IC50,8.74,CHEMBL4128926,2018,CHEMBL4118122,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]7-OH-DPAT from human recombinant dopamine D2S receptor after 60 mins by scintillation counting analysis,129,143,O=C(NC1CCC1)c1nc(CC2CCCCC2)c(-c2cccc3ccccc23)s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1,CHEMBL4880035,Ki,5.905,CHEMBL4558518,2021,CHEMBL4507288,,SGC Frankfurt - Donated Chemical Probes,GPCRScan assay: inhibition of D2,146,144,O=S(=O)(c1ccccc1)C1(c2ccccc2)CCC(NCC2CCCN2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N1CCCC1CNC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1,CHEMBL5213926,Ki,5.91,CHEMBL4558518,2023,CHEMBL5212743,,EUbOPEN Chemogenomic Library Literature Data,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000741a DRD2,155,145,O=S(=O)(c1ccccc1)C1(c2ccccc2)CCC(NCC2CCCN2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)NCCCCCCN1CCC(O)(c2ccc(Cl)cc2)CC1,CHEMBL3300162,Ki,6.045,CHEMBL3299092,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,96,146,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)NCCCCCN1CCC(O)(c2ccc(Cl)cc2)CC1,CHEMBL3300162,Ki,5.69,CHEMBL3299091,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,96,146,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)NCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL3300162,Ki,7.37,CHEMBL3298829,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,96,146,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)NCCCCN1CCC(O)(c2ccc(Cl)cc2)CC1,CHEMBL3300162,Ki,5.68,CHEMBL3298825,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,96,146,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)NCCCN1CCC(O)(c2ccc(Cl)cc2)CC1,CHEMBL3300162,Ki,5.87,CHEMBL3298757,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,96,146,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)NCCN1CCC(O)(c2ccc(Cl)cc2)CC1,CHEMBL3300162,Ki,5.56,CHEMBL3298756,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,96,146,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)NC[C@H]1CC[C@H](CN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3089794,Ki,6.83,CHEMBL3085823,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc(N2CCN(CC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)NC[C@H]1CC[C@H](CN2CCc3ccccc3C2)CC1,CHEMBL3089794,Ki,5.94,CHEMBL3085813,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc2c(c1)CCN(CC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N[C@H]1CC[C@@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3089794,Ki,7.48,CHEMBL3085824,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N[C@H]1CC[C@@H](CCN2CCc3ccccc3C2)CC1,CHEMBL3089794,Ki,5.97,CHEMBL3085814,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3089794,Ki,7.98,CHEMBL3085820,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc(N2CCCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3089794,Ki,7.4,CHEMBL3085821,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5381008,Ki,8.09,CHEMBL3085821,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,155,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(C#N)cc3C2)CC1,CHEMBL3089794,Ki,5.65,CHEMBL3085818,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccc([N+](=O)[O-])cc3C2)CC1,CHEMBL3089794,Ki,6.42,CHEMBL3085817,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,CHEMBL3089794,Ki,6.13,CHEMBL3088209,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3089794,Ki,6.51,CHEMBL3085822,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc(N2CCN(CC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)N[C@H]1CC[C@H](CN2CCc3ccccc3C2)CC1,CHEMBL3089794,Ki,6.45,CHEMBL3085812,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc2c(c1)CCN(CC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)OC(=O)Nc1ccc(CCN2CCc3ccccc3C2)cc1,CHEMBL3089794,Ki,6.26,CHEMBL3085815,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,87,115,c1ccc(CCN2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)Oc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1,CHEMBL3706129,Ki,6.77,CHEMBL3676916,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",96,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)Oc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)cc1,CHEMBL3705135,Ki,5.5,CHEMBL3642812,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL1663583,IC50,7.92,CHEMBL1255588,2010,CHEMBL1649335,Bioorg Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,67,148,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL1817460,Ki,9.3,CHEMBL1255588,2011,CHEMBL1811872,J Med Chem,Scientific Literature,Displacement of [3H]methyl-spiperone from human dopamine D2s receptor,76,149,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL2395588,IC50,8.85,CHEMBL1255588,2013,CHEMBL2390917,Bioorg Med Chem,Scientific Literature,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,87,150,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL2395699,IC50,8.66,CHEMBL1255588,2013,CHEMBL2390830,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,87,151,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL2395699,Ki,9.13,CHEMBL1255588,2013,CHEMBL2390830,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,87,151,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL3265956,Ki,9.43,CHEMBL1255588,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,96,82,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL3270692,Ki,8.59,CHEMBL1255588,2014,CHEMBL3259695,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,97,152,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL670395,Ki,9.22,CHEMBL1255588,1997,CHEMBL1129926,Bioorg Med Chem Lett,Scientific Literature,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,9,153,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL881984,IC50,8.05,CHEMBL1255588,2005,CHEMBL1140374,J Med Chem,Scientific Literature,Percent inhibition against Dopamine receptor D2 at 1 uM,39,154,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL953137,IC50,8.06,CHEMBL1255588,2008,CHEMBL1140203,J Med Chem,Scientific Literature,Displacement of radiolabeled (+)butaclamol from human dopamine D2S receptor,58,155,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL953137,Ki,8.54,CHEMBL1255588,2008,CHEMBL1140203,J Med Chem,Scientific Literature,Displacement of radiolabeled (+)butaclamol from human dopamine D2S receptor,58,155,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1,CHEMBL982014,IC50,7.82,CHEMBL1255588,2008,CHEMBL1155111,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,58,156,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1,CHEMBL3876354,IC50,8.96,CHEMBL3885419,2017,CHEMBL3875185,Bioorg Med Chem,Scientific Literature,Displacement of [3H]methyl-spiperone from human recombinant dopamine D2S receptor expressed in HEK293 cells measured after 60 mins by scintillation counting method,123,157,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1,CHEMBL3295410,IC50,8.3,CHEMBL8514,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Antagonist activity at human recombinant at D2S receptor assessed as inhibition of dopamine-induced cAMP accumulation,97,158,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1,CHEMBL3297335,Ki,10.4,CHEMBL8514,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human recombinant D2S receptor expressed in HEK293 cells,97,159,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1,CHEMBL3413553,Ki,10.4,CHEMBL8514,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2S receptor expressed in HEK293 cells,108,160,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1,CHEMBL3779713,IC50,8.96,CHEMBL8514,2016,CHEMBL3774372,Bioorg Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human recombinant Dopamine D2S receptor expressed in HEK293 cells,114,161,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1,CHEMBL4001156,IC50,9.09,CHEMBL8514,2017,CHEMBL4000185,J Med Chem,Scientific Literature,Displacement of [3H]methyl-spiperone from human recombinant D2S receptor in HEK293 cells after 60 mins by scintillation counting,123,162,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1,CHEMBL4001156,Ki,9.57,CHEMBL8514,2017,CHEMBL4000185,J Med Chem,Scientific Literature,Displacement of [3H]methyl-spiperone from human recombinant D2S receptor in HEK293 cells after 60 mins by scintillation counting,123,162,c1ccc2c(c1)CCc1cccc3c1C2CN1CCCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(C)(C)C)c1,CHEMBL3379351,Ki,5.88,CHEMBL3322997,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)nc(C(C)(C)C)n1,CHEMBL3379351,Ki,6.44,CHEMBL3323009,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1,CHEMBL671744,IC50,7.21,CHEMBL305660,1995,CHEMBL1128457,J Med Chem,Scientific Literature,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,4,164,O=C(CCCN1CCC(OC(c2ccccc2)c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1,CHEMBL3706129,Ki,5.95,CHEMBL3676905,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)cc1,CHEMBL3705135,Ki,5.78,CHEMBL3642807,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",87,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1ccc(CN2CCC(C3CCc4ccccc4C3=O)CC2)cc1,CHEMBL673013,Ki,6.39,CHEMBL124411,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,3,165,O=C1c2ccccc2CCC1C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1ccc(CN2CCC3(CCc4ccccc4C3=O)CC2)cc1,CHEMBL673013,Ki,6.41,CHEMBL542462,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,3,165,O=C1c2ccccc2CCC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1ccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)cc1,CHEMBL1057875,Ki,6.2,CHEMBL564298,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,62,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1,CHEMBL670394,Ki,5.76,CHEMBL349904,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,13,120,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1ccc(S(=O)(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1,CHEMBL3706129,Ki,7.16,CHEMBL3676933,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,55,O=S(=O)(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1ccccc1OCCN1CCC(N(CC2CC2)S(=O)(=O)c2ccc(F)cc2)CC1,CHEMBL3750144,Ki,6.8,CHEMBL3746083,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,114,167,O=S(=O)(c1ccccc1)N(CC1CC1)C1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)n1,CHEMBL865866,Ki,6.67,CHEMBL202175,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1ncccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(C2CC2)cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)n1,CHEMBL3379351,Ki,6.72,CHEMBL3323010,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2cc(C3CC3)ncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(C/C=C/CN3C(=O)CCc4ccccc43)CC2)cc(C(F)(F)F)n1,CHEMBL853595,Ki,6.59,CHEMBL201557,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,53,O=C1CCc2ccccc2N1CC=CCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCCC(=O)NCc3ccccc3)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.76,CHEMBL424690,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=C(CCCCCN1CCN(c2ccncn2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CC(=O)c4ccccc43)CC2)cc(C(F)(F)F)n1,CHEMBL853595,Ki,6.85,CHEMBL201386,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,53,O=C1CC(=O)N(CCCCN2CCN(c3ccncn3)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CCC(=O)c4ccccc43)CC2)cc(C(F)(F)F)n1,CHEMBL853595,Ki,6.61,CHEMBL201232,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,53,O=C1CCC(=O)N(CCCCN2CCN(c3ccncn3)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CCCc4c(O)cccc43)CC2)cc(C(F)(F)F)n1,CHEMBL853595,Ki,7.03,CHEMBL201318,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,53,O=C1CCCc2ccccc2N1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CCCc4ccccc43)CC2)cc(C(F)(F)F)n1,CHEMBL853595,Ki,6.93,CHEMBL380597,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,53,O=C1CCCc2ccccc2N1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CCSc4ccccc43)CC2)cc(C(F)(F)F)n1,CHEMBL853595,Ki,7.08,CHEMBL370191,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,53,O=C1CCSc2ccccc2N1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)CCc4ccccc43)CC2)cc(C(F)(F)F)n1,CHEMBL853595,Ki,6.9,CHEMBL383205,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,53,O=C1CCc2ccccc2N1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCN3C(=O)COc4ccccc43)CC2)cc(C(F)(F)F)n1,CHEMBL853595,Ki,6.45,CHEMBL382591,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,53,O=C1COc2ccccc2N1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCN3CCC(=O)CCC3=O)CC2)cc(C(F)(F)F)n1,CHEMBL853595,Ki,7.19,CHEMBL201481,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,53,O=C1CCC(=O)N(CCCCN2CCN(c3ccncn3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)C3CCN(Cc4ccccc4)CC3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,6.47,CHEMBL3323116,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)C3CCN(c4ccccc4)CC3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,6.09,CHEMBL3323115,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)C1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)CCc3ccccc3)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.61,CHEMBL207871,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=C(CCc1ccccc1)NCCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)NCC3CCCCC3)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.8,CHEMBL202857,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=C(NCCCCN1CCN(c2ccncn2)CC1)NCC1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)NCCc3ccccc3)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.63,CHEMBL377299,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=C(NCCCCN1CCN(c2ccncn2)CC1)NCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)NCc3ccccc3)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.86,CHEMBL424678,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=C(NCCCCN1CCN(c2ccncn2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)Nc3ccccc3)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,7.23,CHEMBL205497,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=C(NCCCCN1CCN(c2ccncn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)[C@H]3CC[C@H](c4ccccc4)CC3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,5.82,CHEMBL3323117,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)C1CCC(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1,CHEMBL3372144,IC50,6.38,CHEMBL3323012,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,97,169,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,6.04,CHEMBL3323012,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)cc(C(F)(F)F)n1,CHEMBL4054777,Ki,5.4,CHEMBL4096858,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,123,170,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)cc(C(F)(F)F)n1,CHEMBL4054778,Ki,5.57,CHEMBL4096858,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,123,171,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccn4n3)CC2)cc(C(F)(F)F)n1,CHEMBL4054777,Ki,6.37,CHEMBL4085920,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,123,170,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccn4n3)CC2)cc(C(F)(F)F)n1,CHEMBL4054778,Ki,6.7,CHEMBL4085920,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,123,171,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4cccnc4s3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,6.17,CHEMBL3323014,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4c(CO)cccc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,6.03,CHEMBL3323113,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c2ccccc2n1,CHEMBL3379351,Ki,5.84,CHEMBL3323004,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ncnc3ccccc23)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3372144,IC50,6.58,CHEMBL3323011,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,97,169,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3372150,IC50,6.96,CHEMBL3323011,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHO cells assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by dopamine potency shift assay,97,172,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,6.29,CHEMBL3323011,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379354,Ki,6.15,CHEMBL3323011,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from wild type human D2R expressed in HEK293 cell membranes by gamma counting method,97,173,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379897,Ki,6.83,CHEMBL3323011,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from chimeric human D2 receptor possessing extracellular loop II of D3 receptor expressed in HEK293 cell membranes by gamma counting method,97,174,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379904,IC50,5.64,CHEMBL3323011,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,97,175,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4cccnc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3372144,IC50,7.43,CHEMBL3323015,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,97,169,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2cccnc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4cccnc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,6.36,CHEMBL3323015,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2cccnc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4cccnc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379904,IC50,6.69,CHEMBL3323015,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,97,175,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2cccnc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3372144,IC50,7.31,CHEMBL3323016,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,97,169,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccncc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3372150,IC50,7.6,CHEMBL3323016,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHO cells assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by dopamine potency shift assay,97,172,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccncc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,6.35,CHEMBL3323016,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccncc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccncc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379904,IC50,6.38,CHEMBL3323016,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,97,175,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccncc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4nc(Cl)ccc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3372144,IC50,7.66,CHEMBL3323017,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,97,169,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ncccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4nc(Cl)ccc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,6.18,CHEMBL3323017,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ncccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4nc(Cl)ccc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379904,IC50,5.94,CHEMBL3323017,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,97,175,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ncccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3nc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1,CHEMBL3372144,IC50,6.52,CHEMBL3323013,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,97,169,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1nc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3nc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,6.47,CHEMBL3323013,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1nc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3nc4ccccc4[nH]3)CC2)cc(C(F)(F)F)n1,CHEMBL3379904,IC50,6.31,CHEMBL3323013,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,97,175,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1nc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3sc4ncccc4c3N)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,6.32,CHEMBL3323018,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,97,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3c(=O)ccc4ccccc43)CC2)cc(C(F)(F)F)n1,CHEMBL853595,Ki,6.82,CHEMBL201743,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,53,O=c1ccc2ccccc2n1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3cc(C#N)c(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,6.33,CHEMBL201509,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1ccn(CCCCN2CCN(c3ccncn3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3cc(C(F)(F)F)c(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,6.19,CHEMBL382568,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1ccn(CCCCN2CCN(c3ccncn3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3cc(C(F)(F)F)ccc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.4,CHEMBL205498,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=c1ccccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3cc(Cl)c(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,6.66,CHEMBL201240,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1ccn(CCCCN2CCN(c3ccncn3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3cc(Cl)ccc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.89,CHEMBL205238,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=c1ccccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3cc(F)c(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,6.22,CHEMBL202827,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1ccn(CCCCN2CCN(c3ccncn3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(-c4ccccc4)cc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.28,CHEMBL207880,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=c1cc(-c2ccccc2)ccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(-c4ccccc4)nc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.78,CHEMBL200028,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=c1nc(-c2ccccc2)ccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(-c4ccccc4)nc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,6.78,CHEMBL200028,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1nc(-c2ccccc2)ccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.71,CHEMBL383188,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=c1ccn(CCCCN2CCN(c3ccncn3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(=O)[nH]c3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,6.71,CHEMBL383188,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1ccn(CCCCN2CCN(c3ccncn3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(C(F)(F)F)cc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.64,CHEMBL205733,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=c1ccccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(C(F)(F)F)nc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.03,CHEMBL205961,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=c1ncccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(C4CC4)nc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,6.81,CHEMBL202229,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1nc(C2CC2)ccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(C4CCC4)nc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,6.56,CHEMBL202298,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1nc(C2CCC2)ccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(C4CCCCC4)nc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,6.52,CHEMBL199663,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1nc(C2CCCCC2)ccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(N4CCC4)nc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,7.09,CHEMBL199453,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1nc(N2CCC2)ccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(N4CCCCC4)nc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,7.05,CHEMBL201376,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1nc(N2CCCCC2)ccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3ccc(O)cc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,7.59,CHEMBL202670,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=c1ccccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3cccc(C(F)(F)F)c3=O)CC2)cc(C(F)(F)F)n1,CHEMBL862319,Ki,6.39,CHEMBL206528,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=c1ccccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCCn3cccnc3=O)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,6.35,CHEMBL203200,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,O=c1ncccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(C)c1nc(N2CCN(CCCSc3nccc(O)n3)CC2)cc(C(F)(F)F)n1,CHEMBL865866,Ki,6.46,CHEMBL439338,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,44,168,c1cnc(SCCCN2CCN(c3ccncn3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(CCCN1CCCC(c2ccccc2)C1)S(=O)(=O)c1ccccc1,CHEMBL865592,Ki,6.66,CHEMBL204269,2006,CHEMBL1139656,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from the cloned human D2 receptor expressed in CHO cells,44,176,O=S(=O)(CCCCN1CCCC(c2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(CCCN1CCCC(c2cnco2)C1)S(=O)(=O)c1ccccc1,CHEMBL865592,Ki,5.82,CHEMBL379238,2006,CHEMBL1139656,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from the cloned human D2 receptor expressed in CHO cells,44,176,O=S(=O)(CCCCN1CCCC(c2cnco2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(CCCN1CC[C@@H]2CCCC[C@H]2C1)S(=O)(=O)c1ccccc1,CHEMBL865592,Ki,6.05,CHEMBL202780,2006,CHEMBL1139656,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from the cloned human D2 receptor expressed in CHO cells,44,176,O=S(=O)(CCCCN1CCC2CCCCC2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.3,CHEMBL3695391,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.39,CHEMBL3664845,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.27,CHEMBL3676861,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.74,CHEMBL3697974,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",97,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.9,CHEMBL3642800,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.76,CHEMBL3695425,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.55,CHEMBL3664848,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.38,CHEMBL3676879,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.12,CHEMBL3697977,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",97,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.0,CHEMBL3642764,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,6.85,CHEMBL108146,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)=C1c2ccc(Cl)cc2C=C(N2CCN(C)CC2)c2ccccc21,CHEMBL675960,Ki,6.16,CHEMBL328246,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,3,57,C=C1c2ccccc2C=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)=C1c2ccccc2C=C(C2=CCN(C)CC2)c2cc(Cl)ccc21,CHEMBL672525,Ki,6.36,CHEMBL163239,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,4,75,C=C1c2ccccc2C=C(C2=CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)=C1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21,CHEMBL671374,Ki,6.24,CHEMBL94067,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,3,73,C=C1c2ccccc2C=C(C2=CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)=C1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21,CHEMBL672525,Ki,6.24,CHEMBL94067,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,4,75,C=C1c2ccccc2C=C(C2=CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)=C1c2ccccc2C=C(N2CCN(C)CC2)c2ccccc21,CHEMBL675960,Ki,6.54,CHEMBL88870,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,3,57,C=C1c2ccccc2C=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)=CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,7.13,CHEMBL3695437,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)=CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.74,CHEMBL3676898,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)=CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.7,CHEMBL3642757,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21,CHEMBL945767,Ki,7.17,CHEMBL400236,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,58,106,c1ccc2c(N3CCN(CCc4ccc5c(c4)CCC5)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)NCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL670172,Ki,5.7,CHEMBL20114,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)NCc1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2,CHEMBL1261591,Ki,7.92,CHEMBL1259145,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,67,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)NCc1ccc2c(c1)[C@@H](N1CCN(C)CC1)Cc1ccccc1S2,CHEMBL1261591,Ki,8.35,CHEMBL1259190,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,67,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)NCc1ccc2c(c1)[C@H](N1CCN(C)CC1)Cc1ccccc1S2,CHEMBL1261591,Ki,7.51,CHEMBL1259189,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,67,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.54,CHEMBL3695376,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.4,CHEMBL3664836,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.4,CHEMBL3676859,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.87,CHEMBL3697967,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",97,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.15,CHEMBL3642752,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)Nc1cccc(C2CCN(CCCC(=O)c3ccc(Cl)cc3)CC2)c1,CHEMBL894444,Ki,6.21,CHEMBL394569,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,50,122,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(Cl)c(Cl)c4)cc3)CC2)c1,CHEMBL894444,Ki,5.54,CHEMBL389129,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,50,122,c1ccc(Oc2ccc(CN3CCC(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(Cl)cc4)cc3)CC2)c1,CHEMBL894444,Ki,6.96,CHEMBL245010,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,51,122,c1ccc(Oc2ccc(CN3CCC(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)c1,CHEMBL894444,Ki,6.33,CHEMBL245231,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,51,122,c1ccc(Oc2ccc(CN3CCC(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C(=O)Nc1cccc(C2CCN(Cc3ccc(Oc4ccccc4)cc3)CC2)c1,CHEMBL894444,Ki,6.92,CHEMBL389128,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,51,122,c1ccc(Oc2ccc(CN3CCC(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,5.6,CHEMBL321871,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,27,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.67,CHEMBL3695377,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.62,CHEMBL3664837,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.36,CHEMBL3676860,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.88,CHEMBL3697968,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",97,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.18,CHEMBL3642748,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,6.47,CHEMBL104713,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,27,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,5.97,CHEMBL3695428,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.18,CHEMBL3676890,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.89,CHEMBL3642770,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CCN1CCN2c3cccc4[nH]cc(c34)CC2C1,CHEMBL3294601,Ki,7.62,CHEMBL3286574,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,97,178,c1cc2c3c(c[nH]c3c1)CC1CNCCN21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CN1CCN2c3cccc4[nH]cc(c34)CC2C1,CHEMBL3294601,Ki,6.51,CHEMBL3286572,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,97,178,c1cc2c3c(c[nH]c3c1)CC1CNCCN21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CCO4,CHEMBL674942,Ki,5.3,CHEMBL169322,1997,CHEMBL1129892,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,9,179,c1c2c(cc3c1CCC1NCCOC31)OCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)COC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,CHEMBL3089794,Ki,5.28,CHEMBL3088213,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,88,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(C#N)cc3)cc(N3CCN(C)CC3)nc21,CHEMBL3800738,Ki,6.69,CHEMBL3797435,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,114,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(C(F)(F)F)cc3)cc(N3CCN(C)CC3)nc21,CHEMBL3800738,Ki,6.43,CHEMBL3797717,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,114,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(C(F)(F)F)cc3)cc(N3CCNCC3)nc21,CHEMBL3800738,Ki,5.77,CHEMBL3799529,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,114,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(O)cc3)cc(N3CCN(C)CC3)nc21,CHEMBL3800738,Ki,6.97,CHEMBL3800539,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,114,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CS(=O)(=O)n1ccc2c(-c3ccc(OCc4ccccc4)cc3)cc(N3CCN(C)CC3)nc21,CHEMBL3800738,Ki,7.07,CHEMBL3800150,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,114,180,c1ccc(COc2ccc(-c3cc(N4CCNCC4)nc4[nH]ccc34)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CS(=O)(=O)n1ccc2c(-c3ccc4[nH]ccc4c3)cc(N3CCN(C)CC3)nc21,CHEMBL3800738,Ki,6.42,CHEMBL3798478,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,114,180,c1cc2cc(-c3cc(N4CCNCC4)nc4[nH]ccc34)ccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CS(=O)(=O)n1ccc2c(-c3cccc(C(F)(F)F)c3)cc(N3CCN(C)CC3)nc21,CHEMBL3800738,Ki,6.2,CHEMBL3798840,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,114,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CS(=O)(=O)n1ccc2c(-c3ccccc3)cc(N3CCN(C)CC3)nc21,CHEMBL3800738,Ki,6.26,CHEMBL3799638,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,114,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)CS(=O)(=O)n1ccc2c(-c3ccccc3C(F)(F)F)cc(N3CCN(C)CC3)nc21,CHEMBL3800738,Ki,6.95,CHEMBL3799547,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,114,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O,CHEMBL665376,Ki,10.4,CHEMBL317488,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),16,181,C1CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O,CHEMBL665377,Ki,9.89,CHEMBL317488,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,16,182,C1CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O,CHEMBL666180,Ki,10.22,CHEMBL317488,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p (pretreatment with 100 nM of compound),16,183,C1CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O,CHEMBL666181,Ki,7.13,CHEMBL317488,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,16,184,C1CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O,CHEMBL666182,Ki,7.22,CHEMBL317488,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),16,185,C1CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O,CHEMBL666183,Ki,7.165,CHEMBL317488,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,16,186,C1CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(N)=O,CHEMBL670962,Ki,10.05,CHEMBL317488,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,16,187,C1CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,CHEMBL3294602,Ki,7.825,CHEMBL493,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,97,188,O=C(NC1OC2C3CCCN3C(=O)CN2C1=O)C1C=C2c3cccc4[nH]cc(c34)CC2NC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,CHEMBL5346625,Ki,9.21,CHEMBL493,2024,CHEMBL5344475,RSC Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) assessed as inhibition constant,159,189,O=C(NC1OC2C3CCCN3C(=O)CN2C1=O)C1C=C2c3cccc4[nH]cc(c34)CC2NC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12,CHEMBL672313,Ki,8.0,CHEMBL493,1997,CHEMBL1130416,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,9,190,O=C(NC1OC2C3CCCN3C(=O)CN2C1=O)C1C=C2c3cccc4[nH]cc(c34)CC2NC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)C[C@H]1C(=O)N[C@@H](Cc2ccccc2)[C@]2(O)O[C@@](C)(NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)C(=O)N12,CHEMBL672230,Ki,8.5,CHEMBL2112882,2003,CHEMBL1145901,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 in CHO cells using [125I]iodosulpiride,33,191,O=C1CN2C(=O)C(NC(=O)C3C=C4c5cccc6[nH]cc(c56)CC4NC3)OC2C(Cc2ccccc2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1,CHEMBL3706129,Ki,6.54,CHEMBL3676925,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Cn1nc(S(=O)(=O)c2cccc3ccccc23)c2cc(N3CCNCC3)ccc21,CHEMBL1286377,Ki,5.72,CHEMBL1275630,2010,CHEMBL1275334,J Med Chem,Scientific Literature,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,67,192,O=S(=O)(c1cccc2ccccc12)c1n[nH]c2ccc(N3CCNCC3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)N(C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)C(C)C,CHEMBL3872755,Ki,9.14,CHEMBL3900752,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,114,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C(=O)c1ccccc1,CHEMBL4686220,IC50,7.23,CHEMBL4794013,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,141,193,O=C(NCCCN1CCC(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)N(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)C(=O)c1ccccc1,CHEMBL4686220,IC50,6.28,CHEMBL4752859,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,141,193,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)N1CCC[C@@H](c2cccc(C#N)c2)C1,CHEMBL679938,Ki,6.97,CHEMBL93383,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)N1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1,CHEMBL911524,Ki,6.0,CHEMBL379593,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,44,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)N1CCN(CCN2CCN(c3cccc(C#N)c3)C2=O)CC1,CHEMBL1057875,Ki,6.5,CHEMBL571456,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,62,166,O=C1N(CCN2CCNCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)N1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,CHEMBL1057875,Ki,6.7,CHEMBL560715,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,62,166,O=C1N(CCN2CCNCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)N1CCN(CCN2CCN(c3cccc(OC(F)(F)F)c3)C2=O)CC1,CHEMBL1057875,Ki,6.6,CHEMBL549894,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,62,166,O=C1N(CCN2CCNCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)N1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3,CHEMBL670881,Ki,6.0,CHEMBL333725,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride fromd human Dopamine receptor D2A expressed in LtK- cells,6,137,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)NCC(O)c1ccc(O)c(O)c1,CHEMBL3801476,Ki,4.32,CHEMBL434,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,114,195,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)NCC(O)c1ccc(O)c(O)c1,CHEMBL3801477,Ki,4.92,CHEMBL434,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,114,196,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)N[C@@H]1CCc2c(F)cccc2C1,CHEMBL672183,Ki,5.61,CHEMBL342630,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,6,197,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)N[C@@H]1CCc2c(F)cccc2C1,CHEMBL672184,Ki,5.23,CHEMBL342630,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,6,198,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Nc1cc2c(cc1NS(=O)(=O)c1ccc(-c3ccc(Cl)cc3)cc1)CCN(C)CC2,CHEMBL905981,Ki,7.3,CHEMBL231350,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,51,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)OC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,CHEMBL3089794,Ki,5.83,CHEMBL3088212,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,88,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1cc2c(cc1NS(=O)(=O)c1ccc(-c3ccc(Cl)cc3)cc1)CCN(C)CC2,CHEMBL905981,Ki,8.2,CHEMBL231349,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,51,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(Cc2cc[nH]n2)CC3)cc1,CHEMBL1108513,Ki,6.2,CHEMBL1078208,2009,CHEMBL1154336,Bioorg Med Chem Lett,Scientific Literature,Agonist activity at dopamine D2 receptor,62,200,O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccc2[nH]cc(C3=CCN(Cc4ccccc4)CC3)c2c1,CHEMBL4368222,Ki,6.49,CHEMBL4457881,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,133,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccc2[nH]cc(C3=CCN(Cc4cccs4)CC3)c2c1,CHEMBL4368222,Ki,6.33,CHEMBL4558444,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,133,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2cccs2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,CHEMBL1057875,Ki,6.5,CHEMBL559386,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,62,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC3,CHEMBL5385535,Ki,7.05,CHEMBL5435325,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,155,201,O=c1ccc2ccc(OCCCCN3CCc4c(oc5ccccc45)C3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1,CHEMBL889238,Ki,7.1,CHEMBL390184,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,51,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1C1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)c(F)c3)CC2)CC1,CHEMBL889238,Ki,7.1,CHEMBL229084,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,51,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21,CHEMBL3776608,Ki,6.6,CHEMBL3775598,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,114,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL3887359,Ki,9.06,CHEMBL3952761,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",108,117,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,CHEMBL3887359,Ki,8.89,CHEMBL3978288,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",108,117,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,CHEMBL3887359,Ki,9.03,CHEMBL3921903,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",108,117,O=c1ccc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)NCc3cccc(F)c3)CC2)CC1,CHEMBL948052,Ki,6.83,CHEMBL256041,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,58,204,O=C(NCc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cc(Cl)cc3Cl)CC2)CC1,CHEMBL948052,Ki,7.59,CHEMBL256040,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,58,204,O=C(Nc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(Cl)cccc3Cl)CC2)CC1,CHEMBL948052,Ki,7.795,CHEMBL256597,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,58,204,O=C(Nc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3c(F)cccc3F)CC2)CC1,CHEMBL948052,Ki,8.14,CHEMBL270589,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,58,204,O=C(Nc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cc(F)ccc3F)CC2)CC1,CHEMBL948052,Ki,8.02,CHEMBL257097,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,58,204,O=C(Nc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)c(F)c3)CC2)CC1,CHEMBL948052,Ki,7.085,CHEMBL256804,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,58,204,O=C(Nc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccc(F)cc3F)CC2)CC1,CHEMBL948052,Ki,8.305,CHEMBL403280,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,58,204,O=C(Nc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3cccc(Cl)c3)CC2)CC1,CHEMBL948052,Ki,7.025,CHEMBL257077,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,58,204,O=C(Nc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(C2CCC(NC(=O)Nc3ccccc3Cl)CC2)CC1,CHEMBL948052,Ki,6.77,CHEMBL257098,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,58,204,O=C(Nc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL2169117,Ki,8.51,CHEMBL2165121,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,80,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1,CHEMBL672575,Ki,7.6,CHEMBL309106,2000,CHEMBL1133729,J Med Chem,Scientific Literature,Binding affinity towards recombinant human Dopamine receptor D2S was determined using [3H]spiperone as radioligand,21,206,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)C(=O)N(c1ccccc1)C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(C[C@@H](O)CNC(=O)c2ccc3c(c2)C(=O)N(c2ccc(N(C)C)cc2)C3=O)CC1,CHEMBL672912,Ki,7.64,CHEMBL309106,2000,CHEMBL1133729,J Med Chem,Scientific Literature,Binding affinity towards recombinant human Dopamine receptor D2L was determined using [3H]spiperone as radioligand,21,207,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)C(=O)N(c1ccccc1)C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN(Cc2cccc(C(=O)N3CCCCC3)c2)CC1,CHEMBL670744,Ki,8.66,CHEMBL10085,1997,CHEMBL1129884,Bioorg Med Chem Lett,Scientific Literature,Compound was measured in vivo for its binding affinity at Dopamine receptor D2 using [3H]spiperone as radioligand.,9,208,O=C(c1cccc(CN2CCN(c3ccccc3)CC2)c1)N1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1,CHEMBL894519,Ki,7.62,CHEMBL234649,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(Cc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cc(Cl)ccc3F)CC2)CC1,CHEMBL894519,Ki,6.45,CHEMBL394139,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1,CHEMBL894519,Ki,7.38,CHEMBL391035,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1,CHEMBL894519,Ki,6.89,CHEMBL233410,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1,CHEMBL894519,Ki,7.16,CHEMBL234874,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1,CHEMBL894519,Ki,6.37,CHEMBL236830,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1,CHEMBL894519,Ki,6.91,CHEMBL236617,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1,CHEMBL894519,Ki,6.93,CHEMBL233592,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1,CHEMBL894519,Ki,6.7,CHEMBL233407,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1,CHEMBL894519,Ki,7.13,CHEMBL232779,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3)CC2)CC1,CHEMBL894519,Ki,6.72,CHEMBL391107,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1,CHEMBL894519,Ki,7.26,CHEMBL234679,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3F)CC2)CC1,CHEMBL894519,Ki,6.83,CHEMBL399195,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1,CHEMBL894519,Ki,7.29,CHEMBL232592,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cccnc3)CC2)CC1,CHEMBL894519,Ki,7.82,CHEMBL234854,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1,CHEMBL894519,Ki,7.21,CHEMBL232609,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)Cc3ccccc3)CC2)CC1,CHEMBL894519,Ki,7.15,CHEMBL234650,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(Cc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3Cl)CC2)CC1,CHEMBL894519,Ki,7.12,CHEMBL393104,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(Cl)cc3F)CC2)CC1,CHEMBL894519,Ki,7.38,CHEMBL233582,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(F)cc3)CC2)CC1,CHEMBL894519,Ki,7.57,CHEMBL428197,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)CC2)CC1,CHEMBL894519,Ki,7.24,CHEMBL392377,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccc(S(C)(=O)=O)cc3)CC2)CC1,CHEMBL894519,Ki,7.85,CHEMBL236618,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)CC1,CHEMBL894519,Ki,7.41,CHEMBL233416,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(Cl)c3F)CC2)CC1,CHEMBL894519,Ki,6.57,CHEMBL393105,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccc(F)c3)CC2)CC1,CHEMBL894519,Ki,7.19,CHEMBL232780,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3)CC2)CC1,CHEMBL894519,Ki,7.47,CHEMBL234669,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3C#N)CC2)CC1,CHEMBL894519,Ki,8.62,CHEMBL234680,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3F)CC2)CC1,CHEMBL894519,Ki,7.51,CHEMBL234681,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3ccccc3[N+](=O)[O-])CC2)CC1,CHEMBL894519,Ki,7.07,CHEMBL232593,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cccnc3)CC2)CC1,CHEMBL894519,Ki,7.26,CHEMBL391016,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1N1CCN([C@H]2CC[C@H](NS(=O)(=O)c3cnc(Cl)c(Br)c3)CC2)CC1,CHEMBL894519,Ki,7.1,CHEMBL233790,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,51,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1OCCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,CHEMBL3413541,Ki,6.92,CHEMBL3409259,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,108,210,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCOc4ccccc4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,CHEMBL3413541,Ki,6.96,CHEMBL3409258,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,108,210,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccccc4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1cccnc1N(C)C1CCN(Cc2ccc(I)cc2)CC1,CHEMBL5235437,Ki,6.25,CHEMBL4096543,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2 receptor expressed in Sf9 cells assessed as inhibition constant,146,211,c1ccc(CN2CCC(Nc3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)Oc1cccnc1N(C)C1CCN(Cc2ccccc2)CC1,CHEMBL671073,IC50,6.21,CHEMBL64119,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,13,212,c1ccc(CN2CCC(Nc3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)S(=O)(=O)n1ccc2c(-c3ccc(C(F)(F)F)cc3)cc(N3CCN(C)CC3)nc21,CHEMBL3800738,Ki,7.6,CHEMBL3799120,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,114,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)[C@@H](O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.04,CHEMBL3697989,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",97,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)[C@H](O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.13,CHEMBL3697990,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",97,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1cc(-c2ccsc2)cc(N2CCN(C)CC2)n1,CHEMBL5391038,Ki,8.88,CHEMBL5408427,2023,CHEMBL5390222,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay,155,213,c1cc(-c2ccsc2)cc(N2CCNCC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1cc2c(cc1NS(=O)(=O)c1ccc(-c3ccc(Cl)cc3)cc1)CCN(C)CC2,CHEMBL905981,Ki,7.0,CHEMBL397476,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,51,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1,CHEMBL3706129,Ki,6.4,CHEMBL3676928,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1,CHEMBL872891,Ki,5.75,CHEMBL320440,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",27,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccc(Cl)cc1CN1CCN(CC(=O)N2c3ccccc3C[C@H]2C)CC1,CHEMBL675680,Ki,6.66,CHEMBL108011,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,27,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccc(S(=O)(=O)Cc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,CHEMBL1225698,Ki,6.5,CHEMBL1223598,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,67,93,O=S(=O)(Cc1ccc(C23CNCC2C3)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccc(S(=O)(=O)Nc2ccc(C34CNCC3C4)cc2)cc1,CHEMBL1225698,Ki,6.199999999999999,CHEMBL1223657,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,67,93,O=S(=O)(Nc1ccc(C23CNCC2C3)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccc(S(=O)(=O)Nc2ccc([C@@]34C[C@@H]3CN(C)C4)cc2)cc1,CHEMBL1225698,Ki,7.2,CHEMBL1224639,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,67,93,O=S(=O)(Nc1ccc(C23CNCC2C3)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,CHEMBL1225698,Ki,6.6,CHEMBL1224638,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,67,93,O=S(=O)(Nc1ccc(C23CNCC2C3)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,CHEMBL1057875,Ki,7.1,CHEMBL540241,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,62,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1cccc(OCCN2C3CCC2CC(NS(=O)(=O)c2ccc(F)cc2)C3)c1,CHEMBL3762073,Ki,7.22,CHEMBL3759205,2016,CHEMBL3758131,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,114,215,O=S(=O)(NC1CC2CCC(C1)N2CCOc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1cccc(OCCN2C3CCC2CC(NS(=O)(=O)c2cccc(F)c2)C3)c1,CHEMBL3762073,Ki,6.7,CHEMBL3759617,2016,CHEMBL3758131,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,114,215,O=S(=O)(NC1CC2CCC(C1)N2CCOc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1N1CCN(CCCCCC(=O)N2CCc3ccccc3C2)CC1,CHEMBL1034994,Ki,8.89,CHEMBL492282,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,58,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1N1CCN(CCCCCC(=O)N2Cc3ccccc3C2)CC1,CHEMBL1034994,Ki,7.19,CHEMBL494119,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,58,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)N1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1,CHEMBL894060,Ki,7.82,CHEMBL243744,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,51,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(C#N)cc2)CC1,CHEMBL1034994,Ki,7.7,CHEMBL494312,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,59,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(OS(C)(=O)=O)cc2)CC1,CHEMBL1034994,Ki,8.11,CHEMBL494661,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,59,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1N1CCN(CCCCCC(=O)NCc2ccccc2)CC1,CHEMBL1034994,Ki,8.04,CHEMBL492872,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,59,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1N1CCN(CCCCCC(=O)NCc2ccncc2)CC1,CHEMBL1034994,Ki,7.68,CHEMBL522343,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,59,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccncc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCCN1CCC(NS(=O)(=O)c2ccc(F)cc2)CC1,CHEMBL4178665,Ki,6.48,CHEMBL4216126,2017,CHEMBL4177556,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 or CHO-K1 cells after 1 hr by microbeta counting analysis,123,217,O=S(=O)(NC1CCN(CCCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(CNS(=O)(=O)c2ccc(F)cc2)CC1,CHEMBL2162846,Ki,7.3,CHEMBL2159457,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,80,218,O=S(=O)(NCC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2)CC1,CHEMBL2162846,Ki,7.18,CHEMBL2159460,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,80,218,O=S(=O)(NCC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(N(C)S(=O)(=O)c2ccc(F)cc2)CC1,CHEMBL3750144,Ki,7.3,CHEMBL3747071,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,114,167,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(N(C)S(=O)(=O)c2cccc(F)c2)CC1,CHEMBL3750144,Ki,7.35,CHEMBL3747114,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,114,167,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(N(C)S(=O)(=O)c2ccccc2)CC1,CHEMBL3750144,Ki,7.22,CHEMBL3747052,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,114,167,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(N(C)S(=O)(=O)c2cnn(C)c2)CC1,CHEMBL3750144,Ki,7.34,CHEMBL3747459,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,114,167,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1cn[nH]c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(N(CC2CC2)S(=O)(=O)c2ccc(F)cc2)CC1,CHEMBL3750144,Ki,7.7,CHEMBL3747744,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,114,167,O=S(=O)(c1ccccc1)N(CC1CC1)C1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(N(CC2CC2)S(=O)(=O)c2cccc(F)c2)CC1,CHEMBL3750144,Ki,7.82,CHEMBL3747148,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,114,167,O=S(=O)(c1ccccc1)N(CC1CC1)C1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(N(CC2CC2)S(=O)(=O)c2cnn(C)c2)CC1,CHEMBL3750144,Ki,7.75,CHEMBL3745882,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,114,167,O=S(=O)(c1cn[nH]c1)N(CC1CC1)C1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(NC(=O)c2ccc3ccccc3n2)C1,CHEMBL2162846,Ki,7.1,CHEMBL2159468,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,80,218,O=C(NC1CCN(CCOc2ccccc2)C1)c1ccc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cc(F)ccc2F)CC1,CHEMBL3744663,Ki,6.83,CHEMBL3740235,2015,CHEMBL3739404,Medchemcomm,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,108,219,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2ccc(F)cc2)CC1,CHEMBL2162846,Ki,7.29,CHEMBL2159465,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,80,218,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc(Cl)c2)C1,CHEMBL2162846,Ki,7.6,CHEMBL2159485,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,80,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc(F)c2)CC1,CHEMBL3744663,Ki,6.99,CHEMBL3740054,2015,CHEMBL3739404,Medchemcomm,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,108,219,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc(F)c2)CC1,CHEMBL3762073,Ki,6.99,CHEMBL3740054,2016,CHEMBL3758131,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,114,215,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc3cccnc23)C1,CHEMBL2162846,Ki,8.0,CHEMBL2159477,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,80,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1cccc2cccnc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc3ncccc23)CC1,CHEMBL3744663,Ki,6.98,CHEMBL3739680,2015,CHEMBL3739404,Medchemcomm,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,108,219,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1cccc2ncccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2ccccc2F)CC1,CHEMBL3744663,Ki,7.29,CHEMBL3742076,2015,CHEMBL3739404,Medchemcomm,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,108,219,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cccs2)C1,CHEMBL2162846,Ki,7.8,CHEMBL2159470,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,80,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CCC(NS(=O)(=O)c2cnn(C)c2)CC1,CHEMBL3744663,Ki,6.85,CHEMBL3739745,2015,CHEMBL3739404,Medchemcomm,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,108,219,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1cn[nH]c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CC[C@@H](NS(=O)(=O)c2ccc(Cl)s2)C1,CHEMBL2162846,Ki,7.7,CHEMBL2159487,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,80,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1ccccc1OCCN1CC[C@H](NS(=O)(=O)c2ccc(Cl)s2)C1,CHEMBL2162846,Ki,7.6,CHEMBL2159490,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,80,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1nc(CN2CC[C@H](c3ccccc3)C2)cs1,CHEMBL4137914,Ki,5.5,CHEMBL4159893,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,129,220,c1ccc(C2CCN(Cc3cscn3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1nc2c(N3CCNCC3)ccnc2n1Cc1cccc(Cl)c1,CHEMBL4146376,Ki,5.53,CHEMBL4161308,2018,CHEMBL4145461,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,221,c1ccc(Cn2cnc3c(N4CCNCC4)ccnc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1nc2c(N3CCNCC3)ccnc2n1Cc1cccc(F)c1,CHEMBL4146376,Ki,5.46,CHEMBL4169236,2018,CHEMBL4145461,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,221,c1ccc(Cn2cnc3c(N4CCNCC4)ccnc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)c1nc2c(N3CCNCC3)nccc2n1S(=O)(=O)c1cccc(Cl)c1,CHEMBL4736131,Ki,5.88,CHEMBL4742804,2021,CHEMBL4732141,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L expressed in CHO-K1 cell membranes incubated for 1 hr by micro-beta plate reader based analysis,146,222,O=S(=O)(c1ccccc1)n1cnc2c(N3CCNCC3)nccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C)n1nc(S(=O)(=O)c2cccc3ccccc23)c2cc(N3CCNCC3)ccc21,CHEMBL1286377,Ki,5.69,CHEMBL1277837,2010,CHEMBL1275334,J Med Chem,Scientific Literature,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,67,192,O=S(=O)(c1cccc2ccccc12)c1n[nH]c2ccc(N3CCNCC3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(C1CC1)N1CCC(C2CCc3ccccc3C2=O)CC1,CHEMBL673013,Ki,6.11,CHEMBL542217,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,3,165,O=C1c2ccccc2CCC1C1CCN(CC2CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(CCCc1ccccc1)CNC(=O)/N=C(\N)NCCCc1nnc(N)s1,CHEMBL5151464,Ki,6.35,CHEMBL5198795,2021,CHEMBL5149991,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,146,223,O=C(N=CNCCCc1nncs1)NCCCCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(CN1c2ccccc2Sc2ccccc21)N(C)C,CHEMBL3090831,IC50,7.0,CHEMBL643,2013,CHEMBL3085767,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,88,224,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(CNC(=O)/N=C(\N)NCCCc1nnc(N)s1)C1CCCCC1,CHEMBL5151464,Ki,5.79,CHEMBL5204599,2021,CHEMBL5149991,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,146,223,O=C(N=CNCCCc1nncs1)NCCC1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1)c1ccccc1,CHEMBL1947794,IC50,5.6,CHEMBL1945036,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,80,225,O=c1[nH]c2cccc(CCNCCc3ccc(CNCCc4ccccc4)cc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(Cc1cccc(CNCCc2c(Cl)cccc2Cl)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12,CHEMBL1947794,IC50,6.9,CHEMBL1945297,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,81,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(O)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL3863990,Ki,6.16,CHEMBL3916231,2016,CHEMBL3862037,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,114,226,c1ccc(C(SCCN2CCNCC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(O)CN1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4711026,Ki,6.16,CHEMBL3916231,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,141,140,c1ccc(C(SCCN2CCNCC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(O)CN1CCN(CC[S+]([O-])C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL3863990,Ki,6.53,CHEMBL3931765,2016,CHEMBL3862037,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,114,226,c1ccc(C([SH+]CCN2CCNCC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(O)CN1CCN(CC[S+]([O-])C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4711026,Ki,6.53,CHEMBL3931765,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,141,140,c1ccc(C([SH+]CCN2CCNCC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(O)CN1[C@H](C)CN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)C[C@@H]1C,CHEMBL4711026,Ki,4.92,CHEMBL4636778,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,141,140,c1ccc(C(SCCN2CCNCC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,6.57,CHEMBL108616,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(Oc1cc(Cl)cc(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.8,CHEMBL4860006,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(Oc1cc(Cl)ccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.43,CHEMBL4846146,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(Oc1ccc(Cl)c(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.12,CHEMBL4861431,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(Oc1cccc(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4366763,Ki,6.25,CHEMBL4522568,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,133,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(Oc1cccc(Cl)c1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.37,CHEMBL4855393,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(Oc1ccccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4366763,Ki,6.0,CHEMBL4447416,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,133,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(Oc1ccccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.0,CHEMBL4447416,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(Oc1ccccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL5216600,Ki,6.0,CHEMBL4447416,2022,CHEMBL5214932,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,153,229,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(Sc1ccccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4366763,Ki,6.28,CHEMBL4515075,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,133,228,c1ccc(SCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC([Se]c1ccccc1)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4366763,Ki,6.18,CHEMBL4462404,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,133,228,c1ccc([Se]Cc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC(c1ccc(Cl)cc1)N1CCN(CC(=O)N2c3ccccc3CC2C)CC1,CHEMBL872891,Ki,5.9,CHEMBL106751,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",27,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C(=O)/C=C(\O)c2ccc(Cl)cc2)CCN(Cc2ccccc2)CC1,CHEMBL672209,Ki,6.39,CHEMBL2112284,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,9,230,O=C(C=Cc1ccccc1)C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C(=O)NCCCCN2CCN(c3ccc(Cl)cc3)CC2)CCCCC1,CHEMBL670172,Ki,6.0,CHEMBL20367,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,O=C(NCCCCN1CCN(c2ccccc2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)CCCCC1,CHEMBL670172,Ki,6.1,CHEMBL20655,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,O=C(NCCN1CCN(c2ccccc2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)COC1,CHEMBL3707825,Ki,6.65,CHEMBL3664874,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1COC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)COC1,CHEMBL3707837,Ki,7.09,CHEMBL3698008,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",97,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1COC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)C2C(=O)N(CCCCN3CCN(c4cccc5sccc45)CC3)C(=O)C21,CHEMBL4254801,IC50,8.08,CHEMBL4284353,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,129,130,O=C1C2CC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1,CHEMBL4254801,IC50,8.14,CHEMBL4291215,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,129,130,O=C1CCCC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1,CHEMBL4037101,Ki,5.37,CHEMBL284092,2018,CHEMBL4033775,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2 receptor expressed in HEK cells,129,231,O=C1CCCC(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)CC(=O)N(CCCCN2CCN(c3ncccn3)CC2)C(=O)C1,CHEMBL870200,Ki,7.24,CHEMBL284092,2006,CHEMBL1147799,J Med Chem,Scientific Literature,Binding affinity to D2 receptor by radioligand binding assay,44,232,O=C1CCCC(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)CC(=O)N(CCCCN2Cc3ccccc3C2)C(=O)C1,CHEMBL3863657,Ki,5.53,CHEMBL3908870,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,114,59,O=C1CCCC(=O)N1CCCCN1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)CCNc2c(CCN3CCN(c4nsc5ccccc45)CC3)cc(F)cc21,CHEMBL872392,Ki,7.26,CHEMBL363829,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,c1cc2c(c(CCN3CCN(c4nsc5ccccc45)CC3)c1)NCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)CCNc2c(CCN3CCN(c4nsc5ccccc45)CC3)cccc21,CHEMBL872392,Ki,7.23,CHEMBL194312,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,c1cc2c(c(CCN3CCN(c4nsc5ccccc45)CC3)c1)NCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)C[C@@H]2C[C@@](C)(CN2CCN2CCN(c3cccc(Cl)c3)C2=O)C1,CHEMBL1044430,Ki,7.0,CHEMBL563563,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,62,233,O=C1N(CCN2CC3CCCC2C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)C[C@@H]2C[C@@](C)(CN2CCN2CCN(c3cccc(Cl)c3)C2=O)C1,CHEMBL1059864,Ki,7.0,CHEMBL563563,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,62,234,O=C1N(CCN2CC3CCCC2C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)Cc2cccc(OCCNCC3(F)CCN(C(=O)c4ccc(F)c(Cl)c4)CC3)c2O1,CHEMBL4670399,Ki,7.54,CHEMBL4790600,2020,CHEMBL4665789,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2 receptor stably expressed in CHO-K1 cell membranes measured after 60 mins by Microbeta2 scintillation counting method,141,235,O=C(c1ccccc1)N1CCC(CNCCOc2cccc3c2OCC3)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)Cc2cccc3c2N1C(=O)C(N1CCN(Cc2ccc(Cl)cc2)CC1)CC3,CHEMBL672162,Ki,6.7,CHEMBL439646,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,33,236,O=C1C(N2CCN(Cc3ccccc3)CC2)CCc2cccc3c2N1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,6.93,CHEMBL317879,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,27,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)NC(=O)N(CC(O)CN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1=O,CHEMBL4259653,Ki,5.94,CHEMBL4292541,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C1CNC(=O)N1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)NC(=O)N(CC(O)CN2CCN(c3ccccc3C#N)CC2)C1=O,CHEMBL4259653,Ki,5.46,CHEMBL4288040,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C1CNC(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)NC1=O,CHEMBL872394,Ki,8.13,CHEMBL199045,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,39,238,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)[C@@H]2CC[C@]13CCN(CCN1CCN(c4cccc(Cl)c4)C1=O)C3C2,CHEMBL1044430,Ki,6.5,CHEMBL562833,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,62,233,O=C1N(CCN2CCC34CCC(CC23)C4)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)[C@@H]2CC[C@]13CCN(CCN1CCN(c4cccc(Cl)c4)C1=O)C3C2,CHEMBL1059864,Ki,6.5,CHEMBL562833,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,62,234,O=C1N(CCN2CCC34CCC(CC23)C4)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)[C@H]2CC[C@]1(C)CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,CHEMBL1044430,Ki,7.5,CHEMBL564930,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,63,233,O=C1N(CCN2CC3CCC(C3)C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(C)[C@H]2CC[C@]1(C)CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,CHEMBL1059864,Ki,7.5,CHEMBL564930,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,63,234,O=C1N(CCN2CC3CCC(C3)C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(CCCCN2CCN(c3ccccn3)CC2)Cc2cc(Cl)ccc2C1=O,CHEMBL4815619,Ki,5.49,CHEMBL4871868,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,146,118,O=C1c2ccccc2CC1CCCCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(CCCN2CCN(c3ccccn3)CC2)Cc2cc(Cl)ccc2C1=O,CHEMBL4815619,Ki,5.96,CHEMBL4846823,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,146,118,O=C1c2ccccc2CC1CCCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2cc(-c3ccc(Cl)cc3)[nH]n2)CCN(Cc2ccccc2)CC1,CHEMBL672209,Ki,6.62,CHEMBL80207,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,9,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(Br)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3C#N)CC2)C1=O,CHEMBL4148417,Ki,6.3,CHEMBL4170613,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,129,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.0,CHEMBL246020,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,51,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(Cl)cc2)NC(=O)N(CC(O)CN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1=O,CHEMBL4148417,Ki,6.22,CHEMBL4166804,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,129,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(Cl)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3C#N)CC2)C1=O,CHEMBL4148417,Ki,5.89,CHEMBL4174055,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,129,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCC(Oc3ccc(Cl)cc3)CC2)C1=O,CHEMBL4259653,Ki,5.39,CHEMBL4291141,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCC(Oc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCC(Oc3ccccc3)CC2)C1=O,CHEMBL4259653,Ki,5.36,CHEMBL4290738,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCC(Oc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(C(=O)c3ccccc3)CC2)C1=O,CHEMBL4259653,Ki,5.0,CHEMBL4279397,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C(c1ccccc1)N1CCN(CCCN2C(=O)NC(c3ccccc3)C2=O)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1=O,CHEMBL3771916,Ki,6.58,CHEMBL3771222,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,114,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1=O,CHEMBL4259654,Ki,6.58,CHEMBL3771222,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from D2 receptor (unknown origin),129,241,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(Cc3cccc4ccccc34)CC2)C1=O,CHEMBL4259653,Ki,5.28,CHEMBL4287320,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(Cc2cccc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(Cc3ccccc3)CC2)C1=O,CHEMBL4259653,Ki,4.7,CHEMBL4288077,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccc(Cl)c(Cl)c3)CC2)C1=O,CHEMBL3771916,Ki,5.7,CHEMBL3770581,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,114,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccc(Cl)cc3)CC2)C1=O,CHEMBL3771916,Ki,5.37,CHEMBL3770522,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,114,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccc(F)cc3)CC2)C1=O,CHEMBL3771916,Ki,5.25,CHEMBL3770293,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,114,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccc(F)cc3F)CC2)C1=O,CHEMBL3771916,Ki,5.17,CHEMBL3769536,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,114,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3cccc(Cl)c3Cl)CC2)C1=O,CHEMBL3771916,Ki,6.52,CHEMBL3771309,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,114,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3cccc4ccccc34)CC2)C1=O,CHEMBL4259653,Ki,6.53,CHEMBL4282860,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2cccc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3)CC2)C1=O,CHEMBL3771916,Ki,5.54,CHEMBL3769836,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,114,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3C#N)CC2)C1=O,CHEMBL3771916,Ki,6.03,CHEMBL3770639,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,114,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3Cl)CC2)C1=O,CHEMBL3771916,Ki,6.08,CHEMBL3769606,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,114,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3F)CC2)C1=O,CHEMBL3771916,Ki,5.77,CHEMBL3770473,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,114,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc(F)cc2)NC(=O)N(CC(O)CN2CCc3ccccc3C2)C1=O,CHEMBL4259653,Ki,5.23,CHEMBL4284656,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccc3ccccc3c2)NC(=O)N(CC(O)CN2CCN(c3ccccc3C#N)CC2)C1=O,CHEMBL4259653,Ki,6.58,CHEMBL4292237,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C1NC(c2ccc3ccccc3c2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2cccc3ccccc23)NC(=O)N(CC(O)CN2CCN(C(c3ccccc3)c3ccccc3)CC2)C1=O,CHEMBL4259653,Ki,6.56,CHEMBL4283960,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C1NC(c2cccc3ccccc23)C(=O)N1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2cccc3ccccc23)NC(=O)N(CC(O)CN2CCN(c3ccccc3C#N)CC2)C1=O,CHEMBL4259653,Ki,6.38,CHEMBL4294549,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,129,237,O=C1NC(c2cccc3ccccc23)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1(c2ccccc2)NC(=O)N(CC(O)CN2CCN(c3ccccc3C#N)CC2)C1=O,CHEMBL4148417,Ki,5.77,CHEMBL4162279,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,129,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1=CC(C)=[N+]2C1=C(c1ccc(OCCCN3CCCCC3)cc1)c1c(C)cc(C)n1[B-]2(F)F,CHEMBL2328677,Ki,5.71,CHEMBL2323582,2013,CHEMBL2321700,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO-K1 cells,88,242,[BH2-]1n2cccc2C(c2ccc(OCCCN3CCCCC3)cc2)=C2C=CC=[N+]12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CC(=O)N(C)c2c(CCN3CCN(c4nsc5ccccc45)CC3)cccc21,CHEMBL872392,Ki,7.09,CHEMBL372541,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,O=C1CCc2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CC(=O)Nc2c(CCN3CCN(c4n[s+]([O-])c5ccccc45)CC3)cc(F)cc21,CHEMBL872392,Ki,7.04,CHEMBL425208,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,O=C1CCc2cccc(CCN3CCN(c4n[sH+]c5ccccc45)CC3)c2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CC(=O)Nc2c(CCN3CCN(c4nsc5ccccc45)CC3)cc(F)cc21,CHEMBL872392,Ki,7.82,CHEMBL197870,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,O=C1CCc2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CC(=O)Nc2c(CCN3CCN(c4nsc5ccccc45)CC3)cccc21,CHEMBL872392,Ki,7.68,CHEMBL371289,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,O=C1CCc2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CC(=O)c2ccc(N3CCN(C)CC3)cc2N1S(=O)(=O)c1ccc2ccccc2c1,CHEMBL1647768,IC50,6.87,CHEMBL1642118,2011,CHEMBL1641464,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,76,243,O=C1CCN(S(=O)(=O)c2ccc3ccccc3c2)c2cc(N3CCNCC3)ccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CC(C)(C)N(C(=O)CN2CCN(Cc3ccc(Cl)cc3)CC2)c2ccccc21,CHEMBL872882,Ki,7.46,CHEMBL104160,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,27,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCC(CN2CCN(c3cccc(Cl)c3Cl)CC2)CN1CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,6.84,CHEMBL5435235,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,155,244,c1ccc(C(CCN2CCCC(CN3CCN(c4ccccc4)CC3)C2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCCCN1CCN1CCN(c2cccc(Cl)c2)C1=O,CHEMBL1057875,Ki,7.6,CHEMBL561054,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,63,166,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCCN(CCN2CCN(c3cccc(Cl)c3)C2=O)C1,CHEMBL1057875,Ki,7.7,CHEMBL552371,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,63,166,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(C(=O)C2CCCCC2)c2c(CCN3CCN(c4nsc5ccccc45)CC3)cccc21,CHEMBL872392,Ki,7.6,CHEMBL197677,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,O=C(C1CCCCC1)N1CCCc2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(C(=O)c2ccccc2)c2c(CCN3CCN(c4nsc5ccccc45)CC3)cccc21,CHEMBL872392,Ki,7.8,CHEMBL194953,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,O=C(c1ccccc1)N1CCCc2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(C2=Cc3cc(Cl)ccc3Cc3ccccc32)CC1,CHEMBL671374,Ki,5.85,CHEMBL269396,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,3,73,C1=C(N2CCCCC2)c2ccccc2Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(CCCN2C(=O)CCc3ccccc32)CC1,CHEMBL4048883,Ki,5.35,CHEMBL4074104,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,129,245,O=C1CCc2ccccc2N1CCCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,CHEMBL1057875,Ki,7.8,CHEMBL551914,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,63,166,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(CC[C@H]2CCCCN2S(=O)(=O)c2cccc3ccccc23)CC1,CHEMBL672232,Ki,6.4,CHEMBL1788231,2000,CHEMBL1133573,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,21,246,O=S(=O)(c1cccc2ccccc12)N1CCCCC1CCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2ccc(Cl)c(Cl)c2)CC1,CHEMBL672232,Ki,6.0,CHEMBL333784,2000,CHEMBL1133573,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,21,246,O=S(=O)(c1ccccc1)N1CCCC1CCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(Br)c2)CC1,CHEMBL672232,Ki,6.1,CHEMBL116448,2000,CHEMBL1133573,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,21,246,O=S(=O)(c1ccccc1)N1CCCC1CCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1,CHEMBL672232,Ki,6.5,CHEMBL282199,2000,CHEMBL1133573,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,21,246,O=S(=O)(c1ccccc1)N1CCCC1CCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1,CHEMBL673593,Ki,6.5,CHEMBL282199,2001,CHEMBL1134402,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,25,247,O=S(=O)(c1ccccc1)N1CCCC1CCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc3ccccc23)CC1,CHEMBL672232,Ki,6.2,CHEMBL94984,2000,CHEMBL1133573,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,21,246,O=S(=O)(c1cccc2ccccc12)N1CCCC1CCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(CCc2ccc(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2)CC1,CHEMBL4821052,Ki,8.57,CHEMBL4861643,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),146,248,c1ccc2c(C3CCN(CCCCOc4ccc(CCN5CCCCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(CCc2ccc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2)CC1,CHEMBL4821052,Ki,8.13,CHEMBL4861193,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),146,248,c1ccc2c(C3CCN(CCCOc4ccc(CCN5CCCCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL672164,Ki,5.26,CHEMBL57478,1996,CHEMBL1129306,J Med Chem,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,6,249,c1ccc2c(CN3CCCCC3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCc2cc(F)ccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,5.65,CHEMBL107391,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,27,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CCc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,5.38,CHEMBL106897,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,27,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CN(C(=O)CN2CCN(Cc3ccc(Cl)cc3)CC2)c2ccccc21,CHEMBL872882,Ki,5.36,CHEMBL320067,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,27,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CN(CCCCNC(=O)C(C)(C)C)CCN1c1ccc(Cl)cc1,CHEMBL670172,Ki,5.8,CHEMBL20854,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1CNc2cccc(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c2C1,CHEMBL872394,Ki,7.82,CHEMBL197839,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,39,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)CCCN2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c2NC1=O,CHEMBL872392,Ki,7.14,CHEMBL197614,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,39,103,O=C1CCc2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2cccc3c2N1C(=O)C(N1CCN(Cc2ccc(Cl)cc2)CC1)CC3,CHEMBL672162,Ki,6.86,CHEMBL349833,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,33,236,O=C1C(N2CCN(Cc3ccccc3)CC2)CCc2cccc3c2N1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872891,Ki,7.04,CHEMBL104788,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",27,214,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2ccc(F)cc2)CC1,CHEMBL872891,Ki,7.15,CHEMBL419356,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",27,214,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2ccc(F)cc2Cl)CC1,CHEMBL872891,Ki,6.29,CHEMBL326202,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",27,214,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2cccc(Cl)c2)CC1,CHEMBL872891,Ki,7.21,CHEMBL104832,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",27,214,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2cccc(F)c2)CC1,CHEMBL872891,Ki,7.28,CHEMBL104719,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2ccccc2Cl)CC1,CHEMBL872891,Ki,6.08,CHEMBL106914,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CC1CCN(Cc2ccccc2F)CC1,CHEMBL872891,Ki,5.85,CHEMBL104155,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CN1CCN(CCc2ccc(Cl)cc2)CC1,CHEMBL872891,Ki,5.28,CHEMBL323022,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CN1CCN(CCc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2cc(Cl)cc(Cl)c2)CC1,CHEMBL872891,Ki,6.67,CHEMBL107020,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2cc(F)cc(F)c2)CC1,CHEMBL872891,Ki,5.52,CHEMBL107804,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(C(C)(C)C)cc2)CC1,CHEMBL872891,Ki,5.72,CHEMBL419916,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(C(F)(F)F)cc2)CC1,CHEMBL872891,Ki,5.28,CHEMBL104321,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL673093,Ki,8.05,CHEMBL106916,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Dopamine receptor D2 functional activity was assessed via inhibition of forskolin stimulated cAMP production from Whole cells,28,250,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,6.68,CHEMBL106916,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,28,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(F)cc2)CC1,CHEMBL872891,Ki,6.05,CHEMBL104614,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(OC(F)(F)F)cc2)CC1,CHEMBL872891,Ki,5.42,CHEMBL106208,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)CN1CCN(Cc2cccc(OC(F)(F)F)c2)CC1,CHEMBL872891,Ki,6.21,CHEMBL419908,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Cc2ccccc2N1C(=O)NCCCCN(C)[C@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL5236912,Ki,7.57,CHEMBL5272965,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor assessed as inhibition constant,146,251,O=C(NCCCCNC1Cc2cccc3[nH]c(=O)n(c23)C1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1N(C(=O)CN2CCN(Cc3ccc(Cl)cc3)CC2)c2ccccc2C1(C)C,CHEMBL872882,Ki,6.05,CHEMBL107384,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,28,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1NCCc2cc(O)c(O)cc21,CHEMBL670395,Ki,5.27,CHEMBL416732,1997,CHEMBL1129926,Bioorg Med Chem Lett,Scientific Literature,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,9,153,c1ccc2c(c1)CCNC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Oc2c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)cccc2N(C)C1=O,CHEMBL872394,Ki,7.45,CHEMBL197943,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,39,238,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)NC1=O,CHEMBL872394,Ki,8.35,CHEMBL198070,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,39,238,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21,CHEMBL671374,Ki,6.17,CHEMBL91350,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,3,73,C1=C(C2=Cc3ccccc3Cc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21,CHEMBL672525,Ki,6.17,CHEMBL544184,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,4,75,C1=C(C2=Cc3ccccc3Cc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1c2ccccc2C=C(N2CCN(C)CC2)c2ccccc21,CHEMBL672524,Ki,7.03,CHEMBL432762,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the D2L dopamine receptor in COS7 cells,5,252,C1=C(N2CCNCC2)c2ccccc2Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC1c2ccccc2C=C(N2CCN(C)CC2)c2ccccc21,CHEMBL675960,Ki,7.03,CHEMBL432762,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,3,57,C1=C(N2CCNCC2)c2ccccc2Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)C(CCN(C)C)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,4.46,CHEMBL346331,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,146,253,c1ccc(Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)N(c1ccccc1)C1CCN(CCc2ccccc2)CC1,CHEMBL5046486,Ki,4.68,CHEMBL596,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,146,253,c1ccc(CCN2CCC(Nc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21,CHEMBL945767,Ki,7.47,CHEMBL253022,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,59,106,c1ccc2c(N3CCN(CCc4ccc5c(c4)CCC5)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL2168000,Ki,7.81,CHEMBL2165678,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,81,254,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)NCCCCN1CCN(c2ccccc2OC)CC1,CHEMBL2168000,Ki,7.08,CHEMBL2165679,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,81,254,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.46,CHEMBL3695366,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.69,CHEMBL3664820,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1,CHEMBL3705383,Ki,7.04,CHEMBL3695362,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,54,c1cc(C2CCN(CCC3CCCCC3)CC2)c2ccoc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.32,CHEMBL3676850,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",97,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.13,CHEMBL3697957,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",97,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.09,CHEMBL3642713,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,6.11,CHEMBL3642682,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1,CHEMBL3705135,Ki,6.79,CHEMBL3642696,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2sccc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,7.75,CHEMBL3902496,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,114,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)Nc1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C,CHEMBL1073809,Ki,6.3,CHEMBL601634,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,67,102,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)Nc1nc(C)c(-c2ccc3ccn(S(=O)(=O)c4ccccc4)c3c2)[nH]1,CHEMBL4354013,Ki,5.44,CHEMBL4483304,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,133,125,O=S(=O)(c1ccccc1)n1ccc2ccc(-c3cnc[nH]3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.41,CHEMBL3318824,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,98,127,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.8,CHEMBL3318824,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,98,128,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)(C)C(=O)NCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL670172,Ki,6.0,CHEMBL21011,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)(C)C(=O)NCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL670172,Ki,5.6,CHEMBL283353,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)(C)C(=O)NCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL672101,Ki,5.6,CHEMBL283353,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity was measured at the cloned human Dopamine receptor D2 using [3H]spiroperidol as radioligand.,13,255,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)(C)c1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,CHEMBL1225698,Ki,7.3,CHEMBL1223602,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,67,93,O=S(=O)(Nc1ccc(C23CNCC2C3)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,5.92,CHEMBL3695415,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.45,CHEMBL3664863,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.34,CHEMBL3676876,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.15,CHEMBL3642753,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)Cc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,CHEMBL3387736,Ki,7.54,CHEMBL3344462,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,98,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)N1CCC[C@@H](c2cccc(C#N)c2)C1,CHEMBL678343,Ki,7.01,CHEMBL413483,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",3,257,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)N1CCC[C@@H](c2cccc(C#N)c2)C1,CHEMBL679938,Ki,6.73,CHEMBL413483,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)Oc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,CHEMBL3877884,Ki,6.48,CHEMBL3894329,2017,CHEMBL3877260,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,123,258,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(C)Oc1c(O)ccc2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,CHEMBL3877884,Ki,6.98,CHEMBL3936976,2017,CHEMBL3877260,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,123,258,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(CNC(=O)/N=C(\N)NCCCc1sc(N)nc1C)c1ccccc1,CHEMBL4815484,Ki,6.28,CHEMBL4848815,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,146,259,O=C(N=CNCCCc1cncs1)NCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12,CHEMBL4880035,Ki,6.475,CHEMBL4522930,2021,CHEMBL4800722,,SGC Frankfurt - Donated Chemical Probes,GPCRScan assay: inhibition of D2,146,144,c1cc2ccc(N3CCCCC3)nc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12,CHEMBL5479826,Ki,6.47,CHEMBL4522930,2024,CHEMBL5465560,,EUbOPEN Chemogenomic Library Literature Data,Selectivity interaction (GPCR panel (PDSP screen)) EUB0001492b DRD2,159,260,c1cc2ccc(N3CCCCC3)nc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12,CHEMBL3801477,Ki,4.07,CHEMBL160519,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,114,196,O=c1ccc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.91,CHEMBL3697988,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",98,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(Oc1cc(Cl)cc(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.43,CHEMBL4876727,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(Oc1cc(Cl)ccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.5,CHEMBL4860275,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(Oc1cc(Cl)ccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL5216600,Ki,6.5,CHEMBL4860275,2022,CHEMBL5214932,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,153,229,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(Oc1ccc(Cl)c(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.24,CHEMBL4857676,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(Oc1cccc(Cl)c1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.38,CHEMBL4873623,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(Oc1cccc(Cl)c1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL5216600,Ki,6.38,CHEMBL4873623,2022,CHEMBL5214932,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,153,229,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC(Oc1ccccc1)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,5.82,CHEMBL4847379,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC1(C)CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)C(=O)C1,CHEMBL4254801,IC50,7.96,CHEMBL4286717,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,129,130,O=C1CCCC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC1(CC)CC(OCCCN2CCN(c3cccc(C(F)(F)F)n3)CC2)(c2ccccn2)CCO1,CHEMBL5363864,Ki,5.91,CHEMBL5415842,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,155,244,c1ccc(N2CCN(CCCOC3(c4ccccn4)CCOCC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC1(CC)CC(OCCCN2CCN(c3cccc(Cl)c3Cl)CC2)(c2ccccn2)CCO1,CHEMBL5363864,Ki,6.91,CHEMBL5415691,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,155,244,c1ccc(N2CCN(CCCOC3(c4ccccn4)CCOCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC1(CC)CC(OCCCNCc2cccc(Cl)c2Cl)(c2ccccn2)CCO1,CHEMBL5363864,Ki,4.87,CHEMBL5407845,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,155,244,c1ccc(CNCCCOC2(c3ccccn3)CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC1(CC)Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,6.89,CHEMBL326250,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,28,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC1(CCCCN2CCN(c3ccc(Cl)cc3)CC2)C(=O)Nc2cc(F)ccc21,CHEMBL927100,Ki,6.02,CHEMBL409662,2008,CHEMBL1144747,J Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor,59,261,O=C1Nc2ccccc2C1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,6.29,CHEMBL107793,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,28,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC#Cc1cc(CN2CCN(c3ccccc3OC)CC2)c2cccccc1-2,CHEMBL2214282,Ki,7.22,CHEMBL2207634,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,81,38,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC#Cc1cc(CN2CCN(c3ccccc3OC)CC2)c2cccccc1-2,CHEMBL2214283,Ki,7.12,CHEMBL2207634,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,81,39,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(=O)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21,CHEMBL945767,Ki,7.57,CHEMBL400235,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,59,106,c1ccc2c(N3CCN(CCc4ccc5c(c4)CCC5)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL870468,Ki,6.4,CHEMBL212597,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,44,262,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.71,CHEMBL3695426,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.56,CHEMBL3664838,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.34,CHEMBL3676878,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.84,CHEMBL3697969,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",98,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.08,CHEMBL3642769,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,8.55,CHEMBL3962525,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,114,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1,CHEMBL4677471,Ki,7.08,CHEMBL4761274,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,146,263,c1ccc2c(c1)CCN(CCC1CCCCC1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(=O)Oc1cccc2c1-c1cccc3c1[C@@H](C2)N(CCC)CC3,CHEMBL1811739,Ki,7.26,CHEMBL478671,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,76,264,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(C)(C)C(=O)NCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL670172,Ki,5.8,CHEMBL20444,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(C)(C)C(=O)NCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL670172,Ki,5.6,CHEMBL20725,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(CCC)C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL870468,Ki,5.73,CHEMBL215581,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,44,262,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(CCC)NC(=O)c1cc2ccccc2[nH]1,CHEMBL4053560,Ki,4.87,CHEMBL4064919,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,123,265,c1ccc2[nH]ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(Oc1cc(Cl)cc(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.42,CHEMBL4864448,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(Oc1cc(Cl)ccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.64,CHEMBL4858771,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC(Oc1cccc(Cl)c1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.3,CHEMBL4869411,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1,CHEMBL4048883,Ki,6.04,CHEMBL4098720,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,129,245,O=C1CCc2ccccc2N1CCCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.39,CHEMBL3695429,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.18,CHEMBL3676902,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.94,CHEMBL3642771,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCC(C)(C)C(=O)NCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL670172,Ki,5.8,CHEMBL20996,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",6,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCC(Oc1cc(Cl)cc(Cl)c1)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.57,CHEMBL4849077,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCC(Oc1cc(Cl)ccc1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.99,CHEMBL4864863,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCC(Oc1cccc(Cl)c1Cl)c1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4819277,Ki,6.3,CHEMBL4873127,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,141,227,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1,CHEMBL1248543,Ki,7.11,CHEMBL1242950,2010,CHEMBL1240489,J Med Chem,Scientific Literature,Binding affinity to human dopamine D2S receptor by radioligand displacement assay,67,266,O=C(CCCN1CCCCC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1,CHEMBL4048883,Ki,6.17,CHEMBL3354065,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,129,245,O=C1CCc2ccccc2N1CCCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1,CHEMBL5106582,Ki,6.17,CHEMBL3354065,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,153,267,O=C1CCc2ccccc2N1CCCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1,CHEMBL4048883,Ki,6.28,CHEMBL4080675,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,129,245,O=C1CCc2ccccc2N1CCCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCCCCC(=O)N1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL2020816,IC50,6.11,CHEMBL2016607,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,81,268,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020816,IC50,5.84,CHEMBL2016625,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,81,268,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020817,Ki,8.045,CHEMBL2016625,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,81,269,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCCCCC(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL2020816,IC50,5.05,CHEMBL2016614,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,81,268,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.74,CHEMBL1200986,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,98,127,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,9.34,CHEMBL1200986,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,98,128,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCCCCCN1CCC(c2cccc(O)c2)C1,CHEMBL4223412,Ki,6.33,CHEMBL4229178,2018,CHEMBL4219212,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,129,270,c1ccc(C2CCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCCCCN1CCC(c2cccc(O)c2)C1,CHEMBL4223412,Ki,7.21,CHEMBL4225278,2018,CHEMBL4219212,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,129,270,c1ccc(C2CCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCCCN1CCC(c2cccc(O)c2)C1,CHEMBL4223412,Ki,6.43,CHEMBL4224763,2018,CHEMBL4219212,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,129,270,c1ccc(C2CCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCCN1CCC(c2cccc(O)c2)C1,CHEMBL4223412,Ki,6.43,CHEMBL4226336,2018,CHEMBL4219212,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,129,270,c1ccc(C2CCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCN(CCc1ccccc1)CCc1cccc(O)c1,CHEMBL2182829,IC50,5.9,CHEMBL2180641,2012,CHEMBL2177058,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirol-induced mitogenesis incubated for 24 hrs by [3H]thymidine incorporation assay,81,271,c1ccc(CCNCCc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCN(CCc1ccccc1)CCc1cccc(O)c1,CHEMBL2182832,Ki,6.08,CHEMBL2180641,2012,CHEMBL2177058,J Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,81,272,c1ccc(CCNCCc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCN1CCC(c2cccc(O)c2)C1,CHEMBL4223412,Ki,5.45,CHEMBL4227192,2018,CHEMBL4219212,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,129,270,c1ccc(C2CCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCNC(=O)/N=C(\N)NC1CCc2nc(N)sc2C1,CHEMBL4815484,Ki,5.9,CHEMBL4876799,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,146,259,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C,CHEMBL4815484,Ki,6.25,CHEMBL4853668,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,146,259,c1cscn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCNC(=O)/N=C(\N)Nc1cccc(-c2csc(N)n2)c1,CHEMBL4815484,Ki,5.6,CHEMBL4872375,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,146,259,c1ccc(-c2cscn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCNC[C@H]1CCc2ccc(O)cc2O1,CHEMBL3117737,Ki,6.585,CHEMBL3115585,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,98,273,c1ccc2c(c1)CCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCNC[C@H]1CCc2ccc(O)cc2O1,CHEMBL3117738,Ki,6.800000000000001,CHEMBL3115585,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,98,274,c1ccc2c(c1)CCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCNC[C@H]1CCc2ccc(O)cc2O1,CHEMBL3117739,Ki,8.145,CHEMBL3115585,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,98,275,c1ccc2c(c1)CCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,CHEMBL3877884,Ki,6.14,CHEMBL3963862,2017,CHEMBL3877260,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,123,258,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL5335368,Ki,5.83,CHEMBL5410716,2023,CHEMBL5331137,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,155,276,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCOc1ccc(C2(O)CCN(Cc3c[nH]c4ccccc34)CC2)cc1,CHEMBL902495,Ki,6.8,CHEMBL398368,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,51,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCc1ccc2c(c1)Cc1ccccc1C2CN,CHEMBL994219,Ki,5.2,CHEMBL86760,2008,CHEMBL1142528,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,59,277,c1ccc2c(c1)Cc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCCn1cc(CN2CCC(O)(c3ccc(Cl)cc3)CC2)c2ccccc21,CHEMBL902495,Ki,6.73,CHEMBL246855,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,51,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCN(CCc1ccccc1)CCc1cccc(O)c1,CHEMBL2182832,Ki,5.85,CHEMBL2180637,2012,CHEMBL2177058,J Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,81,272,c1ccc(CCNCCc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCN1CCN2c3cccc4[nH]cc(c34)CC2C1,CHEMBL3294601,Ki,7.01,CHEMBL3286573,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,98,178,c1cc2c3c(c[nH]c3c1)CC1CNCCN21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12,CHEMBL5442215,Ki,6.53,CHEMBL1516474,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,c1ccc2[nH]ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCNC(=O)/N=C(\N)NCCCc1cnc(N)s1,CHEMBL5151464,Ki,5.46,CHEMBL5183205,2021,CHEMBL5149991,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,146,223,c1cscn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1,CHEMBL5151464,Ki,5.02,CHEMBL5207281,2021,CHEMBL5149991,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,146,223,c1nncs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C,CHEMBL4815484,Ki,6.35,CHEMBL4860528,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,146,259,c1cscn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL3806800,IC50,7.78,CHEMBL3805826,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,114,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,CHEMBL3877884,Ki,6.4,CHEMBL3964242,2017,CHEMBL3877260,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,123,258,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCOc1c(O)ccc2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,CHEMBL3877884,Ki,7.64,CHEMBL3945856,2017,CHEMBL3877260,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,123,258,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL5335368,Ki,5.84,CHEMBL5399568,2023,CHEMBL5331137,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,155,276,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2,CHEMBL3783165,Ki,6.55,CHEMBL3780140,2016,CHEMBL3779868,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,114,278,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,CHEMBL3387736,Ki,7.33,CHEMBL3344460,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,98,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN(CCC)[C@@H]1CCc2c(F)cccc2C1,CHEMBL672183,Ki,7.34,CHEMBL141510,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,6,197,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN(CCC)[C@@H]1CCc2c(F)cccc2C1,CHEMBL672184,Ki,6.68,CHEMBL141510,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,6,198,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN(CCCC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCN(CCCC)CCCC)cc3)nc3ccccc32)cc1,CHEMBL670392,Ki,6.33,CHEMBL87716,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,C(=CCn1c(-c2ccccc2)nc2ccccc21)Cn1c(-c2ccccc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN(CCc1ccccc1)CCc1cccc(O)c1,CHEMBL2182832,Ki,5.91,CHEMBL2180640,2012,CHEMBL2177058,J Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,81,272,c1ccc(CCNCCc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2,CHEMBL3863990,Ki,7.17,CHEMBL11493,2016,CHEMBL3862037,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,114,226,c1ccc(C(OC2CC3CCC(C2)N3)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCC(c2cccc(O)c2)C1,CHEMBL4223412,Ki,5.54,CHEMBL4225830,2018,CHEMBL4219212,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,129,270,c1ccc(C2CCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCC2(CC1)CCN(c1ccccc1OC)C2,CHEMBL4397357,Ki,4.59,CHEMBL4453955,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,133,279,c1ccc(N2CCC3(CCNCC3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCC2(CC1)CCN(c1ccccc1OC)CC2,CHEMBL4397357,Ki,4.57,CHEMBL4435834,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,133,279,c1ccc(N2CCC3(CCNCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCC2(CCN(c3ccccc3OC)C2)C1,CHEMBL4397357,Ki,4.58,CHEMBL4483472,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,133,279,c1ccc(N2CCC3(CCNC3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCC[C@@H]1CNC(=O)c1cc(Cl)cc2c1OCCN2C,CHEMBL672310,Ki,6.2,CHEMBL279729,2000,CHEMBL1133417,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,21,280,O=C(NCC1CCCN1)c1cccc2c1OCCN2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCC[C@H]1CNC(=O)c1cc(Cl)cc2c1OCCN2C,CHEMBL672310,Ki,7.92,CHEMBL283528,2000,CHEMBL1133417,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,21,280,O=C(NCC1CCCN1)c1cccc2c1OCCN2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCN(CCCN2C(=O)CCc3ccccc32)CC1,CHEMBL4048883,Ki,5.29,CHEMBL4064222,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,129,245,O=C1CCc2ccccc2N1CCCN1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCN(c2cc(CC)cc(Cl)c2OC)CC1,CHEMBL4429153,Ki,7.53,CHEMBL4440301,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,114,281,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCN(c2cccc(C#N)c2)CC1,CHEMBL4053560,Ki,6.31,CHEMBL4086613,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,123,265,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCN(c2cccc(CC)c2Cl)CC1,CHEMBL4429153,Ki,8.53,CHEMBL4471669,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,114,281,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL2168000,Ki,8.47,CHEMBL2165677,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,81,254,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4052936,Ki,8.47,CHEMBL2165677,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,123,282,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCN(c2ccccc2OC)CC1,CHEMBL2168000,Ki,7.69,CHEMBL26789,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,81,254,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCN(c2ccccc2OC)CC1,CHEMBL4397357,Ki,7.69,CHEMBL26789,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,133,279,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCN(c2ccccc2OCCF)CC1,CHEMBL4350893,Ki,7.83,CHEMBL4438361,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",133,283,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCN(c2ccccc2OCCF)CC1,CHEMBL4397357,Ki,7.65,CHEMBL4438361,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,133,279,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCN2c3cccc4[nH]cc(c34)CC2C1,CHEMBL3294601,Ki,6.96,CHEMBL3286571,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,98,178,c1cc2c3c(c[nH]c3c1)CC1CNCCN21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCc2cc(C#N)ccc2C1,CHEMBL4053560,Ki,5.08,CHEMBL4062165,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,123,265,c1ccc2c(c1)CCNC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN1CCc2ccc(C#N)cc2C1,CHEMBL4053560,Ki,6.08,CHEMBL4083890,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,123,265,c1ccc2c(c1)CCNC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCNC(=O)c1cc2ccccc2[nH]1,CHEMBL2168000,Ki,4.87,CHEMBL2164434,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,81,254,c1ccc2[nH]ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCNC(=O)c1ccc2c(c1)[C@H]1OCCN(CCC)[C@@H]1CC2,CHEMBL981461,Ki,5.34,CHEMBL519688,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCNC1CCc2c(cccc2OC)C1,CHEMBL670536,Ki,6.16,CHEMBL131851,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,6,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN[C@@H]1CCc2c(F)cccc2C1,CHEMBL672183,Ki,6.59,CHEMBL141511,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,6,197,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCN[C@@H]1CCc2c(F)cccc2C1,CHEMBL672184,Ki,6.1,CHEMBL141511,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,6,198,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCOC(=O)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3,CHEMBL672490,Ki,8.24,CHEMBL102175,1992,CHEMBL1125523,J Med Chem,Scientific Literature,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",0,286,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccc4[nH]ccc4c3O1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,CHEMBL3877884,Ki,6.97,CHEMBL3905947,2017,CHEMBL3877260,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,123,258,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCOc1c(O)ccc2c1CN1CCc3cc(OCCC)c(O)cc3[C@@H]1C2,CHEMBL5335368,Ki,6.23,CHEMBL5425375,2023,CHEMBL5331137,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,155,276,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL5335368,Ki,5.56,CHEMBL5399166,2023,CHEMBL5331137,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,155,276,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2,CHEMBL3783165,Ki,6.92,CHEMBL3781840,2016,CHEMBL3779868,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,114,278,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCSC1=CCc2ccc(/N=C/N3CCc4cc(OC)c(OC)cc4C3)cc21,CHEMBL886705,Ki,5.09,CHEMBL241283,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,51,129,C1=Cc2cc(N=CN3CCc4ccccc4C3)ccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCSC1CCc2ccc(/N=C/N3CCc4cc(OC)c(OC)cc4C3)cc21,CHEMBL886705,Ki,5.51,CHEMBL429644,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,51,129,C(=Nc1ccc2c(c1)CCC2)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1cc(-c2ccoc2)nc(N2CCN(C)CC2)n1,CHEMBL4199279,Ki,7.43,CHEMBL4204059,2018,CHEMBL4196098,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hR,129,287,c1cc(-c2ccoc2)nc(N2CCNCC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1cc(-c2ccsc2)cc(N2CCN(C)CC2)n1,CHEMBL5391038,Ki,9.7,CHEMBL5394961,2023,CHEMBL5390222,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay,155,213,c1cc(-c2ccsc2)cc(N2CCNCC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,CHEMBL3387736,Ki,7.75,CHEMBL3344458,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,98,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,CHEMBL3387745,IC50,6.04,CHEMBL3344458,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) after 40 mins by [35S]GTP-gammaS binding assay in presence of quinpirole,98,288,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,CHEMBL1285353,IC50,8.57,CHEMBL1276350,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,67,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1ccc(S(=O)(=O)Nc2ccc([C@]34CNC[C@H]3C4)cc2)cc1,CHEMBL1225698,Ki,6.9,CHEMBL1223601,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,67,93,O=S(=O)(Nc1ccc(C23CNCC2C3)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(C)CC3)cc1,CHEMBL905981,Ki,7.5,CHEMBL231334,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,51,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(Cc2cc[nH]n2)CC3)cc1,CHEMBL1108513,Ki,7.0,CHEMBL1080046,2009,CHEMBL1154336,Bioorg Med Chem Lett,Scientific Literature,Agonist activity at dopamine D2 receptor,63,200,O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCNCC3)cc1,CHEMBL905981,Ki,6.8,CHEMBL266018,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,51,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CN(C)C3)cc1,CHEMBL905981,Ki,6.7,CHEMBL395501,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,51,199,O=S(=O)(Nc1ccc2c(c1)CNC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CN(C)CC3)cc1,CHEMBL905981,Ki,6.4,CHEMBL231333,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,51,199,O=S(=O)(Nc1ccc2c(c1)CNCC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CNC3)cc1,CHEMBL905981,Ki,6.1,CHEMBL231326,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,51,199,O=S(=O)(Nc1ccc2c(c1)CNC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1ccc(S(=O)(=O)Nc2ccc3c(c2)CNCC3)cc1,CHEMBL905981,Ki,6.05,CHEMBL388247,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,51,199,O=S(=O)(Nc1ccc2c(c1)CNCC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1,CHEMBL894060,Ki,7.22,CHEMBL243743,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,51,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCc1cnc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2,CHEMBL672175,Ki,5.72,CHEMBL283247,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,16,290,c1ccc2c(c1)CCC1NCc3ncccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2,CHEMBL3801662,Ki,6.44,CHEMBL3798803,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,114,291,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2,CHEMBL3801665,Ki,7.89,CHEMBL3798803,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,114,292,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1803210,Ki,7.28,CHEMBL1803050,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,76,293,c1ccc(N2CCN(Cc3ccc(OCCCCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1803211,Ki,7.17,CHEMBL1803050,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,76,294,c1ccc(N2CCN(Cc3ccc(OCCCCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)cc2OC)nn1,CHEMBL1920023,Ki,7.92,CHEMBL1916551,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,76,295,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)C3Cc4ccccc4C3)cc2OC)nn1,CHEMBL1920024,Ki,8.39,CHEMBL1916551,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,76,296,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1,CHEMBL3578854,Ki,7.62,CHEMBL3577344,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,21,O=C(NCCCCNCCc1cccc2[nH]c(=O)ccc12)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1,CHEMBL3578855,Ki,7.28,CHEMBL3577344,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,22,O=C(NCCCCNCCc1cccc2[nH]c(=O)ccc12)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)cc2OC)nn1,CHEMBL3578854,Ki,7.75,CHEMBL3577345,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,21,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)cc2OC)nn1,CHEMBL3578855,Ki,7.52,CHEMBL3577345,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,22,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1,CHEMBL3578854,Ki,9.33,CHEMBL3577346,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,21,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1,CHEMBL3578855,Ki,9.27,CHEMBL3577346,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,108,22,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1,CHEMBL4015806,Ki,6.7,CHEMBL4068702,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,123,297,O=C(NCCCCN1CCCN(c2cccc3[nH]c(=O)ccc23)CC1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1,CHEMBL4015807,Ki,6.66,CHEMBL4068702,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,123,298,O=C(NCCCCN1CCCN(c2cccc3[nH]c(=O)ccc23)CC1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1920023,Ki,7.77,CHEMBL1916552,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,76,295,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1920024,Ki,7.92,CHEMBL1916552,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,76,296,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1,CHEMBL4015806,Ki,6.46,CHEMBL4070604,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,123,297,O=C(NCCCN1CCCN(c2cccc3[nH]c(=O)ccc23)CC1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(C(=O)NCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1,CHEMBL4015807,Ki,6.36,CHEMBL4070604,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,123,298,O=C(NCCCN1CCCN(c2cccc3[nH]c(=O)ccc23)CC1)c1ccc(OCCCc2c[nH]nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1803210,Ki,7.17,CHEMBL1803049,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,76,293,c1ccc(N2CCN(Cc3ccc(OCCCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1803211,Ki,7.28,CHEMBL1803049,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,76,294,c1ccc(N2CCN(Cc3ccc(OCCCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1803214,Ki,7.92,CHEMBL1803049,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells in presence of 100 mM sodium chloride,76,299,c1ccc(N2CCN(Cc3ccc(OCCCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1920023,Ki,7.17,CHEMBL1803049,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,76,295,c1ccc(N2CCN(Cc3ccc(OCCCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1920024,Ki,7.28,CHEMBL1803049,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,76,296,c1ccc(N2CCN(Cc3ccc(OCCCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(COc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1803210,Ki,7.2,CHEMBL1803030,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,76,293,c1ccc(N2CCN(Cc3ccc(OCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCCn1cc(COc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1803211,Ki,7.16,CHEMBL1803030,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,76,294,c1ccc(N2CCN(Cc3ccc(OCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C(=O)C1CCCCC1)[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL671651,Ki,6.74,CHEMBL78860,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,9,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C(C)C)[C@@H]1CCc2c(F)cccc2C1,CHEMBL672183,Ki,5.82,CHEMBL345087,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,6,197,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C(C)C)[C@@H]1CCc2c(F)cccc2C1,CHEMBL672184,Ki,5.33,CHEMBL345087,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,6,198,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C(C)C)[C@@H]1CCc2cccc(O)c2[C@@H]1C,CHEMBL670884,Ki,6.21,CHEMBL288721,1995,CHEMBL1128333,J Med Chem,Scientific Literature,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,5,300,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C(C)C)[C@@H]1COc2cccc(C(C)=O)c2C1,CHEMBL670887,Ki,4.52,CHEMBL3085215,2000,CHEMBL1133455,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2A by measuring its ability to displace [3H]raclopride from D2A receptor expressed in mouse fibroblast (LtK-) cells,21,301,c1ccc2c(c1)CCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C)C1CCc2ccc(O)cc2C1,CHEMBL670173,Ki,9.17,CHEMBL335392,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,6,302,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C)C1CCc2ccc(O)cc2C1,CHEMBL670536,Ki,6.72,CHEMBL335392,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,6,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801662,Ki,5.93,CHEMBL3797740,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,291,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801665,Ki,7.9,CHEMBL3797740,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,292,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C/C=C/I)C1CCc2c(O)cccc2C1,CHEMBL670083,Ki,6.49,CHEMBL263282,1994,CHEMBL1127788,J Med Chem,Scientific Literature,Tested for the inhibitory activity against Dopamine D2 receptor in infected Sf9 cells,3,303,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C/C=C/I)C1CCc2c(O)cccc2C1,CHEMBL675959,Ki,8.44,CHEMBL263282,1994,CHEMBL1127788,J Med Chem,Scientific Literature,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,3,304,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C/C=C/I)C1CCc2cc(O)ccc2C1,CHEMBL670083,Ki,6.26,CHEMBL336851,1994,CHEMBL1127788,J Med Chem,Scientific Literature,Tested for the inhibitory activity against Dopamine D2 receptor in infected Sf9 cells,3,303,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C/C=C/I)C1CCc2cc(O)ccc2C1,CHEMBL675959,Ki,8.01,CHEMBL336851,1994,CHEMBL1127788,J Med Chem,Scientific Literature,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,3,304,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C/C=C/I)C1CCc2ccc(O)cc2C1,CHEMBL670083,Ki,6.58,CHEMBL110239,1994,CHEMBL1127788,J Med Chem,Scientific Literature,Tested for the inhibitory activity against Dopamine D2 receptor in infected Sf9 cells,3,303,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C/C=C/I)C1CCc2ccc(O)cc2C1,CHEMBL675959,Ki,8.18,CHEMBL110239,1994,CHEMBL1127788,J Med Chem,Scientific Literature,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,3,304,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C/C=C/I)C1CCc2cccc(O)c2C1,CHEMBL673097,Ki,5.97,CHEMBL284716,1993,CHEMBL1126858,J Med Chem,Scientific Literature,Inhibitory activity against [125I]- NCQ298 binding to dopamine receptor D2 in Sf 9 cells,1,305,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C/C=C/I)C1COc2c(O)cccc2C1,CHEMBL670083,Ki,6.11,CHEMBL133085,1994,CHEMBL1127788,J Med Chem,Scientific Literature,Tested for the inhibitory activity against Dopamine D2 receptor in infected Sf9 cells,3,303,c1ccc2c(c1)CCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(C/C=C/I)C1COc2c(O)cccc2C1,CHEMBL675959,Ki,7.97,CHEMBL133085,1994,CHEMBL1127788,J Med Chem,Scientific Literature,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,3,304,c1ccc2c(c1)CCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CC1CC1)[C@@H]1CCc2ccc3[nH]c(C(N)=O)cc3c2C1,CHEMBL670667,Ki,6.41,CHEMBL1788192,1993,CHEMBL1126741,J Med Chem,Scientific Literature,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,1,306,c1cc2c3c(ccc2[nH]1)CCC(NCC1CC1)C3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1)[C@@H]1C[C@H]1c1ccc(Cl)cc1,CHEMBL5363864,Ki,6.01,CHEMBL5397609,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,155,244,c1ccc(C(CCNC2CC2c2ccccc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CC=C(C#C[Si](C)(C)C)CC1,CHEMBL670558,Ki,6.01,CHEMBL163087,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity on High Affinity Site of Dopamine receptor D2S,21,9,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CC=C(C#C[Si](C)(C)C)CC1,CHEMBL672527,Ki,6.8,CHEMBL163087,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding affinity on High Affinity Site of Dopamine receptor D2L,21,6,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CC=C(C#C[Si](C)(C)C)CC1,CHEMBL672529,Ki,7.8,CHEMBL163087,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2L,21,12,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CC=C(C#C[Si](C)(C)C)CC1,CHEMBL872880,Ki,7.77,CHEMBL163087,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2S,21,15,C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CC=C(C#Cc2ccccc2)CC1,CHEMBL672381,Ki,4.82,CHEMBL166325,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was tested on High Affinity Site of Dopamine receptor D2L,21,307,C(#Cc1ccccc1)C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CC=C(C#Cc2ccccc2)CC1,CHEMBL672954,Ki,4.82,CHEMBL166325,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was tested on High Affinity Site of Dopamine receptor D2S,21,308,C(#Cc1ccccc1)C1=CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCC(=C(C#C[Si](C)(C)C)C#C[Si](C)(C)C)CC1,CHEMBL670558,Ki,4.89,CHEMBL164736,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity on High Affinity Site of Dopamine receptor D2S,21,9,C=C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCC(=C(C#C[Si](C)(C)C)C#C[Si](C)(C)C)CC1,CHEMBL672527,Ki,4.96,CHEMBL164736,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding affinity on High Affinity Site of Dopamine receptor D2L,21,6,C=C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCC(=C(C#Cc2ccccc2)C#Cc2ccccc2)CC1,CHEMBL670558,Ki,5.14,CHEMBL165171,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity on High Affinity Site of Dopamine receptor D2S,21,9,C(#Cc1ccccc1)C(C#Cc1ccccc1)=C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCC(=C(C#Cc2ccccc2)C#Cc2ccccc2)CC1,CHEMBL672527,Ki,5.28,CHEMBL165171,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding affinity on High Affinity Site of Dopamine receptor D2L,21,6,C(#Cc1ccccc1)C(C#Cc1ccccc1)=C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCC(=C(C#N)C#N)CC1,CHEMBL670558,Ki,4.82,CHEMBL164950,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity on High Affinity Site of Dopamine receptor D2S,21,9,C=C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCC2=C(CCC/C2=N\O)C1,CHEMBL5128620,Ki,5.65,CHEMBL132575,2022,CHEMBL5126552,Eur J Med Chem,Scientific Literature,Agonist activity at dopamine D2 receptor (unknown origin),153,309,N=C1CCCC2=C1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2c(O)cccc2C1,CHEMBL1050539,Ki,7.23,CHEMBL273273,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,67,310,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2c(O)cccc2C1,CHEMBL1065654,Ki,7.23,CHEMBL273273,2010,CHEMBL1157569,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,67,311,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2c(O)cccc2C1,CHEMBL671420,Ki,8.22,CHEMBL273273,1995,CHEMBL1128506,J Med Chem,Scientific Literature,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,5,312,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2c(O)cccc2C1,CHEMBL671421,Ki,7.58,CHEMBL273273,1995,CHEMBL1128506,J Med Chem,Scientific Literature,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,5,313,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2c(cccc2OC)C1,CHEMBL670536,Ki,6.38,CHEMBL11615,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,6,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(CCc3ccc(/C(C)=N\O)cc3)ccc2C1,CHEMBL674345,Ki,6.1,CHEMBL130282,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,6,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(CCc3ccc(C(=O)OCC)cc3)ccc2C1,CHEMBL674345,Ki,6.6,CHEMBL130101,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(CCc3ccc(C(C)=O)cc3)ccc2C1,CHEMBL674345,Ki,6.0,CHEMBL133800,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(CCc3ccc(O)cc3)ccc2C1,CHEMBL674345,Ki,6.5,CHEMBL130304,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(CCc3ccc(OC)cc3)ccc2C1,CHEMBL674345,Ki,6.6,CHEMBL441089,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(CCc3ccccc3)ccc2C1,CHEMBL674345,Ki,6.4,CHEMBL130665,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(CN(C(=O)OC)c3ccc(OC)cc3)ccc2C1,CHEMBL674345,Ki,6.1,CHEMBL133166,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(NCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(CN(C(C)=O)c3ccc(OC)cc3)ccc2C1,CHEMBL674345,Ki,6.2,CHEMBL338496,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(NCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(CN(C(N)=O)c3ccc(OC)cc3)ccc2C1,CHEMBL674345,Ki,5.2,CHEMBL338938,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(NCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(CS(=O)(=O)c3ccc(OC)cc3)ccc2C1,CHEMBL674345,Ki,6.2,CHEMBL334529,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,O=S(=O)(Cc1ccc2c(c1)CCCC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(CSc3ccc(OC)cc3)ccc2C1,CHEMBL674345,Ki,6.7,CHEMBL130843,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(SCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc(OC)ccc2C1,CHEMBL671420,Ki,5.41,CHEMBL106047,1995,CHEMBL1128506,J Med Chem,Scientific Literature,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,5,312,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cc3c(cc2C1)OCC3,CHEMBL674942,Ki,6.6,CHEMBL140184,1997,CHEMBL1129892,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,10,179,c1c2c(cc3c1CCO3)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2ccc(O)cc2C1,CHEMBL1065654,Ki,6.7,CHEMBL285755,2010,CHEMBL1157569,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,67,311,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2ccc(O)cc2C1,CHEMBL2162509,Ki,5.84,CHEMBL1255966,2012,CHEMBL2157876,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,81,315,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2ccc(O)cc2C1,CHEMBL3801662,Ki,6.84,CHEMBL285755,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,291,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2ccc(O)cc2C1,CHEMBL3801665,Ki,8.64,CHEMBL285755,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,292,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2ccc(O)cc2C1,CHEMBL673097,Ki,6.85,CHEMBL285755,1993,CHEMBL1126858,J Med Chem,Scientific Literature,Inhibitory activity against [125I]- NCQ298 binding to dopamine receptor D2 in Sf 9 cells,1,305,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2ccc(O)cc2C1,CHEMBL675959,Ki,6.85,CHEMBL285755,1994,CHEMBL1127788,J Med Chem,Scientific Literature,Tested for the inhibitory activity against D2H (high-affinity states) receptor in infected HEK 293 cells.,3,304,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cccc(O)c2C1,CHEMBL670781,Ki,7.08,CHEMBL56,1997,CHEMBL1129976,J Med Chem,Scientific Literature,Binding affinity against Dopamine receptor D2,10,316,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cccc(O)c2C1,CHEMBL672485,Ki,7.07,CHEMBL56,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cccc(O)c2C1,CHEMBL672486,Ki,7.07,CHEMBL56,1993,CHEMBL1126639,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,83,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cccc(O)c2C1,CHEMBL673097,Ki,5.49,CHEMBL56,1993,CHEMBL1126858,J Med Chem,Scientific Literature,Inhibitory activity against [125I]- NCQ298 binding to dopamine receptor D2 in Sf 9 cells,1,305,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2cccc(OS(=O)(=O)C(F)(F)F)c2C1,CHEMBL673095,Ki,7.21,CHEMBL28437,1995,CHEMBL1128298,J Med Chem,Scientific Literature,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,5,317,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2ccsc2C1,CHEMBL671417,Ki,7.57,CHEMBL103857,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1cc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2n[nH]cc2C1,CHEMBL671420,Ki,6.28,CHEMBL318740,1995,CHEMBL1128506,J Med Chem,Scientific Literature,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,5,312,c1[nH]nc2c1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2nc(N)ccc2C1,CHEMBL671420,Ki,8.3,CHEMBL110888,1995,CHEMBL1128506,J Med Chem,Scientific Literature,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,5,312,c1cnc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2nc(N)ccc2C1,CHEMBL671421,Ki,7.77,CHEMBL110888,1995,CHEMBL1128506,J Med Chem,Scientific Literature,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,5,313,c1cnc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2nc(N)sc2C1,CHEMBL671420,Ki,7.24,CHEMBL105512,1995,CHEMBL1128506,J Med Chem,Scientific Literature,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,5,312,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2nc(N)sc2C1,CHEMBL671421,Ki,6.33,CHEMBL105512,1995,CHEMBL1128506,J Med Chem,Scientific Literature,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,5,313,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2nc(OC)ccc2C1,CHEMBL671420,Ki,5.92,CHEMBL105509,1995,CHEMBL1128506,J Med Chem,Scientific Literature,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,5,312,c1cnc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2ncccc2C1,CHEMBL671420,Ki,6.33,CHEMBL105977,1995,CHEMBL1128506,J Med Chem,Scientific Literature,In vitro binding affinity is the ability to displace [3H]N-0437 from human Dopamine receptor D2 expressed in CHO-K1 cells,5,312,c1cnc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2ncccc2C1,CHEMBL671421,Ki,6.57,CHEMBL105977,1995,CHEMBL1128506,J Med Chem,Scientific Literature,In vitro binding affinity is the ability to displace [3H]spiperone from human Dopamine receptor D2 expressed in CHO-K1 cells,5,313,c1cnc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCc2sccc2C1,CHEMBL671417,Ki,7.7,CHEMBL103622,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1cc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCn2ncc(C=O)c2C1,CHEMBL872127,Ki,5.23,CHEMBL198174,2005,CHEMBL1141074,J Med Chem,Scientific Literature,Binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,319,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCn2ncc(C=O)c2C1,CHEMBL872131,Ki,5.4,CHEMBL198174,2005,CHEMBL1141074,J Med Chem,Scientific Literature,Binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,320,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCn2ncc(Cl)c2C1,CHEMBL872139,Ki,6.92,CHEMBL194099,2005,CHEMBL1141074,J Med Chem,Scientific Literature,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,321,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCn2ncc(Cl)c2C1,CHEMBL872141,Ki,4.92,CHEMBL194099,2005,CHEMBL1141074,J Med Chem,Scientific Literature,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,322,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCn2ncc(Cl)c2C1,CHEMBL872142,Ki,6.68,CHEMBL194099,2005,CHEMBL1141074,J Med Chem,Scientific Literature,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,323,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCn2nccc2C1,CHEMBL872138,Ki,4.75,CHEMBL196928,2005,CHEMBL1141074,J Med Chem,Scientific Literature,Low binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,324,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCn2nccc2C1,CHEMBL872139,Ki,6.66,CHEMBL196928,2005,CHEMBL1141074,J Med Chem,Scientific Literature,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,321,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCn2nccc2C1,CHEMBL872141,Ki,5.07,CHEMBL196928,2005,CHEMBL1141074,J Med Chem,Scientific Literature,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,322,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1CCn2nccc2C1,CHEMBL872142,Ki,6.8,CHEMBL196928,2005,CHEMBL1141074,J Med Chem,Scientific Literature,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,323,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1COc2c(O)cccc2C1,CHEMBL669149,Ki,6.89,CHEMBL38428,1999,CHEMBL1132392,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,16,325,c1ccc2c(c1)CCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1COc2c(ccc3sc(N)nc23)C1,CHEMBL671516,Ki,6.27,CHEMBL332677,2000,CHEMBL1133651,J Med Chem,Scientific Literature,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]-0437 as radioligand.,21,326,c1nc2c3c(ccc2s1)CCCO3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1COc2c(ccc3sc(N)nc23)C1,CHEMBL872883,Ki,5.46,CHEMBL332677,2000,CHEMBL1133651,J Med Chem,Scientific Literature,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]spiperone as radioligand.,21,327,c1nc2c3c(ccc2s1)CCCO3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1COc2c(cccc2-c2ccc(C(F)(F)F)cc2)C1,CHEMBL669149,Ki,6.12,CHEMBL43073,1999,CHEMBL1132392,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,16,325,c1ccc(-c2cccc3c2OCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1COc2c(cccc2-c2ccc(OC)cc2)C1,CHEMBL669149,Ki,5.96,CHEMBL41200,1999,CHEMBL1132392,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,16,325,c1ccc(-c2cccc3c2OCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1COc2c(cccc2-c2ccccc2)C1,CHEMBL669149,Ki,6.23,CHEMBL41134,1999,CHEMBL1132392,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,16,325,c1ccc(-c2cccc3c2OCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1COc2c(cccc2-c2ccoc2)C1,CHEMBL669149,Ki,7.32,CHEMBL38580,1999,CHEMBL1132392,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,16,325,c1cc2c(c(-c3ccoc3)c1)OCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1COc2c(cccc2-c2ccsc2)C1,CHEMBL669149,Ki,6.4,CHEMBL39847,1999,CHEMBL1132392,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,16,325,c1cc2c(c(-c3ccsc3)c1)OCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1COc2c(cccc2C(=O)c2ccoc2)C1,CHEMBL669149,Ki,5.87,CHEMBL38656,1999,CHEMBL1132392,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to inhibit [3H]raclopride binding to cloned human D2A receptors expressed in mouse fibroblast (LtK-) cells,16,325,O=C(c1ccoc1)c1cccc2c1OCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1COc2ccc3nc(N)sc3c2C1,CHEMBL671516,Ki,7.33,CHEMBL116372,2000,CHEMBL1133651,J Med Chem,Scientific Literature,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]-0437 as radioligand.,21,326,c1nc2ccc3c(c2s1)CCCO3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1COc2ccc3nc(N)sc3c2C1,CHEMBL872883,Ki,5.23,CHEMBL116372,2000,CHEMBL1133651,J Med Chem,Scientific Literature,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]spiperone as radioligand.,21,327,c1nc2ccc3c(c2s1)CCCO3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1Cc2cc3nc(N)sc3cc2C1,CHEMBL5128620,Ki,7.57,CHEMBL325710,2022,CHEMBL5126552,Eur J Med Chem,Scientific Literature,Agonist activity at dopamine D2 receptor (unknown origin),153,309,c1nc2cc3c(cc2s1)CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1Cc2cc3nc(N)sc3cc2C1,CHEMBL671517,Ki,7.57,CHEMBL325710,2000,CHEMBL1133651,J Med Chem,Scientific Literature,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]NPA as radioligand.,21,328,c1nc2cc3c(cc2s1)CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)C1Cc2ccc3nc(N)sc3c2C1,CHEMBL671517,Ki,6.3,CHEMBL118636,2000,CHEMBL1133651,J Med Chem,Scientific Literature,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]NPA as radioligand.,21,328,c1nc2ccc3c(c2s1)CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)CC1CCc2ccsc2C1,CHEMBL671417,Ki,5.51,CHEMBL103912,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1cc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)CC1CCc2sccc2C1,CHEMBL671417,Ki,5.69,CHEMBL104135,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1cc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)CC1COc2cccc(OC)c2C1,CHEMBL670073,IC50,5.59,CHEMBL11262,1996,CHEMBL1129704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,7,329,c1ccc2c(c1)CCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL995087,Ki,5.01,CHEMBL484204,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,59,16,c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL995088,Ki,5.06,CHEMBL484204,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,59,17,c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCN(CCC)CCC)cc3)nc3ccccc32)cc1,CHEMBL670392,Ki,6.46,CHEMBL315137,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,C(=CCn1c(-c2ccccc2)nc2ccccc21)Cn1c(-c2ccccc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)CC[C@H]1CC[C@H](Nc2ncccn2)CC1,CHEMBL672206,Ki,5.62,CHEMBL165381,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,13,62,c1cnc(NC2CCCCC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)CCc1cccc2c1CC(=O)N2,CHEMBL3587541,Ki,8.43,CHEMBL589,2014,CHEMBL3585327,Medchemcomm,Scientific Literature,Binding affinity to human dopamine D2 receptor,98,330,O=C1Cc2ccccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)CCc1cccc2c1CC(=O)N2,CHEMBL672313,Ki,8.14,CHEMBL589,1997,CHEMBL1130416,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,10,190,O=C1Cc2ccccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)CCc1cccc2c1CC(=O)N2,CHEMBL981461,Ki,6.16,CHEMBL589,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,O=C1Cc2ccccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(F)cccc2C1,CHEMBL669147,Ki,7.58,CHEMBL69985,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,16,331,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(F)cccc2C1,CHEMBL669148,Ki,6.7,CHEMBL69985,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,16,332,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(F)cccc2C1,CHEMBL672183,Ki,7.58,CHEMBL69985,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,7,197,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(F)cccc2C1,CHEMBL672184,Ki,6.7,CHEMBL69985,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,7,198,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(O)cccc2C1,CHEMBL670173,Ki,7.26,CHEMBL15146,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,7,302,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(O)cccc2C1,CHEMBL670536,Ki,7.05,CHEMBL15146,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C,CHEMBL665374,Ki,7.82,CHEMBL278751,1994,CHEMBL1150496,Bioorg Med Chem Lett,Scientific Literature,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),3,333,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C,CHEMBL673016,Ki,7.89,CHEMBL278751,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C,CHEMBL674345,Ki,7.2,CHEMBL278751,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(OS(=O)(=O)C(F)(F)F)cccc2[C@@H]1C,CHEMBL665374,Ki,6.26,CHEMBL161811,1994,CHEMBL1150496,Bioorg Med Chem Lett,Scientific Literature,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),3,333,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(ccc(C(O)Cc3ccc(Cl)cc3)c2OC)C1,CHEMBL674345,Ki,6.2,CHEMBL129997,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(ccc(C(O)Cc3ccc(Cl)cc3)c2OC)[C@@H]1C,CHEMBL674345,Ki,6.2,CHEMBL132574,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(ccc(C(O)Cc3ccccc3)c2OC)C1,CHEMBL674345,Ki,6.0,CHEMBL130423,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(ccc(CCc3ccc(C(F)(F)F)cc3)c2OC)C1,CHEMBL674345,Ki,7.0,CHEMBL424458,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(ccc(CCc3ccc(Cl)cc3)c2OC)C1,CHEMBL674345,Ki,6.9,CHEMBL132769,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669147,Ki,8.2,CHEMBL68573,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,16,331,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669148,Ki,7.34,CHEMBL68573,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,16,332,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cc(CCc3ccc(/C(C)=N\O)cc3)ccc2C1,CHEMBL674345,Ki,6.5,CHEMBL336971,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cc(CCc3ccc(C(C)=O)cc3)ccc2C1,CHEMBL674345,Ki,6.1,CHEMBL133519,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cc(CCc3ccc(Cl)cc3)ccc2C1,CHEMBL674345,Ki,6.4,CHEMBL132789,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cc(CS(=O)(=O)c3ccc(I)cc3)ccc2C1,CHEMBL674345,Ki,6.7,CHEMBL130678,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,O=S(=O)(Cc1ccc2c(c1)CCCC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cc(CS(=O)(=O)c3ccc(OC)cc3)ccc2C1,CHEMBL674345,Ki,6.3,CHEMBL131556,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,O=S(=O)(Cc1ccc2c(c1)CCCC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,CHEMBL1050539,Ki,6.7,CHEMBL301559,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,67,310,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,CHEMBL3801477,Ki,7.4,CHEMBL301559,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,115,196,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,CHEMBL670173,Ki,7.47,CHEMBL301559,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,7,302,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,CHEMBL670536,Ki,7.25,CHEMBL301559,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,CHEMBL671417,Ki,7.47,CHEMBL301559,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,CHEMBL671651,Ki,9.3,CHEMBL301559,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,10,113,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccc(O)cc2C1,CHEMBL926379,Ki,6.7,CHEMBL301559,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccc(OC)cc2C1,CHEMBL670536,Ki,5.23,CHEMBL134326,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccc3[nH]c(C#N)cc3c2C1,CHEMBL670667,Ki,7.46,CHEMBL71920,1993,CHEMBL1126741,J Med Chem,Scientific Literature,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,1,306,c1cc2c3c(ccc2[nH]1)CCCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccc3[nH]c(C(N)=O)cc3c2C1,CHEMBL670667,Ki,6.67,CHEMBL1744036,1993,CHEMBL1126741,J Med Chem,Scientific Literature,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,1,306,c1cc2c3c(ccc2[nH]1)CCCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccc3[nH]cc(C(C)=O)c3c2C1,CHEMBL673017,Ki,7.77,CHEMBL65274,1993,CHEMBL1126740,J Med Chem,Scientific Literature,In vitro binding affinity against dopamine receptor D2 using [3H]raclopride as radioligand in CHO cells (sc),1,334,c1cc2c3c(ccc2[nH]1)CCCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cccc(C(=O)OC)c2[C@@H]1C,CHEMBL670884,Ki,7.23,CHEMBL40634,1995,CHEMBL1128333,J Med Chem,Scientific Literature,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,5,300,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cccc(C(C)=O)c2[C@@H]1C,CHEMBL670884,Ki,7.4,CHEMBL290091,1995,CHEMBL1128333,J Med Chem,Scientific Literature,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,5,300,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cccc(O)c2C1,CHEMBL664743,Ki,6.09,CHEMBL26998,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,21,335,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cccc(O)c2C1,CHEMBL670667,Ki,7.03,CHEMBL26998,1993,CHEMBL1126741,J Med Chem,Scientific Literature,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,1,306,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cccc(O)c2C1,CHEMBL673095,Ki,7.05,CHEMBL26998,1995,CHEMBL1128298,J Med Chem,Scientific Literature,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,5,317,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cccc(O)c2[C@@H]1C,CHEMBL670884,Ki,7.52,CHEMBL43475,1995,CHEMBL1128333,J Med Chem,Scientific Literature,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,5,300,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cccc(OC)c2[C@@H]1C,CHEMBL670884,Ki,7.47,CHEMBL290446,1995,CHEMBL1128333,J Med Chem,Scientific Literature,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,5,300,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2cccc(OS(=O)(=O)C(F)(F)F)c2[C@@H]1C,CHEMBL670884,Ki,6.91,CHEMBL290546,1995,CHEMBL1128333,J Med Chem,Scientific Literature,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,5,300,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCc2ccccc2[C@@H]1C,CHEMBL670884,Ki,7.06,CHEMBL41802,1995,CHEMBL1128333,J Med Chem,Scientific Literature,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,5,300,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCn2nccc2C1,CHEMBL1769067,Ki,4.26,CHEMBL197159,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,336,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCn2nccc2C1,CHEMBL1769068,Ki,4.28,CHEMBL197159,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,76,337,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1CCn2nccc2C1,CHEMBL1769072,Ki,4.24,CHEMBL197159,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,338,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc(O)c2C[C@H]1C,CHEMBL671417,Ki,7.85,CHEMBL15136,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3c2N(C1)C(=O)NC3,CHEMBL673016,Ki,7.24,CHEMBL24110,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,O=C1NCc2cccc3c2N1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,CHEMBL3801662,Ki,6.84,CHEMBL3797209,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,291,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,CHEMBL3801665,Ki,8.59,CHEMBL3797209,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,292,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,CHEMBL4011220,IC50,6.8,CHEMBL3797209,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,123,339,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,CHEMBL4011224,IC50,6.03,CHEMBL3797209,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,123,340,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,CHEMBL4011228,IC50,7.0,CHEMBL3797209,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,123,341,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL4011211,Ki,7.06,CHEMBL4068455,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,123,342,O=C(NCCCCn1c(=O)n2c3c(cccc31)CCC2)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL4011220,IC50,6.15,CHEMBL4068455,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Antagonist activity at renilla luciferase-tagged human dopamine D2 receptor expressed in HEK293 cells coexpressing mVenus-fused beta-arrestin 2 assessed as reduction in quinpirole-mediated beta-arrestin 2 recruitment preincubated for 15 mins followed by quinpirole addition measured for 1 sec by BRET assay,123,339,O=C(NCCCCn1c(=O)n2c3c(cccc31)CCC2)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL4011224,IC50,5.44,CHEMBL4068455,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,123,340,O=C(NCCCCn1c(=O)n2c3c(cccc31)CCC2)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL4011228,IC50,5.7,CHEMBL4068455,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,123,341,O=C(NCCCCn1c(=O)n2c3c(cccc31)CCC2)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3ccc(=O)n(c23)C1,CHEMBL673016,Ki,8.46,CHEMBL24978,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,O=c1ccc2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3nc(O)n(c23)C1,CHEMBL3801665,Ki,7.94,CHEMBL26181,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,292,c1cc2c3c(c1)ncn3CCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3nc(O)n(c23)C1,CHEMBL673016,Ki,8.77,CHEMBL26181,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1cc2c3c(c1)ncn3CCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@@H]1Cc2cccc3nc(S)n(c23)C1,CHEMBL673016,Ki,9.22,CHEMBL281248,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1cc2c3c(c1)ncn3CCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2c(F)ccc(O)c2C1,CHEMBL664743,Ki,5.42,CHEMBL22778,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,21,335,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2c(O)cccc2C1,CHEMBL3801477,Ki,8.15,CHEMBL269004,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,115,196,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2c(O)cccc2C1,CHEMBL670173,Ki,7.85,CHEMBL269004,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,7,302,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2c(O)cccc2C1,CHEMBL670536,Ki,8.22,CHEMBL269004,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2c(ccc(O)c2O)C1,CHEMBL5128620,Ki,8.7,CHEMBL155596,2022,CHEMBL5126552,Eur J Med Chem,Scientific Literature,Agonist activity at dopamine D2 receptor (unknown origin),153,309,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2c(cccc2-c2c(OC)cccc2OC)C1,CHEMBL830366,Ki,5.92,CHEMBL361875,2004,CHEMBL1138658,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to human dopamine D2A receptor expressed in Ltk cells,37,343,c1ccc(-c2cccc3c2CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2cc(CCc3ccc(Cl)cc3)ccc2C1,CHEMBL674345,Ki,6.9,CHEMBL132724,1996,CHEMBL1129777,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2 in mouse LtK- cells using [3H]spiperone.,7,314,c1ccc(CCc2ccc3c(c2)CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2ccc(O)cc2C1,CHEMBL670173,Ki,6.56,CHEMBL305706,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,7,302,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2ccc(O)cc2C1,CHEMBL670536,Ki,5.32,CHEMBL305706,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2ccc(OC)cc2C1,CHEMBL670536,Ki,5.47,CHEMBL135944,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2ccc3[nH]c(C#N)cc3c2C1,CHEMBL670667,Ki,6.05,CHEMBL1744035,1993,CHEMBL1126741,J Med Chem,Scientific Literature,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,1,306,c1cc2c3c(ccc2[nH]1)CCCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2ccc3[nH]cc(C(C)=O)c3c2C1,CHEMBL673017,Ki,6.37,CHEMBL63449,1993,CHEMBL1126740,J Med Chem,Scientific Literature,In vitro binding affinity against dopamine receptor D2 using [3H]raclopride as radioligand in CHO cells (sc),1,334,c1cc2c3c(ccc2[nH]1)CCCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2cccc(OC)c2[C@H]1C,CHEMBL670884,Ki,5.98,CHEMBL287770,1995,CHEMBL1128333,J Med Chem,Scientific Literature,In vitro binding affinity towards human Dopamine receptor D2A was determined in mouse fibroblast LtK cells using [3H]raclopride,5,300,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2nn3ccccc3c2C1,CHEMBL672385,Ki,7.07,CHEMBL310867,2002,CHEMBL1134894,Bioorg Med Chem Lett,Scientific Literature,Binding affinity of compound measured using [3H]spiperone for the cloned human Dopamine receptor D2L (high/low affinity is given as 85/6400),28,344,c1ccn2nc3c(c2c1)CCCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCc2nn3ccccc3c2C1,CHEMBL672574,Ki,7.46,CHEMBL310867,2002,CHEMBL1134894,Bioorg Med Chem Lett,Scientific Literature,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 short (high/low affinity is given as 35/3700),28,345,c1ccn2nc3c(c2c1)CCCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C#N)ccc2C1,CHEMBL829826,Ki,5.19,CHEMBL372020,2005,CHEMBL1143571,J Med Chem,Scientific Literature,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,39,346,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C#N)ccc2C1,CHEMBL829827,Ki,5.29,CHEMBL372020,2005,CHEMBL1143571,J Med Chem,Scientific Literature,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,39,347,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C#N)ccc2C1,CHEMBL829839,Ki,6.72,CHEMBL372020,2005,CHEMBL1143571,J Med Chem,Scientific Literature,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,39,348,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C#N)ccc2C1,CHEMBL829840,Ki,6.89,CHEMBL372020,2005,CHEMBL1143571,J Med Chem,Scientific Literature,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,39,349,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1,CHEMBL829826,Ki,5.16,CHEMBL316983,2005,CHEMBL1143571,J Med Chem,Scientific Literature,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,39,346,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1,CHEMBL829827,Ki,5.52,CHEMBL316983,2005,CHEMBL1143571,J Med Chem,Scientific Literature,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,39,347,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1,CHEMBL829839,Ki,7.28,CHEMBL316983,2005,CHEMBL1143571,J Med Chem,Scientific Literature,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,39,348,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1,CHEMBL829840,Ki,7.39,CHEMBL316983,2005,CHEMBL1143571,J Med Chem,Scientific Literature,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,39,349,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1,CHEMBL872139,Ki,7.28,CHEMBL316983,2005,CHEMBL1141074,J Med Chem,Scientific Literature,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,321,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1,CHEMBL872142,Ki,7.39,CHEMBL316983,2005,CHEMBL1141074,J Med Chem,Scientific Literature,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,323,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1,CHEMBL885374,Ki,5.16,CHEMBL316983,2005,CHEMBL1141074,J Med Chem,Scientific Literature,"Binding affinity (low) towards human dopamine receptor 2 long against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",39,350,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2c(C=O)ccc2C1,CHEMBL885377,Ki,5.52,CHEMBL316983,2005,CHEMBL1141074,J Med Chem,Scientific Literature,"Binding affinity (low) towards human dopamine receptor 2 short against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",39,351,c1cc2n(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2nccc2C1,CHEMBL1769067,Ki,6.39,CHEMBL193337,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,336,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2nccc2C1,CHEMBL1769068,Ki,6.57,CHEMBL193337,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,76,337,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2nccc2C1,CHEMBL1769072,Ki,8.34,CHEMBL193337,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,338,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2nccc2C1,CHEMBL872138,Ki,4.82,CHEMBL193337,2005,CHEMBL1141074,J Med Chem,Scientific Literature,Low binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,324,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2nccc2C1,CHEMBL872139,Ki,6.75,CHEMBL193337,2005,CHEMBL1141074,J Med Chem,Scientific Literature,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,321,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2nccc2C1,CHEMBL872141,Ki,5.0,CHEMBL193337,2005,CHEMBL1141074,J Med Chem,Scientific Literature,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,322,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)[C@H]1CCn2nccc2C1,CHEMBL872142,Ki,6.6,CHEMBL193337,2005,CHEMBL1141074,J Med Chem,Scientific Literature,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,323,c1cc2n(n1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCC)c1ccc(C2CN(CCC)[C@@H](C)CO2)cn1,CHEMBL4361371,Ki,5.08,CHEMBL4562186,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,c1cncc(C2CNCCO2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)[C@@H]1CCc2ccc3[nH]c(C#N)cc3c2C1,CHEMBL670667,Ki,7.36,CHEMBL1744088,1993,CHEMBL1126741,J Med Chem,Scientific Literature,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,1,306,O=C1CCCC(=O)N1CCCCNC1CCc2ccc3[nH]ccc3c2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)[C@@H]1CCc2ccc3[nH]c(C(N)=O)cc3c2C1,CHEMBL670667,Ki,7.42,CHEMBL1744037,1993,CHEMBL1126741,J Med Chem,Scientific Literature,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,1,306,O=C1CCCC(=O)N1CCCCNC1CCc2ccc3[nH]ccc3c2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1C(=O)CC(C)(C)CC1=O)[C@H]1CCc2ccc3[nH]c(C(N)=O)cc3c2C1,CHEMBL670667,Ki,6.04,CHEMBL1788191,1993,CHEMBL1126741,J Med Chem,Scientific Literature,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,1,306,O=C1CCCC(=O)N1CCCCNC1CCc2ccc3[nH]ccc3c2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1,CHEMBL670073,IC50,8.0,CHEMBL11592,1996,CHEMBL1129704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,7,329,O=C1CC2(CCCC2)CC(=O)N1CCCCNC1COc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)CC1COc2cccc(OC)c2C1,CHEMBL670073,IC50,5.75,CHEMBL417608,1996,CHEMBL1129704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,7,329,O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)[C@@H]1CCc2c(F)cccc2C1,CHEMBL672183,Ki,8.31,CHEMBL138998,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,7,197,O=C1CC2(CCCC2)CC(=O)N1CCCCNC1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)[C@@H]1CCc2c(F)cccc2C1,CHEMBL672794,Ki,7.77,CHEMBL138998,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,7,353,O=C1CC2(CCCC2)CC(=O)N1CCCCNC1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1CCN(c2cccc(Cl)c2Cl)CC1)C1CCc2ccc(O)cc2C1,CHEMBL670524,Ki,8.06,CHEMBL157036,2002,CHEMBL1135449,Bioorg Med Chem Lett,Scientific Literature,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,28,27,c1ccc(N2CCN(CCCCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Cc1ccc2c(c1)Cc1ccccc1-2,CHEMBL1777183,Ki,6.57,CHEMBL1774546,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,76,354,c1ccc(N2CCN(CCCCNCc3ccc4c(c3)Cc3ccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Cc1ccc2ccccc2c1,CHEMBL1777183,Ki,6.5,CHEMBL1774548,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,76,354,c1ccc(N2CCN(CCCCNCc3ccc4ccccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1CCN(c2cccc(Cl)c2Cl)CC1)Cc1csc2ccccc12,CHEMBL1777183,Ki,6.79,CHEMBL1774544,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,76,354,c1ccc(N2CCN(CCCCNCc3csc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2cc(O)c(O)cc2C1,CHEMBL926379,Ki,7.66,CHEMBL254203,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,c1ccc(N2CCN(CCCCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1,CHEMBL670524,Ki,6.94,CHEMBL155826,2002,CHEMBL1135449,Bioorg Med Chem Lett,Scientific Literature,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,28,27,c1ccc(N2CCN(CCCCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1,CHEMBL926379,Ki,7.71,CHEMBL155826,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,c1ccc(N2CCN(CCCCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1CCN(c2ccccc2OC)CC1)Cc1ccc2c(c1)Cc1ccccc1-2,CHEMBL1777183,Ki,6.71,CHEMBL1774545,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,76,354,c1ccc(N2CCN(CCCCNCc3ccc4c(c3)Cc3ccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1CCN(c2ccccc2OC)CC1)Cc1ccc2ccccc2c1,CHEMBL1777183,Ki,6.92,CHEMBL1774547,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,76,354,c1ccc(N2CCN(CCCCNCc3ccc4ccccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCN1CCN(c2ccccc2OC)CC1)Cc1csc2ccccc12,CHEMBL1777183,Ki,7.16,CHEMBL1774543,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,76,354,c1ccc(N2CCN(CCCCNCc3csc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)/C=C/c1ccc(F)cc1)C1Cc2ccccc2C1,CHEMBL3592693,Ki,7.72,CHEMBL3590080,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,108,355,O=C(C=Cc1ccccc1)NCCCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)/C=C/c1ccc(F)cc1)C1Cc2ccccc2C1,CHEMBL3592694,Ki,8.54,CHEMBL3590080,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,108,356,O=C(C=Cc1ccccc1)NCCCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)/N=N/c1cc(F)c(F)c(F)c1)C1Cc2ccccc2C1,CHEMBL3592693,Ki,7.4,CHEMBL3590083,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,108,355,O=C(N=Nc1ccccc1)NCCCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)/N=N/c1cc(F)c(F)c(F)c1)C1Cc2ccccc2C1,CHEMBL3592694,Ki,7.92,CHEMBL3590083,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,108,356,O=C(N=Nc1ccccc1)NCCCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)/N=N/c1ccc(F)c(F)c1)C1Cc2ccccc2C1,CHEMBL3592693,Ki,7.6,CHEMBL3590082,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,108,355,O=C(N=Nc1ccccc1)NCCCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)/N=N/c1ccc(F)c(F)c1)C1Cc2ccccc2C1,CHEMBL3592694,Ki,7.89,CHEMBL3590082,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,108,356,O=C(N=Nc1ccccc1)NCCCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)/N=N/c1ccc(F)cc1)C1Cc2ccccc2C1,CHEMBL3592693,Ki,7.64,CHEMBL3590081,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,108,355,O=C(N=Nc1ccccc1)NCCCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)/N=N/c1ccc(F)cc1)C1Cc2ccccc2C1,CHEMBL3592694,Ki,7.44,CHEMBL3590081,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,108,356,O=C(N=Nc1ccccc1)NCCCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cc(Cl)ccc1OC,CHEMBL4406061,Ki,5.85,CHEMBL4577162,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cc(F)ccc1OC,CHEMBL4406061,Ki,6.29,CHEMBL4531363,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1ccc(Cl)cc1,CHEMBL4406061,Ki,5.5,CHEMBL4472900,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1ccc(F)cc1,CHEMBL4406061,Ki,5.23,CHEMBL4569006,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cccc(Cl)c1,CHEMBL4406061,Ki,5.46,CHEMBL4453478,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cccc(Cl)c1Cl,CHEMBL4406061,Ki,5.82,CHEMBL4456007,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cccc(F)c1,CHEMBL4406061,Ki,5.46,CHEMBL4590839,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)C[C@@H]1C[C@H]1c1cccc(Cl)c1Cl,CHEMBL4406061,Ki,6.27,CHEMBL4439544,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)C[C@H]1C[C@@H]1c1cccc(Cl)c1Cl,CHEMBL4406061,Ki,6.0,CHEMBL4586582,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,CHEMBL4011211,Ki,8.07,CHEMBL4093477,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,123,342,O=C(NCCCCNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,CHEMBL4011224,IC50,5.53,CHEMBL4093477,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,123,340,O=C(NCCCCNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,CHEMBL4011228,IC50,5.34,CHEMBL4093477,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,123,341,O=C(NCCCCNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCN(CCC)C7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1)C1Cc2ccccc2C1,CHEMBL4736183,Ki,7.23,CHEMBL4740785,2021,CHEMBL4732144,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,146,25,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCNC7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCN(CCC)C7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1)C1Cc2ccccc2C1,CHEMBL4736183,Ki,6.6,CHEMBL4792999,2021,CHEMBL4732144,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,146,25,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCNC7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCN(CCC)C7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1)C1Cc2ccccc2C1,CHEMBL4736183,Ki,6.57,CHEMBL4748201,2021,CHEMBL4732144,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,146,25,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(-c2ccc(OCc3cn(CCOCCOCCOCCn4cc(COc5ccc(-c6ccc(C(=O)NCCCCNC7Cc8ccccc8C7)cc6)cc5)nn4)nn3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CC=C(C#C[Si](C)(C)C)CC1,CHEMBL995087,Ki,6.66,CHEMBL483593,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,59,16,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CC=C(C#C[Si](C)(C)C)CC1,CHEMBL995088,Ki,6.44,CHEMBL483593,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,59,17,O=C(NCCCCNC1CC=CCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CC=C(C#Cc2ccccc2)CC1,CHEMBL995087,Ki,5.26,CHEMBL484357,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,59,16,O=C(NCCCCNC1CC=C(C#Cc2ccccc2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CC=C(C#Cc2ccccc2)CC1,CHEMBL995088,Ki,5.33,CHEMBL484357,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,59,17,O=C(NCCCCNC1CC=C(C#Cc2ccccc2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCCCC1,CHEMBL995087,Ki,5.33,CHEMBL485227,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,59,16,O=C(NCCCCNC1CCCCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCCCC1,CHEMBL995088,Ki,5.2,CHEMBL485227,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,59,17,O=C(NCCCCNC1CCCCC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(Br)cccc2C1,CHEMBL672226,Ki,6.6,CHEMBL60038,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,10,358,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(C#N)cccc2C1,CHEMBL672226,Ki,7.0,CHEMBL416508,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,10,358,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(Cl)cccc2C1,CHEMBL672226,Ki,6.4,CHEMBL51977,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,10,358,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(Cl)cccc2C1,CHEMBL672227,Ki,6.4,CHEMBL51977,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,16,131,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(O)cccc2C1,CHEMBL672226,Ki,7.6,CHEMBL58669,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,10,358,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2C(N)=O)C1,CHEMBL672226,Ki,6.2,CHEMBL59960,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,10,358,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2OC)C1,CHEMBL672226,Ki,6.9,CHEMBL61717,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,10,358,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2OCC2CC2)C1,CHEMBL672226,Ki,6.1,CHEMBL61444,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,10,358,O=C(NCCCCNC1CCc2c(cccc2OCC2CC2)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2OS(=O)(=O)C(F)(F)F)C1,CHEMBL672226,Ki,6.4,CHEMBL57219,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,10,358,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2OS(=O)(=O)C(F)(F)F)C1,CHEMBL672227,Ki,6.4,CHEMBL57219,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,16,131,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(cccc2OS(C)(=O)=O)C1,CHEMBL672226,Ki,6.6,CHEMBL291801,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,10,358,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2ccccc2C1,CHEMBL672226,Ki,6.5,CHEMBL60713,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,10,358,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2n[nH]cc2C1,CHEMBL670658,Ki,6.3,CHEMBL91156,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",16,359,O=C(NCCCCNC1CCc2n[nH]cc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(C(C)(C)C)ncc2C1,CHEMBL670658,Ki,5.8,CHEMBL92439,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",16,359,O=C(NCCCCNC1CCc2ncncc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(C)ncc2C1,CHEMBL670658,Ki,5.6,CHEMBL93336,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",16,359,O=C(NCCCCNC1CCc2ncncc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(N(C)C)ncc2C1,CHEMBL670658,Ki,5.8,CHEMBL90897,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",16,359,O=C(NCCCCNC1CCc2ncncc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(N)ncc2C1,CHEMBL670658,Ki,6.8,CHEMBL91460,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",16,359,O=C(NCCCCNC1CCc2ncncc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(N)sc2C1,CHEMBL670658,Ki,6.7,CHEMBL90433,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",16,359,O=C(NCCCCNC1CCc2ncsc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(NC)ncc2C1,CHEMBL670658,Ki,5.6,CHEMBL91510,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",16,359,O=C(NCCCCNC1CCc2ncncc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(SC)ncc2C1,CHEMBL670658,Ki,5.9,CHEMBL328002,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",16,359,O=C(NCCCCNC1CCc2ncncc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2ncnc(OC)c2C1,CHEMBL670658,Ki,5.8,CHEMBL93794,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",16,359,O=C(NCCCCNC1CCc2ncncc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2ncncc2C1,CHEMBL670658,Ki,5.9,CHEMBL92438,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",16,359,O=C(NCCCCNC1CCc2ncncc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2ncc(C=O)c2C1,CHEMBL1769067,Ki,5.08,CHEMBL1765631,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,336,O=C(NCCCCNC1CCn2nccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2ncc(C=O)c2C1,CHEMBL1769068,Ki,5.33,CHEMBL1765631,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,76,337,O=C(NCCCCNC1CCn2nccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2ncc(Cl)c2C1,CHEMBL1769067,Ki,7.0,CHEMBL1765630,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,336,O=C(NCCCCNC1CCn2nccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2ncc(Cl)c2C1,CHEMBL1769068,Ki,7.37,CHEMBL1765630,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,76,337,O=C(NCCCCNC1CCn2nccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2nccc2C1,CHEMBL1769067,Ki,6.82,CHEMBL1765629,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,336,O=C(NCCCCNC1CCn2nccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCn2nccc2C1,CHEMBL1769068,Ki,7.11,CHEMBL1765629,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,76,337,O=C(NCCCCNC1CCn2nccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1Cc2cccn3ncc(c23)C1,CHEMBL1769067,Ki,6.57,CHEMBL1765632,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,336,O=C(NCCCCNC1Cc2cccn3ncc(c23)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1Cc2cccn3ncc(c23)C1,CHEMBL1769068,Ki,6.62,CHEMBL1765632,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,76,337,O=C(NCCCCNC1Cc2cccn3ncc(c23)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@@H]1CCn2nccc2C1,CHEMBL1769067,Ki,6.52,CHEMBL1765634,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,336,O=C(NCCCCNC1CCn2nccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@@H]1CCn2nccc2C1,CHEMBL1769072,Ki,7.31,CHEMBL1765634,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,338,O=C(NCCCCNC1CCn2nccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1,CHEMBL1769067,Ki,8.28,CHEMBL1765633,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,336,O=C(NCCCCNC1CCn2nccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)[C@H]1CCn2nccc2C1,CHEMBL1769072,Ki,9.0,CHEMBL1765633,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2long receptor expressed in CHO cells after 60 mins,76,338,O=C(NCCCCNC1CCn2nccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1cc(Cl)ccc1OC,CHEMBL4406061,Ki,5.68,CHEMBL4455719,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1cc(F)ccc1OC,CHEMBL4406061,Ki,5.5,CHEMBL4442408,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1cccc(Cl)c1Cl,CHEMBL4406061,Ki,5.63,CHEMBL4527244,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@@H]1C[C@H]1c1cc(F)ccc1OC,CHEMBL4406061,Ki,5.87,CHEMBL4475406,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@@H]1C[C@H]1c1cccc(Cl)c1Cl,CHEMBL4406061,Ki,6.26,CHEMBL4443039,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@H]1C[C@@H]1c1cc(F)ccc1OC,CHEMBL4406061,Ki,5.91,CHEMBL4593394,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,141,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@H]1C[C@@H]1c1cccc(Cl)c1Cl,CHEMBL4406061,Ki,5.99,CHEMBL4522558,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN(CCC)C5Cc6ccccc6C5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1,CHEMBL1920023,Ki,7.8,CHEMBL1916549,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,76,295,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCNC5Cc6ccccc6C5)cc4)nn3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN(CCC)C5Cc6ccccc6C5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1,CHEMBL1920024,Ki,7.8,CHEMBL1916549,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,76,296,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCNC5Cc6ccccc6C5)cc4)nn3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN5CCN(c6ccccc6OC)CC5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1,CHEMBL1920023,Ki,7.6,CHEMBL1916720,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,76,295,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN5CCN(c6ccccc6)CC5)cc4)nn3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN5CCN(c6ccccc6OC)CC5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1,CHEMBL1920024,Ki,7.77,CHEMBL1916720,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,76,296,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN5CCN(c6ccccc6)CC5)cc4)nn3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(CN5CCN(c6ccccc6OC)CC5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1,CHEMBL1920023,Ki,7.85,CHEMBL1916548,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,76,295,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(CN5CCN(c6ccccc6)CC5)cc4)nn3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(CN5CCN(c6ccccc6OC)CC5)cc4OC)nn3)nn2)c(OC)c1)C1Cc2ccccc2C1,CHEMBL1920024,Ki,8.06,CHEMBL1916548,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,77,296,O=C(NCCCCNC1Cc2ccccc2C1)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(CN5CCN(c6ccccc6)CC5)cc4)nn3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(Cl)ccc1OC,CHEMBL4406061,Ki,5.95,CHEMBL4456964,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(F)ccc1OC,CHEMBL4406061,Ki,5.96,CHEMBL4454872,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1ccc(Cl)cc1,CHEMBL4406061,Ki,5.34,CHEMBL4469584,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1ccc(F)cc1,CHEMBL4406061,Ki,5.25,CHEMBL4550187,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cccc(Cl)c1,CHEMBL4406061,Ki,5.4,CHEMBL4525624,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cccc(Cl)c1Cl,CHEMBL4406061,Ki,5.68,CHEMBL4590211,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cccc(F)c1,CHEMBL4406061,Ki,5.32,CHEMBL4439535,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc2ccccc2c1)C[C@@H]1C[C@H]1c1cccc(Cl)c1Cl,CHEMBL4406061,Ki,6.17,CHEMBL4454380,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCNC(=O)c1ccc2ccccc2c1)C[C@H]1C[C@@H]1c1cccc(Cl)c1Cl,CHEMBL4406061,Ki,5.94,CHEMBL4580817,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010153,Ki,9.08,CHEMBL4071868,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,123,360,c1ccc2c(c1)CCC(NCCCCOc1ccc3ccnn3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010156,Ki,8.6,CHEMBL4071868,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,123,361,c1ccc2c(c1)CCC(NCCCCOc1ccc3ccnn3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010153,Ki,9.03,CHEMBL4071185,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,123,360,c1ccc2c(c1)CCC(NCCCCOc1ccc3ccnn3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010156,Ki,8.62,CHEMBL4071185,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,123,361,c1ccc2c(c1)CCC(NCCCCOc1ccc3ccnn3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccc2c(c1)NC(=O)CC2)Cc1cc2cccc(OCC)c2o1,CHEMBL5385535,Ki,5.89,CHEMBL5411545,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,155,201,O=C1CCc2ccc(OCCCCNCc3cc4ccccc4o3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC1CC1c1cccc(Cl)c1Cl,CHEMBL4842092,Ki,6.37,CHEMBL4846101,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,146,362,O=c1ccc2ccc(OCCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1,CHEMBL4010153,Ki,7.32,CHEMBL4102616,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,123,360,c1ccc2c(c1)CCC(NCCCCOc1ccc3ccnn3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1,CHEMBL4010156,Ki,6.92,CHEMBL4102616,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,123,361,c1ccc2c(c1)CCC(NCCCCOc1ccc3ccnn3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010153,Ki,9.12,CHEMBL4097330,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,360,c1ccc2c(c1)CCC(NCCCCOc1ccc3ccnn3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010156,Ki,9.2,CHEMBL4097330,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,361,c1ccc2c(c1)CCC(NCCCCOc1ccc3ccnn3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010153,Ki,9.06,CHEMBL4098859,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,360,c1ccc2c(c1)CCC(NCCCCOc1ccn3nccc3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010156,Ki,8.66,CHEMBL4098859,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,361,c1ccc2c(c1)CCC(NCCCCOc1ccn3nccc3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010153,Ki,9.05,CHEMBL4090208,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,360,c1ccc2c(c1)CCC(NCCCCOc1ccn3nccc3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010156,Ki,8.64,CHEMBL4090208,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,361,c1ccc2c(c1)CCC(NCCCCOc1ccn3nccc3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1,CHEMBL4010153,Ki,7.41,CHEMBL4094869,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,360,c1ccc2c(c1)CCC(NCCCCOc1ccn3nccc3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1,CHEMBL4010156,Ki,7.02,CHEMBL4094869,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,361,c1ccc2c(c1)CCC(NCCCCOc1ccn3nccc3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010153,Ki,9.15,CHEMBL4078348,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,360,c1ccc2c(c1)CCC(NCCCCOc1ccn3nccc3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1,CHEMBL4010156,Ki,8.68,CHEMBL4078348,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,361,c1ccc2c(c1)CCC(NCCCCOc1ccn3nccc3c1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCc1cn(CCOCCOCCOCCOCCOCCn2cc(CCCCN(CCC)C3Cc4ccccc4C3)nn2)nn1)C1Cc2ccccc2C1,CHEMBL4736183,Ki,7.32,CHEMBL4755336,2021,CHEMBL4732144,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,146,25,c1ccc2c(c1)CC(NCCCCc1cn(CCOCCOCCOCCOCCOCCn3cc(CCCCNC4Cc5ccccc5C4)nn3)nn1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCc1cn(CCOCCOCCOCCOCCn2cc(CCCCN(CCC)C3Cc4ccccc4C3)nn2)nn1)C1Cc2ccccc2C1,CHEMBL4736183,Ki,7.18,CHEMBL4786420,2021,CHEMBL4732144,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,146,25,c1ccc2c(c1)CC(NCCCCc1cn(CCOCCOCCOCCOCCn3cc(CCCCNC4Cc5ccccc5C4)nn3)nn1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCc1cn(CCOCCOCCOCCn2cc(CCCCN(CCC)C3Cc4ccccc4C3)nn2)nn1)C1Cc2ccccc2C1,CHEMBL4736183,Ki,7.14,CHEMBL4790018,2021,CHEMBL4732144,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2R isoform 2 stably expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting method,146,25,c1ccc2c(c1)CC(NCCCCc1cn(CCOCCOCCOCCn3cc(CCCCNC4Cc5ccccc5C4)nn3)nn1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCn1cc(-c2ccc(-c3ccccc3)cc2)nn1)C1CC=C(C#C[Si](C)(C)C)CC1,CHEMBL995087,Ki,6.16,CHEMBL485384,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,59,16,C1=CCC(NCCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCn1cc(-c2ccc(-c3ccccc3)cc2)nn1)C1CC=C(C#C[Si](C)(C)C)CC1,CHEMBL995088,Ki,6.17,CHEMBL485384,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,59,17,C1=CCC(NCCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCn1cc(-c2ccc(-c3ccccc3)cc2)nn1)C1CC=C(C#Cc2ccccc2)CC1,CHEMBL995087,Ki,6.68,CHEMBL491466,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,59,16,C(#Cc1ccccc1)C1=CCC(NCCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCCn1cc(-c2ccc(-c3ccccc3)cc2)nn1)C1CC=C(C#Cc2ccccc2)CC1,CHEMBL995088,Ki,6.75,CHEMBL491466,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,59,17,C(#Cc1ccccc1)C1=CCC(NCCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C(=O)c1ccccc1,CHEMBL4686220,IC50,7.73,CHEMBL4761441,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,142,193,O=C(NCCCN1CCC(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)C(=O)c1ccccc1,CHEMBL4686220,IC50,6.32,CHEMBL4745192,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,142,193,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1,CHEMBL926379,Ki,6.78,CHEMBL254198,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,c1ccc(N2CCN(CCCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCN1CCN(c2ccccc2OC)CC1)C(=O)c1ccccc1,CHEMBL4686220,IC50,6.33,CHEMBL4746563,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,142,193,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCN1CCN(c2ccccn2)CC1)C(=O)c1ccccc1,CHEMBL4686220,IC50,5.16,CHEMBL4754651,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,142,193,O=C(NCCCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(Cl)ccc1OC,CHEMBL4406061,Ki,6.63,CHEMBL4584372,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OC,CHEMBL4406061,Ki,5.93,CHEMBL4442936,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(C(=O)c2cc3ccccc3[nH]2)CC1)[C@H]1CCc2c(O)cccc2C1,CHEMBL1050539,Ki,7.32,CHEMBL569746,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,67,310,O=C(c1cc2ccccc2[nH]1)N1CCN(CCNC2CCc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccc(Br)cc1,CHEMBL3626473,Ki,7.24,CHEMBL3622099,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,108,0,c1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccc(Br)cc1,CHEMBL3626475,Ki,7.29,CHEMBL3622099,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,108,2,c1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccc(OC)cc1,CHEMBL3626473,Ki,6.92,CHEMBL3622098,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,108,0,c1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(Cc2cc3ccccc3[nH]2)CC1)Cc1ccc(Br)cc1,CHEMBL3626473,Ki,6.04,CHEMBL3622103,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,108,0,c1ccc(CNCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(Cc2cc3ccccc3[nH]2)CC1)Cc1ccc(OC)cc1,CHEMBL3626473,Ki,5.39,CHEMBL3622102,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,108,0,c1ccc(CNCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(Cc2cc3ccccc3[nH]2)CC1)c1ccc(Br)cc1,CHEMBL3626473,Ki,6.66,CHEMBL3622095,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,108,0,c1ccc(NCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(Cc2cc3ccccc3[nH]2)CC1)c1ccc(OC)cc1,CHEMBL3626473,Ki,6.28,CHEMBL3622094,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,108,0,c1ccc(NCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccc(-c3ccccc3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1,CHEMBL1050539,Ki,6.58,CHEMBL514885,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,67,310,c1ccc(-c2ccc(N3CCN(CCNC4CCc5ncsc5C4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccc(-c3ccncc3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1,CHEMBL1050539,Ki,6.57,CHEMBL570188,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,67,310,c1cc(-c2ccc(N3CCN(CCNC4CCc5ncsc5C4)CC3)cc2)ccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccc(O)c3ncccc23)CC1)C1CCc2c(O)cccc2C1,CHEMBL1065654,Ki,7.38,CHEMBL599841,2010,CHEMBL1157569,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,67,311,c1ccc2c(c1)CCC(NCCN1CCN(c3cccc4ncccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccc(O)c3ncccc23)CC1)C1CCc2ccc(O)cc2C1,CHEMBL1065654,Ki,7.07,CHEMBL602264,2010,CHEMBL1157569,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,68,311,c1ccc2c(c1)CCC(NCCN1CCN(c3cccc4ncccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccc3ccccc3c2)CC1)C1CCc2ccc(O)cc2C1,CHEMBL1050539,Ki,8.05,CHEMBL569003,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1ccc2c(c1)CCC(NCCN1CCN(c3ccc4ccccc4c3)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2cccc(Cl)c2Cl)CC1)C1CCc2c(O)cccc2C1,CHEMBL926379,Ki,7.84,CHEMBL252539,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2cccc(Cl)c2Cl)CC1)C1CCc2ccc(O)cc2C1,CHEMBL670524,Ki,7.56,CHEMBL156689,2002,CHEMBL1135449,Bioorg Med Chem Lett,Scientific Literature,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,28,27,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2cccc3ccccc23)CC1)C1CCc2ccc(O)cc2C1,CHEMBL1050539,Ki,7.87,CHEMBL569747,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1ccc2c(c1)CCC(NCCN1CCN(c3cccc4ccccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2cccc3ncccc23)CC1)C1CCc2ccc(O)cc2C1,CHEMBL1050539,Ki,8.28,CHEMBL568822,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1ccc2c(c1)CCC(NCCN1CCN(c3cccc4ncccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2cccc3ncccc23)CC1)[C@H]1CCc2nc(N)sc2C1,CHEMBL1050539,Ki,7.24,CHEMBL569107,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1cc(N2CCN(CCNC3CCc4ncsc4C3)CC2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2c(O)cccc2C1,CHEMBL926379,Ki,7.23,CHEMBL250552,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2cc(O)c(O)cc2C1,CHEMBL926379,Ki,7.15,CHEMBL254202,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2cc(O)ccc2C1,CHEMBL926379,Ki,6.19,CHEMBL253992,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc(N)cc2C1,CHEMBL926379,Ki,6.2,CHEMBL252342,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1,CHEMBL670524,Ki,6.67,CHEMBL156639,2002,CHEMBL1135449,Bioorg Med Chem Lett,Scientific Literature,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,28,27,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1,CHEMBL926379,Ki,6.85,CHEMBL156639,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccccc2)CC1)C1CCc2ccc3c(c2C1)CC(=O)N3,CHEMBL926379,Ki,7.04,CHEMBL252343,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,O=C1Cc2c(ccc3c2CC(NCCN2CCN(c4ccccc4)CC2)CC3)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccccc2)CC1)[C@@H]1CCc2c(O)cccc2C1,CHEMBL1050539,Ki,7.58,CHEMBL457025,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccccc2)CC1)[C@@H]1CCc2ccc(O)cc2C1,CHEMBL1050539,Ki,7.39,CHEMBL456825,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccccc2)CC1)[C@H]1CCc2c(O)cccc2C1,CHEMBL1065654,Ki,7.58,CHEMBL457024,2010,CHEMBL1157569,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,68,311,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccccc2OC)CC1)C1CCc2c(O)cccc2C1,CHEMBL926379,Ki,7.45,CHEMBL399164,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,59,28,c1ccc(N2CCN(CCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccnc3c(O)cccc23)CC1)C1CCc2c(O)cccc2C1,CHEMBL1065654,Ki,7.86,CHEMBL599636,2010,CHEMBL1157569,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,68,311,c1ccc2c(c1)CCC(NCCN1CCN(c3ccnc4ccccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccnc3c(O)cccc23)CC1)C1CCc2ccc(O)cc2C1,CHEMBL1065654,Ki,8.07,CHEMBL599635,2010,CHEMBL1157569,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,68,311,c1ccc2c(c1)CCC(NCCN1CCN(c3ccnc4ccccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)C1CCc2c(cccc2OC)C1,CHEMBL1050539,Ki,8.31,CHEMBL568801,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1ccc2c(c1)CCC(NCCN1CCN(c3ccnc4ccccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)C1CCc2ccc(O)cc2C1,CHEMBL1050539,Ki,8.15,CHEMBL570187,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1ccc2c(c1)CCC(NCCN1CCN(c3ccnc4ccccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)[C@H]1CCc2c(O)cccc2C1,CHEMBL1065654,Ki,8.43,CHEMBL602065,2010,CHEMBL1157569,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned dopamine D2L receptor expressed in HEK cells,68,311,c1ccc2c(c1)CCC(NCCN1CCN(c3ccnc4ccccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)[C@H]1CCc2c(cccc2OC)C1,CHEMBL1050539,Ki,8.43,CHEMBL569977,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1ccc2c(c1)CCC(NCCN1CCN(c3ccnc4ccccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2ccnc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,CHEMBL1050539,Ki,6.96,CHEMBL577073,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1ccc2c(N3CCN(CCNC4CCc5ncsc5C4)CC3)ccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2nccc3ccccc23)CC1)C1CCc2ccc(O)cc2C1,CHEMBL1050539,Ki,7.66,CHEMBL569322,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1ccc2c(c1)CCC(NCCN1CCN(c3nccc4ccccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCN1CCN(c2nccc3ccccc23)CC1)[C@H]1CCc2nc(N)sc2C1,CHEMBL1050539,Ki,6.57,CHEMBL571992,2010,CHEMBL1156805,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,68,310,c1ccc2c(N3CCN(CCNC4CCc5ncsc5C4)CC3)nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCNC(=O)/C=C/c1ccc(F)cc1)C1Cc2ccccc2C1,CHEMBL3592693,Ki,7.37,CHEMBL3590084,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,108,355,O=C(C=Cc1ccccc1)NCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCNC(=O)/C=C/c1ccc(F)cc1)C1Cc2ccccc2C1,CHEMBL3592694,Ki,7.89,CHEMBL3590084,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,109,356,O=C(C=Cc1ccccc1)NCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCNC(=O)/N=N/c1cc(F)c(F)c(F)c1)C1Cc2ccccc2C1,CHEMBL3592693,Ki,6.96,CHEMBL3589577,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,109,355,O=C(N=Nc1ccccc1)NCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCNC(=O)/N=N/c1cc(F)c(F)c(F)c1)C1Cc2ccccc2C1,CHEMBL3592694,Ki,7.14,CHEMBL3589577,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,109,356,O=C(N=Nc1ccccc1)NCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCNC(=O)/N=N/c1ccc(F)c(F)c1)C1Cc2ccccc2C1,CHEMBL3592693,Ki,8.41,CHEMBL3589576,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,109,355,O=C(N=Nc1ccccc1)NCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCNC(=O)/N=N/c1ccc(F)c(F)c1)C1Cc2ccccc2C1,CHEMBL3592694,Ki,8.07,CHEMBL3589576,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,109,356,O=C(N=Nc1ccccc1)NCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCNC(=O)/N=N/c1ccc(F)cc1)C1Cc2ccccc2C1,CHEMBL3592693,Ki,8.3,CHEMBL3589575,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,109,355,O=C(N=Nc1ccccc1)NCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCNC(=O)/N=N/c1ccc(F)cc1)C1Cc2ccccc2C1,CHEMBL3592694,Ki,8.4,CHEMBL3589575,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,109,356,O=C(N=Nc1ccccc1)NCCNC1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CC[C@]1(O)C[C@@H](NC(=O)c2ccc3ccccc3c2)C1)C1CC1c1ccc(Cl)cc1,CHEMBL3270692,Ki,6.18,CHEMBL3265063,2014,CHEMBL3259695,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,98,152,O=C(NC1CC(CCNC2CC2c2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CC[C@]1(O)C[C@@H](NC(=O)c2ccc3ccccc3c2)C1)[C@@H]1C[C@H]1c1ccc(Cl)cc1,CHEMBL3270692,Ki,6.21,CHEMBL3265067,2014,CHEMBL3259695,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,98,152,O=C(NC1CC(CCNC2CC2c2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CC[C@]1(O)C[C@@H](NC(=O)c2ccc3ccccc3c2)C1)[C@H]1C[C@@H]1c1cccc(Cl)c1,CHEMBL3270692,Ki,5.91,CHEMBL3265065,2014,CHEMBL3259695,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,98,152,O=C(NC1CC(CCNC2CC2c2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CC[C@]1(O)C[C@@H](NC(=O)c2ccc3ccccc3c2)C1)[C@H]1C[C@@H]1c1ccccc1Cl,CHEMBL3270692,Ki,6.04,CHEMBL3265064,2014,CHEMBL3259695,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,98,152,O=C(NC1CC(CCNC2CC2c2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CC[C@]1(O)C[C@H](NC(=O)c2ccc3ccccc3c2)C1)[C@H]1CCc2nc(N)sc2C1,CHEMBL4406530,Ki,7.68,CHEMBL2203406,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperon from human D2RL expressed in HEK293 cell membranes measured after 90 mins by topcount assay,142,363,O=C(NC1CC(CCNC2CCc3ncsc3C2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CC[C@]1(O)C[C@H](NC(=O)c2ccc3ccccc3c2)C1)[C@H]1CCc2nc(N)sc2C1,CHEMBL4406622,Ki,5.41,CHEMBL2203406,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,364,O=C(NC1CC(CCNC2CCc3ncsc3C2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(C)cc1)[C@@H]1CCc2c(O)cccc2C1,CHEMBL671033,Ki,6.77,CHEMBL1159663,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,365,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(C)cc1)[C@H]1CCc2c(O)cccc2C1,CHEMBL671033,Ki,8.17,CHEMBL2092940,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,365,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(N)cc1)C1CCc2c(O)cccc2C1,CHEMBL671033,Ki,8.17,CHEMBL111532,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,365,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(N/C(S)=N/c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)cc1)C1CCc2c(O)cccc2C1,CHEMBL671034,Ki,8.15,CHEMBL320526,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,366,O=C1OC2(c3ccccc3Oc3ccccc32)c2ccc(N=CNc3ccc(CCNC4CCc5ccccc5C4)cc3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(N/C(S)=N/c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)cc1)[C@@H]1CCc2c(O)cccc2C1,CHEMBL670746,Ki,6.96,CHEMBL320779,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,367,O=C1OC2(c3ccccc3Oc3ccccc32)c2ccc(N=CNc3ccc(CCNC4CCc5ccccc5C4)cc3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(N/C(S)=N/c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)cc1)[C@H]1CCc2c(O)cccc2C1,CHEMBL671034,Ki,8.32,CHEMBL109897,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,366,O=C1OC2(c3ccccc3Oc3ccccc32)c2ccc(N=CNc3ccc(CCNC4CCc5ccccc5C4)cc3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(NC(=O)CCC(=O)NCCCCCC(=O)NCc2ccc(C(=O)NCCCCCC(=O)NCCCCCC(=O)NCc3ccc(C(=O)NCCCCCC(=O)NCCCCCCNC(=O)c4nn(-c5ccc(Cl)cc5Cl)c(-c5ccc(Cl)cc5)c4C)cc3)cc2)cc1)C1CCc2c(O)cccc2C1,CHEMBL4368754,Ki,8.38,CHEMBL4579585,2019,CHEMBL4364348,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2R,133,368,O=C(CCCCCNC(=O)c1ccc(CNC(=O)CCCCCNC(=O)CCCCCNC(=O)c2ccc(CNC(=O)CCCCCNC(=O)CCC(=O)Nc3ccc(CCNC4CCc5ccccc5C4)cc3)cc2)cc1)NCCCCCCNC(=O)c1cc(-c2ccccc2)n(-c2ccccc2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(NC(=O)CCC(=O)NCCCCCC(=O)NCc2ccc(C(=O)NCCCCCC(=O)NCCCCCCNC(=O)c3nn(-c4ccc(Cl)cc4Cl)c(-c4ccc(Cl)cc4)c3C)cc2)cc1)C1CCc2c(O)cccc2C1,CHEMBL4368754,Ki,8.66,CHEMBL4541515,2019,CHEMBL4364348,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2R,133,368,O=C(CCCCCNC(=O)c1ccc(CNC(=O)CCCCCNC(=O)CCC(=O)Nc2ccc(CCNC3CCc4ccccc4C3)cc2)cc1)NCCCCCCNC(=O)c1cc(-c2ccccc2)n(-c2ccccc2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(NC(=O)CCC(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCCCCNC(=O)c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C)cc1)C1CCc2c(O)cccc2C1,CHEMBL4368754,Ki,9.08,CHEMBL4467984,2019,CHEMBL4364348,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2R,133,368,O=C(CCCCCNC(=O)CCCCCNC(=O)CCC(=O)Nc1ccc(CCNC2CCc3ccccc3C2)cc1)NCCCCCCNC(=O)c1cc(-c2ccccc2)n(-c2ccccc2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(NC(=O)CCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCCCCNC(=O)c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C)cc1)C1CCc2c(O)cccc2C1,CHEMBL4368754,Ki,8.62,CHEMBL4465127,2019,CHEMBL4364348,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2R,133,368,O=C(CCCCCNC(=O)CCCCCNC(=O)COCCOCCNC(=O)CCC(=O)Nc1ccc(CCNC2CCc3ccccc3C2)cc1)NCCCCCCNC(=O)c1cc(-c2ccccc2)n(-c2ccccc2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(NC(=O)CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCC[C@H](NC(C)=O)C(=O)NCCCCCCNC(=O)c2nn(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)c2C)cc1)C1CCc2c(O)cccc2C1,CHEMBL4368754,Ki,8.96,CHEMBL4546839,2019,CHEMBL4364348,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2R,133,368,O=C(CCCCCNC(=O)CCCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CCC(=O)Nc1ccc(CCNC2CCc3ccccc3C2)cc1)NCCCCCCNC(=O)c1cc(-c2ccccc2)n(-c2ccccc2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,CHEMBL4236717,Ki,7.1,CHEMBL4246185,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,129,23,O=C(COc1cncc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCCCn1cc(CCC(=O)Nc2ccc(CCNC3CCc4ccccc4C3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,CHEMBL4236718,Ki,6.77,CHEMBL4246185,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,130,24,O=C(COc1cncc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCCCn1cc(CCC(=O)Nc2ccc(CCNC3CCc4ccccc4C3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,CHEMBL4236717,Ki,7.3,CHEMBL4241844,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,130,23,O=C(COc1cncc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCn1cc(CCC(=O)Nc2ccc(CCNC3CCc4ccccc4C3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCCCN(C)CCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,CHEMBL4236718,Ki,7.89,CHEMBL4241844,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,130,24,O=C(COc1cncc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCn1cc(CCC(=O)Nc2ccc(CCNC3CCc4ccccc4C3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,CHEMBL4236717,Ki,6.53,CHEMBL4239987,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,130,23,O=C(COc1cncc(C#Cc2cscn2)c1)NCCCCCCn1cc(CCC(=O)Nc2ccc(CCNC3CCc4ccccc4C3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(NC(=O)CCc2cn(CCCCCCNC(=O)COc3cncc(C#Cc4csc(C)n4)c3)nn2)cc1)C1CCc2c(O)cccc2C1,CHEMBL4236718,Ki,6.85,CHEMBL4239987,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,130,24,O=C(COc1cncc(C#Cc2cscn2)c1)NCCCCCCn1cc(CCC(=O)Nc2ccc(CCNC3CCc4ccccc4C3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(Nc2ccc([N+](=O)[O-])c3nonc23)cc1)C1CCc2c(O)cccc2C1,CHEMBL671034,Ki,9.35,CHEMBL109787,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,366,c1ccc2c(c1)CCC(NCCc1ccc(Nc3cccc4nonc34)cc1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(Nc2ccc([N+](=O)[O-])c3nonc23)cc1)[C@@H]1CCc2c(O)cccc2C1,CHEMBL671034,Ki,8.49,CHEMBL113527,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,366,c1ccc2c(c1)CCC(NCCc1ccc(Nc3cccc4nonc34)cc1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccc(Nc2ccc([N+](=O)[O-])c3nonc23)cc1)[C@H]1CCc2c(O)cccc2C1,CHEMBL671034,Ki,9.52,CHEMBL113196,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,366,c1ccc2c(c1)CCC(NCCc1ccc(Nc3cccc4nonc34)cc1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccccc1)C1CCc2c(O)cccc2C1,CHEMBL4368751,Ki,7.88,CHEMBL109684,2019,CHEMBL4364348,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H] spiperone from human D2 dopamine receptor expressed in monkey caudate-putamen membranes,133,369,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccccc1)C1CCc2c(O)cccc2C1,CHEMBL670173,Ki,9.3,CHEMBL109684,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,7,302,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccccc1)C1CCc2c(O)cccc2C1,CHEMBL670536,Ki,7.72,CHEMBL109684,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccccc1)C1CCc2c(O)cccc2C1,CHEMBL671033,Ki,7.88,CHEMBL109684,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,365,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccccc1)C1CCc2ccc(O)cc2C1,CHEMBL670536,Ki,6.28,CHEMBL134747,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccccc1)CCc1cccc(O)c1,CHEMBL2182832,Ki,7.19,CHEMBL1188090,2012,CHEMBL2177058,J Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,81,272,c1ccc(CCNCCc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccccc1)[C@@H]1CCc2c(O)cccc2C1,CHEMBL671033,Ki,7.22,CHEMBL606939,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,365,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccccc1)[C@H]1CCc2c(O)cccc2C1,CHEMBL671033,Ki,8.68,CHEMBL612083,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,365,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccccc1)[C@H]1CCc2c(O)cccc2C1,CHEMBL672210,Ki,7.7,CHEMBL612083,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,13,87,c1ccc(CCNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1cccs1)C1CCc2c(cccc2OC2CCCC2)C1,CHEMBL670536,Ki,5.98,CHEMBL132261,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1csc(CCNC2CCc3c(cccc3OC3CCCC3)C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1cccs1)C1CCc2ccc(O)cc2C1,CHEMBL670173,Ki,9.12,CHEMBL135954,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,7,302,c1csc(CCNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1cccs1)C1CCc2ccc(O)cc2C1,CHEMBL670536,Ki,7.23,CHEMBL135954,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1csc(CCNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1cccs1)[C@@H]1CCc2ccc(OC)cc2C1,CHEMBL670536,Ki,6.26,CHEMBL336295,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1csc(CCNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,CHEMBL670173,Ki,10.22,CHEMBL1303,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,7,302,c1csc(CCNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,CHEMBL670536,Ki,7.7,CHEMBL1303,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1csc(CCNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1,CHEMBL671417,Ki,10.22,CHEMBL1303,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1csc(CCNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1cccs1)[C@H]1CCc2ccc(OC)cc2C1,CHEMBL670173,Ki,6.6,CHEMBL133938,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,7,302,c1csc(CCNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1cccs1)[C@H]1CCc2ccc(OC)cc2C1,CHEMBL670536,Ki,5.91,CHEMBL133938,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1csc(CCNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccsc1)C1CCc2c(O)cccc2C1,CHEMBL670173,Ki,9.85,CHEMBL7806,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,7,302,c1ccc2c(c1)CCC(NCCc1ccsc1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccsc1)C1CCc2c(O)cccc2C1,CHEMBL670536,Ki,7.62,CHEMBL7806,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1ccc2c(c1)CCC(NCCc1ccsc1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccsc1)CCc1cccs1,CHEMBL671417,Ki,5.97,CHEMBL103441,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1csc(CCNCCc2ccsc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(CCc1ccsc1)CCc1ccsc1,CHEMBL671417,Ki,6.36,CHEMBL105623,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1cc(CCNCCc2ccsc2)cs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccc(F)cc1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669147,Ki,7.16,CHEMBL71599,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,16,331,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccc(F)cc1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669148,Ki,7.36,CHEMBL71599,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,16,332,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccc(OC)cc1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669147,Ki,7.19,CHEMBL67923,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,16,331,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccc(OC)cc1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669148,Ki,7.66,CHEMBL67923,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,16,332,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccc([N+](=O)[O-])cc1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669147,Ki,6.67,CHEMBL433121,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,16,331,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccc([N+](=O)[O-])cc1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669148,Ki,7.23,CHEMBL433121,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,16,332,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccccc1)[C@@H]1CCc2c(F)cccc2C1,CHEMBL669145,Ki,6.75,CHEMBL65847,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]quinpirole binding to human dopamine D2A receptor expressed in LtK cells,16,370,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccccc1)[C@@H]1CCc2c(F)cccc2C1,CHEMBL669146,Ki,6.38,CHEMBL65847,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]raclopride binding to human dopamine D2A receptor expressed in LtK cells,16,371,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccccc1)[C@@H]1CCc2c(F)cccc2C1,CHEMBL672183,Ki,6.75,CHEMBL65847,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,7,197,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccccc1)[C@@H]1CCc2c(F)cccc2C1,CHEMBL672184,Ki,6.38,CHEMBL65847,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,7,198,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccccc1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669147,Ki,7.12,CHEMBL68545,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,16,331,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccccc1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669148,Ki,7.18,CHEMBL68545,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,16,332,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccco1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669147,Ki,6.93,CHEMBL303502,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,16,331,c1coc(CNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1ccco1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669148,Ki,6.9,CHEMBL303502,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,17,332,c1coc(CNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1cccs1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669147,Ki,6.47,CHEMBL69706,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,17,331,c1csc(CNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN(Cc1cccs1)[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669148,Ki,6.82,CHEMBL69706,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,17,332,c1csc(CNC2CCc3ccccc3C2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC(c2ccc(N)nc2)OC[C@@H]1C,CHEMBL4361371,Ki,5.76,CHEMBL4464060,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,c1cncc(C2CNCCO2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC(c2ccc(N)nc2)OC[C@@H]1C,CHEMBL5228992,Ki,5.76,CHEMBL4464060,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,146,372,c1cncc(C2CNCCO2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC(c2ccccc2)OC2c3cc(O)ccc3CCC21,CHEMBL671417,Ki,6.43,CHEMBL322638,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1ccc(C2CNC3CCc4ccccc4C3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC2COc3ccc(C#N)cc3C2C1,CHEMBL670398,Ki,6.9,CHEMBL436157,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,17,3,c1ccc2c(c1)OCC1CNCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(CNC(=O)c2c(O)c(CC)cc(Cl)c2OC)C1,CHEMBL4828545,Ki,7.18,CHEMBL4858961,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,146,373,O=C(NCC1CCNC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(COc2nc3ccccc3c3c2CCCN3)CC1,CHEMBL670685,IC50,5.47,CHEMBL35226,2003,CHEMBL1145012,J Med Chem,Scientific Literature,Ability to displace [3H]YM-0915 from Dopamine receptor D2,33,374,c1ccc2c3c(c(OCC4CCNCC4)nc2c1)CCCN3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(N2C(=O)C(=O)c3ccccc32)CC1,CHEMBL2211560,Ki,4.89,CHEMBL2207495,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,O=C1C(=O)N(C2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(N2C(=O)C(=O)c3ccccc32)CC1,CHEMBL2211561,Ki,4.92,CHEMBL2207495,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,O=C1C(=O)N(C2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2c[nH]c3cc(F)ccc23)CC1,CHEMBL2211560,Ki,7.37,CHEMBL2207484,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2c(C3CCNCC3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2c[nH]c3cc(F)ccc23)CC1,CHEMBL2211561,Ki,7.57,CHEMBL2207484,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,c1ccc2c(C3CCNCC3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cc3ccccc3s2)CC1,CHEMBL2211560,Ki,6.24,CHEMBL2207498,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2sc(C3CCNCC3)cc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cc3ccccc3s2)CC1,CHEMBL2211561,Ki,5.63,CHEMBL2207498,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,c1ccc2sc(C3CCNCC3)cc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2ccc(Cl)cc2)CC1,CHEMBL2344228,Ki,6.025,CHEMBL2048227,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2ccc(OC)cc2)CC1,CHEMBL2344228,Ki,4.619999999999999,CHEMBL2048230,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2ccc3c(c2)N(S(=O)(=O)c2ccccc2)CC3)CC1,CHEMBL4479923,Ki,6.49,CHEMBL4536834,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,115,378,O=S(=O)(c1ccccc1)N1CCc2ccc(C3CCNCC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2ccc3ccccc3c2)CC1,CHEMBL2211560,Ki,5.81,CHEMBL2207497,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2cc(C3CCNCC3)ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2ccc3ccccc3c2)CC1,CHEMBL2211561,Ki,5.54,CHEMBL2207497,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,c1ccc2cc(C3CCNCC3)ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc(C(F)(F)F)c2)CC1,CHEMBL2344228,Ki,6.725,CHEMBL2336285,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc(O)c2)C1,CHEMBL4223409,Ki,7.17,CHEMBL81675,2018,CHEMBL4219212,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,130,379,c1ccc(C2CCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc(O)c2)CC1,CHEMBL1066831,Ki,5.59,CHEMBL592618,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,68,380,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc(O)c2)CC1,CHEMBL1066832,Ki,6.46,CHEMBL592618,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,68,381,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc(OC)c2)CC1,CHEMBL2344228,Ki,5.8100000000000005,CHEMBL2336284,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc(S(=O)(=O)C3CCCC3)c2)CC1,CHEMBL2344228,Ki,5.41,CHEMBL2336289,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,O=S(=O)(c1cccc(C2CCNCC2)c1)C1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1,CHEMBL1066831,Ki,4.76,CHEMBL596802,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,68,380,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1,CHEMBL1066832,Ki,5.12,CHEMBL596802,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,68,381,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1,CHEMBL4723553,Ki,4.76,CHEMBL596802,2020,CHEMBL4715859,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 (low) receptor (unknown origin),142,382,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1,CHEMBL4723554,Ki,5.12,CHEMBL596802,2020,CHEMBL4715859,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 (high) receptor (unknown origin),142,383,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc(S(C)(=O)=O)c2)CC1,CHEMBL5225126,Ki,5.0,CHEMBL596802,2022,CHEMBL5223132,Bioorg Med Chem,Scientific Literature,Binding affinity to D2R receptor (unknown origin),153,384,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc3ccccc23)CC1,CHEMBL2211560,Ki,7.39,CHEMBL2207496,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2c(C3CCNCC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cccc3ccccc23)CC1,CHEMBL2211561,Ki,6.95,CHEMBL2207496,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,c1ccc2c(C3CCNCC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2ccccc2)CC1,CHEMBL2344228,Ki,6.785,CHEMBL2048226,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2ccccc2OC)CC1,CHEMBL2344228,Ki,7.91,CHEMBL2336280,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cn(C)c3cc(F)ccc23)CC1,CHEMBL2211560,Ki,6.8,CHEMBL2207485,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2c(C3CCNCC3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cn(C)c3cc(F)ccc23)CC1,CHEMBL2211561,Ki,6.56,CHEMBL2207485,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,c1ccc2c(C3CCNCC3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cn(C)c3ccc(F)cc23)CC1,CHEMBL2211560,Ki,7.72,CHEMBL2207486,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2c(C3CCNCC3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2cn(C)c3ccc(F)cc23)CC1,CHEMBL2211561,Ki,7.5,CHEMBL2207486,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,c1ccc2c(C3CCNCC3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2coc3ccccc23)CC1,CHEMBL2211560,Ki,6.09,CHEMBL2207488,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2c(C3CCNCC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2coc3ccccc23)CC1,CHEMBL2211561,Ki,5.57,CHEMBL2207488,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,c1ccc2c(C3CCNCC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2csc3ccccc23)CC1,CHEMBL2211560,Ki,7.58,CHEMBL2207487,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2c(C3CCNCC3)csc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2csc3ccccc23)CC1,CHEMBL2211561,Ki,6.92,CHEMBL2207487,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,c1ccc2c(C3CCNCC3)csc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2n[nH]c3ccccc23)CC1,CHEMBL2211560,Ki,6.73,CHEMBL2207490,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2c(C3CCNCC3)n[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2n[nH]c3ccccc23)CC1,CHEMBL2211561,Ki,5.97,CHEMBL2207490,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,c1ccc2c(C3CCNCC3)n[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL2211560,Ki,7.47,CHEMBL2207489,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2c(C3CCNCC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL2211561,Ki,6.71,CHEMBL2207489,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,c1ccc2c(C3CCNCC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,CHEMBL2211560,Ki,6.34,CHEMBL2207493,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,O=c1[nH]c2ccccc2n1C1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,CHEMBL2211561,Ki,6.43,CHEMBL2207493,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,O=c1[nH]c2ccccc2n1C1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(n2c(=O)n(C)c3cc(Cl)ccc32)CC1,CHEMBL2211560,Ki,5.29,CHEMBL2207494,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,O=c1[nH]c2ccccc2n1C1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(n2c(=O)n(C)c3cc(Cl)ccc32)CC1,CHEMBL2211561,Ki,5.7,CHEMBL2207494,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,O=c1[nH]c2ccccc2n1C1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(n2ccc3ccccc32)CC1,CHEMBL2211560,Ki,6.96,CHEMBL2207491,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2c(c1)ccn2C1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(n2ccc3ccccc32)CC1,CHEMBL2211561,Ki,5.95,CHEMBL2207491,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,81,376,c1ccc2c(c1)ccn2C1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC(n2cnc3ccccc32)CC1,CHEMBL2211560,Ki,4.97,CHEMBL2207492,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human high affinity Dopamine D2S receptor by competition binding assay,81,375,c1ccc2c(c1)ncn2C1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC2Cc3c(O)cccc3CC21,CHEMBL673016,Ki,7.96,CHEMBL2114337,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC2Cc3c(O)cccc3C[C@H]21,CHEMBL673016,Ki,8.62,CHEMBL25359,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC2Cc3c(cccc3OC)C[C@H]21,CHEMBL673016,Ki,7.0,CHEMBL278091,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC2c3cccc(O)c3CCC21,CHEMBL673016,Ki,6.845000000000001,CHEMBL10207,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCCN(c2ccc(O)c3c2OCC(=O)N3)CC1,CHEMBL4046973,Ki,6.44,CHEMBL4065797,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,124,385,O=C1COc2c(cccc2N2CCCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCCN(c2ccc(O)c3c2OCC(=O)N3)CC1,CHEMBL4046974,Ki,7.25,CHEMBL4065797,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,124,386,O=C1COc2c(cccc2N2CCCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(-c3ccsc3)c2)C1,CHEMBL679938,Ki,6.87,CHEMBL314536,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1cc(-c2ccsc2)cc(C2CCCNC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(Br)c2)C1,CHEMBL678343,Ki,6.77,CHEMBL92817,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",3,257,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(C#N)c2)C1,CHEMBL678343,Ki,6.58,CHEMBL92183,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",3,257,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(C#N)c2)C1,CHEMBL679938,Ki,6.92,CHEMBL92183,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(C=O)c2)C1,CHEMBL678343,Ki,6.84,CHEMBL92578,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",3,257,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(CC#N)c2)C1,CHEMBL679938,Ki,7.16,CHEMBL93917,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(CO)c2)C1,CHEMBL679938,Ki,6.62,CHEMBL93101,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(O)c2)C1,CHEMBL1066831,Ki,5.64,CHEMBL7549,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,68,380,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(O)c2)C1,CHEMBL1066832,Ki,7.76,CHEMBL7549,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,68,381,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(O)c2)C1,CHEMBL4223409,Ki,6.86,CHEMBL7549,2018,CHEMBL4219212,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,130,379,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(O)c2)C1,CHEMBL665383,Ki,7.57,CHEMBL7549,2002,CHEMBL1134894,Bioorg Med Chem Lett,Scientific Literature,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 short (high/low affinity is given as 27/1800),28,387,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(O)c2)C1,CHEMBL671177,Ki,8.05,CHEMBL7549,2002,CHEMBL1134894,Bioorg Med Chem Lett,Scientific Literature,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 long (high/low affinity is given as 9.0/1800),28,388,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(O)c2)C1,CHEMBL678343,Ki,7.41,CHEMBL7549,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",3,257,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(O)c2)C1,CHEMBL679938,Ki,8.07,CHEMBL7549,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(OC)c2)C1,CHEMBL679938,Ki,6.22,CHEMBL93582,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(OCC(F)(F)F)c2)C1,CHEMBL679938,Ki,6.09,CHEMBL93946,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(OS(=O)(=O)C(F)(F)F)c2)C1,CHEMBL678343,Ki,7.32,CHEMBL90359,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",3,257,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(OS(C)(=O)=O)c2)C1,CHEMBL679938,Ki,6.72,CHEMBL93594,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(S(=O)(=O)N(C)C)c2)C1,CHEMBL678343,Ki,7.04,CHEMBL329443,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",3,257,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(S(=O)(=O)N(C)C)c2)C1,CHEMBL679938,Ki,6.64,CHEMBL329443,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(S(C)(=O)=O)c2)C1,CHEMBL1066831,Ki,5.41,CHEMBL311730,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,68,380,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(S(C)(=O)=O)c2)C1,CHEMBL1066832,Ki,6.12,CHEMBL311730,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,68,381,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H](c2cccc(S(C)(=O)=O)c2)C1,CHEMBL679938,Ki,6.35,CHEMBL311730,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL1059353,Ki,6.02,CHEMBL240773,2009,CHEMBL1154597,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2long receptor expressed in CHO cells,63,389,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL1059354,Ki,6.06,CHEMBL240773,2009,CHEMBL1154597,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2short receptor expressed in CHO cells,63,390,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL2182832,Ki,5.93,CHEMBL240773,2012,CHEMBL2177058,J Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,81,272,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL2400820,Ki,7.16,CHEMBL240773,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cells,88,18,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL2400821,Ki,7.75,CHEMBL240773,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine D2L receptor expressed in CHO cells,88,19,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL2400822,Ki,6.58,CHEMBL240773,2013,CHEMBL2396548,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,88,20,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL3295080,Ki,6.58,CHEMBL240773,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,98,391,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL3295081,Ki,7.16,CHEMBL240773,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,98,392,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL3578854,Ki,6.58,CHEMBL240773,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor transfected in CHO cells after 1 hr by scintillation counting analysis,109,21,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL3578855,Ki,7.16,CHEMBL240773,2015,CHEMBL3576771,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor transfected in CHO cells after 1 hr by scintillation counting analysis,109,22,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL3801476,Ki,6.58,CHEMBL240773,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,115,195,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL3801477,Ki,7.16,CHEMBL240773,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,115,196,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL3801662,Ki,5.53,CHEMBL240773,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,291,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL3801665,Ki,8.26,CHEMBL240773,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,292,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL3888599,IC50,6.33,CHEMBL240773,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Affinity Assay: Each medicament was dissolved in serum-free F12 culture medium containing 100 μM of IBMX. CHO cells which can stably express D2 receptor were pre-incubated at 37° C. for 10 min, and then 10 μM Forskoline and 10 μM Dopanie were added at the same time to react for 10 min. 100 μL, of pre-cooled 1 M of HClO4 was added and the reaction was terminated at 4° C. for 1 hour. 20 μL of 2 M K2CO3 was added to neutralize the reaction. The resulting mixture was centrifugated at 3000 rpm for 15 min, and the precipitate KClO4 was discarded. A certain amount of the supernatant was taken for cAMP detection. Spiperone and Quinpirole were used as positive control.",115,393,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL4011211,Ki,7.88,CHEMBL240773,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL5236927,IC50,8.58,CHEMBL240773,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,146,142,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL665386,Ki,7.28,CHEMBL240773,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells; high binding affinity,25,394,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL671646,Ki,4.51,CHEMBL240773,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells; Low binding affinity,25,395,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL671647,Ki,7.19,CHEMBL240773,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells; high binding affinity,25,396,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL672098,Ki,7.19,CHEMBL240773,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,33,397,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL672099,Ki,7.28,CHEMBL240773,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,33,398,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL672210,Ki,5.59,CHEMBL240773,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,13,87,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL829826,Ki,5.51,CHEMBL240773,2005,CHEMBL1143571,J Med Chem,Scientific Literature,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,39,346,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL829827,Ki,5.52,CHEMBL240773,2005,CHEMBL1143571,J Med Chem,Scientific Literature,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,39,347,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL829839,Ki,7.2,CHEMBL240773,2005,CHEMBL1143571,J Med Chem,Scientific Literature,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,39,348,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL829840,Ki,7.46,CHEMBL240773,2005,CHEMBL1143571,J Med Chem,Scientific Literature,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,39,349,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL872142,Ki,7.46,CHEMBL240773,2005,CHEMBL1141074,J Med Chem,Scientific Literature,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,39,323,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL875028,Ki,5.4,CHEMBL240773,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells; Low binding affinity,25,399,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL885377,Ki,5.52,CHEMBL240773,2005,CHEMBL1141074,J Med Chem,Scientific Literature,"Binding affinity (low) towards human dopamine receptor 2 short against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",39,351,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21,CHEMBL885379,Ki,5.51,CHEMBL240773,2005,CHEMBL1141074,J Med Chem,Scientific Literature,"Binding affinity (low) towards human dopamine receptor 2 (long) against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",39,400,c1n[nH]c2c1CC1NCCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@@H]2c3cc4c(cc3CC[C@H]21)CCO4,CHEMBL674942,Ki,6.3,CHEMBL170976,1997,CHEMBL1129892,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,10,179,c1c2c(cc3c1CCC1NCCCC31)OCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCC[C@H]1CNC(=O)c1c(O)c(CC)cc(Cl)c1OC,CHEMBL4828545,Ki,9.16,CHEMBL4865434,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,146,373,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1,CHEMBL911524,Ki,6.39,CHEMBL213335,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,44,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2ccc(O)c3[nH]c(=O)ccc23)CC1,CHEMBL4046973,Ki,5.72,CHEMBL4092462,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,124,385,O=c1ccc2c(N3CCNCC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2ccc(O)c3[nH]c(=O)ccc23)CC1,CHEMBL4046974,Ki,6.32,CHEMBL4092462,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,124,386,O=c1ccc2c(N3CCNCC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2ccc(O)c3c2OCC(=O)N3)CC1,CHEMBL4046973,Ki,6.92,CHEMBL4087217,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,124,385,O=C1COc2c(cccc2N2CCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2ccc(O)c3c2OCC(=O)N3)CC1,CHEMBL4046974,Ki,7.46,CHEMBL4087217,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,124,386,O=C1COc2c(cccc2N2CCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2ccc(O)c3c2OCCO3)CC1,CHEMBL4046974,Ki,5.24,CHEMBL4094900,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,124,386,c1cc2c(c(N3CCNCC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2ccc(OC)cc2)CC1,CHEMBL2344228,Ki,5.195,CHEMBL449920,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2ccc3c(c2)CCN3S(=O)(=O)c2ccccc2)CC1,CHEMBL4479923,Ki,6.61,CHEMBL4519916,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,115,378,O=S(=O)(c1ccccc1)N1CCc2cc(N3CCNCC3)ccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2ccc3c(c2)N(S(=O)(=O)c2ccccc2)CC3)CC1,CHEMBL4479923,Ki,7.02,CHEMBL4591250,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,115,378,O=S(=O)(c1ccccc1)N1CCc2ccc(N3CCNCC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2cccc(C#N)c2)CC1,CHEMBL2344228,Ki,6.585,CHEMBL480434,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL2168000,Ki,8.28,CHEMBL2165676,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,81,254,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2cccc(O)c2)CC1,CHEMBL1066831,Ki,6.14,CHEMBL447809,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,68,380,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2cccc(O)c2)CC1,CHEMBL1066832,Ki,7.16,CHEMBL447809,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,68,381,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2cccc(OC)c2)CC1,CHEMBL2344228,Ki,6.51,CHEMBL451149,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2cccc(S(C)(=O)=O)c2)CC1,CHEMBL1066831,Ki,5.92,CHEMBL596801,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,68,380,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2cccc(S(C)(=O)=O)c2)CC1,CHEMBL1066832,Ki,6.18,CHEMBL596801,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,68,381,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2cccc3c2CCN3S(=O)(=O)c2ccccc2)CC1,CHEMBL4479923,Ki,7.38,CHEMBL4579883,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,115,378,O=S(=O)(c1ccccc1)N1CCc2c(N3CCNCC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2cccc3c2CN(S(=O)(=O)c2ccccc2)C3)CC1,CHEMBL4479923,Ki,6.75,CHEMBL4537294,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,115,378,O=S(=O)(c1ccccc1)N1Cc2cccc(N3CCNCC3)c2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2ccccc2)CC1,CHEMBL2344228,Ki,6.3149999999999995,CHEMBL114510,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2ccccc2OC)CC1,CHEMBL2344228,Ki,7.68,CHEMBL92887,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN(c2ccccc2S(C)(=O)=O)CC1,CHEMBL2344228,Ki,6.220000000000001,CHEMBL2336282,2013,CHEMBL2331278,Eur J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2S receptor high affinity site expressed in HEK293 cells,88,377,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCN2c3cccc4[nH]cc(c34)CC2C1,CHEMBL3294601,Ki,6.24,CHEMBL3286570,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,98,178,c1cc2c3c(c[nH]c3c1)CC1CNCCN21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCOC2c3cc(C(N)=O)ccc3CCC21,CHEMBL981461,Ki,6.12,CHEMBL449250,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCOC2c3cc(O)ccc3CCC21,CHEMBL671417,Ki,8.21,CHEMBL102582,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCOC2c3cc(O)ccc3SCC21,CHEMBL673090,Ki,6.27,CHEMBL330216,2000,CHEMBL1133458,J Med Chem,Scientific Literature,Tested for antagonist binding affinity by measuring displacement of [3H]spiperone from Human Dopamine receptor D2L expressed in CHO K-1 cells,21,401,c1ccc2c(c1)SCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCOC2c3cc(O)ccc3[S+]([O-])CC21,CHEMBL673086,Ki,6.71,CHEMBL99355,2000,CHEMBL1133458,J Med Chem,Scientific Literature,Tested for agonist binding affinity by measuring displacement of [3H]NPA from Human Dopamine receptor D2L expressed in CHO K-1 cells,21,402,c1ccc2c(c1)[SH+]CC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCOC2c3ccsc3CCC21,CHEMBL671417,Ki,6.2,CHEMBL102632,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,28,318,c1cc2c(s1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(C#N)ccc3CC[C@H]21,CHEMBL981461,Ki,6.1,CHEMBL485352,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(C(=O)N(C)C)ccc3CC[C@H]21,CHEMBL981461,Ki,5.73,CHEMBL485029,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(C(=O)NC)ccc3CC[C@H]21,CHEMBL981461,Ki,5.1,CHEMBL484170,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(C(=O)NCc4ccc(OC)cc4)ccc3CC[C@H]21,CHEMBL981461,Ki,5.47,CHEMBL485027,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,O=C(NCc1ccccc1)c1ccc2c(c1)C1OCCNC1CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(C(C)=O)ccc3CC[C@H]21,CHEMBL981461,Ki,5.51,CHEMBL482978,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(C(N)=O)ccc3CC[C@H]21,CHEMBL981461,Ki,5.92,CHEMBL484599,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,CHEMBL1043566,Ki,8.2,CHEMBL69271,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Agonistic activity at DRD2 receptor,63,403,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,CHEMBL3117737,Ki,7.75,CHEMBL2106804,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,98,273,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,CHEMBL3117738,Ki,7.675,CHEMBL2106804,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,98,274,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,CHEMBL3117739,Ki,9.41,CHEMBL2106804,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,98,275,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,CHEMBL3119984,Ki,8.82,CHEMBL2106804,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Binding affinity to high-affinity state of D2L receptor (unknown origin),98,404,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,CHEMBL673080,Ki,8.21,CHEMBL69271,2000,CHEMBL1133458,J Med Chem,Scientific Literature,"Human Dopamine receptor D2L affinities to determine agonist activity, using [3H]spip as radioligand",21,405,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21,CHEMBL4361371,Ki,7.69,CHEMBL70565,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,c1ccc2c(c1)OCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21,CHEMBL4731081,Ki,7.55,CHEMBL70565,2020,CHEMBL4725442,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,142,406,c1ccc2c(c1)OCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21,CHEMBL4825013,Ki,7.37,CHEMBL70565,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,146,407,c1ccc2c(c1)OCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21,CHEMBL673078,Ki,7.38,CHEMBL70565,2000,CHEMBL1133458,J Med Chem,Scientific Literature,"Human Dopamine receptor D2L affinities to determine agonist activity, using [3H]N-0437 as radioligand",21,408,c1ccc2c(c1)OCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@H]21,CHEMBL673090,Ki,5.93,CHEMBL70565,2000,CHEMBL1133458,J Med Chem,Scientific Literature,Tested for antagonist binding affinity by measuring displacement of [3H]spiperone from Human Dopamine receptor D2L expressed in CHO K-1 cells,21,401,c1ccc2c(c1)OCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3SC[C@@H]21,CHEMBL673086,Ki,7.13,CHEMBL98836,2000,CHEMBL1133458,J Med Chem,Scientific Literature,Tested for agonist binding affinity by measuring displacement of [3H]NPA from Human Dopamine receptor D2L expressed in CHO K-1 cells,21,402,c1ccc2c(c1)SCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(O)ccc3SC[C@H]21,CHEMBL673086,Ki,8.94,CHEMBL98305,2000,CHEMBL1133458,J Med Chem,Scientific Literature,Tested for agonist binding affinity by measuring displacement of [3H]NPA from Human Dopamine receptor D2L expressed in CHO K-1 cells,21,402,c1ccc2c(c1)SCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(OCCCCN4C(=O)c5ccccc5C4=O)ccc3OC[C@H]21,CHEMBL4361371,Ki,5.6,CHEMBL4447227,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,O=C1c2ccccc2C(=O)N1CCCCOc1ccc2c(c1)C1OCCNC1CO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(OCCCCNC(=O)c4cc5ccccc5[nH]4)ccc3OC[C@H]21,CHEMBL4361371,Ki,5.41,CHEMBL4519520,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,O=C(NCCCCOc1ccc2c(c1)C1OCCNC1CO2)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(OCCCCNC(=O)c4cc5ccccc5o4)ccc3OC[C@H]21,CHEMBL4361371,Ki,5.03,CHEMBL4465109,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,O=C(NCCCCOc1ccc2c(c1)C1OCCNC1CO2)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(OCCCCNC(=O)c4cc5cccnc5[nH]4)ccc3OC[C@H]21,CHEMBL4361371,Ki,4.57,CHEMBL4528479,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,O=C(NCCCCOc1ccc2c(c1)C1OCCNC1CO2)c1cc2cccnc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(OCCCCNC(=O)c4ccc5c(c4)Cc4ccccc4-5)ccc3OC[C@H]21,CHEMBL4361371,Ki,5.17,CHEMBL4451708,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,O=C(NCCCCOc1ccc2c(c1)C1OCCNC1CO2)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(OCCCCNC(=O)c4ccc5scnc5c4)ccc3OC[C@H]21,CHEMBL4361371,Ki,5.04,CHEMBL4474113,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,O=C(NCCCCOc1ccc2c(c1)C1OCCNC1CO2)c1ccc2scnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(OCCCCNC(=O)c4nc5ccccc5s4)ccc3OC[C@H]21,CHEMBL4361371,Ki,5.26,CHEMBL4460452,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,O=C(NCCCCOc1ccc2c(c1)C1OCCNC1CO2)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc(OCCCCOc4ccc5c(c4)NC(=O)CC5)ccc3OC[C@H]21,CHEMBL4361371,Ki,5.0,CHEMBL4568693,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,O=C1CCc2ccc(OCCCCOc3ccc4c(c3)C3OCCNC3CO4)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc4c(=O)[nH]ccc4cc3CC[C@H]21,CHEMBL981461,Ki,5.92,CHEMBL482556,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,O=c1[nH]ccc2cc3c(cc12)C1OCCNC1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CCNC4=O,CHEMBL981461,Ki,6.11,CHEMBL484732,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,O=C1NCCc2cc3c(cc21)C1OCCNC1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CCO4,CHEMBL674942,Ki,6.4,CHEMBL169323,1997,CHEMBL1129892,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,10,179,c1c2c(cc3c1CCC1NCCOC31)OCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CCOC4=O,CHEMBL981461,Ki,5.83,CHEMBL485325,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,O=C1OCCc2cc3c(cc21)C1OCCNC1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CNC4=O,CHEMBL981461,Ki,6.08,CHEMBL484598,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,O=C1NCc2cc3c(cc21)C1OCCNC1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)COC4=O,CHEMBL981461,Ki,5.69,CHEMBL485128,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,O=C1OCc2cc3c(cc21)C1OCCNC1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@@H]2c3cc4c(cc3OC[C@H]21)CCO4,CHEMBL674942,Ki,4.9,CHEMBL170923,1997,CHEMBL1129892,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,10,179,c1c2c(cc3c1OCC1NCCOC31)OCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@H]2c3cc(O)ccc3OC[C@@H]21,CHEMBL4731081,Ki,5.12,CHEMBL97424,2020,CHEMBL4725442,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,142,406,c1ccc2c(c1)OCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@H]2c3cc(O)ccc3SC[C@@H]21,CHEMBL673086,Ki,6.07,CHEMBL98197,2000,CHEMBL1133458,J Med Chem,Scientific Literature,Tested for agonist binding affinity by measuring displacement of [3H]NPA from Human Dopamine receptor D2L expressed in CHO K-1 cells,21,402,c1ccc2c(c1)SCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCO[C@H]2c3cc4c(cc3CC[C@@H]21)CNC4=O,CHEMBL981461,Ki,6.3,CHEMBL485127,2009,CHEMBL1154395,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human cloned dopamine D2L receptor expressed in CHO cells,63,284,O=C1NCc2cc3c(cc21)C1OCCNC1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21,CHEMBL672486,Ki,8.96,CHEMBL11066,1993,CHEMBL1126639,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,83,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC[C@@H]2Cc3c(O)cccc3C[C@H]21,CHEMBL673016,Ki,9.3,CHEMBL11066,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC[C@@H]2Cc3c(cccc3OC)C[C@H]21,CHEMBL672486,Ki,7.0600000000000005,CHEMBL11388,1993,CHEMBL1126639,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,83,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC[C@@H]2Cc3c(cccc3OC)C[C@H]21,CHEMBL673016,Ki,7.12,CHEMBL11388,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC[C@@H]2c3cccc(O)c3CC[C@H]21,CHEMBL672485,Ki,7.03,CHEMBL24588,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC[C@H]2Cc3c(O)cccc3C[C@@H]21,CHEMBL672486,Ki,6.04,CHEMBL11065,1993,CHEMBL1126639,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,83,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC[C@H]2Cc3c(O)cccc3C[C@H]21,CHEMBL673016,Ki,6.04,CHEMBL281614,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CC[C@H]2c3cccc(O)c3CC[C@H]21,CHEMBL672485,Ki,6.66,CHEMBL26560,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,78,c1ccc2c(c1)CCC1NCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cc(Cl)c(O)cc2[C@@H]1c1ccccc1,CHEMBL670683,Ki,5.72,CHEMBL293828,1989,CHEMBL1124647,J Med Chem,Scientific Literature,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,0,409,c1ccc(C2NCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2C1Cc1cccc(O)c1-3,CHEMBL1811739,Ki,6.07,CHEMBL329904,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,77,264,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2C1Cc1cccc(OC(=O)CSc2ccccc2)c1-3,CHEMBL1811739,Ki,6.07,CHEMBL1806872,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,77,264,O=C(CSc1ccccc1)Oc1cccc2c1-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2C1Cc1cccc(OC(=O)NC(C)(C)C)c1-3,CHEMBL1811739,Ki,5.55,CHEMBL1806867,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,77,264,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2C1Cc1cccc(OC(=O)NCc2ccccc2)c1-3,CHEMBL1811739,Ki,5.37,CHEMBL1806870,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,77,264,O=C(NCc1ccccc1)Oc1cccc2c1-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2C1Cc1cccc(OC(=O)Nc2cccc4ccccc24)c1-3,CHEMBL1811739,Ki,5.7,CHEMBL1806869,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,77,264,O=C(Nc1cccc2ccccc12)Oc1cccc2c1-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2C1Cc1cccc(OCCCCN2CCN(c4ccccc4OC)CC2)c1-3,CHEMBL1686531,Ki,7.06,CHEMBL1684128,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCCCOc3cccc4c3-c3cccc5c3C(C4)NCC5)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2C1Cc1cccc(OCCCN(CCCN2CCN(c4ccccc4OC)CC2)S(C)(=O)=O)c1-3,CHEMBL1686531,Ki,6.4,CHEMBL1684129,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCCNCCCOc3cccc4c3-c3cccc5c3C(C4)NCC5)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2C1Cc1cccc(OCCCn2cc(CCCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3,CHEMBL1686531,Ki,6.69,CHEMBL1684029,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCCCc3cn(CCCOc4cccc5c4-c4cccc6c4C(C5)NCC6)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2C1Cc1cccc(OCCCn2cc(CCN4CCN(c5ccccc5OC)CC4)nn2)c1-3,CHEMBL1686531,Ki,5.13,CHEMBL1684125,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCc3cn(CCCOc4cccc5c4-c4cccc6c4C(C5)NCC6)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2C1Cc1cccc(OCc2cn(CCCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3,CHEMBL1686531,Ki,6.18,CHEMBL1684028,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCCCn3cc(COc4cccc5c4-c4cccc6c4C(C5)NCC6)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2C1Cc1cccc(OCc2cn(CCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3,CHEMBL1686531,Ki,5.92,CHEMBL1684023,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCCn3cc(COc4cccc5c4-c4cccc6c4C(C5)NCC6)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@@H]1Cc1cccc(OCCCCN2CCN(c4ccccc4OC)CC2)c1-3,CHEMBL1686531,Ki,6.76,CHEMBL1684134,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCCCOc3cccc4c3-c3cccc5c3C(C4)NCC5)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@@H]1Cc1cccc(OCCCn2cc(CCN4CCN(c5ccccc5OC)CC4)nn2)c1-3,CHEMBL1686531,Ki,6.22,CHEMBL1684132,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCc3cn(CCCOc4cccc5c4-c4cccc6c4C(C5)NCC6)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@@H]1Cc1cccc(OCc2cn(CCCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3,CHEMBL1686531,Ki,6.53,CHEMBL1684130,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCCCn3cc(COc4cccc5c4-c4cccc6c4C(C5)NCC6)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1ccc(C)c(O)c1-3,CHEMBL670885,Ki,6.6,CHEMBL119593,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,7,135,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1ccc(C)c(OC)c1-3,CHEMBL670885,Ki,6.62,CHEMBL118771,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,7,135,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL3117737,Ki,8.14,CHEMBL538542,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,98,273,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL3117738,Ki,8.774999999999999,CHEMBL538542,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,98,274,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL3117739,Ki,10.125,CHEMBL538542,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,98,275,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL3119982,Ki,9.96,CHEMBL538542,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Binding affinity to high-affinity state of D2L receptor (unknown origin) expressed in CHO cell membranes,98,411,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL3119983,Ki,9.42,CHEMBL538542,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from high-affinity state of recombinant human dopamine D2L receptor expressed in CHO cells after 45 mins by scintillation counting analysis,98,412,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL672210,Ki,7.3,CHEMBL225230,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,13,87,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1ccc(OS(=O)(=O)C(F)(F)F)c(OC)c1-3,CHEMBL670885,Ki,6.39,CHEMBL119900,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,7,135,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(N)c1-3,CHEMBL1811739,Ki,6.45,CHEMBL1806877,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,77,264,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3,CHEMBL1065707,Ki,6.94,CHEMBL27559,2010,CHEMBL1159064,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,68,413,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3,CHEMBL670880,Ki,7.9,CHEMBL27559,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,7,99,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)CCCCC2CCSS2)c1-3,CHEMBL1811739,Ki,6.76,CHEMBL1806874,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,77,264,O=C(CCCCC1CCSS1)Oc1cccc2c1-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)CCCC[C@@H]2CCSS2)c1-3,CHEMBL1811739,Ki,6.53,CHEMBL1806875,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,77,264,O=C(CCCCC1CCSS1)Oc1cccc2c1-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)CCCC[C@H]2CCSS2)c1-3,CHEMBL1811739,Ki,6.47,CHEMBL1806876,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,77,264,O=C(CCCCC1CCSS1)Oc1cccc2c1-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)NC(C)(C)C)c1-3,CHEMBL1811739,Ki,6.06,CHEMBL1806868,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,77,264,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)NCc2ccccc2)c1-3,CHEMBL1811739,Ki,5.66,CHEMBL1806871,2011,CHEMBL1806354,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,77,264,O=C(NCc1ccccc1)Oc1cccc2c1-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC)c1-3,CHEMBL670881,Ki,6.08,CHEMBL119154,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride fromd human Dopamine receptor D2A expressed in LtK- cells,7,137,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OCCCCN2CCN(c4ccccc4OC)CC2)c1-3,CHEMBL1686531,Ki,6.85,CHEMBL1684135,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCCCOc3cccc4c3-c3cccc5c3C(C4)NCC5)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OCCCn2cc(CCN4CCN(c5ccccc5OC)CC4)nn2)c1-3,CHEMBL1686531,Ki,6.11,CHEMBL1684133,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCc3cn(CCCOc4cccc5c4-c4cccc6c4C(C5)NCC6)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OCc2cn(CCCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3,CHEMBL1686531,Ki,6.21,CHEMBL1684131,2011,CHEMBL1681760,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in human HEK293 cells by liquid scintillation counter,77,410,c1ccc(N2CCN(CCCCn3cc(COc4cccc5c4-c4cccc6c4C(C5)NCC6)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2nn3ccccc3c2C1,CHEMBL665382,Ki,6.89,CHEMBL80845,2002,CHEMBL1134894,Bioorg Med Chem Lett,Scientific Literature,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 short (high/low affinity is given as 130/50000),28,414,c1ccn2nc3c(c2c1)CNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1CCc2nn3ccccc3c2C1,CHEMBL671175,Ki,6.64,CHEMBL80845,2002,CHEMBL1134894,Bioorg Med Chem Lett,Scientific Literature,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 long (high/low affinity is given as 230/53000),28,415,c1ccn2nc3c(c2c1)CNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1COC[C@@H]2c3cc(O)ccc3OC[C@H]21,CHEMBL670173,Ki,7.38,CHEMBL94015,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,7,302,c1ccc2c(c1)OCC1NCOCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1COC[C@@H]2c3cc(O)ccc3OC[C@H]21,CHEMBL670536,Ki,5.93,CHEMBL94015,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1ccc2c(c1)OCC1NCOCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1COC[C@@H]2c3cc(O)ccc3OC[C@H]21,CHEMBL670657,Ki,5.6,CHEMBL94015,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,17,416,c1ccc2c(c1)OCC1NCOCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,CHEMBL3294602,Ki,7.585,CHEMBL531,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,98,188,c1cc2c3c(c[nH]c3c1)CC1NCCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,CHEMBL5346625,Ki,9.21,CHEMBL531,2024,CHEMBL5344475,RSC Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) assessed as inhibition constant,159,189,c1cc2c3c(c[nH]c3c1)CC1NCCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,CHEMBL672210,Ki,7.3,CHEMBL531,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,13,87,c1cc2c3c(c[nH]c3c1)CC1NCCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,CHEMBL672313,Ki,8.4,CHEMBL531,1997,CHEMBL1130416,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,10,190,c1cc2c3c(c[nH]c3c1)CC1NCCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1C[C@H](OCCCCOc2ccc3c(c2)NC(=O)CC3)C[C@H]1CNC(=O)c1c(O)c(CC)cc(Cl)c1OC,CHEMBL4828545,Ki,8.59,CHEMBL4864320,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C1CCc2ccc(OCCCCOC3CNC(CNC(=O)c4ccccc4)C3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1C[C@H](c2ccc(N)nc2)OC[C@@H]1C,CHEMBL5228992,Ki,5.88,CHEMBL5277640,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,147,372,c1cncc(C2CNCCO2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1C[C@H](c2ccc(O)cc2)C[C@@H]2c3cc(O)c(O)cc3CC[C@H]21,CHEMBL2162509,Ki,6.8,CHEMBL2158640,2012,CHEMBL2157876,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,81,315,c1ccc(C2CNC3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1Cc2ccccc2C2c3cc(O)c(O)cc3OCC21,CHEMBL911249,Ki,6.47,CHEMBL1203924,2006,CHEMBL1137342,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,44,417,c1ccc2c(c1)CNC1COc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1[C@@H](C)C[C@@H]2Cc3cccc(OC)c3C[C@@H]21,CHEMBL672486,Ki,6.33,CHEMBL11386,1993,CHEMBL1126639,J Med Chem,Scientific Literature,"Binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",1,83,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN1[C@@H](C)C[C@@H]2Cc3cccc(OC)c3C[C@@H]21,CHEMBL673016,Ki,6.33,CHEMBL11386,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CC1CCNC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCNC1CCc2c(O)cccc2C1,CHEMBL670173,Ki,9.3,CHEMBL334472,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,7,302,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCNC1CCc2c(O)cccc2C1,CHEMBL670536,Ki,6.54,CHEMBL334472,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,7,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCNC1CCc2c(cccc2OC)C1,CHEMBL670536,Ki,6.42,CHEMBL135152,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,8,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCNC1CCc2ccc(O)cc2C1,CHEMBL670173,Ki,8.42,CHEMBL336652,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,8,302,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCNC1CCc2ccc(O)cc2C1,CHEMBL670536,Ki,6.08,CHEMBL336652,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,8,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCNC1CCc2cccc(OS(=O)(=O)C(F)(F)F)c2C1,CHEMBL673095,Ki,6.97,CHEMBL28313,1995,CHEMBL1128298,J Med Chem,Scientific Literature,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,5,317,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCNC1Cc2cc3nc(N)sc3cc2C1,CHEMBL671517,Ki,5.87,CHEMBL118637,2000,CHEMBL1133651,J Med Chem,Scientific Literature,in vitro binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]NPA as radioligand.,21,328,c1nc2cc3c(cc2s1)CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCNCCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL995087,Ki,4.68,CHEMBL444128,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,59,16,c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2c(C(=O)OC)cccc2[C@@H]1C,CHEMBL665374,Ki,5.63,CHEMBL161507,1994,CHEMBL1150496,Bioorg Med Chem Lett,Scientific Literature,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),3,333,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2c(F)cccc2C1,CHEMBL672183,Ki,6.78,CHEMBL139345,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,8,197,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2c(F)cccc2C1,CHEMBL672184,Ki,6.24,CHEMBL139345,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,8,198,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2c(OC)cccc2[C@@H]1C,CHEMBL665374,Ki,6.84,CHEMBL27441,1994,CHEMBL1150496,Bioorg Med Chem Lett,Scientific Literature,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),3,333,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2c(OC)cccc2[C@@H]1C,CHEMBL673016,Ki,7.85,CHEMBL27441,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",1,77,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2c(OS(=O)(=O)C(F)(F)F)cccc2[C@@H]1C,CHEMBL665374,Ki,5.59,CHEMBL349843,1994,CHEMBL1150496,Bioorg Med Chem Lett,Scientific Literature,Binding affinity was measured at cloned mammalian dopamine D2 receptor expressed in CHO-K1 cells (using [3H]U-86170),3,333,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669147,Ki,7.08,CHEMBL71275,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,17,331,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2c(cccc2OC)C1,CHEMBL669148,Ki,6.94,CHEMBL71275,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,17,332,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2ccc(OC)cc2C1,CHEMBL670536,Ki,4.23,CHEMBL335971,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,8,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,CHEMBL673096,Ki,7.3,CHEMBL554220,1995,CHEMBL1128298,J Med Chem,Scientific Literature,In vitro binding affinity towards dopamine D2 receptor by using [3H]U-86170 as radioligand,5,418,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2ccc3[nH]c(C(N)=O)cc3c2C1,CHEMBL670667,Ki,6.07,CHEMBL1744089,1993,CHEMBL1126741,J Med Chem,Scientific Literature,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,1,306,c1cc2c3c(ccc2[nH]1)CCCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2cccc(CS(=O)(=O)C(F)(F)F)c2C1,CHEMBL673095,Ki,7.16,CHEMBL2021539,1995,CHEMBL1128298,J Med Chem,Scientific Literature,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,5,317,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2cccc(CS(=O)(=O)C(F)(F)F)c2C1,CHEMBL872497,Ki,6.51,CHEMBL2021539,1995,CHEMBL1128298,J Med Chem,Scientific Literature,In vitro binding affinity towards Dopamine receptor D2 by using [3H]spiperone as radioligand,5,419,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1CCc2nc(N)sc2C1,CHEMBL4815484,Ki,6.0,CHEMBL249420,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,147,259,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,CHEMBL3801662,Ki,6.06,CHEMBL3800165,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,291,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCC)C1,CHEMBL3801665,Ki,8.09,CHEMBL3800165,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,292,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCOCCCCc2ccccc2)C1,CHEMBL4011211,Ki,7.26,CHEMBL4093223,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=c1n(CCCCCCOCCCCc2ccccc2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL4011211,Ki,7.73,CHEMBL4065353,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=C(NCCCCn1c(=O)n2c3c(cccc31)CCC2)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOCCCCc2ccccc2)C1,CHEMBL4011211,Ki,7.43,CHEMBL4059581,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=c1n(CCCCOCCCCc2ccccc2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1,CHEMBL3801662,Ki,5.61,CHEMBL434665,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,291,c1cc2c3c(c1)ncn3CCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1,CHEMBL3801665,Ki,8.56,CHEMBL434665,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,292,c1cc2c3c(c1)ncn3CCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@@H]1Cc2cccc3nc(O)n(c23)C1,CHEMBL672313,Ki,8.6,CHEMBL434665,1997,CHEMBL1130416,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,10,190,c1cc2c3c(c1)ncn3CCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCC2N=C(N)SC2C1,CHEMBL4223409,Ki,8.41,CHEMBL1201343,2018,CHEMBL4219212,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,130,379,C1=NC2CCCCC2S1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2c(cccc2CS(=O)(=O)C(F)(F)F)C1,CHEMBL673095,Ki,8.06,CHEMBL2021538,1995,CHEMBL1128298,J Med Chem,Scientific Literature,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,5,317,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2c(cccc2CS(=O)(=O)C(F)(F)F)C1,CHEMBL872497,Ki,6.94,CHEMBL2021538,1995,CHEMBL1128298,J Med Chem,Scientific Literature,In vitro binding affinity towards Dopamine receptor D2 by using [3H]spiperone as radioligand,5,419,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2ccc(OC)cc2C1,CHEMBL670536,Ki,5.49,CHEMBL336962,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,8,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2cccc(CS(=O)(=O)C(F)(F)F)c2C1,CHEMBL673095,Ki,6.65,CHEMBL2021524,1995,CHEMBL1128298,J Med Chem,Scientific Literature,In vitro binding affinity towards Dopamine receptor D2 by using [3H]U-86170 as radioligand,5,317,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL3801477,Ki,7.22,CHEMBL301265,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,115,196,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL4361371,Ki,7.96,CHEMBL301265,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,133,352,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL4406530,Ki,8.33,CHEMBL301265,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperon from human D2RL expressed in HEK293 cell membranes measured after 90 mins by topcount assay,142,363,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL4406622,Ki,6.13,CHEMBL301265,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,364,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL5151465,Ki,7.59,CHEMBL301265,2021,CHEMBL5149991,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at high concentration incubated for 140 mins by radioligand competition binding based assay,147,420,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL5151467,Ki,6.0,CHEMBL301265,2021,CHEMBL5149991,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK at low concentration incubated for 140 mins by radioligand competition binding based assay,147,421,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL5387511,Ki,8.41,CHEMBL3182733,2023,CHEMBL5385871,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor assessed as inhibition constant,155,422,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL665384,Ki,7.4,CHEMBL301265,2002,CHEMBL1134894,Bioorg Med Chem Lett,Scientific Literature,Binding affinity of compound measured using [3H]spiperone for the cloned human dopamine receptor D2 short (high/low affinity is given as 40/3600),28,423,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL671176,Ki,7.57,CHEMBL301265,2002,CHEMBL1134894,Bioorg Med Chem Lett,Scientific Literature,Binding affinity of compound measured using [3H]-spiperone for the cloned human dopamine receptor D2 long (high/low affinity is given as 27/5400),28,424,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL671518,Ki,6.86,CHEMBL301265,2000,CHEMBL1133651,J Med Chem,Scientific Literature,in vitro low binding affinity was determined on human Dopamine receptor D2L expressed in chinese hamster ovary(CHO) K-1 cells using [3H]-spiperone as radioligand.,21,425,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL829826,Ki,5.2,CHEMBL301265,2005,CHEMBL1143571,J Med Chem,Scientific Literature,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,40,346,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL829827,Ki,5.72,CHEMBL301265,2005,CHEMBL1143571,J Med Chem,Scientific Literature,Low inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,40,347,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL829839,Ki,7.68,CHEMBL301265,2005,CHEMBL1143571,J Med Chem,Scientific Literature,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2L expressed in CHO cells,40,348,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL829840,Ki,7.68,CHEMBL301265,2005,CHEMBL1143571,J Med Chem,Scientific Literature,High inhibition constant against [3H]spiperone binding to human Dopamine receptor D2S expressed in CHO cells,40,349,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL872138,Ki,5.2,CHEMBL301265,2005,CHEMBL1141074,J Med Chem,Scientific Literature,Low binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,40,324,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL872139,Ki,7.68,CHEMBL301265,2005,CHEMBL1141074,J Med Chem,Scientific Literature,High binding affinity towards human dopamine receptor 2 (long) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,40,321,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL872141,Ki,5.72,CHEMBL301265,2005,CHEMBL1141074,J Med Chem,Scientific Literature,Low binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,40,322,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCN[C@H]1CCc2nc(N)sc2C1,CHEMBL872142,Ki,7.68,CHEMBL301265,2005,CHEMBL1141074,J Med Chem,Scientific Literature,High binding affinity towards human dopamine receptor 2 (short) expressed in Chinese hamster ovary cells using [3H]spiperone (0.5 nM) as radioligand,40,323,c1nc2c(s1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCOC1CCCc2ccc(/N=C/N3CCc4cc(OC)c(OC)cc4C3)cc21,CHEMBL886705,Ki,4.38,CHEMBL240023,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,51,129,C(=Nc1ccc2c(c1)CCCC2)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,CHEMBL3877884,Ki,7.16,CHEMBL3976659,2017,CHEMBL3877260,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,124,258,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCOc1c(O)ccc2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,CHEMBL3877884,Ki,7.39,CHEMBL3954556,2017,CHEMBL3877260,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,124,258,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL5335368,Ki,5.57,CHEMBL5410387,2023,CHEMBL5331137,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,155,276,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OCCC)c3CN1CC2,CHEMBL5335368,Ki,6.09,CHEMBL5438487,2023,CHEMBL5331137,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,155,276,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OCCOCC)c3CN1CC2,CHEMBL5335368,Ki,6.21,CHEMBL5396616,2023,CHEMBL5331137,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,155,276,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2,CHEMBL3783165,Ki,7.0,CHEMBL3780506,2016,CHEMBL3779868,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,115,278,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCOc1cccc(CN2CCN(Cc3cc4ccccc4o3)CC2)c1,CHEMBL1219344,Ki,5.53,CHEMBL1214959,2010,CHEMBL1212881,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,68,426,c1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,8.72,CHEMBL3920432,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,115,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCSc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1,CHEMBL3073105,Ki,8.1,CHEMBL87478,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),88,427,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCSc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1,CHEMBL670391,Ki,8.1,CHEMBL87478,1995,CHEMBL1149936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,5,428,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCSc1nnc(-c2ccccc2)n1C,CHEMBL4397357,Ki,3.74,CHEMBL4588709,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,133,279,c1ccc(-c2nnc[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC[C@@H]1CN(Cc2ccccc2)C[C@@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC,CHEMBL672576,Ki,6.72,CHEMBL424575,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC[C@@H]1CN(Cc2ccccc2)C[C@@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC,CHEMBL672913,Ki,6.72,CHEMBL424575,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC[C@@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC,CHEMBL672576,Ki,7.62,CHEMBL168544,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC[C@@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC,CHEMBL672913,Ki,7.27,CHEMBL168544,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC[C@H]1CN(Cc2ccccc2)C[C@@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC,CHEMBL672576,Ki,6.27,CHEMBL168274,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC[C@H]1CN(Cc2ccccc2)C[C@@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC,CHEMBL672913,Ki,6.01,CHEMBL168274,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC[C@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC,CHEMBL672576,Ki,7.55,CHEMBL168611,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCC[C@H]1CN(Cc2ccccc2)C[C@H]1CNC(=O)c1cc(Cl)c(NC)cc1OC,CHEMBL672913,Ki,7.35,CHEMBL168611,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(C(=O)NCCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1Br,CHEMBL3614290,Ki,9.04,CHEMBL221129,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,109,431,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(C(=O)NCCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1Br,CHEMBL913685,Ki,8.28,CHEMBL221129,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,51,44,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nnn1Cc1ccccc1,CHEMBL3614290,Ki,8.19,CHEMBL425285,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,109,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nnn1Cc1ccccc1,CHEMBL913685,Ki,7.85,CHEMBL425285,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,51,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccc(OC)cc1,CHEMBL3614290,Ki,8.15,CHEMBL218351,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,109,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccc(OC)cc1,CHEMBL913685,Ki,7.37,CHEMBL218351,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,51,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1,CHEMBL3614290,Ki,8.19,CHEMBL218607,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,109,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1,CHEMBL913685,Ki,7.24,CHEMBL218607,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,51,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1Br,CHEMBL3614290,Ki,8.52,CHEMBL386986,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,109,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)nnn1Cc1ccccc1Br,CHEMBL913685,Ki,7.66,CHEMBL386986,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,51,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(C)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,CHEMBL1285353,IC50,6.85,CHEMBL1276766,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1c(Cl)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,CHEMBL1285353,IC50,6.96,CHEMBL1276764,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,CHEMBL1285353,IC50,9.3,CHEMBL1276585,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1C,CHEMBL1285353,IC50,8.3,CHEMBL1276763,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,CHEMBL1285353,IC50,8.49,CHEMBL1276615,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1cc2c(s1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21,CHEMBL671379,Ki,6.15,CHEMBL28338,1995,CHEMBL1128531,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,5,432,c1ccc2c(c1)CCC1NCc3sccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1cc2c(s1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21,CHEMBL672175,Ki,6.15,CHEMBL28338,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,17,290,c1ccc2c(c1)CCC1NCc3sccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1cc2c(s1)CN[C@H]1CCc3cc(O)c(O)cc3[C@H]21,CHEMBL671379,Ki,5.4,CHEMBL544814,1995,CHEMBL1128531,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,5,432,c1ccc2c(c1)CCC1NCc3sccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,CHEMBL3387736,Ki,7.41,CHEMBL3344457,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,98,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,CHEMBL1285353,IC50,7.17,CHEMBL1276351,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1ccc2c(n1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21,CHEMBL672175,Ki,6.35,CHEMBL26965,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,17,290,c1ccc2c(c1)CCC1NCc3ncccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1,CHEMBL894060,Ki,6.91,CHEMBL243742,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,51,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803210,Ki,7.44,CHEMBL1803053,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,77,293,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5ccnn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803211,Ki,7.5,CHEMBL1803053,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,77,294,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5ccnn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCc1nc(CN2CC[C@H](c3ccccc3)C2)cs1,CHEMBL4137914,Ki,5.3,CHEMBL4167807,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,130,220,c1ccc(C2CCN(Cc3cscn3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCn1c(-c2ccccc2)cc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1C,CHEMBL1101348,IC50,5.43,CHEMBL1086756,2010,CHEMBL1154983,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,68,433,O=C(NCCCN1CCN(c2ccccc2)CC1)c1c[nH]c(-c2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCn1c(=O)n2c3c(cccc31)C[C@@H](N(C)CCCCNC(=O)c1cc3ccccc3[nH]1)C2,CHEMBL4011211,Ki,7.66,CHEMBL4078379,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=C(NCCCCNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2,CHEMBL3801662,Ki,6.12,CHEMBL3799157,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,291,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCn1c(=O)n2c3c(cccc31)C[C@@H](NC)C2,CHEMBL3801665,Ki,7.88,CHEMBL3799157,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,115,292,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCCn1ncc2c1-c1c(C)sc(C)c1CCC2,CHEMBL672165,Ki,6.05,CHEMBL318949,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,33,434,c1scc2c1CCCc1cn[nH]c1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,9.29,CHEMBL3971907,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,115,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1,CHEMBL4677471,Ki,7.62,CHEMBL4750939,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,147,263,c1ccc2c(c1)CCN(CCC1CCCCC1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)C1CCc2ccc(O)cc2C1,CHEMBL670173,Ki,8.6,CHEMBL134571,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,8,302,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)C1CCc2ccc(O)cc2C1,CHEMBL670536,Ki,6.76,CHEMBL134571,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,8,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)CCc1c(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)[nH]c2ccccc12,CHEMBL671361,Ki,6.73,CHEMBL330303,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,21,435,c1ccc(-c2cc3ccccc3[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)CCc1c(-c2ccc(C#N)cc2)[nH]c2ccccc12,CHEMBL671361,Ki,9.38,CHEMBL91542,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,21,435,c1ccc(-c2cc3ccccc3[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)CCc1c(-c2ccc(Cl)cc2)[nH]c2ccccc12,CHEMBL671361,Ki,6.6,CHEMBL91463,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,21,435,c1ccc(-c2cc3ccccc3[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)CCc1c(-c2ccc(F)cc2)[nH]c2ccccc12,CHEMBL671361,Ki,7.77,CHEMBL328459,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,21,435,c1ccc(-c2cc3ccccc3[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)CCc1c(-c2cccc(C(F)(F)F)c2)[nH]c2ccccc12,CHEMBL671361,Ki,7.77,CHEMBL90911,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,21,435,c1ccc(-c2cc3ccccc3[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)CCc1c(-c2cccc(F)c2)[nH]c2ccccc12,CHEMBL671361,Ki,7.17,CHEMBL328595,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,21,435,c1ccc(-c2cc3ccccc3[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)CCc1c(-c2cccc([N+](=O)[O-])c2)[nH]c2ccccc12,CHEMBL671361,Ki,7.41,CHEMBL90837,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,21,435,c1ccc(-c2cc3ccccc3[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)CCc1c(-c2ccccc2)[nH]c2ccccc12,CHEMBL671361,Ki,7.07,CHEMBL91549,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,21,435,c1ccc(-c2cc3ccccc3[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)CCc1c(-c2ccccc2F)[nH]c2ccccc12,CHEMBL671361,Ki,6.82,CHEMBL91197,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,21,435,c1ccc(-c2cc3ccccc3[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(C)CCc1c(-c2cccs2)[nH]c2ccccc12,CHEMBL671361,Ki,7.11,CHEMBL92416,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,21,435,c1csc(-c2cc3ccccc3[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)C(=O)NCCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1,CHEMBL862319,Ki,7.76,CHEMBL202858,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,c1cc(N2CCNCC2)ncn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)C(=O)N[C@@H]1C[C@@H]2c3cccc4c3C(=CC4)C[C@H]2N(C)C1,CHEMBL673016,Ki,9.1,CHEMBL285341,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",2,77,C1=C2CC3NCCCC3c3cccc(c32)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,CHEMBL3294602,Ki,9.18,CHEMBL157138,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [125]iodosulpride from human recombinant dopamine D2L receptor expressed in CHO cells after 30 mins,98,188,C1=C2c3cccc4[nH]cc(c34)CC2NCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,CHEMBL5346625,Ki,9.47,CHEMBL157138,2024,CHEMBL5344475,RSC Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) assessed as inhibition constant,159,189,C1=C2c3cccc4[nH]cc(c34)CC2NCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,CHEMBL672210,Ki,9.1,CHEMBL157138,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,13,87,C1=C2c3cccc4[nH]cc(c34)CC2NCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,CHEMBL672313,Ki,9.3,CHEMBL157138,1997,CHEMBL1130416,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,10,190,C1=C2c3cccc4[nH]cc(c34)CC2NCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(Cl)cc3[C@@H](C)C2)CC1,CHEMBL4677471,Ki,7.04,CHEMBL4743651,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,147,263,c1ccc2c(c1)CCN(CCC1CCCCC1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1,CHEMBL1046708,IC50,5.8,CHEMBL584554,2009,CHEMBL1154177,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,63,436,O=C(Nc1ccccc1)N1CCC=C2c3cccc4[nH]cc(c34)CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,CHEMBL670786,Ki,6.92,CHEMBL263881,2002,CHEMBL1135791,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2,28,437,C1=C2c3cccc4[nH]cc(c34)CC2NCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1,CHEMBL672230,Ki,6.9,CHEMBL263881,2003,CHEMBL1145901,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 in CHO cells using [125I]iodosulpiride,33,191,C1=C2c3cccc4[nH]cc(c34)CC2NCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)C1CCc2c(cccc2OC)C1,CHEMBL670536,Ki,6.92,CHEMBL134701,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,8,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CC1=Cc2cn(S(=O)(=O)c3ccccc3)c3cccc(c23)O1,CHEMBL3997508,Ki,5.36,CHEMBL4060194,2017,CHEMBL3994665,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),124,438,O=S(=O)(c1ccccc1)n1cc2c3c(cccc31)OC=C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCC1(C)OC=C(c2ccccc2)C1=O,CHEMBL671745,Ki,5.0,CHEMBL540538,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1COC=C1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OC)cc3)nc3ccccc32)cc1,CHEMBL670392,Ki,5.85,CHEMBL315560,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,C(=CCn1c(-c2ccccc2)nc2ccccc21)Cn1c(-c2ccccc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCC4CCCCC4)cc3)nc3ccccc32)cc1,CHEMBL670392,Ki,5.99,CHEMBL316014,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,C(=CCn1c(-c2ccc(OCCCC3CCCCC3)cc2)nc2ccccc21)Cn1c(-c2ccccc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCN(CC)CC)cc3)nc3ccccc32)cc1,CHEMBL670392,Ki,5.63,CHEMBL316222,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,C(=CCn1c(-c2ccccc2)nc2ccccc21)Cn1c(-c2ccccc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCN4CCN(c5ccccc5)CC4)cc3)nc3ccccc32)cc1,CHEMBL670392,Ki,6.09,CHEMBL86249,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,C(=CCn1c(-c2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2)nc2ccccc21)Cn1c(-c2ccccc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccccc3)nc3ccccc32)cc1,CHEMBL670392,Ki,5.18,CHEMBL430242,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,C(=CCn1c(-c2ccccc2)nc2ccccc21)Cn1c(-c2ccccc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2C/C=C\Cn2c(-c3ccc(OCCCN(CC)CC)cc3)nc3ccccc32)cc1,CHEMBL670392,Ki,5.82,CHEMBL314937,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,C(=CCn1c(-c2ccccc2)nc2ccccc21)Cn1c(-c2ccccc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2CCCCCCn2c(-c3ccc(OCCCN(CC)CC)cc3)nc3ccccc32)cc1,CHEMBL670392,Ki,5.76,CHEMBL313257,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,c1ccc(-c2nc3ccccc3n2CCCCCCn2c(-c3ccccc3)nc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2CCCCn2c(-c3ccc(OCCCN(CC)CC)cc3)nc3ccccc32)cc1,CHEMBL670392,Ki,5.83,CHEMBL313147,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,c1ccc(-c2nc3ccccc3n2CCCCn2c(-c3ccccc3)nc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCCOc1ccc(-c2nc3ccccc3n2Cc2ccc(Cn3c(-c4ccc(OCCCN(CC)CC)cc4)nc4ccccc43)cc2)cc1,CHEMBL670392,Ki,5.46,CHEMBL313692,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,c1ccc(-c2nc3ccccc3n2Cc2ccc(Cn3c(-c4ccccc4)nc4ccccc43)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCN1CCN(c2cccc(Cl)c2)C1=O,CHEMBL1044430,Ki,7.6,CHEMBL563635,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,63,233,O=C1NCCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCN1CCN(c2cccc(Cl)c2)C1=O,CHEMBL1059864,Ki,7.6,CHEMBL563635,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,63,234,O=C1NCCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC,CHEMBL3887246,Ki,7.19,CHEMBL86,2015,CHEMBL3886237,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",109,439,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)CCOc1ccccc1Cc1ccccc1,CHEMBL838569,Ki,5.69,CHEMBL366265,2004,CHEMBL1138672,J Med Chem,Scientific Literature,Binding affinity for human recombinant dopamine receptor D2L,37,440,c1ccc(Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674347,Ki,6.5,CHEMBL277684,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@H](C)[C@H]21,CHEMBL2066740,Ki,4.42,CHEMBL2062852,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,81,442,c1ccc(CN2CC3CCC3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@H](c3ccc(Br)cc3)[C@H]21,CHEMBL2066740,Ki,5.3,CHEMBL2062856,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,81,442,c1ccc(CN2CC3CCC3C2c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@H](c3ccccc3)[C@H]21,CHEMBL2066740,Ki,4.92,CHEMBL2062848,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,81,442,c1ccc(CN2CC3CCC3C2c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@H](c3ccccn3)[C@H]21,CHEMBL2066740,Ki,4.38,CHEMBL2062858,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,81,442,c1ccc(CN2CC3CCC3C2c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@@H](C)[C@@H]21,CHEMBL2066740,Ki,5.41,CHEMBL2062853,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,81,442,c1ccc(CN2CC3CCC3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccc(Br)cc3)[C@@H]21,CHEMBL2066740,Ki,5.7,CHEMBL2062857,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,81,442,c1ccc(CN2CC3CCC3C2c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccccc3)[C@@H]21,CHEMBL2066740,Ki,5.77,CHEMBL2062849,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,81,442,c1ccc(CN2CC3CCC3C2c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccccn3)[C@@H]21,CHEMBL2066740,Ki,4.92,CHEMBL2062859,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,81,442,c1ccc(CN2CC3CCC3C2c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cc(F)ccc1OC,CHEMBL4406061,Ki,6.42,CHEMBL4561808,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(Cl)ccc1OC,CHEMBL4406061,Ki,6.39,CHEMBL4541924,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(F)ccc1OC,CHEMBL4406061,Ki,6.39,CHEMBL4452683,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,O=C(NCCCCNCC1CC1c1ccccc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC,CHEMBL4842092,Ki,6.58,CHEMBL4849780,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,147,362,O=C1CCc2ccc(OCCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC,CHEMBL4842092,Ki,6.49,CHEMBL4865389,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,147,362,O=C1CCc2ccc(OCCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(Cl)ccc1OC,CHEMBL4842092,Ki,6.67,CHEMBL4855583,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,147,362,O=C1CCc2ccc(OCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cc(F)ccc1OC,CHEMBL4842092,Ki,6.8,CHEMBL4865118,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,147,362,O=C1CCc2ccc(OCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(Cl)ccc1OC,CHEMBL4406061,Ki,6.62,CHEMBL4578364,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OC,CHEMBL4406061,Ki,6.56,CHEMBL4590966,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OCCF,CHEMBL4406061,Ki,6.07,CHEMBL4448853,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCc1ccccc1OC(F)(F)F)CCN1CCCC1,CHEMBL959090,Ki,6.58,CHEMBL445977,2008,CHEMBL1150346,J Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,59,443,c1ccc(CCNCCN2CCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCc1ccccc1OC(F)(F)F)CCN1CCCCC1,CHEMBL959090,Ki,6.67,CHEMBL498774,2008,CHEMBL1150346,J Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,59,443,c1ccc(CCNCCN2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(CCc1ccccn1)Cc1csc(C2CCCC2)n1,CHEMBL4137914,Ki,5.23,CHEMBL4165273,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,130,220,c1ccc(CCNCc2csc(C3CCCC3)n2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)C1CCCc2ccccc21,CHEMBL674353,Ki,7.9,CHEMBL113524,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(-c2ccc(CNC3CCCc4ccccc43)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)C1CCc2ccccc21,CHEMBL674353,Ki,9.1,CHEMBL323817,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(-c2ccc(CNC3CCc4ccccc43)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)Cc1ccccc1C,CHEMBL674353,Ki,8.2,CHEMBL113523,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)Cc1ccccc1Cl,CHEMBL674353,Ki,7.7,CHEMBL113606,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)Cc1ccccc1OC,CHEMBL674353,Ki,7.8,CHEMBL110793,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)[C@@H](C)c1ccccc1,CHEMBL674353,Ki,7.6,CHEMBL321244,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1)[C@H](C)c1ccccc1,CHEMBL674353,Ki,8.1,CHEMBL109532,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc(C)cc1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674353,Ki,9.4,CHEMBL112705,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc(Cl)cc1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674353,Ki,9.0,CHEMBL322070,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc(OC)c(OC)c1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674353,Ki,7.5,CHEMBL324044,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc(OC)cc1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674353,Ki,8.7,CHEMBL112735,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccc2c(c1)OCO2)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674353,Ki,8.5,CHEMBL113229,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(-c2ccc(CNCc3ccc4c(c3)OCO4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1cccc(C)c1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674353,Ki,8.1,CHEMBL112268,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1cccc(Cl)c1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674353,Ki,8.0,CHEMBL332270,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1cccc(OC)c1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674353,Ki,7.1,CHEMBL112505,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccccc1)C(=O)NCCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1,CHEMBL862319,Ki,6.67,CHEMBL208228,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,44,141,O=C(NCCCCN1CCN(c2ccncn2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccccc1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674347,Ki,9.1,CHEMBL21967,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccccc1)Cc1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674353,Ki,9.1,CHEMBL21967,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CNCc2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN(Cc1ccccc1)S(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1,CHEMBL674346,Ki,6.3,CHEMBL144055,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",10,445,O=S(=O)(NCc1ccccc1)c1cccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN([C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1,CHEMBL900500,Ki,6.95,CHEMBL429453,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,51,446,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN([C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1)S(=O)(=O)c1ccc(OC)c(OC)c1,CHEMBL900500,Ki,8.57,CHEMBL238401,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,51,446,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)Cc2ccccc21,CHEMBL672162,Ki,7.68,CHEMBL68191,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,33,236,O=C1Nc2ccccc2CC1N1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)Cc2ccccc21,CHEMBL672795,Ki,7.68,CHEMBL68191,2000,CHEMBL1132730,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,21,447,O=C1Nc2ccccc2CC1N1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCc3ccc(OC)cc3)cc21,CHEMBL3239709,Ki,6.52,CHEMBL1503220,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,98,448,O=C(NCc1ccccc1)c1ccc2c(c1)NC(=O)c1ccccc1[SH+]2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(C#N)cc3)cc21,CHEMBL3239709,Ki,7.64,CHEMBL3234537,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,98,448,O=C(NCc1ccccc1)c1ccc2c(c1)NC(=O)c1ccccc1[SH+]2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(F)cc3)cc21,CHEMBL3239709,Ki,7.05,CHEMBL3234536,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,98,448,O=C(NCc1ccccc1)c1ccc2c(c1)NC(=O)c1ccccc1[SH+]2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)N[C@H](C)c3ccc(Br)cc3)cc21,CHEMBL3239709,Ki,6.28,CHEMBL3234538,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,98,448,O=C(NCc1ccccc1)c1ccc2c(c1)NC(=O)c1ccccc1[SH+]2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)N[C@H](C)c3ccc4ccccc4c3)cc21,CHEMBL3239709,Ki,6.54,CHEMBL3234539,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,98,448,O=C(NCc1ccc2ccccc2c1)c1ccc2c(c1)NC(=O)c1ccccc1[SH+]2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CC=C(C2=Cc3ccccc3Cc3ccccc32)CC1,CHEMBL672525,Ki,7.36,CHEMBL542029,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,5,75,C1=C(C2=Cc3ccccc3Cc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CC=C(C2=Cc3ccccc3Oc3ccccc32)CC1,CHEMBL672525,Ki,7.21,CHEMBL556969,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,5,75,C1=C(C2=Cc3ccccc3Oc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CC=C(C2=Nc3cc(Cl)ccc3Nc3ccc(F)cc32)CC1,CHEMBL4816284,Ki,6.47,CHEMBL4853957,2021,CHEMBL4813978,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells assessed as inhibition of dopamine-induced calcium accumulation,147,449,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CHEMBL3872774,IC50,8.52,CHEMBL243712,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Antagonistic activity at D2 receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 assessed as inhibition of dopamine-induced calcium flux by fluo-4 dye based FLIPR assay,115,450,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CHEMBL5215986,Ki,8.52,CHEMBL243712,2021,CHEMBL5214911,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methyl-spiperone from D2R (unknown origin) assessed as inhibition constant by competition binding assay,147,451,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC,CHEMBL895618,Ki,7.9,CHEMBL243712,2007,CHEMBL1148822,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,51,452,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC,CHEMBL674347,Ki,8.2,CHEMBL277945,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CHEMBL1777184,IC50,7.99,CHEMBL26,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,77,453,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CHEMBL3224961,Ki,8.12,CHEMBL26,2011,CHEMBL3217715,Medchemcomm,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin),77,454,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CHEMBL4406527,IC50,7.38,CHEMBL26,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,142,455,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CHEMBL5215982,Ki,8.01,CHEMBL26,2021,CHEMBL5214911,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2R (unknown origin) assessed as inhibition constant,147,456,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CHEMBL839477,Ki,6.92,CHEMBL26,2005,CHEMBL1141881,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 long,40,457,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCC1CNc1nncc2ccc(OC)c(OC)c12,CHEMBL3224961,Ki,8.41,CHEMBL3221299,2011,CHEMBL3217715,Medchemcomm,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin),77,454,c1ccc2c(NCC3CCCN3)nncc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCC1c1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674347,Ki,7.6,CHEMBL277631,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(C3CCCN3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCCC1c1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674347,Ki,8.1,CHEMBL20763,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(C3CCCCN3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCCCCC1c1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674347,Ki,8.1,CHEMBL280177,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(C3CCCCCN3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@@H](c2cccc(C#N)c2)C1,CHEMBL679938,Ki,6.63,CHEMBL90798,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(Br)c(Br)cc(O)c1OC,CHEMBL1285353,IC50,7.59,CHEMBL1276461,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(Br)c(C)cc(O)c1OC,CHEMBL1285353,IC50,8.26,CHEMBL1276616,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(Br)c(Cl)cc(O)c1OC,CHEMBL1285353,IC50,7.24,CHEMBL1276427,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(Br)c(OC)cc(O)c1OC,CHEMBL1285353,IC50,7.17,CHEMBL1276587,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(Br)ccc(O)c1OC,CHEMBL1285353,IC50,7.25,CHEMBL1276710,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(C)c(Br)cc(O)c1OC,CHEMBL1285353,IC50,7.96,CHEMBL1276741,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(C)c(C)cc(O)c1OC,CHEMBL1285353,IC50,8.11,CHEMBL1276528,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(C)c(Cl)cc(O)c1OC,CHEMBL1285353,IC50,7.96,CHEMBL1276711,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(Br)cc(O)c1OC,CHEMBL1285353,IC50,7.77,CHEMBL1276460,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(C)cc(O)c1OC,CHEMBL1285353,IC50,7.59,CHEMBL1276527,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(Cl)cc(O)c1OC,CHEMBL1285353,IC50,7.49,CHEMBL1276708,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(Cl)c(OC)cc(O)c1OC,CHEMBL1285353,IC50,7.15,CHEMBL1276709,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(Cl)ccc(O)c1OC,CHEMBL1285353,IC50,7.19,CHEMBL1276399,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(F)c(Br)cc(O)c1OC,CHEMBL1285353,IC50,8.15,CHEMBL1276740,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(O)c(Br)cc(OC)c1OC,CHEMBL941849,Ki,8.8,CHEMBL76402,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,51,79,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(O)c(Br)cc(OC)c1OC,CHEMBL941850,Ki,9.19,CHEMBL76402,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,52,80,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,CHEMBL3265956,Ki,8.92,CHEMBL8809,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,98,82,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,CHEMBL3270692,Ki,7.9,CHEMBL8809,2014,CHEMBL3259695,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,98,152,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,CHEMBL4345338,IC50,8.74,CHEMBL8809,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,142,458,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,CHEMBL4345342,IC50,6.99,CHEMBL8809,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,142,459,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,CHEMBL4429179,Ki,7.9,CHEMBL8809,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),115,460,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,CHEMBL941849,Ki,7.51,CHEMBL8809,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,52,79,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(O)c(Cl)cc(Cl)c1OC,CHEMBL941850,Ki,7.77,CHEMBL8809,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,52,80,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Br)c1OC,CHEMBL1285353,IC50,8.85,CHEMBL1276494,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Br)c1[N+](=O)[O-],CHEMBL1285353,IC50,6.73,CHEMBL1276495,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(Cl)c1OC,CHEMBL1285353,IC50,8.77,CHEMBL1276712,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)c(O)cc(I)c1OC,CHEMBL1285353,IC50,9.54,CHEMBL1276325,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1Br,CHEMBL1285353,IC50,8.1,CHEMBL1276738,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1O,CHEMBL1285353,IC50,8.0,CHEMBL283099,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,CHEMBL1285353,IC50,8.92,CHEMBL22242,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Br)c1OC,CHEMBL671074,IC50,6.06,CHEMBL22242,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",21,461,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(C)c1OC,CHEMBL1285353,IC50,8.28,CHEMBL1276645,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Cl)c1Br,CHEMBL1285353,IC50,8.25,CHEMBL1276374,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(Cl)c1Cl,CHEMBL1285353,IC50,7.7,CHEMBL1276352,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(I)c1O,CHEMBL941849,Ki,8.38,CHEMBL267723,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2short receptor in CHO cells,52,79,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(I)c1O,CHEMBL941850,Ki,8.38,CHEMBL267723,2007,CHEMBL1139804,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2long receptor in CHO cells,52,80,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(I)c1OC,CHEMBL1285353,IC50,9.17,CHEMBL23464,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(O)c1OC,CHEMBL1285353,IC50,8.06,CHEMBL1276400,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,68,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)ccc(SC)c1OC,CHEMBL1285353,IC50,8.96,CHEMBL1276326,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1c(OC)cccc1OC,CHEMBL1285353,IC50,7.28,CHEMBL282024,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(Br)cc(O)c1OC,CHEMBL1285353,IC50,8.08,CHEMBL1276459,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(Br)cc(OC)c1OC,CHEMBL982124,Ki,11.522878745280337,CHEMBL289330,2008,CHEMBL1157474,Bioorg Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor,59,462,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(Br)ccc1OC,CHEMBL1285353,IC50,7.34,CHEMBL1276268,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(C)cc(O)c1OC,CHEMBL1285353,IC50,7.72,CHEMBL1276742,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(Cl)cc(O)c1OC,CHEMBL1285353,IC50,7.41,CHEMBL1276426,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(Cl)ccc1OC,CHEMBL1285353,IC50,6.59,CHEMBL1276238,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(F)cc(O)c1OC,CHEMBL1285353,IC50,6.44,CHEMBL1276401,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(I)cc(O)c1OC,CHEMBL1285353,IC50,8.52,CHEMBL1276496,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(OC)cc(O)c1OC,CHEMBL1285353,IC50,6.69,CHEMBL1276586,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CHEMBL672576,Ki,7.29,CHEMBL267044,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CHEMBL672579,Ki,7.29,CHEMBL267044,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,21,463,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CHEMBL672913,Ki,6.92,CHEMBL267044,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC,CHEMBL673073,Ki,6.92,CHEMBL267044,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,21,464,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cc([N+](=O)[O-])cc(O)c1OC,CHEMBL1285353,IC50,5.52,CHEMBL1276767,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCC[C@H]1CNC(=O)c1cccc(O)c1OC,CHEMBL1285353,IC50,6.5,CHEMBL1276269,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1,CHEMBL911524,Ki,6.15,CHEMBL215842,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,44,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1,CHEMBL840158,Ki,9.85,CHEMBL178803,2005,CHEMBL1141892,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,40,465,c1ccc(-c2cc(N3CCNCC3)nc3c2CCCCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCC[C@@H](O)CC3)CC1,CHEMBL840158,Ki,8.21,CHEMBL181469,2005,CHEMBL1141892,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,40,465,c1ccc(-c2cc(N3CCNCC3)nc3c2CCCCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCC[C@H](O)CC3)CC1,CHEMBL840158,Ki,7.67,CHEMBL362285,2005,CHEMBL1141892,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,40,465,c1ccc(-c2cc(N3CCNCC3)nc3c2CCCCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CC[C@@H](O)CCC3)CC1,CHEMBL840158,Ki,7.92,CHEMBL179649,2005,CHEMBL1141892,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,40,465,c1ccc(-c2cc(N3CCNCC3)nc3c2CCCCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CC[C@H](O)CCC3)CC1,CHEMBL840158,Ki,8.44,CHEMBL360457,2005,CHEMBL1141892,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against recombinant human dopamine receptor D2L in human liver microsomes,40,465,c1ccc(-c2cc(N3CCNCC3)nc3c2CCCCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCN(c2ccc3c(c2)CCN3S(=O)(=O)c2ccccc2)CC1,CHEMBL4479923,Ki,6.36,CHEMBL4562787,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,115,378,O=S(=O)(c1ccccc1)N1CCc2cc(N3CCNCC3)ccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCN(c2ccc3c(c2)N(S(=O)(=O)c2ccccc2)CC3)CC1,CHEMBL4479923,Ki,6.87,CHEMBL4551220,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,115,378,O=S(=O)(c1ccccc1)N1CCc2ccc(N3CCNCC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCN(c2cccc3c2CCN3S(=O)(=O)c2ccccc2)CC1,CHEMBL4479923,Ki,7.08,CHEMBL4566992,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,115,378,O=S(=O)(c1ccccc1)N1CCc2c(N3CCNCC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCN(c2cccc3c2CN(S(=O)(=O)c2ccccc2)C3)CC1,CHEMBL4479923,Ki,6.51,CHEMBL4549734,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,115,378,O=S(=O)(c1ccccc1)N1Cc2cccc(N3CCNCC3)c2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCN2c3cccc4[nH]cc(c34)CC2C1,CHEMBL3294601,Ki,6.85,CHEMBL3286569,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,98,178,c1cc2c3c(c[nH]c3c1)CC1CNCCN21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCc2cc3nc(N)sc3cc2CC1,CHEMBL2328744,IC50,4.72,CHEMBL2326489,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,88,466,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCc2cc3nc(N)sc3cc2CC1,CHEMBL2328745,Ki,5.6,CHEMBL2326489,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,88,467,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL859832,Ki,7.08,CHEMBL382850,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,45,468,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL859835,Ki,6.6,CHEMBL382850,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,45,469,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1CCc2ccccc2Cc2ccc(O)cc2CC1,CHEMBL982103,Ki,7.11,CHEMBL508399,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,59,470,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1C[C@H]2C[C@@]2(c2ccc(NS(=O)(=O)c3ccc(C(C)C)cc3)cc2)C1,CHEMBL1225698,Ki,7.0,CHEMBL1224697,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,69,93,O=S(=O)(Nc1ccc(C23CNCC2C3)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1[C@@H](c2ccc(-c3cc(S(=O)(=O)CC)ccc3OC)[nH]2)CC[C@H]1c1ccccc1,CHEMBL674353,Ki,6.8,CHEMBL2367896,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(-c2ccc(C3CCC(c4ccccc4)N3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN1[C@H](c2ccccc2)CC[C@H]1c1ccc(-c2cc(S(=O)(=O)CC)ccc2OC)[nH]1,CHEMBL674353,Ki,7.4,CHEMBL111884,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(-c2ccc(C3CCC(c4ccccc4)N3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCNC(=O)Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,7.58,CHEMBL163895,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,33,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCNC(=O)Nc1ccc2c(c1)CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C,CHEMBL1073809,Ki,5.22,CHEMBL600987,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,69,102,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCNC(=O)Nc1cccc(CCN2CCN(c3cccc4nc(C)ccc34)CC2)c1,CHEMBL1635455,Ki,6.5,CHEMBL1632220,2010,CHEMBL1629528,J Med Chem,Scientific Literature,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,69,123,c1ccc(CCN2CCN(c3cccc4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCNC(=O)Nc1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C,CHEMBL1073809,Ki,6.05,CHEMBL604132,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,69,102,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,CHEMBL4187998,IC50,7.42,CHEMBL4210637,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc2c(C3CCN(CCCCOc4ccncc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL3806800,IC50,6.94,CHEMBL3805772,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,115,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCNC(=O)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,CHEMBL4187998,IC50,7.18,CHEMBL4209705,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc(OCCCCN2CCC(c3noc4ccccc34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCNC(=O)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,CHEMBL4187998,IC50,7.23,CHEMBL4218526,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1cncc(OCCCCN2CCC(c3noc4ccccc34)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCNC1CCc2c(cccc2OC)C1,CHEMBL670536,Ki,6.75,CHEMBL134759,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,8,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN[C@@H]1Cc2cc3nc(N)sc3cc2C1,CHEMBL2328744,IC50,6.17,CHEMBL2326486,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,88,466,c1nc2cc3c(cc2s1)CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCN[C@@H]1Cc2cc3nc(N)sc3cc2C1,CHEMBL2328745,Ki,6.82,CHEMBL2326486,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,88,467,c1nc2cc3c(cc2s1)CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,CHEMBL863653,Ki,6.89,CHEMBL212782,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,45,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCO/N=C(\CCN1CCN(c2nccs2)CC1)c1ccccc1,CHEMBL863653,Ki,6.59,CHEMBL377388,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,45,472,N=C(CCN1CCN(c2nccs2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCO/N=C/c1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C,CHEMBL1074771,Ki,6.66,CHEMBL604525,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,69,473,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2CC1CC1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL5046486,Ki,5.41,CHEMBL5083186,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,C=C1C2CCCC1(c1ccccc1)CCN2CC1CC1CCNC(=O)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2CCCCNC(=O)c1cc2ccccc2[nH]1,CHEMBL5046486,Ki,5.53,CHEMBL5082465,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,C=C1C2CCCC1(c1ccccc1)CCN2CCCCNC(=O)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2CCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL5046486,Ki,7.29,CHEMBL5075726,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,C=C1C2CCCC1(c1ccccc1)CCN2CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2CCc1ccccc1,CHEMBL5046486,Ki,6.2,CHEMBL5080654,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,C=C1C2CCCC1(c1ccccc1)CCN2CCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2CCc1ccccc1,CHEMBL5046490,Ki,6.73,CHEMBL5080654,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,147,474,C=C1C2CCCC1(c1ccccc1)CCN2CCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2C[C@@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL5046486,Ki,5.31,CHEMBL5086564,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,C=C1C2CCCC1(c1ccccc1)CCN2CC1CC1CCNC(=O)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)/C=C1\[C@@H]2CCC[C@@]1(c1cccc(O)c1)CCN2C[C@H]1C[C@@H]1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL5046486,Ki,5.54,CHEMBL5077114,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,C=C1C2CCCC1(c1ccccc1)CCN2CC1CC1CCNC(=O)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)C1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,7.23,CHEMBL399396,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,52,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)C1CCN(CC2COc3ccc4[nH]c(C(=O)OC)cc4c3O2)CC1,CHEMBL672490,Ki,6.59,CHEMBL319023,1992,CHEMBL1125523,J Med Chem,Scientific Literature,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",0,286,c1cc2c3c(ccc2[nH]1)OCC(CN1CCCCC1)O3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)N1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,8.0,CHEMBL3914241,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,115,114,c1ccc2c(N3CCN(CCC4CCNCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)N1CCC(NCCNC(=O)c2ccccc2C)CC1,CHEMBL1919022,IC50,5.35,CHEMBL1624037,2011,CHEMBL1914417,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor,77,475,O=C(NCCNC1CCNCC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)N1CCN(Cc2cnn(-c3ccc(Cl)cc3)c2)CC1,CHEMBL5235417,Ki,4.99,CHEMBL5277859,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to D2R (unknown origin) assessed as inhibition constant,147,476,c1ccc(-n2cc(CN3CCNCC3)cn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)N[C@H]1CC[C@@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,8.4,CHEMBL3923240,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,115,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,9.15,CHEMBL3982486,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,115,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,CHEMBL3089794,Ki,5.57,CHEMBL3088211,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,88,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,7.82,CHEMBL164338,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,33,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)Nc1ccc2c(c1)CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C,CHEMBL1073809,Ki,5.41,CHEMBL603485,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,69,102,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1,CHEMBL3762401,Ki,6.04,CHEMBL3758665,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,115,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)[C@@H]1CCCN(CCCC(C)(C)S(=O)(=O)c2ccccc2)C1,CHEMBL865592,Ki,6.15,CHEMBL203400,2006,CHEMBL1139656,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from the cloned human D2 receptor expressed in CHO cells,45,176,O=S(=O)(CCCCN1CCCCC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)c1[nH]c2ccc(F)cc2c1CN1CCN(c2ccccc2)CC1,CHEMBL5235409,Ki,4.66,CHEMBL5280364,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,147,478,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)c1[nH]c2ccccc2c1CCN(C)C,CHEMBL671380,Ki,7.23,CHEMBL317535,2001,CHEMBL1134783,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,25,479,c1ccc2[nH]ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,CHEMBL3295080,Ki,8.13,CHEMBL3287395,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,98,391,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,CHEMBL3295081,Ki,8.17,CHEMBL3287395,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,98,392,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1,CHEMBL4010153,Ki,8.13,CHEMBL4072821,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,360,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1,CHEMBL4010156,Ki,8.09,CHEMBL4072821,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,124,361,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)c1cnn2cccc(CN3CCN(c4ccc(Cl)cc4)CC3)c12,CHEMBL672382,Ki,4.43,CHEMBL91362,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,25,480,c1ccc(N2CCN(Cc3cccn4nccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)c1cnn2cccc(CN3CCN(c4ccc(Cl)cc4)CC3)c12,CHEMBL672572,Ki,4.35,CHEMBL91362,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,25,481,c1ccc(N2CCN(Cc3cccn4nccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOC(=O)c1oc2c(c1C)C(=O)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)C2,CHEMBL1027240,Ki,6.67,CHEMBL459930,2008,CHEMBL1140101,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,59,482,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2occc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,6.0,CHEMBL3642690,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.41,CHEMBL3664856,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOCc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL1930837,Ki,7.08,CHEMBL1928124,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,81,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOCc1ccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL1930838,Ki,6.54,CHEMBL1928124,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,81,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOCc1ccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL1930837,Ki,6.5,CHEMBL1928123,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,81,483,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOCc1ccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL1930838,Ki,6.11,CHEMBL1928123,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,81,484,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1,CHEMBL1930837,Ki,5.01,CHEMBL1928247,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,81,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOCc1ccc(N2CCN(CCCCNC(=O)c3ccccc3)CC2)c(OC)c1,CHEMBL1930838,Ki,4.72,CHEMBL1928247,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,81,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1,CHEMBL1930837,Ki,7.92,CHEMBL1928136,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,82,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOCc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1,CHEMBL1930838,Ki,7.6,CHEMBL1928136,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,82,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1,CHEMBL1930837,Ki,7.5,CHEMBL1928135,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,82,483,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOCc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1,CHEMBL1930838,Ki,7.17,CHEMBL1928135,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,82,484,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL1930837,Ki,7.36,CHEMBL1928120,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,82,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL1930838,Ki,7.02,CHEMBL1928120,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,82,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL1930837,Ki,6.85,CHEMBL1928119,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,82,483,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL1930838,Ki,6.57,CHEMBL1928119,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,82,484,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1,CHEMBL1930837,Ki,8.52,CHEMBL1928134,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,82,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOc1ccn2ncc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2c1,CHEMBL1930838,Ki,7.75,CHEMBL1928134,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,82,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1,CHEMBL1930837,Ki,8.19,CHEMBL1928133,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,82,483,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCOc1ccn2ncc(C(=O)NCCCN3CCN(c4ccccc4OC)CC3)c2c1,CHEMBL1930838,Ki,7.54,CHEMBL1928133,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,82,484,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1803210,Ki,7.75,CHEMBL1803052,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,77,293,c1ccc(N2CCN(Cc3ccc(OCCCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCn1cc(CCCOc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1803211,Ki,7.8,CHEMBL1803052,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,77,294,c1ccc(N2CCN(Cc3ccc(OCCCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCn1cc(COc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1803210,Ki,7.17,CHEMBL1803051,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,77,293,c1ccc(N2CCN(Cc3ccc(OCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOCCn1cc(COc2ccc(CN3CCN(c4ccccc4OC)CC3)cc2OC)nn1,CHEMBL1803211,Ki,7.0,CHEMBL1803051,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,77,294,c1ccc(N2CCN(Cc3ccc(OCc4c[nH]nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCO[C@@]1(CC)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1,CHEMBL670677,Ki,7.61,CHEMBL280804,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,21,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCO[C@]1(CC)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1,CHEMBL670677,Ki,7.15,CHEMBL281554,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,21,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1c(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)sc2ccccc12,CHEMBL870468,Ki,6.71,CHEMBL378914,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cc(N)c(Cl)cc1C(=O)NC[C@@H]1CCN2CCC[C@@H]12,CHEMBL858805,IC50,5.28,CHEMBL201019,2006,CHEMBL1149398,J Med Chem,Scientific Literature,Binding affinity to dopamine receptor D2,45,485,O=C(NCC1CCN2CCCC12)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL5335368,Ki,5.68,CHEMBL5433001,2023,CHEMBL5331137,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,155,276,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc(CCNC(=O)N2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1,CHEMBL671072,IC50,5.54,CHEMBL113956,2001,CHEMBL1134625,J Med Chem,Scientific Literature,Inhibition of human dopamine receptor D2,25,486,O=C(NCCc1ccccc1)N1CCN(CCCC(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,CHEMBL1810621,IC50,5.4,CHEMBL1807825,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,77,487,O=c1[nH]c2cccc(CCNCCSCCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1,CHEMBL1219344,Ki,5.31,CHEMBL1214831,2010,CHEMBL1212881,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,69,426,c1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc(Cl)cc1CN1CCN(CC(=O)N2c3ccccc3C[C@H]2C)CC1,CHEMBL675680,Ki,6.87,CHEMBL326863,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,28,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc(F)cc1C1CC1CN(CC)CCCSc1nnc(-c2ccccc2)n1C,CHEMBL4406061,Ki,6.42,CHEMBL4450429,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc(F)cc1C1CC1CNCCCSc1nnc(-c2ccccc2)n1C,CHEMBL4406061,Ki,6.18,CHEMBL4590356,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)cc1,CHEMBL2169117,Ki,7.28,CHEMBL2165124,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,82,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc([C@H](O)CN2CCN(c3ccccc3F)CC2)cc1,CHEMBL4137914,Ki,5.7,CHEMBL4161676,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,130,220,c1ccc(CCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc2[nH]cc(C3=CCN(Cc4ccc(OC)cc4)CC3)c2c1,CHEMBL4368222,Ki,6.88,CHEMBL4466356,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,134,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc2[nH]cc(C3=CCN(Cc4cccc(OC)c4)CC3)c2c1,CHEMBL4368222,Ki,6.97,CHEMBL4578143,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,134,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc2[nH]cc(C3=CCN(Cc4ccccc4)CC3)c2c1,CHEMBL4368222,Ki,6.82,CHEMBL4454000,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,134,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc2[nH]cc(C3=CCN(Cc4cccs4)CC3)c2c1,CHEMBL4368222,Ki,6.78,CHEMBL4527257,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,134,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2cccs2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2,CHEMBL4671577,Ki,7.33,CHEMBL4758966,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,142,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2,CHEMBL3783165,Ki,6.8,CHEMBL3779928,2016,CHEMBL3779868,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,115,278,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccc2ccccc2c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL870468,Ki,6.56,CHEMBL378512,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc(CN2CCN(Cc3cc4ccccc4o3)CC2)c1,CHEMBL1219344,Ki,5.34,CHEMBL1214895,2010,CHEMBL1212881,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,69,426,c1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1,CHEMBL2169117,Ki,7.68,CHEMBL2165123,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,82,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC3,CHEMBL5385535,Ki,7.78,CHEMBL5430494,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,155,201,O=c1ccc2ccc(OCCCCN3CCc4c(oc5ccccc45)C3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(C(C)NCC3(O)CCCCC3)oc12,CHEMBL5385535,Ki,5.67,CHEMBL5406501,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,155,201,c1ccc2oc(CNCC3CCCCC3)cc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CN(C)CCCCOc3ccc4c(c3)NC(=O)CC4)oc12,CHEMBL5385535,Ki,6.265,CHEMBL5440936,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,155,201,O=C1CCc2ccc(OCCCCNCc3cc4ccccc4o3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCCCCCOc3ccc4c(c3)NC(=O)CC4)oc12,CHEMBL5385535,Ki,6.355,CHEMBL5406355,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,155,201,O=C1CCc2ccc(OCCCCCNCc3cc4ccccc4o3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCCCCCOc3ccc4ccc(=O)[nH]c4c3)oc12,CHEMBL5385535,Ki,6.125,CHEMBL5414152,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,155,201,O=c1ccc2ccc(OCCCCCNCc3cc4ccccc4o3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCCCCOc3ccc4c(C)noc4c3)oc12,CHEMBL5385535,Ki,5.68,CHEMBL5418890,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,c1ccc2oc(CNCCCCOc3ccc4cnoc4c3)cc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCCCCOc3ccc4c(c3)NC(=O)CC4)oc12,CHEMBL5385535,Ki,8.15,CHEMBL5424038,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,O=C1CCc2ccc(OCCCCNCc3cc4ccccc4o3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCCCCOc3ccc4c(c3)OCO4)oc12,CHEMBL5385535,Ki,6.355,CHEMBL5421574,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,c1ccc2oc(CNCCCCOc3ccc4c(c3)OCO4)cc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCCCCOc3ccc4ccc(=O)[nH]c4c3)oc12,CHEMBL5385535,Ki,9.905000000000001,CHEMBL5441140,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,O=c1ccc2ccc(OCCCCNCc3cc4ccccc4o3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCCCCOc3ccc4ccc(=O)oc4c3)oc12,CHEMBL5385535,Ki,8.184999999999999,CHEMBL5418748,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,O=c1ccc2ccc(OCCCCNCc3cc4ccccc4o3)cc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCCCCOc3ccc4oc(C)nc4c3)oc12,CHEMBL5385535,Ki,6.025,CHEMBL5414422,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,c1ccc2oc(CNCCCCOc3ccc4ocnc4c3)cc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCCCCOc3ccc4scnc4c3)oc12,CHEMBL5385535,Ki,7.515,CHEMBL5417227,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,c1ccc2oc(CNCCCCOc3ccc4scnc4c3)cc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCCCOc3ccc4c(c3)NC(=O)CC4)oc12,CHEMBL5385535,Ki,6.96,CHEMBL5401818,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,O=C1CCc2ccc(OCCCNCc3cc4ccccc4o3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCCCOc3ccc4ccc(=O)[nH]c4c3)oc12,CHEMBL5385535,Ki,6.37,CHEMBL5426286,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,O=c1ccc2ccc(OCCCNCc3cc4ccccc4o3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCC[C@H]3CC[C@H](NC(=O)C4CC4)CC3)oc12,CHEMBL5385535,Ki,7.2,CHEMBL5412359,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,O=C(NC1CCC(CCNCc2cc3ccccc3o2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCC[C@H]3CC[C@H](NC(=O)N(C)C)CC3)oc12,CHEMBL5385535,Ki,7.0,CHEMBL5435054,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,c1ccc2oc(CNCCC3CCCCC3)cc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1cccc2cc(CNCC[C@H]3CC[C@H](NC(=O)N4CCCC4)CC3)oc12,CHEMBL5385535,Ki,7.165,CHEMBL5438433,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,156,201,O=C(NC1CCC(CCNCc2cc3ccccc3o2)CC1)N1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1C(=O)NC1CCN(CCOc2cccc(F)c2)CC1,CHEMBL2162846,Ki,7.12,CHEMBL2159463,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,82,218,O=C(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1CN1CCN(Cc2cc3ccccc3o2)CC1,CHEMBL1219344,Ki,5.22,CHEMBL1214962,2010,CHEMBL1212881,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,69,426,c1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,CHEMBL1947794,IC50,5.9,CHEMBL1945290,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,82,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)CC1,CHEMBL4397357,Ki,5.29,CHEMBL4475482,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,134,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL3887359,Ki,8.39,CHEMBL3891542,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",109,117,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,CHEMBL3887359,Ki,8.36,CHEMBL3935170,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",109,117,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,CHEMBL3887359,Ki,8.44,CHEMBL3944009,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",109,117,O=c1ccc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccc(F)cc3)C2=O)CC1,CHEMBL3771916,Ki,6.9,CHEMBL3769534,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,115,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccccc3)C2=O)CC1,CHEMBL4148417,Ki,6.52,CHEMBL4176950,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,130,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCC(=O)NCc2nc3cc(F)ccc3c(=O)n2-c2ccc(OC)cc2)CC1,CHEMBL920904,IC50,5.82,CHEMBL259199,2008,CHEMBL1144677,Bioorg Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,59,489,O=C(CCCN1CCN(c2ccccc2)CC1)NCc1nc2ccccc2c(=O)n1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCC(=O)NCc2nc3ccc(F)cc3c(=O)n2-c2ccc(OC)cc2)CC1,CHEMBL920904,IC50,6.85,CHEMBL406221,2008,CHEMBL1144677,Bioorg Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,59,489,O=C(CCCN1CCN(c2ccccc2)CC1)NCc1nc2ccccc2c(=O)n1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCC(=O)NCc2nc3ccc(F)cc3c(=O)n2-c2ccccc2)CC1,CHEMBL920904,IC50,6.0,CHEMBL260907,2008,CHEMBL1144677,Bioorg Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,59,489,O=C(CCCN1CCN(c2ccccc2)CC1)NCc1nc2ccccc2c(=O)n1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCCCCN2C(=O)c3cccc4cccc(c34)C2=O)CC1,CHEMBL4390409,Ki,7.57,CHEMBL4476432,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,134,490,O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCCCCN2C(=O)c3cccc4cccc2c34)CC1,CHEMBL4390409,Ki,7.96,CHEMBL4587772,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,134,490,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCCCCN2c3cccc4cccc(c34)S2(=O)=O)CC1,CHEMBL4390409,Ki,7.52,CHEMBL4555890,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,134,490,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCCNC(=O)c2n[nH]c3ccccc23)CC1,CHEMBL5362774,Ki,8.01,CHEMBL5412886,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,156,491,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL2169117,Ki,8.55,CHEMBL443034,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,82,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCCc2cc(-c3ccc(OC)c(OC)c3)no2)CC1,CHEMBL672182,Ki,6.92,CHEMBL538723,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,28,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCCc2cc(-c3cccc([N+](=O)[O-])c3)no2)CC1,CHEMBL672182,Ki,7.02,CHEMBL537975,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,28,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCCc2cc(-c3ccccc3)no2)CC1,CHEMBL672182,Ki,6.47,CHEMBL542809,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,28,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCCCc2cc(-c3cccs3)no2)CC1,CHEMBL672182,Ki,6.71,CHEMBL557829,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,28,52,c1ccc(N2CCN(CCCCc3cc(-c4cccs4)no3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCC[C@@H]2CC(c3ccc(OC)c(OC)c3)=NO2)CC1,CHEMBL892631,Ki,7.34,CHEMBL243224,2007,CHEMBL1147208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,52,492,c1ccc(C2=NOC(CCCN3CCN(c4ccccc4)CC3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(CCC[C@H]2CC(c3ccc(OC)c(OC)c3)=NO2)CC1,CHEMBL892631,Ki,7.16,CHEMBL243225,2007,CHEMBL1147208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,52,492,c1ccc(C2=NOC(CCCN3CCN(c4ccccc4)CC3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL2423805,Ki,6.33,CHEMBL2420894,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,88,493,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(Cc2cccc3ccccc23)CC1,CHEMBL2423805,Ki,6.58,CHEMBL2420781,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,88,493,c1ccc(N2CCN(Cc3cccc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(Cc2ccccc2)CC1,CHEMBL2423805,Ki,6.66,CHEMBL2420892,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,88,493,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(Cc2cccnc2)CC1,CHEMBL2423805,Ki,6.59,CHEMBL2420779,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,88,493,c1ccc(N2CCN(Cc3cccnc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(Cc2cccs2)CC1,CHEMBL2423805,Ki,6.79,CHEMBL2420773,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,88,493,c1ccc(N2CCN(Cc3cccs3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1N1CCN(Cc2csc3ccccc23)CC1,CHEMBL2423805,Ki,6.66,CHEMBL2420890,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,88,493,c1ccc(N2CCN(Cc3csc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,CHEMBL672575,Ki,7.11,CHEMBL836,2000,CHEMBL1133729,J Med Chem,Scientific Literature,Binding affinity towards recombinant human Dopamine receptor D2S was determined using [3H]spiperone as radioligand,21,206,c1ccc(CCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(S(N)(=O)=O)c1,CHEMBL672912,Ki,7.89,CHEMBL836,2000,CHEMBL1133729,J Med Chem,Scientific Literature,Binding affinity towards recombinant human Dopamine receptor D2L was determined using [3H]spiperone as radioligand,21,207,c1ccc(CCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)n1,CHEMBL865866,Ki,6.54,CHEMBL202072,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,45,168,O=c1ncccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCOc1csc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)c1,CHEMBL870468,Ki,6.75,CHEMBL437112,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.48,CHEMBL3695401,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.32,CHEMBL3676882,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.96,CHEMBL3642726,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,6.11,CHEMBL3642694,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1,CHEMBL3705135,Ki,6.66,CHEMBL3642708,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2sccc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)Nc1ccc2c(c1)CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C,CHEMBL1073809,Ki,5.48,CHEMBL600986,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,69,102,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)Nc1cccc(N2CCN(CCCCN3C(=O)C4CCCN4C3=O)CC2)c1,CHEMBL664619,Ki,7.66,CHEMBL1204203,2001,CHEMBL1134606,J Med Chem,Scientific Literature,In vitro binding affinity towards D2 receptor was determined,25,494,O=C1C2CCCN2C(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)Nc1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C,CHEMBL1073809,Ki,6.21,CHEMBL602052,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,69,102,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(C(C)N3CCCC3)[nH]2)c1,CHEMBL674347,Ki,6.4,CHEMBL282287,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(CN3CCCC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(C(C)N3CCCCC3)[nH]2)c1,CHEMBL674347,Ki,6.5,CHEMBL20785,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(CN3CCCCC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(C(C)N3CCCCCC3)[nH]2)c1,CHEMBL674347,Ki,7.1,CHEMBL22022,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(CN3CCCCCC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(C3CCCN3Cc3ccccc3)[nH]2)c1,CHEMBL674353,Ki,7.4,CHEMBL326662,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(CN2CCCC2c2ccc(-c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCC3)[nH]2)c1,CHEMBL674347,Ki,6.6,CHEMBL21280,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(CN3CCCC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCC3c3ccccc3)[nH]2)c1,CHEMBL674347,Ki,7.8,CHEMBL280961,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(CN3CCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCC3)[nH]2)c1,CHEMBL674347,Ki,6.8,CHEMBL21118,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(CN3CCCCC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCC3c3ccccc3)[nH]2)c1,CHEMBL674347,Ki,7.9,CHEMBL281177,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(CN3CCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3)[nH]2)c1,CHEMBL674347,Ki,6.8,CHEMBL279039,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(CN3CCCCCC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccc(C)cc3)[nH]2)c1,CHEMBL674353,Ki,7.6,CHEMBL112219,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccc(OC)cc3)[nH]2)c1,CHEMBL674353,Ki,7.6,CHEMBL325859,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3cccc(OC)c3)[nH]2)c1,CHEMBL674353,Ki,6.1,CHEMBL325658,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1,CHEMBL674346,Ki,7.4,CHEMBL22156,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",10,445,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1,CHEMBL674347,Ki,7.4,CHEMBL22156,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1,CHEMBL674353,Ki,7.4,CHEMBL22156,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCC3c3ccccc3C)[nH]2)c1,CHEMBL674353,Ki,5.9,CHEMBL325060,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCCCC3c3ccccc3)[nH]2)c1,CHEMBL674347,Ki,6.5,CHEMBL20395,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(CN3CCCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCC[C@@H]3c3ccccc3)[nH]2)c1,CHEMBL674346,Ki,7.6,CHEMBL1788258,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",10,445,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCCCC[C@H]3c3ccccc3)[nH]2)c1,CHEMBL674346,Ki,7.0,CHEMBL2093000,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",10,445,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCOCC3)[nH]2)c1,CHEMBL674347,Ki,5.5,CHEMBL20407,1996,CHEMBL1152020,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,8,441,c1ccc(-c2ccc(CN3CCOCC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCS(=O)(=O)c1ccc(OC)c(-c2ccc(CN3CCc4ccccc4C3)[nH]2)c1,CHEMBL674353,Ki,7.0,CHEMBL419760,1997,CHEMBL1129831,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity, displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells",10,444,c1ccc(-c2ccc(CN3CCc4ccccc4C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC[11CH2]N1CCO[C@@H]2c3cc(O)ccc3CC[C@H]21,CHEMBL1291980,Ki,8.07,CHEMBL1288585,2010,CHEMBL1287708,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor expressed in CHO cells,69,495,c1ccc2c(c1)CCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC[C@@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.45,CHEMBL3695434,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC[C@@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.26,CHEMBL3676891,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC[C@@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.07,CHEMBL3642816,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4052936,Ki,6.23,CHEMBL4072171,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,124,282,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(C)cc2)CC1,CHEMBL675680,Ki,7.02,CHEMBL321121,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,28,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL675680,Ki,6.66,CHEMBL319923,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,28,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC[C@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.47,CHEMBL3676892,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC[C@H](O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.05,CHEMBL3642766,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CC[C@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4052936,Ki,7.03,CHEMBL4092928,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,124,282,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1c(-c2ccccc2)nc(O)n1C1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,7.58,CHEMBL91498,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,17,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1c(Br)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,CHEMBL1285353,IC50,7.77,CHEMBL1276646,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1c(C)c2n(c1C)[B-](F)(F)[N+]1=C3C=CC=C(NCCCCN4CCN(c5cccc(Cl)c5Cl)CC4)N3[B-](F)(F)[N+]1=C2,CHEMBL5133886,Ki,6.3,CHEMBL5207676,2022,CHEMBL5131451,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,153,497,[BH2-]1N2C(NCCCCN3CCN(c4ccccc4)CC3)=CC=CC2=[N+]2[BH2-]n3cccc3C=[N+]12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1c(C)c2n(c1C)[B-](F)(F)[N+]1=C3C=CC=C(NCCCCN4CCN(c5ccccc5OC)CC4)N3[B-](F)(F)[N+]1=C2,CHEMBL5133886,Ki,6.51,CHEMBL5197956,2022,CHEMBL5131451,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,153,497,[BH2-]1N2C(NCCCCN3CCN(c4ccccc4)CC3)=CC=CC2=[N+]2[BH2-]n3cccc3C=[N+]12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1c(C2CCN(Cc3ccccc3)CC2)n[nH]c1-c1ccc(Cl)cc1,CHEMBL672209,Ki,7.46,CHEMBL78933,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,10,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1c(Cl)cc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,CHEMBL1285353,IC50,7.92,CHEMBL1276428,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1c[nH]c(C(=O)NCCCCN2CCN(c3cccc(CC)c3Cl)CC2)n1,CHEMBL4429153,Ki,7.9,CHEMBL4543524,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ncc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(-c2ccoc2)nc(N2CCN(C)CC2)n1,CHEMBL4199279,Ki,6.33,CHEMBL4208934,2018,CHEMBL4196098,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hR,130,287,c1cc(-c2ccoc2)nc(N2CCNCC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NCC2CCCN(CCCCNC(=O)c3cc4ccccc4[nH]3)C2)c1O,CHEMBL4828545,Ki,5.88,CHEMBL4862405,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCCN(CCCCNC(=O)c2cc3ccccc3[nH]2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NCC2CCCN(CCCCNC(=O)c3cc4ccccc4o3)C2)c1O,CHEMBL4828545,Ki,5.75,CHEMBL4869151,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCCN(CCCCNC(=O)c2cc3ccccc3o2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NCC2CCCN2CC(=O)N2CCC(c3ccccc3)(c3ccccc3)C2)c1O,CHEMBL5046486,Ki,5.62,CHEMBL5079053,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,O=C(NCC1CCCN1CC(=O)N1CCC(c2ccccc2)(c2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NCC2CCCN2CCCCNCCC(C(=O)N(C)C)(c2ccccc2)c2ccccc2)c1O,CHEMBL5046486,Ki,6.3,CHEMBL5075990,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,O=C(NCC1CCCN1CCCCNCCC(c1ccccc1)c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NCC2CCCN2CCCCNCCC(C(=O)N(C)C)(c2ccccc2)c2ccccc2)c1O,CHEMBL5046490,Ki,7.03,CHEMBL5075990,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,147,474,O=C(NCC1CCCN1CCCCNCCC(c1ccccc1)c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NCC2CCN(C)C2)c1O,CHEMBL4828545,Ki,6.66,CHEMBL4875195,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCNC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NCC2CCN(CC)C2)c1O,CHEMBL4828545,Ki,7.42,CHEMBL4871669,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCNC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2)c1O,CHEMBL4828545,Ki,8.65,CHEMBL4861573,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O,CHEMBL3270692,Ki,10.07,CHEMBL8946,2014,CHEMBL3259695,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,98,152,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O,CHEMBL3863990,Ki,9.59,CHEMBL8946,2016,CHEMBL3862037,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,115,226,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1O,CHEMBL4828545,Ki,9.93,CHEMBL8946,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCC(C#N)(c2ccccc2)c2ccccc2)c1O,CHEMBL5046486,Ki,4.91,CHEMBL5091656,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,O=C(NCC1CCCN1CCC(c1ccccc1)c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCCCNC(=O)c2cc3ccccc3[nH]2)c1O,CHEMBL4828545,Ki,6.76,CHEMBL4871811,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCCN1CCCCNC(=O)c1cc2ccccc2[nH]1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCCCNC(=O)c2cc3ccccc3o2)c1O,CHEMBL4828545,Ki,7.56,CHEMBL4853938,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCCN1CCCCNC(=O)c1cc2ccccc2o1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCCCNCCC(C(=O)N(C)C)(c2ccccc2)c2ccccc2)c1O,CHEMBL5046486,Ki,5.76,CHEMBL5089932,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,O=C(NCC1CCCN1CCCCNCCC(c1ccccc1)c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCCCOc2ccc3c(c2)NC(=O)CC3)c1O,CHEMBL4828545,Ki,7.6,CHEMBL4849107,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C1CCc2ccc(OCCCCN3CCCC3CNC(=O)c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCCc2ccccc2)c1O,CHEMBL4828545,Ki,6.79,CHEMBL4864366,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCCN1CCCc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2CCc2c(C)nc3n(c2=O)CCCC3)c1O,CHEMBL4828545,Ki,7.13,CHEMBL4876353,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCCN1CCc1cnc2n(c1=O)CCCC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2Cc2ccccc2)c1O,CHEMBL4828545,Ki,6.69,CHEMBL4858824,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCCN1Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2CCCN2Cc2ccccc2)c1OCc1ccccc1,CHEMBL4828545,Ki,5.59,CHEMBL4868275,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCCN1Cc1ccccc1)c1ccccc1OCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCNC(=O)c3cc4ccccc4[nH]3)CN2)c1O,CHEMBL4828545,Ki,8.6,CHEMBL4860478,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CC(OCCCCNC(=O)c2cc3ccccc3[nH]2)CN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCNC(=O)c3cc4ccccc4[nH]3)CN2CC)c1O,CHEMBL4828545,Ki,8.73,CHEMBL4853568,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CC(OCCCCNC(=O)c2cc3ccccc3[nH]2)CN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCNC(=O)c3cc4ccccc4o3)CN2)c1O,CHEMBL4828545,Ki,8.64,CHEMBL4850300,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CC(OCCCCNC(=O)c2cc3ccccc3o2)CN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCNC(=O)c3cc4ccccc4o3)CN2CC)c1O,CHEMBL4828545,Ki,9.02,CHEMBL4846561,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CC(OCCCCNC(=O)c2cc3ccccc3o2)CN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCNCCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CN2)c1O,CHEMBL5046486,Ki,8.03,CHEMBL5081136,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,O=C(NCC1CC(OCCCCNCCC(c2ccccc2)c2ccccc2)CN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCO)CN2)c1O,CHEMBL4828545,Ki,8.72,CHEMBL4847432,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCOCc3ccccc3)CN2)c1O,CHEMBL4828545,Ki,8.14,CHEMBL4856983,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CC(OCCCCOCc2ccccc2)CN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCCOc3ccc4c(c3)NC(=O)CC4)CN2)c1O,CHEMBL4828545,Ki,8.75,CHEMBL4873313,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C1CCc2ccc(OCCCCOC3CNC(CNC(=O)c4ccccc4)C3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(C(=O)NC[C@@H]2C[C@@H](OCCCc3ccccc3)CN2)c1O,CHEMBL4828545,Ki,8.13,CHEMBL4868595,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,147,373,O=C(NCC1CC(OCCCc2ccccc2)CN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(C)CC2)c1,CHEMBL4429153,Ki,6.63,CHEMBL4543685,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1,CHEMBL4415924,Ki,4.68,CHEMBL4534566,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1,CHEMBL4415924,Ki,4.97,CHEMBL4546210,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1,CHEMBL4415924,Ki,4.88,CHEMBL4476394,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1,CHEMBL4429153,Ki,4.94,CHEMBL4476394,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4o3)CC2)c1,CHEMBL4429153,Ki,5.79,CHEMBL4436025,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC(O)CCNC(=O)c3ccc4c(c3)OCO4)CC2)c1,CHEMBL4415924,Ki,6.44,CHEMBL4464971,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2)c1,CHEMBL4429153,Ki,7.56,CHEMBL4521947,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1,CHEMBL4429153,Ki,6.86,CHEMBL4459533,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1,CHEMBL4361371,Ki,8.73,CHEMBL4551518,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,134,352,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CCCCc3cn(CCC(C(=O)N(C)C)(c4ccccc4)c4ccccc4)nn3)CC2)c1,CHEMBL5363864,Ki,6.54,CHEMBL5415451,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,c1ccc(C(CCn2cc(CCCCN3CCN(c4ccccc4)CC3)nn2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4=CC5C=CC=CC5N4)CC3)CC2)c1,CHEMBL5381008,Ki,6.94,CHEMBL5427065,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1=CC2C=CC=CC2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(=O)CCOC)CC3)CC2)c1,CHEMBL5381008,Ki,7.82,CHEMBL5424897,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(=O)N(C)C)CC3)CC2)c1,CHEMBL5381008,Ki,8.38,CHEMBL5409134,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(=O)NC)CC3)CC2)c1,CHEMBL5381008,Ki,8.24,CHEMBL5437660,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(=O)OC(C)(C)C)CC3)CC2)c1,CHEMBL5381008,Ki,7.17,CHEMBL5424241,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(N)=O)CC3)CC2)c1,CHEMBL5381008,Ki,8.28,CHEMBL5409755,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(C[C@@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1,CHEMBL4415924,Ki,4.72,CHEMBL4527078,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1,CHEMBL4415924,Ki,4.87,CHEMBL4570554,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(C[C@@H]3C[C@@H](O)CN3CCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1,CHEMBL5363864,Ki,6.06,CHEMBL5434650,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,c1ccc(C(CCN2CCCC2CN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(C[C@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1,CHEMBL4415924,Ki,4.67,CHEMBL4436317,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1,CHEMBL4415924,Ki,4.97,CHEMBL4555827,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCN(Cc3cn(CCC(C(=O)N(C)C)(c4ccccc4)c4ccccc4)nn3)CC2)c1,CHEMBL5363864,Ki,5.84,CHEMBL5407131,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,c1ccc(C(CCn2cc(CN3CCN(c4ccccc4)CC3)nn2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(Cl)c(OC)c(N2CCNCC2)c1,CHEMBL4429153,Ki,6.21,CHEMBL4586327,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,CHEMBL1285353,IC50,8.54,CHEMBL1276529,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Br,CHEMBL1285353,IC50,8.64,CHEMBL1276561,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1CC,CHEMBL1285353,IC50,8.75,CHEMBL1276647,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,CHEMBL1285353,IC50,9.04,CHEMBL1276560,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1F,CHEMBL1285353,IC50,8.82,CHEMBL1276559,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc(O)c(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,CHEMBL1285353,IC50,8.89,CHEMBL1276327,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc2c(cc1N1CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC1)OCO2,CHEMBL4415924,Ki,6.27,CHEMBL4463620,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccc3c(c2)OCO3)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc2c(cc1N1CCN(CC(O)CCNC(=O)c3cc4ccccc4o3)CC1)OCO2,CHEMBL4415924,Ki,5.84,CHEMBL4465596,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccc3c(c2)OCO3)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,CHEMBL3387736,Ki,7.39,CHEMBL3344456,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,98,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc(-c2cc(N3CCN(C)CC3)nc3c2ccn3S(=O)(=O)CC(C)C)cc1,CHEMBL3800738,Ki,6.21,CHEMBL3798953,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,115,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc(C(=O)N2CCN(CCOc3ccc(OC)cc3)CC2)cc1,CHEMBL4406527,IC50,5.22,CHEMBL4451542,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,142,455,O=C(c1ccccc1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1,CHEMBL3706129,Ki,6.69,CHEMBL3676926,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc(CCNCCCSCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,CHEMBL1810621,IC50,5.6,CHEMBL1807824,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,77,487,O=c1[nH]c2cccc(CCNCCSCCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1,CHEMBL872891,Ki,6.12,CHEMBL321538,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",28,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1,CHEMBL675680,Ki,6.12,CHEMBL106169,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,28,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc(O)c(OC)c1C(=O)NC[C@@H]1CCCN1CC,CHEMBL1285353,IC50,6.91,CHEMBL1276765,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1,CHEMBL1285353,IC50,7.4,CHEMBL1276677,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Br,CHEMBL1285353,IC50,7.96,CHEMBL1276739,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1Cl,CHEMBL1285353,IC50,8.38,CHEMBL1276375,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc(OC)c(C(=O)NC[C@@H]2CCCN2CC)c1OC,CHEMBL1285353,IC50,8.89,CHEMBL282925,2010,CHEMBL1275273,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,69,289,O=C(NCC1CCCN1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc2c(c1)C(C1=CCN(C)CC1)=Nc1cc(C)ccc1N2,CHEMBL4816284,Ki,6.56,CHEMBL4868181,2021,CHEMBL4813978,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells assessed as inhibition of dopamine-induced calcium accumulation,147,449,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2,CHEMBL4671577,Ki,7.55,CHEMBL4760903,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,142,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1ccccc1N2,CHEMBL4671577,Ki,6.78,CHEMBL4756987,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,142,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2,CHEMBL1936228,Ki,6.38,CHEMBL104571,2012,CHEMBL1932931,Eur J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor,82,499,c1ccc2c(c1)CCC1NCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc2c(c1O)-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670885,Ki,5.69,CHEMBL115524,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,8,135,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc2c(c1OC)-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670885,Ki,6.39,CHEMBL331005,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,8,135,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc2c3c1CCN(C)[C@@H]3Cc1ccc(OC)c(OC)c1-2,CHEMBL4345338,IC50,7.55,CHEMBL4439029,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,142,458,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2,CHEMBL4345338,IC50,7.39,CHEMBL4442011,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,142,458,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(C)CC2)c1Cl,CHEMBL4429153,Ki,7.24,CHEMBL4469777,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(C/C=C/CNC(=O)c3nc(C)c[nH]3)CC2)c1Cl,CHEMBL4429153,Ki,7.79,CHEMBL4564507,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ncc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl,CHEMBL4415924,Ki,6.61,CHEMBL4515234,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC(F)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl,CHEMBL4415924,Ki,6.48,CHEMBL4553059,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl,CHEMBL4415924,Ki,6.88,CHEMBL4451683,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl,CHEMBL4429153,Ki,6.82,CHEMBL4451683,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cc4ccccc4o3)CC2)c1Cl,CHEMBL4429153,Ki,6.79,CHEMBL4517102,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC(O)CCNC(=O)c3ccc4c(c3)OCO4)CC2)c1Cl,CHEMBL4415924,Ki,6.37,CHEMBL4518618,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC(O)CCNC(=O)c3cn4ccccc4n3)CC2)c1Cl,CHEMBL4429153,Ki,6.71,CHEMBL4517898,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC(O)CCNC(=O)c3nc(C)c[nH]3)CC2)c1Cl,CHEMBL4429153,Ki,6.82,CHEMBL4516799,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ncc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC(O)CCNCCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl,CHEMBL5046486,Ki,6.34,CHEMBL5071238,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC(O)CCNCCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl,CHEMBL5046490,Ki,6.94,CHEMBL5071238,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,147,474,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl,CHEMBL5046486,Ki,7.37,CHEMBL5088070,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,c1ccc(C(CCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl,CHEMBL5046490,Ki,7.69,CHEMBL5088070,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,147,474,c1ccc(C(CCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCC(O)CNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl,CHEMBL4429153,Ki,8.17,CHEMBL4552939,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCC(c3cccc(O)c3)c3cccc(O)c3)CC2)c1Cl,CHEMBL5046486,Ki,6.73,CHEMBL5083441,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,c1ccc(C(CCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCC(c3cccc(O)c3)c3cccc(OC)c3)CC2)c1Cl,CHEMBL5046486,Ki,6.72,CHEMBL5083473,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,c1ccc(C(CCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCC(c3cccc(OC)c3)c3cccc(OC)c3)CC2)c1Cl,CHEMBL5046486,Ki,6.77,CHEMBL5092243,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,c1ccc(C(CCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl,CHEMBL4429153,Ki,8.26,CHEMBL4544583,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1Cl,CHEMBL4429153,Ki,8.2,CHEMBL4476699,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c1Cl,CHEMBL4429153,Ki,8.25,CHEMBL4555307,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCCCNC(=O)c3nc(C)c[nH]3)CC2)c1Cl,CHEMBL4429153,Ki,7.91,CHEMBL4461461,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ncc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCCCNC(=O)c3nc4sccn4c3C)CC2)c1Cl,CHEMBL4429153,Ki,8.33,CHEMBL4577414,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccsc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCCCNCCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl,CHEMBL5046486,Ki,7.21,CHEMBL5074399,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCCCNCCC(C(=O)N(C)C)(c3ccccc3)c3ccccc3)CC2)c1Cl,CHEMBL5046490,Ki,7.36,CHEMBL5074399,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,147,474,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1Cl,CHEMBL4361371,Ki,9.07,CHEMBL4471817,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,134,352,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4=CC5C=CC=CC5N4)CC3)CC2)c1Cl,CHEMBL5381008,Ki,8.24,CHEMBL5421925,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1=CC2C=CC=CC2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)COC)CC3)CC2)c1Cl,CHEMBL5381008,Ki,8.75,CHEMBL5408223,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)N(C)C)CC3)CC2)c1Cl,CHEMBL5381008,Ki,9.12,CHEMBL5415846,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)N4CCc5ncccc5C4)CC3)CC2)c1Cl,CHEMBL5381008,Ki,9.06,CHEMBL5404807,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)N1CCc2ncccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)NC)CC3)CC2)c1Cl,CHEMBL5381008,Ki,9.32,CHEMBL5425134,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4ccc(-c5cccnc5)cc4)CC3)CC2)c1Cl,CHEMBL5381008,Ki,8.74,CHEMBL5440422,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1ccc(-c2cccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4ccnc5ccccc45)CC3)CC2)c1Cl,CHEMBL5381008,Ki,8.11,CHEMBL5404054,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(C[C@@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl,CHEMBL4415924,Ki,6.05,CHEMBL4446609,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(C[C@@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl,CHEMBL4415924,Ki,6.66,CHEMBL4483569,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(C[C@H](F)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl,CHEMBL4415924,Ki,7.1,CHEMBL4584497,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCN(C[C@H](O)CCNC(=O)c3cc4ccccc4[nH]3)CC2)c1Cl,CHEMBL4415924,Ki,7.12,CHEMBL4519938,2019,CHEMBL4414587,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,498,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(N2CCNCC2)c1Cl,CHEMBL4429153,Ki,6.86,CHEMBL4441358,2016,CHEMBL4428060,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2L receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting analysis,115,281,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1,CHEMBL4392163,Ki,5.94,CHEMBL4437912,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,500,O=C(CN1CCC(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1,CHEMBL4392176,IC50,4.79,CHEMBL4437912,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,134,501,O=C(CN1CCC(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1,CHEMBL4392186,IC50,4.17,CHEMBL4437912,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,134,502,O=C(CN1CCC(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(NC(=O)CN2CCN(c3ccc(Cl)cn3)CC2)c1,CHEMBL4392163,Ki,4.33,CHEMBL4443848,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,134,500,O=C(CN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(NC(=O)CN2CCN(c3ccc(Cl)cn3)CC2)c1,CHEMBL4392176,IC50,4.33,CHEMBL4443848,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,134,501,O=C(CN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(NC(=O)CN2CCN(c3ccc(Cl)cn3)CC2)c1,CHEMBL4392186,IC50,4.15,CHEMBL4443848,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,134,502,O=C(CN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(NC(=O)CN2CCN(c3ccccn3)CC2)c1,CHEMBL4392168,Ki,6.22,CHEMBL4442548,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H](R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by scintillation counting method,134,503,O=C(CN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(NC(=O)CN2CCN(c3ccccn3)CC2)c1,CHEMBL4392176,IC50,4.39,CHEMBL4442548,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,134,501,O=C(CN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc(NC(=O)CN2CCN(c3ccccn3)CC2)c1,CHEMBL4392186,IC50,4.05,CHEMBL4442548,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,134,502,O=C(CN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670880,Ki,7.1,CHEMBL118254,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,8,99,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1,CHEMBL894060,Ki,6.76,CHEMBL243523,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,52,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1cn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)[nH]c1=O,CHEMBL865866,Ki,6.83,CHEMBL202774,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,45,168,O=c1ccn(CCCCN2CCN(c3ccncn3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1nc(N)[nH]c1-c1cn(S(=O)(=O)c2ccccc2)c2ccc(OC)cc12,CHEMBL4354013,Ki,5.79,CHEMBL4516784,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,134,125,O=S(=O)(c1ccccc1)n1cc(-c2cnc[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1nc(N)[nH]c1-c1cn(S(=O)(=O)c2ccccc2)c2ccccc12,CHEMBL4354013,Ki,5.8,CHEMBL4469860,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,134,125,O=S(=O)(c1ccccc1)n1cc(-c2cnc[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1nc2c(N3CCNCC3)ccnc2n1Cc1cccc(Cl)c1,CHEMBL4146376,Ki,5.21,CHEMBL4164541,2018,CHEMBL4145461,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,130,221,c1ccc(Cn2cnc3c(N4CCNCC4)ccnc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1nc2c(N3CCNCC3)ccnc2n1Cc1cccc(F)c1,CHEMBL4146376,Ki,5.46,CHEMBL4175829,2018,CHEMBL4145461,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,130,221,c1ccc(Cn2cnc3c(N4CCNCC4)ccnc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1nc2c(N3CCNCC3)nccc2n1S(=O)(=O)c1cccc(Cl)c1,CHEMBL4736131,Ki,6.05,CHEMBL4756814,2021,CHEMBL4732141,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L expressed in CHO-K1 cell membranes incubated for 1 hr by micro-beta plate reader based analysis,147,222,O=S(=O)(c1ccccc1)n1cnc2c(N3CCNCC3)nccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1nc2c(N3CCNCC3)nccc2n1S(=O)(=O)c1cccc(F)c1,CHEMBL4736131,Ki,6.16,CHEMBL4760105,2021,CHEMBL4732141,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L expressed in CHO-K1 cell membranes incubated for 1 hr by micro-beta plate reader based analysis,147,222,O=S(=O)(c1ccccc1)n1cnc2c(N3CCNCC3)nccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1nc2cc3c(c(Br)c2o1)CCN(CCCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,CHEMBL948181,Ki,6.4,CHEMBL256482,2008,CHEMBL1142271,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,59,504,c1cc(-c2nnc(SCCCCN3CCc4cc5ncoc5cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1nc2cc3c(c(C)c2o1)CCN(CCCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,CHEMBL948181,Ki,6.2,CHEMBL269994,2008,CHEMBL1142271,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,59,504,c1cc(-c2nnc(SCCCCN3CCc4cc5ncoc5cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1nn(C)c2cc3c(cc12)CCN(CCCSc1nnc(-c2cccc4nc(C)ccc24)n1C)CC3,CHEMBL948181,Ki,6.4,CHEMBL256477,2008,CHEMBL1142271,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,59,504,c1cc(-c2nnc(SCCCN3CCc4cc5cn[nH]c5cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1,CHEMBL5442215,Ki,6.13,CHEMBL1200492,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=c1n(CCOc2ccccc2)cnn1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1sccc1N1CCC[C@@H](c2cccc(C#N)c2)C1,CHEMBL678343,Ki,6.87,CHEMBL93570,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",3,257,c1ccc(C2CCCN(c3ccsc3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCc1sccc1N1CCC[C@@H](c2cccc(C#N)c2)C1,CHEMBL679938,Ki,7.96,CHEMBL93570,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCN(c3ccsc3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCn1c(SCCCN2CCC3(CC2)CCN(c2ccccc2OC)CC3)nnc1-c1ccccc1,CHEMBL4397357,Ki,5.25,CHEMBL4554630,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,134,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCn1cncc1-c1c[nH]c2c(F)cc(I)cc12,CHEMBL4394035,Ki,5.52,CHEMBL4555349,2019,CHEMBL4393658,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,134,505,c1ccc2c(-c3cnc[nH]3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCn1cncc1-c1c[nH]c2ccc(C(F)(F)F)cc12,CHEMBL4394035,Ki,5.06,CHEMBL4592256,2019,CHEMBL4393658,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,134,505,c1ccc2c(-c3cnc[nH]3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCn1cncc1-c1c[nH]c2ccc(Cl)c(F)c12,CHEMBL4394035,Ki,5.03,CHEMBL4476372,2019,CHEMBL4393658,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,134,505,c1ccc2c(-c3cnc[nH]3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCn1cncc1-c1c[nH]c2ccc(I)c(F)c12,CHEMBL4394035,Ki,5.15,CHEMBL4452569,2019,CHEMBL4393658,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,134,505,c1ccc2c(-c3cnc[nH]3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCn1cncc1-c1c[nH]c2ccc(I)cc12,CHEMBL4369114,Ki,5.32,CHEMBL4216263,2018,CHEMBL4368858,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2LR receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,130,506,c1ccc2c(-c3cnc[nH]3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCn1cncc1-c1c[nH]c2ccc(I)cc12,CHEMBL4394035,Ki,5.31,CHEMBL4216263,2019,CHEMBL4393658,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,134,505,c1ccc2c(-c3cnc[nH]3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCn1ncc2c1-c1c(C)sc(C)c1CCC2,CHEMBL672165,Ki,6.4,CHEMBL99208,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,33,434,c1scc2c1CCCc1cn[nH]c1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CCn1ncc2c1-c1c(Cl)sc(Cl)c1CCC2,CHEMBL672165,Ki,6.31,CHEMBL98945,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,33,434,c1scc2c1CCCc1cn[nH]c1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(/C=N/c1ccc2c(c1)C(O)CC2)Cc1ccccc1,CHEMBL886705,Ki,4.23,CHEMBL392888,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,52,129,C(=Nc1ccc2c(c1)CCC2)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C(=O)/C=C/c1ccccc1)C1CCN(Cc2ccccc2)CC1,CHEMBL667743,IC50,5.15,CHEMBL325063,1994,CHEMBL1127992,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from dopamine D2 receptor,3,49,O=C(C=Cc1ccccc1)NC1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C(=O)C#Cc1ccccc1)C1CCN(Cc2ccccc2)CC1,CHEMBL667743,IC50,5.31,CHEMBL111964,1994,CHEMBL1127992,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from dopamine D2 receptor,3,49,O=C(C#Cc1ccccc1)NC1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccccc1,CHEMBL3872755,Ki,8.62,CHEMBL3953773,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,116,114,O=C(Nc1ccccc1)NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C(=O)c1cccs1)[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL671651,Ki,7.78,CHEMBL80315,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,10,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN(CCO)[C@@H]1C[C@H]1c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,5.13,CHEMBL5410159,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,c1ccc(C(CCNC2CC2c2ccccc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)C1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,6.93,CHEMBL5418819,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,c1ccc(C(CCN2CCC(CCN3CCN(c4ccccc4)CC3)C2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,5.24,CHEMBL841,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,147,253,c1ccc(C2CCN(CCC(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1CCN(c2cccc(C(F)(F)F)n2)CC1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,5.83,CHEMBL5417253,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,c1ccc(C(CCN2CCN(c3ccccn3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,7.13,CHEMBL5085974,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,148,253,c1ccc(C(CCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046490,Ki,7.5,CHEMBL5085974,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,148,474,c1ccc(C(CCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1CCN(c2nsc3ccccc23)CC1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,6.33,CHEMBL5409322,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,c1ccc(C(CCN2CCN(c3nsc4ccccc34)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1CCc2ccc(C#N)cc2C1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,5.64,CHEMBL5084145,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,148,253,c1ccc(C(CCN2CCc3ccccc3C2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1C[C@H](F)C[C@H]1C(=O)NCCCCN1CCN(c2cccc(C(F)(F)F)n2)CC1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,5.7,CHEMBL5412606,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,O=C(NCCCCN1CCN(c2ccccn2)CC1)C1CCCN1CCC(c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1C[C@H](F)C[C@H]1C(=O)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,6.57,CHEMBL5421714,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,O=C(NCCCCN1CCN(c2ccccc2)CC1)C1CCCN1CCC(c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1C[C@H](F)C[C@H]1C(=O)NCCCCN1CCN(c2nsc3ccccc23)CC1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,6.49,CHEMBL5395539,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,O=C(NCCCCN1CCN(c2nsc3ccccc23)CC1)C1CCCN1CCC(c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1C[C@H](O)C/C1=C\N1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,5.85,CHEMBL5406129,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,C(=C1CCCN1CCC(c1ccccc1)c1ccccc1)N1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1C[C@H](O)C[C@H]1C(=O)NCCCCN1CCN(c2cccc(C(F)(F)F)n2)CC1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,5.65,CHEMBL5404724,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,O=C(NCCCCN1CCN(c2ccccn2)CC1)C1CCCN1CCC(c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1C[C@H](O)C[C@H]1C(=O)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,6.85,CHEMBL5414796,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,O=C(NCCCCN1CCN(c2ccccc2)CC1)C1CCCN1CCC(c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1C[C@H](O)C[C@H]1CN1CCN(c2cccc(C(F)(F)F)n2)CC1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,5.33,CHEMBL5398747,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,c1ccc(C(CCN2CCCC2CN2CCN(c3ccccn3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN1C[C@H](O)C[C@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,5.93,CHEMBL5432993,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,c1ccc(C(CCN2CCCC2CN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCNCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,6.16,CHEMBL5087543,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,148,253,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCNCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046490,Ki,6.78,CHEMBL5087543,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,148,474,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCNCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,7.36,CHEMBL5073754,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,148,253,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCNCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046490,Ki,7.64,CHEMBL5073754,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,148,474,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCNCCCCN1CCc2ccc(C#N)cc2C1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,5.91,CHEMBL5090215,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,148,253,c1ccc(C(CCNCCCCN2CCc3ccccc3C2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCNCCc1ccccc1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,5.44,CHEMBL5070377,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,148,253,c1ccc(CCNCCC(c2ccccc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN[C@@H]1C[C@H]1c1ccc(Cl)cc1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,6.07,CHEMBL5398913,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,c1ccc(C(CCNC2CC2c2ccccc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)C(CCN[C@@H]1C[C@H]1c1ccc(F)cc1)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,5.1,CHEMBL5436551,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,156,244,c1ccc(C(CCNC2CC2c2ccccc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,5.97,CHEMBL3695416,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.04,CHEMBL3676887,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.59,CHEMBL3642763,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",88,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)CN1CCc2cc3nc(N)sc3cc2CC1,CHEMBL2328744,IC50,5.11,CHEMBL2326492,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,88,466,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)CN1CCc2cc3nc(N)sc3cc2CC1,CHEMBL2328745,Ki,5.3,CHEMBL2326492,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,88,467,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N1CCC(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5381008,Ki,8.14,CHEMBL5436957,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCCC3CCNCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5381008,Ki,7.69,CHEMBL5400528,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCNCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N1CCC(O)(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C1,CHEMBL5381008,Ki,7.05,CHEMBL5420316,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCCC3CCNC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N1CCC(O)(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5381008,Ki,7.42,CHEMBL5426620,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCCC3CCNCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)NC[C@H]1CC[C@H](CN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3089794,Ki,7.37,CHEMBL3085825,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,88,115,c1ccc(N2CCN(CC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3089794,Ki,6.99,CHEMBL3085826,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,88,115,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@@H](CCN2CCc3ccccc3C2)CC1,CHEMBL3089794,Ki,4.87,CHEMBL3085816,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,89,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,7.16,CHEMBL3695436,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",98,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,7.28,CHEMBL3664887,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(C(F)(F)F)n3)CC2)CC1,CHEMBL5381008,Ki,7.57,CHEMBL5402212,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL2026141,Ki,8.24,CHEMBL2024517,2012,CHEMBL2021900,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2L receptor,82,507,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL2026142,Ki,9.09,CHEMBL2024517,2012,CHEMBL2021900,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2S receptor,82,508,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3089794,Ki,7.75,CHEMBL2028019,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,89,115,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3293231,IC50,8.774999999999999,CHEMBL2028019,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,98,509,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3295080,Ki,9.33,CHEMBL2028019,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,99,391,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3295081,Ki,9.39,CHEMBL2028019,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,99,392,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL3872755,Ki,8.89,CHEMBL2028019,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,116,114,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL4012540,Ki,9.31,CHEMBL2028019,2017,CHEMBL4011616,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,124,510,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL4012541,Ki,9.16,CHEMBL2028019,2017,CHEMBL4011616,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHO cells,124,511,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL4054777,Ki,9.33,CHEMBL2028019,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,124,170,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL4054778,Ki,9.39,CHEMBL2028019,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,124,171,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL4314365,Ki,9.31,CHEMBL2028019,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,134,512,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL4677471,Ki,9.31,CHEMBL2028019,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,148,263,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL4842092,Ki,8.84,CHEMBL2028019,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,148,362,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5145883,Ki,9.3,CHEMBL2028019,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Modulation of human D2L receptor,153,513,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5381008,Ki,9.11,CHEMBL2028019,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5442215,Ki,8.2,CHEMBL2024517,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.52,CHEMBL3698021,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.49,CHEMBL3642755,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,9.28,CHEMBL3960785,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,116,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3cccc(Cl)c3C2)CC1,CHEMBL4394479,IC50,7.15,CHEMBL4451797,2019,CHEMBL4393669,J Med Chem,Scientific Literature,Antagonist activity at D2L receptor (unknown origin) expressed in human HTLA cells assessed as inhibition of dopamine-stimulated beta-arrestin2 recruitment measured after 20 to 22 hrs by brightglo-luciferase reporter gene assay,134,514,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1,CHEMBL3089794,Ki,6.0,CHEMBL3085802,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,89,115,c1ccc2c(c1)CCN(CCC1CCCCC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc(Cl)c2Cl)CC1,CHEMBL4842092,Ki,5.915,CHEMBL4851121,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,148,362,c1ccc(C2CC2CNCCC2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc3c2OCCO3)CC1,CHEMBL4842092,Ki,5.64,CHEMBL4870901,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,148,362,c1cc2c(c(C3CC3CNCCC3CCCCC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)N[C@H]1CC[C@H](CCNCC2CC2c2cccc3ccccc23)CC1,CHEMBL4842092,Ki,6.08,CHEMBL4863920,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,148,362,c1ccc2c(C3CC3CNCCC3CCCCC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)c1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,CHEMBL2328744,IC50,6.52,CHEMBL2326481,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,89,466,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)c1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,CHEMBL2328745,Ki,7.38,CHEMBL2326481,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,89,467,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,6.1,CHEMBL109189,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)c1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,CHEMBL2328744,IC50,6.0,CHEMBL2326482,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,89,466,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)c1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,CHEMBL2328745,Ki,7.38,CHEMBL2326482,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,89,467,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C(=O)c1cccnc1NCCCN1CCN(c2ccccc2-c2ccccc2)CC1,CHEMBL670091,Ki,6.9,CHEMBL90746,1997,CHEMBL1130120,J Med Chem,Scientific Literature,The compound's binding affinity against Dopamine receptor D2,10,515,c1ccc(-c2ccccc2N2CCN(CCCNc3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12,CHEMBL670963,Ki,8.19,CHEMBL300647,1991,CHEMBL1125700,J Med Chem,Scientific Literature,The compound was tested for binding affinity against Dopamine receptor D2 using raclopride as radioligand,0,516,C1=CC2(CCC1)c1ccccc1C=Cc1ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12,CHEMBL670964,Ki,9.18,CHEMBL300647,1991,CHEMBL1125700,J Med Chem,Scientific Literature,The compound was tested for binding affinity against dopamine receptor D2 using raclopride as radioligand,0,517,C1=CC2(CCC1)c1ccccc1C=Cc1ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12,CHEMBL670964,Ki,7.699999999999999,CHEMBL45491,1991,CHEMBL1125700,J Med Chem,Scientific Literature,The compound was tested for binding affinity against dopamine receptor D2 using raclopride as radioligand,0,517,C1=CC2(CCC1)c1ccccc1CCc1ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C1CCc2cc(O)c(O)cc2C1,CHEMBL672210,Ki,6.47,CHEMBL611801,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,13,87,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C1CCc2ccc(O)cc2C1,CHEMBL670173,Ki,8.27,CHEMBL135932,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,8,302,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C1CCc2ccc(O)cc2C1,CHEMBL670536,Ki,7.26,CHEMBL135932,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,8,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21,CHEMBL1030600,Ki,8.53,CHEMBL908,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,63,518,C=C1c2ccccc2Sc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC1(C)CC(=O)C(c2ccccc2)=CO1,CHEMBL672709,Ki,5.39,CHEMBL552858,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,519,O=C1CCOC=C1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC1=CC2=CN(S(=O)(=O)c3ccccc3)C3=CC=CC(O1)C23,CHEMBL3997508,Ki,5.17,CHEMBL4061189,2017,CHEMBL3994665,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),124,438,O=S(=O)(c1ccccc1)N1C=C2C=COC3C=CC=C1C23,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC1=Cc2cn(S(=O)(=O)c3cccc4ccccc34)c3cccc(c23)O1,CHEMBL3997508,Ki,5.83,CHEMBL4083059,2017,CHEMBL3994665,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),124,438,O=S(=O)(c1cccc2ccccc12)n1cc2c3c(cccc31)OC=C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC1CC2c3cc(F)ccc3Cc3ccc(F)cc3N2O1,CHEMBL672501,IC50,6.35,CHEMBL314107,2002,CHEMBL1135381,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for human cloned Dopamine receptor D2L,28,520,c1ccc2c(c1)Cc1ccccc1N1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1,CHEMBL672501,IC50,8.06,CHEMBL315772,2002,CHEMBL1135381,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for human cloned Dopamine receptor D2L,28,520,c1ccc2c(c1)Cc1ccccc1N1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC1CC2c3ccccc3Cc3ccc(Cl)cc3N2O1,CHEMBL672502,IC50,8.06,CHEMBL315772,2002,CHEMBL1135009,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2L,28,521,c1ccc2c(c1)Cc1ccccc1N1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC1CC2c3ccccc3Cc3ccc(F)cc3N2O1,CHEMBL672501,IC50,7.44,CHEMBL84931,2002,CHEMBL1135381,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for human cloned Dopamine receptor D2L,28,520,c1ccc2c(c1)Cc1ccccc1N1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1,CHEMBL672501,IC50,6.06,CHEMBL83658,2002,CHEMBL1135381,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for human cloned Dopamine receptor D2L,28,520,c1ccc2c(c1)Cc1ccccc1N1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1,CHEMBL672502,IC50,6.06,CHEMBL83658,2002,CHEMBL1135009,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2L,28,521,c1ccc2c(c1)Cc1ccccc1N1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC1CC2c3ccccc3Cc3ccccc3N2O1,CHEMBL857158,IC50,6.06,CHEMBL83658,2002,CHEMBL1135380,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for human cloned Dopamine receptor D2L,28,522,c1ccc2c(c1)Cc1ccccc1N1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CC1CC2c3ccccc3Cc3ccncc3N2O1,CHEMBL672502,IC50,5.72,CHEMBL331077,2002,CHEMBL1135009,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2L,28,521,c1ccc2c(c1)Cc1ccncc1N1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.72,CHEMBL3318848,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,99,127,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.74,CHEMBL3318848,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,99,128,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCC(C#N)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,4.75,CHEMBL346898,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,148,253,c1ccc(Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCC(C(=O)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,7.37,CHEMBL5093200,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,148,253,O=C(NCCCCN1CCN(c2ccccc2)CC1)C(c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCC1(c2ccccc2)OC=C(c2ccccc2)C1=O,CHEMBL671745,Ki,5.57,CHEMBL545454,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCC1(c2ccccc2)OC=CC1=O,CHEMBL671745,Ki,5.0,CHEMBL540033,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C=COC1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCC1CC2c3ccccc3Cc3ccccc3N2O1,CHEMBL857158,IC50,5.02,CHEMBL313189,2002,CHEMBL1135380,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for human cloned Dopamine receptor D2L,28,522,c1ccc2c(c1)Cc1ccccc1N1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCC=C1c2ccccc2CCc2ccccc21,CHEMBL1030600,Ki,6.71,CHEMBL629,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,63,518,C=C1c2ccccc2CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1C(=O)c2ccccc2/C=C\c2ccccc21,CHEMBL4669829,Ki,5.05,CHEMBL4756446,2020,CHEMBL4665756,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),142,523,O=C1Nc2ccccc2C=Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2CCc2ccccc21,CHEMBL3090831,IC50,6.39,CHEMBL11,2013,CHEMBL3085767,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,89,224,c1ccc2c(c1)CCc1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2CCc2ccccc21,CHEMBL672315,Ki,6.14,CHEMBL11,2004,CHEMBL1148436,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2 using [3H]spiperone as radioligand,37,524,c1ccc2c(c1)CCc1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL1030600,Ki,8.39,CHEMBL71,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,63,518,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL2162509,Ki,8.92,CHEMBL71,2012,CHEMBL2157876,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,82,315,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL3090831,IC50,7.92,CHEMBL71,2013,CHEMBL3085767,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,89,224,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL3265956,Ki,8.21,CHEMBL71,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,99,82,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL3413551,IC50,9.0,CHEMBL71,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHOK1 cells assessed as inhibition of apomorphine-induced calcium mobilization by radiometric and luminescence plate counting method,109,525,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL3414320,IC50,9.0,CHEMBL71,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Antagonist activity against human recombinant dopmaine D2L receptor expressed in CHOK1 cells assessed as reduction in apomorphine-induced increase in intracellular Ca2+ levels by aequorin based radiometric and luminescence plate counting method,109,526,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL4195154,IC50,8.52,CHEMBL71,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO-K1 cells co-expressing Galphaqi5 assessed as decrease in apomorphine-induced calcium mobilization preincubated for 30 mins followed by apomorphine challenge measured for 30 secs by aequorin-derived luminescence assay,130,527,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL4368000,Ki,8.74,CHEMBL71,2019,CHEMBL4364313,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,134,528,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL4401065,Ki,8.74,CHEMBL71,2019,CHEMBL4400523,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,134,529,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL5046640,Ki,8.63,CHEMBL71,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,148,530,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL670742,Ki,8.52,CHEMBL1713,1993,CHEMBL1126639,J Med Chem,Scientific Literature,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled D2 sites in cloned CHO cells",2,531,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL895618,Ki,8.0,CHEMBL71,2007,CHEMBL1148822,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,52,452,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21,CHEMBL911249,Ki,8.1,CHEMBL71,2006,CHEMBL1137342,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,45,417,c1ccc2c(c1)Nc1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCCOc1ccc(-c2nc3ccccc3n2C/C=C/Cn2c(-c3ccc(OCCCN(C)C)cc3)nc3ccccc32)cc1,CHEMBL670392,Ki,5.3,CHEMBL87625,1995,CHEMBL1128063,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned Dopamine D2 receptor in CHO cells by [3H]spiperone displacement.,5,51,C(=CCn1c(-c2ccccc2)nc2ccccc21)Cn1c(-c2ccccc2)nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCN(Cc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1)C(=O)/C=C/c1ccccc1,CHEMBL840226,Ki,6.1,CHEMBL188486,2005,CHEMBL1142810,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 expressed in CHO cells using the radioligand [125I]iodosulpiride,40,532,O=C(C=Cc1ccccc1)NCc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCN(Cc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1)C(=O)CCC1CCCC1,CHEMBL840226,Ki,5.9,CHEMBL191460,2005,CHEMBL1142810,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 expressed in CHO cells using the radioligand [125I]iodosulpiride,40,532,O=C(CCC1CCCC1)NCc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCN1C(=O)c2ccccc2/C=C\c2ccccc21,CHEMBL4669829,Ki,4.94,CHEMBL4746800,2020,CHEMBL4665756,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),142,523,O=C1Nc2ccccc2C=Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCN1C(=O)c2ccccc2N(C)C(=O)c2ccccc21,CHEMBL4669829,Ki,4.18,CHEMBL4742201,2020,CHEMBL4665756,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),142,523,O=C1Nc2ccccc2C(=O)Nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCN1C(=O)c2ccccc2N(C)c2ccccc21,CHEMBL4669829,Ki,4.52,CHEMBL1442422,2020,CHEMBL4665756,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),142,523,O=C1Nc2ccccc2Nc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CHEMBL672169,Ki,7.89,CHEMBL285802,2004,CHEMBL1149193,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,37,533,C1=Cc2ccccc2Sc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21,CHEMBL672179,Ki,7.96,CHEMBL285802,2001,CHEMBL1134342,J Med Chem,Scientific Literature,Binding affinity towards human D2 dopamine receptor.,25,534,C1=Cc2ccccc2Sc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCOc1ccccc1Cc1ccccc1,CHEMBL838569,Ki,5.56,CHEMBL186720,2004,CHEMBL1138672,J Med Chem,Scientific Literature,Binding affinity for human recombinant dopamine receptor D2L,37,440,c1ccc(Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCSC(C)(C)C,CHEMBL672171,Ki,6.48,CHEMBL158973,2004,CHEMBL1147426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 by the displacement of [3H]spiperone radioligand from the cloned receptor expressed in CHO cells,37,535,,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCSc1cccc(-c2ccccc2)n1,CHEMBL672171,Ki,6.35,CHEMBL161765,2004,CHEMBL1147426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 by the displacement of [3H]spiperone radioligand from the cloned receptor expressed in CHO cells,37,535,c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCSc1cccc(Br)n1,CHEMBL672171,Ki,6.06,CHEMBL158285,2004,CHEMBL1147426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 by the displacement of [3H]spiperone radioligand from the cloned receptor expressed in CHO cells,37,535,c1ccncc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCSc1cccc(C2CCCCC2)n1,CHEMBL672171,Ki,5.89,CHEMBL158402,2004,CHEMBL1147426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 by the displacement of [3H]spiperone radioligand from the cloned receptor expressed in CHO cells,37,535,c1ccc(C2CCCCC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCSc1nc(-c2ccncc2)cs1,CHEMBL672171,Ki,6.89,CHEMBL350166,2004,CHEMBL1147426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 by the displacement of [3H]spiperone radioligand from the cloned receptor expressed in CHO cells,37,535,c1cc(-c2cscn2)ccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCc1cc(O)c(O)c2c1CCc1ccccc1-2,CHEMBL5231713,Ki,7.41,CHEMBL5283457,2020,CHEMBL5230125,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from D2DR (unknown origin),142,76,c1ccc2c(c1)CCc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCc1cccc2c1cc(C(=O)c1ccccc1)n2S(=O)(=O)c1ccccc1,CHEMBL671380,Ki,6.12,CHEMBL126340,2001,CHEMBL1134783,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,25,479,O=C(c1ccccc1)c1cc2ccccc2n1S(=O)(=O)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCc1cccc2c1ccn2S(=O)(=O)c1ccccc1,CHEMBL671380,Ki,5.8,CHEMBL92139,2001,CHEMBL1134783,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,25,479,O=S(=O)(c1ccccc1)n1ccc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)CCc1cn(S(=O)(=O)c2ccccc2)c2ccccc12,CHEMBL671380,Ki,7.21,CHEMBL93868,2001,CHEMBL1134783,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,25,479,O=S(=O)(c1ccccc1)n1ccc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(Br)cc3[C@H]2O1,CHEMBL829120,Ki,6.43,CHEMBL195856,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)Oc1ccccc1C1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1,CHEMBL829120,Ki,7.17,CHEMBL364270,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)Oc1ccccc1C1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1,CHEMBL829120,Ki,6.72,CHEMBL195706,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)Oc1ccccc1C1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C[C@@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1,CHEMBL829120,Ki,7.92,CHEMBL363581,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)Sc1ccccc1C1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Br)cc3[C@H]2O1,CHEMBL829120,Ki,7.18,CHEMBL193435,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)Oc1ccccc1C1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1,CHEMBL829120,Ki,8.23,CHEMBL435301,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)Oc1ccccc1C1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(F)cc3[C@H]2O1,CHEMBL829120,Ki,7.5,CHEMBL194659,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)Oc1ccccc1C1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1,CHEMBL829120,Ki,8.705,CHEMBL193639,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)Sc1ccccc1C1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C[C@H]1C[C@@H]2c3ccccc3Cc3ccccc3[C@H]2O1,CHEMBL829120,Ki,7.21,CHEMBL329566,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)Cc1ccccc1C1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)C[C@H]1C[C@@H]2c3ccccc3Sc3ccc(F)cc3[C@H]2O1,CHEMBL829120,Ki,7.92,CHEMBL366164,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)Sc1ccccc1C1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)[nH]c2ccccc12,CHEMBL3372144,IC50,6.51,CHEMBL3323019,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,99,169,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)[nH]c2ccccc12,CHEMBL3379351,Ki,6.28,CHEMBL3323019,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,99,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)nc2ccccn12,CHEMBL3372144,IC50,6.66,CHEMBL3323112,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,99,169,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)nc2ccccn12,CHEMBL3379351,Ki,6.52,CHEMBL3323112,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,99,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)nc2ccccn12,CHEMBL3379354,Ki,6.72,CHEMBL3323112,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from wild type human D2R expressed in HEK293 cell membranes by gamma counting method,99,173,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1c(C(=O)NCCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)nc2ccccn12,CHEMBL3379897,Ki,7.14,CHEMBL3323112,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from chimeric human D2 receptor possessing extracellular loop II of D3 receptor expressed in HEK293 cell membranes by gamma counting method,99,174,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1,CHEMBL3857974,Ki,7.12,CHEMBL3968569,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,116,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1cccc(CN/C=C2/C(=O)NC(=O)c3ccccc32)c1,CHEMBL4137914,Ki,5.1,CHEMBL4176546,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,130,220,O=C1NC(=O)c2ccccc2C1=CNCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1cccc2nc(C(=O)NCCCCN3CCN(c4cc(C(F)(F)F)nc(C(C)(C)C)n4)CC3)cn12,CHEMBL3372144,IC50,6.55,CHEMBL3323114,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,99,169,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1cccc2nc(C(=O)NCCCCN3CCN(c4cc(C(F)(F)F)nc(C(C)(C)C)n4)CC3)cn12,CHEMBL3379351,Ki,6.53,CHEMBL3323114,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,99,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1cccc2nc(C(=O)NCCCCN3CCN(c4cc(C(F)(F)F)nc(C(C)(C)C)n4)CC3)cn12,CHEMBL3379354,Ki,6.61,CHEMBL3323114,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from wild type human D2R expressed in HEK293 cell membranes by gamma counting method,99,173,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)Cc1cccc2nc(C(=O)NCCCCN3CCN(c4cc(C(F)(F)F)nc(C(C)(C)C)n4)CC3)cn12,CHEMBL3379897,Ki,6.75,CHEMBL3323114,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from chimeric human D2 receptor possessing extracellular loop II of D3 receptor expressed in HEK293 cell membranes by gamma counting method,99,174,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.6,CHEMBL3695404,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.64,CHEMBL3664890,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.33,CHEMBL3676888,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.89,CHEMBL3698025,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.11,CHEMBL3642743,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)S(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,6.27,CHEMBL3642695,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)S(=O)(=O)c1ccc2c(c1)CCN2C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,5.42,CHEMBL106917,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,28,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)[C@@H]1CCN(c2cc(-c3ccccc3)nc3ccnn23)C1,CHEMBL4880035,Ki,6.4399999999999995,CHEMBL4520293,2021,CHEMBL4507322,,SGC Frankfurt - Donated Chemical Probes,GPCRScan assay: inhibition of D2,148,144,c1ccc(-c2cc(N3CCCC3)n3nccc3n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)[C@@H]1CCN(c2cc(-c3ccccc3)nc3ccnn23)C1,CHEMBL5214422,Ki,6.43,CHEMBL4520293,2023,CHEMBL5212743,,EUbOPEN Chemogenomic Library Literature Data,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000353a DRD2,156,538,c1ccc(-c2cc(N3CCCC3)n3nccc3n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)[C@@H]1CCN(c2cc(-c3ccccc3)nc3ccnn23)C1,CHEMBL5214423,Ki,6.43,CHEMBL4520293,2023,CHEMBL5212743,,EUbOPEN Chemogenomic Library Literature Data,Selectivity interaction (PRESTO-Tango GPCR-ome screening) EUB0000353a DRD2,156,539,c1ccc(-c2cc(N3CCCC3)n3nccc3n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)[C@@H]1Cc2cccc3nc(O)n(c23)C1,CHEMBL672313,Ki,7.92,CHEMBL422344,1997,CHEMBL1130416,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,10,190,c1cc2c3c(c1)ncn3CCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)[C@@H]1Cc2cccc3ncn(c23)C1,CHEMBL672313,Ki,5.89,CHEMBL345458,1997,CHEMBL1130416,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,10,190,c1cc2c3c(c1)ncn3CCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)c1ccc(-c2cccc3c2CC[C@H]2[C@H]3c3cc(O)c(Cl)cc3CCN2C)cc1,CHEMBL1074771,Ki,7.92,CHEMBL597310,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,69,473,c1ccc(-c2cccc3c2CCC2NCCc4ccccc4C32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)c1ccc(/C=C/C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)cc1,CHEMBL672227,Ki,6.3,CHEMBL53351,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,17,131,O=C(C=Cc1ccccc1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)c1ccc(C(=O)NC/C=C/CN2CCN(c3ccccc3OCCF)CC2)cc1,CHEMBL1694505,Ki,7.45,CHEMBL1689008,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,77,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)c1ccc(C(=O)NCCCCN2CCC(c3cccc(O)c3)C2)cc1,CHEMBL4223412,Ki,6.46,CHEMBL4226226,2018,CHEMBL4219212,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblasts membranes by radioligand binding assay,130,270,O=C(NCCCCN1CCC(c2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)c1ccc(C(=O)NCCCCN2CCN(c3ccccc3OCCF)CC2)cc1,CHEMBL1694505,Ki,7.82,CHEMBL1689002,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,77,540,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)c1ccc(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1,CHEMBL4416273,Ki,8.28,CHEMBL4568709,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,134,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)c1ccc(Cc2ccc3c4c2-c2c(ccc(O)c2O)C[C@H]4N(C)CC3)cc1,CHEMBL2399862,Ki,7.1,CHEMBL3216146,2013,CHEMBL2396540,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,89,542,c1ccc(Cc2ccc3c4c2-c2ccccc2CC4NCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C)c1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1,CHEMBL894060,Ki,7.5,CHEMBL243955,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,52,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C1CCN(CCOc2ccccc2-c2ccccc2)CC1)S(=O)(=O)c1ccc(F)cc1,CHEMBL3750144,Ki,7.27,CHEMBL3745815,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,116,167,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C1CCN(CCOc2ccccc2-c2ccccc2)CC1)S(=O)(=O)c1ccccc1,CHEMBL3750144,Ki,7.28,CHEMBL3746713,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,116,167,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C1CCN(CCOc2ccccc2-c2ccccc2)CC1)S(=O)(=O)c1cnn(C)c1,CHEMBL3750144,Ki,7.46,CHEMBL3747003,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,116,167,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1cn[nH]c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C1CCN(CCOc2ccccc2C(C)(C)C)CC1)S(=O)(=O)c1ccc(F)cc1,CHEMBL3750144,Ki,6.49,CHEMBL3746079,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,116,167,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C1CCN(CCOc2ccccc2C(C)(C)C)CC1)S(=O)(=O)c1cccc(F)c1,CHEMBL3750144,Ki,6.54,CHEMBL3745975,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,116,167,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C1CCN(CCOc2ccccc2C(C)(C)C)CC1)S(=O)(=O)c1ccccc1,CHEMBL3750144,Ki,6.44,CHEMBL3746806,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,116,167,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C1CCN(CCOc2ccccc2C(C)(C)C)CC1)S(=O)(=O)c1cnn(C)c1,CHEMBL3750144,Ki,6.55,CHEMBL3746771,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,116,167,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1cn[nH]c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CC#Cc1ccccc1)C1CCN(Cc2ccccc2)CC1,CHEMBL667743,IC50,5.39,CHEMBL112957,1994,CHEMBL1127992,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from dopamine D2 receptor,3,49,C(#Cc1ccccc1)CNC1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CC(=O)NC(C)(C)C)C(=O)CCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL5236927,IC50,5.81,CHEMBL5274482,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,148,142,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CC(=O)NC1CCCCC1)C(=O)CCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL5236927,IC50,8.54,CHEMBL5268231,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,148,142,O=C(CCCN1CCN(c2ccccc2)CC1)NCC(=O)NC1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CC(=O)NCc1ccccc1)C(=O)CCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL5236927,IC50,8.34,CHEMBL5278239,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,148,142,O=C(CCCN1CCN(c2ccccc2)CC1)NCC(=O)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CC/C=C1\c2ccccc2Sc2ccc(Cl)cc21)Cc1ccc(OCCCN2CCCCC2)cc1,CHEMBL1030600,Ki,7.28,CHEMBL517407,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,63,518,C(CCNCc1ccc(OCCCN2CCCCC2)cc1)=C1c2ccccc2Sc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)CCN(C)CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.49,CHEMBL3318847,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,99,127,O=C(CCNCCNCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)CCN(C)CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.66,CHEMBL3318847,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,99,128,O=C(CCNCCNCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)Cc1ccc2c(c1)Cc1ccccc1-2,CHEMBL1777183,Ki,5.69,CHEMBL1773087,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,77,354,c1ccc(N2CCN(CCCCNCc3ccc4c(c3)Cc3ccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)Cc1ccc2c(c1)Cc1ccccc1-2,CHEMBL1777183,Ki,6.06,CHEMBL1774551,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,77,354,c1ccc(N2CCN(CCCCNCc3ccc4c(c3)Cc3ccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCC=C1c2ccccc2CCc2ccccc21)C(=O)Cc1ccc(OCCCN2CCCCC2)cc1,CHEMBL1030600,Ki,6.04,CHEMBL457957,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,63,518,O=C(Cc1ccc(OCCCN2CCCCC2)cc1)NCCC=C1c2ccccc2CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCC=C1c2ccccc2CCc2ccccc21)Cc1ccc(OCCCN2CCCCC2)cc1,CHEMBL1030600,Ki,7.0,CHEMBL459350,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,63,518,C(CCNCc1ccc(OCCCN2CCCCC2)cc1)=C1c2ccccc2CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCC12CCC(c3ccccc31)c1ccccc12)Cc1ccc(OCCCN2CCCCC2)cc1,CHEMBL1030600,Ki,6.84,CHEMBL517244,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,63,518,c1ccc2c(c1)C1CCC2(CCCNCc2ccc(OCCCN3CCCCC3)cc2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801662,Ki,5.37,CHEMBL3798179,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,116,291,O=C(NCCCCNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801665,Ki,8.24,CHEMBL3798179,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,116,292,O=C(NCCCCNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCCNC(=O)c1cc2ccccc2o1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801662,Ki,4.83,CHEMBL3800633,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,116,291,O=C(NCCCCNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCCNC(=O)c1cc2ccccc2o1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801665,Ki,7.81,CHEMBL3800633,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,116,292,O=C(NCCCCNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2c(O)cccc2C1,CHEMBL672226,Ki,6.9,CHEMBL59642,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,10,358,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCCNC(=O)c1ccc(-c2ccccc2)cc1)C1CCc2nc(N)ncc2C1,CHEMBL670658,Ki,5.8,CHEMBL93703,1999,CHEMBL1131981,Bioorg Med Chem Lett,Scientific Literature,"Tested for the ability to displace [125I]iodosulpiride from human cloned Dopamine receptor D2, expressed in CHO cells.",17,359,O=C(NCCCCNC1CCc2ncncc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCCNC(=O)c1ccc2c(c1)Cc1ccccc1-2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801662,Ki,5.43,CHEMBL3799626,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,116,291,O=C(NCCCCNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCCNC(=O)c1ccc2c(c1)Cc1ccccc1-2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801665,Ki,8.26,CHEMBL3799626,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,116,292,O=C(NCCCCNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC1CC1c1cccc(Cl)c1Cl,CHEMBL4842092,Ki,6.49,CHEMBL4870140,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,148,362,O=C1CCc2ccc(OCCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCCOc1ccc2c(c1)NC(=O)CC2)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL4011211,Ki,7.4,CHEMBL4096422,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=C1CCc2ccc(OCCCCNC3Cc4cccc5[nH]c(=O)n(c45)C3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCN1c2ccccc2Sc2ccc(Cl)cc21)Cc1ccc(OCCCN2CCCCC2)cc1,CHEMBL1030600,Ki,7.39,CHEMBL459373,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,63,518,c1ccc2c(c1)Sc1ccccc1N2CCCNCc1ccc(OCCCN2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OCCF,CHEMBL4406061,Ki,5.61,CHEMBL4585289,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,142,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(C2COOC2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,CHEMBL1044430,Ki,5.8,CHEMBL567919,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,63,233,O=C1N(CCNCC23CCC(CC2)C3)CCN1C1COOC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(c2ccc(F)cc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,CHEMBL1044430,Ki,6.2,CHEMBL562836,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,63,233,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(c2ccc(F)cc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,CHEMBL1059864,Ki,6.2,CHEMBL562836,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,63,234,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(c2ccc3c(c2)OCO3)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,CHEMBL1059864,Ki,5.8,CHEMBL564347,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,63,234,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(c2cccc(C(F)(F)F)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,CHEMBL1044430,Ki,7.7,CHEMBL558058,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,63,233,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(c2cccc(C(F)(F)F)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,CHEMBL1059864,Ki,7.7,CHEMBL558058,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,63,234,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(c2cccc(Cl)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,CHEMBL1044430,Ki,6.9,CHEMBL563274,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,63,233,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(c2cccc(Cl)c2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,CHEMBL1059864,Ki,6.9,CHEMBL563274,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,63,234,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(c2cccc(Cl)c2)C1=O)Cc1cc2ccccc2s1,CHEMBL1044430,Ki,7.3,CHEMBL554738,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,63,233,O=C1N(CCNCc2cc3ccccc3s2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(c2cccc(Cl)c2)C1=O)Cc1cc2ccccc2s1,CHEMBL1059864,Ki,7.3,CHEMBL554738,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,63,234,O=C1N(CCNCc2cc3ccccc3s2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(c2ccccc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,CHEMBL1044430,Ki,6.7,CHEMBL562948,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,63,233,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCN1CCN(c2ccccc2)C1=O)C[C@]12CC[C@H](CC1)C2(C)C,CHEMBL1059864,Ki,6.7,CHEMBL562948,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,63,234,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCOCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)sc12)CCc1ccccc1,CHEMBL1810621,IC50,5.6,CHEMBL1807874,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,77,487,O=c1[nH]c2cccc(CCNCCCOCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CC[C@@H]1CC[C@@H](CNC(=O)c2cc3ccccc3[nH]2)C1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL5228992,Ki,8.34,CHEMBL5273776,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,148,372,O=C(NCC1CCC(CCNC2Cc3cccc4[nH]c(=O)n(c34)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CC[C@@H]1CC[C@@H](CNC(=O)c2cc3ccccc3[nH]2)C1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL5228996,Ki,5.88,CHEMBL5273776,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,148,543,O=C(NCC1CCC(CCNC2Cc3cccc4[nH]c(=O)n(c34)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CC[C@@H]1CC[C@H](CNC(=O)c2cc3ccccc3[nH]2)C1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL5228992,Ki,8.69,CHEMBL5273118,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,148,372,O=C(NCC1CCC(CCNC2Cc3cccc4[nH]c(=O)n(c34)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CC[C@@H]1CC[C@H](CNC(=O)c2cc3ccccc3[nH]2)C1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL5228996,Ki,6.07,CHEMBL5273118,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,148,543,O=C(NCC1CCC(CCNC2Cc3cccc4[nH]c(=O)n(c34)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCc1c[nH]c2ccccc12)Cc1ccc(-c2ccccc2)o1,CHEMBL4316415,Ki,6.43,CHEMBL4552041,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,142,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCc1ccccc1)CC[C@H]1CC[C@H](Nc2ncccn2)CC1,CHEMBL672206,Ki,7.41,CHEMBL164979,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,13,62,c1ccc(CCNCCC2CCC(Nc3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCc1ccccc1)[C@H]1C2C3CC4C5C3CC2C5C41,CHEMBL2432454,Ki,5.29,CHEMBL2432058,2013,CHEMBL2429832,Bioorg Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,89,69,c1ccc(CCNC2C3C4CC5C6C4CC3C6C52)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCc1ccccc1OC(F)(F)F)CCN1CCCC1,CHEMBL959090,Ki,6.29,CHEMBL498565,2008,CHEMBL1150346,J Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,59,443,c1ccc(CCNCCN2CCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(CCc1ccccc1OC(F)(F)F)CCN1CCCCC1,CHEMBL959090,Ki,6.84,CHEMBL497338,2008,CHEMBL1150346,J Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,59,443,c1ccc(CCNCCN2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C[C@@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL5228992,Ki,8.02,CHEMBL5287555,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,148,372,O=C(NCCC1CC1CNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(C[C@H]1C[C@@H]1CCNC(=O)c1cc2ccccc2[nH]1)[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL5228992,Ki,7.31,CHEMBL5286161,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,148,372,O=C(NCCC1CC1CNC1Cc2cccc3[nH]c(=O)n(c23)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1,CHEMBL4880035,Ki,5.415,CHEMBL561132,2021,CHEMBL4507290,,SGC Frankfurt - Donated Chemical Probes,GPCRScan assay: inhibition of D2,148,144,O=S(=O)(NC1CCc2cc3ccccc3n2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1,CHEMBL5214284,Ki,5.43,CHEMBL561132,2023,CHEMBL5212743,,EUbOPEN Chemogenomic Library Literature Data,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000297b DRD2,156,545,O=S(=O)(NC1CCc2cc3ccccc3n2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN([C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)S(=O)(=O)c1cccs1,CHEMBL3872755,Ki,9.52,CHEMBL3895540,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,116,114,O=S(=O)(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(c1ccc([C@]23CNC[C@H]2C3)cc1)S(=O)(=O)c1ccccc1,CHEMBL1225698,Ki,6.3,CHEMBL1223599,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,69,93,O=S(=O)(Nc1ccc(C23CNCC2C3)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN(c1ncccn1)[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1,CHEMBL672206,Ki,8.32,CHEMBL165047,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,13,62,c1ccc(N2CCN(CCC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)CCc2ccccc21,CHEMBL672795,Ki,5.13,CHEMBL63209,2000,CHEMBL1132730,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,21,447,O=C1Nc2ccccc2CCC1N1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)Cc2ccccc21,CHEMBL4039163,Ki,6.88,CHEMBL305276,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,124,546,O=C1Nc2ccccc2CC1N1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)Cc2ccccc21,CHEMBL5235417,Ki,6.88,CHEMBL305276,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to D2R (unknown origin) assessed as inhibition constant,148,476,O=C1Nc2ccccc2CC1N1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C(=O)C(N2CCN(Cc3ccc(Cl)cc3)CC2)Cc2ccccc21,CHEMBL672795,Ki,6.88,CHEMBL305276,2000,CHEMBL1132730,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,21,447,O=C1Nc2ccccc2CC1N1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCCc3cccs3)cc21,CHEMBL3239709,Ki,6.72,CHEMBL3234522,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,99,448,O=C(NCCc1cccs1)c1ccc2c(c1)NC(=O)c1ccccc1[SH+]2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCCN3CCCC3)cc21,CHEMBL3239709,Ki,6.68,CHEMBL3234543,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,99,448,O=C(NCCN1CCCC1)c1ccc2c(c1)NC(=O)c1ccccc1[SH+]2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCCc3cccs3)cc21,CHEMBL3239709,Ki,7.0,CHEMBL3234544,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,99,448,O=C(NCCc1cccs1)c1ccc2c(c1)NC(=O)c1ccccc1[SH+]2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3ccc(Br)cc3)cc21,CHEMBL3239709,Ki,6.62,CHEMBL3234541,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,99,448,O=C(NCc1ccccc1)c1ccc2c(c1)NC(=O)c1ccccc1[SH+]2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C(=O)c2ccccc2[S@+]([O-])c2ccc(C(=O)NCc3cccnc3)cc21,CHEMBL3239709,Ki,6.51,CHEMBL3234542,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,99,448,O=C(NCc1cccnc1)c1ccc2c(c1)NC(=O)c1ccccc1[SH+]2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2,CHEMBL5442215,Ki,6.12,CHEMBL543113,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,c1ccc(C(OC2CC3CCC(C2)N3)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C2CCC1CC(OC(c1ccccc1)c1ccc(Cl)cc1)C2,CHEMBL671385,Ki,5.76,CHEMBL310310,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,25,547,c1ccc(C(OC2CC3CCC(C2)N3)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C2CCC1CC(OC1c3ccccc3Cc3ccccc31)C2,CHEMBL671385,Ki,6.17,CHEMBL320114,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,25,547,c1ccc2c(c1)Cc1ccccc1C2OC1CC2CCC(C1)N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C2CCC1CC1(C2)OC=C(c2ccccc2)C1=O,CHEMBL671745,Ki,5.0,CHEMBL541055,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CC1CCC(C2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)c2ccccc2C1=O,CHEMBL4708967,IC50,6.91,CHEMBL4777098,2020,CHEMBL4706522,Eur J Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,142,548,O=C1NCC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1,CHEMBL3757886,Ki,8.05,CHEMBL3187365,2015,CHEMBL3751719,Medchemcomm,Scientific Literature,Displacement of [3H]N-methylspiperone from human cloned D2 dopamine receptor expressed in human fibroblasts incubated for 90 mins by scintillation counting based radioligand binding assay,109,549,c1ccc2c(c1)Oc1ccccc1C1CNCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CC=C(C2=Cc3ccccc3Cc3ccccc32)CC1,CHEMBL672525,Ki,7.05,CHEMBL554670,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,5,75,C1=C(C2=Cc3ccccc3Cc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CC=C(C2=Cc3ccccc3Oc3ccccc32)CC1,CHEMBL672525,Ki,6.64,CHEMBL163863,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,5,75,C1=C(C2=Cc3ccccc3Oc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CC=C(C2=Nc3cc(Cl)ccc3Nc3ccc(F)cc32)CC1,CHEMBL4816284,Ki,6.39,CHEMBL4852403,2021,CHEMBL4813978,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells assessed as inhibition of dopamine-induced calcium accumulation,148,449,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CC=C(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL4671577,Ki,5.86,CHEMBL4748915,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,142,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CC=C(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL4816284,Ki,5.86,CHEMBL4748915,2021,CHEMBL4813978,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells assessed as inhibition of dopamine-induced calcium accumulation,148,449,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CC=C(C2=Nc3cc(F)ccc3Nc3ccc(Cl)cc32)CC1,CHEMBL4816284,Ki,6.97,CHEMBL4875709,2021,CHEMBL4813978,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells assessed as inhibition of dopamine-induced calcium accumulation,148,449,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1,CHEMBL672315,Ki,6.95,CHEMBL516,2004,CHEMBL1148436,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2 using [3H]spiperone as radioligand,37,524,C1=Cc2ccccc2C(=C2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1,CHEMBL5442215,Ki,5.76,CHEMBL1633,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=C1Cc2ccccc2C(=C2CCNCC2)c2ccsc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(=C2c3ccccc3CCc3sccc32)CC1,CHEMBL3095674,Ki,8.62,CHEMBL294951,2013,CHEMBL3091369,Bioorg Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),89,550,c1ccc2c(c1)CCc1sccc1C2=C1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)CC1,CHEMBL3707825,Ki,6.83,CHEMBL3664873,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)CC1,CHEMBL3707837,Ki,7.2,CHEMBL3698007,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(C2=Cc3cc(Cl)ccc3Cc3ccccc32)CC1,CHEMBL671374,Ki,6.25,CHEMBL7430,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,3,73,C1=C(C2CCNCC2)c2ccccc2Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(C2=Cc3ccccc3Oc3ccccc32)CC1,CHEMBL672525,Ki,7.09,CHEMBL539057,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,5,75,C1=C(C2CCNCC2)c2ccccc2Oc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(C2=Nc3cc(Cl)ccc3Nc3ccccc32)=CC1(C)C,CHEMBL4671577,Ki,5.93,CHEMBL4782694,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,142,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(NC2=Nc3cccnc3Nc3ccc(Cl)cc32)CC1,CHEMBL673081,Ki,5.96,CHEMBL356149,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,28,551,c1cnc2c(c1)N=C(NC1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cccnc4)cc23)CC1,CHEMBL2327488,Ki,7.12,CHEMBL2325932,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1ccc(-n2cc(C3CCNCC3)c3cc(-c4cccnc4)ccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccn(C)n4)cc23)CC1,CHEMBL2327488,Ki,6.8,CHEMBL2326176,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1ccc(-n2cc(C3CCNCC3)c3cc(-c4cc[nH]n4)ccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccncc4)cc23)CC1,CHEMBL2327488,Ki,7.57,CHEMBL2325930,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1ccc(-n2cc(C3CCNCC3)c3cc(-c4ccncc4)ccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ccnn4C)cc23)CC1,CHEMBL2327488,Ki,7.82,CHEMBL2325926,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1ccc(-n2cc(C3CCNCC3)c3cc(-c4ccn[nH]4)ccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1,CHEMBL1261591,Ki,6.58,CHEMBL1259203,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc(-n2cc(C3CCNCC3)c3cc(-c4cncnc4)ccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cncnc4)cc23)CC1,CHEMBL2327488,Ki,6.92,CHEMBL1259203,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1ccc(-n2cc(C3CCNCC3)c3cc(-c4cncnc4)ccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4cnn(C)c4)cc23)CC1,CHEMBL2327488,Ki,6.82,CHEMBL2325928,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1ccc(-n2cc(C3CCNCC3)c3cc(-c4cn[nH]c4)ccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4ncn(C)n4)cc23)CC1,CHEMBL2327488,Ki,6.66,CHEMBL2326175,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1ccc(-n2cc(C3CCNCC3)c3cc(-c4nc[nH]n4)ccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(-c4nnn(C)n4)cc23)CC1,CHEMBL2327488,Ki,7.16,CHEMBL2325935,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1ccc(-n2cc(C3CCNCC3)c3cc(-c4nn[nH]n4)ccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cccnc4)cc23)CC1,CHEMBL2327488,Ki,5.96,CHEMBL2325933,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1cncc(-c2ccc3c(c2)c(C2CCNCC2)cn3-c2ccncc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccncc4)cc23)CC1,CHEMBL2327488,Ki,6.58,CHEMBL2325931,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1cc(-c2ccc3c(c2)c(C2CCNCC2)cn3-c2ccncc2)ccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4ccnn4C)cc23)CC1,CHEMBL2327488,Ki,6.06,CHEMBL2325927,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1cc(-n2cc(C3CCNCC3)c3cc(-c4ccn[nH]4)ccc32)ccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cncnc4)cc23)CC1,CHEMBL2327488,Ki,6.08,CHEMBL2325934,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1cc(-n2cc(C3CCNCC3)c3cc(-c4cncnc4)ccc32)ccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2cn(-c3ccncc3)c3ccc(-c4cnn(C)c4)cc23)CC1,CHEMBL2327488,Ki,5.19,CHEMBL2325929,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,89,552,c1cc(-n2cc(C3CCNCC3)c3cc(-c4cn[nH]c4)ccc32)ccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC(c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)CC1=O,CHEMBL3855278,Ki,5.77,CHEMBL3983684,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,116,105,O=C1CC(c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)CCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC2(CC1)OC(C)(c1ccccc1)CC2=O,CHEMBL671745,Ki,5.0,CHEMBL69259,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1CC(c2ccccc2)OC12CCNCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC2(CC1)OC(c1ccccc1)=CC2=O,CHEMBL671745,Ki,5.54,CHEMBL556133,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C=C(c2ccccc2)OC12CCNCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC2(CC1)OC=C(c1ccc(F)cc1)C2=O,CHEMBL671745,Ki,5.58,CHEMBL555900,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCNCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3,CHEMBL3226695,Ki,6.9,CHEMBL3217984,2012,CHEMBL3217546,Medchemcomm,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,82,553,c1ccc2c(c1)CSc1cccc3c1N2C1CCNCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC2C=C(O)C(O)=C3C(c4ccccc4)CC1C32,CHEMBL5231713,Ki,7.89,CHEMBL5273758,2020,CHEMBL5230125,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from D2DR (unknown origin),142,76,C1=CC2CCNC3CC(c4ccccc4)C(=C1)C23,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCC(c2c(-c3ccccc3)[nH]c3ccccc23)C1,CHEMBL671367,Ki,7.55,CHEMBL43819,2001,CHEMBL1134475,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,25,554,c1ccc(-c2[nH]c3ccccc3c2C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1,CHEMBL5442215,Ki,5.93,CHEMBL1200809,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=c1c2ccccc2c(Cc2ccccc2)nn1C1CCCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCCC1CCN1c2c(Cl)cc(Cl)cc2Sc2cc(Cl)cc(Cl)c21,CHEMBL4771176,Ki,6.19,CHEMBL4797066,2020,CHEMBL4765353,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human D2 receptor (unknown origin) expressed in HEK293 cell membranes,142,555,c1ccc2c(c1)Sc1ccccc1N2CCC1CCCCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCCC1CCN1c2ccc(Br)cc2Sc2cc(Br)ccc21,CHEMBL4771176,Ki,6.16,CHEMBL4791959,2020,CHEMBL4765353,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human D2 receptor (unknown origin) expressed in HEK293 cell membranes,142,555,c1ccc2c(c1)Sc1ccccc1N2CCC1CCCCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCCC1CCN1c2ccc(Br)cc2[Se]c2cc(Br)ccc21,CHEMBL4771176,Ki,6.43,CHEMBL4778666,2020,CHEMBL4765353,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human D2 receptor (unknown origin) expressed in HEK293 cell membranes,142,555,c1ccc2c(c1)[Se]c1ccccc1N2CCC1CCCCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCCC1CN1CCN(c2cccc(Cl)c2)C1=O,CHEMBL1106075,Ki,7.8,CHEMBL1079190,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,69,556,O=C1N(CC2CCCCN2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,CHEMBL827187,Ki,5.775,CHEMBL611207,2004,CHEMBL1137093,Bioorg Med Chem Lett,Scientific Literature,Low binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,37,557,c1ccc2c(c1)Sc1ccccc1N2CCC1CCCCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,CHEMBL827195,Ki,8.79,CHEMBL611207,2004,CHEMBL1137093,Bioorg Med Chem Lett,Scientific Literature,High binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,37,558,c1ccc2c(c1)Sc1ccccc1N2CCC1CCCCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,CHEMBL833053,IC50,7.155,CHEMBL611207,2004,CHEMBL1137093,Bioorg Med Chem Lett,Scientific Literature,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,37,559,c1ccc2c(c1)Sc1ccccc1N2CCC1CCCCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCC[C@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,CHEMBL833053,IC50,6.005,CHEMBL608530,2004,CHEMBL1137093,Bioorg Med Chem Lett,Scientific Literature,Concentration required to inhibit [3H]YM-09151-2 binding to human D2 dopamine receptor,37,559,c1ccc2c(c1)Sc1ccccc1N2CCC1CCCCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCC[C@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21,CHEMBL840079,Ki,6.445,CHEMBL608530,2004,CHEMBL1137093,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 dopamine receptor was determined by using [3H]YM-09151-2 as radioligand,37,560,c1ccc2c(c1)Sc1ccccc1N2CCC1CCCCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCN(C2=Nc3cccnc3Nc3ccc(Cl)cc32)CC1,CHEMBL673081,Ki,4.72,CHEMBL148042,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,28,551,c1cnc2c(c1)N=C(N1CCCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCN(c2ccc(O)c3c2OCC(=O)N3)CC1,CHEMBL4046973,Ki,5.19,CHEMBL4084712,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,124,385,O=C1COc2c(cccc2N2CCCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCN(c2ccc(O)c3c2OCC(=O)N3)CC1,CHEMBL4046974,Ki,5.47,CHEMBL4084712,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,124,386,O=C1COc2c(cccc2N2CCCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCC[C@@H](c2cccc(C#N)c2)C1,CHEMBL679938,Ki,5.98,CHEMBL90662,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",3,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2c([nH]c3ccccc23)Cc2ccccc2CC1,CHEMBL908321,Ki,6.84,CHEMBL216439,2006,CHEMBL1137400,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L dopamine receptor expressed in CHO cells,45,561,c1ccc2c(c1)CCNCCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2c([nH]c3ccccc23)Cc2ccccc2CC1,CHEMBL912405,Ki,7.42,CHEMBL216439,2006,CHEMBL1137400,J Med Chem,Scientific Literature,Activity at human D2L dopamine receptor expressed in HEK293 cells by calcium fluorescence assay,45,562,c1ccc2c(c1)CCNCCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2c([nH]c3ccccc23)Cc2ccccc2CC1,CHEMBL982103,Ki,6.94,CHEMBL216439,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,59,470,c1ccc2c(c1)CCNCCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2c1cccc2N1CCN(CCCc2c[nH]c3ccccc23)CC1,CHEMBL872394,Ki,7.05,CHEMBL198041,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,40,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)CCCN2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2cc(O)ccc2Cc2ccccc2CC1,CHEMBL895724,Ki,6.29,CHEMBL389356,2007,CHEMBL1148752,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,52,563,c1ccc2c(c1)CCCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL908321,Ki,7.84,CHEMBL216258,2006,CHEMBL1137400,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L dopamine receptor expressed in CHO cells,45,561,c1ccc2c(c1)CCCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL912405,Ki,8.82,CHEMBL216258,2006,CHEMBL1137400,J Med Chem,Scientific Literature,Activity at human D2L dopamine receptor expressed in HEK293 cells by calcium fluorescence assay,45,562,c1ccc2c(c1)CCCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL982103,Ki,7.87,CHEMBL216258,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,59,470,c1ccc2c(c1)CCCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2ccccc2Cc2cc(O)ccc2CC1,CHEMBL895724,Ki,7.2,CHEMBL394779,2007,CHEMBL1148752,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,52,563,c1ccc2c(c1)CCCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2ccccc2Cc2ccc(O)cc2CC1,CHEMBL895724,Ki,7.13,CHEMBL231070,2007,CHEMBL1148752,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,52,563,c1ccc2c(c1)CCCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2ccccc2Cc2ccc(O)cc2CC1,CHEMBL982103,Ki,7.38,CHEMBL231070,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,59,470,c1ccc2c(c1)CCCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCCc2ccccc2Cc2ccc(O)cc2CCC1,CHEMBL895724,Ki,6.42,CHEMBL389559,2007,CHEMBL1148752,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,52,563,c1ccc2c(c1)CCCNCCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1,CHEMBL4880035,Ki,5.595,CHEMBL4576555,2021,CHEMBL4507307,,SGC Frankfurt - Donated Chemical Probes,GPCRScan assay: inhibition of D2,148,144,O=C(Nc1cn2cc(-c3ccccc3)ccc2n1)c1ccc(CC(=O)N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1,CHEMBL5213382,Ki,5.56,CHEMBL4576555,2023,CHEMBL5212743,,EUbOPEN Chemogenomic Library Literature Data,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a DRD2,156,564,O=C(Nc1cn2cc(-c3ccccc3)ccc2n1)c1ccc(CC(=O)N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C(C(=O)NC(C)(C)C)C1,CHEMBL5236927,IC50,5.83,CHEMBL5278254,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,148,142,O=C(CCCN1CCN(c2ccccc2)CC1)N1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C(C(=O)NC2CCCCC2)C1,CHEMBL5236927,IC50,8.78,CHEMBL5270832,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,148,142,O=C(NC1CCCCC1)C1CNCCN1C(=O)CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C(C(=O)NCc2ccccc2)C1,CHEMBL5236927,IC50,8.96,CHEMBL5273430,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,148,142,O=C(NCc1ccccc1)C1CNCCN1C(=O)CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Cc3cc(Cl)ccc3Cc3ccccc32)CC1,CHEMBL675960,Ki,6.28,CHEMBL275696,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,4,57,C1=C(N2CCNCC2)c2ccccc2Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Cc3cc(Cl)ccc3Oc3ccccc32)CC1,CHEMBL675960,Ki,8.06,CHEMBL88464,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,4,57,C1=C(N2CCNCC2)c2ccccc2Oc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Cc3ccccc3Cc3ccc(Cl)cc32)CC1,CHEMBL675960,Ki,9.0,CHEMBL7617,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,4,57,C1=C(N2CCNCC2)c2ccccc2Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Cc3ccccc3Oc3ccc(Cl)cc32)CC1,CHEMBL672525,Ki,8.6,CHEMBL90882,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,5,75,C1=C(N2CCNCC2)c2ccccc2Oc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Cc3ccccc3Oc3ccc(Cl)cc32)CC1,CHEMBL675960,Ki,8.6,CHEMBL90882,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,4,57,C1=C(N2CCNCC2)c2ccccc2Oc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Cc3ccccc3Oc3ccccc32)CC1,CHEMBL672525,Ki,7.68,CHEMBL89970,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,5,75,C1=C(N2CCNCC2)c2ccccc2Oc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Cc3ccccc3Oc3ccccc32)CC1,CHEMBL675960,Ki,7.68,CHEMBL89970,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,4,57,C1=C(N2CCNCC2)c2ccccc2Oc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Cn3cccc3Sc3ccccc32)CC1,CHEMBL672100,Ki,7.89,CHEMBL367045,2004,CHEMBL1139457,J Med Chem,Scientific Literature,In vitro binding affinity towards Dopamine receptor D2 in human using [3H]-spiperone as radioligand,37,565,C1=C(N2CCNCC2)c2ccccc2Sc2cccn21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)CCCCCCC(=O)N3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,CHEMBL2020816,IC50,5.665,CHEMBL2016608,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,82,268,O=C(CCCCCCC(=O)N1c2ccccc2N=C(N2CCNCC2)c2ccccc21)N1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)Nc3cc(Cl)cc(Cl)c3)c3ccccc32)CC1,CHEMBL911524,Ki,5.41,CHEMBL212384,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(Nc1ccccc1)N1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(C)c3ccccc32)CC1,CHEMBL671374,Ki,5.96,CHEMBL266723,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,4,73,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(N)c3ccccc32)CC1,CHEMBL870468,Ki,6.19,CHEMBL215140,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)/C=C/c3ccccc3)c3ccccc32)CC1,CHEMBL870468,Ki,5.8,CHEMBL386424,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(C=Cc1ccccc1)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)C(F)(F)F)c3ccccc32)CC1,CHEMBL870468,Ki,5.72,CHEMBL212486,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)C3CCCCC3)c3ccccc32)CC1,CHEMBL870468,Ki,5.75,CHEMBL213388,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)N3CCN(C(=O)CCC(=O)NN4c5ccc(Cl)cc5N=C(N5CCN(C)CC5)c5ccccc54)CC3)c3ccccc32)CC1,CHEMBL2020816,IC50,5.79,CHEMBL2016622,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,82,268,O=C(CCC(=O)N1CCN(C(=O)CCC(=O)NN2c3ccccc3N=C(N3CCNCC3)c3ccccc32)CC1)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC(=O)OCCOC(=O)CCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,CHEMBL2020816,IC50,5.62,CHEMBL2016624,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,82,268,O=C(CCC(=O)OCCOC(=O)CCC(=O)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC3CCCC3)c3ccccc32)CC1,CHEMBL870468,Ki,5.71,CHEMBL211461,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(CCC1CCCC1)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCC(=O)N3CCN(C(=O)CCCC(=O)N4CCN(C(=O)CCCC(=O)NN5c6ccc(Cl)cc6N=C(N6CCN(C)CC6)c6ccccc65)CC4)CC3)c3ccccc32)CC1,CHEMBL2020816,IC50,5.58,CHEMBL2016623,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,82,268,O=C(CCCC(=O)N1CCN(C(=O)CCCC(=O)N2CCN(C(=O)CCCC(=O)NN3c4ccccc4N=C(N4CCNCC4)c4ccccc43)CC2)CC1)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,CHEMBL2020816,IC50,5.6850000000000005,CHEMBL2016615,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,82,268,O=C(CCCCC(=O)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCCCCCC(=O)NN3c4ccc(Cl)cc4N=C(N4CCN(C)CC4)c4ccccc43)c3ccccc32)CC1,CHEMBL2020816,IC50,5.61,CHEMBL2016616,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,82,268,O=C(CCCCCCC(=O)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCc3ccccc3)c3ccccc32)CC1,CHEMBL870468,Ki,6.21,CHEMBL215611,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(CCc1ccccc1)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(Cl)cc(Cl)cc3Cl)c3ccccc32)CC1,CHEMBL870468,Ki,6.41,CHEMBL213881,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(Cl)cccc3Cl)c3ccccc32)CC1,CHEMBL870468,Ki,6.62,CHEMBL386122,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(F)cccc3C(F)(F)F)c3ccccc32)CC1,CHEMBL870468,Ki,6.42,CHEMBL213492,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(F)cccc3C(F)(F)F)c3ccccc32)CC1,CHEMBL870474,Ki,6.42,CHEMBL213492,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at dopamine D2 receptor,45,566,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3C(F)(F)F)c3ccccc32)CC1,CHEMBL870468,Ki,7.04,CHEMBL377756,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3Cl)c3ccccc32)CC1,CHEMBL870468,Ki,6.3,CHEMBL378669,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3Cl)c3ccccc32)CC1,CHEMBL870474,Ki,6.3,CHEMBL378669,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at dopamine D2 receptor,45,566,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(Cl)cc(Cl)c3)c3ccccc32)CC1,CHEMBL870468,Ki,6.22,CHEMBL427230,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(F)c(F)c(F)c3F)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,6.57,CHEMBL213466,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(F)c(F)c(F)c3F)c3ccccc32)CC1,CHEMBL911524,Ki,5.89,CHEMBL212438,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(F)ccc3C(F)(F)F)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,7.16,CHEMBL378341,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(Br)cc3)c3ccccc32)CC1,CHEMBL870468,Ki,5.62,CHEMBL213775,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(C#N)cc3)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,6.71,CHEMBL378648,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(Cl)c(Cl)c3)c3ccccc32)CC1,CHEMBL870468,Ki,5.19,CHEMBL212077,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(Cl)cc3)c3ccccc32)CC1,CHEMBL870468,Ki,5.03,CHEMBL214142,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(F)cc3C(F)(F)F)c3ccccc32)CC1,CHEMBL911524,Ki,5.79,CHEMBL437917,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4c(c3)OCO4)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,6.54,CHEMBL212700,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4c(c3)OCO4)c3ccccc32)CC1,CHEMBL911524,Ki,6.08,CHEMBL213668,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4ccccc4c3)c3ccccc32)CC1,CHEMBL870468,Ki,5.88,CHEMBL213882,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4ccccc4n3)c3ccccc32)CC1,CHEMBL870468,Ki,6.03,CHEMBL213443,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(C#N)c3)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,6.76,CHEMBL212402,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(C#N)c3)c3ccccc32)CC1,CHEMBL911524,Ki,5.44,CHEMBL212905,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(C(F)(F)F)c3)c3ccccc32)CC1,CHEMBL911524,Ki,5.87,CHEMBL380236,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(Cl)c3)c3ccccc32)CC1,CHEMBL870468,Ki,6.74,CHEMBL213084,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(F)c3)c3ccccc32)CC1,CHEMBL870468,Ki,6.04,CHEMBL213083,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(F)c3F)c3ccccc32)CC1,CHEMBL911524,Ki,6.27,CHEMBL384269,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(I)c3)c3ccccc32)CC1,CHEMBL870468,Ki,6.46,CHEMBL377584,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc4ccccc34)c3ccccc32)CC1,CHEMBL870468,Ki,6.34,CHEMBL213834,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc4ccccc34)c3ccccc32)CC1,CHEMBL870474,Ki,6.34,CHEMBL213834,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at dopamine D2 receptor,45,566,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3)c3ccccc32)CC1,CHEMBL870468,Ki,5.94,CHEMBL212608,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3)c3ccccc32)CC1,CHEMBL911524,Ki,5.94,CHEMBL212608,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3-n3ccnc3)c3ccccc32)CC1,CHEMBL870468,Ki,5.52,CHEMBL212844,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1-n1ccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Br)c3ccccc32)CC1,CHEMBL911524,Ki,6.1,CHEMBL377877,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1,CHEMBL870468,Ki,6.74,CHEMBL212912,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1,CHEMBL870474,Ki,6.74,CHEMBL212912,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at dopamine D2 receptor,45,566,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1,CHEMBL911524,Ki,6.74,CHEMBL212912,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3F)c3ccccc32)CC1,CHEMBL870468,Ki,6.43,CHEMBL213477,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3I)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,7.44,CHEMBL212936,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,45,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3N3CCCCC3)c3ccccc32)CC1,CHEMBL870468,Ki,6.67,CHEMBL212383,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1N1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3N3CCN(C)CC3)c3ccccc32)CC1,CHEMBL870468,Ki,5.42,CHEMBL210016,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1N1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3NC3CCCCC3)c3ccccc32)CC1,CHEMBL870468,Ki,5.42,CHEMBL212186,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,45,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1NC1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Oc3ccccc3)c3ccccc32)CC1,CHEMBL870468,Ki,6.37,CHEMBL214407,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,46,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1Oc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccnc3)c3ccccc32)CC1,CHEMBL911524,Ki,4.9,CHEMBL215997,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,46,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccnc3Cl)c3ccccc32)CC1,CHEMBL870468,Ki,6.2,CHEMBL384500,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,46,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccco3)c3ccccc32)CC1,CHEMBL870468,Ki,6.08,CHEMBL426868,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,46,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccs3)c3ccccc32)CC1,CHEMBL870468,Ki,5.83,CHEMBL379874,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,46,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccncc3)c3ccccc32)CC1,CHEMBL911524,Ki,4.55,CHEMBL384248,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,46,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccncc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccon3)c3ccccc32)CC1,CHEMBL870468,Ki,6.34,CHEMBL213372,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,46,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccon1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccsc3)c3ccccc32)CC1,CHEMBL870468,Ki,5.52,CHEMBL212896,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,46,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccsc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cnn(-c4ccccc4)c3C(F)(F)F)c3ccccc32)CC1,CHEMBL870468,Ki,5.68,CHEMBL405751,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,46,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1cnn(-c2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3nccc4ccccc34)c3ccccc32)CC1,CHEMBL870468,Ki,6.32,CHEMBL213278,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,46,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1nccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3sccc3-c3ccccc3)c3ccccc32)CC1,CHEMBL870468,Ki,7.11,CHEMBL384916,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,46,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1sccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1,CHEMBL671075,IC50,7.52,CHEMBL70319,1999,CHEMBL1132638,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,17,567,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL1027240,Ki,6.65,CHEMBL42,2008,CHEMBL1140101,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,59,482,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL1030600,Ki,7.08,CHEMBL42,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,63,518,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL1059279,Ki,6.65,CHEMBL42,2009,CHEMBL1154195,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,63,568,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL1061432,Ki,7.39,CHEMBL42,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,63,569,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL1061433,Ki,7.55,CHEMBL42,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,63,570,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020816,IC50,6.69,CHEMBL42,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,82,268,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020817,Ki,6.98,CHEMBL42,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,82,269,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2162846,Ki,7.14,CHEMBL42,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,82,218,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL3073105,Ki,8.15,CHEMBL42,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),89,427,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL3106891,Ki,6.65,CHEMBL42,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,99,134,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL3222870,Ki,6.65,CHEMBL42,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,77,571,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL3226695,Ki,6.0,CHEMBL42,2012,CHEMBL3217546,Medchemcomm,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,82,553,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL3240292,Ki,7.05,CHEMBL42,2014,CHEMBL3232770,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from wild-type human dopamine D2S receptor expressed in CHO-K1 cell membrane after 2 hrs by beta counting,99,572,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL3240293,Ki,7.24,CHEMBL42,2014,CHEMBL3232770,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor S5.43T/S5.46A mutant expressed in CHO-K1 cell membrane after 2 hrs by beta counting,99,573,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL3381713,Ki,6.68,CHEMBL42,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),99,574,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL3707630,Ki,6.72,CHEMBL42,2013,CHEMBL3638417,,BindingDB Patent Bioactivity Data,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",89,575,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL3757886,Ki,6.37,CHEMBL42,2015,CHEMBL3751719,Medchemcomm,Scientific Literature,Displacement of [3H]N-methylspiperone from human cloned D2 dopamine receptor expressed in human fibroblasts incubated for 90 mins by scintillation counting based radioligand binding assay,109,549,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL3821459,Ki,6.89,CHEMBL42,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Inhibition of D2 receptor (unknown origin),116,576,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL3880782,Ki,7.14,CHEMBL42,2004,CHEMBL3880399,,SureChEMBL Patent Bioactivity Data,Competitive antagonist activity against human dopamine D2 receptor short isoform by R-SAT assay,37,577,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL4229838,Ki,7.15,CHEMBL42,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,130,578,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL4394479,IC50,6.85,CHEMBL42,2019,CHEMBL4393669,J Med Chem,Scientific Literature,Antagonist activity at D2L receptor (unknown origin) expressed in human HTLA cells assessed as inhibition of dopamine-stimulated beta-arrestin2 recruitment measured after 20 to 22 hrs by brightglo-luciferase reporter gene assay,134,514,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL4671577,Ki,6.41,CHEMBL42,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,142,488,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL4686240,Ki,6.8,CHEMBL42,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin),142,579,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL4718597,Ki,6.89,CHEMBL42,2016,CHEMBL4715748,Bioorg Med Chem,Scientific Literature,Binding affinity to human dopamine D2 receptor,116,580,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL4816284,Ki,6.41,CHEMBL42,2021,CHEMBL4813978,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells assessed as inhibition of dopamine-induced calcium accumulation,148,449,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL5145822,Ki,6.82,CHEMBL42,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,153,581,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL5235409,Ki,7.39,CHEMBL42,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,148,478,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL670113,IC50,6.64,CHEMBL42,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,13,582,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL670394,Ki,6.81,CHEMBL42,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,13,120,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL670395,Ki,6.6,CHEMBL42,1997,CHEMBL1129926,Bioorg Med Chem Lett,Scientific Literature,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,10,153,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL670553,Ki,7.55,CHEMBL42,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,17,583,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL670681,Ki,6.65,CHEMBL42,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,37,584,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL670684,Ki,7.5,CHEMBL42,2001,CHEMBL1134798,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity for Dopamine receptor D2,25,585,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671074,IC50,6.95,CHEMBL42,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",21,461,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671075,IC50,6.58,CHEMBL42,1999,CHEMBL1132638,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,17,567,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671363,Ki,7.39,CHEMBL42,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,28,34,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671365,Ki,7.55,CHEMBL42,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,29,35,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671369,Ki,7.04,CHEMBL42,1997,CHEMBL1130121,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,10,586,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671370,Ki,7.13,CHEMBL42,1996,CHEMBL1129307,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,8,587,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671371,Ki,7.13,CHEMBL42,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,17,588,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671374,Ki,6.66,CHEMBL42,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,4,73,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671375,Ki,7.13,CHEMBL42,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,17,496,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671378,Ki,7.04,CHEMBL42,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,10,589,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671416,Ki,6.89,CHEMBL42,2003,CHEMBL1136328,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to inhibit the binding of [3H]spiperone to cloned human Dopamine receptor D2 using apomorphine induced climbing test in male Swiss mice,33,590,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671731,Ki,7.39,CHEMBL42,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,29,45,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL671732,Ki,7.55,CHEMBL42,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,29,46,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672100,Ki,6.58,CHEMBL42,2004,CHEMBL1139457,J Med Chem,Scientific Literature,In vitro binding affinity towards Dopamine receptor D2 in human using [3H]-spiperone as radioligand,37,565,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672162,Ki,6.95,CHEMBL42,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,33,236,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672164,Ki,7.13,CHEMBL42,1996,CHEMBL1129306,J Med Chem,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,8,249,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672169,Ki,6.82,CHEMBL42,2004,CHEMBL1149193,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,37,533,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672173,Ki,6.59,CHEMBL42,1997,CHEMBL1130009,J Med Chem,Scientific Literature,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,10,591,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672178,Ki,6.86,CHEMBL42,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 was determined via standard competitive displacement assays using [3H]-YM 09151 as the competitive ligand,29,592,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672179,Ki,6.72,CHEMBL42,2001,CHEMBL1134342,J Med Chem,Scientific Literature,Binding affinity towards human D2 dopamine receptor.,25,534,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672209,Ki,7.13,CHEMBL42,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,10,230,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672308,Ki,7.16,CHEMBL42,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,25,593,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672382,Ki,7.39,CHEMBL42,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,25,480,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672383,Ki,7.39,CHEMBL42,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,21,594,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672525,Ki,6.66,CHEMBL42,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,5,75,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672572,Ki,7.55,CHEMBL42,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,25,481,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672578,Ki,7.55,CHEMBL42,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Competitive binding affinity against human Dopamine receptor D2S by displacing [3H]spiperone from CHO cells,22,595,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672579,Ki,7.55,CHEMBL42,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672580,Ki,7.55,CHEMBL42,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,17,47,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL672795,Ki,6.95,CHEMBL42,2000,CHEMBL1132730,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,22,447,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL673073,Ki,7.41,CHEMBL42,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL673074,Ki,7.39,CHEMBL42,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,17,48,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL673081,Ki,6.43,CHEMBL42,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,29,551,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL673082,Ki,6.06,CHEMBL42,2000,CHEMBL1133667,J Med Chem,Scientific Literature,"In vitro binding affinity towards Dopamine receptor D2L, using [3H]spiroperidol radioligand in Sf9 baculovirus expression.",22,596,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL674342,Ki,6.87,CHEMBL42,2003,CHEMBL1136328,Bioorg Med Chem Lett,Scientific Literature,Cataleptogenic effect against cloned human Dopamine receptor D2 in male Sprague-Dawley rats in a bar test,33,597,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL829120,Ki,6.84,CHEMBL42,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL838638,Ki,7.11,CHEMBL42,2004,CHEMBL1137161,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2,37,598,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL866799,Ki,7.39,CHEMBL42,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,46,599,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL866800,Ki,7.55,CHEMBL42,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,46,600,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL870468,Ki,6.68,CHEMBL42,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,46,262,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL872217,IC50,8.05,CHEMBL42,2005,CHEMBL1140446,J Med Chem,Scientific Literature,Inhibitory concentration against dopamine receptor D2,40,601,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL872499,Ki,7.41,CHEMBL42,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,17,602,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL872891,Ki,6.86,CHEMBL42,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",29,214,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL895618,Ki,6.9,CHEMBL42,2007,CHEMBL1148822,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,52,452,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL911524,Ki,6.68,CHEMBL42,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,46,194,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL923071,Ki,6.65,CHEMBL42,2007,CHEMBL1140677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone human cloned dopamine D2 receptor,52,603,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL992743,Ki,6.89,CHEMBL42,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,59,604,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cc(Cl)ccc3Oc3ccccc32)CC1,CHEMBL675960,Ki,6.82,CHEMBL7828,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,4,57,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1O2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3N(NC(=O)c3cc(F)c(F)c(F)c3F)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,6.12,CHEMBL213145,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,46,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3N(NC(=O)c3cc(F)ccc3C(F)(F)F)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,6.38,CHEMBL213193,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,46,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3N(NC(=O)c3ccc(C#N)cc3)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,5.71,CHEMBL213201,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,46,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3N(NC(=O)c3ccc4c(c3)OCO4)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,5.9,CHEMBL213472,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,46,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3N(NC(=O)c3cccc(C#N)c3)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,5.93,CHEMBL213238,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,46,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3N(NC(=O)c3ccccc3I)c3ccc(Cl)cc32)CC1,CHEMBL911524,Ki,6.64,CHEMBL214503,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,46,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Nc3ccc(Cl)cc32)CC1,CHEMBL671075,IC50,7.47,CHEMBL415300,1999,CHEMBL1132638,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,17,567,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Nc3ccc(Cl)cc32)CC1,CHEMBL671374,Ki,7.33,CHEMBL415300,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,4,73,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Nc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1,CHEMBL671075,IC50,6.85,CHEMBL72292,1999,CHEMBL1132638,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,17,567,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1,CHEMBL671374,Ki,5.6,CHEMBL73538,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,4,73,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Nc3sc(CO)cc32)CC1,CHEMBL671419,Ki,7.66,CHEMBL100454,1997,CHEMBL1150510,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity of compound against neuronal Dopamine receptor D2,10,605,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CHEMBL672525,Ki,7.68,CHEMBL831,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,5,75,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1O2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CHEMBL675960,Ki,7.68,CHEMBL831,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated by inhibition of [3H]spiperone binding to COS cells transfected with human dopamine D-2(long) receptor,4,57,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1O2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Oc3ccc(Cl)cc32)CC1,CHEMBL884444,IC50,7.27,CHEMBL831,1999,CHEMBL1132638,J Med Chem,Scientific Literature,Compound was tested in vitro for its binding affinity towards human Dopamine receptor D2,17,606,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1O2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Oc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1,CHEMBL671075,IC50,7.28,CHEMBL430798,1999,CHEMBL1132638,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,17,567,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1O2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Sc3ccc(Cl)cc32)CC1,CHEMBL3705566,Ki,9.31,CHEMBL304902,2014,CHEMBL3639279,,BindingDB Patent Bioactivity Data,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",99,607,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Sc3ccc(F)cc32)CC1,CHEMBL3705566,Ki,8.96,CHEMBL3646151,2014,CHEMBL3639279,,BindingDB Patent Bioactivity Data,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",99,607,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3ccccc3Sc3ccc(OS(=O)(=O)C(F)(F)F)cc32)CC1,CHEMBL671075,IC50,7.64,CHEMBL73589,1999,CHEMBL1132638,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,17,567,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2=Nc3cccnc3Nc3ccc(Cl)cc32)CC1,CHEMBL673081,Ki,5.65,CHEMBL63576,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,29,551,c1cnc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccc4)cc32)CC1,CHEMBL1261591,Ki,8.74,CHEMBL1259043,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc(-c2ccc3c(c2)C(N2CCNCC2)Cc2ccccc2S3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccccn4)cc32)CC1,CHEMBL1261591,Ki,8.72,CHEMBL1259006,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc(-c2ccc3c(c2)C(N2CCNCC2)Cc2ccccc2S3)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cccnc4)cc32)CC1,CHEMBL1261591,Ki,9.21,CHEMBL1259023,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1cncc(-c2ccc3c(c2)C(N2CCNCC2)Cc2ccccc2S3)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccn(C)n4)cc32)CC1,CHEMBL1261591,Ki,8.8,CHEMBL1259232,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1cc(-c3cc[nH]n3)ccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccncc4)cc32)CC1,CHEMBL1261591,Ki,8.96,CHEMBL1259024,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1cc(-c3ccncc3)ccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ccnn4C)cc32)CC1,CHEMBL1261591,Ki,9.07,CHEMBL1259231,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1cc(-c3ccn[nH]3)ccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cncnc4)cc32)CC1,CHEMBL1261591,Ki,9.14,CHEMBL1259042,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1cc(-c3cncnc3)ccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(-c4cnn(C)c4)cc32)CC1,CHEMBL1261591,Ki,8.64,CHEMBL1258987,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1cc(-c3cn[nH]c3)ccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(-c4ncn(C)n4)cc32)CC1,CHEMBL1261591,Ki,8.23,CHEMBL1258988,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1cc(-c3nc[nH]n3)ccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnn(C)n4)cc32)CC1,CHEMBL1261591,Ki,8.64,CHEMBL1259216,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1cc(-c3nn[nH]n3)ccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(-c4nnn(C)n4)cc32)CC1,CHEMBL1261596,Ki,9.36,CHEMBL1259216,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in HEK293 cells,69,608,c1ccc2c(c1)CC(N1CCNCC1)c1cc(-c3nn[nH]n3)ccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(C#N)cc32)CC1,CHEMBL1261591,Ki,8.85,CHEMBL1259112,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(CN)cc32)CC1,CHEMBL1261591,Ki,7.46,CHEMBL1259113,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(CNC(=O)C(C)(C)C)cc32)CC1,CHEMBL1261591,Ki,8.21,CHEMBL1259158,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(Cc4nnn(C)n4)cc32)CC1,CHEMBL1261596,Ki,9.46,CHEMBL1259128,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in HEK293 cells,69,608,c1ccc2c(c1)CC(N1CCNCC1)c1cc(Cc3nn[nH]n3)ccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(Cc4nnnn4C)cc32)CC1,CHEMBL1261596,Ki,8.72,CHEMBL1259129,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor expressed in HEK293 cells,69,608,c1ccc2c(c1)CC(N1CCNCC1)c1cc(Cc3nnn[nH]3)ccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(C2Cc3ccccc3Sc3ccc(Cl)cc32)CC1,CHEMBL1261591,Ki,9.17,CHEMBL64249,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)CC1,CHEMBL3707825,Ki,6.98,CHEMBL3664880,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,111,O=C(CN1CCNCC1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)CC1,CHEMBL3707837,Ki,7.42,CHEMBL3698011,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,O=C(CN1CCNCC1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(CCCN2C(=O)c3ccccc3/C=C\c3ccccc32)CC1,CHEMBL4669829,Ki,5.12,CHEMBL4796968,2020,CHEMBL4665756,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),142,523,O=C1c2ccccc2C=Cc2ccccc2N1CCCN1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(CCCNC(=O)c2cc(=O)c3ccccc3[nH]2)CC1,CHEMBL4137914,Ki,5.43,CHEMBL4166411,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,130,220,O=C(NCCCN1CCNCC1)c1cc(=O)c2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(CCN2CCN(c3cccc(Cl)c3)C2=O)CC1,CHEMBL1057875,Ki,6.3,CHEMBL571221,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,63,166,O=C1N(CCN2CCNCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(CCc2ccc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2)CC1,CHEMBL4821052,Ki,7.87,CHEMBL4857918,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),148,248,c1ccc2c(C3CCN(CCCOc4ccc(CCN5CCNCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(Cc2ccc(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2)CC1,CHEMBL4821052,Ki,8.72,CHEMBL4846866,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),148,248,c1ccc2c(C3CCN(CCCCOc4ccc(CN5CCNCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(Cc2ccc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2)CC1,CHEMBL4821052,Ki,8.77,CHEMBL4865907,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),148,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCNCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C,CHEMBL4671577,Ki,7.55,CHEMBL3039528,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,142,488,c1ccc(C2CC(N3CCNCC3)c3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN([C@@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1,CHEMBL1261591,Ki,8.14,CHEMBL64875,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN([C@H]2Cc3ccccc3Sc3ccc(Cl)cc32)CC1,CHEMBL1261591,Ki,8.96,CHEMBL303313,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,69,108,c1ccc2c(c1)CC(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2cc(-c3ccc(C(F)(F)F)cc3)c3ccn(S(C)(=O)=O)c3n2)CC1,CHEMBL3800738,Ki,5.91,CHEMBL3800153,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,116,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2cc(-c3ccsc3)cc(CC3CCCCC3)n2)CC1,CHEMBL5391038,Ki,7.08,CHEMBL5396600,2023,CHEMBL5390222,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay,156,213,c1cc(-c2cc(CC3CCCCC3)nc(N3CCNCC3)c2)cs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](CCN4CCC(c5cccc6c5CCO6)CC4)CC3)cc2)CC1,CHEMBL3705383,Ki,6.83,CHEMBL3695397,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](CCN4CCC(c5coc6ccccc56)CC4)CC3)cc2)CC1,CHEMBL3706129,Ki,7.3,CHEMBL3676907,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc(C(=O)N[C@H]3CC[C@H](CCN4CCN(c5nccc6c5CCO6)CC4)CC3)cc2)CC1,CHEMBL3705135,Ki,6.75,CHEMBL3642794,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc(O)c3[nH]c(=O)ccc23)CC1,CHEMBL4046973,Ki,6.11,CHEMBL4094407,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,124,385,O=c1ccc2c(N3CCNCC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc(O)c3[nH]c(=O)ccc23)CC1,CHEMBL4046974,Ki,6.6,CHEMBL4094407,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,124,386,O=c1ccc2c(N3CCNCC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc(O)c3c2OCC(=O)N3)CC1,CHEMBL4046973,Ki,6.2,CHEMBL4102646,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,124,385,O=C1COc2c(cccc2N2CCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc(O)c3c2OCC(=O)N3)CC1,CHEMBL4046974,Ki,6.7,CHEMBL4102646,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,124,386,O=C1COc2c(cccc2N2CCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc(O)c3c2OCCO3)CC1,CHEMBL4046973,Ki,5.5,CHEMBL4064759,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,124,385,c1cc2c(c(N3CCNCC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc(O)c3c2OCCO3)CC1,CHEMBL4046974,Ki,5.82,CHEMBL4064759,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,124,386,c1cc2c(c(N3CCNCC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc3[nH]nc(S(=O)(=O)c4cccc5ccccc45)c3c2)CC1,CHEMBL1286377,Ki,6.48,CHEMBL1277104,2010,CHEMBL1275334,J Med Chem,Scientific Literature,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,69,192,O=S(=O)(c1cccc2ccccc12)c1n[nH]c2ccc(N3CCNCC3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc3[nH]nc(S(=O)(=O)c4ccccc4)c3c2)CC1,CHEMBL1286377,Ki,6.45,CHEMBL1277917,2010,CHEMBL1275334,J Med Chem,Scientific Literature,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,69,192,O=S(=O)(c1ccccc1)c1n[nH]c2ccc(N3CCNCC3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc3c(c2)N(S(=O)(=O)c2ccccc2)CC3)CC1,CHEMBL4479923,Ki,6.34,CHEMBL4586276,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,116,378,O=S(=O)(c1ccccc1)N1CCc2ccc(N3CCNCC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc3ccn(S(=O)(=O)c4ccccc4)c3c2)CC1,CHEMBL4735854,Ki,6.62,CHEMBL4759208,2021,CHEMBL4732129,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from dopamine D2 receptor (unknown origin) incubated for 1 hr by microbeta counting method,148,609,O=S(=O)(c1ccccc1)n1ccc2ccc(N3CCNCC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc3nc(CN4CCN(c5ccc(Cl)c(Cl)c5)CC4)cn3n2)CC1,CHEMBL866799,Ki,5.1,CHEMBL380287,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,46,599,c1ccc(N2CCN(Cc3cn4nc(N5CCNCC5)ccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2ccc3nc(CN4CCN(c5ccc(Cl)c(Cl)c5)CC4)cn3n2)CC1,CHEMBL866800,Ki,5.11,CHEMBL380287,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,46,600,c1ccc(N2CCN(Cc3cn4nc(N5CCNCC5)ccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL2168000,Ki,7.34,CHEMBL2165673,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,82,254,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2cccc3c2CCN3S(=O)(=O)c2ccccc2)CC1,CHEMBL4479923,Ki,6.68,CHEMBL4534733,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,116,378,O=S(=O)(c1ccccc1)N1CCc2c(N3CCNCC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,CHEMBL4735854,Ki,7.51,CHEMBL4759730,2021,CHEMBL4732129,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from dopamine D2 receptor (unknown origin) incubated for 1 hr by microbeta counting method,148,609,O=S(=O)(c1ccccc1)n1ccc2c(N3CCNCC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(C(C)(C)Sc3ccc4ccccc4c3)n2)CC1,CHEMBL5216600,Ki,6.52,CHEMBL5219240,2022,CHEMBL5214932,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,153,229,c1ccc2cc(SCc3ncnc(N4CCNCC4)n3)ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(CCCOc3cc(Cl)ccc3Cl)n2)CC1,CHEMBL4819277,Ki,6.38,CHEMBL4849230,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,142,227,c1ccc(OCCCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(CCCOc3ccc(Cl)c(Cl)c3)n2)CC1,CHEMBL4819277,Ki,6.45,CHEMBL4868911,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,142,227,c1ccc(OCCCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(CCCOc3cccc(Cl)c3Cl)n2)CC1,CHEMBL4819277,Ki,6.69,CHEMBL4860719,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,142,227,c1ccc(OCCCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(COc3ccc(Cl)cc3Cl)n2)CC1,CHEMBL4366763,Ki,5.91,CHEMBL4473083,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,134,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(COc3cccc(Cl)c3)n2)CC1,CHEMBL4366763,Ki,6.17,CHEMBL4524981,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,134,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(COc3ccccc3)n2)CC1,CHEMBL4366763,Ki,5.87,CHEMBL4465929,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,134,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(COc3ccccc3Cl)n2)CC1,CHEMBL4366763,Ki,5.63,CHEMBL4548041,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,134,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(CS(=O)(=O)c3ccccc3Cl)n2)CC1,CHEMBL4366763,Ki,4.3,CHEMBL4441655,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,134,228,O=S(=O)(Cc1ncnc(N2CCNCC2)n1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(CSc3ccccc3)n2)CC1,CHEMBL4366763,Ki,6.13,CHEMBL4557247,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,134,228,c1ccc(SCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(CSc3ccccc3Cl)n2)CC1,CHEMBL4366763,Ki,6.48,CHEMBL4591878,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,134,228,c1ccc(SCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(C[Se]c3ccccc3)n2)CC1,CHEMBL4366763,Ki,6.3,CHEMBL4580959,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,134,228,c1ccc([Se]Cc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc(N)nc(Cc3c[nH]c4ccccc34)n2)CC1,CHEMBL5216600,Ki,5.71,CHEMBL4086515,2022,CHEMBL5214932,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,153,229,c1ccc2c(Cc3ncnc(N4CCNCC4)n3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN(c2nc3ccccc3c(Cl)c2Sc2ccccc2)CC1,CHEMBL672311,Ki,7.51,CHEMBL15242,2001,CHEMBL1134832,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to Dopamine receptor D2 was determined,25,610,c1ccc(Sc2cc3ccccc3nc2N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12,CHEMBL4710573,IC50,8.39,CHEMBL3306803,2020,CHEMBL4706566,Eur J Med Chem,Scientific Literature,Partial agonist activity at presynaptic D2 receptor (unknown origin),142,611,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCN3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12,CHEMBL4710574,IC50,8.49,CHEMBL3306803,2020,CHEMBL4706566,Eur J Med Chem,Scientific Literature,Antagonist activity at postsynaptic D2 receptor (unknown origin),142,612,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCN3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN2c3cccc4[nH]cc(c34)CC2C1,CHEMBL3294601,Ki,6.18,CHEMBL3286568,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,99,178,c1cc2c3c(c[nH]c3c1)CC1CNCCN21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN2c3ccccc3Cc3ccccc3C2C1,CHEMBL672501,IC50,5.15,CHEMBL6437,2002,CHEMBL1135381,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for human cloned Dopamine receptor D2L,29,520,c1ccc2c(c1)Cc1ccccc1N1CCNCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN2c3ccccc3Cc3ccccc3C2C1,CHEMBL829120,Ki,5.66,CHEMBL6437,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,40,536,c1ccc2c(c1)Cc1ccccc1N1CCNCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCN2c3ccccc3Cc3ccccc3C2C1,CHEMBL857158,IC50,5.15,CHEMBL6437,2002,CHEMBL1135380,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for human cloned Dopamine receptor D2L,29,522,c1ccc2c(c1)Cc1ccccc1N1CCNCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCO[C@@H]2c3cc4c(cc3CC[C@H]21)CCO4,CHEMBL674942,Ki,6.4,CHEMBL171826,1997,CHEMBL1129892,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,10,179,c1c2c(cc3c1CCC1NCCOC31)OCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCOc2c(C(=O)NC[C@@H]3CCCN3CCc3ccccc3)cc(Cl)cc21,CHEMBL672310,Ki,6.1,CHEMBL281363,2000,CHEMBL1133417,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,22,280,O=C(NCC1CCCN1CCc1ccccc1)c1cccc2c1OCCN2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCOc2c(C(=O)NC[C@H]3CCCN3CCc3ccccc3)cc(Cl)cc21,CHEMBL672310,Ki,7.24,CHEMBL279937,2000,CHEMBL1133417,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,22,280,O=C(NCC1CCCN1CCc1ccccc1)c1cccc2c1OCCN2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCOc2cc(O)ccc2Cc2ccccc2CC1,CHEMBL838569,Ki,6.56,CHEMBL184050,2004,CHEMBL1138672,J Med Chem,Scientific Literature,Binding affinity for human recombinant dopamine receptor D2L,37,440,c1ccc2c(c1)CCNCCOc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2c(Cl)c(O)c(O)c(Cl)c2C(c2ccccc2)C1,CHEMBL669942,Ki,3.0915149811213505,CHEMBL544118,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at high affinity state.,0,88,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2c([nH]c3ccccc23)CC(c2ccccc2)CC1,CHEMBL859832,Ki,6.03,CHEMBL201584,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,46,468,c1ccc(C2CCNCCc3c([nH]c4ccccc34)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1,CHEMBL3106129,Ki,6.08,CHEMBL3104091,2014,CHEMBL3102773,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-Methylspiperone from dopamine D2 receptor (unknown origin),99,613,c1ccc2c(c1)CCc1cccc3c4c(n-2c13)CCNC4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2c(cc(O)c(O)c2Br)C(c2ccccc2)C1,CHEMBL669945,Ki,6.31,CHEMBL554009,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,0,85,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2c(cc(O)c(O)c2Br)C(c2ccccc2)C1,CHEMBL669946,Ki,5.4,CHEMBL554009,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,0,86,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1,CHEMBL669945,Ki,7.11,CHEMBL543398,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,0,85,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1,CHEMBL669946,Ki,5.57,CHEMBL543398,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,0,86,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2c(sc3ncn(CCN4CCN(c5ccnc6ccccc56)CC4)c(=O)c23)C1,CHEMBL863370,Ki,8.84,CHEMBL198463,2005,CHEMBL1141234,Bioorg Med Chem Lett,Scientific Literature,Inhibitory activity against dopamine D2(long) receptor,40,614,O=c1c2c3c(sc2ncn1CCN1CCN(c2ccnc4ccccc24)CC1)CNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2c(sc3ncn(CCN4CCN(c5cncc6ccccc56)CC4)c(=O)c23)C1,CHEMBL863370,Ki,8.92,CHEMBL370110,2005,CHEMBL1141234,Bioorg Med Chem Lett,Scientific Literature,Inhibitory activity against dopamine D2(long) receptor,40,614,O=c1c2c3c(sc2ncn1CCN1CCN(c2cncc4ccccc24)CC1)CNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2c3c(cc4nc(N)sc24)-c2c(ccc(O)c2O)C[C@H]31,CHEMBL937845,Ki,6.48,CHEMBL520610,2008,CHEMBL1155028,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,59,615,c1ccc2c(c1)CC1NCCc3c1c-2cc1ncsc31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(-c3ccc(O)cc3)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL986942,Ki,8.42,CHEMBL517028,2008,CHEMBL1149860,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human cloned dopamine D2 receptor expressed in CHO cell membrane,59,616,c1ccc(-c2cc3c4c(c2)-c2ccccc2CC4NCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(-c3ccccc3)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL986942,Ki,7.06,CHEMBL465054,2008,CHEMBL1149860,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human cloned dopamine D2 receptor expressed in CHO cell membrane,59,616,c1ccc(-c2cc3c4c(c2)-c2ccccc2CC4NCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Br)c(NS(=O)(=O)c3ccc(-c4ccc(Cl)cc4)cc3)cc2CC1,CHEMBL905981,Ki,7.2,CHEMBL231546,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,52,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Br)c(O)cc2C(c2ccc(N)cc2)C1,CHEMBL671034,Ki,5.8,CHEMBL321042,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,366,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Br)c(O)cc2C(c2ccc(Nc3ccc([N+](=O)[O-])c4nonc34)cc2)C1,CHEMBL671034,Ki,6.15,CHEMBL322760,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,366,c1ccc2c(c1)CCNCC2c1ccc(Nc2cccc3nonc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Br)c(O)cc2C(c2ccccc2)C1,CHEMBL671033,Ki,5.87,CHEMBL324017,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,365,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(NS(=O)(=O)c3ccc(-c4ccc(Cl)cc4)cc3)cc2CC1,CHEMBL905981,Ki,7.4,CHEMBL231648,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,52,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(C)S(=O)(=O)c3ccccc3)cc2)C1,CHEMBL1073809,Ki,6.48,CHEMBL599487,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,69,102,O=S(=O)(NCc1ccc(C2CNCCc3ccccc32)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(C)S(C)(=O)=O)cc2)C1,CHEMBL1073809,Ki,5.22,CHEMBL603901,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(C3CCC3)S(C)(=O)=O)cc2)C1,CHEMBL1073809,Ki,5.7,CHEMBL599282,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc2c(c1)CCNCC2c1ccc(CNC2CCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(Cc3ccccc3)c3ccc(F)cc3F)cc2)C1,CHEMBL1073809,Ki,6.26,CHEMBL597702,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc(CN(Cc2ccc(C3CNCCc4ccccc43)cc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CNC3CCC3)cc2)C1,CHEMBL1073809,Ki,5.7,CHEMBL596622,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc2c(c1)CCNCC2c1ccc(CNC2CCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CNc3ccccc3)cc2)C1,CHEMBL1073809,Ki,5.7,CHEMBL604108,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc(NCc2ccc(C3CNCCc4ccccc43)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,CHEMBL1073809,Ki,6.0,CHEMBL62,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,CHEMBL4276601,IC50,7.51,CHEMBL62,2018,CHEMBL4270672,J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor long isoform (unknown origin) expressed in HEK293 cells assessed as inhibition of dopamine-induced calcium flux after 15 mins by calcium 4-dye based FLIPR assay,130,617,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,CHEMBL4339971,IC50,5.69,CHEMBL62,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,134,618,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,CHEMBL4709853,IC50,7.59,CHEMBL1814790,2020,CHEMBL4706549,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO-K1 cells assessed as inhibition of dopamine-induced calcium flux incubated for 60 mins at 37 degC followed by 15 mins incubation at room temperature and subsequent dopamine addition by calcium 4 dye based FLIPR assay,143,619,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1,CHEMBL670683,Ki,6.05,CHEMBL62,1989,CHEMBL1124647,J Med Chem,Scientific Literature,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,0,409,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H]1Cc1ccccc1,CHEMBL670683,Ki,6.84,CHEMBL64117,1989,CHEMBL1124647,J Med Chem,Scientific Literature,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,0,409,c1ccc(CC2NCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@@H]1c1ccccc1,CHEMBL670683,Ki,5.73,CHEMBL303993,1989,CHEMBL1124647,J Med Chem,Scientific Literature,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,0,409,c1ccc(C2NCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H](c2ccccc2)C1,CHEMBL672307,Ki,7.7,CHEMBL63321,1988,CHEMBL1123996,J Med Chem,Scientific Literature,Ability to partially antagonise [3H]-SCH- 23388 binding to the Dopamine receptor D2,0,620,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]1c1ccccc1,CHEMBL670683,Ki,4.72,CHEMBL293158,1989,CHEMBL1124647,J Med Chem,Scientific Literature,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,0,409,c1ccc(C2NCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cc(CN4CCCCC4)ccc3CC[C@@H]21,CHEMBL1073809,Ki,7.58,CHEMBL600998,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc2c(c1)CCNC1CCc3ccc(CN4CCCCC4)cc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cc(CN4CCN(c5ccccn5)CC4)ccc3CC[C@@H]21,CHEMBL1073809,Ki,8.89,CHEMBL601635,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc(N2CCN(Cc3ccc4c(c3)C3c5ccccc5CCNC3CC4)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccc(N)cc3CC[C@@H]21,CHEMBL1073809,Ki,5.27,CHEMBL598515,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccc(NC(=O)Nc4c(Cl)cccc4Cl)cc3CC[C@@H]21,CHEMBL1073809,Ki,5.96,CHEMBL599977,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,O=C(Nc1ccccc1)Nc1ccc2c(c1)CCC1NCCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccc(NS(C)(=O)=O)cc3CC[C@@H]21,CHEMBL1073809,Ki,5.52,CHEMBL597909,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cc(F)cc(F)c4)c3CC[C@@H]21,CHEMBL1074771,Ki,6.51,CHEMBL597100,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc(-c2cccc3c2CCC2NCCc4ccccc4C32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccc(CO)cc4)c3CC[C@@H]21,CHEMBL1074771,Ki,7.05,CHEMBL604176,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc(-c2cccc3c2CCC2NCCc4ccccc4C32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccc5[nH]ccc5c4)c3CC[C@@H]21,CHEMBL1074771,Ki,7.29,CHEMBL597503,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3c(-c4ccc5[nH]ccc5c4)cccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc(C#N)c4)c3CC[C@@H]21,CHEMBL1074771,Ki,6.23,CHEMBL598105,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc(-c2cccc3c2CCC2NCCc4ccccc4C32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc(F)c4)c3CC[C@@H]21,CHEMBL1074771,Ki,6.65,CHEMBL598104,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc(-c2cccc3c2CCC2NCCc4ccccc4C32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc(OC(F)(F)F)c4)c3CC[C@H]21,CHEMBL1074771,Ki,5.79,CHEMBL604383,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc(-c2cccc3c2CCC2NCCc4ccccc4C32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc([N+](=O)[O-])c4)c3CC[C@@H]21,CHEMBL1074771,Ki,6.21,CHEMBL605339,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc(-c2cccc3c2CCC2NCCc4ccccc4C32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccccc4)c3CC[C@@H]21,CHEMBL1074771,Ki,7.1,CHEMBL599528,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc(-c2cccc3c2CCC2NCCc4ccccc4C32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccs4)c3CC[C@@H]21,CHEMBL1074771,Ki,7.03,CHEMBL597900,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1csc(-c2cccc3c2CCC2NCCc4ccccc4C32)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccncc4)c3CC[C@@H]21,CHEMBL1074771,Ki,6.12,CHEMBL605127,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3c(-c4ccncc4)cccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(/C=N/O)c3CC[C@@H]21,CHEMBL1074771,Ki,6.05,CHEMBL604732,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(/C=N/OCc4ccccc4)c3CC[C@@H]21,CHEMBL1074771,Ki,7.16,CHEMBL599135,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,C(=NOCc1ccccc1)c1cccc2c1CCC1NCCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(/C=N/Oc4ccccc4)c3CC[C@@H]21,CHEMBL1074771,Ki,6.91,CHEMBL605354,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,C(=NOc1ccccc1)c1cccc2c1CCC1NCCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(Br)c3CC[C@@H]21,CHEMBL1074771,Ki,5.77,CHEMBL600083,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(C#N)c3CC[C@@H]21,CHEMBL1074771,Ki,5.88,CHEMBL604127,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(C(=O)O)c3CC[C@@H]21,CHEMBL1074771,Ki,6.38,CHEMBL598915,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(C=O)c3CC[C@@H]21,CHEMBL1074771,Ki,5.86,CHEMBL604316,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(CO)c3CC[C@@H]21,CHEMBL1074771,Ki,5.78,CHEMBL599116,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(N)c3CC[C@@H]21,CHEMBL1073809,Ki,5.68,CHEMBL591685,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(N4CCCC4=O)c3CC[C@@H]21,CHEMBL1074771,Ki,5.86,CHEMBL598949,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,O=C1CCCN1c1cccc2c1CCC1NCCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(NC(=O)C4CC4)c3CC[C@@H]21,CHEMBL1073809,Ki,5.67,CHEMBL602659,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,O=C(Nc1cccc2c1CCC1NCCc3ccccc3C21)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(NC(=O)Nc4c(Cl)cccc4Cl)c3CC[C@@H]21,CHEMBL1073809,Ki,6.25,CHEMBL604129,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,O=C(Nc1ccccc1)Nc1cccc2c1CCC1NCCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(NS(C)(=O)=O)c3CC[C@@H]21,CHEMBL1073809,Ki,6.0,CHEMBL604135,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(O)c3CC[C@@H]21,CHEMBL1074771,Ki,6.36,CHEMBL604314,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21,CHEMBL1073809,Ki,6.01,CHEMBL298406,2010,CHEMBL1156835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,70,102,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21,CHEMBL1074771,Ki,6.01,CHEMBL298406,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21,CHEMBL4671577,Ki,5.91,CHEMBL298406,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,143,488,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(O)c(O)c3c2C1Cc1ccccc1-3,CHEMBL4344297,Ki,6.47,CHEMBL2414991,2020,CHEMBL4342460,J Nat Prod,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO-K1 cells by radioligand competitive binding analysis,143,621,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(O)c(O)c3c2C1Cc1ccccc1-3,CHEMBL5231713,Ki,7.41,CHEMBL2414991,2020,CHEMBL5230125,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from D2DR (unknown origin),143,76,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(O)c(O)cc2C(c2ccccc2)C1,CHEMBL872494,Ki,5.72,CHEMBL545000,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,0,622,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(O)c(O)cc2C1Cc1ccc(O)c(O)c1,CHEMBL670395,Ki,5.72,CHEMBL19844,1997,CHEMBL1129926,Bioorg Med Chem Lett,Scientific Literature,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,10,153,c1ccc(CC2NCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(O)c(O)cc2C1Cc1ccccc1Br,CHEMBL4344297,Ki,6.54,CHEMBL4591554,2020,CHEMBL4342460,J Nat Prod,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO-K1 cells by radioligand competitive binding analysis,143,621,c1ccc(CC2NCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(O)ccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL885887,Ki,7.13,CHEMBL245571,2007,CHEMBL1139077,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,52,623,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(O)ccc2Cc2ccc(O)cc2CC1,CHEMBL861435,Ki,7.23,CHEMBL381936,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,46,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc(O)ccc2Cc2ccc(O)cc2CC1,CHEMBL861441,Ki,7.72,CHEMBL381936,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,46,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc3c(c4c2[C@H]1Cc1ccccc1-4)OCO3,CHEMBL5371295,IC50,4.73,CHEMBL483825,2023,CHEMBL5370537,Eur J Med Chem,Scientific Literature,Antagonist activity at D2R (unknown origin),156,626,c1ccc2c(c1)CC1NCCc3cc4c(c-2c31)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc3nc(N)sc3cc2CC1,CHEMBL2328744,IC50,5.85,CHEMBL2326488,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,89,466,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cc3nc(N)sc3cc2CC1,CHEMBL2328745,Ki,5.82,CHEMBL2326488,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,89,467,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc(CO)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL2399862,Ki,7.37,CHEMBL2397382,2013,CHEMBL2396540,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,89,542,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc(Cc3ccc(O)c4ccccc34)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL2399862,Ki,6.77,CHEMBL2397385,2013,CHEMBL2396540,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,89,542,c1ccc2c(c1)CC1NCCc3ccc(Cc4cccc5ccccc45)c-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc(Cc3ccc(O)cc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL2399862,Ki,7.33,CHEMBL2397383,2013,CHEMBL2396540,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,89,542,c1ccc(Cc2ccc3c4c2-c2ccccc2CC4NCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc(Cc3ccccc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL2399862,Ki,7.11,CHEMBL2397381,2013,CHEMBL2396540,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,89,542,c1ccc(Cc2ccc3c4c2-c2ccccc2CC4NCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc(NS(=O)(=O)c3ccc(-c4ccc(C#N)cc4)cc3)cc2CC1,CHEMBL905981,Ki,6.3,CHEMBL231640,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,52,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc(NS(=O)(=O)c3ccc(-c4ccc(Cl)cc4)cc3)cc2CC1,CHEMBL905981,Ki,6.8,CHEMBL231430,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,52,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc(NS(=O)(=O)c3ccc(-c4ccc(Cl)cc4)s3)cc2CC1,CHEMBL905981,Ki,6.4,CHEMBL388674,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,52,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc(NS(=O)(=O)c3ccc(-c4ccc(F)c(Cl)c4)cc3)cc2CC1,CHEMBL905981,Ki,7.3,CHEMBL231431,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,52,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc(OCCCN3CCC(c4noc5cc(F)ccc45)CC3)cc2C1=O,CHEMBL4709853,IC50,8.2,CHEMBL4764679,2020,CHEMBL4706549,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO-K1 cells assessed as inhibition of dopamine-induced calcium flux incubated for 60 mins at 37 degC followed by 15 mins incubation at room temperature and subsequent dopamine addition by calcium 4 dye based FLIPR assay,143,619,O=C1NCCc2ccc(OCCCN3CCC(c4noc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3[nH]c(=O)c4cccc5c4c3c2[C@H]1C5,CHEMBL670883,Ki,5.21,CHEMBL253318,2001,CHEMBL1134169,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,25,627,O=c1[nH]c2ccc3c4c2c2c(cccc12)CC4NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c(=O)[nH]c4cccc5c4c3c2[C@H]1C5,CHEMBL670883,Ki,7.26,CHEMBL253319,2001,CHEMBL1134169,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,25,627,O=c1[nH]c2cccc3c2c2c4c(ccc12)CCNC4C3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c(=O)oc4cccc5c4c3c2[C@H]1C5,CHEMBL670883,Ki,6.27,CHEMBL122485,2001,CHEMBL1134169,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,25,627,O=c1oc2cccc3c2c2c4c(ccc12)CCNC4C3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)C3,CHEMBL664743,Ki,7.08,CHEMBL284586,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,22,335,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)C3,CHEMBL670883,Ki,7.08,CHEMBL284586,2001,CHEMBL1134169,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,25,627,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)C3=O,CHEMBL670677,Ki,6.5,CHEMBL26471,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,22,110,O=C1c2cccc3c2-c2c1ccc1c2C(C3)NCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N,CHEMBL670677,Ki,5.65,CHEMBL27251,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,22,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N,CHEMBL672309,Ki,5.65,CHEMBL27251,2003,CHEMBL1145819,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2,33,628,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3N,CHEMBL673593,Ki,5.65,CHEMBL27251,2001,CHEMBL1134402,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,25,247,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@H]3O,CHEMBL670677,Ki,6.67,CHEMBL285352,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,22,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@@]3(C)O,CHEMBL670677,Ki,6.74,CHEMBL27309,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,22,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@H]3N,CHEMBL670677,Ki,6.58,CHEMBL281048,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,22,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@H]3N,CHEMBL672309,Ki,6.58,CHEMBL281048,2003,CHEMBL1145819,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2,33,628,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@H]3O,CHEMBL670677,Ki,7.62,CHEMBL26751,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,22,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3c4c2[C@H]1Cc1cccc(c1-4)[C@]3(C)O,CHEMBL670677,Ki,7.58,CHEMBL417473,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,22,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3cnc4cccc5c4c3c2[C@H]1C5,CHEMBL670883,Ki,5.88,CHEMBL120927,2001,CHEMBL1134169,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,25,627,c1cc2c3c(c1)ncc1ccc4c(c13)C(C2)NCC4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3ncc4cccc5c4c3c2[C@H]1C5,CHEMBL670883,Ki,6.49,CHEMBL122453,2001,CHEMBL1134169,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,25,627,c1cc2c3c(c1)cnc1ccc4c(c13)C(C2)NCC4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccc3oc(=O)c4cccc5c4c3c2[C@H]1C5,CHEMBL670883,Ki,6.58,CHEMBL124419,2001,CHEMBL1134169,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,25,627,O=c1oc2ccc3c4c2c2c(cccc12)CC4NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2C1Cc1ccc(N)cc1-3,CHEMBL4628381,Ki,6.17,CHEMBL4634039,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,143,31,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2C1Cc1ccc2nc(N)sc2c1-3,CHEMBL4625526,Ki,5.76,CHEMBL4641502,2020,CHEMBL4622954,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-Methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells incubated for 90 mins by microbeta counting method,143,629,c1cc2c3c(c1)-c1c(ccc4ncsc14)CC3NCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL1066831,Ki,6.61,CHEMBL53,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,70,380,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL1066832,Ki,9.21,CHEMBL53,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,70,381,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL2066740,Ki,7.3,CHEMBL53,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,82,442,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL2399862,Ki,7.28,CHEMBL53,2013,CHEMBL2396540,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,89,542,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL3136959,IC50,6.93,CHEMBL53,2013,CHEMBL3132795,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,89,630,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL3413550,IC50,8.38,CHEMBL53,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Agonist activity at human dopamine D2 receptor expressed in CHOK1 cells assessed as calcium mobilization by radiometric and luminescence plate counting method,109,631,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL4368000,Ki,7.38,CHEMBL53,2019,CHEMBL4364313,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,134,528,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL4401065,Ki,7.38,CHEMBL53,2019,CHEMBL4400523,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,134,529,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL4628391,Ki,7.09,CHEMBL53,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpride from human D2 receptor expressed in CHO cells incubated for 40 mins by radio ligand binding assay,143,632,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL664743,Ki,7.38,CHEMBL53,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,22,335,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL670676,Ki,7.38,CHEMBL53,1995,CHEMBL1128704,J Med Chem,Scientific Literature,Ability to displace [3H]raclopride binding to cloned human Dopamine receptor D2A,5,633,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL670741,Ki,7.58,CHEMBL53,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled D2 sites in cloned CHO cells",2,634,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL670742,Ki,7.58,CHEMBL53,1993,CHEMBL1126639,J Med Chem,Scientific Literature,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled D2 sites in cloned CHO cells",2,531,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL670880,Ki,7.38,CHEMBL53,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,8,99,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL670883,Ki,7.38,CHEMBL53,2001,CHEMBL1134169,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand.,25,627,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL670885,Ki,7.38,CHEMBL53,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,8,135,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL673248,Ki,7.55,CHEMBL53,1994,CHEMBL1127372,J Med Chem,Scientific Literature,Tested for binding affinity towards human D2L receptor using [3H]spiperone as radioligand,4,65,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL673593,Ki,7.38,CHEMBL53,2001,CHEMBL1134402,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,25,247,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL910434,Ki,8.44,CHEMBL53,2006,CHEMBL1137302,J Med Chem,Scientific Literature,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,46,635,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL937845,Ki,7.01,CHEMBL53,2008,CHEMBL1155028,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,59,615,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3,CHEMBL986942,Ki,7.5,CHEMBL53,2008,CHEMBL1149860,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human cloned dopamine D2 receptor expressed in CHO cell membrane,59,616,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,CHEMBL3136959,IC50,5.36,CHEMBL3134064,2013,CHEMBL3132795,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,89,630,O=C(CCC(=O)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,CHEMBL3136959,IC50,5.27,CHEMBL3134065,2013,CHEMBL3132795,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,89,630,O=C(CCCCC(=O)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,CHEMBL3136959,IC50,5.44,CHEMBL3134066,2013,CHEMBL3132795,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,89,630,O=C(CCCCCCC(=O)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,CHEMBL3136959,IC50,5.87,CHEMBL3134067,2013,CHEMBL3132795,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,89,630,O=C(CCCCCCCCC(=O)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,CHEMBL3136959,IC50,6.74,CHEMBL3134068,2013,CHEMBL3132795,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,89,630,O=C(CCCCCCCCCCC(=O)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,CHEMBL3136959,IC50,5.57,CHEMBL3134070,2013,CHEMBL3132795,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,89,630,O=C(CCCCCCCCCCCCCCCCC(=O)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCCCCCCCCCCCCCCC(=O)NCCCOc2ccc4c(c2O)-c2cccc5c2[C@@H](C4)N(C)CC5)c(O)c1-3,CHEMBL3136959,IC50,5.81,CHEMBL3134071,2013,CHEMBL3132795,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,89,630,O=C(CCCCCCCCCCCCCCCCCCC(=O)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3)NCCCOc1ccc2c(c1)-c1cccc3c1C(C2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccc(OCCCNC(=O)CCCCCNC(=O)OC(C)(C)C)c(O)c1-3,CHEMBL3136959,IC50,5.18,CHEMBL3134063,2013,CHEMBL3132795,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting,89,630,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1cccc(-c2c(OS(=O)(=O)C(F)(F)F)cccc2OS(=O)(=O)C(F)(F)F)c1-3,CHEMBL673593,Ki,5.65,CHEMBL282413,2001,CHEMBL1134402,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,25,247,c1ccc(-c2cccc3c2-c2cccc4c2C(C3)NCC4)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1cccc(-c2ccccc2)c1-3,CHEMBL670880,Ki,6.63,CHEMBL25924,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,8,99,c1ccc(-c2cccc3c2-c2cccc4c2C(C3)NCC4)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1cccc(-c2ccccc2)c1-3,CHEMBL673593,Ki,6.63,CHEMBL25924,2001,CHEMBL1134402,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,25,247,c1ccc(-c2cccc3c2-c2cccc4c2C(C3)NCC4)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1cccc(C#N)c1-3,CHEMBL670880,Ki,6.74,CHEMBL115969,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,8,99,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3,CHEMBL1065707,Ki,6.68,CHEMBL119455,2010,CHEMBL1159064,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,70,413,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3,CHEMBL670676,Ki,7.23,CHEMBL119455,1995,CHEMBL1128704,J Med Chem,Scientific Literature,Ability to displace [3H]raclopride binding to cloned human Dopamine receptor D2A,5,633,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3,CHEMBL670880,Ki,7.23,CHEMBL119455,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,8,99,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3,CHEMBL670885,Ki,7.23,CHEMBL119455,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,8,135,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1cccc(OS(=O)(=O)C(F)(F)F)c1-3,CHEMBL670880,Ki,6.71,CHEMBL333836,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,8,99,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccccc1-3,CHEMBL664743,Ki,6.28,CHEMBL281357,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,22,335,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccccc1-3,CHEMBL670880,Ki,6.28,CHEMBL281357,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,8,99,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2cccc3c2[C@H]1Cc1ccccc1-3,CHEMBL673593,Ki,6.28,CHEMBL281357,2001,CHEMBL1134402,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,25,247,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2[nH]c3ccc(O)cc3c2CC1,CHEMBL885887,Ki,7.42,CHEMBL245570,2007,CHEMBL1139077,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,52,623,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2[nH]c3ccc(O)cc3c2CC1,CHEMBL982103,Ki,7.36,CHEMBL245570,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,59,470,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL3757879,Ki,7.35,CHEMBL441618,2015,CHEMBL3751719,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,109,636,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL861435,Ki,7.35,CHEMBL441618,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,46,624,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL861441,Ki,7.72,CHEMBL441618,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,46,625,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL885887,Ki,7.35,CHEMBL441618,2007,CHEMBL1139077,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,52,623,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL908321,Ki,7.35,CHEMBL441618,2006,CHEMBL1137400,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L dopamine receptor expressed in CHO cells,46,561,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL912405,Ki,7.72,CHEMBL441618,2006,CHEMBL1137400,J Med Chem,Scientific Literature,Activity at human D2L dopamine receptor expressed in HEK293 cells by calcium fluorescence assay,46,562,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1,CHEMBL982103,Ki,7.38,CHEMBL441618,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,59,470,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2[nH]c3ccccc3c2C[C@@H]1CO,CHEMBL1954777,Ki,6.57,CHEMBL1949728,2011,CHEMBL1949524,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in human HEK293 cells,77,637,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2[nH]c3ccccc3c2C[C@H]1CO,CHEMBL1954777,Ki,5.53,CHEMBL1949729,2011,CHEMBL1949524,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in human HEK293 cells,77,637,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2c(O)cccc2CC1,CHEMBL861435,Ki,7.08,CHEMBL203689,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,46,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2c(O)cccc2CC1,CHEMBL861441,Ki,8.1,CHEMBL203689,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,46,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2c([nH]c3ccccc23)CC1,CHEMBL1105125,Ki,7.26,CHEMBL1087301,2010,CHEMBL1155427,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,70,638,c1ccc2c(c1)CCNCCc1[nH]c3ccccc3c1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2c(ccc(O)c2Cl)CC1,CHEMBL861435,Ki,9.0,CHEMBL380464,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,46,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2c(ccc(O)c2Cl)CC1,CHEMBL861441,Ki,9.89,CHEMBL380464,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,46,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2c[nH]c3cccc(c23)CC1,CHEMBL1105125,Ki,8.4,CHEMBL1087300,2010,CHEMBL1155427,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,70,638,c1ccc2c(c1)CCNCCc1cccc3[nH]cc(c13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2cc(Cl)c(O)c(Cl)c2CC1,CHEMBL861435,Ki,7.06,CHEMBL383451,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,46,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2cc(Cl)c(O)c(Cl)c2CC1,CHEMBL861441,Ki,7.43,CHEMBL383451,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,46,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2cc(N)c(O)cc2CC1,CHEMBL861435,Ki,7.43,CHEMBL204098,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,46,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2cc(N)c(O)cc2CC1,CHEMBL861441,Ki,7.58,CHEMBL204098,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,46,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2cc(O)c(Cl)cc2CC1,CHEMBL861435,Ki,8.7,CHEMBL203047,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,46,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2cc(O)c(Cl)cc2CC1,CHEMBL861441,Ki,8.32,CHEMBL203047,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,46,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2cc(O)c(O)cc2CC1,CHEMBL859832,Ki,7.18,CHEMBL1202298,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,46,468,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2cc(O)ccc2CC1,CHEMBL861435,Ki,7.43,CHEMBL382010,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,46,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2cc(O)ccc2CC1,CHEMBL861441,Ki,7.72,CHEMBL382010,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,46,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccc(O)c(Cl)c2CC1,CHEMBL861435,Ki,8.4,CHEMBL203637,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,46,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccc(O)c(Cl)c2CC1,CHEMBL861441,Ki,8.21,CHEMBL203637,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,46,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccc(O)c(Cl)c2CC1,CHEMBL982103,Ki,8.45,CHEMBL203637,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,59,470,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccc(O)cc2CC1,CHEMBL1038853,Ki,7.76,CHEMBL201170,2009,CHEMBL1152600,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,63,639,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccc(O)cc2CC1,CHEMBL3757879,Ki,7.35,CHEMBL201170,2015,CHEMBL3751719,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,109,636,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccc(O)cc2CC1,CHEMBL859832,Ki,7.47,CHEMBL1204122,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,46,468,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccc(O)cc2CC1,CHEMBL859835,Ki,7.76,CHEMBL1204122,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,46,469,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccc(O)cc2CC1,CHEMBL861435,Ki,7.76,CHEMBL201170,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,46,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccc(O)cc2CC1,CHEMBL861441,Ki,7.47,CHEMBL201170,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,46,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccc(O)cc2CC1,CHEMBL885887,Ki,7.76,CHEMBL201170,2007,CHEMBL1139077,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,52,623,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccc(O)cc2CC1,CHEMBL982103,Ki,7.76,CHEMBL201170,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,59,470,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccccc2CC1,CHEMBL3757879,Ki,7.25,CHEMBL201525,2015,CHEMBL3751719,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,109,636,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccccc2CC1,CHEMBL859832,Ki,8.07,CHEMBL201525,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,46,468,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccccc2CC1,CHEMBL859835,Ki,7.25,CHEMBL201525,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,46,469,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccccc2CC1,CHEMBL885887,Ki,7.25,CHEMBL201525,2007,CHEMBL1139077,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,52,623,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccccc2CC1,CHEMBL982103,Ki,7.23,CHEMBL201525,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,59,470,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccn(C)c2CC1,CHEMBL859832,Ki,6.58,CHEMBL201483,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,46,468,c1ccc2c(c1)CCNCCc1[nH]ccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccn(C)c2CC1,CHEMBL859835,Ki,6.15,CHEMBL201483,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,46,469,c1ccc2c(c1)CCNCCc1[nH]ccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccsc2CC1,CHEMBL3757879,Ki,6.72,CHEMBL201093,2015,CHEMBL3751719,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,109,636,c1ccc2c(c1)CCNCCc1sccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccsc2CC1,CHEMBL859832,Ki,7.04,CHEMBL201093,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,46,468,c1ccc2c(c1)CCNCCc1sccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2ccsc2CC1,CHEMBL859835,Ki,6.7,CHEMBL201093,2006,CHEMBL1147728,J Med Chem,Scientific Literature,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by radioligand binding assay,46,469,c1ccc2c(c1)CCNCCc1sccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2sc3ccccc3c2CC1,CHEMBL3757879,Ki,8.82,CHEMBL3753266,2015,CHEMBL3751719,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,109,636,c1ccc2c(c1)CCNCCc1c(sc3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CCc2ccccc2Cc2sccc2CC1,CHEMBL3757879,Ki,7.35,CHEMBL3752512,2015,CHEMBL3751719,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 dopamine receptor incubated for 90 mins by radioligand binding assay,109,636,c1ccc2c(c1)CCNCCc1ccsc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CN(c2ccccc2)C2(CCN(CCCC(=O)c3ccc(F)cc3)CC2)C1=O,CHEMBL3270692,Ki,9.88,CHEMBL267932,2014,CHEMBL3259695,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,99,152,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CN(c2ccccc2)C2(CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)C1=O,CHEMBL1815674,Ki,6.21,CHEMBL1813589,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,77,640,O=C1CCc2ccc(OCCCCN3CCC4(CC3)C(=O)NCN4c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CN(c2ccccc2)C2(CCN(Cc3coc4ccccc34)CC2)C1=O,CHEMBL1176478,Ki,8.15,CHEMBL1169896,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,70,641,O=C1NCN(c2ccccc2)C12CCN(Cc1coc3ccccc13)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1CN(c2ccccc2)C2(CCN(Cc3csc4ccccc34)CC2)C1=O,CHEMBL1176478,Ki,7.15,CHEMBL1169728,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,70,641,O=C1NCN(c2ccccc2)C12CCN(Cc1csc3ccccc13)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C[C@@H](NC(=O)C(C)(C)C)CC2c3cccc4[nH]c(Cl)c(c34)C[C@H]21,CHEMBL673016,Ki,8.44,CHEMBL25074,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",2,77,c1cc2c3c(c[nH]c3c1)CC1NCCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21,CHEMBL5442215,Ki,7.21,CHEMBL1200517,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=C(NC1OC2C3CCCN3C(=O)C(Cc3ccccc3)N2C1=O)C1CNC2Cc3c[nH]c4cccc(c34)C2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1C[C@H](C(N)=O)C=C2c3cccc4[nH]c(Br)c(c34)C[C@H]21,CHEMBL672210,Ki,8.7,CHEMBL609151,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,14,87,C1=C2c3cccc4[nH]cc(c34)CC2NCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN1Cc2cc(Cl)c(O)cc2[C@H](c2ccccc2)C1,CHEMBL670683,Ki,6.58,CHEMBL302393,1989,CHEMBL1124647,J Med Chem,Scientific Literature,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,0,409,c1ccc(C2CNCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)CN1CN(c2ccccc2)C2(CCN(Cc3cc4c(cc3Cl)OCO4)CC2)C1=O,CHEMBL671072,IC50,5.67,CHEMBL115222,2001,CHEMBL1134625,J Med Chem,Scientific Literature,Inhibition of human dopamine receptor D2,25,486,O=C1NCN(c2ccccc2)C12CCN(Cc1ccc3c(c1)OCO3)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5381008,Ki,8.92,CHEMBL5433284,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(C(=O)N[C@H]2[C@@H]3COC[C@@H]32)cc2c1O[C@H](CF)[C@H]2c1ccccc1,CHEMBL4880035,Ki,6.05,CHEMBL4637208,2021,CHEMBL4630902,,SGC Frankfurt - Donated Chemical Probes,GPCRScan assay: inhibition of D2,148,144,O=C(NC1C2COCC21)c1ccc2c(c1)C(c1ccccc1)CO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(C)cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL3806800,IC50,7.05,CHEMBL3806047,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(F)cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL3806800,IC50,5.8,CHEMBL3805262,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1F,CHEMBL3806800,IC50,7.64,CHEMBL3805518,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCC(c3noc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,CHEMBL4187998,IC50,7.22,CHEMBL4210030,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc2c(C3CCN(CCCCOc4ccncc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(C(C)=O)c1,CHEMBL3806800,IC50,7.42,CHEMBL3805434,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1C,CHEMBL3806800,IC50,8.01,CHEMBL3805120,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1Cl,CHEMBL3806800,IC50,7.46,CHEMBL3806224,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc1F,CHEMBL3806800,IC50,7.41,CHEMBL3805884,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccn1,CHEMBL4187998,IC50,7.58,CHEMBL4214528,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc(N2CCN(CCCCOc3ccncc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCN(c3cccc4c3OC(F)(F)O4)CC2)ccc1F,CHEMBL3806800,IC50,7.52,CHEMBL3804965,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3cccc4c3OCO4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sc(F)cc34)CC2)ccn1,CHEMBL4187998,IC50,8.1,CHEMBL4217182,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1cc(N2CCN(CCCCOc3ccncc3)CC2)c2ccsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccc1F,CHEMBL3806800,IC50,7.37,CHEMBL3805649,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3cccc4sccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCN(c3cccc4sccc34)CC2)ccn1,CHEMBL4187998,IC50,7.62,CHEMBL4209188,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1cc(N2CCN(CCCCOc3ccncc3)CC2)c2ccsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccc1F,CHEMBL3806800,IC50,7.92,CHEMBL3805099,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3nsc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,CHEMBL4187998,IC50,7.94,CHEMBL4213342,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc2c(N3CCN(CCCCOc4ccncc4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1ccc(-c2ccc(C(=O)NCCCCN3CCc4ccc(OS(=O)(=O)C(F)(F)F)cc4C3)cc2)cc1,CHEMBL672227,Ki,7.0,CHEMBL54777,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,17,131,O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1ccc(Cl)c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL3806800,IC50,7.23,CHEMBL3805327,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1ccc(OC)c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL3806800,IC50,7.92,CHEMBL3804943,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1ccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL3806800,IC50,7.16,CHEMBL3805376,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1ccc2c(c1)CCO[C@@H]2CCN1CCN(c2ccc(OC)cc2)CC1,CHEMBL672208,Ki,6.8,CHEMBL71798,1998,CHEMBL1131250,J Med Chem,Scientific Literature,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes.,14,642,c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1ccc2c(c1)CCO[C@H]2CCN1CCN(c2ccc(OC)cc2)CC1,CHEMBL5113786,Ki,6.62,CHEMBL71838,2021,CHEMBL5113374,Eur J Med Chem,Scientific Literature,Displacement of PNU-86170 from human dopamine D2 receptor expressed in CHO cell membrane incubated for 1 hr by competitive radioligand binding assay based,148,643,c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1ccc2c(c1)CCO[C@H]2CCN1CCN(c2ccc(OC)cc2)CC1,CHEMBL672208,Ki,6.62,CHEMBL71838,1998,CHEMBL1131250,J Med Chem,Scientific Literature,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes.,14,642,c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(-c2ccc(C(=O)NCCCCN3CCc4ccc(OS(=O)(=O)C(F)(F)F)cc4C3)cc2)c1,CHEMBL672227,Ki,6.9,CHEMBL52724,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,17,131,O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,CHEMBL3806800,IC50,8.07,CHEMBL3805559,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCC(c3noc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)n1,CHEMBL4187998,IC50,8.03,CHEMBL4205772,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc(OCCCCN2CCC(c3noc4ccccc34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCN(c3ccc4ccsc4c3)CC2)n1,CHEMBL4187998,IC50,6.38,CHEMBL4211473,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc(OCCCCN2CCN(c3ccc4ccsc4c3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL3806800,IC50,7.5,CHEMBL3805077,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1C,CHEMBL3806800,IC50,5.44,CHEMBL3806091,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1F,CHEMBL3806800,IC50,6.77,CHEMBL3805046,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1OC,CHEMBL3806800,IC50,6.7,CHEMBL3805515,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)n1,CHEMBL4187998,IC50,7.29,CHEMBL4207328,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc(N2CCN(CCCCOc3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4c3OC(F)(F)O4)CC2)c1,CHEMBL3806800,IC50,8.39,CHEMBL3805165,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3cccc4c3OCO4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4sccc34)CC2)c1,CHEMBL3806800,IC50,7.04,CHEMBL3805704,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3cccc4sccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCN(c3cccc4sccc34)CC2)n1,CHEMBL4187998,IC50,7.07,CHEMBL4202443,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc(OCCCCN2CCN(c3cccc4sccc34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)n1,CHEMBL4187998,IC50,7.94,CHEMBL4214642,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc(OCCCCN2CCN(c3nsc4ccccc34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cccc(OCCCCN2CCN(c3nsc4ccccc34)CC2)c1,CHEMBL3806800,IC50,8.0,CHEMBL3805860,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3nsc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1ccccc1OCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL3806800,IC50,6.78,CHEMBL3804954,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,116,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,CHEMBL4187998,IC50,6.52,CHEMBL4204832,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc(OCCCCN2CCC(c3noc4ccccc34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1ccnc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)c1,CHEMBL4187998,IC50,7.05,CHEMBL4215048,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1ccc(OCCCCN2CCN(c3nsc4ccccc34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,CHEMBL4187998,IC50,6.91,CHEMBL4213586,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1cncc(OCCCCN2CCC(c3noc4ccccc34)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC(=O)c1cncc(OCCCCN2CCN(c3nsc4cc(F)ccc34)CC2)c1,CHEMBL4187998,IC50,7.07,CHEMBL4205326,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,130,471,c1cncc(OCCCCN2CCN(c3nsc4ccccc34)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC1CCc2c(cccc2OC)C1,CHEMBL670536,Ki,6.88,CHEMBL135048,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,8,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNCC1CC2c3ccccc3Cc3ccccc3N2O1,CHEMBL857158,IC50,5.77,CHEMBL81485,2002,CHEMBL1135380,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for human cloned Dopamine receptor D2L,29,522,c1ccc2c(c1)Cc1ccccc1N1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNCC1Cc2cc3ccn(S(=O)(=O)c4cccc5ccccc45)c3cc21,CHEMBL3872136,Ki,5.6,CHEMBL3961596,2017,CHEMBL3871306,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,124,119,O=S(=O)(c1cccc2ccccc12)n1ccc2cc3c(cc21)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNCC1Cc2ccc3c(ccn3S(=O)(=O)c3cccc4ccccc34)c21,CHEMBL3872136,Ki,6.0,CHEMBL3948819,2017,CHEMBL3871306,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,124,119,O=S(=O)(c1cccc2ccccc12)n1ccc2c3c(ccc21)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNCC1Cc2ccc3c(ccn3S(=O)(=O)c3ccccc3)c21,CHEMBL3872136,Ki,5.7,CHEMBL3929918,2017,CHEMBL3871306,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,124,119,O=S(=O)(c1ccccc1)n1ccc2c3c(ccc21)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNCCCC12CCC(c3ccccc31)c1ccccc12,CHEMBL1030600,Ki,6.18,CHEMBL21731,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,63,518,c1ccc2c(c1)C1CCC2c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC[C@@H]1OCCc2ccsc21,CHEMBL5233300,IC50,4.62,CHEMBL4650337,2021,CHEMBL5233201,RSC Med Chem,Scientific Literature,Agonist activity at D2 (unknown origin) by beta-arrestin recruitment assay,148,644,c1cc2c(s1)COCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNC[C@H](O)c1ccc(O)c(O)c1,CHEMBL3801477,Ki,6.04,CHEMBL679,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,116,196,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,CHEMBL4880035,Ki,5.665,CHEMBL4520788,2021,CHEMBL4507273,,SGC Frankfurt - Donated Chemical Probes,GPCRScan assay: inhibition of D2,148,144,c1ccc(-c2csc(CNc3ncnc4ccccc34)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1,CHEMBL5213955,Ki,5.63,CHEMBL4520788,2023,CHEMBL5212743,,EUbOPEN Chemogenomic Library Literature Data,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000743a DRD2,156,645,c1ccc(-c2csc(CNc3ncnc4ccccc34)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1,CHEMBL5442215,Ki,6.16,CHEMBL2138684,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,c1ccc2c3c([nH]c2c1)CCCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cc(C#N)cc3[nH]c(=O)n(c23)C1,CHEMBL3801665,Ki,5.29,CHEMBL3798018,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,116,292,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801662,Ki,4.79,CHEMBL419792,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,116,291,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801665,Ki,7.77,CHEMBL419792,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,116,292,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL4011211,Ki,7.33,CHEMBL419792,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL5228992,Ki,7.09,CHEMBL419792,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,148,372,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL5228996,Ki,4.79,CHEMBL419792,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,148,543,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL672313,Ki,8.05,CHEMBL419792,1997,CHEMBL1130416,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,11,190,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOCCCCc2ccccc2)C1,CHEMBL4011211,Ki,6.91,CHEMBL4086953,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=c1n(CCCCCCCCCCCCOCCCCc2ccccc2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCCCOc2ccc3c(c2)NC(=O)CC3)C1,CHEMBL4011211,Ki,6.55,CHEMBL4100734,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=C1CCc2ccc(OCCCCCCCCCCCCn3c(=O)n4c5c(cccc53)CCC4)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1,CHEMBL4011211,Ki,7.62,CHEMBL4076129,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=c1n(CCCCCCCCCCOCCCCc2ccccc2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1,CHEMBL4011224,IC50,5.35,CHEMBL4076129,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,124,340,O=c1n(CCCCCCCCCCOCCCCc2ccccc2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCCCOCCCCc2ccccc2)C1,CHEMBL4011228,IC50,6.1,CHEMBL4076129,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells coexpressing renilla luciferase-fused GalphaoA/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced GalphaoA activation by BRET assay,124,341,O=c1n(CCCCCCCCCCOCCCCc2ccccc2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCCCOCCCCc2ccccc2)C1,CHEMBL4011211,Ki,7.41,CHEMBL4097572,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=c1n(CCCCCCCCOCCCCc2ccccc2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCCCOCCCCc2ccccc2)C1,CHEMBL4011211,Ki,7.22,CHEMBL4071243,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=c1n(CCCCCCOCCCCc2ccccc2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOCCCCc2ccccc2)C1,CHEMBL4011211,Ki,6.92,CHEMBL4060603,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=c1n(CCCCOCCCCc2ccccc2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1,CHEMBL4011211,Ki,6.47,CHEMBL4077430,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=C1CCc2ccc(OCCCCn3c(=O)n4c5c(cccc53)CCC4)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCCCOc2ccc3c(c2)NC(=O)CC3)C1,CHEMBL4011224,IC50,5.39,CHEMBL4077430,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in forskolin stimulated-HEK293 cells coexpressing renilla luciferase-fused Galphai1/GFP10-fused Ggamma2 assessed as inhibition of quinpirole-induced Galphai1 activation by BRET assay,124,340,O=C1CCc2ccc(OCCCCn3c(=O)n4c5c(cccc53)CCC4)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCCCc2ccccc2)C1,CHEMBL4011211,Ki,6.96,CHEMBL4100322,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=c1n(CCOCCOCCCCc2ccccc2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCCCc2ccccc2)C1,CHEMBL4011211,Ki,7.46,CHEMBL4085282,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=c1n(CCOCCOCCOCCCCc2ccccc2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3c2n(c(=O)n3CCOCCOCCOCCOc2ccc3c(c2)NC(=O)CC3)C1,CHEMBL4011211,Ki,6.51,CHEMBL4095452,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,124,342,O=C1CCc2ccc(OCCOCCOCCOCCn3c(=O)n4c5c(cccc53)CCC4)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1Cc2cccc3ncn(c23)C1,CHEMBL672313,Ki,6.45,CHEMBL348285,1997,CHEMBL1130416,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]U-86170.,11,190,c1cc2c3c(c1)ncn3CCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@@H]1c2cc3ccn(S(=O)(=O)c4ccccc4)c3cc2[C@H]1CCO,CHEMBL3872136,Ki,4.8,CHEMBL3890882,2017,CHEMBL3871306,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,124,119,O=S(=O)(c1ccccc1)n1ccc2cc3c(cc21)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@H]1c2c(ccc3c2ccn3S(=O)(=O)c2ccccc2)[C@@H]1CCO,CHEMBL3872136,Ki,4.8,CHEMBL3966484,2017,CHEMBL3871306,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,124,119,O=S(=O)(c1ccccc1)n1ccc2c3c(ccc21)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CN[C@H]1c2cc3c(ccn3S(=O)(=O)c3ccccc3)cc2[C@@H]1CCO,CHEMBL3872136,Ki,5.2,CHEMBL3963688,2017,CHEMBL3871306,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,125,119,O=S(=O)(c1ccccc1)n1ccc2cc3c(cc21)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC2CCN(Cc3ccccc3)C2C)cc1Cl,CHEMBL4822008,Ki,8.58,CHEMBL20734,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),148,646,O=C(NC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC2CCN(Cc3ccccc3)CC2)cc1Cl,CHEMBL671368,Ki,7.62,CHEMBL112395,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCN(Cc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC2CCN(Cc3ccccc3)CC2)cc1Cl,CHEMBL872881,Ki,7.82,CHEMBL112395,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCN(Cc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2)cc1Cl,CHEMBL672576,Ki,7.24,CHEMBL169222,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2)cc1Cl,CHEMBL672913,Ki,6.96,CHEMBL169222,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl,CHEMBL672576,Ki,7.68,CHEMBL355566,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl,CHEMBL672913,Ki,7.29,CHEMBL355566,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl,CHEMBL672576,Ki,8.0,CHEMBL354180,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl,CHEMBL672913,Ki,7.55,CHEMBL354180,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@H]2CCN(Cc3ccccc3)C2)cc1Cl,CHEMBL672576,Ki,7.07,CHEMBL166587,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@H]2CCN(Cc3ccccc3)C2)cc1Cl,CHEMBL672913,Ki,6.96,CHEMBL166587,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl,CHEMBL672576,Ki,6.92,CHEMBL413343,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl,CHEMBL672913,Ki,6.48,CHEMBL413343,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl,CHEMBL672576,Ki,7.1,CHEMBL169193,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)NC[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl,CHEMBL672913,Ki,6.82,CHEMBL169193,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)N[C@H]2CCCN(Cc3ccccc3)C2)cc1Cl,CHEMBL671368,Ki,6.685,CHEMBL447476,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)N[C@H]2CCCN(Cc3ccccc3)C2)cc1Cl,CHEMBL872881,Ki,6.785,CHEMBL447476,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C)cc1Cl,CHEMBL671368,Ki,7.685,CHEMBL109912,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCN(Cc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)C[C@@H]2C)cc1Cl,CHEMBL872881,Ki,7.8,CHEMBL109912,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCN(Cc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl,CHEMBL671368,Ki,7.75,CHEMBL111749,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc1Cl,CHEMBL872881,Ki,7.84,CHEMBL111749,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl,CHEMBL671368,Ki,8.535,CHEMBL326454,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc(OC)c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc1Cl,CHEMBL872881,Ki,8.61,CHEMBL326454,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1cc[n+](CCNC(=O)c2ccn3c(-c4c(C)noc4C)cnc3c2)cc1,CHEMBL5464398,IC50,5.85,CHEMBL5410211,2023,CHEMBL5463728,,SGC Frankfurt - Donated Chemical Probes,Bayer Inhouse kinase panel (DRD2),156,647,O=C(NCC[n+]1ccccc1)c1ccn2c(-c3cnoc3)cnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1ccc(C(=O)NCCCCN2CCCN(c3ccccc3OC)CC2)cc1,CHEMBL2388819,Ki,6.77,CHEMBL2386623,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,89,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,7.51,CHEMBL168051,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,33,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1,CHEMBL894060,Ki,6.97,CHEMBL244161,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,52,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1nc(Cl)c(SC)c(N2CCN(C)CC2)n1,CHEMBL672311,Ki,8.27,CHEMBL407641,2001,CHEMBL1134832,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to Dopamine receptor D2 was determined,25,610,c1cc(N2CCNCC2)ncn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1nc(Cl)c(Sc2ccccc2)c(N2CCN(C)CC2)n1,CHEMBL672311,Ki,6.73,CHEMBL14899,2001,CHEMBL1134832,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to Dopamine receptor D2 was determined,25,610,c1ccc(Sc2cncnc2N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1ncc2c(n1)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)CC2=O,CHEMBL1059279,Ki,6.63,CHEMBL583772,2009,CHEMBL1154195,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,63,568,O=C1CC(CN2CCC(C(=O)c3ccccc3)CC2)Cc2ncncc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CNc1ncc2c(n1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O,CHEMBL1059279,Ki,7.31,CHEMBL576756,2009,CHEMBL1154195,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,63,568,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2ncncc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(/CCN1CCC(c2ccccn2)CC1)c1ccc(Cl)cc1,CHEMBL863653,Ki,7.71,CHEMBL437532,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,46,472,N=C(CCN1CCC(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cc(F)cc(F)c1,CHEMBL863653,Ki,6.65,CHEMBL215705,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,46,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)c(C)c1,CHEMBL863653,Ki,7.21,CHEMBL215450,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,46,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CHEMBL863653,Ki,6.66,CHEMBL427048,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,46,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccc(C#N)c1,CHEMBL863653,Ki,6.9,CHEMBL211836,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,46,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccc(C)c1,CHEMBL863653,Ki,7.17,CHEMBL212903,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,46,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccc(F)c1,CHEMBL863653,Ki,7.33,CHEMBL213164,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,46,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(/CCN1CCN(c2ccccn2)CC1)c1cccnc1,CHEMBL863653,Ki,5.74,CHEMBL212291,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(/c1ccc(Cl)cc1)C(C)CN1CCN(c2ccccn2)CC1,CHEMBL863653,Ki,6.84,CHEMBL213004,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(/c1ccc(Cl)cc1)C(CNOC)CN1CCN(c2ccccn2)CC1,CHEMBL863653,Ki,6.79,CHEMBL212288,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(/c1ccc(Cl)cc1)C(O)CN1CCN(c2ccccn2)CC1,CHEMBL863653,Ki,6.43,CHEMBL441529,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCC(c2ccccn2)CC1)c1ccc(Cl)cc1,CHEMBL863653,Ki,7.6,CHEMBL210101,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCC(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cc(F)cc(F)c1,CHEMBL863653,Ki,6.88,CHEMBL211732,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(C)c(C)c1,CHEMBL863653,Ki,6.86,CHEMBL212444,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)c(Cl)c1,CHEMBL863653,Ki,7.19,CHEMBL378324,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(Cl)cc1,CHEMBL863653,Ki,7.2,CHEMBL212235,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(F)c(Cl)c1,CHEMBL863653,Ki,6.77,CHEMBL378576,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CHEMBL863653,Ki,6.78,CHEMBL212969,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(C)c1,CHEMBL863653,Ki,7.17,CHEMBL212861,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(Cl)c1,CHEMBL863653,Ki,7.01,CHEMBL212784,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1cccc(F)c1,CHEMBL863653,Ki,7.0,CHEMBL426510,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,CHEMBL863653,Ki,6.76,CHEMBL377050,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1C,CHEMBL863653,Ki,6.95,CHEMBL437687,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CCN1CCN(c2ccccn2)CC1C)c1ccc(Cl)cc1,CHEMBL863653,Ki,7.12,CHEMBL212292,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\CN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CHEMBL863653,Ki,5.6,CHEMBL212891,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C(\c1ccc(Cl)cc1)C(O)CN1CCN(c2ccccn2)CC1,CHEMBL863653,Ki,6.0,CHEMBL214247,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,47,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO/N=C/c1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C,CHEMBL1074771,Ki,6.32,CHEMBL599134,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)C1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,7.22,CHEMBL246231,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,52,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1,CHEMBL5442215,Ki,6.55,CHEMBL405355,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=C(OCCCN1CCC(c2ccccc2)(c2ccccc2)CC1)C1=CNC=CC1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)CN(CC(=O)NCCOCCOCCNC(=O)CCC(=O)Nc1ccc(CCN2CN(c3ccccc3)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C2=O)cc1)CC(=O)NCCOCCOCCNC(=O)CCC(=O)Nc1ccc(CCN2CN(c3ccccc3)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C2=O)cc1,CHEMBL4310164,IC50,7.82,CHEMBL4515776,2018,CHEMBL4308850,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells co-expressing A2A receptor assessed as reduction in sumanirole-induced response after 90 mins by DMR analysis,130,648,O=C(CCC(=O)Nc1ccc(CCN2CN(c3ccccc3)C3(CCN(CCCC(=O)c4ccccc4)CC3)C2=O)cc1)NCCOCCOCCNC(=O)CNCC(=O)NCCOCCOCCNC(=O)CCC(=O)Nc1ccc(CCN2CN(c3ccccc3)C3(CCN(CCCC(=O)c4ccccc4)CC3)C2=O)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)CN(CC(=O)NCCOCCOCCNC(C)=O)CC(=O)NCCOCCOCCNC(=O)CCC(=O)Nc1ccc(CCN2CN(c3ccccc3)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C2=O)cc1,CHEMBL4310164,IC50,6.55,CHEMBL4542935,2018,CHEMBL4308850,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells co-expressing A2A receptor assessed as reduction in sumanirole-induced response after 90 mins by DMR analysis,130,648,O=C(CCCN1CCC2(CC1)C(=O)N(CCc1ccccc1)CN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,6.48,CHEMBL108979,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)N1CCc2ccc(/N=C/N3CCc4cc(OC)c(OC)cc4C3)cc21,CHEMBL886705,Ki,4.85,CHEMBL241101,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,52,129,C(=Nc1ccc2c(c1)NCC2)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.88,CHEMBL3664831,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.16,CHEMBL3697962,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)Nc1cccc(CCN2CCN(c3cccc4nc(C)ccc34)CC2)c1,CHEMBL1635455,Ki,6.7,CHEMBL1631532,2010,CHEMBL1629528,J Med Chem,Scientific Literature,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,70,123,c1ccc(CCN2CCN(c3cccc4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(C)cc2)CC1,CHEMBL675680,Ki,6.31,CHEMBL105745,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,29,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL675680,Ki,5.93,CHEMBL107631,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,29,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC(n2c(O)nc4ccccc42)CC1)O3,CHEMBL672490,Ki,8.17,CHEMBL418802,1992,CHEMBL1125523,J Med Chem,Scientific Literature,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",0,286,c1ccc2c(c1)ncn2C1CCN(CC2COc3ccc4[nH]ccc4c3O2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3,CHEMBL672489,Ki,8.51,CHEMBL320173,1992,CHEMBL1125523,J Med Chem,Scientific Literature,Compound was evaluated for the binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using [3H]U-86170 as radioligand,0,649,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccc4[nH]ccc4c3O1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1cc2c3c(ccc2[nH]1)OCC(CNCCCc1ccccc1)O3,CHEMBL672490,Ki,7.8,CHEMBL318374,1992,CHEMBL1125523,J Med Chem,Scientific Literature,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",0,286,c1ccc(CCCNCC2COc3ccc4[nH]ccc4c3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(-c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671381,Ki,6.1,CHEMBL108243,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,37,650,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(-c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,5.1,CHEMBL108243,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(Cn2c(-c3ccccc3)nc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(/C=C/c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671381,Ki,7.17,CHEMBL111054,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,37,650,C(=Cc1nc2ccccc2n1Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(/C=C/c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,7.42,CHEMBL111054,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,C(=Cc1nc2ccccc2n1Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(CCc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671381,Ki,6.86,CHEMBL108289,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,37,650,c1ccc(CCc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(CCc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,7.62,CHEMBL108289,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(CCc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(CNc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,5.96,CHEMBL108564,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(CNc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671381,Ki,6.53,CHEMBL324619,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,37,650,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,7.14,CHEMBL324619,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(C[S+]([O-])c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671381,Ki,5.82,CHEMBL108242,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,37,650,c1ccc(C[SH+]c2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(C[S+]([O-])c2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,6.26,CHEMBL108242,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(C[SH+]c2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(Cc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,5.21,CHEMBL320734,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(Cc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(Nc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671381,Ki,5.27,CHEMBL110063,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 in presence of 0.5% human serum albumin,37,650,c1ccc(Cn2c(Nc3ccccc3)nc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(Nc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,5.82,CHEMBL110063,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(Cn2c(Nc3ccccc3)nc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1,CHEMBL670394,Ki,6.59,CHEMBL165113,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,14,120,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1cccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)c1,CHEMBL671383,Ki,5.96,CHEMBL107988,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,37,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C,CHEMBL1074771,Ki,6.04,CHEMBL598730,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc2c(c1)CCNC1CCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(=O)c1coc2c1C(=O)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)C2,CHEMBL1027240,Ki,7.07,CHEMBL461627,2008,CHEMBL1140101,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,59,482,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2occc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(C)(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.93,CHEMBL3698013,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.39,CHEMBL3664840,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.74,CHEMBL3697971,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(C)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.1,CHEMBL3642815,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)OC,CHEMBL3705383,Ki,6.44,CHEMBL3695435,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)OC,CHEMBL3706129,Ki,7.31,CHEMBL3676897,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)OC,CHEMBL3705135,Ki,5.86,CHEMBL3642789,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC(CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)OC,CHEMBL3705135,Ki,5.63,CHEMBL3642790,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC1(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)CCCCC1,CHEMBL3707825,Ki,6.71,CHEMBL3664879,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC1(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)CC1,CHEMBL3707837,Ki,7.06,CHEMBL3698012,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC1(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)CCCCC1,CHEMBL3707837,Ki,6.6,CHEMBL3697991,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL4416273,Ki,8.72,CHEMBL422334,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,134,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,7.17,CHEMBL246438,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,52,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC1=CC2CCN(C)C3CC(c4ccccc4)C(=C1OC)C23,CHEMBL5231713,Ki,5.42,CHEMBL5286231,2020,CHEMBL5230125,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from D2DR (unknown origin),143,76,C1=CC2CCNC3CC(c4ccccc4)C(=C1)C23,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.17,CHEMBL3695367,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.29,CHEMBL3664826,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1,CHEMBL3705383,Ki,6.59,CHEMBL3695363,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,54,c1cc(C2CCN(CCC3CCCCC3)CC2)c2ccoc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.1,CHEMBL3676851,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.62,CHEMBL3697959,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.81,CHEMBL3642715,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,5.94,CHEMBL3642686,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1,CHEMBL3705135,Ki,6.66,CHEMBL3642700,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,56,c1cc2sccc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,8.02,CHEMBL3903560,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,116,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC1=C(C(=O)OC)[C@H](c2ccc(F)c(F)c2)N(C(=O)NCCCN2CCC(c3cccc(NC(C)=O)c3)CC2)C(=O)N1,CHEMBL894444,Ki,5.55,CHEMBL185271,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,52,122,O=C1NC=CC(c2ccccc2)N1C(=O)NCCCN1CCC(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC1[C@@H]2CC[C@H]1CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,CHEMBL1044430,Ki,6.5,CHEMBL541435,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,63,233,O=C1N(CCN2CC3CCC(C3)C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCC1[C@@H]2CC[C@H]1CN(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,CHEMBL1059864,Ki,6.5,CHEMBL541435,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,63,234,O=C1N(CCN2CC3CCC(C3)C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N1CCC(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5381008,Ki,7.71,CHEMBL5438081,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCCC3CCNCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5381008,Ki,7.07,CHEMBL5435745,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCNCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N1CCC(O)(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C1,CHEMBL5381008,Ki,6.76,CHEMBL5399129,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCCC3CCNC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N1CCC(O)(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5381008,Ki,6.9,CHEMBL5421827,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCCC3CCNCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3ccc(F)c4occc34)CC2)CC1,CHEMBL3705383,Ki,6.21,CHEMBL3695420,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,54,c1cc(C2CCN(CCC3CCCCC3)CC2)c2ccoc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.29,CHEMBL3695359,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.37,CHEMBL3664815,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1,CHEMBL3705383,Ki,6.54,CHEMBL3695355,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,54,c1cc(C2CCN(CCC3CCCCC3)CC2)c2ccoc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.15,CHEMBL3676847,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(C(F)(F)F)n3)CC2)CC1,CHEMBL5381008,Ki,6.9,CHEMBL5434229,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5381008,Ki,8.54,CHEMBL5431103,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,156,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(OC)c3F)CC2)CC1,CHEMBL5381008,Ki,6.32,CHEMBL5403268,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,157,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.76,CHEMBL3697952,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nc(C)cc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.83,CHEMBL3642779,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",89,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nc(C)cc4occc34)CC2)CC1,CHEMBL3705135,Ki,6.37,CHEMBL3642776,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3ncc(C)c4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.45,CHEMBL3642787,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3ncc(C)c4occc34)CC2)CC1,CHEMBL3705135,Ki,5.61,CHEMBL3642783,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.83,CHEMBL3642712,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,5.87,CHEMBL3642683,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1,CHEMBL3705135,Ki,6.52,CHEMBL3642697,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,c1cc2sccc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,CHEMBL1947794,IC50,6.1,CHEMBL1945292,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,82,225,O=c1[nH]c2cccc(CCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCOCCOc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1,CHEMBL5351445,Ki,6.89,CHEMBL5422870,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCOCCOc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1,CHEMBL5351446,Ki,7.13,CHEMBL5422870,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCOc1c(O)ccc2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2,CHEMBL3877884,Ki,7.75,CHEMBL3982215,2017,CHEMBL3877260,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,125,258,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCCS(=O)(=O)n1ccc2c(-c3ccc(C(F)(F)F)cc3)cc(N3CCN(C)CC3)nc21,CHEMBL3800738,Ki,7.28,CHEMBL3798490,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,116,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCOc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccc(OC)cc3)CC2)cc1,CHEMBL3857974,Ki,6.49,CHEMBL3983496,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,116,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCOc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1,CHEMBL3857974,Ki,7.44,CHEMBL3985152,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,116,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCOc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1,CHEMBL4041731,Ki,6.98,CHEMBL4071929,2017,CHEMBL4041469,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from recombinant human D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting method,125,651,c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC[C@@H](C)N1CCN(c2cccc(F)c2C#N)CC1,CHEMBL4137914,Ki,5.16,CHEMBL4173442,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,130,220,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC[C@@H]1CCCN1CCc1c(-c2ccccc2)[nH]c2ccccc12,CHEMBL671361,Ki,7.04,CHEMBL91446,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,22,435,c1ccc(-c2[nH]c3ccccc3c2CCN2CCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC[C@@H]1CCCN1N1CCN(c2cccc(Cl)c2)C1=O,CHEMBL1044430,Ki,7.1,CHEMBL555744,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,63,233,O=C1N(c2ccccc2)CCN1N1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC[C@@H]1CCCN1N1CCN(c2cccc(Cl)c2)C1=O,CHEMBL1059864,Ki,7.1,CHEMBL555744,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,63,234,O=C1N(c2ccccc2)CCN1N1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COC[C@H]1CCCN1CCc1c(-c2ccccc2)[nH]c2ccccc12,CHEMBL671361,Ki,5.52,CHEMBL91122,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,22,435,c1ccc(-c2[nH]c3ccccc3c2CCN2CCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COCc1nc2cnc3cc(-c4c(C)noc4C)c(OC[C@H]4CCNC4)cc3c2n1[C@H](C)c1ccccc1,CHEMBL5303889,IC50,5.5,CHEMBL4639128,2021,CHEMBL4630907,,SGC Frankfurt - Donated Chemical Probes,Cross screening panel,148,652,c1ccc(Cn2cnc3cnc4cc(-c5cnoc5)c(OCC5CCNC5)cc4c32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@@H](C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C(C)C,CHEMBL3707837,Ki,7.05,CHEMBL3698014,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.33,CHEMBL3664846,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.82,CHEMBL3697976,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.1,CHEMBL3642813,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)C1,CHEMBL3707825,Ki,6.48,CHEMBL3664843,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,111,O=C(CC1CCCC1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)C1,CHEMBL3707837,Ki,6.74,CHEMBL3697973,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,O=C(CC1CCCC1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5occc45)CC3)CC2)C1,CHEMBL3705135,Ki,6.1,CHEMBL3642680,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,O=C(CC1CCCC1)NC1CCC(CCN2CCN(c3nccc4occc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@@H]1CC[C@@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5sccc45)CC3)CC2)C1,CHEMBL3705135,Ki,6.6,CHEMBL3642699,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,O=C(CC1CCCC1)NC1CCC(CCN2CCN(c3nccc4sccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@@]1(C)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1,CHEMBL670677,Ki,7.15,CHEMBL281923,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,22,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@@]1(C)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1,CHEMBL672309,Ki,7.15,CHEMBL281923,2003,CHEMBL1145819,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2,33,628,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H](C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C(C)C,CHEMBL3707837,Ki,6.95,CHEMBL3698015,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.3,CHEMBL3664847,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.6,CHEMBL3697975,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H](C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.17,CHEMBL3642811,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)CC1,CHEMBL3707825,Ki,6.44,CHEMBL3664875,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,111,O=C(CC1CCCCC1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)CC1,CHEMBL3706129,Ki,7.17,CHEMBL3676917,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",99,55,O=C(CC1CCCCC1)NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)CC1,CHEMBL3707837,Ki,6.12,CHEMBL3698006,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",99,112,O=C(CC1CCCCC1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)C1,CHEMBL3705135,Ki,5.89,CHEMBL3642767,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,O=C(CC1CCCC1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)CC1,CHEMBL3705135,Ki,5.61,CHEMBL3642742,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,O=C(CC1CCCCC1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5occc45)CC3)CC2)CC1,CHEMBL3705135,Ki,5.83,CHEMBL3642687,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,O=C(CC1CCCCC1)NC1CCC(CCN2CCN(c3nccc4occc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5sccc45)CC3)CC2)C1,CHEMBL3705135,Ki,6.61,CHEMBL3642703,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,O=C(CC1CCCC1)NC1CCC(CCN2CCN(c3nccc4sccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@H]1CC[C@H](CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5sccc45)CC3)CC2)CC1,CHEMBL3705135,Ki,6.52,CHEMBL3642698,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",90,56,O=C(CC1CCCCC1)NC1CCC(CCN2CCN(c3nccc4sccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@]1(C)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1,CHEMBL670677,Ki,8.15,CHEMBL281924,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,22,110,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CO[C@]1(C)c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1,CHEMBL672309,Ki,8.15,CHEMBL281924,2003,CHEMBL1145819,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2,33,628,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(-c2ccco2)ccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670886,Ki,6.24,CHEMBL119150,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,8,98,c1coc(-c2ccc3c(c2)-c2cccc4c2C(C3)NCC4)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(-c2nc(CNC[C@@H]3CCN(Cc4ccccc4)C3)co2)cc(Br)c2ccccc12,CHEMBL672579,Ki,4.76,CHEMBL62601,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(CNCc3coc(-c4ccc5ccccc5c4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(-c2nc(CNC[C@@H]3CCN(Cc4ccccc4)C3)co2)cc(Br)c2ccccc12,CHEMBL673073,Ki,4.34,CHEMBL62601,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(CNCc3coc(-c4ccc5ccccc5c4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(Br)c2ccccc12,CHEMBL672170,Ki,5.42,CHEMBL61789,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)ccc2ccccc12,CHEMBL672170,Ki,6.08,CHEMBL345820,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3ccc(C)cc3)CC2)cc(Br)c2ccccc12,CHEMBL672800,Ki,6.0,CHEMBL29610,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3ccc([N+](=O)[O-])cc3)CC2)cc(Br)c2ccccc12,CHEMBL672800,Ki,5.25,CHEMBL287443,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3cccc(C)c3)CC2)cc(Br)c2ccccc12,CHEMBL672800,Ki,5.92,CHEMBL283034,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3cccc(C)c3C)CC2)cc(Br)c2ccccc12,CHEMBL672800,Ki,5.93,CHEMBL29182,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3cccc(Cl)c3)CC2)cc(Br)c2ccccc12,CHEMBL672800,Ki,6.15,CHEMBL442535,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3cccc([N+](=O)[O-])c3)CC2)cc(Br)c2ccccc12,CHEMBL672800,Ki,5.89,CHEMBL29435,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3ccccc3)CC2)cc(Br)c2ccccc12,CHEMBL672800,Ki,5.72,CHEMBL30208,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3ccccc3)CC2)cc(C#N)c2ccccc12,CHEMBL672800,Ki,7.15,CHEMBL282083,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3ccccc3)CC2)cc(Cl)c2ccccc12,CHEMBL672800,Ki,5.6,CHEMBL416939,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3ccccc3)CC2)ccc2ccccc12,CHEMBL672800,Ki,5.16,CHEMBL284896,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3ccccc3C)CC2)cc(Br)c2ccccc12,CHEMBL672800,Ki,6.32,CHEMBL28964,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3ccccc3Cl)CC2)cc(Br)c2ccccc12,CHEMBL672800,Ki,6.29,CHEMBL30206,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCCN2CCN(c3ccccc3[N+](=O)[O-])CC2)cc(Br)c2ccccc12,CHEMBL672800,Ki,6.82,CHEMBL29436,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,8,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12,CHEMBL671368,Ki,5.65,CHEMBL113471,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NCCC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NCC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12,CHEMBL872881,Ki,5.635,CHEMBL113471,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NCCC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12,CHEMBL671368,Ki,6.04,CHEMBL325818,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)NC[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12,CHEMBL872881,Ki,6.22,CHEMBL325818,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12,CHEMBL670554,Ki,6.89,CHEMBL298875,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human cloned dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,655,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12,CHEMBL671368,Ki,6.785,CHEMBL298875,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(Br)c2ccccc12,CHEMBL872881,Ki,6.82,CHEMBL298875,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(C#Cc2ccccc2)c2ccccc12,CHEMBL671368,Ki,5.15,CHEMBL109472,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCN(Cc2ccccc2)C1)c1cc(C#Cc2ccccc2)c2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(C#Cc2ccccc2)c2ccccc12,CHEMBL872881,Ki,5.33,CHEMBL109472,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCN(Cc2ccccc2)C1)c1cc(C#Cc2ccccc2)c2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(I)c2ccccc12,CHEMBL671368,Ki,6.97,CHEMBL325772,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@@H]2CCN(Cc3ccccc3)C2)cc(I)c2ccccc12,CHEMBL872881,Ki,7.4,CHEMBL325772,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc(Br)c2ccccc12,CHEMBL671368,Ki,6.154999999999999,CHEMBL430522,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@@H]2C)cc(Br)c2ccccc12,CHEMBL872881,Ki,6.37,CHEMBL430522,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc(Br)c2ccccc12,CHEMBL670554,Ki,6.77,CHEMBL321492,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human cloned dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,655,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc(Br)c2ccccc12,CHEMBL671368,Ki,6.62,CHEMBL321492,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(=O)N[C@H]2CN(Cc3ccccc3)C[C@H]2C)cc(Br)c2ccccc12,CHEMBL872881,Ki,6.87,CHEMBL321492,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C(C)=O)ccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670886,Ki,5.53,CHEMBL324372,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,8,98,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C)ccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670885,Ki,6.61,CHEMBL332178,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,8,135,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(C)ccc2c1-c1cccc3c1[C@@H](C2)NCC3,CHEMBL670886,Ki,5.33,CHEMBL117730,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]raclopride displacement.,8,98,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(Cl)cc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1Cl,CHEMBL671074,IC50,6.64,CHEMBL1202204,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",22,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(Cl)cc2c(c1Cl)Cc1ccccc1CCN(C)CC2,CHEMBL861435,Ki,6.68,CHEMBL203734,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,47,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(Cl)cc2c(c1Cl)Cc1ccccc1CCN(C)CC2,CHEMBL861441,Ki,8.6,CHEMBL203734,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,47,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(Cl)cccc1N1CCN(CC(O)CCNC(=O)c2cnc3ccccc3c2)CC1,CHEMBL3599873,Ki,6.05,CHEMBL3597638,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1,CHEMBL860506,Ki,7.38,CHEMBL209876,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,47,657,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1,CHEMBL860507,Ki,7.55,CHEMBL209876,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,47,658,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1,CHEMBL3599873,Ki,7.28,CHEMBL3597641,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1,CHEMBL3599873,Ki,7.14,CHEMBL3597642,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cnc3ccccc3c2)CC1,CHEMBL3599873,Ki,7.37,CHEMBL3597637,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cnc3ccccc3c2)CC1,CHEMBL3599945,IC50,7.2,CHEMBL3597637,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,109,659,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(O)cc2c3c1-c1ccccc1CC3N(C)CC2,CHEMBL5371288,IC50,5.94,CHEMBL4061197,2023,CHEMBL5370537,Eur J Med Chem,Scientific Literature,Antagonist activity at D2R (unknown origin) transfected in HEK293 cells by FLIPR assay,157,660,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(O)cc2c3c1-c1ccccc1CC3NCC2,CHEMBL5371288,IC50,5.24,CHEMBL4069337,2023,CHEMBL5370537,Eur J Med Chem,Scientific Literature,Antagonist activity at D2R (unknown origin) transfected in HEK293 cells by FLIPR assay,157,660,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(O)cc2c3c1-c1ccccc1C[C@H]3NCC2,CHEMBL5371288,IC50,5.24,CHEMBL469423,2023,CHEMBL5370537,Eur J Med Chem,Scientific Literature,Antagonist activity at D2R (unknown origin) transfected in HEK293 cells by FLIPR assay,157,660,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(O)ccc2c1CN1CCc3cc(OCCF)c(O)cc3[C@@H]1C2,CHEMBL5335368,Ki,5.3,CHEMBL5428803,2023,CHEMBL5331137,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,157,276,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCC4,CHEMBL3888603,Ki,6.83,CHEMBL2334882,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",116,661,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)CCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,CHEMBL2342830,IC50,6.0,CHEMBL1457510,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,90,662,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,CHEMBL2343279,Ki,6.84,CHEMBL1457510,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,CHEMBL3999639,Ki,7.31,CHEMBL1457510,2017,CHEMBL3997822,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor after 1 hr,125,664,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1,CHEMBL961026,Ki,5.42,CHEMBL516088,2009,CHEMBL1153452,Bioorg Med Chem,Scientific Literature,Inhibition of human cloned dopamine D2 receptor by competitive binding experiment,63,665,O=C(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(OCCF)cccc1[C@H](O)C1CCN(CCc2ccc(F)cc2)CC1,CHEMBL961026,Ki,5.57,CHEMBL515472,2009,CHEMBL1153452,Bioorg Med Chem,Scientific Literature,Inhibition of human cloned dopamine D2 receptor by competitive binding experiment,63,665,c1ccc(CCN2CCC(Cc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1c(OS(=O)(=O)C(F)(F)F)ccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670885,Ki,5.98,CHEMBL334116,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,8,135,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(/C=C/C(=O)Oc2c(OC)ccc3c2CN2CCc4cc5c(cc4C2C3)OCO5)ccc1OC(C)=O,CHEMBL4339971,IC50,5.1,CHEMBL2314740,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,O=C(C=Cc1ccccc1)Oc1cccc2c1CN1CCc3cc4c(cc3C1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(Br)cc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1OC,CHEMBL2388819,Ki,7.23,CHEMBL59713,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,90,97,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(Br)cc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1OC,CHEMBL3238580,Ki,7.23,CHEMBL59713,2013,CHEMBL3232965,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,90,666,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1920023,Ki,6.96,CHEMBL1916550,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,77,295,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN5CCN(c6ccccc6)CC5)cc4)nn3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1920024,Ki,6.96,CHEMBL1916550,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,77,296,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(OCCCc2cn(CCCCCCCCn3cc(CCCOc4ccc(C(=O)NCCCCN5CCN(c6ccccc6)CC5)cc4)nn3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(C(=O)NCCCCN2CCO[C@@H]3c4ccccc4OC[C@H]32)cc(OC)c1OC,CHEMBL4825013,Ki,6.15,CHEMBL4863032,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,148,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)cc(OC)c1OC,CHEMBL911524,Ki,6.57,CHEMBL213110,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,47,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc(OC)c1OC,CHEMBL911524,Ki,5.25,CHEMBL379875,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,47,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(C(=O)NN2c3ccccc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)cc(OC)c1OC,CHEMBL911524,Ki,5.49,CHEMBL377420,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,47,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL671343,IC50,6.96,CHEMBL14376,1995,CHEMBL1128281,J Med Chem,Scientific Literature,Binding affinity against Dopamine receptor D2 was determined using [ [3H]-spiperone radioligand,5,667,c1ccc(OCCCN2CCC(c3noc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(C)ccc1CN1CCN(C2CCc3cccc4c3N(C2=O)C(C)(C)C4)CC1,CHEMBL672162,Ki,6.02,CHEMBL159742,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,33,236,O=C1C(N2CCN(Cc3ccccc3)CC2)CCc2cccc3c2N1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(C)ccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL1815674,Ki,8.34,CHEMBL1813593,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,77,640,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCN(C)C)c2c(c1OC)-c1ccccc1CC2,CHEMBL5231713,Ki,6.5,CHEMBL5279818,2020,CHEMBL5230125,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from D2DR (unknown origin),143,76,c1ccc2c(c1)CCc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCN2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1OCCCSSCCN,CHEMBL4044352,Ki,6.0,CHEMBL4082245,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,125,668,c1ccc(CCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCN2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1OCCCSSCCN,CHEMBL4044353,Ki,6.03,CHEMBL4082245,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,125,669,c1ccc(CCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCN2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1OCCSSCCN,CHEMBL4044352,Ki,5.82,CHEMBL4065455,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,125,668,c1ccc(CCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCN2CCC(O)(c3ccc(Cl)cc3)CC2)ccc1OCCSSCCN,CHEMBL4044353,Ki,5.82,CHEMBL4065455,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,125,669,c1ccc(CCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,CHEMBL3801476,Ki,7.2,CHEMBL3800636,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,116,195,c1ccc(CCCOc2ccc(CCNCCc3ccccc3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,CHEMBL3801477,Ki,6.92,CHEMBL3800636,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,116,196,c1ccc(CCCOc2ccc(CCNCCc3ccccc3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,CHEMBL3801476,Ki,7.19,CHEMBL3799455,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,116,195,O=c1ccc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,CHEMBL3801477,Ki,6.8,CHEMBL3799455,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,116,196,O=c1ccc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,CHEMBL3801476,Ki,7.92,CHEMBL3800341,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,116,195,O=C1COc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,CHEMBL3801477,Ki,7.77,CHEMBL3800341,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,116,196,O=C1COc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,CHEMBL3801476,Ki,5.72,CHEMBL3799427,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,116,195,c1ccc(CCCOc2ccc(CCNCCc3ccccc3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,CHEMBL3801477,Ki,5.77,CHEMBL3799427,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,116,196,c1ccc(CCCOc2ccc(CCNCCc3ccccc3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,CHEMBL3801476,Ki,5.54,CHEMBL3800468,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,117,195,O=c1ccc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,CHEMBL3801477,Ki,5.64,CHEMBL3800468,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,117,196,O=c1ccc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,CHEMBL3801476,Ki,6.51,CHEMBL3797205,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,117,195,O=C1COc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,CHEMBL3801477,Ki,7.02,CHEMBL3797205,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,117,196,O=C1COc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,CHEMBL3801476,Ki,6.96,CHEMBL3800303,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,117,195,c1ccc(CCCOc2ccc(CCNCCc3ccccc3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1,CHEMBL3801477,Ki,7.17,CHEMBL3800303,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,117,196,c1ccc(CCCOc2ccc(CCNCCc3ccccc3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,CHEMBL3801476,Ki,5.24,CHEMBL3800400,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,117,195,O=c1ccc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1,CHEMBL3801477,Ki,5.5,CHEMBL3800400,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,117,196,O=c1ccc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,CHEMBL3801476,Ki,6.89,CHEMBL3798748,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,117,195,O=C1COc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1,CHEMBL3801477,Ki,7.19,CHEMBL3798748,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,117,196,O=C1COc2c(CCNCCc3ccc(OCCCc4ccccc4)cc3)cccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCCC2)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL4821052,Ki,8.21,CHEMBL4877940,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),148,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCCCC2)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL4821052,Ki,8.02,CHEMBL4870307,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),148,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCCCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(C)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803210,Ki,8.01,CHEMBL1803054,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,77,293,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCNCC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(C)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803211,Ki,8.14,CHEMBL1803054,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,77,294,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCNCC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccc(Cl)cc3)CC2)c(OCCF)cc1OC,CHEMBL931954,Ki,6.12,CHEMBL256637,2008,CHEMBL1143133,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 long receptor,59,670,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccc(Cl)cc3)CC2)ccc1OCCF,CHEMBL931954,Ki,4.68,CHEMBL404888,2008,CHEMBL1143133,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 long receptor,60,670,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)ccc1F,CHEMBL1926041,Ki,4.77,CHEMBL1923293,2011,CHEMBL1921774,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,77,671,c1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)ccc1F,CHEMBL1926042,Ki,4.8,CHEMBL1923293,2011,CHEMBL1921774,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,77,672,c1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)c(OCCF)cc1OC,CHEMBL931954,Ki,7.03,CHEMBL270406,2008,CHEMBL1143133,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 long receptor,60,670,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCCc1cn(CCCCCCCCCCn2cc(CCCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803210,Ki,7.77,CHEMBL1803026,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,77,293,c1ccc(N2CCN(Cc3ccc(OCCCCc4cn(CCCCCCCCCCn5cc(CCCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCCc1cn(CCCCCCCCCCn2cc(CCCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803211,Ki,8.09,CHEMBL1803026,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,77,294,c1ccc(N2CCN(Cc3ccc(OCCCCc4cn(CCCCCCCCCCn5cc(CCCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803210,Ki,7.64,CHEMBL1803025,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,77,293,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCCCn5cc(CCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803211,Ki,7.77,CHEMBL1803025,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,77,294,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCCCn5cc(CCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(C5CCCCC5)CC4)cc3OC)nn2)nn1,CHEMBL1803210,Ki,7.72,CHEMBL1803055,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,77,293,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(C8CCCCC8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(C5CCCCC5)CC4)cc3OC)nn2)nn1,CHEMBL1803211,Ki,7.77,CHEMBL1803055,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,77,294,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(C8CCCCC8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803210,Ki,7.66,CHEMBL1803024,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,77,293,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803211,Ki,7.39,CHEMBL1803024,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,77,294,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803214,Ki,7.46,CHEMBL1803024,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells in presence of 100 mM sodium chloride,77,299,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1920023,Ki,7.66,CHEMBL1803024,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,77,295,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCCCCCCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1920024,Ki,7.39,CHEMBL1803024,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,77,296,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCCCCCCCn5cc(CCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCOCCOCCOCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803210,Ki,8.32,CHEMBL1803029,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,78,293,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCOCCOCCOCCn5cc(CCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCOCCOCCOCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803211,Ki,8.21,CHEMBL1803029,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,78,294,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCOCCOCCOCCn5cc(CCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCOCCOCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803210,Ki,8.55,CHEMBL1803028,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,78,293,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCOCCOCCn5cc(CCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCCc1cn(CCOCCOCCn2cc(CCCOc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803211,Ki,8.43,CHEMBL1803028,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,78,294,c1ccc(N2CCN(Cc3ccc(OCCCc4cn(CCOCCOCCn5cc(CCCOc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCCF,CHEMBL931954,Ki,6.51,CHEMBL256492,2008,CHEMBL1143133,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 long receptor,60,670,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc2cccc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236717,Ki,6.4,CHEMBL4241776,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,130,23,O=C(COc1cccc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc2cccc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236718,Ki,6.6,CHEMBL4241776,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,130,24,O=C(COc1cccc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236717,Ki,6.52,CHEMBL4242453,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,130,23,O=C(COc1cncc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCCCN(C)CCCCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236718,Ki,6.94,CHEMBL4242453,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,130,24,O=C(COc1cncc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCN(C)CCCCCNC(=O)COc2cccc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236717,Ki,6.83,CHEMBL4241180,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,130,23,O=C(COc1cccc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCN(C)CCCCCNC(=O)COc2cccc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236718,Ki,7.03,CHEMBL4241180,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,130,24,O=C(COc1cccc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCN(C)CCCCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236717,Ki,6.88,CHEMBL4246881,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,130,23,O=C(COc1cncc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCN(C)CCCCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236718,Ki,7.35,CHEMBL4246881,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,130,24,O=C(COc1cncc(C#Cc2cscn2)c1)NCCCCCNCCCCCCCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCn2cc(COc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803210,Ki,7.8,CHEMBL1803023,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,78,293,c1ccc(N2CCN(Cc3ccc(OCc4cn(CCCCCCCCn5cc(COc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCCCCCCCn2cc(COc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803211,Ki,7.6,CHEMBL1803023,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,78,294,c1ccc(N2CCN(Cc3ccc(OCc4cn(CCCCCCCCn5cc(COc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCOCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236717,Ki,6.36,CHEMBL4249547,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,130,23,O=C(COc1cncc(C#Cc2cscn2)c1)NCCOCCOCCOCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCOCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236718,Ki,6.6,CHEMBL4249547,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,130,24,O=C(COc1cncc(C#Cc2cscn2)c1)NCCOCCOCCOCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCOCCOCCOCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236717,Ki,6.45,CHEMBL4239573,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting,130,23,O=C(COc1cncc(C#Cc2cscn2)c1)NCCOCCOCCOCCOCCOCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCOCCOCCOCCNC(=O)COc2cncc(C#Cc3csc(C)n3)c2)nn1,CHEMBL4236718,Ki,6.73,CHEMBL4239573,2018,CHEMBL4229559,J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from recombinant human dopamine D2 receptor expressed in HEK293T cell membranes co-expressing mGluR5a (unknown origin) after 1 hr by liquid scintillation counting,130,24,O=C(COc1cncc(C#Cc2cscn2)c1)NCCOCCOCCOCCOCCOCCn1cc(COc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCn2cc(COc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803210,Ki,8.48,CHEMBL1803027,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,78,293,c1ccc(N2CCN(Cc3ccc(OCc4cn(CCOCCOCCn5cc(COc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCN(c3ccccc3OC)CC2)ccc1OCc1cn(CCOCCOCCn2cc(COc3ccc(CN4CCN(c5ccccc5OC)CC4)cc3OC)nn2)nn1,CHEMBL1803211,Ki,8.47,CHEMBL1803027,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,78,294,c1ccc(N2CCN(Cc3ccc(OCc4cn(CCOCCOCCn5cc(COc6ccc(CN7CCN(c8ccccc8)CC7)cc6)nn5)nn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(CN2CCOCC2)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL4821052,Ki,8.59,CHEMBL4873319,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),148,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(COCCOCCOCCOCCOCc2ccc(N3CCN(CCCCNC(=O)c4ccccc4)CC3)c(OC)c2)ccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1,CHEMBL1930837,Ki,6.55,CHEMBL1928248,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,82,483,O=C(NCCCCN1CCN(c2ccc(COCCOCCOCCOCCOCc3ccc(N4CCN(CCCCNC(=O)c5ccccc5)CC4)cc3)cc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(COCCOCCOCCOCCOCc2ccc(N3CCN(CCCCNC(=O)c4ccccc4)CC3)c(OC)c2)ccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1,CHEMBL1930838,Ki,6.57,CHEMBL1928248,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,82,484,O=C(NCCCCN1CCN(c2ccc(COCCOCCOCCOCCOCc3ccc(N4CCN(CCCCNC(=O)c5ccccc5)CC4)cc3)cc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(Cl)ccc1CN1CCN(CC(=O)N2c3ccccc3C[C@H]2C)CC1,CHEMBL675680,Ki,6.56,CHEMBL106862,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,29,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(Cl)ccc1N1CCN(CCCCNC(=O)C(C)(C)C)CC1,CHEMBL670172,Ki,6.8,CHEMBL20251,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",8,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(Cl)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,CHEMBL671074,IC50,7.77,CHEMBL1202211,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",22,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(F)cc(N2CCN(CCCCNC(=O)c3ccc(-n4ccnc4)cc3)CC2)c1,CHEMBL938625,Ki,6.88,CHEMBL514908,2009,CHEMBL1140855,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,63,673,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-n2ccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(F)cc(N2CCN(CCCCNC(=O)c3ccc4nonc4c3)CC2)c1,CHEMBL938625,Ki,5.87,CHEMBL458354,2009,CHEMBL1140855,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,63,673,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2nonc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(F)ccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)CC1,CHEMBL4397357,Ki,4.71,CHEMBL4459784,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,135,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(F)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,CHEMBL671074,IC50,8.0,CHEMBL1202214,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",22,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N(C)C(C)=O)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1,CHEMBL672576,Ki,4.72,CHEMBL168372,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N(C)C(C)=O)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1,CHEMBL672913,Ki,4.52,CHEMBL168372,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N(C)C(C)=O)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1,CHEMBL672576,Ki,4.55,CHEMBL169631,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N(C)C(C)=O)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1,CHEMBL672913,Ki,4.42,CHEMBL169631,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)NC1CC2CCCC(C1)N2Cc1ccccc1,CHEMBL670399,Ki,9.6,CHEMBL122533,1995,CHEMBL1128138,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor,5,674,O=C(NC1CC2CCCC(C1)N2Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC,CHEMBL858805,IC50,6.64,CHEMBL1729,2006,CHEMBL1149398,J Med Chem,Scientific Literature,Binding affinity to dopamine receptor D2,47,485,O=C(NC1CCN(CCCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1,CHEMBL671368,Ki,7.75,CHEMBL325109,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCN(Cc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1,CHEMBL872881,Ki,7.92,CHEMBL325109,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCN(Cc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1,CHEMBL672576,Ki,6.19,CHEMBL167414,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1,CHEMBL672913,Ki,5.85,CHEMBL167414,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1,CHEMBL672576,Ki,6.27,CHEMBL168566,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1,CHEMBL672913,Ki,6.09,CHEMBL168566,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)NC[C@H]1CCN2CCC[C@H]12,CHEMBL858805,IC50,5.41,CHEMBL37333,2006,CHEMBL1149398,J Med Chem,Scientific Literature,Binding affinity to dopamine receptor D2,47,485,O=C(NCC1CCN2CCCC12)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCCN(Cc2ccccc2)C1,CHEMBL671368,Ki,5.449999999999999,CHEMBL112831,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,33,36,O=C(NC1CCCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCCN(Cc2ccccc2)C1,CHEMBL872881,Ki,5.67,CHEMBL112831,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,33,37,O=C(NC1CCCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(Cc2ccccc2)C[C@@H]1C,CHEMBL671368,Ki,7.2,CHEMBL322802,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone [0.5 nM (Kd=0.1 nM)] from human recombinant dopamine receptor D2L expressed in CHO cells,34,36,O=C(NC1CCN(Cc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N)c(Cl)cc1C(=O)N[C@H]1CCN(Cc2ccccc2)C[C@@H]1C,CHEMBL872881,Ki,7.300000000000001,CHEMBL322802,2003,CHEMBL1136241,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone [0.5 nM (Kd=0.2-0.45 nM)] from human recombinant dopamine receptor D2S expressed in CHO cells at 0.5 nM concentration,34,37,O=C(NC1CCN(Cc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)ccc1F,CHEMBL3776608,Ki,6.3,CHEMBL3775753,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,117,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(NC(C)=O)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1,CHEMBL672576,Ki,4.68,CHEMBL353087,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(NC(C)=O)c(Cl)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1,CHEMBL672913,Ki,4.72,CHEMBL353087,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(NC(C)=O)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1,CHEMBL672576,Ki,4.6,CHEMBL167032,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc(NC(C)=O)c(Cl)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1,CHEMBL672913,Ki,4.57,CHEMBL167032,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,17,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc([C@]23CNC[C@H]2C3)ccc1NS(=O)(=O)c1ccc(C(C)C)cc1,CHEMBL1225698,Ki,7.3,CHEMBL1224699,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,70,93,O=S(=O)(Nc1ccc(C23CNCC2C3)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(c(C(=O)NC[C@@H]3CCCN3CCc3ccccc3)c1)OCC2,CHEMBL672310,Ki,6.92,CHEMBL148352,2000,CHEMBL1133417,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,22,280,O=C(NCC1CCCN1CCc1ccccc1)c1cccc2c1OCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(c(OC)c1O)CC1c3cc4c(cc3CCN1C2)OCO4,CHEMBL4339971,IC50,5.97,CHEMBL4544045,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1NS(=O)(=O)c1ccc(-c3ccc(Cl)cc3)cc1)CCN(C)CC2,CHEMBL905981,Ki,8.4,CHEMBL231249,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,52,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)C(C)N(Cc1cccc(O)c1OC)CC2,CHEMBL3783165,Ki,5.96,CHEMBL3780975,2016,CHEMBL3779868,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,117,278,c1ccc(CN2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)C1Cc3cc(OC)c(OC)cc3CN1CC2,CHEMBL4339971,IC50,5.45,CHEMBL4528264,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)C1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL3783165,Ki,6.94,CHEMBL595489,2016,CHEMBL3779868,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,117,278,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)C1Cc3ccc(OC)c(OC)c3CN1CC2,CHEMBL3783165,Ki,6.99,CHEMBL3780481,2016,CHEMBL3779868,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,117,278,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)C1Cc3ccc(OCC4CC4)c(OC)c3CN1CC2,CHEMBL3783165,Ki,7.27,CHEMBL3780184,2016,CHEMBL3779868,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,117,278,c1ccc2c(c1)CCN1Cc3cc(OCC4CC4)ccc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)C1Cc3ccc(OCCCO)c(OC)c3CN1CC2,CHEMBL3783165,Ki,6.68,CHEMBL3780268,2016,CHEMBL3779868,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,117,278,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CC1c3cc(OC)c(OC)cc3CCN1C2,CHEMBL4339971,IC50,5.59,CHEMBL4521450,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CC1c3cc4c(cc3CCN1C2)OCO4,CHEMBL4339971,IC50,5.31,CHEMBL4551037,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21,CHEMBL2343279,Ki,6.95,CHEMBL320397,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CCN1Cc3c(ccc(OC)c3OC)C[C@@H]21,CHEMBL3999639,Ki,7.37,CHEMBL2334885,2017,CHEMBL3997822,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor after 1 hr,125,664,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc(-c3ccccc3)cc1)CC2,CHEMBL4269466,Ki,6.1,CHEMBL4287471,2018,CHEMBL4266003,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]N-Methylspiperone from human dopamine D2 receptor expressed in fibroblasts,130,675,O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc(C(N)=O)cc1)CC2,CHEMBL4269466,Ki,6.07,CHEMBL4282887,2018,CHEMBL4266003,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]N-Methylspiperone from human dopamine D2 receptor expressed in fibroblasts,130,675,O=C(NCCCCN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc(Cl)cc1)CC2,CHEMBL4269466,Ki,5.96,CHEMBL4283982,2018,CHEMBL4266003,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]N-Methylspiperone from human dopamine D2 receptor expressed in fibroblasts,130,675,O=C(NCCCCN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc3ccccc3c1)CC2,CHEMBL4269466,Ki,6.16,CHEMBL4287062,2018,CHEMBL4266003,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]N-Methylspiperone from human dopamine D2 receptor expressed in fibroblasts,130,675,O=C(NCCCCN1CCc2ccccc2C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(Br)cc1)CC2,CHEMBL4822008,Ki,7.12,CHEMBL4848910,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),148,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(C#N)cc1)CC2,CHEMBL4822008,Ki,6.72,CHEMBL4876546,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),148,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(Cl)cc1)CC2,CHEMBL4822008,Ki,7.33,CHEMBL4854935,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),148,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(F)cc1)CC2,CHEMBL4822008,Ki,7.28,CHEMBL4876207,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),148,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(I)c(OC)c1)CC2,CHEMBL4822008,Ki,7.57,CHEMBL4855891,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),148,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(I)cc1)CC2,CHEMBL4822008,Ki,7.08,CHEMBL4855361,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),148,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc3ccccc3c1)CC2,CHEMBL4822008,Ki,6.51,CHEMBL4855019,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),148,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1cccc(Br)c1)CC2,CHEMBL4822008,Ki,6.82,CHEMBL4876926,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),148,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1cccc(C#N)c1)CC2,CHEMBL4822008,Ki,7.41,CHEMBL4877460,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),149,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1cccc(Cl)c1)CC2,CHEMBL4822008,Ki,7.0,CHEMBL4854512,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),149,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1cccc(Cl)c1Cl)CC2,CHEMBL4822008,Ki,6.55,CHEMBL4862839,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),149,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccccc1Br)CC2,CHEMBL4822008,Ki,6.38,CHEMBL4856161,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),149,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccccc1Cl)CC2,CHEMBL4822008,Ki,6.72,CHEMBL4863748,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),149,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccccc1OC)CC2,CHEMBL4822008,Ki,7.11,CHEMBL4878121,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),149,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2,CHEMBL2060922,IC50,6.29,CHEMBL2057456,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,82,676,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2,CHEMBL2060922,Ki,6.83,CHEMBL2057456,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,82,676,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2,CHEMBL2343279,Ki,6.83,CHEMBL2057456,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,CHEMBL2060922,IC50,6.34,CHEMBL2057457,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,82,676,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,CHEMBL2060922,Ki,6.79,CHEMBL2057457,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,82,676,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,CHEMBL2343279,Ki,6.79,CHEMBL2057457,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,CHEMBL3888598,IC50,6.34,CHEMBL2057457,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",117,677,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,CHEMBL3888598,Ki,6.79,CHEMBL2057457,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",117,677,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,CHEMBL3888603,Ki,6.79,CHEMBL2057457,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",117,661,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3cc4c(cc3CN1CC2)OCO4,CHEMBL2343279,Ki,7.5,CHEMBL2334893,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CCN1Cc3cc4c(cc3CC21)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3cc4c(cc3CN1CC2)OCO4,CHEMBL3888598,IC50,7.04,CHEMBL2334893,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",117,677,c1ccc2c(c1)CCN1Cc3cc4c(cc3CC21)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3cc4c(cc3CN1CC2)OCO4,CHEMBL3888598,Ki,7.49,CHEMBL2334893,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",117,677,c1ccc2c(c1)CCN1Cc3cc4c(cc3CC21)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL1038853,Ki,6.01,CHEMBL487387,2009,CHEMBL1152600,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,64,639,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL2060922,IC50,6.98,CHEMBL487387,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,82,676,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL2060922,Ki,7.25,CHEMBL487387,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,82,676,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL2343279,Ki,7.96,CHEMBL487387,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL3387736,Ki,6.98,CHEMBL487387,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,99,256,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL3387745,IC50,5.36,CHEMBL487387,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) after 40 mins by [35S]GTP-gammaS binding assay in presence of quinpirole,99,288,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL3877884,Ki,6.01,CHEMBL487387,2017,CHEMBL3877260,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,125,258,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL5335368,Ki,6.01,CHEMBL487387,2023,CHEMBL5331137,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,157,276,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(O)c3CN1CC2,CHEMBL2343279,Ki,6.67,CHEMBL1235966,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2,CHEMBL2343279,Ki,7.04,CHEMBL2334891,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2,CHEMBL3999644,Ki,7.38,CHEMBL2334891,2017,CHEMBL3997822,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human FLAG-tagged dopamine D2 receptor expressed in HEK293 cells after 1 hr,125,678,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)(C)C)cc3CN1CC2,CHEMBL3387736,Ki,6.72,CHEMBL3344463,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,100,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)C)cc3CN1CC2,CHEMBL3387736,Ki,8.12,CHEMBL3344459,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,100,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)C)cc3CN1CC2,CHEMBL3387745,IC50,6.8,CHEMBL3344459,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) after 40 mins by [35S]GTP-gammaS binding assay in presence of quinpirole,100,288,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)Cl)cc3CN1CC2,CHEMBL3387736,Ki,7.78,CHEMBL3344469,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,100,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3sc(CC4CC4)cc3CN1CC2,CHEMBL3387736,Ki,7.94,CHEMBL3344466,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,100,256,c1ccc2c(c1)CCN1Cc3cc(CC4CC4)sc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3sc(CC4CCC4)cc3CN1CC2,CHEMBL3387736,Ki,7.47,CHEMBL3344465,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,100,256,c1ccc2c(c1)CCN1Cc3cc(CC4CCC4)sc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3sc(CCC(C)C)cc3CN1CC2,CHEMBL3387736,Ki,7.1,CHEMBL3344461,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,100,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3sc(CCCCCl)cc3CN1CC2,CHEMBL3387736,Ki,7.92,CHEMBL3344470,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,100,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3sc(CCCCl)cc3CN1CC2,CHEMBL3387736,Ki,7.74,CHEMBL3344468,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,100,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3sc(CCCl)cc3CN1CC2,CHEMBL3387736,Ki,7.46,CHEMBL3344467,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,100,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@@H]1Cc3sccc3CN1CC2,CHEMBL3387736,Ki,7.05,CHEMBL3344356,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from D2 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,100,256,c1ccc2c(c1)CCN1Cc3ccsc3CC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(Cl)cc3)CCN1CC2,CHEMBL2346210,Ki,7.83,CHEMBL2335740,2013,CHEMBL2331372,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,90,679,c1ccc(C2CCN3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(OC(F)(F)F)cc3)CCN1CC2,CHEMBL2346209,IC50,8.22,CHEMBL2335736,2013,CHEMBL2331372,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,90,680,c1ccc(C2CCN3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(OC(F)(F)F)cc3)CCN1CC2,CHEMBL2346210,Ki,8.4,CHEMBL2335736,2013,CHEMBL2331372,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,90,679,c1ccc(C2CCN3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2,CHEMBL2346209,IC50,6.42,CHEMBL2335741,2013,CHEMBL2331372,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,90,680,c1ccc(C2CCN3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2,CHEMBL2346210,Ki,7.0,CHEMBL2335741,2013,CHEMBL2331372,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,90,679,c1ccc(C2CCN3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1O)[C@H]1Cc3ccc(OC)c(OC)c3CN1CC2,CHEMBL2343279,Ki,6.98,CHEMBL2334892,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)C(=O)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)C2,CHEMBL670681,Ki,6.5,CHEMBL155388,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,37,584,O=C1CC(CN2CCC(C(=O)c3ccccc3)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)C(=O)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)C2,CHEMBL670681,Ki,6.82,CHEMBL155257,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,37,584,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)C(=O)CC(CN1CCN(c3ccccc3OC)CC1)C2,CHEMBL670681,Ki,6.08,CHEMBL157046,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,37,584,O=C1CC(CN2CCN(c3ccccc3)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C(C)=C/c4ccccc4)CC3)[C@@H]1CO2,CHEMBL840034,Ki,6.64,CHEMBL91157,2005,CHEMBL1142735,J Med Chem,Scientific Literature,Inhibition of [3H]spiperone binding to Dopamine receptor D2,40,681,C(=Cc1ccccc1)CN1CCN(CC2ON=C3c4ccccc4OCC32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)C1=NO[C@@H](CN3CCN(C/C=C/c4ccccc4)CC3)[C@@H]1CO2,CHEMBL840034,Ki,6.02,CHEMBL328114,2005,CHEMBL1142735,J Med Chem,Scientific Literature,Inhibition of [3H]spiperone binding to Dopamine receptor D2,40,681,C(=Cc1ccccc1)CN1CCN(CC2ON=C3c4ccccc4OCC32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)C1Cc3c(cc(O)c(OC)c3OC)CN1CC2,CHEMBL4339971,IC50,5.05,CHEMBL4453330,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)C1Cc3c(cc(OC)c(O)c3OC)CN1CC2,CHEMBL4339971,IC50,5.2,CHEMBL4585730,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)C1Cc3ccc(O)cc3CN1CC2,CHEMBL4339971,IC50,5.82,CHEMBL4561303,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)C1Cc3ccc(OC)c(O)c3CN1CC2,CHEMBL4339971,IC50,5.51,CHEMBL2314745,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)CN(/C=N/c1ccc3c(c1)C(O)CCCC3)CC2,CHEMBL886705,Ki,5.77,CHEMBL392887,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,52,129,C(=Nc1ccc2c(c1)CCCCC2)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)CN(/C=N/c1ccc3c(c1)C(OC(C)=O)CC3)CC2,CHEMBL886705,Ki,4.92,CHEMBL241102,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,52,129,C(=Nc1ccc2c(c1)CCC2)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)CN(/C=N/c1ccc3c(c1)C(OC(C)=O)CCC3)CC2,CHEMBL886705,Ki,4.96,CHEMBL240022,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,52,129,C(=Nc1ccc2c(c1)CCCC2)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)CN(/C=N/c1ccc3c(c1)C(OC(C)=O)CCCC3)CC2,CHEMBL886705,Ki,4.85,CHEMBL392970,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,52,129,C(=Nc1ccc2c(c1)CCCCC2)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)CN(/C=N/c1ccc3c(c1)N(C(=O)OC(C)(C)C)CC3)CC2,CHEMBL886705,Ki,4.27,CHEMBL240021,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,52,129,C(=Nc1ccc2c(c1)NCC2)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)CN(CCCCNC(=O)c1cc(Br)cc(OC)c1OC)CC2,CHEMBL3238580,Ki,5.66,CHEMBL291439,2013,CHEMBL3232965,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,90,666,O=C(NCCCCN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)CN(CCCCc1nc3cc(Cl)ccc3s1)CC2,CHEMBL3863657,Ki,6.38,CHEMBL3959919,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,117,59,c1ccc2c(c1)CCN(CCCCc1nc3ccccc3s1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)CN(CCCCn1cc(-c3ccc(F)cc3)c3ccccc31)CC2,CHEMBL1833373,Ki,6.06,CHEMBL1831166,2011,CHEMBL1828538,Eur J Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human D2 receptor expressed in CHO cells,78,682,c1ccc(-c2cn(CCCCN3CCc4ccccc4C3)c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)CN(CCNC(=O)c1cc(C)ccc1OC)CC2,CHEMBL1781414,Ki,5.54,CHEMBL64260,2011,CHEMBL1777734,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,78,683,O=C(NCCN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)CN(Cc1ccccc1CNC(=O)c1ccc(C#N)cc1)CC2,CHEMBL4822008,Ki,7.3,CHEMBL4878587,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),149,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)CN(Cc1ccccc1CNC(=O)c1cccc(C#N)c1)CC2,CHEMBL4822008,Ki,7.34,CHEMBL4846574,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),149,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)Cc1ccccc1CCCN(C)CC2,CHEMBL895724,Ki,5.99,CHEMBL397207,2007,CHEMBL1148752,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,52,563,c1ccc2c(c1)CCCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)N(CCCCN1CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC1)C(=O)CCC2=O,CHEMBL853595,Ki,6.33,CHEMBL203471,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,47,53,O=C1CCC(=O)N(CCCCN2CCN(c3ccncn3)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2,CHEMBL3888598,IC50,5.76,CHEMBL3982119,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",117,677,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2,CHEMBL3888598,Ki,6.48,CHEMBL3982119,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",117,677,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,CHEMBL2060922,IC50,5.94,CHEMBL2057451,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,82,676,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,CHEMBL2060922,Ki,6.65,CHEMBL2057451,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,82,676,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,CHEMBL3888598,IC50,5.94,CHEMBL2057451,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",117,677,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2,CHEMBL3888598,Ki,6.65,CHEMBL2057451,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",117,677,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL2342830,IC50,4.73,CHEMBL448891,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,90,662,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL2343279,Ki,6.52,CHEMBL448891,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2,CHEMBL3999639,Ki,6.27,CHEMBL448891,2017,CHEMBL3997822,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor after 1 hr,125,664,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2,CHEMBL3999644,Ki,5.95,CHEMBL487182,2017,CHEMBL3997822,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human FLAG-tagged dopamine D2 receptor expressed in HEK293 cells after 1 hr,125,678,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2,CHEMBL4339971,IC50,6.35,CHEMBL487182,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c3c(c1)-c1c(O)cccc1C[C@H]3N(C)CC2,CHEMBL1065707,Ki,6.63,CHEMBL270426,2010,CHEMBL1159064,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,70,413,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c3c(c1O)-c1cc(N)ccc1CC3N(C)CC2,CHEMBL4628381,Ki,6.64,CHEMBL4637246,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,143,31,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c3c(c1O)-c1cc([N+](=O)[O-])ccc1CC3N(C)CC2,CHEMBL4628381,Ki,6.5,CHEMBL4636948,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,143,31,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c3c(c1OC)-c1cc(N)ccc1CC3N(C)CC2,CHEMBL4628381,Ki,6.58,CHEMBL4639398,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,143,31,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c3c(c1OC)-c1cc(NC(C)=O)ccc1CC3N(C)CC2,CHEMBL4628381,Ki,6.01,CHEMBL4637673,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,143,31,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c3c(c1OC)-c1cc(O)ccc1C[C@H]3NCC2,CHEMBL5371295,IC50,5.28,CHEMBL5409644,2023,CHEMBL5370537,Eur J Med Chem,Scientific Literature,Antagonist activity at D2R (unknown origin),157,626,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c3c(c1OC)-c1cc([N+](=O)[O-])ccc1CC3N(C)CC2,CHEMBL4628381,Ki,6.32,CHEMBL4646927,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,143,31,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4,CHEMBL1066743,Ki,6.07,CHEMBL467094,2010,CHEMBL1153197,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor,70,684,c1cc2c3c(c1)-c1cc4c(cc1CC3NCC2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c3c(c1OC)-c1ccccc1CC3N(C)CC2,CHEMBL5231713,Ki,6.76,CHEMBL2414990,2020,CHEMBL5230125,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from D2DR (unknown origin),143,76,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c3c(c1OC)-c1ccccc1CC3N(C)CC2,CHEMBL5371288,IC50,4.83,CHEMBL2414990,2023,CHEMBL5370537,Eur J Med Chem,Scientific Literature,Antagonist activity at D2R (unknown origin) transfected in HEK293 cells by FLIPR assay,157,660,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2c3c(c1OC1CC1)-c1cc(N)ccc1CC3N(C)CC2,CHEMBL4628381,Ki,6.02,CHEMBL4636318,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,143,31,c1ccc2c(c1)CC1NCCc3ccc(OC4CC4)c-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2ccccc2cc1C(=O)CCC1CCN(Cc2ccccc2)CC1,CHEMBL672215,Ki,6.4,CHEMBL292186,1996,CHEMBL1129308,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,8,685,O=C(CCC1CCN(Cc2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2ccccc2cc1C(=O)NC1CCN(Cc2ccccc2)C1,CHEMBL672215,Ki,7.4,CHEMBL60708,1996,CHEMBL1129308,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,9,685,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2ccccc2cc1C(=O)NCC1CCN(Cc2ccccc2)CC1,CHEMBL672215,Ki,6.9,CHEMBL61248,1996,CHEMBL1129308,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,9,685,O=C(NCC1CCN(Cc2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2ccccc2cc1C(=O)NCC1CCN(Cc2ccccc2)CC1,CHEMBL887349,Ki,6.9,CHEMBL61248,2007,CHEMBL1144602,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor,52,686,O=C(NCC1CCN(Cc2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2ccccc2cc1C(=O)OCC1CCN(Cc2ccccc2)C1,CHEMBL672215,Ki,5.0,CHEMBL57019,1996,CHEMBL1129308,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,9,685,O=C(OCC1CCN(Cc2ccccc2)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2ccccc2cc1C(=O)OCC1CCN(Cc2ccccc2)CC1,CHEMBL672215,Ki,5.5,CHEMBL59326,1996,CHEMBL1129308,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,9,685,O=C(OCC1CCN(Cc2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2ccccc2cc1CC(=O)CC1CCN(Cc2ccccc2)CC1,CHEMBL672215,Ki,5.9,CHEMBL61090,1996,CHEMBL1129308,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,9,685,O=C(Cc1ccc2ccccc2c1)CC1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2ccccc2cc1COCC1CCN(Cc2ccccc2)CC1,CHEMBL672215,Ki,6.0,CHEMBL57407,1996,CHEMBL1129308,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,9,685,c1ccc(CN2CCC(COCc3ccc4ccccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2ccccc2cc1OC(=O)CC1CCN(Cc2ccccc2)CC1,CHEMBL672215,Ki,5.1,CHEMBL433255,1996,CHEMBL1129308,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,9,685,O=C(CC1CCN(Cc2ccccc2)CC1)Oc1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2ccccc2cc1OCCC1CCN(Cc2ccccc2)CC1,CHEMBL672215,Ki,5.8,CHEMBL59075,1996,CHEMBL1129308,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,9,685,c1ccc(CN2CCC(CCOc3ccc4ccccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C,CHEMBL3624486,IC50,6.1,CHEMBL3623290,2015,CHEMBL3621142,J Med Chem,Scientific Literature,Inhibition of recombinant D2 receptor (unknown origin),109,687,O=C(Oc1ccc2ncnc(Nc3ccccc3)c2c1)N1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2c(=O)n(CCCCN3CCCC(c4c[nH]c5ccc(OC)cc45)C3)c(=O)n3ccccc23)cc1,CHEMBL4401065,Ki,4.95,CHEMBL4570209,2019,CHEMBL4400523,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,135,529,O=c1c(-c2ccccc2)c2ccccn2c(=O)n1CCCCN1CCCC(c2c[nH]c3ccccc23)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2c(=O)n(CCCCN3CCCC(c4c[nH]c5ccccc45)C3)c(=O)n3ccccc23)cc1,CHEMBL4401065,Ki,5.95,CHEMBL4469813,2019,CHEMBL4400523,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,135,529,O=c1c(-c2ccccc2)c2ccccn2c(=O)n1CCCCN1CCCC(c2c[nH]c3ccccc23)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2c3n(c(=O)n(CCCCN4CCCC(c5c[nH]c6ccc(OC)cc56)C4)c2=O)CCCC3)cc1,CHEMBL4368000,Ki,5.74,CHEMBL4471755,2019,CHEMBL4364313,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,135,528,O=c1c(-c2ccccc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)c(OC)c1,CHEMBL672182,Ki,5.42,CHEMBL544925,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,29,52,c1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)cc1OC,CHEMBL672182,Ki,5.58,CHEMBL542571,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,29,52,c1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)c(OC)c1,CHEMBL672182,Ki,5.66,CHEMBL542573,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,29,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1OC,CHEMBL672182,Ki,5.47,CHEMBL557409,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,29,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4C)CC3)on2)cc1OC,CHEMBL672182,Ki,5.85,CHEMBL541791,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,29,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4F)CC3)on2)cc1OC,CHEMBL672182,Ki,5.29,CHEMBL554897,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,29,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4OC)CC3)on2)c(OC)c1,CHEMBL672182,Ki,6.36,CHEMBL543278,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,29,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cc(CCCCN3CCN(c4ccccc4OC)CC3)on2)cc1OC,CHEMBL672182,Ki,6.38,CHEMBL541025,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,29,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cc(F)ccc2N2CCN(CCCCCC(=O)NCc3ccc(C#N)cc3)CC2)cc1,CHEMBL3857974,Ki,6.28,CHEMBL3897426,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,117,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cc(N3CCN(C)CC3)nc3c2ccn3S(=O)(=O)CC(C)C)cc1,CHEMBL3800738,Ki,7.66,CHEMBL3797651,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,117,180,c1ccc(-c2cc(N3CCNCC3)nc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cc3c(=O)n(CCN4CCN(c5ccccc5Cl)CC4)c(=O)[nH]c3[nH]2)cc1,CHEMBL864519,Ki,6.78,CHEMBL370136,2006,CHEMBL1148546,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,47,688,O=c1[nH]c2[nH]c(-c3ccccc3)cc2c(=O)n1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2ccc(CNCCc3c[nH]c4ccc(OC)cc34)o2)cc1,CHEMBL4316415,Ki,5.87,CHEMBL4519266,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,143,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1,CHEMBL671073,IC50,7.3,CHEMBL292943,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,14,212,c1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cccc3c2CC[C@H]2[C@H]3c3cc(O)c(Cl)cc3CCN2C)cc1,CHEMBL1074771,Ki,6.26,CHEMBL603872,2010,CHEMBL1156846,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperon from dopamine D2 receptor expressed in mouse LTK cells by scintillation counting,70,473,c1ccc(-c2cccc3c2CCC2NCCc4ccccc4C32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2ccccc2)c(CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL5351445,Ki,6.89,CHEMBL5403204,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2ccccc2)c(CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL5351446,Ki,7.11,CHEMBL5403204,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)NCc3ccc(C#N)cc3)CC2)cc1,CHEMBL3857974,Ki,6.53,CHEMBL3924375,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,117,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)NCc3ccc(OCCCN4CCOCC4)cc3)CC2)cc1,CHEMBL3857974,Ki,6.58,CHEMBL3896355,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,117,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccc(OCCCN2CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)NCc3ccc(OCCN4CCOCC4)cc3)CC2)cc1,CHEMBL3857974,Ki,6.43,CHEMBL3955917,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,117,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccc(OCCN2CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)NCc3ccc(OCCO)cc3)CC2)cc1,CHEMBL3857974,Ki,6.38,CHEMBL3984541,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,117,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)N[C@@H](C)c3ccc(C#N)cc3)CC2)cc1,CHEMBL3857974,Ki,6.51,CHEMBL3986254,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,117,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)N[C@@H](C)c3ccccc3)CC2)cc1,CHEMBL3857974,Ki,6.75,CHEMBL3892201,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,117,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)N[C@H](C)c3ccc(C#N)cc3)CC2)cc1,CHEMBL3857974,Ki,6.61,CHEMBL3971125,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,117,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2ccccc2N2CCN(CCCCCC(=O)N[C@H](C)c3ccccc3)CC2)cc1,CHEMBL3857974,Ki,6.53,CHEMBL3932551,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,117,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2cn(CCCCN3CCN(c4ccccc4OC)CC3)nn2)cc1,CHEMBL2434803,Ki,6.67,CHEMBL2430441,2013,CHEMBL2429816,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,90,689,c1ccc(-c2cn(CCCCN3CCN(c4ccccc4)CC3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2nc(CN(C)C[C@@H]3Cc4ccccc4O3)c(C)o2)cc1C,CHEMBL4137914,Ki,5.17,CHEMBL4164695,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,130,220,c1ccc(-c2nc(CNCC3Cc4ccccc4O3)co2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2nc(O)n(C3CCN(Cc4ccccc4)CC3)c2C)cc1,CHEMBL671375,Ki,6.96,CHEMBL450021,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,17,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cc1,CHEMBL895462,Ki,6.7,CHEMBL242600,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,52,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cn1,CHEMBL895462,Ki,5.9,CHEMBL244945,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,52,690,c1cncc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-n2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nn2)cc1,CHEMBL1044860,Ki,7.31,CHEMBL574030,2009,CHEMBL1154112,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,64,691,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(-c2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-n2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nn2)cc1,CHEMBL1044861,Ki,5.77,CHEMBL574030,2009,CHEMBL1154112,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,64,692,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(-c2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-n2cc(CCCC(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nn2)cc1,CHEMBL1044860,Ki,9.0,CHEMBL572867,2009,CHEMBL1154112,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,64,691,O=C(CCCc1cn(-c2ccccc2)nn1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(-n2cc(CCCC(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nn2)cc1,CHEMBL1044861,Ki,7.17,CHEMBL572867,2009,CHEMBL1154112,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,64,692,O=C(CCCc1cn(-c2ccccc2)nn1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(/C=C/C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL671730,Ki,7.92,CHEMBL127311,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(/C=C/C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)cc1,CHEMBL672227,Ki,6.5,CHEMBL52987,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,17,131,O=C(C=Cc1ccccc1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(OS(C)(=O)=O)cc4CC3)CC2)cc1,CHEMBL674348,Ki,7.5,CHEMBL2113356,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,34,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN(C)C[C@@H]2CCN(Cc3ccccc3)C2)co1,CHEMBL672579,Ki,5.49,CHEMBL64668,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(CNCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN(C)C[C@@H]2CCN(Cc3ccccc3)C2)co1,CHEMBL673073,Ki,5.42,CHEMBL64668,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(CNCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN2CCN(Cc3ccccc3)CC2)co1,CHEMBL672579,Ki,6.1,CHEMBL64696,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCN(Cc3coc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN2CCN(Cc3ccccc3)CC2)co1,CHEMBL673073,Ki,5.82,CHEMBL64696,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCN(Cc3coc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN2CCN(Cc3ccccc3)CC2)cs1,CHEMBL672579,Ki,7.07,CHEMBL293645,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCN(Cc3csc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN2CCN(Cc3ccccc3)CC2)cs1,CHEMBL673073,Ki,6.68,CHEMBL293645,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCN(Cc3csc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)co1,CHEMBL672579,Ki,6.48,CHEMBL64288,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)co2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)co1,CHEMBL673073,Ki,6.16,CHEMBL64288,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)co2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)cs1,CHEMBL672579,Ki,6.36,CHEMBL64325,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)cs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)cs1,CHEMBL673073,Ki,6.21,CHEMBL64325,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)cs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)C2)co1,CHEMBL672579,Ki,5.18,CHEMBL2111526,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)C2)co1,CHEMBL673073,Ki,5.08,CHEMBL2111526,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)CC2)co1,CHEMBL672579,Ki,6.2,CHEMBL293225,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)CC2)co1,CHEMBL673073,Ki,6.03,CHEMBL293225,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)CC2)cs1,CHEMBL672579,Ki,6.98,CHEMBL62624,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(NCc3csc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC2CCN(Cc3ccccc3)CC2)cs1,CHEMBL673073,Ki,6.71,CHEMBL62624,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(NCc3csc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNCC2CCN(Cc3ccccc3)C2)co1,CHEMBL672579,Ki,6.68,CHEMBL2111525,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(CNCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNCC2CCN(Cc3ccccc3)C2)co1,CHEMBL673073,Ki,6.29,CHEMBL2111525,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(CNCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNCC2CCN(Cc3ccccc3)C2)cs1,CHEMBL672579,Ki,7.04,CHEMBL2111528,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(CNCc3csc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNCC2CCN(Cc3ccccc3)C2)cs1,CHEMBL673073,Ki,6.73,CHEMBL2111528,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(CNCc3csc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNCCC2CCN(Cc3ccccc3)C2)co1,CHEMBL672579,Ki,6.51,CHEMBL2111527,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(CCNCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNCCC2CCN(Cc3ccccc3)C2)co1,CHEMBL673073,Ki,6.29,CHEMBL2111527,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(CCNCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNCC[C@@H]2CCN(Cc3ccccc3)C2)co1,CHEMBL672579,Ki,5.96,CHEMBL65641,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(CCNCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNCC[C@@H]2CCN(Cc3ccccc3)C2)co1,CHEMBL673073,Ki,5.97,CHEMBL65641,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(CCNCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)c[nH]1,CHEMBL672579,Ki,5.56,CHEMBL64566,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(CNCc3c[nH]c(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)c[nH]1,CHEMBL673073,Ki,5.2,CHEMBL64566,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(CNCc3c[nH]c(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)co1,CHEMBL672579,Ki,6.61,CHEMBL62602,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(CNCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)co1,CHEMBL673073,Ki,6.5,CHEMBL62602,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(CNCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)cs1,CHEMBL672579,Ki,6.55,CHEMBL64139,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(CNCc3csc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CNC[C@@H]2CCN(Cc3ccccc3)C2)cs1,CHEMBL673073,Ki,6.38,CHEMBL64139,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(CNCc3csc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN[C@@H]2CCN(Cc3ccccc3)C2)co1,CHEMBL672579,Ki,5.7,CHEMBL64752,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,22,463,c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1-c1nc(CN[C@@H]2CCN(Cc3ccccc3)C2)co1,CHEMBL673073,Ki,5.61,CHEMBL64752,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,22,464,c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1,CHEMBL672576,Ki,5.8,CHEMBL353090,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,17,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C(=O)NC[C@@H]1CCN(Cc2ccccc2)C1,CHEMBL672913,Ki,5.51,CHEMBL353090,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,18,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1,CHEMBL672576,Ki,5.82,CHEMBL423440,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (short) by [3H]-spiperone displacement.,18,429,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C(=O)NC[C@H]1CCN(Cc2ccccc2)C1,CHEMBL672913,Ki,5.7,CHEMBL423440,1999,CHEMBL1132075,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 (long) by [3H]-spiperone displacement.,18,430,O=C(NCC1CCN(Cc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C1=NCC[C@@H](CN2CCN(c3ccccc3)CC2)N1,CHEMBL672098,Ki,4.8,CHEMBL353220,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,34,397,c1ccc(C2=NCCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C1=NCC[C@@H](CN2CCN(c3ccccc3)CC2)N1,CHEMBL672099,Ki,4.85,CHEMBL353220,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,34,398,c1ccc(C2=NCCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C1=NCC[C@H](CN2CCN(c3ccccc3)CC2)N1,CHEMBL672098,Ki,4.36,CHEMBL169889,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,34,397,c1ccc(C2=NCCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C1=NCC[C@H](CN2CCN(c3ccccc3)CC2)N1,CHEMBL672099,Ki,4.37,CHEMBL169889,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,34,398,c1ccc(C2=NCCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)CO1,CHEMBL665385,Ki,6.505,CHEMBL313320,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,25,695,c1ccc(C2=NC(CN3CCN(c4ccccc4)CC3)CO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)CO1,CHEMBL671178,Ki,6.03,CHEMBL313320,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,25,696,c1ccc(C2=NC(CN3CCN(c4ccccc4)CC3)CO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)[C@@H](C)O1,CHEMBL665385,Ki,5.1850000000000005,CHEMBL315564,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,25,695,c1ccc(C2=NC(CN3CCN(c4ccccc4)CC3)CO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1C1=N[C@@H](CN2CCN(c3ccccc3)CC2)[C@@H](C)O1,CHEMBL671178,Ki,5.055,CHEMBL315564,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,25,696,c1ccc(C2=NC(CN3CCN(c4ccccc4)CC3)CO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,7.43,CHEMBL233849,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,52,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Br)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,7.44,CHEMBL429076,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,52,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)C2CCN([C@H]3CCN(Cc4ccc(F)cc4)C[C@@H]3O)CC2)cc1,CHEMBL1827958,Ki,5.83,CHEMBL1822390,2011,CHEMBL1821670,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,78,697,O=C(c1ccccc1)C1CCN(C2CCN(Cc3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)CCCN2CCc3ccccc3C2)cc1,CHEMBL3821452,Ki,6.6,CHEMBL3817898,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,117,698,O=C(CCCN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)N2CCN(CCOc3cccc(OC)c3)CC2)cc1,CHEMBL4406527,IC50,5.17,CHEMBL4552311,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1ccccc1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)N2CCN(CCOc3ccccc3OC)CC2)cc1,CHEMBL4406527,IC50,5.05,CHEMBL4449219,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1ccccc1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL827419,IC50,7.21,CHEMBL370713,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,40,699,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL828890,Ki,7.01,CHEMBL370713,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,40,700,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL828891,Ki,7.52,CHEMBL370713,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,40,701,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL838683,Ki,7.52,CHEMBL370713,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,40,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)NCCCCN2CCN(c3ccccc3Cl)CC2)cc1OC,CHEMBL913685,Ki,6.55,CHEMBL221549,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,52,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)NCCCCN2CCO[C@@H]3c4cc(OC)ccc4OC[C@H]32)cc1,CHEMBL4825013,Ki,6.16,CHEMBL4864112,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)NCCCCN2CCO[C@@H]3c4ccccc4OC[C@H]32)cc1,CHEMBL4825013,Ki,6.25,CHEMBL4862320,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)NCc2ccccc2CN2CCc3cc(OC)c(O)cc3C2)cc1,CHEMBL4822008,Ki,7.13,CHEMBL4857166,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),149,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1,CHEMBL870468,Ki,5.52,CHEMBL215885,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,47,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,6.71,CHEMBL234231,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,52,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C(F)(F)F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,8.72,CHEMBL234232,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,52,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C)cc1CN1CCN(C2CCc3cccc4c3N(C2=O)C(C)(C)C4)CC1,CHEMBL672162,Ki,6.5,CHEMBL351612,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,34,236,O=C1C(N2CCN(Cc3ccccc3)CC2)CCc2cccc3c2N1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,6.96,CHEMBL393725,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,52,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,7.3,CHEMBL233623,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,52,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2(C)NC(=O)N(CC(O)CN3CCN(C(c4ccccc4)c4ccccc4)CC3)C2=O)cc1,CHEMBL4148417,Ki,6.03,CHEMBL4163626,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,130,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2(C)NC(=O)N(CC(O)CN3CCN(c4ccccc4C#N)CC3)C2=O)cc1,CHEMBL4148417,Ki,6.11,CHEMBL4171652,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,130,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2(C)NC(=O)N(CC(O)CN3CCN(c4ccccc4OC)CC3)C2=O)cc1,CHEMBL4148417,Ki,5.93,CHEMBL4163778,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,130,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2(O)CCN(Cc3c[nH]c4ccccc34)CC2)cc1,CHEMBL902495,Ki,6.75,CHEMBL245614,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,52,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5nc(C)ccc45)n2C)C3)cc1,CHEMBL1107668,Ki,5.9,CHEMBL1079578,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,70,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5ncccc45)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1,CHEMBL1107668,Ki,6.75,CHEMBL1079837,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,70,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1C(F)(F)F,CHEMBL1107668,Ki,6.699999999999999,CHEMBL1081408,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,70,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)cc1Cl,CHEMBL1107668,Ki,6.35,CHEMBL1079494,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,70,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2=CC(=O)C3(CCN(CCc4ccccc4)CC3)O2)cc1,CHEMBL671745,Ki,5.08,CHEMBL543591,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C=C(c2ccccc2)OC12CCN(CCc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2=COC3(CCN(CCc4ccccc4)CC3)C2=O)cc1,CHEMBL671745,Ki,5.68,CHEMBL556035,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(CCc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2=COC3(CCN(CCc4ccccc4)CC3)CC2=O)cc1,CHEMBL672709,Ki,5.83,CHEMBL545697,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,519,O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2=NO[C@@H](CCCN3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)C2)cc1OC,CHEMBL892631,Ki,6.4,CHEMBL390181,2007,CHEMBL1147208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,52,492,c1ccc(C2=NOC(CCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2=NO[C@H](CCCN3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)C2)cc1OC,CHEMBL892631,Ki,7.1,CHEMBL243012,2007,CHEMBL1147208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,52,492,c1ccc(C2=NOC(CCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324908,Ki,4.76,CHEMBL5434856,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,157,704,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324912,IC50,5.63,CHEMBL5434856,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,157,705,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324922,IC50,4.84,CHEMBL5434856,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,157,706,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1,CHEMBL671372,Ki,6.16,CHEMBL146757,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,18,707,O=C1COc2ccc(CN3CCC(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(C2CCN(Cc3ccc4c(c3)OCC(=O)N4)CC2)cc1,CHEMBL671372,Ki,5.95,CHEMBL149497,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,18,707,O=C1COc2cc(CN3CCC(c4ccccc4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CC(C)NCC(O)c2ccc(O)c(NC=O)c2)cc1,CHEMBL3801477,Ki,4.89,CHEMBL1256786,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,117,196,c1ccc(CCNCCc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CCC(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1Cl,CHEMBL870468,Ki,6.24,CHEMBL215950,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,47,262,O=C(CCc1ccccc1)NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CCCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1,CHEMBL1839313,Ki,5.24,CHEMBL1834261,2011,CHEMBL1833923,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,78,708,c1ccc(CCCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CCCN2CCC(CCC(=O)c3cc(Cl)c(N)c4c3OCCO4)CC2)cc1OC,CHEMBL665381,Ki,6.5,CHEMBL69733,1995,CHEMBL1153669,Bioorg Med Chem Lett,Scientific Literature,Compound was evaluated for binding affinity against Dopamine D2 receptor using radioligand binding assay,5,709,O=C(CCC1CCN(CCCc2ccccc2)CC1)c1cccc2c1OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)cc1OC,CHEMBL1044430,Ki,7.0,CHEMBL554693,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,64,233,O=C1N(CCNCCc2ccccc2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)cc1OC,CHEMBL1059864,Ki,7.0,CHEMBL554693,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,64,234,O=C1N(CCNCCc2ccccc2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC,CHEMBL3736706,Ki,5.76,CHEMBL3735756,2015,CHEMBL3734659,Medchemcomm,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in stable fibroblast after 90 mins by scintillation counting method,109,710,c1ccc(CCCN(CCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CN2CC=C(c3c[nH]c4ccc(OC(C)C)cc34)CC2)cc1,CHEMBL4368222,Ki,6.78,CHEMBL4548632,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,135,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CN2CC=C(c3c[nH]c4ccc(OC)cc34)CC2)cc1,CHEMBL4368222,Ki,6.83,CHEMBL4449936,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,135,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CN2CC=C(c3c[nH]c4ccccc34)CC2)cc1,CHEMBL4368222,Ki,7.06,CHEMBL4565126,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,135,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CN2CCC(CC(=O)N3c4ccccc4CC3C)CC2)cc1,CHEMBL872891,Ki,6.8,CHEMBL104579,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",29,214,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CN2CCC3(CCc4ccccc4C3=O)CC2)cc1,CHEMBL673013,Ki,5.85,CHEMBL542709,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1,CHEMBL872891,Ki,5.68,CHEMBL323525,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",29,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1,CHEMBL675680,Ki,6.17,CHEMBL105317,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,29,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1,CHEMBL1219344,Ki,5.57,CHEMBL1214830,2010,CHEMBL1212881,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,70,426,c1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CN2CCOC(CCc3ccccc3)C2)cc1,CHEMBL3383656,IC50,4.78,CHEMBL3335539,2014,CHEMBL3352711,ACS Med Chem Lett,Scientific Literature,Inhibition of human dopamine D2L receptor,100,711,c1ccc(CCC2CN(Cc3ccccc3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,CHEMBL2328744,IC50,6.4,CHEMBL2326479,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,90,466,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)cc1,CHEMBL2328745,Ki,7.04,CHEMBL2326479,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,90,467,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1,CHEMBL5351445,Ki,6.8,CHEMBL5439853,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1,CHEMBL5351446,Ki,7.43,CHEMBL5439853,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CNCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,CHEMBL3626473,Ki,5.4,CHEMBL3622100,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,109,0,c1ccc(CNCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)cc1,CHEMBL1947794,IC50,6.1,CHEMBL1945289,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,82,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1C1CC1CN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1,CHEMBL4406061,Ki,6.67,CHEMBL4475699,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,143,357,c1ccc(-c2nnc(SCCCN(CC3CC3)CC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4842092,Ki,7.42,CHEMBL4859410,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=C1CCc2ccc(OCCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,7.81,CHEMBL4857759,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4842092,Ki,7.49,CHEMBL4852808,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=C1CCc2ccc(OCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,7.48,CHEMBL4846472,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1CN1CCN(C2CCc3cccc4c3N(C2=O)C(C)(C)C4)CC1,CHEMBL672162,Ki,6.66,CHEMBL354699,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,34,236,O=C1C(N2CCN(Cc3ccccc3)CC2)CCc2cccc3c2N1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1CN1CCN(CC(=O)N2c3ccccc3C[C@H]2C)CC1,CHEMBL675680,Ki,7.55,CHEMBL104751,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,29,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,CHEMBL671074,IC50,8.3,CHEMBL1202205,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",22,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL948052,Ki,7.96,CHEMBL271913,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,60,204,O=C(Nc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1OC[C@@H]1CN(Cc2ccc(Cl)cc2)CCO1,CHEMBL4039163,Ki,6.88,CHEMBL4080034,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,125,546,c1ccc(CN2CCOC(COc3ccccc3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1,CHEMBL889238,Ki,6.89,CHEMBL388897,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,52,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1,CHEMBL889238,Ki,7.16,CHEMBL442059,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,52,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,6.795,CHEMBL233816,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,52,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1,CHEMBL894519,Ki,6.23,CHEMBL234474,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,52,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1,CHEMBL889238,Ki,6.81,CHEMBL228279,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,52,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1,CHEMBL889238,Ki,7.09,CHEMBL390192,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,52,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,7.11,CHEMBL234607,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,52,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,7.52,CHEMBL4876116,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,6.5,CHEMBL4867794,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL5337412,Ki,7.89,CHEMBL4867794,2024,CHEMBL5335811,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,159,712,O=c1ccc2ccc(OCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4842092,Ki,7.94,CHEMBL4862770,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=C1CCc2ccc(OCCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cl)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,7.89,CHEMBL4875081,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c2C)cc1,CHEMBL3614290,Ki,8.82,CHEMBL221866,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,109,431,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c2C)cc1,CHEMBL913685,Ki,8.04,CHEMBL221866,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,52,44,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(c4ccccc4OC)CC3)c2C)cc1,CHEMBL3614290,Ki,8.57,CHEMBL220754,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,109,431,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cn2nnc(C(=O)NCCCCCN3CCN(c4ccccc4OC)CC3)c2C)cc1,CHEMBL913685,Ki,7.77,CHEMBL220754,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,52,44,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cn2nnc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2C)cc1,CHEMBL3614290,Ki,7.89,CHEMBL437525,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,109,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Cn2nnc(C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)c2C)cc1,CHEMBL913685,Ki,7.26,CHEMBL437525,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,52,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1C1CC1CN(C)CCCSc1nnc(-c2ccccc2)n1C,CHEMBL4406061,Ki,6.49,CHEMBL4514800,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,143,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1C1CC1CN(CCCSc1nnc(-c2ccccc2)n1C)C(C)C,CHEMBL4406061,Ki,6.29,CHEMBL4453405,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,143,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4842092,Ki,7.31,CHEMBL4862439,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=C1CCc2ccc(OCCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,7.37,CHEMBL4872467,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4842092,Ki,7.56,CHEMBL4864436,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=C1CCc2ccc(OCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,7.59,CHEMBL4874021,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1C1CC1CNCCCSc1nnc(-c2ccccc2)n1C,CHEMBL4406061,Ki,6.6,CHEMBL4514586,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,143,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,6.76,CHEMBL233814,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,53,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,6.86,CHEMBL392066,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,53,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,7.36,CHEMBL4852524,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,6.44,CHEMBL4852835,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1[C@@H]1C[C@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL5337412,Ki,8.18,CHEMBL4852835,2024,CHEMBL5335811,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,159,712,O=c1ccc2ccc(OCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,7.68,CHEMBL4862890,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(F)cc1[C@H]1C[C@@H]1CNCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,8.18,CHEMBL4863832,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(CCCCN2CCC(O)(c3ccc(Cl)c(C(F)(F)F)c3)CC2)c2ccc(OC)cc2)cc1,CHEMBL4260833,Ki,6.38,CHEMBL4293307,2018,CHEMBL4257579,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,130,713,c1ccc(C2CCN(CCCCN(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2ccc(C#N)cc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323478,Ki,6.6,CHEMBL4445706,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,135,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2ccc(C#N)cc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323479,Ki,6.96,CHEMBL4445706,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,135,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2ccc(F)cc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323478,Ki,6.8,CHEMBL4582096,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,135,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2ccc(F)cc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323479,Ki,6.96,CHEMBL4582096,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,135,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2cccc(F)c2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323478,Ki,7.23,CHEMBL4585384,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,135,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2cccc(F)c2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323479,Ki,7.46,CHEMBL4585384,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,135,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2cccc(OC)c2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323478,Ki,6.82,CHEMBL4442419,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,135,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2cccc(OC)c2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323479,Ki,6.96,CHEMBL4442419,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,135,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2ccccc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323478,Ki,7.35,CHEMBL4460743,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,135,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2ccccc2)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323479,Ki,7.72,CHEMBL4460743,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,135,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2ccccc2F)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323478,Ki,7.38,CHEMBL4434714,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,135,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N(Cc2ccccc2F)NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1,CHEMBL4323479,Ki,7.72,CHEMBL4434714,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,135,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCC3(CCN(CCCSc4nnc(-c5ccccc5)n4C)CC3)CC2)c(OC)c1,CHEMBL4397357,Ki,4.19,CHEMBL4483044,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,135,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCC3(CCN(CCCSc4nnc(-c5ccccc5)n4C)CC3)CC2)cc1,CHEMBL4032441,Ki,3.979443991541845,CHEMBL4100699,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,125,714,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCC3(CCN(CCCSc4nnc(-c5ccccc5)n4C)CC3)CC2)cc1,CHEMBL4397357,Ki,3.979443991541845,CHEMBL4100699,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,135,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)cc1,CHEMBL3776608,Ki,5.8,CHEMBL3775023,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,117,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCC3OCCc4cc(C(N)=O)ccc43)CC2)cc1,CHEMBL672207,Ki,6.46,CHEMBL69385,1998,CHEMBL1131250,J Med Chem,Scientific Literature,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes,14,715,c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,CHEMBL672208,Ki,5.84,CHEMBL71724,1998,CHEMBL1131250,J Med Chem,Scientific Literature,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes.,14,642,c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCCCCN3C(=O)c4cccc5cccc(c45)C3=O)CC2)cc1,CHEMBL4390409,Ki,4.4,CHEMBL4447330,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,135,490,O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCCCCN3C(=O)c4cccc5cccc3c45)CC2)cc1,CHEMBL4390409,Ki,6.75,CHEMBL4443185,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,135,490,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCCCCN3C(=O)c4ccccc4S3(=O)=O)CC2)cc1,CHEMBL4308346,Ki,6.02,CHEMBL4439144,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,135,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c(OC)c1,CHEMBL1815674,Ki,7.6,CHEMBL1813592,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,78,640,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)cc1,CHEMBL1815674,Ki,6.99,CHEMBL1813585,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,78,640,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCN3C(=O)CCc4ccccc43)CC2)cc1,CHEMBL5106582,Ki,4.68,CHEMBL5178868,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,153,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCN3CCN(C(=O)c4ccccc4)CC3)CC2)cc1,CHEMBL5145822,Ki,5.26,CHEMBL5173624,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,153,581,O=C(c1ccccc1)N1CCN(CCCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCN3CCN(c4ncccc4C#N)CC3)CC2)cc1,CHEMBL5145822,Ki,5.82,CHEMBL5193798,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,153,581,c1ccc(N2CCN(CCCN3CCN(c4ccccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCOc3c(C)cc(C)cc3C)CC2)cc1,CHEMBL4195136,Ki,5.3,CHEMBL4205526,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,130,717,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,CHEMBL3073105,Ki,6.53,CHEMBL312877,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),90,427,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,CHEMBL670391,Ki,6.53,CHEMBL312877,1995,CHEMBL1149936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,5,428,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCCc3ccc4[nH]c(=S)[nH]c4c3)CC2)cc1,CHEMBL3073105,Ki,7.48,CHEMBL2298821,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),90,427,S=c1[nH]c2ccc(CCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCNC(=O)c3cc(Br)c4ccccc4c3OC)CC2)cc1,CHEMBL672800,Ki,5.25,CHEMBL29336,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,9,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCOc3ccc4[nH]c(=S)[nH]c4c3)CC2)cc1,CHEMBL3073105,Ki,6.98,CHEMBL2298831,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),90,427,S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CC[C@@H]3OCCc4cc(C(N)=O)ccc43)CC2)cc1,CHEMBL672208,Ki,6.49,CHEMBL71635,1998,CHEMBL1131250,J Med Chem,Scientific Literature,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes.,14,642,c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4cccs4)CC3)CC2)cc1,CHEMBL671651,Ki,6.75,CHEMBL312803,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,11,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1,CHEMBL672206,Ki,8.22,CHEMBL351617,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,14,62,c1ccc(N2CCN(CCC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CC[C@H]3OCCc4cc(C(N)=O)ccc43)CC2)cc1,CHEMBL672208,Ki,6.41,CHEMBL71907,1998,CHEMBL1131250,J Med Chem,Scientific Literature,The compound was tested for CNS binding affinity towards Dopamine receptor D2 from cloned Human membranes.,14,642,c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(CCc3c[nH]c4ncccc34)CC2)cc1,CHEMBL671652,Ki,6.05,CHEMBL347291,1999,CHEMBL1132519,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,18,58,c1ccc(N2CCN(CCc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1,CHEMBL671074,IC50,6.12,CHEMBL1202224,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",22,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(Cc3c(C)nc4cc(C)nc(C)n34)CC2)cc1,CHEMBL1061432,Ki,6.58,CHEMBL564709,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,64,569,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(Cc3c(C)nc4cc(C)nc(C)n34)CC2)cc1,CHEMBL1061433,Ki,6.8,CHEMBL564709,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,64,570,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(Cc3c(C)nc4cc(C)ncn34)CC2)cc1,CHEMBL1061432,Ki,5.04,CHEMBL550920,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,64,569,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(Cc3c(C)nc4cc(C)ncn34)CC2)cc1,CHEMBL1061433,Ki,4.89,CHEMBL550920,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,64,570,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(N2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1,CHEMBL671372,Ki,5.25,CHEMBL348435,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,18,707,O=C1COc2ccc(CN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NC(=O)NC2CCC(N3CCN(c4ccccc4OC(C)C)CC3)CC2)c(OC)c1,CHEMBL948052,Ki,6.295,CHEMBL256853,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,60,204,O=C(Nc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1-c1ccc(F)cc1,CHEMBL5351445,Ki,7.05,CHEMBL5407341,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1cccc(-c2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)cc1-c1ccc(F)cc1,CHEMBL5351446,Ki,7.28,CHEMBL5407341,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1cccc(-c2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1,CHEMBL3626473,Ki,6.37,CHEMBL3622096,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,109,0,c1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,CHEMBL3626473,Ki,5.12,CHEMBL3622092,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,109,0,c1ccc(NCCN2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NS(=O)(=O)c2ccc(Br)cc2)cc1N1CCN(C)CC1,CHEMBL674350,Ki,5.4,CHEMBL292759,1999,CHEMBL1132410,J Med Chem,Scientific Literature,Compound was tested for its binding affinity against Dopamine receptor D2 in human cloned receptors in CHO cells using [125 I]iodosulpride,18,718,O=S(=O)(Nc1cccc(N2CCNCC2)c1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN(C)CC1,CHEMBL670660,Ki,6.1,CHEMBL29846,2002,CHEMBL1135108,Bioorg Med Chem Lett,Scientific Literature,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",29,719,O=S(=O)(Nc1cccc(N2CCNCC2)c1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN(C)CC1,CHEMBL674350,Ki,6.1,CHEMBL29846,1999,CHEMBL1132410,J Med Chem,Scientific Literature,Compound was tested for its binding affinity against Dopamine receptor D2 in human cloned receptors in CHO cells using [125 I]iodosulpride,18,718,O=S(=O)(Nc1cccc(N2CCNCC2)c1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN2CCCCC2C1,CHEMBL670660,Ki,6.4,CHEMBL29410,2002,CHEMBL1135108,Bioorg Med Chem Lett,Scientific Literature,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",29,719,O=S(=O)(Nc1cccc(N2CCN3CCCCC3C2)c1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN2CCC[C@@H]2C1,CHEMBL670660,Ki,5.7,CHEMBL282971,2002,CHEMBL1135108,Bioorg Med Chem Lett,Scientific Literature,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",29,719,O=S(=O)(Nc1cccc(N2CCN3CCCC3C2)c1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCN2CCC[C@H]2C1,CHEMBL670660,Ki,5.8,CHEMBL29433,2002,CHEMBL1135108,Bioorg Med Chem Lett,Scientific Literature,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",29,719,O=S(=O)(Nc1cccc(N2CCN3CCCC3C2)c1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1,CHEMBL670660,Ki,5.6,CHEMBL431298,2002,CHEMBL1135108,Bioorg Med Chem Lett,Scientific Literature,"The compound was tested for the binding affinity towards human cloned Dopamine receptor D2 in CHO cells, using [125I]iodosulpride as radioligand",29,719,O=S(=O)(Nc1cccc(N2CCNCC2)c1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1,CHEMBL674350,Ki,5.6,CHEMBL542139,1999,CHEMBL1132410,J Med Chem,Scientific Literature,Compound was tested for its binding affinity against Dopamine receptor D2 in human cloned receptors in CHO cells using [125 I]iodosulpride,18,718,O=S(=O)(Nc1cccc(N2CCNCC2)c1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1,CHEMBL927708,Ki,6.34,CHEMBL431298,2008,CHEMBL1140794,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,60,720,O=S(=O)(Nc1cccc(N2CCNCC2)c1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OC(C)CN2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1,CHEMBL4406527,IC50,4.75,CHEMBL4585248,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1ccccc1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OC)c(C(=O)NCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL670113,IC50,6.6,CHEMBL144811,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,14,582,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OC)c(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)c1,CHEMBL675680,Ki,7.23,CHEMBL319043,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,29,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OC)c(N2CCN(CCCCNC(=O)c3ccc(Br)cc3)CC2)c1,CHEMBL670400,Ki,7.0,CHEMBL70866,1995,CHEMBL1128113,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,5,721,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1,CHEMBL894519,Ki,7.09,CHEMBL236832,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,53,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OC)c(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)c1,CHEMBL894519,Ki,7.21,CHEMBL234194,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,53,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OC)c2c1C[C@@H]1c3c(cc4c(c3-2)OCO4)CCN1C,CHEMBL5371295,IC50,4.74,CHEMBL5417155,2023,CHEMBL5370537,Eur J Med Chem,Scientific Literature,Antagonist activity at D2R (unknown origin),157,626,c1ccc2c(c1)CC1NCCc3cc4c(c-2c31)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4,CHEMBL3888598,IC50,5.6,CHEMBL3897805,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",117,677,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4,CHEMBL3888598,Ki,6.31,CHEMBL3897805,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",117,677,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,CHEMBL4406527,IC50,5.92,CHEMBL4580359,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1cc2ccccc2[nH]1)N1CCN(CCCCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1,CHEMBL4406527,IC50,6.16,CHEMBL4442293,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1cc2ccccc2[nH]1)N1CCN(CCCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCN(C)CCN(C)C(=O)c2ccc(OC)cc2)cc1,CHEMBL4406527,IC50,4.75,CHEMBL4459353,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(NCCNCCOc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCN2CCN(C(=O)c3c[nH]c4ccccc34)CC2)cc1,CHEMBL4406527,IC50,5.55,CHEMBL4533633,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1c[nH]c2ccccc12)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCN2CCN(C(=O)c3cc4c(C)cccc4[nH]3)CC2)cc1,CHEMBL4406527,IC50,6.13,CHEMBL4460818,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4n3C)CC2)cc1,CHEMBL4406527,IC50,5.02,CHEMBL4530116,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4o3)CC2)cc1,CHEMBL4406527,IC50,5.11,CHEMBL4577889,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1cc2ccccc2o1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4s3)CC2)cc1,CHEMBL4406527,IC50,5.29,CHEMBL4472861,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1cc2ccccc2s1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCN2CCN(C(=O)c3ccc(Cl)cc3)CC2)cc1,CHEMBL4406527,IC50,5.05,CHEMBL4513935,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1ccccc1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCN2CCN(C(=O)c3ccc(OC)cc3)CC2)cc1,CHEMBL4406527,IC50,4.8,CHEMBL1700053,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1ccccc1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCN2CCN(C(=O)c3ccc4[nH]ccc4c3)CC2)cc1,CHEMBL4406527,IC50,5.34,CHEMBL4472813,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1ccc2[nH]ccc2c1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCNCCCOc2ccccc2)cc1,CHEMBL671378,Ki,5.71,CHEMBL128276,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OCCNCCCOc2ccccc2)cc1,CHEMBL835389,Ki,5.71,CHEMBL128276,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,40,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1,CHEMBL670394,Ki,6.04,CHEMBL351098,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,14,120,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Oc2ccc(CN3CCC(c4cccc(NC(=O)C(C)C)c4)CC3)cc2)cc1,CHEMBL894444,Ki,5.85,CHEMBL245229,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,53,122,c1ccc(Oc2ccc(CN3CCC(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(Oc2cccc(CN3CCC(c4cccc(NC(=O)C(C)C)c4)CC3)c2)cc1,CHEMBL894444,Ki,6.0,CHEMBL390212,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,53,122,c1ccc(Oc2cccc(CN3CCC(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)C(C)C)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1,CHEMBL674346,Ki,6.7,CHEMBL344531,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)Cc2ccccc2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1,CHEMBL674346,Ki,6.9,CHEMBL145141,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,O=S(=O)(Cc1ccccc1)c1cccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N(C)C)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1,CHEMBL674346,Ki,7.0,CHEMBL280490,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N(C)c2ccccc2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1,CHEMBL674346,Ki,6.2,CHEMBL145545,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,O=S(=O)(Nc1ccccc1)c1cccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N(C)c2ccccc2)cc1-c1ccc(CN2CCCCC[C@@H]2c2ccccc2)[nH]1,CHEMBL674346,Ki,6.3,CHEMBL1788252,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,O=S(=O)(Nc1ccccc1)c1cccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N(C)c2ccccc2)cc1-c1ccc(CN2CCCCC[C@H]2c2ccccc2)[nH]1,CHEMBL674346,Ki,5.8,CHEMBL2093001,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,O=S(=O)(Nc1ccccc1)c1cccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N2CCCc3ccccc32)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1,CHEMBL674346,Ki,6.0,CHEMBL145408,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,O=S(=O)(c1cccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1)N1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N2CCOCC2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1,CHEMBL674346,Ki,7.0,CHEMBL423198,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,O=S(=O)(c1cccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1)N1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N2CCc3ccc(I)cc32)cc1N1CCNCC1,CHEMBL674343,Ki,5.6,CHEMBL414628,2001,CHEMBL1134050,Bioorg Med Chem Lett,Scientific Literature,Compound was evaluated for binding affinity against Dopamine receptor D2 in CHO cells using [125I]iodosulpiride as the radioligand,25,723,O=S(=O)(c1cccc(N2CCNCC2)c1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N2CCc3ccccc3C2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1,CHEMBL674346,Ki,6.7,CHEMBL356526,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,O=S(=O)(c1cccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC,CHEMBL889238,Ki,6.75,CHEMBL228659,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC,CHEMBL889238,Ki,6.97,CHEMBL228608,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC,CHEMBL889238,Ki,6.84,CHEMBL390129,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC,CHEMBL900500,Ki,6.78,CHEMBL390129,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC,CHEMBL889238,Ki,6.84,CHEMBL229085,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC,CHEMBL900500,Ki,6.84,CHEMBL229085,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC,CHEMBL889238,Ki,6.96,CHEMBL228334,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC,CHEMBL900500,Ki,6.95,CHEMBL228334,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC,CHEMBL889238,Ki,6.56,CHEMBL387833,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC,CHEMBL900500,Ki,6.64,CHEMBL387833,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC,CHEMBL889238,Ki,6.7,CHEMBL538397,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC,CHEMBL900500,Ki,6.48,CHEMBL538397,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC,CHEMBL894519,Ki,6.5600000000000005,CHEMBL391530,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,53,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC,CHEMBL900500,Ki,6.87,CHEMBL391530,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC,CHEMBL900500,Ki,6.72,CHEMBL438673,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OCC4CC4)CC3)CC2)cc1OC,CHEMBL894519,Ki,6.91,CHEMBL233584,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,53,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4cc(F)ccc4OC(C)C)CC3)CC2)cc1OC,CHEMBL889238,Ki,7.03,CHEMBL390473,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccc(F)cc4OC(C)C)CC3)CC2)cc1OC,CHEMBL889238,Ki,6.98,CHEMBL228658,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC,CHEMBL889238,Ki,7.26,CHEMBL388361,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC(C)C)CC3)CC2)cc1OC,CHEMBL900500,Ki,7.26,CHEMBL388361,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC,CHEMBL889238,Ki,6.88,CHEMBL228278,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OC4CC4)CC3)CC2)cc1OC,CHEMBL900500,Ki,6.88,CHEMBL228278,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC,CHEMBL889238,Ki,7.08,CHEMBL228389,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC,CHEMBL900500,Ki,7.08,CHEMBL228389,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC,CHEMBL889238,Ki,7.06,CHEMBL228607,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCC(F)F)CC3)CC2)cc1OC,CHEMBL900500,Ki,7.06,CHEMBL228607,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC,CHEMBL889238,Ki,6.55,CHEMBL228606,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,53,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCC(c4ccccc4OCCF)CC3)CC2)cc1OC,CHEMBL900500,Ki,6.55,CHEMBL228606,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC,CHEMBL894519,Ki,7.21,CHEMBL236621,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,53,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1OC,CHEMBL900500,Ki,7.21,CHEMBL236621,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OCC(F)(F)F)CC3)CC2)cc1OC,CHEMBL900500,Ki,6.94,CHEMBL238402,2007,CHEMBL1137555,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,53,446,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)Nc2ccccc2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1,CHEMBL674346,Ki,6.2,CHEMBL144141,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,O=S(=O)(Nc1ccccc1)c1cccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)Oc2ccccc2)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1,CHEMBL674346,Ki,6.0,CHEMBL433552,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,O=S(=O)(Oc1ccccc1)c1cccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)n2cc(C)c3cc(Cl)ccc32)cc1NC1CCN(C)CC1,CHEMBL2185773,Ki,6.52,CHEMBL2179217,2012,CHEMBL2176989,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor,82,724,O=S(=O)(c1cccc(NC2CCNCC2)c1)n1ccc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(=O)(=O)n2cc(C)c3cc(Cl)cnc32)cc1NC1CCN(C)CC1,CHEMBL2185773,Ki,5.74,CHEMBL2179222,2012,CHEMBL2176989,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor,82,724,O=S(=O)(c1cccc(NC2CCNCC2)c1)n1ccc2cccnc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(S(N)(=O)=O)cc1-c1ccc(CN2CCCCCC2c2ccccc2)[nH]1,CHEMBL674346,Ki,6.4,CHEMBL144600,1997,CHEMBL1129847,Bioorg Med Chem Lett,Scientific Literature,"Ability to displace [125I]sulpiride from human Dopamine receptor D2, expressed in CHO cells",11,445,c1ccc(-c2ccc(CN3CCCCCC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc(SC)cc1C(=O)NC[C@@H]1CCCN1CCc1ccccc1,CHEMBL672310,Ki,6.34,CHEMBL356945,2000,CHEMBL1133417,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,22,280,O=C(NCC1CCCN1CCc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc([C@@H]2C[C@H]2NCCC(C(=O)N(C)C)(c2ccccc2)c2ccccc2)cc1,CHEMBL5363864,Ki,5.06,CHEMBL5417643,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,157,244,c1ccc(C(CCNC2CC2c2ccccc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccc(Cl)cc3Cl)CC2)cc1,CHEMBL671074,IC50,8.15,CHEMBL1202206,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",22,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,7.35,CHEMBL429623,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,53,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc([N+](=O)[O-])cc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,7.75,CHEMBL234422,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,53,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]c(C(=O)NC/C=C/CN3CCN(c4ccccc4OC)CC3)cc2c1,CHEMBL3136930,Ki,6.92,CHEMBL3133866,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,90,725,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]c(C(=O)NC/C=C/CN3CCN(c4ccccc4OCCF)CC3)cc2c1,CHEMBL3136930,Ki,7.18,CHEMBL3133865,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,90,725,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]c(C(=O)NCCC(F)CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2c1,CHEMBL1777183,Ki,6.64,CHEMBL1774541,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,78,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]c(C(=O)NCCC(F)CN3CCN(c4ccccc4OC)CC3)cc2c1,CHEMBL1777183,Ki,6.52,CHEMBL1774540,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,78,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]c(C(=O)NCCC(O)CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2c1,CHEMBL3591366,Ki,6.66,CHEMBL1627314,2015,CHEMBL3588810,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,109,726,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]c(C(=O)NCCCCN3CCN(c4cccc5ccccc45)CC3)cc2c1,CHEMBL3599873,Ki,7.86,CHEMBL3597644,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]c(C)c(CCNCc3ccc(-c4ccc(O)cc4)o3)c2c1,CHEMBL4316415,Ki,6.78,CHEMBL4536315,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,143,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]c3c(c2c1)CCN(C)CCc1ccccc1C3,CHEMBL885887,Ki,7.92,CHEMBL396560,2007,CHEMBL1139077,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,53,623,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]c3c(c2c1)CCN=C3c1cc([N+](=O)[O-])cn1C,CHEMBL886705,Ki,3.6989700043360187,CHEMBL241099,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,53,129,c1c[nH]c(C2=NCCc3c2[nH]c2ccccc32)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]c3c(c2c1)CCNC3Cc1ccc2c(c1)OCO2,CHEMBL886705,Ki,5.72,CHEMBL391190,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,53,129,c1ccc2c3c([nH]c2c1)C(Cc1ccc2c(c1)OCO2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C(=O)NC/C=C/CN3CCN(c4ccccc4OC)CC3)c2c1,CHEMBL3136930,Ki,7.93,CHEMBL3133872,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,90,725,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1c[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C(=O)NC/C=C/CN3CCN(c4ccccc4OCCF)CC3)c2c1,CHEMBL3136930,Ki,8.12,CHEMBL3133873,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,90,725,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1c[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C(=O)NCCCCN3CCN(c4ccccc4OCCF)CC3)c2c1,CHEMBL3136930,Ki,8.7,CHEMBL3133871,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,90,725,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1c[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C3=CCN(Cc4cc(=O)[nH]c5ccccc45)CC3)c2c1,CHEMBL4368218,Ki,7.24,CHEMBL4463034,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHO cell membranes,135,727,O=c1cc(CN2CC=C(c3c[nH]c4ccccc34)CC2)c2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C3=CCN(Cc4ccccc4)CC3)c2c1,CHEMBL4368222,Ki,7.2,CHEMBL366081,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,135,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C3=CCN(Cc4ccco4)CC3)c2c1,CHEMBL4368222,Ki,6.85,CHEMBL4543263,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,135,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccco2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C3=CCN(Cc4cccs4)CC3)c2c1,CHEMBL4368222,Ki,6.85,CHEMBL4444351,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,135,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2cccs2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C3CC(=O)N(CCCCN4CCC(c5c[nH]c6ccc(F)cc56)CC4)C3=O)c2c1,CHEMBL4314365,Ki,7.21,CHEMBL4571321,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,135,512,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C3CC(=O)N(CCCCN4CCC(c5c[nH]c6ccccc56)CC4)C3=O)c2c1,CHEMBL4314365,Ki,7.8,CHEMBL4483554,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,135,512,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C3CCN(CCCCN4C(=O)CC(c5c[nH]c6ccc(F)cc56)C4=O)CC3)c2c1,CHEMBL4314365,Ki,7.7,CHEMBL4454176,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,135,512,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C3CCN(CCCCN4C(=O)CC(c5c[nH]c6ccc(OC)cc56)C4=O)CC3)c2c1,CHEMBL4314365,Ki,6.66,CHEMBL4591440,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,135,512,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C3CCN(CCCCN4C(=O)CC(c5c[nH]c6ccccc56)C4=O)CC3)c2c1,CHEMBL2379237,Ki,6.79,CHEMBL2377591,2013,CHEMBL2375249,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr,90,728,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C3CCN(CCCCN4C(=O)CC(c5c[nH]c6ccccc56)C4=O)CC3)c2c1,CHEMBL4314365,Ki,6.79,CHEMBL2377591,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,135,512,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(C3CCN(CCCN4C(=O)CC(c5c[nH]c6ccccc56)C4=O)CC3)c2c1,CHEMBL2379237,Ki,6.46,CHEMBL2377443,2013,CHEMBL2375249,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr,90,728,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c2c1,CHEMBL872394,Ki,7.82,CHEMBL196132,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,40,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CCNCc3ccc(-c4ccc(Cl)cc4)o3)c2c1,CHEMBL4316415,Ki,6.24,CHEMBL4593671,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,143,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CCNCc3ccc(-c4ccc(O)cc4)o3)c2c1,CHEMBL4316415,Ki,6.66,CHEMBL4583082,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,143,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CCNCc3ccc(-c4cccc(O)c4)o3)c2c1,CHEMBL4316415,Ki,6.41,CHEMBL4435528,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,143,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CCNCc3ccc(-c4cn[nH]c4)o3)c2c1,CHEMBL4316415,Ki,5.76,CHEMBL4591410,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,143,544,c1ccc2c(CCNCc3ccc(-c4cn[nH]c4)o3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CCNCc3ccc(-c4cnc5ccccc5c4)o3)c2c1,CHEMBL4316415,Ki,5.99,CHEMBL4448285,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,143,544,c1ccc2ncc(-c3ccc(CNCCc4c[nH]c5ccccc45)o3)cc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CN3CCC(O)(c4ccc(Br)cc4)CC3)c2c1,CHEMBL1176478,Ki,8.6,CHEMBL1170096,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,70,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CN3CCC(O)(c4ccc(Cl)cc4)CC3)c2c1,CHEMBL1176478,Ki,8.38,CHEMBL1170094,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,70,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CN3CCC(O)(c4ccc(I)cc4)CC3)c2c1,CHEMBL1176478,Ki,9.05,CHEMBL1173288,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,70,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CN3CCC(O)(c4ccc(SC)cc4)CC3)c2c1,CHEMBL902495,Ki,8.26,CHEMBL247058,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,53,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CN3CCC(O)(c4ccccc4)CC3)c2c1,CHEMBL1176478,Ki,5.86,CHEMBL1173363,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,70,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)c2c1,CHEMBL1176478,Ki,7.9,CHEMBL1173778,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,70,641,O=c1[nH]c2ccccc2n1C1CCN(Cc2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CN3[C@@H]4CC[C@H]3C[C@](O)(c3ccc(Cl)cc3)C4)c2c1,CHEMBL1033058,Ki,7.41,CHEMBL3084510,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,60,729,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2[nH]cc(CN3[C@@H]4CC[C@H]3C[C@](O)(c3ccc(SC)cc3)C4)c2c1,CHEMBL1033058,Ki,6.26,CHEMBL3084511,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,60,729,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(C(=O)NC/C=C/CN3CCN(c4ccccc4OCCF)CC3)c[nH]c2c1,CHEMBL3136930,Ki,8.23,CHEMBL3133874,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,90,725,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1c[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)C(=O)N(CCN1CCN(c3ccc(Cl)cc3)CC1)CC2,CHEMBL673083,Ki,5.4,CHEMBL330470,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,22,730,O=C1c2ccccc2CCN1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)C(C1=CCN(C)CC1)=Nc1cc(C)ccc1N2,CHEMBL4816284,Ki,6.48,CHEMBL4855524,2021,CHEMBL4813978,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells assessed as inhibition of dopamine-induced calcium accumulation,149,449,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2,CHEMBL4671577,Ki,7.16,CHEMBL4757297,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,143,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)C(CCCN1CCN(c3ccc(Cl)cc3)CC1)CCC2,CHEMBL673083,Ki,6.01,CHEMBL420067,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,23,730,c1ccc(N2CCN(CCCC3CCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)C(CCCN1CCN(c3ccccc3OC)CC1)CCC2,CHEMBL670113,IC50,6.82,CHEMBL424125,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,14,582,c1ccc(N2CCN(CCCC3CCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)C(NCCN1CCN(c3ccc(Cl)cc3)CC1)CCC2,CHEMBL673083,Ki,6.58,CHEMBL328283,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,23,730,c1ccc(N2CCN(CCNC3CCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)C1(CCC2)CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,CHEMBL1261449,Ki,6.6,CHEMBL1258605,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,70,731,c1ccc2c(c1)CCCC21CCN(CCCSc2nnc(-c3cnco3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2,CHEMBL670398,Ki,6.7,CHEMBL294275,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,18,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CC(CN1CCC(C(=O)c3ccc(F)cc3)CC1)CC2=O,CHEMBL670681,Ki,6.42,CHEMBL153956,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,37,584,O=C1CC(CN2CCC(C(=O)c3ccccc3)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O,CHEMBL670681,Ki,6.34,CHEMBL421801,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,37,584,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CC(CN1CCN(c3ccccc3OC)CC1)CC2=O,CHEMBL670681,Ki,6.65,CHEMBL155426,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,37,584,O=C1CC(CN2CCN(c3ccccc3)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CC(N)CC2,CHEMBL670536,Ki,5.24,CHEMBL422274,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,9,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CC(NC(=O)CCN1CCN(c3ccccc3OC)CC1)CC2,CHEMBL670113,IC50,6.19,CHEMBL2373210,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,14,582,O=C(CCN1CCN(c2ccccc2)CC1)NC1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCC(C1CCN(CCc3ccccc3)CC1)C2=O,CHEMBL673013,Ki,6.66,CHEMBL330865,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCC(C1CCN(Cc3ccccc3)CC1)C2=O,CHEMBL673013,Ki,6.27,CHEMBL123014,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCC1(CCN(CCCC(=O)c3ccc(F)cc3)CC1)O2,CHEMBL697295,Ki,8.7,CHEMBL357807,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,29,732,O=C(CCCN1CCC2(CCc3ccccc3O2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCC1(CCN(CCc3ccc(F)cc3F)CC1)O2,CHEMBL697295,Ki,6.24,CHEMBL146233,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,29,732,c1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCCC21CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,CHEMBL1261449,Ki,6.0,CHEMBL1258492,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,70,731,c1ccc2c(c1)CCCC21CCN(CCCSc2nnc(-c3cnco3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCCN(C)CCCc1ccccc1C2,CHEMBL895724,Ki,6.76,CHEMBL231171,2007,CHEMBL1148752,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,53,563,c1ccc2c(c1)CCCNCCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCCN(C)CCc1ccccc1C2,CHEMBL895724,Ki,7.6,CHEMBL389357,2007,CHEMBL1148752,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,53,563,c1ccc2c(c1)CCCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCCN(C)CCc1ccccc1C2,CHEMBL982103,Ki,7.61,CHEMBL389357,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,60,470,c1ccc2c(c1)CCCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCCN(CCCCN1CCN(c3ccccc3OC)CC1)C2=O,CHEMBL1771855,Ki,8.49,CHEMBL1771105,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,78,42,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCCN(CCCCN1CCN(c3ccccc3OC)CC1)C2=O,CHEMBL1771856,Ki,9.03,CHEMBL1771105,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,78,43,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN(C)C2Cc1ccccc1C,CHEMBL1038853,Ki,5.13,CHEMBL594127,2009,CHEMBL1152600,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,64,639,c1ccc(CC2NCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN(C)CCCc1ccccc1C2,CHEMBL895724,Ki,7.06,CHEMBL276778,2007,CHEMBL1148752,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,53,563,c1ccc2c(c1)CCCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN(C)CCCc1ccccc1C2,CHEMBL982103,Ki,7.06,CHEMBL276778,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,60,470,c1ccc2c(c1)CCCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN(C)CCc1c([nH]c3ccccc13)C2,CHEMBL885887,Ki,7.64,CHEMBL396561,2007,CHEMBL1139077,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,53,623,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN(C)CCc1cc(OC)ccc1C2,CHEMBL861435,Ki,8.19,CHEMBL204065,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,47,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN(C)CCc1cc(OC)ccc1C2,CHEMBL861441,Ki,9.21,CHEMBL204065,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,47,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN(C)CCc1ccccc1C2,CHEMBL1038853,Ki,7.89,CHEMBL380330,2009,CHEMBL1152600,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,64,639,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN(C)CCc1ccccc1C2,CHEMBL861435,Ki,7.89,CHEMBL380330,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,47,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN(C)CCc1ccccc1C2,CHEMBL861441,Ki,9.26,CHEMBL380330,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,47,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN(C)CCc1ccccc1C2,CHEMBL885887,Ki,7.89,CHEMBL380330,2007,CHEMBL1139077,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,53,623,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN(C)CCc1ccccc1C2,CHEMBL982103,Ki,7.89,CHEMBL380330,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,60,470,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN1CC[C@](O)(c3ccc(Cl)cc3)C[C@H]21,CHEMBL2346209,IC50,6.0,CHEMBL2335738,2013,CHEMBL2331372,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,90,680,c1ccc(C2CCN3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN1CC[C@](O)(c3ccc(Cl)cc3)C[C@H]21,CHEMBL2346210,Ki,6.71,CHEMBL2335738,2013,CHEMBL2331372,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,90,679,c1ccc(C2CCN3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CCN1Cc3ccccc3CC21,CHEMBL1038853,Ki,6.5,CHEMBL596448,2009,CHEMBL1152600,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,64,639,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)C2,CHEMBL672225,Ki,6.7,CHEMBL161916,2001,CHEMBL1134827,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,25,733,O=C(C=Cc1ccccc1)NC1CCC(CCN2Cc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,CHEMBL2060922,IC50,6.06,CHEMBL2057453,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,82,676,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,CHEMBL2060922,Ki,6.46,CHEMBL2057453,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,82,676,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2,CHEMBL2343279,Ki,6.46,CHEMBL2057453,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)Cc1ccccc1CCCN(C)CC2,CHEMBL895724,Ki,5.86,CHEMBL231374,2007,CHEMBL1148752,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,53,563,c1ccc2c(c1)CCCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)Cc1ccccc1CCN(C)CC2,CHEMBL861435,Ki,7.21,CHEMBL381946,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,47,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)Cc1ccccc1CCN(C)CC2,CHEMBL861441,Ki,7.68,CHEMBL381946,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,47,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)OCC1CN(Cc3ccccc3)CC21,CHEMBL670398,Ki,6.6,CHEMBL59662,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,18,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)OCCN(C)CCc1ccccc1C2,CHEMBL838569,Ki,6.8,CHEMBL184049,2004,CHEMBL1138672,J Med Chem,Scientific Literature,Binding affinity for human recombinant dopamine receptor D2L,37,440,c1ccc2c(c1)CCNCCOc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)C3CCCCC3)[C@@H]1CO2,CHEMBL4825013,Ki,6.16,CHEMBL4862275,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cc(OC)c(OC)c(OC)c3)[C@@H]1CO2,CHEMBL4825013,Ki,6.02,CHEMBL4855879,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cc4ccccc4[nH]3)[C@@H]1CO2,CHEMBL4825013,Ki,6.13,CHEMBL4854351,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccc(-c4ccccc4)cc3)[C@@H]1CO2,CHEMBL4825013,Ki,5.97,CHEMBL4864074,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccc(Br)cc3)[C@@H]1CO2,CHEMBL4825013,Ki,6.02,CHEMBL4853503,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccc(Cl)cc3)[C@@H]1CO2,CHEMBL4825013,Ki,6.01,CHEMBL4860687,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccc([N+](=O)[O-])cc3)[C@@H]1CO2,CHEMBL4825013,Ki,6.23,CHEMBL4864813,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccc4ccccc4c3)[C@@H]1CO2,CHEMBL4825013,Ki,6.19,CHEMBL4864969,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cccc(Cl)c3)[C@@H]1CO2,CHEMBL4825013,Ki,6.11,CHEMBL4853993,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cccc4ccccc34)[C@@H]1CO2,CHEMBL4825013,Ki,6.07,CHEMBL4877715,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccccc3)[C@@H]1CO2,CHEMBL4825013,Ki,6.25,CHEMBL4848710,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cccnc3)[C@@H]1CO2,CHEMBL4825013,Ki,6.13,CHEMBL4862790,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3ccco3)[C@@H]1CO2,CHEMBL4825013,Ki,6.04,CHEMBL4875181,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)[C@H]1OCCN(CCCCNC(=O)c3cccs3)[C@@H]1CO2,CHEMBL4825013,Ki,6.09,CHEMBL4852472,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(-c1[nH]c(N)nc1C)cn2S(=O)(=O)c1ccc2ccccc2c1,CHEMBL4354013,Ki,5.63,CHEMBL4451939,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,135,125,O=S(=O)(c1ccc2ccccc2c1)n1cc(-c2cnc[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(-c1[nH]c(N)nc1C)cn2S(=O)(=O)c1cccc2ccccc12,CHEMBL4354013,Ki,5.88,CHEMBL4442332,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,135,125,O=S(=O)(c1cccc2ccccc12)n1cc(-c2cnc[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(-c1[nH]c(NCC(F)F)nc1C)cn2S(=O)(=O)c1ccccc1,CHEMBL4354013,Ki,5.4,CHEMBL4453733,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,135,125,O=S(=O)(c1ccccc1)n1cc(-c2cnc[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(-c1[nH]c(NCCc3ccccc3)nc1C)cn2S(=O)(=O)c1ccccc1,CHEMBL4354013,Ki,5.67,CHEMBL4519004,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,135,125,O=S(=O)(c1ccccc1)n1cc(-c2cnc(NCCc3ccccc3)[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(-c1[nH]c(NCc3ccccc3)nc1C)cn2S(=O)(=O)c1ccccc1,CHEMBL4354013,Ki,5.93,CHEMBL4520003,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,135,125,O=S(=O)(c1ccccc1)n1cc(-c2cnc(NCc3ccccc3)[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(-c1[nH]c3cccc[n+]3c1C)cn2S(=O)(=O)c1ccccc1,CHEMBL4354013,Ki,5.5,CHEMBL4455699,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,135,125,O=S(=O)(c1ccccc1)n1cc(-c2c[n+]3ccccc3[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(-c1c(C)nc(N)n1CC(F)F)cn2S(=O)(=O)c1ccccc1,CHEMBL4354013,Ki,5.42,CHEMBL4463737,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,135,125,O=S(=O)(c1ccccc1)n1cc(-c2cnc[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(-c1cnc(N)[nH]1)cn2S(=O)(=O)c1cccc(F)c1,CHEMBL4354013,Ki,5.15,CHEMBL4590882,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,135,125,O=S(=O)(c1ccccc1)n1cc(-c2cnc[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(-c1cnc(N)[nH]1)cn2S(=O)(=O)c1ccccc1,CHEMBL4354013,Ki,5.92,CHEMBL4435010,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,135,125,O=S(=O)(c1ccccc1)n1cc(-c2cnc[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(-c1nc3n(c1C)CCCN3)cn2S(=O)(=O)c1ccccc1,CHEMBL4354013,Ki,5.91,CHEMBL4572629,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,135,125,O=S(=O)(c1ccccc1)n1cc(-c2cn3c(n2)NCCC3)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(C1=CCNCC1)cn2S(=O)(=O)c1ccc2cccnc2c1,CHEMBL4426355,Ki,6.62,CHEMBL4447846,2016,CHEMBL4425120,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells by microbeta liquid scintillation counting,117,734,O=S(=O)(c1ccc2cccnc2c1)n1cc(C2=CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(C1=CCNCC1)cn2S(=O)(=O)c1cccc2ncccc12,CHEMBL4426355,Ki,6.52,CHEMBL4440130,2016,CHEMBL4425120,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells by microbeta liquid scintillation counting,117,734,O=S(=O)(c1cccc2ncccc12)n1cc(C2=CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(C1=CCNCC1)cn2S(=O)(=O)c1cncc2ccccc12,CHEMBL4426355,Ki,5.48,CHEMBL4469309,2016,CHEMBL4425120,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells by microbeta liquid scintillation counting,117,734,O=S(=O)(c1cncc2ccccc12)n1cc(C2=CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c(CCN(C)C)cn2S(=O)(=O)c1ccccc1,CHEMBL671380,Ki,6.68,CHEMBL76237,2001,CHEMBL1134783,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 using [3H]spiperone radioligand in CHO cells,25,479,O=S(=O)(c1ccccc1)n1ccc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1)c1c(n2C)Cc2ccccc2CCN(C)CC1,CHEMBL885887,Ki,8.77,CHEMBL245764,2007,CHEMBL1139077,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,53,623,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1O)CN1CCc3cc(O)c(O)cc3C1C2,CHEMBL4339971,IC50,7.12,CHEMBL4438471,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC(C)=O)CN1CCc3cc4c(cc3C1C2)OCO4,CHEMBL4339971,IC50,6.38,CHEMBL2314734,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3,CHEMBL4345338,IC50,7.52,CHEMBL4467483,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,143,458,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3,CHEMBL4345342,IC50,9.91,CHEMBL4467483,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,143,459,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3,CHEMBL4345338,IC50,6.484999999999999,CHEMBL4564103,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,143,458,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3,CHEMBL4345342,IC50,6.44,CHEMBL4564103,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,143,459,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3,CHEMBL4345338,IC50,7.35,CHEMBL4579687,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,143,458,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3,CHEMBL4345342,IC50,5.49,CHEMBL4579687,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,143,459,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3,CHEMBL4345338,IC50,5.71,CHEMBL4513262,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,143,458,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3,CHEMBL4345342,IC50,5.05,CHEMBL4513262,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at D2 long receptor (unknown origin) transfected in human HEK293T cells assessed as increase in cAMP accumulation incubated for 2 hrs by cAMP Glo-sensor assay,143,459,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)-c1ccc(C)c3c1[C@@H](C2)N(C)CC3,CHEMBL4345338,IC50,5.44,CHEMBL4589737,2020,CHEMBL4342494,ACS Med Chem Lett,Scientific Literature,Antagonist activity at C-terminal RLuc8-fused D2 long receptor (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,143,458,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)CN1CCc3cc(O)c(O)cc3C1C2,CHEMBL4339971,IC50,7.4,CHEMBL2314747,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,135,618,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,CHEMBL2343279,Ki,6.92,CHEMBL490533,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,90,663,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,CHEMBL3999639,Ki,7.1,CHEMBL490533,2017,CHEMBL3997822,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor after 1 hr,125,664,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c(n1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21,CHEMBL672175,Ki,6.28,CHEMBL285924,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,18,290,c1ccc2c(c1)CCC1NCc3ncccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(C(F)(F)F)cc1)CC3,CHEMBL5232011,Ki,5.43,CHEMBL91938,2021,CHEMBL5230136,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor assessed as inhibition constant,149,735,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(C(F)(F)F)cc1)CC3,CHEMBL671369,Ki,5.43,CHEMBL91938,1997,CHEMBL1130121,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,11,586,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(C)cc1)CC3,CHEMBL5232011,Ki,5.93,CHEMBL329126,2021,CHEMBL5230136,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor assessed as inhibition constant,149,735,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(C)cc1)CC3,CHEMBL671369,Ki,5.93,CHEMBL329126,1997,CHEMBL1130121,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,11,586,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c3c(c(=O)oc2c1)CN(Cc1cccc(Cl)c1)CC3,CHEMBL5232011,Ki,5.26,CHEMBL90569,2021,CHEMBL5230136,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor assessed as inhibition constant,149,735,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c3c(c(=O)oc2c1)CN(Cc1cccc(Cl)c1)CC3,CHEMBL671369,Ki,5.26,CHEMBL90569,1997,CHEMBL1130121,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,11,586,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccccc1)CC3,CHEMBL5232011,Ki,6.36,CHEMBL328054,2021,CHEMBL5230136,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor assessed as inhibition constant,149,735,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccccc1)CC3,CHEMBL671369,Ki,6.36,CHEMBL328054,1997,CHEMBL1130121,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,11,586,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2c3c(c(=O)oc2c1OC)CN(Cc1ccccc1)CC3,CHEMBL671369,Ki,6.18,CHEMBL330100,1997,CHEMBL1130121,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,11,586,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2cc(S(=O)(=O)N[C@@H]3CCN(CCCc4noc5ccccc45)C3)ccc2c1,CHEMBL4685403,Ki,8.51,CHEMBL4744007,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,143,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2cc(S(=O)(=O)N[C@H]3CCN(CCCc4noc5ccccc45)C3)ccc2c1,CHEMBL4685403,Ki,7.25,CHEMBL4764557,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,143,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2cc([C@H](C)C(=O)NCCCN3CCN(c4ccccc4OC)CC3)ccc2c1,CHEMBL671730,Ki,7.02,CHEMBL126331,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(Cc1ccc2ccccc2c1)NCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2ccnc(N3CCN(CCCCNC(=O)c4cc5cccc(OC)c5o4)CC3)c2c1,CHEMBL861746,Ki,6.29,CHEMBL201027,2006,CHEMBL1148573,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,47,737,O=C(NCCCCN1CCN(c2nccc3ccccc23)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2nc(CCCN3CCC(c4ccccn4)CC3)sc2c1,CHEMBL5324908,Ki,6.37,CHEMBL5399720,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,157,704,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2nc(CCCN3CCC(c4ccccn4)CC3)sc2c1,CHEMBL5324912,IC50,5.58,CHEMBL5399720,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,157,705,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2nc(CCCN3CCC(c4ccccn4)CC3)sc2c1,CHEMBL5324922,IC50,5.35,CHEMBL5399720,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,157,706,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2nc(NC(=O)CCCCN3CCN(c4ccc(Cl)cc4)CC3)sc2c1,CHEMBL3608115,Ki,6.71,CHEMBL3605344,2015,CHEMBL3603825,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,109,738,O=C(CCCCN1CCN(c2ccccc2)CC1)Nc1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2ncc(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)c2c1,CHEMBL4708967,IC50,7.11,CHEMBL4749223,2020,CHEMBL4706522,Eur J Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,143,548,O=c1cnc2ccccc2n1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2ncc(C(=O)NCCC(O)CN3CCN(c4ccccc4OC)CC3)cc2c1,CHEMBL3599873,Ki,6.11,CHEMBL3597653,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2oc(C(=O)NCCC(F)CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2c1,CHEMBL1777183,Ki,6.55,CHEMBL1774533,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,78,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2oc(C(=O)NCCC(F)CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2c1,CHEMBL1777184,IC50,5.8,CHEMBL1774533,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,78,453,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2oc(C(=O)NCCC(F)CN3CCN(c4ccccc4OC)CC3)cc2c1,CHEMBL1777183,Ki,6.56,CHEMBL1774532,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,78,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccc2occ(CN3[C@@H]4CC[C@H]3C[C@](O)(c3ccc(Cl)cc3)C4)c2c1,CHEMBL1033058,Ki,8.82,CHEMBL3084520,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,60,729,c1ccc(C2CC3CCC(C2)N3Cc2coc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(-c2cccc(CN3CCN(c4cccc5nc(O)oc45)CC3)c2)c1,CHEMBL672308,Ki,8.0,CHEMBL309215,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,25,593,c1ccc(-c2cccc(CN3CCN(c4cccc5ncoc45)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)c1,CHEMBL671073,IC50,6.31,CHEMBL64671,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,14,212,c1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(-c2ccccc2CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL5351445,Ki,6.66,CHEMBL5416644,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(-c2ccccc2CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL5351446,Ki,7.06,CHEMBL5416644,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(-c2ccccc2NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL5351445,Ki,6.92,CHEMBL5411404,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(-c2ccccc2NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL5351446,Ki,6.96,CHEMBL5411404,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(-c2csc(CCN3CCN(c4ccccc4OC)CC3)n2)c1,CHEMBL670113,IC50,6.06,CHEMBL2373205,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,14,582,c1ccc(-c2csc(CCN3CCN(c4ccccc4)CC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)c1,CHEMBL895462,Ki,8.1,CHEMBL242599,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,53,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(/C=C/C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)c1,CHEMBL672227,Ki,6.5,CHEMBL416842,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,18,131,O=C(C=Cc1ccccc1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(C#N)cc4CC3)CC2)c1,CHEMBL674940,Ki,6.2,CHEMBL87600,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,23,121,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(OS(C)(=O)=O)cc4CC3)CC2)c1,CHEMBL674348,Ki,7.2,CHEMBL2368618,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,34,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3Cc4ccc(C#N)cc4C3)CC2)c1,CHEMBL672225,Ki,6.0,CHEMBL161853,2001,CHEMBL1134827,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,25,733,O=C(C=Cc1ccccc1)NC1CCC(CCN2Cc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=CCNCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c2cccc(OC)c2)c1,CHEMBL5046486,Ki,5.28,CHEMBL5076359,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,149,253,C(CNCCCCN1CCN(c2ccccc2)CC1)=C(c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)CCCN2CCN(c3ccc(Cl)cc3)CC2)c1,CHEMBL673083,Ki,5.59,CHEMBL327245,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,23,730,O=C(CCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)CCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL670113,IC50,7.89,CHEMBL26677,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,14,582,O=C(CCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL838683,Ki,7.41,CHEMBL175875,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,40,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL672170,Ki,5.81,CHEMBL347290,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL672170,Ki,6.6,CHEMBL152869,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCCN2CCN(c3ccc(Cl)cc3)CC2)c1,CHEMBL672170,Ki,5.63,CHEMBL315879,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCCN2CCN(c3ccc(Cl)cc3)CC2)c1,CHEMBL673083,Ki,5.63,CHEMBL315879,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,23,730,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCCN2CCN(c3cccc(C)c3C)CC2)c1,CHEMBL672170,Ki,7.11,CHEMBL433741,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL672170,Ki,5.85,CHEMBL152391,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCCN2CCN(c3cccc4ccccc34)CC2)c1,CHEMBL672170,Ki,6.03,CHEMBL152756,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL672170,Ki,6.17,CHEMBL152159,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCCN2CCN(c3nccc4ccccc34)CC2)c1,CHEMBL672170,Ki,6.11,CHEMBL152587,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCN1CCN(c2nccc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCCN2CCN(c3noc4ccccc34)CC2)c1,CHEMBL672170,Ki,6.68,CHEMBL423040,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCN2CCN(c3ccc(Cl)cc3)CC2)c1,CHEMBL672170,Ki,5.4,CHEMBL92713,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCN2CCN(c3ccc(Cl)cc3)CC2)c1,CHEMBL673083,Ki,5.4,CHEMBL92713,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,23,730,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL672170,Ki,5.95,CHEMBL152576,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL672170,Ki,5.52,CHEMBL357448,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCN2CCN(c3ccc(C)cc3)CC2)c1,CHEMBL672170,Ki,5.13,CHEMBL156845,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1,CHEMBL672170,Ki,5.72,CHEMBL93403,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCN2CCN(c3ccc(Cl)cc3)CC2)c1,CHEMBL673083,Ki,5.72,CHEMBL93403,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,23,730,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL672170,Ki,5.43,CHEMBL156599,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL670113,IC50,6.16,CHEMBL286725,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,14,582,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL672170,Ki,6.33,CHEMBL286725,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NCc2ccccc2CN2CCc3cc(OC)c(O)cc3C2)c1,CHEMBL4822008,Ki,6.85,CHEMBL4867331,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),149,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)c1,CHEMBL911524,Ki,6.86,CHEMBL384069,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,47,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)c1,CHEMBL870468,Ki,5.95,CHEMBL214016,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,47,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C(=O)NN2c3ccccc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)c1,CHEMBL911524,Ki,5.86,CHEMBL213239,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,47,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c1,CHEMBL1107668,Ki,6.65,CHEMBL1080489,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,70,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C2=NCCc3c2[nH]c2ccc(OC)cc32)c1,CHEMBL886705,Ki,4.6,CHEMBL241082,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,53,129,c1ccc(C2=NCCc3c2[nH]c2ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C2=NCCc3c2[nH]c2ccccc32)c1,CHEMBL886705,Ki,4.51,CHEMBL240888,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,53,129,c1ccc(C2=NCCc3c2[nH]c2ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C2CCCN(CCN3CCN(c4cccc(Cl)c4)C3=O)C2)c1,CHEMBL1044430,Ki,7.6,CHEMBL556496,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,64,233,O=C1N(CCN2CCCC(c3ccccc3)C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(C2CCCN(CCN3CCN(c4cccc(Cl)c4)C3=O)C2)c1,CHEMBL1059864,Ki,7.6,CHEMBL556496,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,64,234,O=C1N(CCN2CCCC(c3ccccc3)C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CC(=O)N2CCC(C)c3cccc(CCN4CCN(c5nsc6ccccc56)CC4)c32)c1,CHEMBL872392,Ki,8.4,CHEMBL199161,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,40,103,O=C(Cc1ccccc1)N1CCCc2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CC2NCCc3c2[nH]c2ccc(OC)cc32)c1,CHEMBL886705,Ki,5.82,CHEMBL393275,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,53,129,c1ccc(CC2NCCc3c2[nH]c2ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CC2NCCc3c2[nH]c2ccccc32)c1,CHEMBL886705,Ki,5.8,CHEMBL319005,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,53,129,c1ccc(CC2NCCc3c2[nH]c2ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCCCN2CCN(Cc3cc4ccccc4o3)CC2)c1,CHEMBL1839313,Ki,6.32,CHEMBL1834260,2011,CHEMBL1833923,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,78,708,c1ccc(CCCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCCCN2CCN(c3ccc(Cl)cc3)CC2)c1,CHEMBL673083,Ki,5.56,CHEMBL318747,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,23,730,c1ccc(CCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCCN2CCN(Cc3cc4ccccc4o3)CC2)c1,CHEMBL1839313,Ki,6.25,CHEMBL1834257,2011,CHEMBL1833923,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,78,708,c1ccc(CCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)c1,CHEMBL1044430,Ki,7.3,CHEMBL563926,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,64,233,O=C1N(CCNCCc2ccccc2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)c1,CHEMBL1059864,Ki,7.3,CHEMBL563926,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,64,234,O=C1N(CCNCCc2ccccc2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCCCCN2CCN(c3ccc(F)cc3)CC2)c1,CHEMBL938581,Ki,3.0721165896692932,CHEMBL514098,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCCCN2CCN(c3ccc(F)cc3)CC2)c1,CHEMBL938581,Ki,2.8781120148963186,CHEMBL456673,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL938581,Ki,4.17,CHEMBL516334,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCCCN2CCN(c3ncccn3)CC2)c1,CHEMBL938581,Ki,3.0685421293109947,CHEMBL487760,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCCCN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCCN2CCN(C)CC2)c1,CHEMBL938581,Ki,3.2479515521805613,CHEMBL518931,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCCN2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCCN2CCN(c3ccc(F)cc3)CC2)c1,CHEMBL938581,Ki,3.183758700008217,CHEMBL457921,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)c1,CHEMBL938581,Ki,2.850165303284215,CHEMBL457899,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCCN2CCN(c3cccc(Cl)c3)CC2)c1,CHEMBL938581,Ki,3.5257837359237447,CHEMBL458792,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL938581,Ki,5.2,CHEMBL456647,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCCN2CCN(c3ncccn3)CC2)c1,CHEMBL938581,Ki,4.7,CHEMBL456675,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCCN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCCN2CCc3ccccc3C2)c1,CHEMBL938581,Ki,3.9430951486635273,CHEMBL485720,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCCN2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCN2CCN(C)CC2)c1,CHEMBL938581,Ki,3.7495799976911064,CHEMBL487960,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCN2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCN2CCN(c3ccccc3OC)CC2)c1,CHEMBL938581,Ki,3.369572124974976,CHEMBL514286,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCCN2CCN(c3ncccn3)CC2)c1,CHEMBL938581,Ki,3.201349354554731,CHEMBL456674,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,60,739,c1ccc(CCc2ccccc2OCCN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCc2cccc(OC)c2)c1,CHEMBL907725,Ki,5.3,CHEMBL217886,2006,CHEMBL1137322,J Med Chem,Scientific Literature,Binding affinity to D2 receptor,47,72,c1ccc(CCc2ccccc2OCc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCc2ccccc2)c1,CHEMBL907725,Ki,5.3,CHEMBL214739,2006,CHEMBL1137322,J Med Chem,Scientific Literature,Binding affinity to D2 receptor,47,72,c1ccc(CCc2ccccc2OCc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCc2ccccn2)c1,CHEMBL907725,Ki,5.3,CHEMBL387052,2006,CHEMBL1137322,J Med Chem,Scientific Literature,Binding affinity to D2 receptor,47,72,c1ccc(CCc2ccccc2OCc2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CCc2ccccc2OCc2cccnc2)c1,CHEMBL907725,Ki,5.3,CHEMBL217281,2006,CHEMBL1137322,J Med Chem,Scientific Literature,Binding affinity to D2 receptor,47,72,c1ccc(CCc2ccccc2OCc2cccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CN(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c2ccc(F)cc2)c1,CHEMBL4323478,Ki,6.96,CHEMBL4550633,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,135,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CN(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c2ccc(F)cc2)c1,CHEMBL4323479,Ki,7.21,CHEMBL4550633,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,135,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CN2CC=C(c3c[nH]c4ccc(OC(C)C)cc34)CC2)c1,CHEMBL4368222,Ki,6.52,CHEMBL4460839,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,135,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CN2CC=C(c3c[nH]c4ccc(OC)cc34)CC2)c1,CHEMBL4368222,Ki,6.95,CHEMBL4460564,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,135,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CN2CC=C(c3c[nH]c4ccccc34)CC2)c1,CHEMBL4368222,Ki,7.57,CHEMBL4552542,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,135,60,C1=C(c2c[nH]c3ccccc23)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CN2CCC(n3c(O)nc(-c4ccccc4)c3C)CC2)c1,CHEMBL671375,Ki,6.05,CHEMBL91155,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CN2CCN(Cc3cc4ccccc4o3)CC2)c1,CHEMBL1219344,Ki,5.24,CHEMBL1214894,2010,CHEMBL1212881,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,71,426,c1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CN2CC[C@H](NC(=O)c3ccc(-c4cccs4)cc3)C2)c1,CHEMBL860444,Ki,5.35,CHEMBL427555,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,40,740,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,CHEMBL2328744,IC50,6.05,CHEMBL2326480,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,90,466,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CN2CCc3cc4nc(N)sc4cc3CC2)c1,CHEMBL2328745,Ki,7.47,CHEMBL2326480,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,90,467,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CNCCN2CCN(c3ccc(Cl)cc3)CC2)c1,CHEMBL673083,Ki,5.3,CHEMBL96462,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,23,730,c1ccc(CNCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(CNCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)sc34)c2)c1,CHEMBL1947794,IC50,6.1,CHEMBL1945044,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,82,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)c1,CHEMBL3776608,Ki,6.4,CHEMBL3774412,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,117,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CC(O)CN3C(=O)NC(C)(c4ccc(F)cc4)C3=O)CC2)c1,CHEMBL3771916,Ki,5.29,CHEMBL3769441,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,117,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCCCCCN3C(=O)c4cccc5cccc(c45)C3=O)CC2)c1,CHEMBL4390409,Ki,6.57,CHEMBL4532741,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,135,490,O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCCCCCN3C(=O)c4cccc5cccc3c45)CC2)c1,CHEMBL4390409,Ki,6.94,CHEMBL4542754,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,135,490,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCCCCCN3C(=O)c4ccccc4S3(=O)=O)CC2)c1,CHEMBL4308346,Ki,6.95,CHEMBL4456046,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,135,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCCCN3CCc4ccccc4C3=O)CC2)c1,CHEMBL993531,Ki,6.8,CHEMBL478688,2009,CHEMBL1153914,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,64,741,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4n3C)CC2)c1,CHEMBL3381713,Ki,6.66,CHEMBL3358102,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),100,574,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCCCNC(=O)c3ccc(-c4ccsc4)cc3)CC2)c1,CHEMBL4350893,Ki,5.74,CHEMBL4570430,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",136,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCCCNC(=O)c3ccc(-n4ccnc4)cc3)CC2)c1,CHEMBL938625,Ki,6.61,CHEMBL514562,2009,CHEMBL1140855,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,64,673,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-n2ccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCCCNC(=O)c3n[nH]c4ccccc34)CC2)c1,CHEMBL5362774,Ki,6.97,CHEMBL5409227,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,157,491,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCCCn3ncc(=O)n(C)c3=O)CC2)c1,CHEMBL861210,Ki,5.59,CHEMBL426317,2006,CHEMBL1146943,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 dopamine receptor by radioligand binding assay,47,742,O=c1cnn(CCCCN2CCN(c3ccccc3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCCN3C(=O)CCc4ccccc43)CC2)c1,CHEMBL5106582,Ki,5.51,CHEMBL5191408,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,153,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1,CHEMBL1044430,Ki,6.9,CHEMBL563435,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,64,233,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1,CHEMBL1059864,Ki,6.9,CHEMBL563435,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,64,234,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,CHEMBL1057875,Ki,6.8,CHEMBL559920,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,64,166,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCN3CCCCCC3)C2=O)c1,CHEMBL1106075,Ki,7.4,CHEMBL1081487,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,71,556,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCN3CCN(C(C)C)CC3)C2=O)c1,CHEMBL1057875,Ki,5.6,CHEMBL550358,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,64,166,O=C1N(CCN2CCNCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCNC(=O)c3cc(Br)c4ccccc4c3OC)CC2)c1,CHEMBL672800,Ki,5.89,CHEMBL29849,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,9,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCOc3ccc4[nH]c(=O)[nH]c4c3)CC2)c1,CHEMBL3073105,Ki,7.35,CHEMBL2299003,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),90,427,O=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CCOc3ccc4[nH]c(=S)[nH]c4c3)CC2)c1,CHEMBL3073105,Ki,7.88,CHEMBL2298830,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),90,427,S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)N(C)C)CC3)CC2)c1F,CHEMBL5381008,Ki,6.87,CHEMBL5427695,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,157,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4cccs4)CC3)CC2)c1,CHEMBL671651,Ki,7.92,CHEMBL310577,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,11,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1,CHEMBL671074,IC50,6.77,CHEMBL1202217,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(NC(=O)CCN2CCN(c3ccc(Cl)cc3)CC2)c1,CHEMBL673083,Ki,6.55,CHEMBL329228,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,23,730,O=C(CCN1CCN(c2ccccc2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(Nc2nc(Cc3ccccc3)nc3c2CCNCC3)c1,CHEMBL2396124,IC50,6.79,CHEMBL2393246,2013,CHEMBL2390866,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,90,743,c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(OC)c1-c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL673593,Ki,5.69,CHEMBL283065,2001,CHEMBL1134402,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,25,247,c1ccc(-c2cccc3c2-c2cccc4c2C(C3)NCC4)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(OC)c1-c1cccc2c1CC[C@H](N(C)C)C2,CHEMBL830366,Ki,6.62,CHEMBL363466,2004,CHEMBL1138658,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to human dopamine D2A receptor expressed in Ltk cells,37,343,c1ccc(-c2cccc3c2CCCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21,CHEMBL911524,Ki,7.01,CHEMBL212807,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,47,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL870468,Ki,6.47,CHEMBL425069,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,47,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL870474,Ki,6.47,CHEMBL425069,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at dopamine D2 receptor,47,566,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL911524,Ki,6.47,CHEMBL425069,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,47,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(OC)c1C(=O)NN1c2ccccc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21,CHEMBL911524,Ki,6.71,CHEMBL215414,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,47,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(OC)c1CC(=O)N1CCC(C)c2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c21,CHEMBL872392,Ki,7.96,CHEMBL262469,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,40,103,O=C(Cc1ccccc1)N1CCCc2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(OCCN2CCN(C(=O)c3cc4cnccc4[nH]3)CC2)c1,CHEMBL4406527,IC50,5.13,CHEMBL4594046,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1cc2cnccc2[nH]1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc(OCCN2CCN(C(=O)c3nc4ccccc4[nH]3)CC2)c1,CHEMBL4406527,IC50,5.7,CHEMBL4471623,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,143,455,O=C(c1nc2ccccc2[nH]1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,CHEMBL671362,Ki,5.89,CHEMBL74355,2000,CHEMBL1132835,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]-spiperone from CHO cells expressing human Dopamine receptor D2 was determined,23,744,c1ccc(CCN2CCC(Cc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,CHEMBL697295,Ki,5.89,CHEMBL74355,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,29,732,c1ccc(CCN2CCC(Cc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,CHEMBL830303,Ki,5.89,CHEMBL74355,2005,CHEMBL1142766,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2,40,745,c1ccc(CCN2CCC(Cc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC,CHEMBL961033,Ki,5.65,CHEMBL74355,2009,CHEMBL1153452,Bioorg Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor by competitive binding experiment,64,746,c1ccc(CCN2CCC(Cc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2[nH]cc(CCNCc3ccc(-c4ccc(O)cc4)o3)c12,CHEMBL4316415,Ki,6.75,CHEMBL4474618,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,143,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2[nH]cc(CN3CCC(O)(c4ccc(Br)cc4)CC3)c12,CHEMBL1176478,Ki,8.64,CHEMBL1170095,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,71,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2[nH]cc(CN3CCC(O)(c4ccc(Cl)cc4)CC3)c12,CHEMBL1176478,Ki,8.38,CHEMBL1169904,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,71,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2[nH]cc(CN3CCC(O)(c4ccc(I)cc4)CC3)c12,CHEMBL1176478,Ki,9.05,CHEMBL1173287,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,71,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2[nH]cc(CN3CCC(O)(c4ccc(I)cc4)CC3)c12,CHEMBL3239709,Ki,9.05,CHEMBL1200270,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,100,448,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2[nH]cc(CN3CCC(n4c(=O)[nH]c5ccccc54)CC3)c12,CHEMBL1176478,Ki,7.63,CHEMBL1173436,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,71,641,O=c1[nH]c2ccccc2n1C1CCN(Cc2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1-c1cccc3c1[C@@H](C2)N(C(C)C)CC3,CHEMBL670880,Ki,6.0,CHEMBL115402,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,9,99,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670880,Ki,6.26,CHEMBL117841,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,9,99,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1C1CCN(CCc3ccccc3)[C@H]1CC2,CHEMBL672487,Ki,6.41,CHEMBL416519,1993,CHEMBL1127015,J Med Chem,Scientific Literature,"Compound was evaluated for the binding affinity against [3H]U-86,170-labeled dopamine receptor D2 in cloned CHO cells",2,747,c1ccc(CCN2CCC3c4ccccc4CCC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CC(CNCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2,CHEMBL670073,IC50,7.53,CHEMBL416523,1996,CHEMBL1129704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,9,329,O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CC1(CCCN1CCCCN1C(=O)CC3(CCCC3)CC1=O)CO2,CHEMBL670678,IC50,5.96,CHEMBL11265,1996,CHEMBL1129704,Bioorg Med Chem Lett,Scientific Literature,Compound was evaluated for the binding affinity towards Dopamine receptor D2 by displacement of [3H]SCH-23390.,9,748,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCCC12COc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CCC(N(C)C)C2,CHEMBL670536,Ki,6.74,CHEMBL134866,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,9,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CCC(N(C)CCCCNC(=O)c1ccc(-c3ccccc3)cc1)C2,CHEMBL672226,Ki,6.5,CHEMBL59554,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,11,358,O=C(NCCCCNC1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CCC(N)C2,CHEMBL670536,Ki,6.48,CHEMBL30560,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,9,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CCCC(=O)N2CCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1,CHEMBL853595,Ki,6.61,CHEMBL202704,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,47,53,O=C1CCCc2ccccc2N1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CCCC21CCN(CCCSc2nnc(-c3ocnc3C)n2C)C1,CHEMBL1261449,Ki,6.4,CHEMBL1258493,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,71,731,c1ccc2c(c1)CCCC21CCN(CCCSc2nnc(-c3cnco3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CCCC2CCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL673083,Ki,5.47,CHEMBL321557,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,23,730,c1ccc(N2CCN(CCCC3CCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CCCC2NCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL673083,Ki,5.5,CHEMBL2112375,2000,CHEMBL1133667,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 (long) by [3H]spiroperidol displacement.,23,730,c1ccc(N2CCN(CCNC3CCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CCN(CCN1CCN(c3ccc(Cl)cc3)CC1)C2=O,CHEMBL673084,Ki,5.5,CHEMBL96799,2000,CHEMBL1133667,J Med Chem,Scientific Literature,"In vitro binding affinity towards human Dopamine receptor D2L, using [3H]spiroperidol radioligand in Sf9 baculovirus expression.",23,749,O=C1c2ccccc2CCN1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CCN2C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,6.31,CHEMBL319650,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,29,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CC[C@@H](NCc1ccccc1)C2,CHEMBL669147,Ki,5.88,CHEMBL65896,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,18,331,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CC[C@@H](NCc1ccccc1)C2,CHEMBL669148,Ki,6.0,CHEMBL65896,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,18,332,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CC[C@@H]1[C@@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.1,CHEMBL97149,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,14,750,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CC[C@H]1CN(CCn3c(=O)[nH]c4c(sc5cccnc54)c3=O)C[C@@H]21,CHEMBL670782,Ki,7.71,CHEMBL40650,1997,CHEMBL1130166,J Med Chem,Scientific Literature,Binding affinity against Dopamine receptor D2 using [3H]spiroperidol as radioligand,11,751,O=c1[nH]c2c(sc3cccnc32)c(=O)n1CCN1CC2CCc3ccccc3C2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CC[C@H]1[C@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.3,CHEMBL2111591,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,14,750,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1CC[C@H]1[C@H]2CCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.2,CHEMBL97118,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,14,750,O=C(NCCCCN1CCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1C[C@@H]1c3c(cc4c(c3-2)OCO4)CCN1C,CHEMBL5371295,IC50,6.07,CHEMBL601020,2023,CHEMBL5370537,Eur J Med Chem,Scientific Literature,Antagonist activity at D2R (unknown origin),157,626,c1ccc2c(c1)CC1NCCc3cc4c(c-2c31)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1Cc1ccccc1CCN(C)CC2,CHEMBL861435,Ki,6.79,CHEMBL379662,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from D2L dopamine receptor,47,624,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c1Cc1ccccc1CCN(C)CC2,CHEMBL861441,Ki,7.4,CHEMBL379662,2006,CHEMBL1138197,J Med Chem,Scientific Literature,Inhibition of D2L dopamine receptor in HEK 293 cells by intracellular calcium assay,47,625,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c3c(oc12)CN(C/C=C/COc1ccc2ccc(=O)[nH]c2c1)CC3,CHEMBL5385535,Ki,6.855,CHEMBL5414097,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=c1ccc2ccc(OCC=CCN3CCc4c(oc5ccccc45)C3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c3c(oc12)CN(CCCCOc1ccc2c(c1)NC(=O)C2)CC3,CHEMBL5385535,Ki,5.495,CHEMBL5415178,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=C1Cc2ccc(OCCCCN3CCc4c(oc5ccccc45)C3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c3c(oc12)CN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC3,CHEMBL5385535,Ki,7.405,CHEMBL5409419,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=C1CCc2ccc(OCCCCN3CCc4c(oc5ccccc45)C3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC3,CHEMBL5385535,Ki,7.07,CHEMBL5426242,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=c1ccc2ccc(OCCCCN3CCc4c(oc5ccccc45)C3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)n(C)c2c1)CC3,CHEMBL5385535,Ki,5.64,CHEMBL5395417,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=c1ccc2ccc(OCCCCN3CCc4c(oc5ccccc45)C3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)oc2c1)CC3,CHEMBL5385535,Ki,6.535,CHEMBL5393856,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=c1ccc2ccc(OCCCCN3CCc4c(oc5ccccc45)C3)cc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c3c(oc12)CN(CCCCOc1ccc2cccnc2c1)CC3,CHEMBL5385535,Ki,5.87,CHEMBL5402456,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,c1cnc2cc(OCCCCN3CCc4c(oc5ccccc45)C3)ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c3c(oc12)CN(CCCCOc1ccc2scnc2c1)CC3,CHEMBL5385535,Ki,4.585,CHEMBL5410217,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,c1ccc2c3c(oc2c1)CN(CCCCOc1ccc2scnc2c1)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c3c(oc12)CN(CCCOc1ccc2c(c1)NC(=O)CC2)CC3,CHEMBL5385535,Ki,6.69,CHEMBL5433201,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=C1CCc2ccc(OCCCN3CCc4c(oc5ccccc45)C3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2c3c(oc12)CN(CCCOc1ccc2ccc(=O)[nH]c2c1)CC3,CHEMBL5385535,Ki,6.825,CHEMBL5427288,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=c1ccc2ccc(OCCCN3CCc4c(oc5ccccc45)C3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2cc(C(=O)NCCCCN3CCN(c4[nH]nc5ccccc45)CC3)oc12,CHEMBL861746,Ki,7.25,CHEMBL202713,2006,CHEMBL1148573,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,47,737,O=C(NCCCCN1CCN(c2[nH]nc3ccccc23)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)oc12,CHEMBL672170,Ki,6.43,CHEMBL196476,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,29,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)oc12,CHEMBL861746,Ki,6.43,CHEMBL196476,2006,CHEMBL1148573,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,47,737,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2cc(C(=O)NCCCCN3CCN(c4cccc5nccnc45)CC3)oc12,CHEMBL861746,Ki,5.9,CHEMBL201326,2006,CHEMBL1148573,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,47,737,O=C(NCCCCN1CCN(c2cccc3nccnc23)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2cc(CNCCCCOc3ccc4c(c3)NC(=O)CC4)oc12,CHEMBL5385535,Ki,7.475,CHEMBL5425434,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=C1CCc2ccc(OCCCCNCc3cc4ccccc4o3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2cc(CNCCCCOc3ccc4ccc(=O)[nH]c4c3)oc12,CHEMBL5385535,Ki,8.395,CHEMBL5417857,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=c1ccc2ccc(OCCCCNCc3cc4ccccc4o3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2cc(CNCCCCOc3ccc4ccc(=O)[nH]c4c3)sc12,CHEMBL5385535,Ki,6.15,CHEMBL5396612,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=c1ccc2ccc(OCCCCNCc3cc4ccccc4s3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2cc(CNCCCOc3ccc4ccc(=O)[nH]c4c3)sc12,CHEMBL5385535,Ki,6.74,CHEMBL5405133,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,157,201,O=c1ccc2ccc(OCCCNCc3cc4ccccc4s3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2nc(CCCN3CCC(c4ccccn4)CC3)sc12,CHEMBL5324908,Ki,6.17,CHEMBL5406300,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,157,704,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2nc(CCCN3CCC(c4ccccn4)CC3)sc12,CHEMBL5324912,IC50,5.74,CHEMBL5406300,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,157,705,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2nc(CCCN3CCC(c4ccccn4)CC3)sc12,CHEMBL5324922,IC50,5.65,CHEMBL5406300,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,157,706,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n12,CHEMBL4619928,IC50,7.91,CHEMBL4634009,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,143,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1-c1cc2c(=O)n(CCN3CCN(c4ccccc4Cl)CC3)c(=O)[nH]c2[nH]1,CHEMBL864519,Ki,6.44,CHEMBL197656,2006,CHEMBL1148546,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,47,688,O=c1[nH]c2[nH]c(-c3ccccc3)cc2c(=O)n1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1-c1cccc(CN2CCN(c3ncccn3)CC2)c1,CHEMBL671073,IC50,6.44,CHEMBL64487,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,14,212,c1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1-c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670881,Ki,5.88,CHEMBL333085,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride fromd human Dopamine receptor D2A expressed in LtK- cells,9,137,c1ccc(-c2cccc3c2-c2cccc4c2C(C3)NCC4)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1-c1cn(CCC(O)CN2CCN(c3ccccc3OC)CC2)nn1,CHEMBL3591124,Ki,5.99,CHEMBL3588992,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,109,753,c1ccc(-c2cn(CCCCN3CCN(c4ccccc4)CC3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1-c1nnc(SCCCN2CCC3(CC2)CCN(c2ccccc2OC)CC3)n1C,CHEMBL4397357,Ki,5.67,CHEMBL4590969,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1-c1nnc(SCCCN2CCc3ccc(-c4cc(C)on4)cc3CC2)n1C,CHEMBL895462,Ki,7.1,CHEMBL390429,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,53,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1/C=C/C(=O)NCCCCN1CCN(c2ccccc2OC)CC1,CHEMBL671730,Ki,7.85,CHEMBL126441,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1/C=C/C(=O)N[C@H]1CC[C@H](CCN2CCc3ccc(OS(C)(=O)=O)cc3CC2)CC1,CHEMBL674348,Ki,7.0,CHEMBL2368633,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,34,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C(=O)CCCCCN1CCN(c2noc3ccccc23)CC1,CHEMBL672386,Ki,7.11,CHEMBL159022,2003,CHEMBL1145970,J Med Chem,Scientific Literature,Binding affinity of compound was tested for Dopamine receptor D2L,34,754,O=C(CCCCCN1CCN(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C(=O)NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL838683,Ki,8.43,CHEMBL414839,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,40,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C(=O)NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21,CHEMBL4825013,Ki,6.06,CHEMBL4849734,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,149,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C(=O)NCCN1CCN(c2ccccc2OC)CC1,CHEMBL670113,IC50,6.09,CHEMBL356358,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,14,582,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL911524,Ki,5.95,CHEMBL379560,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,47,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C(c1ccccc1)N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL897619,Ki,6.2,CHEMBL240600,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,53,755,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C(c1ccccc1OC)N1CCN(CCCCNC(=O)/C=C/c2ccccc2)CC1,CHEMBL897619,Ki,6.01,CHEMBL240564,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,53,755,O=C(C=Cc1ccccc1)NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C(c1ccccc1OC)N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL897619,Ki,6.21,CHEMBL391120,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,53,755,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C(c1ccccc1OC)N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL897619,Ki,6.5,CHEMBL391895,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,53,755,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNC/C=C/COc1ccc2c(c1)NC(=O)CC2,CHEMBL4842092,Ki,6.34,CHEMBL4855775,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=C1CCc2ccc(OCC=CCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNC/C=C/COc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,6.9,CHEMBL4871762,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCC=CCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNCCCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4842092,Ki,6.59,CHEMBL4859394,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=C1CCc2ccc(OCCCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNCCCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,6.66,CHEMBL4871774,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4842092,Ki,7.21,CHEMBL4862301,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=C1CCc2ccc(OCCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,7.22,CHEMBL4872548,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4842092,Ki,6.9,CHEMBL4863992,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=C1CCc2ccc(OCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,6.81,CHEMBL4850635,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=c1ccc2ccc(OCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NC(=O)N(C)C)CC1,CHEMBL4842092,Ki,5.74,CHEMBL4845711,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,c1ccc(C2CC2CNCCC2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NC(=O)N2CCCC2)CC1,CHEMBL4842092,Ki,5.66,CHEMBL4874131,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=C(NC1CCC(CCNCC2CC2c2ccccc2)CC1)N1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NC(=O)c2ccccc2)CC1,CHEMBL4842092,Ki,5.98,CHEMBL4876611,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=C(NC1CCC(CCNCC2CC2c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CC1CNCC[C@H]1CC[C@H](NS(=O)(=O)c2ccccc2)CC1,CHEMBL4842092,Ki,6.01,CHEMBL4864369,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,149,362,O=S(=O)(NC1CCC(CCNCC2CC2c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1C1CCN(CNC(=O)c2cccc(C)c2)CC1,CHEMBL910434,Ki,7.57,CHEMBL376092,2006,CHEMBL1137302,J Med Chem,Scientific Literature,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,47,635,O=C(NCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CCCCN1CCN(Cc2cc3ccccc3o2)CC1,CHEMBL1839313,Ki,6.37,CHEMBL1834259,2011,CHEMBL1833923,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,78,708,c1ccc(CCCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CCCN1CCN(Cc2cc3ccccc3o2)CC1,CHEMBL1839313,Ki,5.23,CHEMBL1834256,2011,CHEMBL1833923,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,78,708,c1ccc(CCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CCN1CCN(Cc2cc3ccccc3o2)CC1,CHEMBL1839313,Ki,5.78,CHEMBL1834252,2011,CHEMBL1833923,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,78,708,c1ccc(CCN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CCNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,CHEMBL1947794,IC50,6.2,CHEMBL1944694,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,82,225,O=c1[nH]c2cccc(CCNCCc3ccc(CNCCc4ccccc4)cc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CCNc1nc(N)nc(NCCc2c[nH]c3ccccc23)n1,CHEMBL5121178,Ki,4.88,CHEMBL5174637,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,153,756,c1ccc(CCNc2ncnc(NCCc3c[nH]c4ccccc34)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CN(C)Cc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,CHEMBL1947794,IC50,6.0,CHEMBL1945291,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,82,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CN1CCN(CC(=O)N2c3ccccc3CC2C)CC1,CHEMBL872891,Ki,6.65,CHEMBL321734,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",29,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CN1CCN(Cc2cc3ccccc3o2)CC1,CHEMBL1219344,Ki,5.29,CHEMBL1214961,2010,CHEMBL1212881,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,71,426,c1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CNCCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,CHEMBL1947794,IC50,6.0,CHEMBL1945299,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,82,225,O=c1[nH]c2cccc(CCNCCc3cccc(CCNCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CNCc1ccc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,CHEMBL1947794,IC50,5.7,CHEMBL1945504,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,82,225,O=c1[nH]c2cccc(CCNCCc3ccc(CNCc4ccccc4)cc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CNCc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)cc1,CHEMBL1947794,IC50,5.6,CHEMBL1945040,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,82,225,O=c1[nH]c2cccc(CCNCCc3ccc(CNCc4ccccc4)cc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CNCc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)sc23)c1,CHEMBL1947794,IC50,6.0,CHEMBL1945039,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,82,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1CNN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL911524,Ki,6.7,CHEMBL211910,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,47,194,c1ccc(CNN2c3ccccc3N=C(N3CCNCC3)c3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N(C(=O)c1ccccc1)C1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL897619,Ki,5.33,CHEMBL241018,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,53,755,O=C(NCCCCN1CCC(N(C(=O)c2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N(C(C)=O)C1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL897619,Ki,4.88,CHEMBL238875,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,53,755,O=C(NCCCCN1CCC(Nc2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1C=CC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)CC1,CHEMBL4397357,Ki,6.71,CHEMBL4525842,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,C1=CC2(CCN(CCCSc3nnc(-c4ccccc4)[nH]3)CC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)C1,CHEMBL4032441,Ki,4.42,CHEMBL4071189,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,125,714,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CN(c3ccccc3)C4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CC2(CN(CCCSc3nnc(-c4ccccc4)n3C)C2)C1,CHEMBL4032441,Ki,4.67,CHEMBL4077251,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,125,714,c1ccc(-c2nnc(SCCCN3CC4(C3)CN(c3ccccc3)C4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC(CNCC2COc3ccc(Cl)cc3O2)CC1,CHEMBL669156,Ki,7.88,CHEMBL418854,1999,CHEMBL1132360,J Med Chem,Scientific Literature,The compound was tested for binding affinity against human Dopamine receptor D2L,18,757,c1ccc(N2CCC(CNCC3COc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC12CCN(CCCSc1nnc(-c3ccccc3)n1C)CC2,CHEMBL4032441,Ki,4.53,CHEMBL4092015,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,125,714,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN4c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC12CN(CCCSc1nnc(-c3ccccc3)n1C)C2,CHEMBL4032441,Ki,3.9395099153876325,CHEMBL4079642,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,125,714,c1ccc(-c2nnc(SCCCN3CC4(CCN4c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCCNC(=O)c3ccc(-c4ccsc4)cc3)CC2)CC1,CHEMBL4397357,Ki,5.56,CHEMBL4516504,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,O=C(NCCCCN1CCC2(CC1)CCN(c1ccccc1)CC2)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCCNC(=O)c3ccc(N(C)C)cc3)CC2)CC1,CHEMBL4397357,Ki,5.42,CHEMBL4528652,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,O=C(NCCCCN1CCC2(CC1)CCN(c1ccccc1)CC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCCSc3nnc(-c4ccccc4)n3C)CC2)CC1,CHEMBL4397357,Ki,5.03,CHEMBL4466055,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2nnc(SCCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCOc3ccc4c(c3)NC(=O)CC4)CC2)CC1,CHEMBL4397357,Ki,5.58,CHEMBL4558652,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,O=C1CCc2ccc(OCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3ncc(-c4ccccc4)[nH]3)CC2)CC1,CHEMBL4397357,Ki,5.23,CHEMBL4461920,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2cnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3ncc(-c4ccccc4)n3C)CC2)CC1,CHEMBL4397357,Ki,4.45,CHEMBL4515093,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2cnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccc(-c5ccsc5)cc4)n3C)CC2)CC1,CHEMBL4397357,Ki,5.49,CHEMBL4541692,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(N2CCC3(CCN(CCCSc4nnc(-c5ccc(-c6ccsc6)cc5)[nH]4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccc(-c5ncco5)cc4)n3C)CC2)CC1,CHEMBL4397357,Ki,5.8,CHEMBL4549664,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(N2CCC3(CCN(CCCSc4nnc(-c5ccc(-c6ncco6)cc5)[nH]4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccc(F)cc4)n3C)CC2)CC1,CHEMBL4397357,Ki,4.8,CHEMBL4535104,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccc(N(C)C)cc4)n3C)CC2)CC1,CHEMBL4397357,Ki,4.92,CHEMBL4541869,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)[nH]3)CC2)CC1,CHEMBL4397357,Ki,5.93,CHEMBL4438524,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)C2)C1,CHEMBL4032441,Ki,5.2,CHEMBL4076516,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,125,714,c1ccc(-c2nnc(SCCCN3CCC4(CCN(c5ccccc5)C4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)C2)CC1,CHEMBL4397357,Ki,4.68,CHEMBL4476163,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2nnc(SCCCN3CCC4(CCN(c5ccccc5)CC4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)C1,CHEMBL4032441,Ki,5.21,CHEMBL4062553,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,125,714,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)C4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)C1,CHEMBL4397357,Ki,5.21,CHEMBL4062553,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)C4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)CC1,CHEMBL4032441,Ki,4.96,CHEMBL4084262,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,125,714,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)CC1,CHEMBL4397357,Ki,4.96,CHEMBL4084262,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)CC1,CHEMBL4397362,IC50,5.79,CHEMBL4084262,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Antagonist activity at recombinant human D2 receptor expressed in CHOK1 cells assessed as inhibition of quinpirole-induced beta arrestin2 recruitment preincubated for 30 mins followed by quinpirole addition and measured after 90 mins by coelenterazine-based beta-galactosidase reporter gene assay,136,758,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3N)CC2)CC1,CHEMBL4397357,Ki,4.86,CHEMBL4552459,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4F)n3C)CC2)CC1,CHEMBL4397357,Ki,4.71,CHEMBL4534961,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4cccnc4)n3C)CC2)CC1,CHEMBL4397357,Ki,4.31,CHEMBL4516927,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(N2CCC3(CCN(CCCSc4nnc(-c5cccnc5)[nH]4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCCSc3nnc(C4CCCCC4)n3C)CC2)CC1,CHEMBL4397357,Ki,4.9,CHEMBL4451865,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(N2CCC3(CCN(CCCSc4nnc(C5CCCCC5)[nH]4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCN(CCSc3nnc(-c4ccccc4)n3C)CC2)CC1,CHEMBL4397357,Ki,5.05,CHEMBL4514100,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(-c2nnc(SCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CCNCC2)CC1,CHEMBL4397357,Ki,4.0,CHEMBL4470847,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,136,279,c1ccc(N2CCC3(CCNCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2(CN(CCCSc3nnc(-c4ccccc4)n3C)C2)C1,CHEMBL4032441,Ki,4.22,CHEMBL4089290,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,125,714,c1ccc(-c2nnc(SCCCN3CC4(CCN(c5ccccc5)C4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21,CHEMBL3776608,Ki,6.5,CHEMBL3775618,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,117,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1,CHEMBL2388819,Ki,6.86,CHEMBL2386613,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,90,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2cc3ccccc3o2)CC1,CHEMBL2388819,Ki,6.9,CHEMBL2386607,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL2388819,Ki,6.9,CHEMBL2386614,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(-c3ccc(F)cc3)s2)CC1,CHEMBL2388819,Ki,6.55,CHEMBL2386619,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(-c3ccccc3)s2)CC1,CHEMBL2388819,Ki,6.97,CHEMBL2386615,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(-c3ccsc3)cc2)CC1,CHEMBL2388819,Ki,6.89,CHEMBL2386604,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(Br)nc2)CC1,CHEMBL2388819,Ki,6.84,CHEMBL2386621,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(Br)s2)CC1,CHEMBL2388819,Ki,7.36,CHEMBL2386618,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(C)s2)CC1,CHEMBL2388819,Ki,7.25,CHEMBL2386612,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(CCF)cc2)CC1,CHEMBL2388819,Ki,6.97,CHEMBL2386608,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(CCO)cc2)CC1,CHEMBL2388819,Ki,6.82,CHEMBL2386616,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(Cl)cc2)CC1,CHEMBL2388819,Ki,6.96,CHEMBL2386610,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(Cl)nc2)CC1,CHEMBL2388819,Ki,6.92,CHEMBL2386620,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(F)cc2)CC1,CHEMBL2388819,Ki,7.02,CHEMBL2386611,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(N(C)C)cc2)CC1,CHEMBL2388819,Ki,6.92,CHEMBL2386605,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2ccc(SC)cc2)CC1,CHEMBL2388819,Ki,7.0,CHEMBL2386606,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2cccc(OC)c2OC)CC1,CHEMBL2388819,Ki,6.82,CHEMBL2386622,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCNC(=O)c2cccc3c2-c2ccccc2C3=O)CC1,CHEMBL2388819,Ki,7.0,CHEMBL2386617,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL3887359,Ki,8.4,CHEMBL3973357,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",109,117,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,CHEMBL3887359,Ki,8.24,CHEMBL3929710,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",109,117,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,CHEMBL3887359,Ki,8.68,CHEMBL3957278,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",109,117,O=c1ccc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C)CC1,CHEMBL2168000,Ki,6.58,CHEMBL2165674,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,82,254,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc(Br)cc(OC)c2OCCF)CC1,CHEMBL1694505,Ki,7.24,CHEMBL1689001,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,78,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc(Br)ccc2OCCF)CC1,CHEMBL1694505,Ki,7.87,CHEMBL1688999,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,78,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc(C)ccc2OCCF)CC1,CHEMBL1694505,Ki,7.75,CHEMBL1688998,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,78,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc(I)ccc2OCCF)CC1,CHEMBL1694505,Ki,7.88,CHEMBL1689000,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,78,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc3cc(OCCF)ccc3[nH]2)CC1,CHEMBL3136930,Ki,7.22,CHEMBL3133867,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,91,725,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc3cc(OCCOCCF)ccc3[nH]2)CC1,CHEMBL3136930,Ki,6.92,CHEMBL3133868,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,91,725,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc3cc(OCCOCCOCCF)ccc3[nH]2)CC1,CHEMBL3136930,Ki,6.81,CHEMBL3133869,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,91,725,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(-c3ccccn3)cc2)CC1,CHEMBL3705175,IC50,6.76,CHEMBL394541,2014,CHEMBL3638880,,BindingDB Patent Bioactivity Data,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",100,759,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(-c3ccccn3)cc2)CC1,CHEMBL895648,Ki,7.16,CHEMBL394541,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,53,126,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(-c3ccccn3)cc2)CC1,CHEMBL895651,IC50,6.76,CHEMBL394541,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,53,760,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(CCF)cc2)CC1,CHEMBL1694505,Ki,6.88,CHEMBL1688995,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,78,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(OCCF)cc2)CC1,CHEMBL1694505,Ki,7.26,CHEMBL1688996,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,78,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc(OCCOCCF)cc2)CC1,CHEMBL1694505,Ki,7.23,CHEMBL1688997,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,78,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,CHEMBL3705175,IC50,6.75,CHEMBL244989,2014,CHEMBL3638880,,BindingDB Patent Bioactivity Data,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",100,759,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,CHEMBL895648,Ki,7.32,CHEMBL244989,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,54,126,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C/C=C/CNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,CHEMBL895651,IC50,6.75,CHEMBL244989,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,54,760,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C2CC3CC(N4CCN(c5ccccc5OC)CC4)CC3C2)CC1,CHEMBL671730,Ki,6.2,CHEMBL126277,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,c1ccc(N2CCN(C3CC4CC(N5CCN(c6ccccc6)CC5)CC4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C2CC3CC(NC(=O)c4ccc5ccccc5c4)CC3C2)CC1,CHEMBL671730,Ki,6.75,CHEMBL340313,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(NC1CC2CC(N3CCN(c4ccccc4)CC3)CC2C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C2CC3CC(NC4CC5CC(N6CCN(c7ccccc7OC)CC6)CC5C4)CC3C2)CC1,CHEMBL671730,Ki,6.99,CHEMBL341481,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,c1ccc(N2CCN(C3CC4CC(NC5CC6CC(N7CCN(c8ccccc8)CC7)CC6C5)CC4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3[nH]2)CC1,CHEMBL1777183,Ki,6.38,CHEMBL1774534,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,78,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3o2)CC1,CHEMBL1777183,Ki,6.48,CHEMBL1774385,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,78,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL1777183,Ki,6.62,CHEMBL1774538,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,78,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(F)CCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL1777184,IC50,6.38,CHEMBL1774538,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirole-induced mitogenesis,78,453,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,CHEMBL1777183,Ki,6.41,CHEMBL1774383,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,78,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(F)CCNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,CHEMBL1777183,Ki,5.54,CHEMBL1774536,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,78,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,CHEMBL3270692,Ki,5.96,CHEMBL242644,2014,CHEMBL3259695,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,100,152,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,CHEMBL895648,Ki,6.55,CHEMBL242644,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,54,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,CHEMBL895648,Ki,6.6,CHEMBL242218,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,54,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc3cc(F)ccc3n2)CC1,CHEMBL3599873,Ki,6.0,CHEMBL3597648,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc3ccccc3n2)CC1,CHEMBL3599873,Ki,6.03,CHEMBL3597646,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCNC(=O)c2ccc3cccnc3c2)CC1,CHEMBL3599873,Ki,5.99,CHEMBL3597654,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCNC(=O)c2cnc3ccc(C)cc3c2)CC1,CHEMBL3599873,Ki,6.15,CHEMBL3597652,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCNC(=O)c2cnc3ccc(F)cc3c2)CC1,CHEMBL3599873,Ki,6.17,CHEMBL3597651,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCNC(=O)c2cnc3ccccc3c2)CC1,CHEMBL3599873,Ki,6.04,CHEMBL3597649,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,109,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1,CHEMBL3591124,Ki,6.09,CHEMBL3588990,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,109,753,c1ccc(-c2ccc(-c3cn(CCCCN4CCN(c5ccccc5)CC4)nn3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccc4[nH]ccc4c3)nn2)CC1,CHEMBL3591124,Ki,6.1,CHEMBL3588997,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,109,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5[nH]ccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccc4c(c3)Cc3ccccc3-4)nn2)CC1,CHEMBL3591124,Ki,6.22,CHEMBL3588993,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,109,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5c(c4)Cc4ccccc4-5)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccc4ccccc4c3)nn2)CC1,CHEMBL3591124,Ki,6.72,CHEMBL3588989,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,109,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5ccccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccc4ncccc4c3)nn2)CC1,CHEMBL3591124,Ki,6.37,CHEMBL3588994,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,109,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5ncccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CCn2cc(-c3ccccc3)nn2)CC1,CHEMBL3591124,Ki,5.92,CHEMBL3588991,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,109,753,c1ccc(-c2cn(CCCCN3CCN(c4ccccc4)CC3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(C)C2=O)CC1,CHEMBL4259653,Ki,5.67,CHEMBL4277406,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,131,237,O=C1CNC(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccc(Br)cc3)C2=O)CC1,CHEMBL4148417,Ki,6.57,CHEMBL4170657,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,131,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccc(C)cc3)C2=O)CC1,CHEMBL4148417,Ki,6.06,CHEMBL4176588,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,131,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccc(Cl)cc3)C2=O)CC1,CHEMBL4148417,Ki,6.44,CHEMBL4159967,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,131,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccc(F)cc3)C2=O)CC1,CHEMBL3771916,Ki,6.15,CHEMBL3302600,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,117,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccc4ccccc4c3)C2=O)CC1,CHEMBL4259653,Ki,6.82,CHEMBL4284331,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,131,237,O=C1NC(c2ccc3ccccc3c2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3cccc(F)c3)C2=O)CC1,CHEMBL4148417,Ki,6.57,CHEMBL4174681,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,131,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3cccc4ccccc34)C2=O)CC1,CHEMBL4259653,Ki,6.59,CHEMBL4280511,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,131,237,O=C1NC(c2cccc3ccccc23)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccccc3)C2=O)CC1,CHEMBL4148417,Ki,5.99,CHEMBL4168743,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,131,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(C)(c3ccccc3F)C2=O)CC1,CHEMBL4148417,Ki,6.52,CHEMBL4160262,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,131,239,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC(O)CN2C(=O)NC(c3ccccc3)(c3ccccc3)C2=O)CC1,CHEMBL4148417,Ki,6.3,CHEMBL4170484,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,131,239,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC2CC(=O)c3ccccc3C2)CC1,CHEMBL670681,Ki,6.69,CHEMBL310153,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,37,584,O=C1CC(CN2CCN(c3ccccc3)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC2CN=C3c4ccccc4N=C(SC)N32)CC1,CHEMBL671485,Ki,6.35,CHEMBL1744044,1998,CHEMBL1131058,J Med Chem,Scientific Literature,Compound is evaluated for binding affinity towards Dopamine receptor D2 using [3H]spiperone in CHO cells,14,761,C1=Nc2ccccc2C2=NCC(CN3CCN(c4ccccc4)CC3)N12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC2CN=C3c4ccccc4NC(=O)N32)CC1,CHEMBL671485,Ki,6.8,CHEMBL106737,1998,CHEMBL1131058,J Med Chem,Scientific Literature,Compound is evaluated for binding affinity towards Dopamine receptor D2 using [3H]spiperone in CHO cells,14,761,O=C1Nc2ccccc2C2=NCC(CN3CCN(c4ccccc4)CC3)N12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC2CN=C3c4ccccc4NC(=O)N32)CC1,CHEMBL672180,Ki,6.62,CHEMBL106737,1998,CHEMBL1131058,J Med Chem,Scientific Literature,Compound is evaluated for binding affinity towards recombinant human Dopamine receptor D2 using [3H]spiperone in CHO cells,14,762,O=C1Nc2ccccc2C2=NCC(CN3CCN(c4ccccc4)CC3)N12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC2COCC(c3ccccc3)(c3ccccc3)O2)CC1,CHEMBL4391918,Ki,6.95,CHEMBL4466677,2019,CHEMBL4390666,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting,136,763,c1ccc(N2CCN(CC3COCC(c4ccccc4)(c4ccccc4)O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCC(=O)NC2CCc3c(cccc3OC)C2)CC1,CHEMBL670113,IC50,6.12,CHEMBL359002,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,14,582,O=C(CCN1CCN(c2ccccc2)CC1)NC1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCC(O)CNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,CHEMBL895648,Ki,7.17,CHEMBL231055,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,54,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCC2CCc3ccc(N)cc3C2=O)CC1,CHEMBL3106891,Ki,7.3,CHEMBL3104648,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,100,134,O=C1c2ccccc2CCC1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCC2CCc3ccc(N)cc3C2O)CC1,CHEMBL3106891,Ki,6.75,CHEMBL3104521,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,100,134,c1ccc(N2CCN(CCC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCC2CCc3ccc([N+](=O)[O-])cc3C2=O)CC1,CHEMBL3106891,Ki,7.38,CHEMBL3104646,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,100,134,O=C1c2ccccc2CCC1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCC2CCc3ccc([N+](=O)[O-])cc3C2O)CC1,CHEMBL3106891,Ki,7.72,CHEMBL3104520,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,100,134,c1ccc(N2CCN(CCC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCC(=O)NCc2nc3ccc(F)cc3c(=O)n2-c2ccccc2)CC1,CHEMBL920904,IC50,5.28,CHEMBL259776,2008,CHEMBL1144677,Bioorg Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,60,489,O=C(CCCN1CCN(c2ccccc2)CC1)NCc1nc2ccccc2c(=O)n1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(/C=N\O)c3c2)CC1,CHEMBL4010153,Ki,9.28,CHEMBL4096353,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(/C=N\O)c3c2)CC1,CHEMBL4010156,Ki,9.01,CHEMBL4096353,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C#N)c3c2)CC1,CHEMBL4010153,Ki,9.26,CHEMBL4070091,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C#N)c3c2)CC1,CHEMBL4010156,Ki,8.96,CHEMBL4070091,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C=O)c3c2)CC1,CHEMBL4010153,Ki,8.82,CHEMBL4088639,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C=O)c3c2)CC1,CHEMBL4010156,Ki,8.85,CHEMBL4088639,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3nccc3c2)CC1,CHEMBL4010153,Ki,7.44,CHEMBL4063282,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3nccc3c2)CC1,CHEMBL4010156,Ki,7.34,CHEMBL4063282,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCC2CCCc3c(OC)cccc32)CC1,CHEMBL670113,IC50,7.7,CHEMBL26929,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,14,582,c1ccc(N2CCN(CCCC3CCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCC(=O)N2CCc3ccccc3C2)CC1,CHEMBL1034994,Ki,7.66,CHEMBL492690,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCC(=O)N2Cc3ccccc3C2)CC1,CHEMBL1034994,Ki,6.14,CHEMBL494316,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)N1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1,CHEMBL894060,Ki,7.58,CHEMBL224820,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,54,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(C#N)cc2)CC1,CHEMBL1034994,Ki,6.51,CHEMBL494512,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(OS(C)(=O)=O)cc2)CC1,CHEMBL1034994,Ki,7.04,CHEMBL522194,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCC(=O)NCc2ccccc2)CC1,CHEMBL1034994,Ki,6.65,CHEMBL495120,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCC(=O)NCc2ccncc2)CC1,CHEMBL1034994,Ki,6.3,CHEMBL493709,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccncc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCCN2C(=O)[C@@H]3[C@H]4CC[C@H](C4)[C@@H]3C2=O)CC1,CHEMBL4629186,Ki,7.39,CHEMBL4645292,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,143,764,O=C1C2C3CCC(C3)C2C(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCCN2C(=O)c3cccc4cccc(c34)C2=O)CC1,CHEMBL4390409,Ki,8.0,CHEMBL4584719,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,136,490,O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCCN2C(=O)c3ccccc3S2(=O)=O)CC1,CHEMBL4308346,Ki,7.21,CHEMBL4565558,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,136,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCCN2C(=O)c3ccccc3S2(=O)=O)CC1,CHEMBL4821476,Ki,9.0,CHEMBL4565558,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,149,765,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCCNC(=O)OC(C)(C)C)CC1,CHEMBL3300162,Ki,7.13,CHEMBL3299097,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCCNC(=O)OC(C)(C)C)CC1,CHEMBL3300164,IC50,8.4,CHEMBL3299097,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,100,766,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL1227764,Ki,6.92,CHEMBL1221593,2010,CHEMBL1221249,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor after 60 mins,71,767,O=C(NCCCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1,CHEMBL1227764,Ki,7.0,CHEMBL1221594,2010,CHEMBL1221249,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor after 60 mins,71,767,O=S(=O)(NCCCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCCNc2nc(N)nc(N)n2)CC1,CHEMBL5121178,Ki,7.7,CHEMBL5197911,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCCCNc3ncncn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCCn2c(=O)n3c4c(cccc42)CCC3)CC1,CHEMBL4390409,Ki,8.7,CHEMBL4538667,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,136,490,O=c1n(CCCCCCN2CCN(c3ccccc3)CC2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCN2C(=O)c3ccccc3S2(=O)=O)CC1,CHEMBL4821476,Ki,7.7,CHEMBL4860754,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,149,765,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCN2CCc3ccccc3C2=O)CC1,CHEMBL993531,Ki,7.69,CHEMBL476808,2009,CHEMBL1153914,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,64,741,O=C1c2ccccc2CCN1CCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCN2Cc3ccc4ccccc4c3C2=O)CC1,CHEMBL2395897,IC50,8.46,CHEMBL2392349,2013,CHEMBL2390830,Eur J Med Chem,Scientific Literature,Inhibition of human recombinant dopamine D2S receptor expressed in HEK293 cells,91,768,O=C1c2c(ccc3ccccc23)CN1CCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)OC(C)(C)C)CC1,CHEMBL3300162,Ki,7.92,CHEMBL3299096,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL3614290,Ki,7.46,CHEMBL140968,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,109,431,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL672384,Ki,7.15,CHEMBL140968,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,29,769,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL672573,Ki,7.12,CHEMBL140968,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,29,770,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL913685,Ki,7.15,CHEMBL140968,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL1227764,Ki,6.59,CHEMBL1221591,2010,CHEMBL1221249,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor after 60 mins,71,767,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2cccc(C#Cc3ccccc3)c2)CC1,CHEMBL898785,Ki,7.51,CHEMBL240584,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,54,40,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cccc(C#Cc2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2cccc(C#Cc3ccccc3)c2)CC1,CHEMBL898786,Ki,7.57,CHEMBL240584,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,54,41,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cccc(C#Cc2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL3614290,Ki,8.15,CHEMBL139600,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,109,431,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL672384,Ki,7.52,CHEMBL139600,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,29,769,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL672573,Ki,7.6,CHEMBL139600,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,29,770,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL913685,Ki,7.52,CHEMBL139600,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2nnn(Cc3ccccc3)c2C)CC1,CHEMBL3614290,Ki,8.6,CHEMBL221587,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2nnn(Cc3ccccc3)c2C)CC1,CHEMBL913685,Ki,8.03,CHEMBL221587,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2nnn(Cc3ccccc3Br)c2C)CC1,CHEMBL3614290,Ki,9.24,CHEMBL217981,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2nnn(Cc3ccccc3Br)c2C)CC1,CHEMBL913685,Ki,8.31,CHEMBL217981,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2sc3nc(C)cc(C)c3c2N)CC1,CHEMBL3300162,Ki,8.04,CHEMBL3298896,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1,CHEMBL3300162,Ki,8.455,CHEMBL3298827,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1,CHEMBL1227764,Ki,6.36,CHEMBL1221592,2010,CHEMBL1221249,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor after 60 mins,71,767,O=S(=O)(NCCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCNc2nc(N)nc(N)n2)CC1,CHEMBL5121178,Ki,7.42,CHEMBL5187317,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCCNc3ncncn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL1815674,Ki,8.14,CHEMBL1813598,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,78,640,O=C1CCc2ccc(OCCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,CHEMBL1815674,Ki,8.13,CHEMBL1813599,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,78,640,O=c1ccc2ccc(OCCCCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCOc2ccc3ccccc3c2)CC1,CHEMBL3762401,Ki,7.47,CHEMBL3758368,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,117,477,c1ccc(N2CCN(CCCCCOc3ccc4ccccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCc2cn(-c3ccc(-c4ccsc4)cc3)nn2)CC1,CHEMBL3374187,Ki,6.96,CHEMBL3353902,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCCc3cn(-c4ccc(-c5ccsc5)cc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCc2cn(-c3ccc(F)cc3)nn2)CC1,CHEMBL3374187,Ki,7.62,CHEMBL3353905,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCc2cn(-c3ccc(N(C)C)cc3)nn2)CC1,CHEMBL3374187,Ki,7.2,CHEMBL3353911,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCc2cn(-c3ccc(SC)cc3)nn2)CC1,CHEMBL3374187,Ki,7.58,CHEMBL3353914,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCc2cn(-c3cccc4cnccc34)nn2)CC1,CHEMBL3374187,Ki,7.75,CHEMBL3353899,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCCc3cn(-c4cccc5cnccc45)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCc2cn(-c3ccccc3)nn2)CC1,CHEMBL3374187,Ki,7.71,CHEMBL3353896,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCCc2cn(-c3ccccc3OC)nn2)CC1,CHEMBL3374187,Ki,7.2,CHEMBL3353908,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2C(=O)C=C(c3ccccc3)C2=O)CC1,CHEMBL671730,Ki,6.48,CHEMBL129502,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C1C=C(c2ccccc2)C(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2C(=O)Cc3ccccc32)CC1,CHEMBL898619,Ki,6.39,CHEMBL394080,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,54,772,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2C(=O)Cc3ccccc32)CC1,CHEMBL898624,Ki,6.54,CHEMBL394080,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,54,773,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2C(=O)c3cc4ccccc4cc3C2=O)CC1,CHEMBL671730,Ki,6.84,CHEMBL125580,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C1c2cc3ccccc3cc2C(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2C(=O)c3cccc4cccc(c34)C2=O)CC1,CHEMBL671730,Ki,7.4,CHEMBL126285,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C1c2cccc3cccc(c23)C(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1,CHEMBL671730,Ki,7.3,CHEMBL126632,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1,CHEMBL4821476,Ki,6.44,CHEMBL238917,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,150,765,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1,CHEMBL898619,Ki,6.44,CHEMBL238917,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,54,772,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2C(=O)c3ccccc3S2(=O)=O)CC1,CHEMBL898624,Ki,8.21,CHEMBL238917,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,54,773,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCCc3cc(-c4cccs4)ccc3C2=O)CC1,CHEMBL1771855,Ki,8.29,CHEMBL1771111,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,78,42,O=C1c2ccc(-c3cccs3)cc2CCCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCCc3cc(-c4cccs4)ccc3C2=O)CC1,CHEMBL1771856,Ki,8.68,CHEMBL1771111,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,78,43,O=C1c2ccc(-c3cccs3)cc2CCCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCCc3ccccc3C2=O)CC1,CHEMBL1771855,Ki,8.41,CHEMBL477206,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,78,42,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCCc3ccccc3C2=O)CC1,CHEMBL1771856,Ki,8.82,CHEMBL477206,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,78,43,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCCc3ccccc3C2=O)CC1,CHEMBL993531,Ki,8.44,CHEMBL477206,2009,CHEMBL1153914,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,64,741,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3c(cccc3-c3ccccc3)C2=O)CC1,CHEMBL1771855,Ki,7.28,CHEMBL1771108,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,78,42,O=C1c2cccc(-c3ccccc3)c2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3c(cccc3-c3ccccc3)C2=O)CC1,CHEMBL1771856,Ki,7.2,CHEMBL1771108,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,78,43,O=C1c2cccc(-c3ccccc3)c2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccccc4)ccc3C2=O)CC1,CHEMBL1771855,Ki,7.42,CHEMBL1771107,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,78,42,O=C1c2ccc(-c3ccccc3)cc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccccc4)ccc3C2=O)CC1,CHEMBL1771856,Ki,7.82,CHEMBL1771107,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,78,43,O=C1c2ccc(-c3ccccc3)cc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccco4)ccc3C2=O)CC1,CHEMBL1771855,Ki,7.8,CHEMBL1771109,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,78,42,O=C1c2ccc(-c3ccco3)cc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccco4)ccc3C2=O)CC1,CHEMBL1771856,Ki,8.32,CHEMBL1771109,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,78,43,O=C1c2ccc(-c3ccco3)cc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4cccs4)ccc3C2=O)CC1,CHEMBL1771855,Ki,7.96,CHEMBL1771110,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,78,42,O=C1c2ccc(-c3cccs3)cc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4cccs4)ccc3C2=O)CC1,CHEMBL1771856,Ki,8.16,CHEMBL1771110,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,78,43,O=C1c2ccc(-c3cccs3)cc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccncc4)ccc3C2=O)CC1,CHEMBL1771855,Ki,8.15,CHEMBL1771112,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,78,42,O=C1c2ccc(-c3ccncc3)cc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(-c4ccncc4)ccc3C2=O)CC1,CHEMBL1771856,Ki,7.89,CHEMBL1771112,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,78,43,O=C1c2ccc(-c3ccncc3)cc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(C#N)ccc3C2=O)CC1,CHEMBL1771855,Ki,7.42,CHEMBL1771113,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,78,42,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(C#N)ccc3C2=O)CC1,CHEMBL1771856,Ki,7.66,CHEMBL1771113,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,78,43,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(F)ccc3C2=O)CC1,CHEMBL1771855,Ki,7.58,CHEMBL1771106,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,78,42,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3cc(F)ccc3C2=O)CC1,CHEMBL1771856,Ki,8.04,CHEMBL1771106,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,78,43,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3ccccc3C2=O)CC1,CHEMBL1771855,Ki,7.68,CHEMBL477250,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,78,42,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3ccccc3C2=O)CC1,CHEMBL1771856,Ki,8.15,CHEMBL477250,2011,CHEMBL1770099,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,78,43,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3ccccc3C2=O)CC1,CHEMBL993531,Ki,7.91,CHEMBL477250,2009,CHEMBL1153914,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,64,741,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2CCc3ncsc3CC2)CC1,CHEMBL4334858,Ki,7.07,CHEMBL4582714,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,136,774,c1ccc(N2CCN(CCCCN3CCc4ncsc4CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2Cc3ccccc3C2=O)CC1,CHEMBL898619,Ki,6.5,CHEMBL393492,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,54,772,O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCN2Cc3ccccc3C2=O)CC1,CHEMBL898624,Ki,7.47,CHEMBL393492,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,54,773,O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/C=C/c2ccccc2)CC1,CHEMBL671730,Ki,7.72,CHEMBL129767,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=CC=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cc(I)c(OC)c(OC)c2)CC1,CHEMBL671730,Ki,7.42,CHEMBL127923,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(-c3ccccc3)cc2)CC1,CHEMBL671730,Ki,7.43,CHEMBL126746,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccc(-c2ccccc2)cc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(/C=C/C(=O)NCCCCN3CCN(c4ccccc4OC)CC3)cc2)CC1,CHEMBL671730,Ki,8.14,CHEMBL129035,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccc(C=CC(=O)NCCCCN2CCN(c3ccccc3)CC2)cc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Br)cc2)CC1,CHEMBL671730,Ki,7.62,CHEMBL341134,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(C#N)cc2)CC1,CHEMBL671730,Ki,8.0,CHEMBL341241,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(C(C)(C)C)cc2)CC1,CHEMBL671730,Ki,6.89,CHEMBL125676,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(C(F)(F)F)cc2)CC1,CHEMBL671730,Ki,7.43,CHEMBL129429,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(C=O)cc2)CC1,CHEMBL671730,Ki,7.94,CHEMBL339062,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Cl)c(Cl)c2)CC1,CHEMBL671730,Ki,7.64,CHEMBL421085,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Cl)cc2)CC1,CHEMBL1291990,Ki,7.65,CHEMBL1180455,2010,CHEMBL1287708,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,71,775,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Cl)cc2)CC1,CHEMBL671730,Ki,7.65,CHEMBL126725,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Cl)cc2Cl)CC1,CHEMBL671730,Ki,7.68,CHEMBL338063,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(F)cc2)CC1,CHEMBL1291989,Ki,7.68,CHEMBL338606,2010,CHEMBL1287708,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,71,776,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(F)cc2)CC1,CHEMBL1291990,Ki,7.57,CHEMBL338606,2010,CHEMBL1287708,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,71,775,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(F)cc2)CC1,CHEMBL671730,Ki,7.68,CHEMBL338606,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(I)cc2)CC1,CHEMBL671730,Ki,7.12,CHEMBL340712,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(OCc3ccccc3)cc2)CC1,CHEMBL671730,Ki,7.5,CHEMBL340851,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccc(OCc2ccccc2)cc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc(Oc3ccccc3)cc2)CC1,CHEMBL671730,Ki,7.19,CHEMBL127230,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccc(Oc2ccccc2)cc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc([N+](=O)[O-])cc2)CC1,CHEMBL671730,Ki,7.85,CHEMBL129465,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc3c(c2)OCO3)CC1,CHEMBL671730,Ki,7.99,CHEMBL127038,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccc2c(c1)OCO2)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccc3ccccc3c2)CC1,CHEMBL671730,Ki,7.5,CHEMBL126749,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccc2ccccc2c1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccc(C(F)(F)F)c2)CC1,CHEMBL671730,Ki,7.3,CHEMBL415520,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccc(Cl)c2)CC1,CHEMBL671730,Ki,7.7,CHEMBL127912,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccc(I)c2)CC1,CHEMBL671730,Ki,6.79,CHEMBL338841,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccc(Oc3ccccc3)c2)CC1,CHEMBL671730,Ki,6.94,CHEMBL126342,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1cccc(Oc2ccccc2)c1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccc3c2OCO3)CC1,CHEMBL671730,Ki,8.1,CHEMBL125459,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1cccc2c1OCO2)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccccc2)CC1,CHEMBL1291990,Ki,7.87,CHEMBL1180430,2010,CHEMBL1287708,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,71,775,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccccc2)CC1,CHEMBL671730,Ki,7.87,CHEMBL126128,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccccc2Cl)CC1,CHEMBL671730,Ki,7.82,CHEMBL127654,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccccc2I)CC1,CHEMBL671730,Ki,7.2,CHEMBL340608,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccnc2)CC1,CHEMBL671730,Ki,7.84,CHEMBL341542,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1cccnc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccco2)CC1,CHEMBL671730,Ki,7.96,CHEMBL341299,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccco1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2cccs2)CC1,CHEMBL671730,Ki,8.02,CHEMBL338552,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1cccs1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/C=C/c2ccsc2)CC1,CHEMBL671730,Ki,7.89,CHEMBL126280,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(C=Cc1ccsc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2cc(F)c(F)c(F)c2)CC1,CHEMBL3592693,Ki,8.18,CHEMBL3590079,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,110,355,O=C(N=Nc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2cc(F)c(F)c(F)c2)CC1,CHEMBL3592694,Ki,8.02,CHEMBL3590079,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,110,356,O=C(N=Nc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)c(F)c2)CC1,CHEMBL3592693,Ki,8.12,CHEMBL3590078,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,110,355,O=C(N=Nc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)c(F)c2)CC1,CHEMBL3592694,Ki,7.92,CHEMBL3590078,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,110,356,O=C(N=Nc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)cc2)CC1,CHEMBL3592693,Ki,7.42,CHEMBL3590077,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 long receptor expressed in CHO cell membranes,110,355,O=C(N=Nc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)cc2)CC1,CHEMBL3592694,Ki,7.47,CHEMBL3590077,2015,CHEMBL3588764,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 short receptor expressed in CHO cell membranes,110,356,O=C(N=Nc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)cc2)CC1,CHEMBL4323478,Ki,7.42,CHEMBL3590077,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(N=Nc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)cc2)CC1,CHEMBL4323479,Ki,7.47,CHEMBL3590077,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(N=Nc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)C(C)(C)C)CC1,CHEMBL670172,Ki,7.7,CHEMBL21008,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",9,107,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)C2(c3ccc(Cl)cc3)CCCC2)CC1,CHEMBL671730,Ki,7.25,CHEMBL127080,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)C1(c2ccccc2)CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)C2CC2c2ccccc2)CC1,CHEMBL671730,Ki,7.09,CHEMBL127114,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)C1CC1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)C2CCCCC2)CC1,CHEMBL3762401,Ki,6.78,CHEMBL26962,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,117,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)CC2CCCCC2)CC1,CHEMBL3762401,Ki,6.49,CHEMBL3758913,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,117,477,O=C(CC1CCCCC1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)CCc2ccccc2)CC1,CHEMBL671730,Ki,7.31,CHEMBL340173,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(CCc1ccccc1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)Cc2ccc3ccccc3c2)CC1,CHEMBL671730,Ki,7.46,CHEMBL339103,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(Cc1ccc2ccccc2c1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)N(C)c2ccccc2)CC1,CHEMBL3762401,Ki,5.81,CHEMBL3759312,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,117,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)N2CCOCC2)CC1,CHEMBL3762401,Ki,6.32,CHEMBL3760063,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,117,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)N1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1,CHEMBL4323478,Ki,6.8,CHEMBL4448166,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1,CHEMBL4323479,Ki,7.03,CHEMBL4448166,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)Nc2cccc(Cl)c2)CC1,CHEMBL3762401,Ki,7.89,CHEMBL3758991,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,117,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)OC(C)(C)C)CC1,CHEMBL3300162,Ki,7.72,CHEMBL3299095,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc(-c3ccco3)[nH]n2)CC1,CHEMBL861746,Ki,6.89,CHEMBL199859,2006,CHEMBL1148573,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,47,737,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc(-c2ccco2)[nH]n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc(C)ccc2C)CC1,CHEMBL1261459,Ki,7.66,CHEMBL1258494,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,71,777,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc(C)ccc2C)CC1,CHEMBL1261460,Ki,7.77,CHEMBL1258494,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,71,778,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3c4ccc(c3o2)CCc2ccc(cc2)CC4)CC1,CHEMBL860506,Ki,6.77,CHEMBL208847,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,47,657,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2c3ccc(c2o1)CCc1ccc(cc1)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3c4ccc(c3o2)CCc2ccc(cc2)CC4)CC1,CHEMBL860507,Ki,7.08,CHEMBL208847,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,48,658,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2c3ccc(c2o1)CCc1ccc(cc1)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(Br)ccc3[nH]2)CC1,CHEMBL913685,Ki,6.96,CHEMBL218444,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(Br)ccc3o2)CC1,CHEMBL913685,Ki,7.02,CHEMBL221681,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(C#N)ccc3[nH]2)CC1,CHEMBL913685,Ki,6.85,CHEMBL220700,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(C#N)ccc3o2)CC1,CHEMBL913685,Ki,6.89,CHEMBL376020,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(C#N)ccc3s2)CC1,CHEMBL913685,Ki,7.17,CHEMBL218318,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(I)ccc3o2)CC1,CHEMBL828760,Ki,7.57,CHEMBL182379,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,37,779,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(I)ccc3o2)CC1,CHEMBL828883,Ki,7.23,CHEMBL182379,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,37,780,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(I)ccc3s2)CC1,CHEMBL828760,Ki,9.0,CHEMBL184993,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,37,779,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(I)ccc3s2)CC1,CHEMBL828883,Ki,7.32,CHEMBL184993,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,37,780,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(O)ccc3[nH]2)CC1,CHEMBL3136930,Ki,7.8,CHEMBL3133875,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,91,725,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(OCCF)ccc3[nH]2)CC1,CHEMBL3136930,Ki,7.62,CHEMBL3133779,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,91,725,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(OCCOCCF)ccc3[nH]2)CC1,CHEMBL3136930,Ki,7.66,CHEMBL3133780,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,91,725,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(OCCOCCOCCF)ccc3[nH]2)CC1,CHEMBL3136930,Ki,7.37,CHEMBL3133862,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,91,725,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc(C#N)cc3[nH]2)CC1,CHEMBL913685,Ki,6.8,CHEMBL218638,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1,CHEMBL1261459,Ki,7.62,CHEMBL210567,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,71,777,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1,CHEMBL1261460,Ki,7.75,CHEMBL210567,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,71,778,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1,CHEMBL860506,Ki,7.890000000000001,CHEMBL210567,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,48,657,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1,CHEMBL860507,Ki,8.07,CHEMBL210567,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,48,658,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cccc(OC)c3o2)CC1,CHEMBL861746,Ki,6.43,CHEMBL201698,2006,CHEMBL1148573,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,48,737,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1,CHEMBL2167045,Ki,7.43,CHEMBL125916,2012,CHEMBL2163217,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from D2 receptor,82,781,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[nH]2)CC1,CHEMBL2168000,Ki,7.43,CHEMBL125916,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,82,254,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[te]2)CC1,CHEMBL672384,Ki,7.2,CHEMBL141419,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,29,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[te]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[te]2)CC1,CHEMBL672573,Ki,7.41,CHEMBL141419,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,29,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[te]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3cn2)CC1,CHEMBL671730,Ki,7.56,CHEMBL129022,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2cn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1,CHEMBL3614290,Ki,6.77,CHEMBL124444,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1,CHEMBL672384,Ki,6.96,CHEMBL124444,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,29,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1,CHEMBL672573,Ki,7.08,CHEMBL124444,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,29,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1,CHEMBL839477,Ki,6.96,CHEMBL124444,2005,CHEMBL1141881,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 long,40,457,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1,CHEMBL913685,Ki,6.96,CHEMBL124444,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3oc2=O)CC1,CHEMBL671730,Ki,7.64,CHEMBL126780,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2oc1=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3oc2=O)CC1,CHEMBL861746,Ki,6.84,CHEMBL126780,2006,CHEMBL1148573,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,48,737,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2oc1=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL1261459,Ki,7.02,CHEMBL424294,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,71,777,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL1261460,Ki,7.14,CHEMBL424294,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,71,778,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL3614290,Ki,7.6,CHEMBL424294,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL672384,Ki,7.06,CHEMBL424294,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,29,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL672573,Ki,7.28,CHEMBL424294,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1,CHEMBL913685,Ki,7.06,CHEMBL424294,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL1031082,Ki,6.51,CHEMBL142020,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,64,782,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL1031088,Ki,6.82,CHEMBL142020,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,64,783,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL1031094,Ki,6.92,CHEMBL142020,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,64,784,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL3614290,Ki,7.0,CHEMBL142020,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL4054777,Ki,6.57,CHEMBL142020,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,125,170,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL4054778,Ki,6.7,CHEMBL142020,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,125,171,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL672384,Ki,6.51,CHEMBL142020,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,30,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL672573,Ki,6.51,CHEMBL142020,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL913685,Ki,6.51,CHEMBL142020,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc(C(C)=O)cc3)cc2)CC1,CHEMBL670400,Ki,7.4,CHEMBL294747,1995,CHEMBL1128113,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,5,721,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc(C(C)=O)cc3)cc2)CC1,CHEMBL672226,Ki,7.4,CHEMBL294747,1997,CHEMBL1153677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,11,358,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc(Cl)cc3)o2)CC1,CHEMBL671730,Ki,6.7,CHEMBL127029,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc(N)cc3)cc2)CC1,CHEMBL670400,Ki,7.7,CHEMBL73665,1995,CHEMBL1128113,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,5,721,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc(S(C)(=O)=O)cc3)cc2)CC1,CHEMBL670400,Ki,7.6,CHEMBL423671,1995,CHEMBL1128113,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,5,721,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc([18F])nc3)cc2)CC1,CHEMBL912013,Ki,7.82,CHEMBL221640,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(long) expressed in CHO cell membrane,54,785,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2cccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccc([18F])nc3)cc2)CC1,CHEMBL912014,Ki,7.92,CHEMBL221640,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) expressed in CHO cell membrane,54,786,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2cccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3cccc([18F])n3)cc2)CC1,CHEMBL912013,Ki,7.57,CHEMBL221652,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(long) expressed in CHO cell membrane,54,785,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3cccc([18F])n3)cc2)CC1,CHEMBL912014,Ki,7.8,CHEMBL221652,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) expressed in CHO cell membrane,54,786,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL1769067,Ki,7.32,CHEMBL112065,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins,78,336,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL1769068,Ki,7.38,CHEMBL112065,2011,CHEMBL1765048,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins,78,337,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1,CHEMBL671730,Ki,7.12,CHEMBL129483,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,CHEMBL895648,Ki,7.55,CHEMBL241973,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,54,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccccn3)cc2)CC1,CHEMBL895651,IC50,6.97,CHEMBL241973,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,54,760,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccsc3)cc2)CC1,CHEMBL4350893,Ki,7.41,CHEMBL4567895,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",136,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3cn(Cc4ccc(-c5ccc(Cn6cc(-c7ccc(C(=O)NCCCCN8CCN(c9ccccc9OC)CC8)cc7)nn6)cc5)cc4)nn3)cc2)CC1,CHEMBL1059353,Ki,5.7,CHEMBL574534,2009,CHEMBL1154597,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2long receptor expressed in CHO cells,64,389,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2cn(Cc3ccc(-c4ccc(Cn5cc(-c6ccc(C(=O)NCCCCN7CCN(c8ccccc8)CC7)cc6)nn5)cc4)cc3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3cn(Cc4ccc(-c5ccc(Cn6cc(-c7ccc(C(=O)NCCCCN8CCN(c9ccccc9OC)CC8)cc7)nn6)cc5)cc4)nn3)cc2)CC1,CHEMBL1059354,Ki,6.11,CHEMBL574534,2009,CHEMBL1154597,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2short receptor expressed in CHO cells,64,390,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2cn(Cc3ccc(-c4ccc(Cn5cc(-c6ccc(C(=O)NCCCCN7CCN(c8ccccc8)CC7)cc6)nn5)cc4)cc3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-n3ccnc3)cc2)CC1,CHEMBL861746,Ki,7.57,CHEMBL201270,2006,CHEMBL1148573,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,48,737,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-n2ccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-n3ccnc3)cc2)CC1,CHEMBL938625,Ki,7.29,CHEMBL201270,2009,CHEMBL1140855,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,64,673,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-n2ccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(Br)cc2)CC1,CHEMBL670400,Ki,7.4,CHEMBL71960,1995,CHEMBL1128113,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,6,721,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(C#Cc3ccccc3)cc2)CC1,CHEMBL898785,Ki,5.85,CHEMBL241424,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,54,40,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(C#Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(C#Cc3ccccc3)cc2)CC1,CHEMBL898786,Ki,6.72,CHEMBL241424,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,54,41,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(C#Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(C(=O)c3ccccc3)cc2)CC1,CHEMBL671730,Ki,7.2,CHEMBL126948,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(C(=O)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(C(C)(C)C)cc2)CC1,CHEMBL671730,Ki,7.58,CHEMBL127288,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(C(C)=O)cc2)CC1,CHEMBL671730,Ki,7.76,CHEMBL126474,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,34,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(CCF)cc2)CC1,CHEMBL1694505,Ki,7.26,CHEMBL1688991,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,78,540,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(CCF)cc2)CC1,CHEMBL3374187,Ki,7.26,CHEMBL1688991,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930837,Ki,7.8,CHEMBL1928132,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,82,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930838,Ki,7.42,CHEMBL1928132,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,82,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930837,Ki,7.6,CHEMBL1928130,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,82,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930838,Ki,7.4,CHEMBL1928130,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930837,Ki,7.85,CHEMBL1928128,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930838,Ki,7.7,CHEMBL1928128,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930837,Ki,7.96,CHEMBL1928126,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCc2ccc(C(=O)NCCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930838,Ki,7.6,CHEMBL1928126,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCc2ccc(C(=O)NCCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(Cl)cc2)CC1,CHEMBL671730,Ki,7.71,CHEMBL126258,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(F)cc2)CC1,CHEMBL884780,Ki,7.01,CHEMBL194727,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,40,787,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(F)cc2)CC1,CHEMBL884781,Ki,6.85,CHEMBL194727,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,40,788,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(F)nc2)CC1,CHEMBL884780,Ki,6.8,CHEMBL198993,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,40,787,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(F)nc2)CC1,CHEMBL884781,Ki,6.62,CHEMBL198993,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,40,788,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(I)cc2)CC1,CHEMBL671730,Ki,6.84,CHEMBL27254,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(I)s2)CC1,CHEMBL828760,Ki,7.46,CHEMBL182652,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,37,779,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(I)s2)CC1,CHEMBL828883,Ki,7.12,CHEMBL182652,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,38,780,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(N(C)C)cc2)CC1,CHEMBL1694505,Ki,7.46,CHEMBL1688990,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(N(C)C)cc2)CC1,CHEMBL3374187,Ki,7.46,CHEMBL1688990,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(N3CCOCC3)cc2)CC1,CHEMBL861746,Ki,6.85,CHEMBL203302,2006,CHEMBL1148573,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,48,737,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(N2CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(OCCF)cc2)CC1,CHEMBL1694505,Ki,7.57,CHEMBL1688992,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(OCCOCCF)cc2)CC1,CHEMBL1694505,Ki,7.68,CHEMBL1688993,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc(OCCOCCOCCF)cc2)CC1,CHEMBL1694505,Ki,7.28,CHEMBL1688994,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,CHEMBL895648,Ki,7.26,CHEMBL110365,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,54,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3c(c2)Cc2ccccc2-3)CC1,CHEMBL895651,IC50,6.65,CHEMBL110365,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,54,760,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3c(c2)OCO3)CC1,CHEMBL861746,Ki,7.06,CHEMBL201551,2006,CHEMBL1148573,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,48,737,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3cc(F)ccc3n2)CC1,CHEMBL3599873,Ki,7.17,CHEMBL3597647,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,110,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL1777183,Ki,7.47,CHEMBL25236,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL2388819,Ki,7.21,CHEMBL540612,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,91,97,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL3762401,Ki,6.73,CHEMBL25236,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,117,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL4406061,Ki,6.61,CHEMBL540612,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,143,357,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL4825013,Ki,7.16,CHEMBL25236,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,150,407,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL5442215,Ki,6.84,CHEMBL540612,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL671730,Ki,7.21,CHEMBL25236,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL672384,Ki,6.68,CHEMBL25236,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,30,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL672573,Ki,6.68,CHEMBL25236,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL829061,Ki,6.66,CHEMBL540612,2005,CHEMBL1139523,J Med Chem,Scientific Literature,Inhibition of [3H]spiperone binding to human dopamine receptor D2 long expressed in Chinese hamster ovary cells,40,789,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL830376,Ki,6.7,CHEMBL540612,2005,CHEMBL1139523,J Med Chem,Scientific Literature,Inhibition of [3H]spiperone binding to human dopamine receptor D2 short,40,790,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL860506,Ki,6.66,CHEMBL25236,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,48,657,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL860507,Ki,6.7,CHEMBL25236,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,48,658,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL876373,Ki,7.21,CHEMBL25236,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2 receptor expressed in CHO cells,40,791,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL897619,Ki,7.28,CHEMBL25236,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,54,755,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL913685,Ki,6.68,CHEMBL25236,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3n2)CC1,CHEMBL3599873,Ki,7.17,CHEMBL127317,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,110,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3n2)CC1,CHEMBL671730,Ki,7.27,CHEMBL126439,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccnn3c2)CC1,CHEMBL672384,Ki,6.85,CHEMBL336930,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,30,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccnn2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccnn3c2)CC1,CHEMBL672573,Ki,7.08,CHEMBL336930,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccnn2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3nccnc3c2)CC1,CHEMBL861746,Ki,6.75,CHEMBL199498,2006,CHEMBL1148573,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from cloned human dopamine receptor D2(long) expressed in rat C6 glioma cells,48,737,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2nccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3nonc3c2)CC1,CHEMBL938625,Ki,7.51,CHEMBL424667,2009,CHEMBL1140855,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,64,673,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2nonc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(-c3cn(Cc4ccc(-c5ccc(Cn6cc(-c7cccc(C(=O)NCCCCN8CCN(c9ccccc9OC)CC8)c7)nn6)cc5)cc4)nn3)c2)CC1,CHEMBL1059353,Ki,4.82,CHEMBL574569,2009,CHEMBL1154597,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2long receptor expressed in CHO cells,64,389,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc(-c2cn(Cc3ccc(-c4ccc(Cn5cc(-c6cccc(C(=O)NCCCCN7CCN(c8ccccc8)CC7)c6)nn5)cc4)cc3)nn2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(-c3cn(Cc4ccc(-c5ccc(Cn6cc(-c7cccc(C(=O)NCCCCN8CCN(c9ccccc9OC)CC8)c7)nn6)cc5)cc4)nn3)c2)CC1,CHEMBL1059354,Ki,5.0,CHEMBL574569,2009,CHEMBL1154597,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2short receptor expressed in CHO cells,64,390,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc(-c2cn(Cc3ccc(-c4ccc(Cn5cc(-c6cccc(C(=O)NCCCCN7CCN(c8ccccc8)CC7)c6)nn5)cc4)cc3)nn2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(C#Cc3ccccc3)c2)CC1,CHEMBL898785,Ki,5.92,CHEMBL391257,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,54,40,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc(C#Cc2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(C#Cc3ccccc3)c2)CC1,CHEMBL898786,Ki,6.55,CHEMBL391257,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,54,41,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc(C#Cc2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(F)n2)CC1,CHEMBL884780,Ki,6.58,CHEMBL197214,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,40,787,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(F)n2)CC1,CHEMBL884781,Ki,6.4,CHEMBL197214,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,40,788,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(I)c2)CC1,CHEMBL671730,Ki,7.17,CHEMBL126502,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1,CHEMBL1930837,Ki,8.74,CHEMBL1928122,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc(OCCOCCOCCOCCOc2cccc(C(=O)NCCCCN3CCN(c4ccccc4)CC3)c2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1,CHEMBL1930838,Ki,8.18,CHEMBL1928122,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc(OCCOCCOCCOCCOc2cccc(C(=O)NCCCCN3CCN(c4ccccc4)CC3)c2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc3c2-c2ccccc2C3=O)CC1,CHEMBL671730,Ki,7.75,CHEMBL126834,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc3ccnn23)CC1,CHEMBL3614290,Ki,7.47,CHEMBL344677,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc2ccnn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc3ccnn23)CC1,CHEMBL672384,Ki,6.82,CHEMBL344677,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,30,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc2ccnn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc3ccnn23)CC1,CHEMBL672573,Ki,7.01,CHEMBL344677,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc2ccnn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc3ccnn23)CC1,CHEMBL913685,Ki,6.82,CHEMBL344677,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc2ccnn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1,CHEMBL1930845,Ki,6.89,CHEMBL26188,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Binding affinity to D2 long receptor,83,792,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccccc2)CC1,CHEMBL1930846,Ki,7.05,CHEMBL26188,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Binding affinity to D2 short receptor,83,793,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccccc2I)CC1,CHEMBL671730,Ki,7.82,CHEMBL126136,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccn3nccc23)CC1,CHEMBL3614290,Ki,6.54,CHEMBL143352,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccn2nccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccn3nccc23)CC1,CHEMBL672384,Ki,6.57,CHEMBL143352,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,30,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccn2nccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccn3nccc23)CC1,CHEMBL672573,Ki,6.75,CHEMBL143352,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccn2nccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cccn3nccc23)CC1,CHEMBL913685,Ki,6.57,CHEMBL143352,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccn2nccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccn3nccc3c2)CC1,CHEMBL3614290,Ki,7.24,CHEMBL342060,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccn3nccc3c2)CC1,CHEMBL672384,Ki,6.72,CHEMBL342060,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,30,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccn3nccc3c2)CC1,CHEMBL672573,Ki,6.92,CHEMBL342060,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2ccn3nccc3c2)CC1,CHEMBL913685,Ki,6.72,CHEMBL342060,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1,CHEMBL3372144,IC50,8.18,CHEMBL3322993,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,100,169,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1,CHEMBL3379351,Ki,7.72,CHEMBL3322993,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,100,163,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1,CHEMBL3379904,IC50,7.58,CHEMBL3322993,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,100,175,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cnc3ccc(F)cc3c2)CC1,CHEMBL3599873,Ki,7.47,CHEMBL3597650,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,110,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1,CHEMBL1930837,Ki,8.34,CHEMBL1928139,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccc(COCCOCCOCCOCCOCc3ccn4ncc(C(=O)NCCCCN5CCN(c6ccccc6)CC5)c4c3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1,CHEMBL1930838,Ki,8.08,CHEMBL1928139,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccc(COCCOCCOCCOCCOCc3ccn4ncc(C(=O)NCCCCN5CCN(c6ccccc6)CC5)c4c3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1,CHEMBL1930837,Ki,9.23,CHEMBL1928137,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccc(OCCOCCOCCOCCOc3ccn4ncc(C(=O)NCCCCN5CCN(c6ccccc6)CC5)c4c3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1,CHEMBL1930838,Ki,8.74,CHEMBL1928137,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccc(OCCOCCOCCOCCOc3ccn4ncc(C(=O)NCCCCN5CCN(c6ccccc6)CC5)c4c3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL672384,Ki,6.96,CHEMBL423735,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,30,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL672573,Ki,7.19,CHEMBL423735,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2coc3ccccc3c2=O)CC1,CHEMBL671730,Ki,7.33,CHEMBL125525,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1coc2ccccc2c1=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2n[nH]c3ccccc23)CC1,CHEMBL5362774,Ki,8.06,CHEMBL5415412,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,157,491,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2nccc3ccccc23)CC1,CHEMBL671730,Ki,7.68,CHEMBL126892,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1nccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2nnn(Cc3ccccc3)c2C)CC1,CHEMBL3614290,Ki,7.46,CHEMBL221843,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2nnn(Cc3ccccc3)c2C)CC1,CHEMBL913685,Ki,6.64,CHEMBL221843,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2nnn(Cc3ccccc3Br)c2C)CC1,CHEMBL3614290,Ki,7.77,CHEMBL385289,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2nnn(Cc3ccccc3Br)c2C)CC1,CHEMBL913685,Ki,7.21,CHEMBL385289,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2sc3ccccc3c2Cl)CC1,CHEMBL671730,Ki,7.14,CHEMBL126313,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1,CHEMBL3300162,Ki,8.2,CHEMBL3298826,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC2=CC=CC3=[N+]4[N+](=Cc5c(C)cc(C)n5[B-]4(F)F)[B-](F)(F)N23)CC1,CHEMBL5133886,Ki,7.09,CHEMBL5202417,2022,CHEMBL5131451,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,154,497,[BH2-]1N2C(NCCCCN3CCN(c4ccccc4)CC3)=CC=CC2=[N+]2[BH2-]n3cccc3C=[N+]12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNC2=CC=CC3=[N+]4[N+](=Cc5cc6ccccc6n5[B-]4(F)F)[B-](F)(F)N23)CC1,CHEMBL5133886,Ki,6.74,CHEMBL5204696,2022,CHEMBL5131451,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,154,497,[BH2-]1N2C(NCCCCN3CCN(c4ccccc4)CC3)=CC=CC2=[N+]2[BH2-]n3c(cc4ccccc43)C=[N+]12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc(F)cc2)CC1,CHEMBL884780,Ki,7.14,CHEMBL194755,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,40,787,O=S(=O)(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc(F)cc2)CC1,CHEMBL884781,Ki,6.92,CHEMBL194755,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,40,788,O=S(=O)(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1,CHEMBL1227764,Ki,7.33,CHEMBL1221545,2010,CHEMBL1221249,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor after 60 mins,71,767,O=S(=O)(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNc2ccc3ccccc3n2)CC1,CHEMBL1225816,Ki,8.25,CHEMBL271989,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,71,794,c1ccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNc2ccccn2)CC1,CHEMBL1225816,Ki,9.1,CHEMBL1223615,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,71,794,c1ccc(N2CCN(CCCCNc3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNc2nc(N)nc(N)n2)CC1,CHEMBL5121178,Ki,7.34,CHEMBL5197737,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCNc3ncncn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNc2nc(N)nc(NCCc3c[nH]c4ccccc34)n2)CC1,CHEMBL5121178,Ki,7.89,CHEMBL5184538,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCNc3ncnc(NCCc4c[nH]c5ccccc45)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCNc2nccc3ccccc23)CC1,CHEMBL1225816,Ki,9.0,CHEMBL1223748,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,71,794,c1ccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc(-c3cn4cc(C)ccc4n3)cc2)CC1,CHEMBL895394,Ki,7.33,CHEMBL231182,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,54,795,c1ccc(N2CCN(CCCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc(-c3cn4ccc(C)cc4n3)cc2)CC1,CHEMBL895394,Ki,7.28,CHEMBL231158,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,54,795,c1ccc(N2CCN(CCCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc(-c3cn4cccc(C)c4n3)cc2)CC1,CHEMBL895394,Ki,6.8,CHEMBL231057,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,54,795,c1ccc(N2CCN(CCCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc(-c3cn4ccccc4n3)cc2)CC1,CHEMBL895394,Ki,6.75,CHEMBL231181,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,54,795,c1ccc(N2CCN(CCCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1,CHEMBL4010153,Ki,8.77,CHEMBL4069145,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,c1ccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1,CHEMBL4010156,Ki,8.38,CHEMBL4069145,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,c1ccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1,CHEMBL4010153,Ki,8.11,CHEMBL4067439,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,c1ccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1,CHEMBL4010156,Ki,8.11,CHEMBL4067439,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,c1ccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL1815674,Ki,9.66,CHEMBL1813590,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,79,640,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL2169117,Ki,9.52,CHEMBL160296,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,83,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL3887359,Ki,9.49,CHEMBL160296,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",110,117,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,CHEMBL3887359,Ki,8.77,CHEMBL3937643,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",110,117,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3ccc(=O)[nH]c3c2)CC1,CHEMBL1815674,Ki,9.85,CHEMBL1813594,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,79,640,O=c1ccc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1,CHEMBL4010153,Ki,9.13,CHEMBL4098803,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,c1ccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1,CHEMBL4010156,Ki,8.74,CHEMBL4098803,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,c1ccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3sc(N)nc3c2)CC1,CHEMBL4334858,Ki,8.55,CHEMBL4462915,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,136,774,c1ccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccc3scnc3c2)CC1,CHEMBL4334858,Ki,8.49,CHEMBL4448120,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,136,774,c1ccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1,CHEMBL4010153,Ki,8.72,CHEMBL4105030,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1,CHEMBL4010156,Ki,8.48,CHEMBL4105030,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1,CHEMBL4010153,Ki,7.92,CHEMBL4079301,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1,CHEMBL4010156,Ki,7.92,CHEMBL4079301,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1,CHEMBL4010153,Ki,8.26,CHEMBL4087187,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1,CHEMBL4010156,Ki,8.29,CHEMBL4087187,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1,CHEMBL4010153,Ki,8.24,CHEMBL4099711,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1,CHEMBL4010156,Ki,8.22,CHEMBL4099711,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,CHEMBL4010153,Ki,9.585,CHEMBL4060461,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1,CHEMBL4010156,Ki,9.36,CHEMBL4060461,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1,CHEMBL4010153,Ki,9.8,CHEMBL4063235,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1,CHEMBL4010156,Ki,9.6,CHEMBL4063235,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1,CHEMBL4010153,Ki,8.64,CHEMBL4098236,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1,CHEMBL4010156,Ki,8.74,CHEMBL4098236,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1,CHEMBL4010153,Ki,7.85,CHEMBL4080762,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,360,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1,CHEMBL4010156,Ki,7.75,CHEMBL4080762,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,125,361,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cc(-c3ccc(F)cc3)no2)CC1,CHEMBL672182,Ki,6.49,CHEMBL544220,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,30,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cc(-c3cccc([N+](=O)[O-])c3)no2)CC1,CHEMBL672182,Ki,6.53,CHEMBL541270,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,30,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cc(-c3ccccc3)no2)CC1,CHEMBL672182,Ki,5.76,CHEMBL544689,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,30,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cc(-c3cccs3)no2)CC1,CHEMBL672182,Ki,6.14,CHEMBL542325,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,30,52,c1ccc(N2CCN(CCCCc3cc(-c4cccs4)no3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cc(/C=C/c3ccccc3)no2)CC1,CHEMBL672182,Ki,6.02,CHEMBL539744,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,30,52,C(=Cc1cc(CCCCN2CCN(c3ccccc3)CC2)on1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccc(-c4ccsc4)cc3)nn2)CC1,CHEMBL3374187,Ki,7.03,CHEMBL3353901,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCc3cn(-c4ccc(-c5ccsc5)cc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccc(F)cc3)nn2)CC1,CHEMBL3374187,Ki,7.33,CHEMBL3353904,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccc(N(C)C)cc3)nn2)CC1,CHEMBL3374187,Ki,6.77,CHEMBL3353910,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccc(SC)cc3)nn2)CC1,CHEMBL3374187,Ki,7.42,CHEMBL3353913,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccc4[nH]ccc4c3)nn2)CC1,CHEMBL3591124,Ki,7.29,CHEMBL3588915,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,110,753,c1ccc(N2CCN(CCCCc3cn(-c4ccc5[nH]ccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccc4c(c3)Cc3ccccc3-4)nn2)CC1,CHEMBL3591124,Ki,7.24,CHEMBL3588914,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,110,753,c1ccc(N2CCN(CCCCc3cn(-c4ccc5c(c4)Cc4ccccc4-5)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccc4ccccc4c3)nn2)CC1,CHEMBL3591124,Ki,7.5,CHEMBL3588913,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,110,753,c1ccc(N2CCN(CCCCc3cn(-c4ccc5ccccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccc4cnccc4c3)nn2)CC1,CHEMBL3591124,Ki,7.08,CHEMBL3588916,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,110,753,c1ccc(N2CCN(CCCCc3cn(-c4ccc5cnccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3cccc4cnccc34)nn2)CC1,CHEMBL3374187,Ki,7.37,CHEMBL3353898,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCc3cn(-c4cccc5cnccc45)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccccc3)nn2)CC1,CHEMBL3374187,Ki,7.51,CHEMBL3353895,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccccc3)nn2)CC1,CHEMBL3591124,Ki,7.27,CHEMBL3353895,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,110,753,c1ccc(N2CCN(CCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccccc3O)nn2)CC1,CHEMBL3374187,Ki,8.03,CHEMBL3353916,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCc2cn(-c3ccccc3OC)nn2)CC1,CHEMBL3374187,Ki,6.86,CHEMBL3353907,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)CC1,CHEMBL3591124,Ki,7.16,CHEMBL3588983,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,110,753,c1ccc(-c2ccc(-c3cn(CCCCN4CCN(c5ccccc5)CC4)nn3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cc(-c3ccc(-c4cnco4)cc3)nn2)CC1,CHEMBL2434803,Ki,6.87,CHEMBL2430438,2013,CHEMBL2429816,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,91,689,c1ccc(N2CCN(CCCCn3cc(-c4ccc(-c5cnco5)cc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cc(-c3ccc(Br)cc3)nn2)CC1,CHEMBL2434803,Ki,6.64,CHEMBL2430442,2013,CHEMBL2429816,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,91,689,c1ccc(-c2cn(CCCCN3CCN(c4ccccc4)CC3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cc(-c3ccc(N)cc3)nn2)CC1,CHEMBL2434803,Ki,6.7,CHEMBL2430440,2013,CHEMBL2429816,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,91,689,c1ccc(-c2cn(CCCCN3CCN(c4ccccc4)CC3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cc(-c3ccc4[nH]ccc4c3)nn2)CC1,CHEMBL3591124,Ki,7.36,CHEMBL3588981,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,110,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5[nH]ccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cc(-c3ccc4c(c3)Cc3ccccc3-4)nn2)CC1,CHEMBL3591124,Ki,7.3,CHEMBL3588921,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,110,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5c(c4)Cc4ccccc4-5)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cc(-c3ccc4ccccc4c3)nn2)CC1,CHEMBL3591124,Ki,7.63,CHEMBL3588920,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,110,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5ccccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cc(-c3ccc4ncccc4c3)nn2)CC1,CHEMBL3591124,Ki,7.37,CHEMBL3588982,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,110,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5ncccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cc(-c3ccccc3)nn2)CC1,CHEMBL2434803,Ki,6.64,CHEMBL2430443,2013,CHEMBL2429816,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,91,689,c1ccc(-c2cn(CCCCN3CCN(c4ccccc4)CC3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cc(-c3ccccc3)nn2)CC1,CHEMBL3591124,Ki,6.86,CHEMBL2430443,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,110,753,c1ccc(-c2cn(CCCCN3CCN(c4ccccc4)CC3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cc(-c3cccnc3)nn2)CC1,CHEMBL2434803,Ki,6.74,CHEMBL2430439,2013,CHEMBL2429816,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from cloned human dopamine D2 receptor,91,689,c1ccc(N2CCN(CCCCn3cc(-c4cccnc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cnc3ccccc3c2=O)CC1,CHEMBL898619,Ki,6.74,CHEMBL239700,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,54,772,O=c1c2ccccc2ncn1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCCn2cnc3ccccc3c2=O)CC1,CHEMBL898624,Ki,8.92,CHEMBL239700,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,54,773,O=c1c2ccccc2ncn1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN(C(=O)c2ccccc2)C(C)C)CC1,CHEMBL4686220,IC50,6.08,CHEMBL4787658,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,143,193,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN(C(=O)c2ccccc2)C2COC2)CC1,CHEMBL4686220,IC50,5.42,CHEMBL4778957,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,143,193,O=C(c1ccccc1)N(CCCN1CCN(c2ccccc2)CC1)C1COC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN(CC2CC2)C(=O)c2ccccc2)CC1,CHEMBL4686220,IC50,6.54,CHEMBL4753512,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,144,193,O=C(c1ccccc1)N(CCCN1CCN(c2ccccc2)CC1)CC1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN2C(=O)CCc3ccccc32)CC1,CHEMBL5106582,Ki,7.09,CHEMBL5189614,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,154,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN2C(=O)COc3ccccc32)CC1,CHEMBL4000277,Ki,7.37,CHEMBL4066435,2015,CHEMBL4000143,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,110,796,O=C1COc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN2C(=O)c3ccccc3C2=O)CC1,CHEMBL671730,Ki,6.52,CHEMBL127979,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C1c2ccccc2C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN2CCCc3ccccc3C2=O)CC1,CHEMBL993531,Ki,6.1,CHEMBL476641,2009,CHEMBL1153914,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,64,741,O=C1c2ccccc2CCCN1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN2CCCc3ncsc3C2)CC1,CHEMBL4334858,Ki,6.75,CHEMBL4475262,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,136,774,c1ccc(N2CCN(CCCN3CCCc4ncsc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN2CCN(C(=O)c3ccccc3)CC2)CC1,CHEMBL5145822,Ki,6.58,CHEMBL5178994,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C(c1ccccc1)N1CCN(CCCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN2CCN(C(=O)c3ccccn3)CC2)CC1,CHEMBL5145822,Ki,6.23,CHEMBL5178688,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C(c1ccccn1)N1CCN(CCCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN2CCN(c3ncccc3C#N)CC2)CC1,CHEMBL5145822,Ki,6.96,CHEMBL5182877,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,c1ccc(N2CCN(CCCN3CCN(c4ccccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCN2CCc3ncsc3CC2)CC1,CHEMBL4334858,Ki,7.19,CHEMBL4570930,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,136,774,c1ccc(N2CCN(CCCN3CCc4ncsc4CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)/N=N/c2ccc(F)cc2)CC1,CHEMBL4323478,Ki,6.96,CHEMBL4534703,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(N=Nc1ccccc1)NCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)/N=N/c2ccc(F)cc2)CC1,CHEMBL4323479,Ki,7.29,CHEMBL4534703,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(N=Nc1ccccc1)NCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Cc2ccc3ccccc3c2)CC1,CHEMBL671730,Ki,7.25,CHEMBL128133,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(Cc1ccc2ccccc2c1)NCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Cc2cccc3ccccc23)CC1,CHEMBL671730,Ki,7.36,CHEMBL126656,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(Cc1cccc2ccccc12)NCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2c(F)cccc2-c2ccccc2)CC1,CHEMBL5351445,Ki,6.68,CHEMBL5421272,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2c(F)cccc2-c2ccccc2)CC1,CHEMBL5351446,Ki,6.85,CHEMBL5421272,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2cc(F)ccc2-c2ccccc2)CC1,CHEMBL5351445,Ki,7.06,CHEMBL5433509,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2cc(F)ccc2-c2ccccc2)CC1,CHEMBL5351446,Ki,7.42,CHEMBL5433509,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccc(F)cc2-c2ccccc2)CC1,CHEMBL5351445,Ki,7.14,CHEMBL5438205,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccc(F)cc2-c2ccccc2)CC1,CHEMBL5351446,Ki,7.4,CHEMBL5438205,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2cccc(F)c2-c2ccccc2)CC1,CHEMBL5351445,Ki,7.58,CHEMBL5412718,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2cccc(F)c2-c2ccccc2)CC1,CHEMBL5351446,Ki,7.89,CHEMBL5412718,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(-c3ccccc3)cc2)CC1,CHEMBL5351445,Ki,6.34,CHEMBL5405333,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(-c3ccccc3)cc2)CC1,CHEMBL5351446,Ki,6.54,CHEMBL5405333,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(C(C)C)cc2)CC1,CHEMBL5351445,Ki,6.4,CHEMBL5396317,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(C(C)C)cc2)CC1,CHEMBL5351446,Ki,6.77,CHEMBL5396317,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(C)cc2)CC1,CHEMBL5351445,Ki,6.96,CHEMBL5427937,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(C)cc2)CC1,CHEMBL5351446,Ki,7.21,CHEMBL5427937,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,157,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(F)cc2)CC1,CHEMBL5351445,Ki,6.68,CHEMBL5395187,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccc(F)cc2)CC1,CHEMBL5351446,Ki,7.12,CHEMBL5395187,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2cccc(F)c2)CC1,CHEMBL5351445,Ki,7.07,CHEMBL5405086,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2cccc(F)c2)CC1,CHEMBL5351446,Ki,7.17,CHEMBL5405086,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccccc2)CC1,CHEMBL5351445,Ki,6.72,CHEMBL5425252,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,32,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccccc2)CC1,CHEMBL5351446,Ki,6.92,CHEMBL5425252,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,33,O=C(NCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(-c3ccccc3)cc2)c2ccc(F)cc2)CC1,CHEMBL4323478,Ki,6.85,CHEMBL4454096,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccc(-c2ccccc2)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(-c3ccccc3)cc2)c2ccc(F)cc2)CC1,CHEMBL4323479,Ki,7.38,CHEMBL4454096,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccc(-c2ccccc2)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(C#N)cc2)c2ccc(Cl)cc2Cl)CC1,CHEMBL4323478,Ki,6.82,CHEMBL4583596,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(C#N)cc2)c2ccc(Cl)cc2Cl)CC1,CHEMBL4323479,Ki,7.03,CHEMBL4583596,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(C#N)cc2)c2ccc(F)cc2)CC1,CHEMBL4323478,Ki,6.68,CHEMBL4520460,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(C#N)cc2)c2ccc(F)cc2)CC1,CHEMBL4323479,Ki,6.92,CHEMBL4520460,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4323478,Ki,7.11,CHEMBL4463200,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4323479,Ki,7.52,CHEMBL4463200,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1,CHEMBL4323478,Ki,6.85,CHEMBL4544086,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1,CHEMBL4323479,Ki,6.96,CHEMBL4544086,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2cccc(F)c2)c2ccc(F)cc2)CC1,CHEMBL4323478,Ki,7.14,CHEMBL4437233,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2cccc(F)c2)c2ccc(F)cc2)CC1,CHEMBL4323479,Ki,7.34,CHEMBL4437233,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Br)cc2)CC1,CHEMBL4323478,Ki,7.26,CHEMBL4439644,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Br)cc2)CC1,CHEMBL4323479,Ki,7.47,CHEMBL4439644,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Cl)cc2)CC1,CHEMBL4323478,Ki,7.5,CHEMBL4470231,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Cl)cc2)CC1,CHEMBL4323479,Ki,7.64,CHEMBL4470231,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Cl)cc2Cl)CC1,CHEMBL4323478,Ki,7.46,CHEMBL4475042,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(Cl)cc2Cl)CC1,CHEMBL4323479,Ki,7.62,CHEMBL4475042,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1,CHEMBL4323478,Ki,8.18,CHEMBL4563944,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1,CHEMBL4323479,Ki,8.37,CHEMBL4563944,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1,CHEMBL4323478,Ki,7.11,CHEMBL4442460,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1,CHEMBL4323479,Ki,7.14,CHEMBL4442460,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,136,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(Br)cc2)CC1,CHEMBL4323478,Ki,7.35,CHEMBL4467437,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,136,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(Br)cc2)CC1,CHEMBL4323479,Ki,7.66,CHEMBL4467437,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,137,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(Cl)cc2)CC1,CHEMBL4323478,Ki,7.39,CHEMBL4570073,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,137,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(Cl)cc2)CC1,CHEMBL4323479,Ki,7.58,CHEMBL4570073,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,137,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(F)cc2)CC1,CHEMBL4323478,Ki,7.04,CHEMBL4442470,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,137,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2F)c2ccc(F)cc2)CC1,CHEMBL4323479,Ki,7.33,CHEMBL4442470,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,137,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccc(-c3ccccc3)cc2)CC1,CHEMBL5351445,Ki,6.47,CHEMBL5415335,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccc(-c3ccccc3)cc2)CC1,CHEMBL5351446,Ki,6.89,CHEMBL5415335,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccc(F)cc2-c2ccccc2)CC1,CHEMBL5351445,Ki,6.85,CHEMBL5394431,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccc(F)cc2-c2ccccc2)CC1,CHEMBL5351446,Ki,7.51,CHEMBL5394431,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2cccc(-c3ccccc3)c2)CC1,CHEMBL5351445,Ki,7.34,CHEMBL5431474,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1cccc(-c2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2cccc(-c3ccccc3)c2)CC1,CHEMBL5351446,Ki,7.75,CHEMBL5431474,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1cccc(-c2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(-c3ccccc3)cc2)CC1,CHEMBL5351445,Ki,7.28,CHEMBL5394229,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(-c3ccccc3)cc2)CC1,CHEMBL5351446,Ki,7.44,CHEMBL5394229,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(C(C)(C)C)cc2)CC1,CHEMBL5351445,Ki,6.92,CHEMBL5416728,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(C(C)(C)C)cc2)CC1,CHEMBL5351446,Ki,7.11,CHEMBL5416728,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(C(C)C)cc2)CC1,CHEMBL5351445,Ki,6.82,CHEMBL5410179,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(C(C)C)cc2)CC1,CHEMBL5351446,Ki,7.05,CHEMBL5410179,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2cccc(F)c2)CC1,CHEMBL5351445,Ki,6.77,CHEMBL5436809,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2cccc(F)c2)CC1,CHEMBL5351446,Ki,6.96,CHEMBL5436809,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccccc2)CC1,CHEMBL5351445,Ki,6.68,CHEMBL5400232,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2L receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,32,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccccc2)CC1,CHEMBL5351446,Ki,7.0,CHEMBL5400232,2023,CHEMBL5346968,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopmaine D2S receptor expressed in CHO cell membrane assessed as inhibition constant by competition binding assay,158,33,O=C(NCCCN1CCN(c2ccccc2)CC1)Nc1ccccc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)OC(C)(C)C)CC1,CHEMBL3300162,Ki,7.795,CHEMBL3299094,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL3614290,Ki,6.82,CHEMBL357684,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL672384,Ki,6.08,CHEMBL357684,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,30,769,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL672573,Ki,6.01,CHEMBL357684,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL913685,Ki,6.08,CHEMBL357684,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccc(-n3ccnc3)cc2)CC1,CHEMBL938625,Ki,6.92,CHEMBL465014,2009,CHEMBL1140855,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,64,673,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc(-n2ccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930837,Ki,7.18,CHEMBL1928131,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930838,Ki,6.82,CHEMBL1928131,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930837,Ki,7.7,CHEMBL1928129,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930838,Ki,7.29,CHEMBL1928129,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930837,Ki,7.5,CHEMBL1928127,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930838,Ki,7.33,CHEMBL1928127,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCCOCc2ccc(C(=O)NCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930837,Ki,7.72,CHEMBL1928125,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCc2ccc(C(=O)NCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccc(COCCOCCOCCOCCOCc3ccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)cc3)cc2)CC1,CHEMBL1930838,Ki,7.38,CHEMBL1928125,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc(COCCOCCOCCOCCOCc2ccc(C(=O)NCCCN3CCN(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccc(I)cc2)CC1,CHEMBL671730,Ki,6.93,CHEMBL421667,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccc3nonc3c2)CC1,CHEMBL938625,Ki,7.05,CHEMBL456232,2009,CHEMBL1140855,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,64,673,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc2nonc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cccc(I)c2)CC1,CHEMBL671730,Ki,6.63,CHEMBL129606,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1,CHEMBL1930837,Ki,8.19,CHEMBL1928121,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cccc(OCCOCCOCCOCCOc2cccc(C(=O)NCCCN3CCN(c4ccccc4)CC3)c2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(C(=O)NCCCN4CCN(c5ccccc5OC)CC4)c3)c2)CC1,CHEMBL1930838,Ki,7.8,CHEMBL1928121,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cccc(OCCOCCOCCOCCOc2cccc(C(=O)NCCCN3CCN(c4ccccc4)CC3)c2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2ccccc2I)CC1,CHEMBL671730,Ki,6.9,CHEMBL263058,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cnccn2)CC1,CHEMBL5145822,Ki,6.07,CHEMBL5202003,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1,CHEMBL1930837,Ki,8.41,CHEMBL1928138,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccc(COCCOCCOCCOCCOCc3ccn4ncc(C(=O)NCCCN5CCN(c6ccccc6)CC5)c4c3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(COCCOCCOCCOCCOCc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1,CHEMBL1930838,Ki,8.33,CHEMBL1928138,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccc(COCCOCCOCCOCCOCc3ccn4ncc(C(=O)NCCCN5CCN(c6ccccc6)CC5)c4c3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1,CHEMBL1930837,Ki,8.57,CHEMBL1926700,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,83,483,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccc(OCCOCCOCCOCCOc3ccn4ncc(C(=O)NCCCN5CCN(c6ccccc6)CC5)c4c3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccc(OCCOCCOCCOCCOc4ccn5ncc(C(=O)NCCCN6CCN(c7ccccc7OC)CC6)c5c4)cc23)CC1,CHEMBL1930838,Ki,8.08,CHEMBL1926700,2012,CHEMBL1926639,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,83,484,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccc(OCCOCCOCCOCCOc3ccn4ncc(C(=O)NCCCN5CCN(c6ccccc6)CC5)c4c3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL1031082,Ki,7.96,CHEMBL140612,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,64,782,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL1031088,Ki,7.89,CHEMBL140612,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,64,783,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL1031094,Ki,7.08,CHEMBL140612,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,64,784,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL672384,Ki,7.96,CHEMBL140612,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,30,769,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL672573,Ki,8.41,CHEMBL140612,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1,CHEMBL3300162,Ki,7.71,CHEMBL3298759,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNC2=Nc3ccccc3OC2)CC1,CHEMBL670396,Ki,6.55,CHEMBL80711,1997,CHEMBL1130531,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,11,797,c1ccc(N2CCN(CCCNC3=Nc4ccccc4OC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCNS(=O)(=O)c2ccc3ccccc3c2)CC1,CHEMBL1227764,Ki,6.88,CHEMBL497749,2010,CHEMBL1221249,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor after 60 mins,71,767,O=S(=O)(NCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc(-c3cn4cc(C)ccc4n3)cc2)CC1,CHEMBL895394,Ki,7.11,CHEMBL230972,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,54,795,c1ccc(N2CCN(CCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc(-c3cn4ccc(C)cc4n3)cc2)CC1,CHEMBL895394,Ki,7.11,CHEMBL231078,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,54,795,c1ccc(N2CCN(CCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc(-c3cn4cccc(C)c4n3)cc2)CC1,CHEMBL895394,Ki,7.31,CHEMBL387569,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,54,795,c1ccc(N2CCN(CCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc(-c3cn4ccccc4n3)cc2)CC1,CHEMBL895394,Ki,7.31,CHEMBL230872,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,54,795,c1ccc(N2CCN(CCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1,CHEMBL3073105,Ki,8.06,CHEMBL313620,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),91,427,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1,CHEMBL3636470,Ki,8.06,CHEMBL313620,2015,CHEMBL3632483,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopaminergic D2 receptor (unknown origin),110,798,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1,CHEMBL670391,Ki,8.06,CHEMBL313620,1995,CHEMBL1149936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,6,428,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1,CHEMBL4195136,Ki,7.01,CHEMBL4209888,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,131,717,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc(C)cc2C)CC1,CHEMBL4195154,IC50,7.75,CHEMBL4209888,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO-K1 cells co-expressing Galphaqi5 assessed as decrease in apomorphine-induced calcium mobilization preincubated for 30 mins followed by apomorphine challenge measured for 30 secs by aequorin-derived luminescence assay,131,527,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc(NC(C)=O)cc2)CC1,CHEMBL4729778,Ki,6.33,CHEMBL4789422,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),144,100,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc3c(C)cc(=O)oc3c2)CC1,CHEMBL2390029,Ki,7.93,CHEMBL51767,2013,CHEMBL2385071,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),91,799,O=c1ccc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL1815674,Ki,8.32,CHEMBL1813596,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,79,640,O=C1CCc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCOc2ccc3ccc(=O)[nH]c3c2)CC1,CHEMBL1815674,Ki,8.59,CHEMBL1813597,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,79,640,O=c1ccc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCSc2nnc(-c3ccccc3)n2C)CC1,CHEMBL4032441,Ki,6.58,CHEMBL4083252,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,125,714,c1ccc(-c2nnc(SCCCN3CCN(c4ccccc4)CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCSc2nnc(-c3ccccc3)n2C)CC1,CHEMBL4397357,Ki,6.58,CHEMBL4083252,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,137,279,c1ccc(-c2nnc(SCCCN3CCN(c4ccccc4)CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCSc2nnc(-c3ccccc3)n2C)CC1,CHEMBL4397362,IC50,6.48,CHEMBL4083252,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Antagonist activity at recombinant human D2 receptor expressed in CHOK1 cells assessed as inhibition of quinpirole-induced beta arrestin2 recruitment preincubated for 30 mins followed by quinpirole addition and measured after 90 mins by coelenterazine-based beta-galactosidase reporter gene assay,137,758,c1ccc(-c2nnc(SCCCN3CCN(c4ccccc4)CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCSc2nnc(-c3ccccc3)n2C)CC1,CHEMBL4397425,Ki,6.24,CHEMBL4083252,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast measured after 90 mins by microbeta scintillation counting method,137,800,c1ccc(-c2nnc(SCCCN3CCN(c4ccccc4)CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2ccc3[nH]c(=S)[nH]c3c2)CC1,CHEMBL3073105,Ki,9.4,CHEMBL2298822,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),91,427,S=c1[nH]c2ccc(CCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2ccc3nc[nH]c3c2)CC1,CHEMBL3073105,Ki,7.01,CHEMBL2298817,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),91,427,c1ccc(N2CCN(CCCc3ccc4nc[nH]c4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(-c3ccc(-c4ccsc4)cc3)nn2)CC1,CHEMBL3374187,Ki,6.8,CHEMBL3353900,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCc3cn(-c4ccc(-c5ccsc5)cc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(-c3ccc(F)cc3)nn2)CC1,CHEMBL3374187,Ki,7.13,CHEMBL3353903,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(-c3ccc(N(C)C)cc3)nn2)CC1,CHEMBL3374187,Ki,6.79,CHEMBL3353909,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(-c3ccc(SC)cc3)nn2)CC1,CHEMBL3374187,Ki,7.36,CHEMBL3353912,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(-c3cccc4cnccc34)nn2)CC1,CHEMBL3374187,Ki,7.1,CHEMBL3353897,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCc3cn(-c4cccc5cnccc45)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(-c3ccccc3)nn2)CC1,CHEMBL3374187,Ki,7.19,CHEMBL3353894,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(-c3ccccc3O)nn2)CC1,CHEMBL3374187,Ki,7.89,CHEMBL3353915,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(-c3ccccc3OC)nn2)CC1,CHEMBL3374187,Ki,6.57,CHEMBL3353906,2015,CHEMBL3352598,Bioorg Med Chem Lett,Scientific Literature,Displacement of of [125I]-IABN from human D2 long receptor expressed in HEK293 cell membranes after 60 mins by filtration binding assay,110,771,c1ccc(N2CCN(CCCc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(-c3ccn4nccc4c3)nn2)CC1,CHEMBL3614290,Ki,6.85,CHEMBL3613873,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,c1ccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(-c3ccn4nccc4c3)nn2)CC1,CHEMBL3614291,Ki,7.09,CHEMBL3613873,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,110,801,c1ccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(CCCN3CCc4cc(O)c(O)cc4C(c4ccccc4C)C3)nn2)CC1,CHEMBL1041331,Ki,7.72,CHEMBL574700,2009,CHEMBL1154108,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,64,802,c1ccc(C2CN(CCCn3cc(CCCN4CCN(c5ccccc5)CC4)nn3)CCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCc2cn(CCCN3CCc4cc(O)c(O)cc4C(c4ccccc4C)C3)nn2)CC1,CHEMBL1044818,IC50,6.32,CHEMBL574700,2009,CHEMBL1154108,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor expressed in HEK293 cells by by [35S]GTPgammaS binding assay in presence of quinpirole,64,803,c1ccc(C2CN(CCCn3cc(CCCN4CCN(c5ccccc5)CC4)nn3)CCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCn2cc(CCCCN3CCc4cc(O)c(O)cc4C(c4cccc(C)c4)C3)nn2)CC1,CHEMBL1041331,Ki,7.1,CHEMBL582945,2009,CHEMBL1154108,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,64,802,c1ccc(C2CN(CCCCc3cn(CCCN4CCN(c5ccccc5)CC4)nn3)CCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCn2cc(CCCCN3CCc4cc(O)c(O)cc4C(c4cccc(C)c4)C3)nn2)CC1,CHEMBL1044818,IC50,5.8,CHEMBL582945,2009,CHEMBL1154108,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor expressed in HEK293 cells by by [35S]GTPgammaS binding assay in presence of quinpirole,64,803,c1ccc(C2CN(CCCCc3cn(CCCN4CCN(c5ccccc5)CC4)nn3)CCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCn2cc(CCCN3CCc4cc(O)c(O)cc4C(c4cccc(C)c4)C3)nn2)CC1,CHEMBL1041331,Ki,6.94,CHEMBL585740,2009,CHEMBL1154108,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,64,802,c1ccc(C2CN(CCCc3cn(CCCN4CCN(c5ccccc5)CC4)nn3)CCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCCn2cc(CCCN3CCc4cc(O)c(O)cc4C(c4ccccc4C)C3)nn2)CC1,CHEMBL1041331,Ki,7.41,CHEMBL574595,2009,CHEMBL1154108,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,64,802,c1ccc(C2CN(CCCc3cn(CCCN4CCN(c5ccccc5)CC4)nn3)CCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCN2C(=O)CC3(CCCC3)CC2=O)CC1,CHEMBL826339,Ki,7.85,CHEMBL13647,2005,CHEMBL1143615,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2,40,804,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCN2CCN(C(=O)c3nn(C)c4ccccc34)CC2)CC1,CHEMBL5145822,Ki,6.2,CHEMBL5209381,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C(c1n[nH]c2ccccc12)N1CCN(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCN2CCN(c3ncccc3C#N)CC2)CC1,CHEMBL5145822,Ki,6.89,CHEMBL5196828,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,c1ccc(N2CCN(CCN3CCN(c4ccccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCN2CCc3ncsc3CC2)CC1,CHEMBL4334858,Ki,6.82,CHEMBL4451351,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,137,774,c1ccc(N2CCN(CCN3CCc4ncsc4CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)/N=N/c2ccc(F)cc2)CC1,CHEMBL4323478,Ki,6.57,CHEMBL4463276,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,137,70,O=C(N=Nc1ccccc1)NCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)/N=N/c2ccc(F)cc2)CC1,CHEMBL4323479,Ki,6.85,CHEMBL4463276,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,137,71,O=C(N=Nc1ccccc1)NCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1,CHEMBL4323478,Ki,7.0,CHEMBL4465002,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,137,70,O=C(NCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)NN(Cc2ccccc2)c2ccc(F)cc2)CC1,CHEMBL4323479,Ki,7.15,CHEMBL4465002,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,137,71,O=C(NCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)OC(C)(C)C)CC1,CHEMBL3300162,Ki,6.77,CHEMBL3299093,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)OC(C)(C)C)CC1,CHEMBL3300164,IC50,7.03,CHEMBL3299093,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in FlpIn CHO cells assessed as inhibition of dopamine-induced ERK1/2 phosphorylation treated for 30 mins prior to dopamine stimulation for 5 mins by AlphaScreen assay,100,766,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2cc(Br)c3ccccc3c2OC)CC1,CHEMBL672800,Ki,6.52,CHEMBL30146,1996,CHEMBL1129096,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine D2 receptors in rat striatum by [3H]spiperone displacement.,9,654,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL672384,Ki,6.28,CHEMBL139722,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,30,769,O=C(NCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL672573,Ki,6.32,CHEMBL139722,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL913685,Ki,6.28,CHEMBL139722,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2ccc(F)cc2)CC1,CHEMBL672308,Ki,8.3,CHEMBL58377,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,25,593,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL1227764,Ki,6.05,CHEMBL1221498,2010,CHEMBL1221249,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor after 60 mins,71,767,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2cn(-c3ccc([N+](=O)[O-])cc3)nn2)CC1,CHEMBL1044860,Ki,8.19,CHEMBL573791,2009,CHEMBL1154112,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,64,691,O=C(NCCN1CCN(c2ccccc2)CC1)c1cn(-c2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2cn(-c3ccc([N+](=O)[O-])cc3)nn2)CC1,CHEMBL1044861,Ki,6.55,CHEMBL573791,2009,CHEMBL1154112,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,64,692,O=C(NCCN1CCN(c2ccccc2)CC1)c1cn(-c2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2cnn3ccccc23)CC1,CHEMBL3614290,Ki,7.07,CHEMBL141845,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,110,431,O=C(NCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2cnn3ccccc23)CC1,CHEMBL672384,Ki,6.54,CHEMBL141845,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,30,769,O=C(NCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2cnn3ccccc23)CC1,CHEMBL672573,Ki,6.85,CHEMBL141845,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,30,770,O=C(NCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2cnn3ccccc23)CC1,CHEMBL839477,Ki,6.54,CHEMBL141845,2005,CHEMBL1141881,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 long,40,457,O=C(NCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2cnn3ccccc23)CC1,CHEMBL913685,Ki,6.54,CHEMBL141845,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,O=C(NCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC(=O)c2sc3nc(OC)c(Cl)c(C)c3c2N)CC1,CHEMBL3300162,Ki,7.32,CHEMBL3298758,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,O=C(NCCN1CCN(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCNC2=Nc3ccccc3OC2)CC1,CHEMBL672101,Ki,6.55,CHEMBL148024,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity was measured at the cloned human Dopamine receptor D2 using [3H]spiroperidol as radioligand.,14,255,c1ccc(N2CCN(CCNC3=Nc4ccccc4OC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1,CHEMBL4195136,Ki,6.72,CHEMBL4207653,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,131,717,c1ccc(OCCOCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCOCCOc2c(C)cc(C)cc2C)CC1,CHEMBL4195154,IC50,7.09,CHEMBL4207653,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO-K1 cells co-expressing Galphaqi5 assessed as decrease in apomorphine-induced calcium mobilization preincubated for 30 mins followed by apomorphine challenge measured for 30 secs by aequorin-derived luminescence assay,131,527,c1ccc(OCCOCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCOCCOc2c(C)cccc2C)CC1,CHEMBL4195129,Ki,6.66,CHEMBL4213647,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHOK1 cell membranes after 60 mins by liquid scintillation counting method,131,805,c1ccc(OCCOCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1,CHEMBL4195136,Ki,6.79,CHEMBL4213352,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,131,717,c1ccc(OCCOCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCOCCOc2cc(C)cc(C)c2C)CC1,CHEMBL4195154,IC50,7.11,CHEMBL4213352,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO-K1 cells co-expressing Galphaqi5 assessed as decrease in apomorphine-induced calcium mobilization preincubated for 30 mins followed by apomorphine challenge measured for 30 secs by aequorin-derived luminescence assay,131,527,c1ccc(OCCOCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCOc2ccc3[nH]c(=O)[nH]c3c2)CC1,CHEMBL3073105,Ki,8.89,CHEMBL2299002,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),91,427,O=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCOc2ccc3[nH]c(=S)[nH]c3c2)CC1,CHEMBL3073105,Ki,9.72,CHEMBL2298829,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),91,427,S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCOc2ccc3nc[nH]c3c2)CC1,CHEMBL3073105,Ki,7.9,CHEMBL2298824,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),91,427,c1ccc(N2CCN(CCOc3ccc4nc[nH]c4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCOc2ccc3nn[nH]c3c2)CC1,CHEMBL3073105,Ki,8.82,CHEMBL2298805,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),91,427,c1ccc(N2CCN(CCOc3ccc4nn[nH]c4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC[C@H]2CC[C@H](NC(=O)c3cccs3)CC2)CC1,CHEMBL671651,Ki,8.85,CHEMBL78950,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,11,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC[C@H]2CC[C@H](Nc3ncccn3)CC2)CC1,CHEMBL670114,IC50,8.0,CHEMBL164792,1998,CHEMBL1131565,J Med Chem,Scientific Literature,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,14,806,c1ccc(N2CCN(CCC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CC[C@H]2CC[C@H](Nc3ncccn3)CC2)CC1,CHEMBL672206,Ki,8.52,CHEMBL164792,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,14,62,c1ccc(N2CCN(CCC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCc2ccc3[nH]nnc3c2)CC1,CHEMBL3073105,Ki,8.27,CHEMBL183776,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),91,427,c1ccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCc2ccc3[nH]nnc3c2)CC1,CHEMBL838638,Ki,8.27,CHEMBL183776,2004,CHEMBL1137161,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2,38,598,c1ccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCc2cn(-c3ccn4ncc(C=O)c4c3)nn2)CC1,CHEMBL3614290,Ki,7.75,CHEMBL3613877,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,111,431,c1ccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCc2cn(-c3ccn4ncc(C=O)c4c3)nn2)CC1,CHEMBL3614291,Ki,8.03,CHEMBL3613877,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,111,801,c1ccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,CHEMBL672180,Ki,6.88,CHEMBL51433,1998,CHEMBL1131058,J Med Chem,Scientific Literature,Compound is evaluated for binding affinity towards recombinant human Dopamine receptor D2 using [3H]spiperone in CHO cells,14,762,O=c1[nH]c2ccccc2c(=O)n1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,CHEMBL672484,Ki,7.5,CHEMBL51433,1998,CHEMBL1131058,J Med Chem,Scientific Literature,Compound is evaluated for binding affinity towards Dopamine receptor D2 using [3H]spiperone in CHO cells at 10 uM,14,807,O=c1[nH]c2ccccc2c(=O)n1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CNC(=O)c2ccc(C)cc2)CC1,CHEMBL671981,Ki,6.54,CHEMBL51023,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,11,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CNC(=O)c2ccc(C)cc2)CC1,CHEMBL835392,Ki,6.76,CHEMBL51023,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,40,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CNC(=O)c2ccc(Cl)cc2)CC1,CHEMBL671981,Ki,6.46,CHEMBL49231,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,11,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CNC(=O)c2ccc(Cl)cc2)CC1,CHEMBL835392,Ki,6.57,CHEMBL49231,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,40,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CNC(=O)c2cccc(C)c2)CC1,CHEMBL671981,Ki,6.08,CHEMBL296506,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,11,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CNC(=O)c2cccc(C)c2)CC1,CHEMBL835392,Ki,5.61,CHEMBL296506,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,40,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CNC(=O)c2cccc(Cl)c2)CC1,CHEMBL671981,Ki,6.35,CHEMBL48819,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,11,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CNC(=O)c2cccc(Cl)c2)CC1,CHEMBL835392,Ki,5.84,CHEMBL48819,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,40,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CNC(=O)c2ccccc2)CC1,CHEMBL671981,Ki,5.73,CHEMBL48807,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,11,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(CNC(=O)c2ccccc2)CC1,CHEMBL835392,Ki,5.61,CHEMBL48807,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,41,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,CHEMBL671074,IC50,8.3,CHEMBL1202216,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(C[C@H]2OCCOC2(c2ccccc2)c2ccccc2)CC1,CHEMBL4391918,Ki,5.66,CHEMBL4441888,2019,CHEMBL4390666,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting,137,763,c1ccc(N2CCN(CC3OCCOC3(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2c(C)[nH]c3nc(N(C)C)ncc23)CC1,CHEMBL1061432,Ki,5.58,CHEMBL558838,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,64,569,c1ccc(N2CCN(Cc3c[nH]c4ncncc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2c(C)[nH]c3nc(N(C)C)ncc23)CC1,CHEMBL1061433,Ki,5.54,CHEMBL558838,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,64,570,c1ccc(N2CCN(Cc3c[nH]c4ncncc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2c(C)nc3cc(C)nc(C)n23)CC1,CHEMBL1061432,Ki,5.64,CHEMBL563614,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,64,569,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2c(C)nc3cc(C)nc(C)n23)CC1,CHEMBL1061433,Ki,5.54,CHEMBL563614,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,64,570,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2c(C)nc3cc(C)ncn23)CC1,CHEMBL1061432,Ki,4.4,CHEMBL561262,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,64,569,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2c(C)nc3cc(C)ncn23)CC1,CHEMBL1061433,Ki,4.28,CHEMBL561262,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,64,570,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(C#Cc3ccccc3)c3cccccc2-3)CC1,CHEMBL2214282,Ki,7.17,CHEMBL2207633,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,38,C(#Cc1cc(CN2CCN(c3ccccc3)CC2)c2cccccc1-2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(C#Cc3ccccc3)c3cccccc2-3)CC1,CHEMBL2214283,Ki,7.19,CHEMBL2207633,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,39,C(#Cc1cc(CN2CCN(c3ccccc3)CC2)c2cccccc1-2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(C#N)c3cccccc2-3)CC1,CHEMBL2214282,Ki,7.41,CHEMBL2207636,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,38,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(C#N)c3cccccc2-3)CC1,CHEMBL2214283,Ki,8.08,CHEMBL2207636,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,39,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN(C)C)c3cccccc2-3)CC1,CHEMBL2214282,Ki,6.85,CHEMBL2207637,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,38,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN(C)C)c3cccccc2-3)CC1,CHEMBL2214283,Ki,6.68,CHEMBL2207637,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,39,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN3CCCCC3)c3cccccc2-3)CC1,CHEMBL2214282,Ki,7.43,CHEMBL2207638,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,38,c1ccc(N2CCN(Cc3cc(CN4CCCCC4)c4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN3CCCCC3)c3cccccc2-3)CC1,CHEMBL2214283,Ki,7.29,CHEMBL2207638,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,39,c1ccc(N2CCN(Cc3cc(CN4CCCCC4)c4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN3CCN(C)CC3)c3cccccc2-3)CC1,CHEMBL2214282,Ki,7.24,CHEMBL2207640,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,38,c1ccc(N2CCN(Cc3cc(CN4CCNCC4)c4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN3CCN(C)CC3)c3cccccc2-3)CC1,CHEMBL2214283,Ki,7.22,CHEMBL2207640,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,39,c1ccc(N2CCN(Cc3cc(CN4CCNCC4)c4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)c3cccccc2-3)CC1,CHEMBL2214282,Ki,6.8,CHEMBL2207642,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,38,c1ccc(N2CCN(Cc3cc(CN4CCN(c5ccccc5)CC4)c4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)c3cccccc2-3)CC1,CHEMBL2214283,Ki,7.02,CHEMBL2207642,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,39,c1ccc(N2CCN(Cc3cc(CN4CCN(c5ccccc5)CC4)c4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN3CCN(c4ccccc4OC)CC3)c3cccccc2-3)CC1,CHEMBL2214282,Ki,7.47,CHEMBL2207641,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,38,c1ccc(N2CCN(Cc3cc(CN4CCN(c5ccccc5)CC4)c4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN3CCN(c4ccccc4OC)CC3)c3cccccc2-3)CC1,CHEMBL2214283,Ki,7.77,CHEMBL2207641,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,39,c1ccc(N2CCN(Cc3cc(CN4CCN(c5ccccc5)CC4)c4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN3CCOCC3)c3cccccc2-3)CC1,CHEMBL2214282,Ki,7.04,CHEMBL2207639,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,38,c1ccc(N2CCN(Cc3cc(CN4CCOCC4)c4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CN3CCOCC3)c3cccccc2-3)CC1,CHEMBL2214283,Ki,6.89,CHEMBL2207639,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,39,c1ccc(N2CCN(Cc3cc(CN4CCOCC4)c4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CO)c3cccccc2-3)CC1,CHEMBL2214282,Ki,7.17,CHEMBL2207635,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,38,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc(CO)c3cccccc2-3)CC1,CHEMBL2214283,Ki,6.82,CHEMBL2207635,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,39,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc3c(=O)[nH]c(N(C)C)nc3[nH]2)CC1,CHEMBL1061432,Ki,6.89,CHEMBL552268,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,64,569,O=c1[nH]cnc2[nH]c(CN3CCN(c4ccccc4)CC3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc3c(=O)[nH]c(N(C)C)nc3[nH]2)CC1,CHEMBL1061433,Ki,6.77,CHEMBL552268,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,64,570,O=c1[nH]cnc2[nH]c(CN3CCN(c4ccccc4)CC3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc3ccccn3n2)CC1,CHEMBL1031082,Ki,6.55,CHEMBL562620,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,64,782,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc3ccccn3n2)CC1,CHEMBL1031088,Ki,6.46,CHEMBL562620,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,64,783,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cc3ccccn3n2)CC1,CHEMBL1031094,Ki,5.44,CHEMBL562620,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,64,784,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2ccc(CN3C(=O)c4ccccc4S3(=O)=O)cc2)CC1,CHEMBL4821476,Ki,8.7,CHEMBL4876545,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,150,765,O=C1c2ccccc2S(=O)(=O)N1Cc1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2ccc(CNC(=O)c3ccc4ccccc4c3)cc2)CC1,CHEMBL671730,Ki,6.7,CHEMBL339620,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2ccc(OCCF)cc2)CC1,CHEMBL931954,Ki,6.92,CHEMBL271513,2008,CHEMBL1143133,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 long receptor,60,670,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2ccc3cccccc2-3)CC1,CHEMBL2214282,Ki,7.62,CHEMBL2207643,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,38,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2ccc3cccccc2-3)CC1,CHEMBL2214283,Ki,7.48,CHEMBL2207643,2012,CHEMBL2203106,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells after 60 mins by scintillation counting analysis,83,39,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2ccc3cccccc2-3)CC1,CHEMBL5235427,Ki,7.48,CHEMBL2207643,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells assessed as inhibition constant,150,810,c1ccc(N2CCN(Cc3ccc4cccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cccc(CNC(=O)c3ccc4ccccc4c3)c2)CC1,CHEMBL671730,Ki,7.35,CHEMBL127807,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCc1cccc(CN2CCN(c3ccccc3)CC2)c1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cccc(OCCF)c2)CC1,CHEMBL931954,Ki,7.24,CHEMBL270408,2008,CHEMBL1143133,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 long receptor,60,670,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2ccccc2CNC(=O)/C=C/c2ccccc2)CC1,CHEMBL671730,Ki,7.75,CHEMBL127234,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(C=Cc1ccccc1)NCc1ccccc1CN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2ccccc2CNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL671730,Ki,7.55,CHEMBL126312,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,O=C(NCc1ccccc1CN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2ccn(-c3ccccc3)c2)CC1,CHEMBL672101,Ki,8.89,CHEMBL28321,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity was measured at the cloned human Dopamine receptor D2 using [3H]spiroperidol as radioligand.,14,255,c1ccc(N2CCN(Cc3ccn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCF)cc3)nn2)CC1,CHEMBL2443402,Ki,6.47,CHEMBL2443005,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCF)cc3)nn2)CC1,CHEMBL2443403,Ki,6.28,CHEMBL2443005,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4F)cc3)nn2)CC1,CHEMBL2443402,Ki,5.39,CHEMBL2443008,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3cn(-c4ccc(OCCCOC5CCCCO5)cc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4F)cc3)nn2)CC1,CHEMBL2443403,Ki,5.82,CHEMBL2443008,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3cn(-c4ccc(OCCCOC5CCCCO5)cc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOCCF)cc3)nn2)CC1,CHEMBL2443402,Ki,6.36,CHEMBL2443007,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCCOCCF)cc3)nn2)CC1,CHEMBL2443403,Ki,6.11,CHEMBL2443007,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCF)cc3)nn2)CC1,CHEMBL2443402,Ki,5.8,CHEMBL2443004,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCF)cc3)nn2)CC1,CHEMBL2443403,Ki,4.75,CHEMBL2443004,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCOCCOCCF)cc3)nn2)CC1,CHEMBL2443402,Ki,5.57,CHEMBL2443006,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccc(OCCOCCOCCF)cc3)nn2)CC1,CHEMBL2443403,Ki,5.54,CHEMBL2443006,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccccc3)nn2)CC1,CHEMBL2443402,Ki,6.92,CHEMBL210232,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccccc3)nn2)CC1,CHEMBL2443403,Ki,7.19,CHEMBL210232,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccccc3)nn2)CC1,CHEMBL871242,Ki,6.92,CHEMBL210232,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,48,66,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(-c3ccccc3)nn2)CC1,CHEMBL871243,Ki,7.19,CHEMBL210232,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,48,67,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(CCCCCCF)nn2)CC1,CHEMBL2443402,Ki,6.34,CHEMBL2443009,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3c[nH]nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(CCCCCCF)nn2)CC1,CHEMBL2443403,Ki,6.25,CHEMBL2443009,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3c[nH]nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(CCOCCF)nn2)CC1,CHEMBL2443402,Ki,5.8,CHEMBL2443010,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3c[nH]nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(CCOCCF)nn2)CC1,CHEMBL2443403,Ki,6.12,CHEMBL2443010,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3c[nH]nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(CCOCCOCCF)nn2)CC1,CHEMBL2443402,Ki,5.11,CHEMBL2443000,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3c[nH]nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(CCOCCOCCF)nn2)CC1,CHEMBL2443403,Ki,5.47,CHEMBL2443000,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3c[nH]nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(CCOCCOCCOCCF)nn2)CC1,CHEMBL2443402,Ki,5.08,CHEMBL2443001,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3c[nH]nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn(CCOCCOCCOCCF)nn2)CC1,CHEMBL2443403,Ki,5.33,CHEMBL2443001,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3c[nH]nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CF)[C@@H](O)[C@H](O)[C@H]3O)nn2)CC1,CHEMBL2443402,Ki,4.62,CHEMBL2443003,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3cn(C4CCCCO4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CF)[C@@H](O)[C@H](O)[C@H]3O)nn2)CC1,CHEMBL2443403,Ki,4.29,CHEMBL2443003,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3cn(C4CCCCO4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)nn2)CC1,CHEMBL2443402,Ki,4.64,CHEMBL2443002,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,91,811,c1ccc(N2CCN(Cc3cn(C4CCCCO4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3F)nn2)CC1,CHEMBL2443403,Ki,4.38,CHEMBL2443002,2013,CHEMBL2440010,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,91,812,c1ccc(N2CCN(Cc3cn(C4CCCCO4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3c(-n4cccn4)cccc3n2)CC1,CHEMBL866799,Ki,6.23,CHEMBL212160,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,48,599,c1ccc(N2CCN(Cc3cn4c(-n5cccn5)cccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3c(-n4cccn4)cccc3n2)CC1,CHEMBL866800,Ki,6.55,CHEMBL212160,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,48,600,c1ccc(N2CCN(Cc3cn4c(-n5cccn5)cccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(Br)ccc3n2)CC1,CHEMBL866799,Ki,6.89,CHEMBL211164,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,48,599,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(Br)ccc3n2)CC1,CHEMBL866800,Ki,6.85,CHEMBL211164,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,48,600,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(-c4ccccc4)c3n2)CC1,CHEMBL866799,Ki,7.31,CHEMBL208274,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,48,599,c1ccc(-c2cccn3cc(CN4CCN(c5ccccc5)CC4)nc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(-c4ccccc4)c3n2)CC1,CHEMBL866800,Ki,7.55,CHEMBL208274,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,48,600,c1ccc(-c2cccn3cc(CN4CCN(c5ccccc5)CC4)nc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(-n4cccn4)c3n2)CC1,CHEMBL866799,Ki,6.28,CHEMBL210551,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,48,599,c1ccc(N2CCN(Cc3cn4cccc(-n5cccn5)c4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(-n4cccn4)c3n2)CC1,CHEMBL866800,Ki,6.55,CHEMBL210551,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,48,600,c1ccc(N2CCN(Cc3cn4cccc(-n5cccn5)c4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(Br)c3n2)CC1,CHEMBL866799,Ki,6.62,CHEMBL211539,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,48,599,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(Br)c3n2)CC1,CHEMBL866800,Ki,6.82,CHEMBL211539,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,48,600,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(C#N)c3n2)CC1,CHEMBL866799,Ki,5.38,CHEMBL210283,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,48,599,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(C#N)c3n2)CC1,CHEMBL866800,Ki,5.57,CHEMBL210283,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,48,600,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(I)c3n2)CC1,CHEMBL866799,Ki,7.06,CHEMBL211590,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,48,599,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(I)c3n2)CC1,CHEMBL866800,Ki,7.01,CHEMBL211590,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,48,600,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(N4CCOCC4)c3n2)CC1,CHEMBL866799,Ki,6.68,CHEMBL211118,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,48,599,c1ccc(N2CCN(Cc3cn4cccc(N5CCOCC5)c4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(C)cc(N4CCOCC4)c3n2)CC1,CHEMBL866800,Ki,7.0,CHEMBL211118,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,48,600,c1ccc(N2CCN(Cc3cn4cccc(N5CCOCC5)c4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(I)ccc3n2)CC1,CHEMBL866799,Ki,7.14,CHEMBL379125,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,48,599,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3cc(I)ccc3n2)CC1,CHEMBL866800,Ki,7.14,CHEMBL379125,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,48,600,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3ccccc3n2)CC1,CHEMBL864789,Ki,6.96,CHEMBL212631,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human dopamine receptor D2(long) in CHO cell membrane,48,813,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3ccccc3n2)CC1,CHEMBL864790,Ki,6.4,CHEMBL212631,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from porcine dopamine receptor D2,48,814,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3ccccc3n2)CC1,CHEMBL866799,Ki,6.0,CHEMBL212631,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,48,599,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3ccccc3n2)CC1,CHEMBL866800,Ki,6.03,CHEMBL212631,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,48,600,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3nc(Cl)ccc3n2)CC1,CHEMBL866799,Ki,7.02,CHEMBL378515,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,48,599,c1ccc(N2CCN(Cc3cn4ncccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cn3nc(Cl)ccc3n2)CC1,CHEMBL866800,Ki,7.1,CHEMBL378515,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,48,600,c1ccc(N2CCN(Cc3cn4ncccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cnc3cc(C)nc(C)n23)CC1,CHEMBL1061432,Ki,5.89,CHEMBL563109,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,64,569,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cnc3cc(C)nc(C)n23)CC1,CHEMBL1061433,Ki,6.24,CHEMBL563109,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1,CHEMBL871242,Ki,7.96,CHEMBL379602,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,48,66,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1,CHEMBL871243,Ki,8.1,CHEMBL379602,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,48,67,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cnn(-c3ccccn3)c2)CC1,CHEMBL871242,Ki,7.4,CHEMBL210404,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,48,66,c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cnn(-c3ccccn3)c2)CC1,CHEMBL871243,Ki,7.51,CHEMBL210404,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,48,67,c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(Cc2cnn(-c3ccccn3)c2)CC1,CHEMBL913685,Ki,7.4,CHEMBL210404,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,54,44,c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCN(c2nc(N)nc(NCCc3c[nH]c4ccccc34)n2)CC1,CHEMBL5121178,Ki,4.87,CHEMBL5171456,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(c3ncnc(NCCc4c[nH]c5ccccc45)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCNCC1,CHEMBL2168000,Ki,6.17,CHEMBL9666,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,83,254,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1N1CCNCC1,CHEMBL3300162,Ki,5.39,CHEMBL9666,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1NC(=O)NC1CCC(N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL948052,Ki,6.225,CHEMBL272340,2008,CHEMBL1143857,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]spiperone from human recombinant dopamine D2 receptor,60,204,O=C(Nc1ccccc1)NC1CCC(N2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1NC1CCN(CCCCN2C(=O)c3ccccc3C2=O)CC1,CHEMBL897619,Ki,5.64,CHEMBL392791,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,54,755,O=C1c2ccccc2C(=O)N1CCCCN1CCC(Nc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1NC1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL897619,Ki,6.79,CHEMBL241225,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,54,755,O=C(NCCCCN1CCC(Nc2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1NCCNc1nc(N)nc(NCCc2c[nH]c3ccccc23)n1,CHEMBL5121178,Ki,5.41,CHEMBL5190020,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(NCCNc2ncnc(NCCc3c[nH]c4ccccc34)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNCC1(F)CCN(C(=O)c2ccc(Cl)c(Cl)c2)CC1,CHEMBL4670399,Ki,6.47,CHEMBL4800575,2020,CHEMBL4665789,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2 receptor stably expressed in CHO-K1 cell membranes measured after 60 mins by Microbeta2 scintillation counting method,144,235,O=C(c1ccccc1)N1CCC(CNCCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNCC1(F)CCN(C(=O)c2ccc(F)c(Cl)c2)CC1,CHEMBL4670399,Ki,6.17,CHEMBL4751777,2020,CHEMBL4665789,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2 receptor stably expressed in CHO-K1 cell membranes measured after 60 mins by Microbeta2 scintillation counting method,144,235,O=C(c1ccccc1)N1CCC(CNCCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1,CHEMBL4041731,Ki,7.91,CHEMBL2312227,2017,CHEMBL4041469,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from recombinant human D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting method,125,651,c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNCC1OCCOC1(c1ccccc1)c1ccccc1,CHEMBL4391918,Ki,6.49,CHEMBL4559278,2019,CHEMBL4390666,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 1 hr by liquid scintillation counting,137,763,c1ccc(OCCNCC2OCCOC2(c2ccccc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNCCc1ccc(O)c(O)c1,CHEMBL3801476,Ki,7.07,CHEMBL3797758,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,117,195,c1ccc(CCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNCCc1ccc(O)c(O)c1,CHEMBL3801477,Ki,7.32,CHEMBL3797758,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,117,196,c1ccc(CCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNC[C@@H](O)COc1cccc2[nH]c3ccccc3c12,CHEMBL3801477,Ki,7.58,CHEMBL3798017,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,117,196,c1ccc(OCCNCCCOc2cccc3[nH]c4ccccc4c23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNC[C@@H](O)c1ccc(O)c(O)c1,CHEMBL3801476,Ki,6.46,CHEMBL3799593,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,117,195,c1ccc(CCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNC[C@@H](O)c1ccc(O)c(O)c1,CHEMBL3801477,Ki,6.7,CHEMBL3799593,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,117,196,c1ccc(CCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNC[C@H](O)COc1cccc2[nH]c3ccccc3c12,CHEMBL3801477,Ki,7.31,CHEMBL3799125,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,117,196,c1ccc(OCCNCCCOc2cccc3[nH]c4ccccc4c23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1,CHEMBL3801476,Ki,6.19,CHEMBL3797876,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,117,195,c1ccc(CCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1,CHEMBL3801477,Ki,6.37,CHEMBL3797876,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,117,196,c1ccc(CCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1OCCNc1nc(N)nc(NCCc2c[nH]c3ccccc23)n1,CHEMBL5121178,Ki,5.36,CHEMBL5189520,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(OCCNc2ncnc(NCCc3c[nH]c4ccccc34)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1[C@@H]1C[C@H]1NCCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1,CHEMBL5363864,Ki,5.81,CHEMBL5412995,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,158,244,c1ccc(C(CCNC2CC2c2ccccc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccccc1[C@]1(O)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12,CHEMBL1033058,Ki,5.68,CHEMBL3084507,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,60,729,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c1=O,CHEMBL862319,Ki,6.78,CHEMBL380171,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,48,141,O=c1ccccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc12,CHEMBL4619928,IC50,6.99,CHEMBL4644500,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,144,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccnc1N1CCN(CCCc2nc3ccccc3s2)CC1,CHEMBL5324908,Ki,6.29,CHEMBL5403504,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,158,704,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccnc1N1CCN(CCCc2nc3ccccc3s2)CC1,CHEMBL5324912,IC50,6.73,CHEMBL5403504,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,158,705,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1cccnc1N1CCN(CCCc2nc3ccccc3s2)CC1,CHEMBL5324922,IC50,6.38,CHEMBL5403504,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,158,706,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccncc1S(=O)(=O)N[C@H]1CC[C@@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,7.04,CHEMBL232607,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,54,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccncc1S(=O)(=O)N[C@H]1CC[C@H](N2CCN(c3ccccc3OC(C)C)CC2)CC1,CHEMBL894519,Ki,7.37,CHEMBL391017,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,55,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ccsc1CNCC[C@@]1(c2ccccn2)CCOC2(CCCC2)C1,CHEMBL5363864,Ki,4.08,CHEMBL2443262,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,158,244,c1ccc(C2(CCNCc3cccs3)CCOC3(CCCC3)C2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1nc(N)c(Cl)cc1C(=O)NC1CC2CCCC(C1)N2Cc1ccccc1,CHEMBL670399,Ki,8.9,CHEMBL131926,1995,CHEMBL1128138,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor,6,674,O=C(NC1CC2CCCC(C1)N2Cc1ccccc1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1nc2sc(C(=O)NCCCCCCN3CCC(c4ccc(Cl)cc4)CC3)c(N)c2c(C)c1Cl,CHEMBL3300162,Ki,9.215,CHEMBL3298828,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,O=C(NCCCCCCN1CCC(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1nc2sc(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c(N)c2c(C)c1Cl,CHEMBL3300162,Ki,7.81,CHEMBL3298830,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
COc1ncccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,5.94,CHEMBL3958949,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,117,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.38,CHEMBL3695368,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",100,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.78,CHEMBL3664867,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1,CHEMBL3705383,Ki,6.81,CHEMBL3695364,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",100,54,c1cc(C2CCN(CCC3CCCCC3)CC2)c2ccoc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.29,CHEMBL3676852,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",100,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.02,CHEMBL3698005,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",100,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)CC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.99,CHEMBL3642716,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.48,CHEMBL3695400,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",100,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.38,CHEMBL3664881,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.33,CHEMBL3676881,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",100,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.84,CHEMBL3697984,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",100,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.9,CHEMBL3642725,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,6.06,CHEMBL3642692,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1,CHEMBL3705135,Ki,6.58,CHEMBL3642707,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,c1cc2sccc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,8.05,CHEMBL3892440,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,118,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,7.75,CHEMBL162102,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,35,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1cc(OCCN2CC3CCC(C2)C3Cc2ccc3c(c2)NC(=O)CC3)ccc1F,CHEMBL1110025,Ki,8.15,CHEMBL1087585,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,71,815,O=C1CCc2ccc(CC3C4CCC3CN(CCOc3ccccc3)C4)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1cc(OCCN2CCC(Cc3ccc4c(c3)NC(=O)CC4)CC2)ccc1F,CHEMBL1110025,Ki,7.72,CHEMBL1087743,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,71,815,O=C1CCc2ccc(CC3CCN(CCOc4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1cc(OCCN2CCC(Oc3ccc4c(c3)NC(=O)CC4)CC2)ccc1F,CHEMBL1110025,Ki,8.05,CHEMBL1087872,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,71,815,O=C1CCc2ccc(OC3CCN(CCOc4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1cc(OCCNCc2ccccc2)ccc1Cl,CHEMBL671654,Ki,7.12,CHEMBL99913,1998,CHEMBL1131356,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,14,816,c1ccc(CNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1cc(OCCNCc2cccs2)ccc1Cl,CHEMBL671654,Ki,8.05,CHEMBL102490,1998,CHEMBL1131356,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,14,816,c1ccc(OCCNCc2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1ccc(CCN2CC3COc4ccc(C#N)cc4C3C2)cc1,CHEMBL670398,Ki,7.6,CHEMBL443006,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,18,3,c1ccc(CCN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1,CHEMBL3762401,Ki,7.26,CHEMBL3758610,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,118,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1cccc(OCCN2CC3CCC(C2)C3Cc2ccc3c(c2)NC(=O)CC3)c1,CHEMBL1110025,Ki,7.96,CHEMBL1087818,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,71,815,O=C1CCc2ccc(CC3C4CCC3CN(CCOc3ccccc3)C4)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1cccc(OCCN2CCC(Cc3ccc4c(c3)NC(=O)CC4)CC2)c1,CHEMBL1110025,Ki,8.05,CHEMBL1088560,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,71,815,O=C1CCc2ccc(CC3CCN(CCOc4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1cccc(OCCN2CCC(Oc3ccc4c(c3)NC(=O)CC4)CC2)c1,CHEMBL1110025,Ki,7.75,CHEMBL1087745,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,71,815,O=C1CCc2ccc(OC3CCN(CCOc4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Nc1cccc(OCCNCc2ccccc2)c1,CHEMBL671654,Ki,7.42,CHEMBL99849,1998,CHEMBL1131356,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,14,816,c1ccc(CNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1,CHEMBL1034994,Ki,6.14,CHEMBL494458,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)CC2,CHEMBL674348,Ki,7.2,CHEMBL2113364,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3cccc(F)c3)CC1)CC2,CHEMBL674348,Ki,7.1,CHEMBL2368622,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3F)CC1)CC2,CHEMBL674348,Ki,7.1,CHEMBL2368625,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc(-c4ncccn4)c3)CC1)CC2,CHEMBL674348,Ki,6.5,CHEMBL3084601,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2ncccn2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc(-n4cccc4)c3)CC1)CC2,CHEMBL674348,Ki,6.6,CHEMBL3084596,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-n2cccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ccccc34)CC1)CC2,CHEMBL674348,Ki,6.5,CHEMBL3084624,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ncccc34)CC1)CC2,CHEMBL674348,Ki,6.7,CHEMBL3084625,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc2ncccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1ccc2c(c1)CC[C@H]1[C@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,5.7,CHEMBL97440,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,14,750,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1ccc2c(c1)CC[C@H]1[C@H]2CCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.0,CHEMBL329702,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,14,750,O=C(NCCCCN1CCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)C2,CHEMBL672225,Ki,6.3,CHEMBL158627,2001,CHEMBL1134827,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,25,733,O=C(C=Cc1ccccc1)NC1CCC(CCN2Cc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1cccc2c1CCC1C2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.5,CHEMBL2111592,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,14,750,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1cccc2c1CC[C@@H]1[C@@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,5.9,CHEMBL319355,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,14,750,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1cccc2c1CC[C@H]1[C@@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.4,CHEMBL317996,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,14,750,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1cccc2c1CC[C@H]1[C@H]2CCCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.6,CHEMBL318925,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,14,750,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)Oc1cccc2c1CC[C@H]1[C@H]2CCN1CCCCNC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.5,CHEMBL99876,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,14,750,O=C(NCCCCN1CCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)cc1,CHEMBL3705383,Ki,6.79,CHEMBL3695447,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",100,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)s1,CHEMBL3705383,Ki,6.71,CHEMBL3695423,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",100,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1,CHEMBL3706129,Ki,7.1,CHEMBL3676931,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",100,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)s1,CHEMBL3706129,Ki,7.22,CHEMBL3676920,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",100,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)s1,CHEMBL3705135,Ki,6.29,CHEMBL3642791,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,5.96,CHEMBL321405,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,38,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3c(F)cccc3F)CC1)CC2,CHEMBL674348,Ki,6.4,CHEMBL2368619,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3cc(F)cc(F)c3)CC1)CC2,CHEMBL674348,Ki,6.6,CHEMBL2368627,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(C#N)cc3)CC1)CC2,CHEMBL674348,Ki,6.9,CHEMBL2368617,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)CC2,CHEMBL674348,Ki,7.1,CHEMBL2368629,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3cccc(C#N)c3)CC1)CC2,CHEMBL674348,Ki,6.8,CHEMBL2368624,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3cccc(F)c3)CC1)CC2,CHEMBL674348,Ki,6.9,CHEMBL2368623,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3C#N)CC1)CC2,CHEMBL674348,Ki,6.8,CHEMBL2368620,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3F)CC1)CC2,CHEMBL674348,Ki,6.9,CHEMBL2368626,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ccccc34)CC1)CC2,CHEMBL674348,Ki,6.2,CHEMBL3084620,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(C(=O)O)CC1)c1ccccc1S2,CHEMBL3887246,Ki,7.85,CHEMBL3954123,2015,CHEMBL3886237,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",111,439,c1ccc2c(c1)Sc1ccccc1N2CCCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(C(N)=O)CC1)c1ccccc1S2,CHEMBL3887246,Ki,10.15,CHEMBL398615,2015,CHEMBL3886237,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",111,439,c1ccc2c(c1)Sc1ccccc1N2CCCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1cccc(/C=C/C(=O)N[C@H]2CC[C@H](CCN3CCc4cc(C#N)ccc4C3)CC2)c1,CHEMBL673026,Ki,6.5,CHEMBL2113352,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,23,817,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1cccc(C2CCN(Cc3ccccc3)CC2)c1,CHEMBL1066831,Ki,6.08,CHEMBL596800,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,71,380,c1ccc(CN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1cccc(C2CCN(Cc3ccccc3)CC2)c1,CHEMBL1066832,Ki,6.41,CHEMBL596800,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,71,381,c1ccc(CN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1cccc(N2CCN(Cc3ccccc3)CC2)c1,CHEMBL1066831,Ki,5.72,CHEMBL597413,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,71,380,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CS(=O)(=O)c1cccc(N2CCN(Cc3ccccc3)CC2)c1,CHEMBL1066832,Ki,6.37,CHEMBL597413,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,71,381,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1cc2c(c(C(=O)NC[C@H]3CCCN3CCc3ccccc3)c1)OCC2,CHEMBL672310,Ki,8.17,CHEMBL149723,2000,CHEMBL1133417,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,23,280,O=C(NCC1CCCN1CCc1ccccc1)c1cccc2c1OCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccc(-c2ccc(C(=O)NC3CCN(Cc4ccccc4)C3)cc2)cc1,CHEMBL839650,Ki,5.4,CHEMBL182075,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccc(C2(O)CCN(Cc3c[nH]c4ccccc34)CC2)cc1,CHEMBL902495,Ki,7.62,CHEMBL401031,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,55,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccc(C2(O)CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL1176478,Ki,6.59,CHEMBL1172209,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,71,641,c1ccc(C2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccc(C2(O)CCN(Cc3coc4ccccc34)CC2)cc1,CHEMBL902495,Ki,7.27,CHEMBL246854,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,55,94,c1ccc(C2CCN(Cc3coc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,6.26,CHEMBL107974,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,38,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccc([C@]2(O)C[C@H]3CC[C@@H](C2)N3Cc2c[nH]c3ccccc23)cc1,CHEMBL1033058,Ki,6.25,CHEMBL3084508,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,60,729,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccc2c(c1)CCN2C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,5.42,CHEMBL318760,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,30,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CHEMBL4771176,Ki,8.1,CHEMBL479,2020,CHEMBL4765353,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human D2 receptor (unknown origin) expressed in HEK293 cell membranes,144,555,c1ccc2c(c1)Sc1ccccc1N2CCC1CCCCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,CHEMBL671484,Ki,7.57,CHEMBL479,2003,CHEMBL1145042,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2,35,819,c1ccc2c(c1)Sc1ccccc1N2CCC1CCCCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1C1CC1CNCCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4842092,Ki,6.44,CHEMBL4861553,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,150,362,O=C1CCc2ccc(OCCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1C1CC1CNCCCCOc1ccc2ccc(=O)[nH]c2c1,CHEMBL4842092,Ki,7.02,CHEMBL4877827,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,150,362,O=c1ccc2ccc(OCCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCCCC(=O)N2CCc3ccccc3C2)CC1,CHEMBL1034994,Ki,7.4,CHEMBL493305,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCCCC(=O)N2Cc3ccccc3C2)CC1,CHEMBL1034994,Ki,7.02,CHEMBL523381,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)N1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1,CHEMBL894060,Ki,8.14,CHEMBL225284,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,55,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(C#N)cc2)CC1,CHEMBL1034994,Ki,8.28,CHEMBL493909,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCCCC(=O)NCc2ccc(OS(C)(=O)=O)cc2)CC1,CHEMBL1034994,Ki,7.52,CHEMBL521687,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCCCC(=O)NCc2ccccc2)CC1,CHEMBL1034994,Ki,7.48,CHEMBL492691,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCCCC(=O)NCc2ccncc2)CC1,CHEMBL1034994,Ki,7.19,CHEMBL495321,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,60,216,O=C(CCCCCN1CCN(c2ccccc2)CC1)NCc1ccncc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL1031082,Ki,7.8,CHEMBL550222,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,65,782,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL1031088,Ki,7.43,CHEMBL550222,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,65,783,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1,CHEMBL1031094,Ki,7.58,CHEMBL550222,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,65,784,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCCNC(=O)c2n[nH]c3ccccc23)CC1,CHEMBL5362774,Ki,8.0,CHEMBL5404031,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,158,491,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL1031082,Ki,8.85,CHEMBL561763,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,65,782,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL1031088,Ki,8.66,CHEMBL561763,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,65,783,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1,CHEMBL1031094,Ki,7.7,CHEMBL561763,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,65,784,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cnn2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1OCCN1CCC(CNS(=O)(=O)c2cccc(Cl)c2)CC1,CHEMBL2162846,Ki,7.3,CHEMBL2159461,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,83,218,O=S(=O)(NCC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1OCCN1CCC(NS(=O)(=O)c2ccc(F)cc2)C1,CHEMBL2162846,Ki,7.39,CHEMBL2159478,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,83,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ccccc1OCCN1CCC(NS(=O)(=O)c2cccc(Cl)c2)C1,CHEMBL2162846,Ki,7.44,CHEMBL2159486,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,83,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
CSc1ncc2c(n1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O,CHEMBL1059279,Ki,7.49,CHEMBL566508,2009,CHEMBL1154195,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,65,568,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2ncncc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](CCCN1C(=O)CCc2ccccc21)N1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1,CHEMBL853595,Ki,6.54,CHEMBL203260,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,48,53,O=C1CCc2ccccc2N1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](NC(=O)CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)c1ccccc1,CHEMBL3857974,Ki,6.94,CHEMBL3960056,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,118,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)C(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.57,CHEMBL3664876,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.05,CHEMBL3697992,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",100,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)C1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,6.7,CHEMBL3650455,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4052936,Ki,5.85,CHEMBL4063564,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,125,282,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,7.41,CHEMBL3647708,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N(CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,6.48,CHEMBL3647714,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(N(CCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N(CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,6.35,CHEMBL3650452,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(N(CCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,6.52,CHEMBL3647710,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,7.6,CHEMBL3647712,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NC(=O)C(Cc2ccccc2)NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCCCC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,7.34,CHEMBL3647675,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCCCCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCCC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,8.16,CHEMBL3647674,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCCCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCCS(=O)(=O)C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,7.71,CHEMBL3650457,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCCS(=O)(=O)CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,7.97,CHEMBL3647673,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCS(=O)(=O)C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,7.25,CHEMBL3647687,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCS(=O)(=O)CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2c(F)c(F)c(F)c(F)c2F)NC1=O,CHEMBL3705539,Ki,7.39,CHEMBL3647683,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2cc(F)cc(F)c2)NC1=O,CHEMBL3705539,Ki,7.59,CHEMBL3647680,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)c(F)c2)NC1=O,CHEMBL3705539,Ki,7.77,CHEMBL3647679,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,7.0,CHEMBL3647678,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2cccc(F)c2)NC1=O,CHEMBL3705539,Ki,7.52,CHEMBL3647681,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,6.51,CHEMBL3647701,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2F)NC1=O,CHEMBL3705539,Ki,7.5,CHEMBL3647682,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCC[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,7.12,CHEMBL3647690,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC[SH+]CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,8.07,CHEMBL3650453,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](CCCCNC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,7.08,CHEMBL3650456,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(CCCCNC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CCN(C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)S(C)(=O)=O)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,6.54,CHEMBL3650454,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NC(=O)CCNCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,7.54,CHEMBL3647677,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,CHEMBL3705539,Ki,7.82,CHEMBL3647709,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,7.49,CHEMBL3647707,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(F)cc2)NC1=O,CHEMBL3705539,Ki,7.49,CHEMBL3647689,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NC(=O)C[SH+]CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2cccnc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,6.75,CHEMBL3647713,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2cccnc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N(CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,CHEMBL3705539,Ki,6.46,CHEMBL3647711,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(N(CCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](N(CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,6.87,CHEMBL3647705,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(N(CCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,CHEMBL3705539,Ki,6.57,CHEMBL3647700,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,6.76,CHEMBL3647699,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCS(=O)(=O)C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,CHEMBL3705539,Ki,6.94,CHEMBL3647695,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCS(=O)(=O)CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,CHEMBL3705539,Ki,7.46,CHEMBL3647684,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCCSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,6.48,CHEMBL3647698,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCCSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCC[S@+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,CHEMBL3705539,Ki,7.1,CHEMBL4110066,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC[SH+]CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NCC[S@@+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,CHEMBL3705539,Ki,7.045,CHEMBL3647688,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC[SH+]CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](CCCCNC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,CHEMBL3705539,Ki,6.95,CHEMBL3647685,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(CCCCNC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](CCCCNC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,7.41,CHEMBL3647686,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(CCCCNC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](CCCCNC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)NC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccc(O)cc2)NC1=O,CHEMBL3705539,Ki,7.65,CHEMBL3647692,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(CCCCNC(=O)C[SH+]CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)NC(=O)C[SH+]CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](CCCCNC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)NC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,7.17,CHEMBL3647693,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(CCCCNC(=O)C[SH+]CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)NC(=O)C[SH+]CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)CSC[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,6.74,CHEMBL3647676,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NC(=O)CSCC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccncc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](NC[C@H](Cc2ccc(O)cc2)NC(=O)C[S+]([O-])C[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)CCCCNC(=O)[C@H](Cc2ccccc2)NC1=O,CHEMBL3705539,Ki,6.83,CHEMBL3647691,2015,CHEMBL3638685,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably transfected with hDRD2 receptor, as follows. The cDNA coding sequence of hDRD2 (GenBank accession No. X51362) was subcloned into the mammalian expression vector pcDNA3.1/GS (Life Technologies). Clonal cell lines stably expressing hDRD2 were obtained by transfection into CHO-K1 cells and subsequently selected with culture medium containing 0.3 mg/mL of zeocin (Life Technologies).Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing hDRD2 were homogenized in ice-cold buffer with 10 mM Tris-HCl, 5 mM EDTA, 3 mM EGTA, 1 mM phenylmethylsuphonyl fluoride, pH 7.6 using Polytron PT10-35GT (Kinematica) at 18,000 rpm for 30 seconds and centrifuged at 500xg for 10 minutes. The supernatant containing the plasma membranes was centrifuged at 100,000xg for 30 minutes and the pellet was resuspended.",111,101,O=C1CNC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccncc2)NC(=O)C(Cc2ccccc2)NC(=O)CNC(=O)C(NCC(Cc2ccccc2)NC(=O)C[SH+]CC2CNC3Cc4c[nH]c5cccc(c45)C3C2)CCCCNC(=O)C(Cc2ccccc2)NC(=O)CN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1CCCCN1CCc1c(-c2ccccc2)[nH]c2ccccc12,CHEMBL671361,Ki,7.68,CHEMBL90263,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,23,435,c1ccc(-c2[nH]c3ccccc3c2CCN2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1CN(CC(=O)N2CCc3ccccc32)C[C@H](C)N1Cc1ccc(Cl)cc1,CHEMBL872891,Ki,5.06,CHEMBL104756,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",30,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1CN(CC(=O)N2CCc3ccccc32)[C@@H](C)CN1Cc1ccc(Cl)cc1,CHEMBL872891,Ki,5.17,CHEMBL107351,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",30,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1CN(CCCNC(=O)CN2CCc3ccccc3C2)C[C@H](C)O1,CHEMBL4137914,Ki,5.5,CHEMBL4169755,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,O=C(CN1CCc2ccccc2C1)NCCCN1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1CN(CC[C@H]2CC[C@H](NC(=O)N(C)C)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,6.54,CHEMBL4779912,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,c1ccc2c(c1)CCN(CCC1CCCCC1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1CN(Cc2ccc(Cl)cc2)CCN1CC(=O)N1CCc2ccccc21,CHEMBL872891,Ki,5.23,CHEMBL104399,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",30,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1CN(Cc2ccc(Cl)cc2)CC[N@@+]1(C)CC(=O)N1CCc2ccccc21,CHEMBL872891,Ki,5.32,CHEMBL104138,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",30,214,O=C(C[NH+]1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1CN(c2cccc3cc(F)ccc23)CCN1CCC1OCCc2c1sc(C(N)=O)c2Cl,CHEMBL881219,Ki,6.54,CHEMBL197982,2005,CHEMBL1140446,J Med Chem,Scientific Literature,Inhibition constant against dopamine receptor D2,41,820,c1ccc2c(N3CCN(CCC4OCCc5ccsc54)CC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1CN(c2ccccc2-c2ccccc2)CCN1CCCCCC(=O)NCc1ccccc1,CHEMBL3857974,Ki,6.75,CHEMBL3958956,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,118,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1C[C@@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,CHEMBL670786,Ki,6.48,CHEMBL138989,2002,CHEMBL1135791,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2,30,437,O=C(C1C=C2c3cccc4[nH]cc(c34)CC2NC1)N1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1C[C@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,CHEMBL670784,Ki,7.22,CHEMBL137781,2002,CHEMBL1135791,J Med Chem,Scientific Literature,Binding affinity against Dopamine receptor D2,30,821,O=C(C1C=C2c3cccc4[nH]cc(c34)CC2NC1)N1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2cc(Cl)cc(Cl)c2)CC1,CHEMBL675680,Ki,6.57,CHEMBL326010,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2cc(Cl)ccc2Cl)CC1,CHEMBL675680,Ki,7.02,CHEMBL105172,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2cc(F)c(Cl)cc2F)CC1,CHEMBL675680,Ki,5.59,CHEMBL104323,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(C(F)(F)F)cc2)CC1,CHEMBL675680,Ki,5.23,CHEMBL105454,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)c(Cl)c2)CC1,CHEMBL675680,Ki,7.37,CHEMBL104678,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL675680,Ki,6.72,CHEMBL108282,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(F)c(F)c2Cl)CC1,CHEMBL675680,Ki,6.7,CHEMBL320515,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(F)cc2)CC1,CHEMBL675680,Ki,6.54,CHEMBL104058,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc3c(c2)OCO3)CC1,CHEMBL675680,Ki,5.84,CHEMBL322222,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccc3c(c2)OCO3)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2cccc(Cl)c2)CC1,CHEMBL675680,Ki,6.13,CHEMBL321698,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2cccc(F)c2)CC1,CHEMBL675680,Ki,6.0,CHEMBL105601,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccccc2Cl)CC1,CHEMBL675680,Ki,5.94,CHEMBL321201,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1NCCc2cc(O)c(O)cc21,CHEMBL3131489,Ki,5.3,CHEMBL1195032,2014,CHEMBL3124851,J Nat Prod,Scientific Literature,Agonist activity at dopamine D2 receptor (unknown origin),100,822,c1ccc2c(c1)CCNC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1OC(c2ccccc2)=N[C@H]1CN1CCN(c2ccccc2)CC1,CHEMBL665385,Ki,6.109999999999999,CHEMBL83306,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,25,695,c1ccc(C2=NC(CN3CCN(c4ccccc4)CC3)CO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1OC(c2ccccc2)=N[C@H]1CN1CCN(c2ccccc2)CC1,CHEMBL671178,Ki,5.795,CHEMBL83306,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,25,696,c1ccc(C2=NC(CN3CCN(c4ccccc4)CC3)CO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4c(F)cccc34)CC2)NC1=O,CHEMBL872394,Ki,9.0,CHEMBL198357,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)NC1=O,CHEMBL872394,Ki,8.33,CHEMBL370457,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)NC1=O,CHEMBL872394,Ki,9.0,CHEMBL198224,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1[C@@H](C)c2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,6.74,CHEMBL319927,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,30,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1[C@@H]2[C@H](CN1Cc1ccccc1)[C@H](CO)[C@H]2N1CCCC1,CHEMBL2066740,Ki,4.18,CHEMBL2062854,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,83,442,c1ccc(CN2CC3CC(N4CCCC4)C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1,CHEMBL664743,Ki,7.71,CHEMBL282863,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,23,335,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21,CHEMBL671374,Ki,6.19,CHEMBL90654,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,4,73,C1=C(C2=Cc3ccccc3Cc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@H]1c2ccccc2N(C(=O)CN2CCN(Cc3ccc(Cl)cc3)CC2)[C@@H]1C,CHEMBL872882,Ki,6.92,CHEMBL326670,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,30,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@]12CC(c3ccccc3)C[C@@H](C1)N(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,CHEMBL1044430,Ki,7.8,CHEMBL551927,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,65,233,O=C1N(CCN2CC3CC(c4ccccc4)CC2C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@@]12CC(c3ccccc3)C[C@@H](C1)N(CCN1CCN(c3cccc(Cl)c3)C1=O)C2,CHEMBL1059864,Ki,7.8,CHEMBL551927,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,65,234,O=C1N(CCN2CC3CC(c4ccccc4)CC2C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H](CCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1)CN1C(=O)CCc2ccccc21,CHEMBL853595,Ki,6.58,CHEMBL426111,2006,CHEMBL1149426,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,48,53,O=C1CCc2ccccc2N1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H](CN1CCN(c2cc(F)c(F)cc2F)CC1)N1C(=O)CC2(CCCC2)CC1=O,CHEMBL826339,Ki,6.24,CHEMBL98241,2005,CHEMBL1143615,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2,41,804,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H](CNc1cncc(Cl)n1)N1CCN(c2ccccc2)CC1,CHEMBL4137914,Ki,6.48,CHEMBL4173176,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1ccc(N2CCN(CCNc3cnccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H](Cc1cc2c(c(C(N)=O)c1)N(CCCO)CC2)NCCOc1ccccc1OCC(F)(F)F,CHEMBL5442215,Ki,6.0,CHEMBL24778,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,c1ccc(OCCNCCc2ccc3c(c2)CCN3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H](NC(=O)CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)c1ccccc1,CHEMBL3857974,Ki,7.28,CHEMBL3941529,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,118,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H](Nc1ccnc(NCCOc2ccc(F)cc2)c1)c1ccccc1,CHEMBL875190,Ki,6.43,CHEMBL363452,2004,CHEMBL1138823,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against D2L receptor,38,823,c1ccc(CNc2ccnc(NCCOc3ccccc3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4052936,Ki,6.5,CHEMBL4085184,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,125,282,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(C#N)cc32)CCN1C,CHEMBL4671577,Ki,6.87,CHEMBL4742056,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(Cl)cc32)CCN1C,CHEMBL4671577,Ki,6.97,CHEMBL4795230,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(F)cc32)CCN1C,CHEMBL4671577,Ki,6.9,CHEMBL4758723,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(OC(F)(F)F)cc32)CCN1C,CHEMBL4671577,Ki,6.96,CHEMBL4745489,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CCN1C,CHEMBL4671577,Ki,6.32,CHEMBL4779001,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C=C(C2=Nc3ccccc3Nc3ccc(Cl)cc32)CCN1C,CHEMBL4671577,Ki,6.91,CHEMBL4740880,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CCCCN1CCc1c(-c2ccccc2)[nH]c2ccccc12,CHEMBL671361,Ki,6.54,CHEMBL90739,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,23,435,c1ccc(-c2[nH]c3ccccc3c2CCN2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](N3C(=O)CC4(CCCC4)CC3=O)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,7.92,CHEMBL4753808,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C1CC2(CCCC2)CC(=O)N1C1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](N3C(=O)[C@@H]4[C@@H]5CC[C@@H](C5)[C@@H]4C3=O)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,7.5,CHEMBL4784751,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C1C2C3CCC(C3)C2C(=O)N1C1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](N3C(=O)[C@@H]4[C@H](C3=O)[C@@H]3C=C[C@H]4C3)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,7.36,CHEMBL4788140,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C1C2C3C=CC(C3)C2C(=O)N1C1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](N3C(=O)[C@H]4CCCC[C@H]4C3=O)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,7.85,CHEMBL4762024,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C1C2CCCCC2C(=O)N1C1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](N3C(=O)c4ccccc4C3=O)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,8.24,CHEMBL4752414,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C1c2ccccc2C(=O)N1C1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)C3CC3)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,8.01,CHEMBL4756826,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)C3CCCCC3)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,7.0,CHEMBL4762918,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)N(C)C)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,8.23,CHEMBL4799863,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,c1ccc2c(c1)CCN(CCC1CCCCC1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)N(C)c3ccccc3)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,6.72,CHEMBL4755563,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C(Nc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)N3CCCC3)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,8.2,CHEMBL4797996,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)N1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)N3CCOCC3)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,8.54,CHEMBL4741702,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)N1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)Nc3ccccc3)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,8.55,CHEMBL4759975,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C(Nc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)[C@@H]3CCCN3)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,7.6,CHEMBL4741673,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)C1CCCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)[C@@H]3CCCO3)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,7.69,CHEMBL4745809,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)C1CCCO1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(CC[C@H]2CC[C@H](NC(=O)c3ccco3)CC2)CCc2ccc(Cl)cc21,CHEMBL4677471,Ki,7.03,CHEMBL4780335,2021,CHEMBL4673287,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from recombinant human D2L receptor expressed in CHO cells,150,263,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CN(c2ccccc2-c2ccccc2)CCN1CCCCCC(=O)NCc1ccccc1,CHEMBL3857974,Ki,6.61,CHEMBL3979307,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,118,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1COC(c2ccc(N)nc2)CN1CCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4361371,Ki,6.95,CHEMBL4443441,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C1CCc2ccc(OCCCCN3CCOC(c4cccnc4)C3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1,CHEMBL4361371,Ki,5.63,CHEMBL4453200,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,c1cncc(C2CNCCO2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C/C=C/COc1ccc2c(c1)NC(=O)CC2,CHEMBL4361371,Ki,6.47,CHEMBL4589785,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C1CCc2ccc(OCC=CCN3CCOC(c4cccnc4)C3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C/C=C1\CCC(CNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL5228992,Ki,7.25,CHEMBL5288831,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NCC1CCC(=CCN2CCOC(c3cccnc3)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C/C=C1\CCC(CNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL5228996,Ki,5.1,CHEMBL5288831,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,543,O=C(NCC1CCC(=CCN2CCOC(c3cccnc3)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC(=O)N1CCC(CNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL5228992,Ki,5.73,CHEMBL5280797,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NCC1CCN(C(=O)CN2CCOC(c3cccnc3)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC(=O)N1CCC(CNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL5228996,Ki,5.1,CHEMBL5280797,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,543,O=C(NCC1CCN(C(=O)CN2CCOC(c3cccnc3)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC(O)CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL4731081,Ki,6.0,CHEMBL4764883,2020,CHEMBL4725442,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,144,406,O=C(NCCCCN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC(O)CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL5228992,Ki,6.0,CHEMBL4764883,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NCCCCN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC1CC1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL4361371,Ki,6.97,CHEMBL4525362,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C(NCCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC1CC1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL4361376,Ki,5.08,CHEMBL4525362,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,137,824,O=C(NCCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC1CC1CNC(=O)c1cc2ccccc2[nH]1,CHEMBL4361371,Ki,6.41,CHEMBL4455770,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C(NCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CCC1CCC(CNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL5228992,Ki,7.06,CHEMBL5291065,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NCC1CCC(CCN2CCOC(c3cccnc3)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CCC1CCC(CNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL5228996,Ki,4.82,CHEMBL5291065,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,543,O=C(NCC1CCC(CCN2CCOC(c3cccnc3)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CCCCNC(=O)c1cc2ccccc2[nH]1,CHEMBL4361371,Ki,6.87,CHEMBL4452064,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C(NCCCCN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CCCCNC(=O)c1cc2ccccc2[nH]1,CHEMBL4361376,Ki,4.68,CHEMBL4452064,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,137,824,O=C(NCCCCN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4361371,Ki,7.46,CHEMBL4435946,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C1CCc2ccc(OCCCCN3CCOC(c4cccnc4)C3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@@H]1CC[C@@H](CNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL5228992,Ki,6.94,CHEMBL5280481,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NCC1CCC(CCN2CCOC(c3cccnc3)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@@H]1CC[C@@H](CNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL5228996,Ki,4.59,CHEMBL5280481,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,543,O=C(NCC1CCC(CCN2CCOC(c3cccnc3)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@@H]1CC[C@H](CNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL5228992,Ki,7.09,CHEMBL5267958,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NCC1CCC(CCN2CCOC(c3cccnc3)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@@H]1CC[C@H](CNC(=O)c2cc3ccccc3[nH]2)C1,CHEMBL5228996,Ki,4.65,CHEMBL5267958,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,543,O=C(NCC1CCC(CCN2CCOC(c3cccnc3)C2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@H]1CC[C@@H](NC(=O)c2cc3ccccc3[nH]2)CC1,CHEMBL5228992,Ki,6.96,CHEMBL5274609,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NC1CCC(CCN2CCOC(c3cccnc3)C2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@H]1CC[C@H](NC(=O)c2cc3ccccc3[nH]2)CC1,CHEMBL4731081,Ki,6.98,CHEMBL4744811,2020,CHEMBL4725442,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,144,406,O=C(NC1CCC(CCN2CCOC(c3cccnc3)C2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CC[C@H]1CC[C@H](NC(=O)c2cc3ccccc3[nH]2)CC1,CHEMBL5228992,Ki,7.06,CHEMBL4744811,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NC1CCC(CCN2CCOC(c3cccnc3)C2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CCn1cc(CNC(=O)c2cc3ccccc3[nH]2)nn1,CHEMBL5228992,Ki,4.87,CHEMBL5266180,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NCc1cn(CCN2CCOC(c3cccnc3)C2)nn1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1CCn1cc(CNC(=O)c2cc3ccccc3[nH]2)nn1,CHEMBL5228996,Ki,4.49,CHEMBL5266180,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,543,O=C(NCc1cn(CCN2CCOC(c3cccnc3)C2)nn1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL4361371,Ki,6.08,CHEMBL4437740,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C(NCCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL4361376,Ki,4.15,CHEMBL4437740,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,137,824,O=C(NCCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL5228992,Ki,6.08,CHEMBL4437740,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NCCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL5228996,Ki,4.15,CHEMBL4437740,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,543,O=C(NCCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@H]1C[C@@H]1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL4361371,Ki,7.06,CHEMBL4551160,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C(NCCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@H]1C[C@@H]1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL4361376,Ki,5.79,CHEMBL4551160,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,137,824,O=C(NCCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@H]1C[C@@H]1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL5228992,Ki,7.06,CHEMBL4551160,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NCCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@H]1C[C@@H]1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL5228996,Ki,5.79,CHEMBL4551160,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-methylscopolamine from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,543,O=C(NCCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@H]1C[C@H]1CCNC(=O)c1cc2ccccc2[nH]1,CHEMBL5228992,Ki,6.43,CHEMBL5286603,2021,CHEMBL5226346,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,150,372,O=C(NCCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@H](c2ccc(N)nc2)CN1,CHEMBL4361371,Ki,5.15,CHEMBL4586223,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,c1cncc(C2CNCCO2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@H](c2ccc(N)nc2)CN1C/C=C/COc1ccc2c(c1)NC(=O)CC2,CHEMBL4361371,Ki,4.68,CHEMBL4436589,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C1CCc2ccc(OCC=CCN3CCOC(c4cccnc4)C3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@H](c2ccc(N)nc2)CN1CC1CC1CNC(=O)c1cc2ccccc2[nH]1,CHEMBL4361371,Ki,4.95,CHEMBL4451063,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C(NCC1CC1CN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@H](c2ccc(N)nc2)CN1CCCCNC(=O)c1cc2ccccc2[nH]1,CHEMBL4361371,Ki,5.28,CHEMBL4458742,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C(NCCCCN1CCOC(c2cccnc2)C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1CO[C@H](c2ccc(N)nc2)CN1CCCCOc1ccc2c(c1)NC(=O)CC2,CHEMBL4361371,Ki,5.58,CHEMBL4452139,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,137,352,O=C1CCc2ccc(OCCCCN3CCOC(c4cccnc4)C3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C[C@H](C)N1C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)CC2N(C)C1,CHEMBL670786,Ki,6.96,CHEMBL343755,2002,CHEMBL1135791,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2,30,437,O=C(C1C=C2c3cccc4[nH]cc(c34)CC2NC1)N1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C[C@H](NS(=O)(=O)c2cc3ccc(Cl)cc3s2)CN1CCCc1noc2cc(F)ccc12,CHEMBL5046640,Ki,6.95,CHEMBL5073337,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,150,530,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C[C@H](NS(=O)(=O)c2cc3ccc(F)cc3s2)CN1CCCc1noc2cc(F)ccc12,CHEMBL5046640,Ki,7.27,CHEMBL5076846,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,150,530,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C[C@H](NS(=O)(=O)c2cc3ccccc3o2)CN1CCCc1noc2cc(F)ccc12,CHEMBL5046640,Ki,7.52,CHEMBL5080719,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,150,530,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C[C@H](NS(=O)(=O)c2cc3ccccc3s2)CN1CCCc1noc2cc(F)ccc12,CHEMBL5046640,Ki,7.26,CHEMBL5090557,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,150,530,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C[C@H](NS(=O)(=O)c2ccc(F)c(Cl)c2)CN1CCCc1noc2cc(F)ccc12,CHEMBL5046640,Ki,6.89,CHEMBL5093017,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,150,530,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C[C@H](NS(=O)(=O)c2ccc3cc(Cl)ccc3c2)CN1CCCc1noc2cc(F)ccc12,CHEMBL5046640,Ki,6.81,CHEMBL5085390,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,150,530,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C[C@H](NS(=O)(=O)c2ccc3ccccc3c2)CN1CCCc1noc2cc(F)ccc12,CHEMBL5046640,Ki,7.33,CHEMBL5088232,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,150,530,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C[C@H](NS(=O)(=O)c2cccc(Cl)c2)CN1CCCc1noc2cc(F)ccc12,CHEMBL5046640,Ki,6.81,CHEMBL5076882,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,150,530,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1C[C@H](NS(=O)(=O)c2csc3ccccc23)CN1CCCc1noc2cc(F)ccc12,CHEMBL5046640,Ki,7.27,CHEMBL5087742,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,150,530,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1csc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1Cc2c([nH]c3ccccc23)Cc2ccccc2CCN1C,CHEMBL1954777,Ki,7.07,CHEMBL1949725,2011,CHEMBL1949524,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in human HEK293 cells,79,637,c1ccc2c(c1)CCNCCc1c([nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1Cc2ccccc2N1C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL675680,Ki,5.03,CHEMBL106119,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4c(F)cccc34)CC2)NC1=O,CHEMBL872394,Ki,8.28,CHEMBL196172,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)NC1=O,CHEMBL872394,Ki,8.16,CHEMBL196514,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccc(F)cc34)CC2)NC1=O,CHEMBL895618,Ki,9.1,CHEMBL196514,2007,CHEMBL1148822,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,55,452,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1Oc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)NC1=O,CHEMBL872394,Ki,8.06,CHEMBL198216,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1[C@H]2[C@@H](CN1Cc1ccccc1)[C@@H](CO)[C@@H]2N1CCCC1,CHEMBL2066740,Ki,4.8,CHEMBL2062855,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,83,442,c1ccc(CN2CC3CC(N4CCCC4)C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1c2c([nH]c3ccc(C(F)(F)F)cc23)C[C@H]2CCN(CCC3(C(=O)O)CCCCC3)C[C@@H]21,CHEMBL2032870,Ki,5.5,CHEMBL2032049,2012,CHEMBL2029200,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,83,825,c1ccc2c3c([nH]c2c1)CC1CCN(CCC2CCCCC2)CC1C3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1c2cccc3c2-c2c1ccc1c2[C@@H](C3)N(C)CC1,CHEMBL664743,Ki,7.41,CHEMBL27132,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,23,335,c1cc2c3c(c1)CC1NCCc4ccc(c-3c41)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@H]1c2ccccc2C=C(C2=CCN(C)CC2)c2ccccc21,CHEMBL671374,Ki,6.14,CHEMBL89719,1994,CHEMBL1127435,J Med Chem,Scientific Literature,Affinity was evaluated as inhibition constant for dopamine D-2 receptor,4,73,C1=C(C2=Cc3ccccc3Cc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@]1(O)CC[C@@H](C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)CC1,CHEMBL3705135,Ki,6.32,CHEMBL3642732,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[C@]1(O)CC[C@H](C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)CC1,CHEMBL3705135,Ki,6.29,CHEMBL3642731,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[Si](C)(C)C#Cc1cccn1C1CCN(Cc2ccccc2)CC1,CHEMBL672580,Ki,5.31,CHEMBL108160,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,18,47,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[Si](C)(C)C#Cc1cccn1C1CCN(Cc2ccccc2)CC1,CHEMBL673074,Ki,5.21,CHEMBL108160,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,18,48,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[Si](C)(C)c1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL671731,Ki,5.51,CHEMBL160454,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,30,45,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
C[Si](C)(C)c1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL671732,Ki,5.55,CHEMBL160454,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,30,46,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1[nH]c(-c2ccccc2)cc1C(=O)NCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL1101348,IC50,5.97,CHEMBL1086626,2010,CHEMBL1154983,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,71,433,O=C(NCCCN1CCN(c2ccccc2)CC1)c1c[nH]c(-c2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1[nH]c(-c2ccccc2)nc1CN1CCN(c2ncccn2)CC1,CHEMBL672173,Ki,5.84,CHEMBL415014,1997,CHEMBL1130009,J Med Chem,Scientific Literature,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,11,591,c1ccc(-c2nc(CN3CCN(c4ncccn4)CC3)c[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1[nH]c2ccc(Cl)cc2c1C1=CCN(CCCCNS(=O)(=O)c2ccc3ccccc3c2)CC1,CHEMBL4041093,Ki,7.0,CHEMBL4079972,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,125,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1[nH]c2ccc(Cl)cc2c1C1=CCN(CCCNS(=O)(=O)c2ccc3ccccc3c2)CC1,CHEMBL4041093,Ki,7.0,CHEMBL4088925,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,125,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1[nH]c2ccc(Cl)cc2c1C1=CCN(CCNS(=O)(=O)c2ccc3ccccc3c2)CC1,CHEMBL4041093,Ki,6.75,CHEMBL4067700,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,125,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1[nH]c2cccc3c2c1C[C@@H]1C3C[C@H](NC(=O)C(C)(C)C)CN1C,CHEMBL673016,Ki,8.51,CHEMBL25013,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",2,77,c1cc2c3c(c[nH]c3c1)CC1NCCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1[nH]c2ccccc2c1CN1CCC(O)(c2ccc(Cl)cc2)CC1,CHEMBL902495,Ki,7.81,CHEMBL246439,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,55,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccc(Cl)cc2)nc(O)n1C1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,6.77,CHEMBL94023,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccc(F)cc2)nc(O)n1C1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,6.54,CHEMBL92189,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2cccc(Cl)c2)nc(O)n1C1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,7.14,CHEMBL94283,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)cnn1C1CCN(Cc2cccc(Cl)c2)CC1,CHEMBL671371,Ki,6.43,CHEMBL24051,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,18,588,c1ccc(CN2CCC(n3cc(-c4ccccc4)cn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)cnn1C1CCN(Cc2ccccc2)CC1,CHEMBL671371,Ki,6.85,CHEMBL25772,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,18,588,c1ccc(CN2CCC(n3cc(-c4ccccc4)cn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)n(-c2ccccc2)c(=O)n1C1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,8.06,CHEMBL93432,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,O=c1n(C2CCN(Cc3ccccc3)CC2)cc(-c2ccccc2)n1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)n(C)c(=O)n1C1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,7.82,CHEMBL328739,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,O=c1[nH]c(-c2ccccc2)cn1C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)n[nH]c1C1=CCN(CCc2ccccc2)CC1,CHEMBL672209,Ki,7.05,CHEMBL80318,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,11,230,C1=C(c2cc(-c3ccccc3)n[nH]2)CCN(CCc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)nc(O)n1C1CCN(CC2CCCCC2)CC1,CHEMBL671375,Ki,7.08,CHEMBL316125,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(-c2cn(C3CCN(CC4CCCCC4)CC3)cn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)nc(O)n1C1CCN(CCCc2ccccc2)CC1,CHEMBL671375,Ki,6.48,CHEMBL327176,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CCCN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)nc(O)n1C1CCN(CCc2ccccc2)CC1,CHEMBL671375,Ki,6.66,CHEMBL91229,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CCN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)nc(O)n1C1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL671375,Ki,7.22,CHEMBL93969,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)nc(O)n1C1CCN(Cc2cccc(Cl)c2)CC1,CHEMBL671375,Ki,5.89,CHEMBL93832,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)nc(O)n1C1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,7.25,CHEMBL91162,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2)nnn1C1CCN(Cc2ccccc2)CC1,CHEMBL671371,Ki,5.8,CHEMBL284346,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,18,588,c1ccc(CN2CCC(n3cc(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccc2Cl)nc(O)n1C1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,7.42,CHEMBL89971,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2ccccn2)nc(O)n1C1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,6.57,CHEMBL91553,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4ccccn4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(-c2cccs2)nc(O)n1C1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,8.11,CHEMBL90005,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4cccs4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(C#Cc2ccc(CN3CCC(CO)CC3)cc2)cc(C(F)F)c2cn(C(C(=O)Nc3nccs3)c3ncn4c3CCC43CC3)nc12,CHEMBL5120437,IC50,6.0,CHEMBL5177023,2022,CHEMBL5113538,J Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),154,827,O=C(Nc1nccs1)C(c1ncn2c1CCC21CC1)n1cc2ccc(C#Cc3ccc(CN4CCCCC4)cc3)cc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(C(=O)NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nnn1Cc1ccccc1,CHEMBL913685,Ki,8.0,CHEMBL221897,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,55,44,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nnn1Cc1ccccc1,CHEMBL3614290,Ki,7.85,CHEMBL373873,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,111,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(C(=O)NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nnn1Cc1ccccc1,CHEMBL913685,Ki,7.41,CHEMBL373873,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,55,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(Cc2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)cc(-c2ccccc2)n1C,CHEMBL1101348,IC50,5.59,CHEMBL1086754,2010,CHEMBL1154983,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,71,433,O=C(NCCCN1CCN(c2ccccc2)CC1)c1c[nH]c(-c2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1,CHEMBL980770,IC50,5.45,CHEMBL461571,2008,CHEMBL1139415,Bioorg Med Chem Lett,Scientific Literature,Displacement of radioligand from dopamine D2S receptor,60,828,O=C(c1ccccc1)c1cn(Cc2ccccc2)c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(C)c2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2oc1=O,CHEMBL670879,Ki,8.23,CHEMBL120661,1998,CHEMBL1130712,Bioorg Med Chem Lett,Scientific Literature,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,14,829,O=c1ccc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(C2CCN(CCc3ccccc3)CC2)n[nH]c1-c1ccc(Cl)cc1,CHEMBL671370,Ki,6.54,CHEMBL61079,1996,CHEMBL1129307,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,9,587,c1ccc(CCN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(C2CCN(CCc3ccccc3)CC2)n[nH]c1-c1ccc(Cl)cc1,CHEMBL672209,Ki,6.54,CHEMBL61079,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,11,230,c1ccc(CCN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(C2CCN(Cc3ccccc3)CC2)n[nH]c1-c1ccc(Cl)cc1,CHEMBL672209,Ki,6.7,CHEMBL309901,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,11,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(C2CCN(Cc3ccccc3)CC2)n[nH]c1-c1ccccc1,CHEMBL671371,Ki,7.05,CHEMBL281195,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,18,588,c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(CN2CCN(c3ccccc3)CC2)cnn1-c1ccccc1,CHEMBL871242,Ki,6.2,CHEMBL377200,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,48,66,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(CN2CCN(c3ccccc3)CC2)cnn1-c1ccccc1,CHEMBL871243,Ki,6.6,CHEMBL377200,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,48,67,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(CN2CCN(c3ccccc3)CC2)cnn1-c1ccccc1,CHEMBL913685,Ki,6.2,CHEMBL377200,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,55,44,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(Cl)cccc1N1CCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,CHEMBL1776016,Ki,8.52,CHEMBL1774072,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,79,830,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(Cn2ncc(N3CCNCC3)c(Cl)c2=O)cccc1NC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL991395,Ki,5.29,CHEMBL458220,2009,CHEMBL1143385,J Med Chem,Scientific Literature,Displacement of [125I]iodosulpiride from dopamine D2 receptor expressed in CHO cells,65,831,O=C(Nc1cccc(Cn2ncc(N3CCNCC3)cc2=O)c1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(OCCCCN2CCN(c3cccc4cc(F)ccc34)CC2)ccc2c1C(=O)NC2,CHEMBL1260558,Ki,8.03,CHEMBL1257737,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(OCCCCN2CCN(c3cccc4cccc(F)c34)CC2)ccc2c1C(=O)NC2,CHEMBL1260558,Ki,8.52,CHEMBL1257616,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(OCCCCN2CCN(c3cccc4ccccc34)CC2)ccc2c1C(=O)NC2,CHEMBL1260558,Ki,7.88,CHEMBL1257495,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(OCCCN2CCN(c3cccc4cc(F)ccc34)CC2)ccc2c1C(=O)NC2,CHEMBL1260558,Ki,8.77,CHEMBL1257736,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(OCCCN2CCN(c3cccc4cccc(F)c34)CC2)ccc2c1C(=O)NC2,CHEMBL1260558,Ki,7.87,CHEMBL1257615,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(OCCCN2CCN(c3cccc4ccccc34)CC2)ccc2c1C(=O)NC2,CHEMBL1260558,Ki,8.17,CHEMBL1257494,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(S(=O)(=O)NCCCCN2CCC(c3noc4cc(F)ccc34)CC2)sc2ccc(Cl)cc12,CHEMBL3297244,Ki,8.82,CHEMBL3290017,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,100,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(S(=O)(=O)NCCCCN2CCC(c3noc4cc(F)ccc34)CC2)sc2ccc(F)cc12,CHEMBL3297244,Ki,8.72,CHEMBL3290016,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,100,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(S(=O)(=O)NCCCCN2CCN(c3noc4ccccc34)CC2)sc2ccc(F)cc12,CHEMBL3297244,Ki,7.34,CHEMBL3289986,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,100,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(S(=O)(=O)NCCCCN2CCN(c3nsc4ccccc34)CC2)sc2ccc(F)cc12,CHEMBL3297244,Ki,7.36,CHEMBL3289962,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,100,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(S(=O)(=O)NCCCN2CCC(c3noc4cc(F)ccc34)CC2)sc2ccc(F)cc12,CHEMBL3297244,Ki,8.1,CHEMBL3290015,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,100,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(S(=O)(=O)NCCCN2CCN(c3nsc4ccccc34)CC2)sc2ccc(F)cc12,CHEMBL3297244,Ki,8.08,CHEMBL3289961,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,100,833,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(S(=O)(=O)N[C@@H]2CCN(CCCc3noc4ccccc34)C2)sc2ccc(Cl)cc12,CHEMBL4685403,Ki,8.05,CHEMBL4780470,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(S(=O)(=O)N[C@@H]2CCN(CCCc3noc4ccccc34)C2)sc2ccc(F)cc12,CHEMBL4685403,Ki,9.2,CHEMBL4747978,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(S(=O)(=O)N[C@H]2CCN(CCCc3noc4ccccc34)C2)sc2ccc(Cl)cc12,CHEMBL4685403,Ki,7.41,CHEMBL4790020,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(S(=O)(=O)N[C@H]2CCN(CCCc3noc4ccccc34)C2)sc2ccc(F)cc12,CHEMBL4685403,Ki,7.82,CHEMBL4778418,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1c(S(=O)(=O)N[C@H]2C[C@H](C)N(CCCc3noc4cc(F)ccc34)C2)sc2ccc(Cl)cc12,CHEMBL5046640,Ki,7.27,CHEMBL5079536,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,150,530,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2cc(N3CCN(C)CC3)nc3c2ccn3S(=O)(=O)CC(C)C)c(C)s1,CHEMBL3800738,Ki,6.19,CHEMBL3800251,2016,CHEMBL3797149,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]NMSP from human dopamine D2S receptor expressed in CHO cell membrane incubated for 1 hr by scintillation counting method,118,180,c1cc2c(-c3ccsc3)cc(N3CCNCC3)nc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C#N)cc4)n2C)CC3)no1,CHEMBL895462,Ki,6.0,CHEMBL243896,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C(F)(F)F)cc4)n2C)CC3)n(C)n1,CHEMBL895462,Ki,6.3,CHEMBL390649,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccn[nH]5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(C(F)(F)F)cc4)n2C)CC3)no1,CHEMBL895462,Ki,6.3,CHEMBL243897,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(Cl)c(Cl)c4)n2C)CC3)no1,CHEMBL895462,Ki,6.3,CHEMBL397222,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc(Cl)cc4)n2C)CC3)no1,CHEMBL895462,Ki,6.4,CHEMBL244279,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc5nc(C)c(C)nc5c4)n2C)CC3)no1,CHEMBL895462,Ki,5.2,CHEMBL243708,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1cnc2cc(-c3nnc(SCCCN4CCc5ccc(-c6ccon6)cc5CC4)[nH]3)ccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccc(Cl)c4)n2C)CC3)no1,CHEMBL895462,Ki,6.7,CHEMBL244278,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccc(F)c4)n2C)CC3)no1,CHEMBL895462,Ki,5.9,CHEMBL244280,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccccc4)n2C)CC3)no1,CHEMBL895462,Ki,6.4,CHEMBL243709,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccccc4Cl)n2C)CC3)no1,CHEMBL895462,Ki,6.5,CHEMBL244087,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccs4)n2C)CC3)no1,CHEMBL895462,Ki,6.6,CHEMBL244086,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1csc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccncc4)n2C)CC3)no1,CHEMBL895462,Ki,6.0,CHEMBL244085,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1cc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)ccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(C)(C)C)n2C)CC3)no1,CHEMBL895462,Ki,6.8,CHEMBL243474,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1nnc(SCCCN2CCc3ccc(-c4ccon4)cc3CC2)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(C)C)n2C)CC3)no1,CHEMBL895462,Ki,6.2,CHEMBL243901,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1nnc(SCCCN2CCc3ccc(-c4ccon4)cc3CC2)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C(F)(F)F)n2C)CC3)no1,CHEMBL895462,Ki,6.8,CHEMBL243900,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1nnc(SCCCN2CCc3ccc(-c4ccon4)cc3CC2)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCC(C)CC4)n2C)CC3)no1,CHEMBL895462,Ki,6.9,CHEMBL243860,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCCCC4)[nH]2)CC3)no1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCCC4)n2C)CC3)no1,CHEMBL895462,Ki,6.6,CHEMBL243859,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCCC4)[nH]2)CC3)no1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCOCC4)n2C)CC3)no1,CHEMBL895462,Ki,5.9,CHEMBL242598,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1cc(-c2ccc3c(c2)CCN(CCCSc2nnc(C4CCOCC4)[nH]2)CC3)no1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)c2)on1,CHEMBL674348,Ki,6.8,CHEMBL3084626,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2ccno2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)on1,CHEMBL674348,Ki,6.3,CHEMBL3084615,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2ccno2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccccc2)n(C2CCN(Cc3ccccc3)CC2)n1,CHEMBL671371,Ki,6.51,CHEMBL24809,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,18,588,c1ccc(CN2CCC(n3nccc3-c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2ccsc2)cc(N2CCN(C)CC2)n1,CHEMBL5391038,Ki,8.13,CHEMBL5420183,2023,CHEMBL5390222,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-NMSP from D2 receptor (unknown origin) assessed as inhibition constant by radioligand binding assay,158,213,c1cc(-c2ccsc2)cc(N2CCNCC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2nnc(SCCCN3CC4CCN(c5ccc(C(F)(F)F)cc5)C4C3)n2C)on1,CHEMBL3776608,Ki,6.8,CHEMBL3775482,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5ccno5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)on1,CHEMBL3855278,Ki,6.28,CHEMBL3978613,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccno4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(=O)oc2c(Cl)c(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12,CHEMBL2390217,IC50,7.58,CHEMBL2387229,2013,CHEMBL2385071,J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 assessed as inhibition of agonist-induced response incubated for 60 mins in incubator followed by 15 mins at room temperature by FLIPR assay,92,834,O=c1ccc2ccc(OCCCCN3CCC(c4noc5ccccc45)CC3)cc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(=O)oc2c(Cl)c(OCCCCN3CCC(c4noc5cc(F)ccc45)CC3)ccc12,CHEMBL4821052,Ki,8.59,CHEMBL2387229,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),150,248,O=c1ccc2ccc(OCCCCN3CCC(c4noc5ccccc45)CC3)cc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12,CHEMBL2390029,Ki,7.97,CHEMBL52096,2013,CHEMBL2385071,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),92,799,O=c1ccc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(=O)oc2cc(OCCCN3CCN(c4ccccc4)CC3)ccc12,CHEMBL670879,Ki,7.86,CHEMBL52096,1998,CHEMBL1130712,Bioorg Med Chem Lett,Scientific Literature,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,14,829,O=c1ccc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)ccc1-c1ccccc1,CHEMBL672227,Ki,6.0,CHEMBL54948,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,18,131,O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)on1,CHEMBL3705383,Ki,6.91,CHEMBL3695394,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",100,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccno1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)on1,CHEMBL3706129,Ki,7.44,CHEMBL3676886,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",100,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccno1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)on1,CHEMBL3705135,Ki,6.4,CHEMBL3642762,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccno1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(OS(C)(=O)=O)cc4CC3)CC2)c2ccccc2n1,CHEMBL674348,Ki,6.2,CHEMBL2113358,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C(F)(F)F)nc(Nc2ccccc2-c2nnn[nH]2)n1,CHEMBL5251269,Ki,5.14,CHEMBL5279691,2023,CHEMBL5247646,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2S receptor stably expressed in CHO cells by Cheng-Prusoff equation analysis,158,835,c1cnc(Nc2ccccc2-c2nnn[nH]2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C(F)(F)F)nc(Nc2ccccc2-c2nnn[nH]2)n1,CHEMBL5251271,Ki,4.8,CHEMBL5279691,2023,CHEMBL5247646,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor stably expressed in CHO cells by Cheng-Prusoff equation analysis,158,836,c1cnc(Nc2ccccc2-c2nnn[nH]2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCCN3CCN(c4ccccc4)CC3)c2)o1,CHEMBL4409079,Ki,7.535,CHEMBL4540218,2019,CHEMBL4406846,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,137,837,O=C(NCCCN1CCN(c2ccccc2)CC1)Oc1cccc(-c2ccco2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)o1,CHEMBL4409079,Ki,6.86,CHEMBL4471658,2019,CHEMBL4406846,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,137,837,O=C(NCCN1CCN(c2ccccc2)CC1)Oc1cccc(-c2ccco2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C(N)=O)c(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)s1,CHEMBL4409079,Ki,6.67,CHEMBL4565200,2019,CHEMBL4406846,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,137,837,O=C(NCCN1CCN(c2ccccc2)CC1)Oc1cccc(-c2cccs2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C)c(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c(C)c1,CHEMBL1261591,Ki,8.31,CHEMBL1259098,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,71,108,c1ccc(-c2ccc3c(c2)C(N2CCNCC2)Cc2ccccc2S3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C)c2c(N)c(C(=O)NCCCCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1,CHEMBL3300162,Ki,6.01,CHEMBL3298686,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,O=C(NCCCCCCN1CCC(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C)c2c(N)c(C(=O)NCCCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1,CHEMBL3300162,Ki,5.7,CHEMBL3298685,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,O=C(NCCCCCN1CCC(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C)c2c(N)c(C(=O)NCCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)sc2n1,CHEMBL3300162,Ki,7.95,CHEMBL3298895,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,100,146,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C)c2c(N)c(C(=O)NCCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1,CHEMBL3300162,Ki,5.65,CHEMBL3298200,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,101,146,O=C(NCCCCN1CCC(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C)c2c(N)c(C(=O)NCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1,CHEMBL3300162,Ki,5.77,CHEMBL3299099,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,101,146,O=C(NCCCN1CCC(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C)c2c(N)c(C(=O)NCCN3CCC(O)(c4ccc(Cl)cc4)CC3)sc2n1,CHEMBL3300162,Ki,6.04,CHEMBL3299098,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,101,146,O=C(NCCN1CCC(c2ccccc2)CC1)c1cc2cccnc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C)n(C2CN(CCCc3nc(-c4ccccc4)no3)C2)n1,CHEMBL4137914,Ki,5.25,CHEMBL4169603,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1ccc(-c2noc(CCCN3CC(n4cccn4)C3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C)n2c1C=[N+]1[N+](=C3C=CC=C(NCCCCN4CCN(c5cccc(Cl)c5Cl)CC4)N3[B-]1(F)F)[B-]2(F)F,CHEMBL5133886,Ki,6.48,CHEMBL5171776,2022,CHEMBL5131451,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,154,497,[BH2-]1N2C(NCCCCN3CCN(c4ccccc4)CC3)=CC=CC2=[N+]2[BH2-]n3cccc3C=[N+]12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(C2CCN(Cc3ccccc3)CC2)[nH]n1,CHEMBL672209,Ki,6.19,CHEMBL77015,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,11,230,c1ccc(CN2CCC(c3ccn[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)on1,CHEMBL3705383,Ki,6.27,CHEMBL3695372,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",101,54,O=C(Cc1ccno1)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)on1,CHEMBL3707825,Ki,6.29,CHEMBL3664832,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,111,O=C(Cc1ccno1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)on1,CHEMBL3706129,Ki,7.08,CHEMBL3676855,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",101,55,O=C(Cc1ccno1)NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)on1,CHEMBL3707837,Ki,6.5,CHEMBL3697963,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",101,112,O=C(Cc1ccno1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(CC(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)on1,CHEMBL3705135,Ki,5.88,CHEMBL3642761,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(Cc1ccno1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(CCN2CCN(c3noc4ccccc34)CC2)c2c(c1)C(C)CC(=O)N2,CHEMBL872392,Ki,7.46,CHEMBL198599,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,41,103,O=C1CCc2cccc(CCN3CCN(c4noc5ccccc45)CC3)c2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(CN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)on1,CHEMBL1044430,Ki,6.8,CHEMBL549438,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,65,233,O=C1N(CCNCc2ccno2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(CN(C)CCN2CCN(c3cccc(Cl)c3)C2=O)on1,CHEMBL1059864,Ki,6.8,CHEMBL549438,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,65,234,O=C1N(CCNCc2ccno2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(CN2CCC3(CC2)OC=C(c2ccccc2)C3=O)on1,CHEMBL671745,Ki,4.5,CHEMBL553082,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(Cc1ccno1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(Cl)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,CHEMBL671074,IC50,6.89,CHEMBL1202210,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(Cl)ccc1OCc1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4366763,Ki,5.36,CHEMBL4560883,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,137,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(F)ccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,CHEMBL671074,IC50,7.17,CHEMBL1202209,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(N2CCN(C)CC2)c2c(c1)N(S(=O)(=O)c1ccc3ccccc3c1)C(C)CC2=O,CHEMBL1647768,IC50,5.75,CHEMBL1642128,2011,CHEMBL1641464,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells,79,243,O=C1CCN(S(=O)(=O)c2ccc3ccccc3c2)c2cccc(N3CCNCC3)c21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)nc(C(C)(C)C)n1,CHEMBL3379351,Ki,6.44,CHEMBL3323008,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,101,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)nc(C(F)(F)F)n1,CHEMBL3379351,Ki,5.44,CHEMBL3323006,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,101,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(NC(=O)NCCN2CCC(O)(Cc3ccccc3)CC2)c2ccccc2n1,CHEMBL5442215,Ki,6.22,CHEMBL567303,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=C(NCCN1CCC(Cc2ccccc2)CC1)Nc1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1,CHEMBL5442215,Ki,5.01,CHEMBL1334465,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=C(Nc1ccccc1)Nc1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1,CHEMBL4880035,Ki,5.0,CHEMBL4526351,2021,CHEMBL4507270,,SGC Frankfurt - Donated Chemical Probes,GPCRScan assay: inhibition of D2,150,144,O=C(Nc1cccc(-n2ccn3nc(-c4cccnc4)cc23)c1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1CN1CCCC1,CHEMBL4821052,Ki,7.9,CHEMBL4857350,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),150,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccc1CN1CCOCC1,CHEMBL4821052,Ki,8.51,CHEMBL4877973,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),150,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(OCCCN2CCN(c3ccccc3)CC2)ccc1Cl,CHEMBL4195136,Ki,6.52,CHEMBL4212812,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,131,717,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)ccc1Cl,CHEMBL4406527,IC50,5.42,CHEMBL4462053,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,144,455,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(OCc2nc(N)nc(N3CCN(C)CC3)n2)ccc1Cl,CHEMBL4366763,Ki,5.91,CHEMBL4527124,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,137,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12,CHEMBL4392130,Ki,5.08,CHEMBL4277264,2019,CHEMBL4390674,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cells measured after 90 mins by microbeta scintillation counting method,137,838,c1cc2occc2c(Oc2ccc(-c3cncc4nccn34)cc2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc(S(=O)(=O)Nc2ccc3c(c2)CCN(C)CC3)ccc1-c1ccc(Cl)cc1,CHEMBL905981,Ki,7.5,CHEMBL230069,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,55,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2cn1,CHEMBL948181,Ki,6.5,CHEMBL273199,2008,CHEMBL1142271,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,60,504,c1cc(-c2nnc(SCCCN3CCc4ccc(-c5ccn[nH]5)cc4CC3)[nH]2)c2ccncc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(c(N3CCN(CC[C@H]4CC[C@H](NC(=O)C5CCOCC5)CC4)CC3)n1)CCO2,CHEMBL3705135,Ki,5.71,CHEMBL3642778,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(c(N3CCN(CC[C@H]4CC[C@H](NC(=O)CC5CCOCC5)CC4)CC3)n1)CCO2,CHEMBL3705135,Ki,5.71,CHEMBL3639416,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(CC1CCOCC1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(cc1NS(=O)(=O)c1ccc(-c3ccc(Cl)cc3)cc1)CCN(C)CC2,CHEMBL905981,Ki,7.8,CHEMBL395525,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,55,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(Cl)cc3)CCN1CC2,CHEMBL2346209,IC50,6.66,CHEMBL2335737,2013,CHEMBL2331372,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,92,680,c1ccc(C2CCN3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(Cl)cc3)CCN1CC2,CHEMBL2346210,Ki,7.91,CHEMBL2335737,2013,CHEMBL2331372,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,92,679,c1ccc(C2CCN3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2,CHEMBL2346209,IC50,6.82,CHEMBL2331599,2013,CHEMBL2331372,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) transfected in CHO cell membranes assessed as inhibition of forskolin-stimulated cAMP level after 10 mins by flash plate assay in presence of dopamine,92,680,c1ccc(C2CCN3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2,CHEMBL2346210,Ki,6.88,CHEMBL2331599,2013,CHEMBL2331372,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,92,679,c1ccc(C2CCN3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(cc1OCCCCN1CCN(c3cccc4cc(F)ccc34)CC1)C(=O)NC2,CHEMBL1260558,Ki,9.09,CHEMBL1258087,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(cc1OCCCCN1CCN(c3cccc4cccc(F)c34)CC1)C(=O)NC2,CHEMBL1260558,Ki,8.63,CHEMBL1257971,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(cc1OCCCCN1CCN(c3cccc4ccccc34)CC1)C(=O)NC2,CHEMBL1260558,Ki,8.61,CHEMBL1257859,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(cc1OCCCN1CCN(c3cccc4cc(F)ccc34)CC1)C(=O)NC2,CHEMBL1260558,Ki,8.42,CHEMBL1258086,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(cc1OCCCN1CCN(c3cccc4cccc(F)c34)CC1)C(=O)NC2,CHEMBL1260558,Ki,7.78,CHEMBL1257970,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(cc1OCCCN1CCN(c3cccc4ccccc34)CC1)C(=O)NC2,CHEMBL1260558,Ki,7.66,CHEMBL1257858,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,71,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(nc1C)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21,CHEMBL672175,Ki,5.04,CHEMBL284959,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,18,290,c1ccc2c(c1)CCC1NCc3ncccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL1066831,Ki,7.5,CHEMBL715,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,71,380,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL1066832,Ki,8.21,CHEMBL715,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,71,381,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL2162846,Ki,8.15,CHEMBL715,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,83,218,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL2352923,IC50,8.0,CHEMBL715,2013,CHEMBL2346662,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from D2 receptor in human corpus striatum after 30 mins by scintillation counting,92,839,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL2352923,Ki,7.96,CHEMBL715,2013,CHEMBL2346662,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from D2 receptor in human corpus striatum after 30 mins by scintillation counting,92,839,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL3226695,Ki,7.0,CHEMBL715,2012,CHEMBL3217546,Medchemcomm,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,83,553,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL3240292,Ki,7.63,CHEMBL715,2014,CHEMBL3232770,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from wild-type human dopamine D2S receptor expressed in CHO-K1 cell membrane after 2 hrs by beta counting,101,572,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL3240293,Ki,6.76,CHEMBL715,2014,CHEMBL3232770,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor S5.43T/S5.46A mutant expressed in CHO-K1 cell membrane after 2 hrs by beta counting,101,573,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL3366156,Ki,7.7,CHEMBL715,2014,CHEMBL3352364,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,101,840,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL3381713,Ki,7.7,CHEMBL715,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),101,574,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL3707630,Ki,7.51,CHEMBL715,2013,CHEMBL3638417,,BindingDB Patent Bioactivity Data,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",92,575,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL3757886,Ki,7.28,CHEMBL715,2015,CHEMBL3751719,Medchemcomm,Scientific Literature,Displacement of [3H]N-methylspiperone from human cloned D2 dopamine receptor expressed in human fibroblasts incubated for 90 mins by scintillation counting based radioligand binding assay,111,549,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL3771916,Ki,8.05,CHEMBL715,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,118,240,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL4148417,Ki,8.05,CHEMBL715,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,131,239,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL4229838,Ki,8.4,CHEMBL715,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,131,578,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL4259653,Ki,8.05,CHEMBL715,2018,CHEMBL4257531,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,131,237,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL4366763,Ki,8.05,CHEMBL715,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,137,228,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL4671577,Ki,7.24,CHEMBL715,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL4819277,Ki,8.05,CHEMBL715,2020,CHEMBL4818985,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,144,227,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL5046640,Ki,7.77,CHEMBL715,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,150,530,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL671419,Ki,7.7,CHEMBL715,1997,CHEMBL1150510,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity of compound against neuronal Dopamine receptor D2,11,605,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL672169,Ki,7.77,CHEMBL715,2004,CHEMBL1149193,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,38,533,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL672179,Ki,8.68,CHEMBL715,2001,CHEMBL1134342,J Med Chem,Scientific Literature,Binding affinity towards human D2 dopamine receptor.,25,534,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL829120,Ki,7.11,CHEMBL715,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,41,536,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL895618,Ki,7.7,CHEMBL715,2007,CHEMBL1148822,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,55,452,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1,CHEMBL992743,Ki,7.7,CHEMBL715,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,60,604,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CCNCC1,CHEMBL671419,Ki,8.05,CHEMBL1125,1997,CHEMBL1150510,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity of compound against neuronal Dopamine receptor D2,11,605,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2c(s1)Nc1ccccc1N=C2N1CC[N+](C)([O-])CC1,CHEMBL671419,Ki,6.92,CHEMBL440512,1997,CHEMBL1150510,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity of compound against neuronal Dopamine receptor D2,11,605,c1ccc2c(c1)N=C(N1CC[NH2+]CC1)c1ccsc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2oc1=O,CHEMBL670879,Ki,7.97,CHEMBL422788,1998,CHEMBL1130712,Bioorg Med Chem Lett,Scientific Literature,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,14,829,O=c1ccc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2nc(C)c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)n2c(C)n1,CHEMBL1061432,Ki,5.48,CHEMBL563078,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2nc(C)c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)n2c(C)n1,CHEMBL1061433,Ki,5.26,CHEMBL563078,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2nc(C)c(CN3CCN(c4ccc(Cl)cc4)CC3)n2c(C)n1,CHEMBL1061432,Ki,4.58,CHEMBL554692,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2nc(C)c(CN3CCN(c4ccc(Cl)cc4)CC3)n2c(C)n1,CHEMBL1061433,Ki,4.24,CHEMBL554692,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2nc(C)c(CN3CCN(c4ccc(F)cc4)CC3)n2c(C)n1,CHEMBL1061432,Ki,5.33,CHEMBL549638,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2nc(C)c(CN3CCN(c4ccc(F)cc4)CC3)n2c(C)n1,CHEMBL1061433,Ki,5.46,CHEMBL549638,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2nc(C)c(CN3CCN(c4ccccc4)CC3)n2c(C)n1,CHEMBL1061432,Ki,5.07,CHEMBL550392,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2nc(C)c(CN3CCN(c4ccccc4)CC3)n2c(C)n1,CHEMBL1061433,Ki,4.96,CHEMBL550392,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2nc(C)c(CN3CCN(c4ccccn4)CC3)n2c(C)n1,CHEMBL1061432,Ki,4.77,CHEMBL562384,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2nc(C)c(CN3CCN(c4ccccn4)CC3)n2c(C)n1,CHEMBL1061433,Ki,5.0,CHEMBL562384,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,c1ccc(N2CCN(Cc3cnc4ccncn34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2occc2c(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4CCOCC4)CC3)CC2)n1,CHEMBL3705135,Ki,6.56,CHEMBL3642774,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(NC1CCC(CCN2CCN(c3nccc4occc34)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cc2occc2c(N2CCN(CC[C@H]3CC[C@H](NC(=O)CC4CCOCC4)CC3)CC2)n1,CHEMBL3705135,Ki,6.19,CHEMBL3642775,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(CC1CCOCC1)NC1CCC(CCN2CCN(c3nccc4occc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(-c2cc3c(=O)n(CCN4CCN(c5ccccc5Cl)CC4)c(=O)[nH]c3[nH]2)cc1,CHEMBL864519,Ki,5.76,CHEMBL370364,2006,CHEMBL1148546,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,48,688,O=c1[nH]c2[nH]c(-c3ccccc3)cc2c(=O)n1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(-c2ccc(S(=O)(=O)Nc3ccc4c(c3)CCN(C)CC4)cc2)s1,CHEMBL905981,Ki,6.5,CHEMBL230070,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,55,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)cc1,CHEMBL1261591,Ki,8.2,CHEMBL1259079,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,71,108,c1ccc(-c2ccc3c(c2)C(N2CCNCC2)Cc2ccccc2S3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)s1,CHEMBL1261591,Ki,8.54,CHEMBL1259005,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,71,108,c1csc(-c2ccc3c(c2)C(N2CCNCC2)Cc2ccccc2S3)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(-c2nc(O)n(C3CCN(Cc4ccccc4)CC3)c2C)cc1,CHEMBL671375,Ki,7.28,CHEMBL263162,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)c(C)n1,CHEMBL3855278,Ki,5.91,CHEMBL3913542,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(-c2nnc(SCCCN3CCc4ccc(-c5cc(C)on5)cc4CC3)n2C)cc1,CHEMBL895462,Ki,6.4,CHEMBL395742,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1ccc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)cn1,CHEMBL1107668,Ki,6.2,CHEMBL1079640,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,71,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)NC2CCc3ccc(CCN4CCN(c5nsc6ccccc56)CC4)cc32)cc1,CHEMBL945767,Ki,7.82,CHEMBL398618,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,60,106,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)cc1,CHEMBL671981,Ki,5.94,CHEMBL300956,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,11,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)cc1,CHEMBL835392,Ki,6.42,CHEMBL300956,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,41,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)NCN2CCN(c3ccccc3Cl)CC2)cc1,CHEMBL671981,Ki,6.33,CHEMBL51536,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,11,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)NCN2CCN(c3ccccc3Cl)CC2)cc1,CHEMBL835392,Ki,7.31,CHEMBL51536,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,41,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1,CHEMBL870468,Ki,5.82,CHEMBL213795,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,48,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)cn1,CHEMBL3705383,Ki,6.82,CHEMBL3695395,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",101,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)cn1,CHEMBL3707825,Ki,6.88,CHEMBL3664828,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cn1,CHEMBL3706129,Ki,7.55,CHEMBL3676914,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",101,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc(Cl)c4Cl)CC3)CC2)s1,CHEMBL671651,Ki,8.0,CHEMBL76908,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,11,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)cn1,CHEMBL3705135,Ki,6.5,CHEMBL3642792,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)OC2(c3ccc(Cl)cc3)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1,CHEMBL3369121,Ki,7.25,CHEMBL3318844,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,101,127,O=C(CCCN1CCC(OC(=O)c2ccccc2)(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(=O)OC2(c3ccc(Cl)cc3)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1,CHEMBL3369122,Ki,7.33,CHEMBL3318844,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,101,128,O=C(CCCN1CCC(OC(=O)c2ccccc2)(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(C)C)c(OCc2nc(N)nc(N3CCN(C)CC3)n2)c1,CHEMBL4366763,Ki,5.96,CHEMBL4520796,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,137,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C(C)C)c(OCc2nc(N)nc(N3CCN(C)CC3)n2)c1,CHEMBL5216600,Ki,5.96,CHEMBL4520796,2022,CHEMBL5214932,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2 receptor expressed in HEK293 cells by radioligand binding assay,154,229,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C(=O)CCCN2CCC(O)(c3cc(C)ccc3C)CC2)c1,CHEMBL1261459,Ki,7.26,CHEMBL1257927,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,71,777,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C(=O)CCCN2CCC(O)(c3cc(C)ccc3C)CC2)c1,CHEMBL1261460,Ki,7.34,CHEMBL1257927,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,71,778,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C(=O)CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)c1,CHEMBL1261459,Ki,7.82,CHEMBL1257811,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,71,777,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C(=O)CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)c1,CHEMBL1261460,Ki,7.37,CHEMBL1257811,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,71,778,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C(=O)CCCN2CCC(c3cc(C)ccc3C)CC2)c1,CHEMBL1261459,Ki,6.4,CHEMBL1258270,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,71,777,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C(=O)CCCN2CCC(c3cc(C)ccc3C)CC2)c1,CHEMBL1261460,Ki,6.58,CHEMBL1258270,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,72,778,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C(=O)CCCN2CCC(c3ccc(Cl)cc3)CC2)c1,CHEMBL1261459,Ki,6.7,CHEMBL1258155,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,72,777,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C(=O)CCCN2CCC(c3ccc(Cl)cc3)CC2)c1,CHEMBL1261460,Ki,6.72,CHEMBL1258155,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,72,778,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C(=O)NCCCCN2CCN(c3cc(C)ccc3C)CC2)c1,CHEMBL1261459,Ki,7.0,CHEMBL1258495,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,72,777,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C(=O)NCCCCN2CCN(c3cc(C)ccc3C)CC2)c1,CHEMBL1261460,Ki,7.07,CHEMBL1258495,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,72,778,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)c1,CHEMBL1261459,Ki,8.47,CHEMBL1257689,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,72,777,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)c1,CHEMBL1261460,Ki,8.19,CHEMBL1257689,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,72,778,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)c1,CHEMBL872891,Ki,6.92,CHEMBL105304,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",30,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(N2CCN(CC(O)CN3C(=O)NC(C)(c4ccc(F)cc4)C3=O)CC2)c1,CHEMBL3771916,Ki,5.74,CHEMBL3769612,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,118,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(N2CCN(CCCC(=O)c3ccc(F)cc3)CC2)c1,CHEMBL1261459,Ki,7.89,CHEMBL1258037,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,72,777,O=C(CCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(N2CCN(CCCC(=O)c3ccc(F)cc3)CC2)c1,CHEMBL1261460,Ki,7.8,CHEMBL1258037,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,72,778,O=C(CCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1,CHEMBL1261459,Ki,7.08,CHEMBL1258383,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,72,777,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C)c(N2CCN(CCCCNC(=O)c3cc4ccccc4s3)CC2)c1,CHEMBL1261460,Ki,7.19,CHEMBL1258383,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,72,778,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2(O)CCN(CCCC(=O)c3ccc(F)cc3)CC2)cc1,CHEMBL4416273,Ki,9.14,CHEMBL2104700,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,137,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C23CC2C(=O)N(CCCCN2CCN(c4cccc5sccc45)CC2)C3=O)cc1,CHEMBL4254801,IC50,7.09,CHEMBL4292254,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,131,130,O=C1C2CC2(c2ccccc2)C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C23CC2CN(CCCSc2nnc(-c4ocnc4C)n2C)C3)c(F)c1,CHEMBL1107668,Ki,6.2,CHEMBL1081869,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2CCN(CC(=O)Nc3cccc(C)c3)CC2)cc1,CHEMBL4392163,Ki,5.11,CHEMBL4473792,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,137,500,O=C(CN1CCC(c2ccccc2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2CCN(CC(=O)Nc3cccc(C)c3)CC2)cc1,CHEMBL4392176,IC50,4.35,CHEMBL4473792,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,137,501,O=C(CN1CCC(c2ccccc2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2CCN(CC(=O)Nc3cccc(C)c3)CC2)cc1,CHEMBL4392186,IC50,4.05,CHEMBL4473792,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,137,502,O=C(CN1CCC(c2ccccc2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2CCN(CC(=O)Nc3cccc(C)c3)CC2)nc1,CHEMBL4392176,IC50,4.15,CHEMBL4587925,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,137,501,O=C(CN1CCC(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2CCN(CCC3NC(=O)c4ccccc43)CC2)cc1C,CHEMBL672174,Ki,5.92,CHEMBL37604,1998,CHEMBL1131363,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,14,841,O=C1NC(CCN2CCC(c3ccccc3)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2CCN(Cc3ccc(Oc4ccc(F)c(F)c4)cc3)CC2)cc1NC(=O)C(C)C,CHEMBL894444,Ki,6.4,CHEMBL242003,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,55,122,c1ccc(Oc2ccc(CN3CCC(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1,CHEMBL671372,Ki,7.28,CHEMBL346398,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,18,707,O=C1COc2ccc(CN3CCC(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1C,CHEMBL671372,Ki,6.24,CHEMBL149596,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,18,707,O=C1COc2ccc(CN3CCC(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2CCN(Cc3ccc4c(c3)OCC(=O)N4)CC2)cc1,CHEMBL671372,Ki,6.54,CHEMBL151286,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,18,707,O=C1COc2cc(CN3CCC(c4ccccc4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2CCN(Cc3ccc4c(c3)OCC(=O)N4)CC2)cc1C,CHEMBL671372,Ki,6.21,CHEMBL147059,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,18,707,O=C1COc2cc(CN3CCC(c4ccccc4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(C2CN(CCCSc3nnc(-c4ccc(-c5noc(C)n5)cc4)n3C)CCO2)cc1,CHEMBL3768209,Ki,4.6,CHEMBL3764246,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,118,132,c1ccc(C2CN(CCCSc3nnc(-c4ccc(-c5ncon5)cc4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CC(C)CNC(=O)/N=C(\N)NCCCc2cnc(N)s2)cc1,CHEMBL5151464,Ki,6.31,CHEMBL5202592,2021,CHEMBL5149991,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,150,223,O=C(N=CNCCCc1cncs1)NCCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CC(C)CNC(=O)/N=C(\N)NCCCc2nnc(N)s2)cc1,CHEMBL5151464,Ki,5.97,CHEMBL5180504,2021,CHEMBL5149991,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,150,223,O=C(N=CNCCCc1nncs1)NCCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CC(C)CNC(=O)/N=C(\N)NCCCc2sc(N)nc2C)cc1,CHEMBL4815484,Ki,6.3,CHEMBL4853107,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,150,259,O=C(N=CNCCCc1cncs1)NCCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CCCNCCCOc2ccccc2)cc1,CHEMBL671378,Ki,6.44,CHEMBL334989,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(CCCNCCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CCN2CCN(c3nsc4ccccc34)CC2)c2c1C(C)CC(=O)N2,CHEMBL872392,Ki,7.96,CHEMBL440389,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,41,103,O=C1CCc2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCC(C3CCc4ccccc4C3=O)CC2)cc1,CHEMBL673013,Ki,7.43,CHEMBL124234,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCC(CC(=O)N3c4ccccc4CC3C)CC2)cc1,CHEMBL872891,Ki,7.41,CHEMBL104716,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",30,214,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCC(CC(=O)N3c4ccccc4CC3C)CC2)cc1C,CHEMBL872882,Ki,6.51,CHEMBL106742,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,30,177,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCC(CC(=O)N3c4ccccc4CC3C)CC2)cc1F,CHEMBL872891,Ki,7.64,CHEMBL104273,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",30,214,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCC(n3c(O)nc4ccccc43)CC2)c(Cl)c1,CHEMBL671072,IC50,6.32,CHEMBL114484,2001,CHEMBL1134625,J Med Chem,Scientific Literature,Inhibition of human dopamine receptor D2,25,486,c1ccc(CN2CCC(n3cnc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(C3=Nc4cc(Cl)ccc4Nc4ccccc43)CC2)c(C)c1,CHEMBL911524,Ki,7.19,CHEMBL378301,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,48,194,c1ccc(CN2CCN(C3=Nc4ccccc4Nc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(C3CCc4cccc5c4N(C3=O)C(C)(C)C5)CC2)cc1,CHEMBL672162,Ki,6.78,CHEMBL351989,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,35,236,O=C1C(N2CCN(Cc3ccccc3)CC2)CCc2cccc3c2N1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(C3CCc4cccc5c4N(C3=O)C(C)C5)CC2)cc1,CHEMBL672162,Ki,7.58,CHEMBL345438,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,35,236,O=C1C(N2CCN(Cc3ccccc3)CC2)CCc2cccc3c2N1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(C3CCc4cccc5c4N(CC5)C3=O)CC2)cc1,CHEMBL5235417,Ki,6.68,CHEMBL351963,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to D2R (unknown origin) assessed as inhibition constant,150,476,O=C1C(N2CCN(Cc3ccccc3)CC2)CCc2cccc3c2N1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(C3CCc4cccc5c4N(CC5)C3=O)CC2)cc1,CHEMBL672162,Ki,6.68,CHEMBL351963,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,35,236,O=C1C(N2CCN(Cc3ccccc3)CC2)CCc2cccc3c2N1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1,CHEMBL677454,Ki,6.85,CHEMBL107742,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Dopamine D2 receptor functional activity was assessed via inhibition of forskolin stimulated cAMP production from Whole cells,30,842,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1,CHEMBL872217,IC50,6.73,CHEMBL107742,2005,CHEMBL1140446,J Med Chem,Scientific Literature,Inhibitory concentration against dopamine receptor D2,41,601,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4CC3C)CC2)cc1,CHEMBL872891,Ki,6.73,CHEMBL107742,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",30,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@@H]3C)CC2)cc1,CHEMBL675680,Ki,5.63,CHEMBL105354,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1,CHEMBL4039163,Ki,6.95,CHEMBL320597,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,125,546,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1,CHEMBL5235417,Ki,6.95,CHEMBL320597,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to D2R (unknown origin) assessed as inhibition constant,150,476,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1,CHEMBL672178,Ki,6.95,CHEMBL320597,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 was determined via standard competitive displacement assays using [3H]-YM 09151 as the competitive ligand,30,592,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1,CHEMBL872217,IC50,6.95,CHEMBL320597,2005,CHEMBL1140446,J Med Chem,Scientific Literature,Inhibitory concentration against dopamine receptor D2,41,601,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CCN(CC(=O)N3c4ccccc4C[C@H]3C)CC2)cc1F,CHEMBL675680,Ki,6.15,CHEMBL317670,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,30,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CN2CC[C@H](NC(=O)c3cccc(-c4cccs4)c3)C2)cc1,CHEMBL860444,Ki,7.22,CHEMBL381019,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,41,740,O=C(NC1CCN(Cc2ccccc2)C1)c1cccc(-c2cccs2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CNCC2(F)CCN(C(=O)c3cc(Br)cs3)CC2)nc1,CHEMBL1259261,Ki,4.14,CHEMBL1259071,2010,CHEMBL1255227,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor,72,843,O=C(c1cccs1)N1CCC(CNCc2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CNCC2(F)CCN(C(=O)c3cc(Br)cs3)CC2)nc1,CHEMBL1259262,Ki,4.0,CHEMBL1259071,2010,CHEMBL1255227,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor,72,844,O=C(c1cccs1)N1CCC(CNCc2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CNCC2(F)CCN(C(=O)c3ccc(F)c(Cl)c3)CC2)nc1,CHEMBL1259261,Ki,4.82,CHEMBL45305,2010,CHEMBL1255227,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor,72,843,O=C(c1ccccc1)N1CCC(CNCc2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CNCC2(F)CCN(C(=O)c3ccc(F)c(Cl)c3)CC2)nc1,CHEMBL1259262,Ki,4.34,CHEMBL45305,2010,CHEMBL1255227,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor,72,844,O=C(c1ccccc1)N1CCC(CNCc2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CNCC2(F)CCN(C(=O)c3coc4ccccc34)CC2)nc1,CHEMBL1259261,Ki,4.57,CHEMBL1258999,2010,CHEMBL1255227,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor,72,843,O=C(c1coc2ccccc12)N1CCC(CNCc2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CNCC2(F)CCN(C(=O)c3coc4ccccc34)CC2)nc1,CHEMBL1259262,Ki,4.55,CHEMBL1258999,2010,CHEMBL1255227,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor,72,844,O=C(c1coc2ccccc12)N1CCC(CNCc2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CNCC2(F)CCN(C(=O)c3csc4ccccc34)CC2)nc1,CHEMBL1259261,Ki,4.7,CHEMBL1259241,2010,CHEMBL1255227,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor,72,843,O=C(c1csc2ccccc12)N1CCC(CNCc2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(CNCC2(F)CCN(C(=O)c3csc4ccccc34)CC2)nc1,CHEMBL1259262,Ki,4.27,CHEMBL1259241,2010,CHEMBL1255227,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor,72,844,O=C(c1csc2ccccc12)N1CCC(CNCc2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(Cl)c(N2CCN(CCCCNC(=O)c3ccc4oc(=O)[nH]c4c3)CC2)c1,CHEMBL3591366,Ki,7.33,CHEMBL3590086,2015,CHEMBL3588810,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,111,726,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2oc(=O)[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(Cl)c(N2CCN(CCCCNC(=O)c3ccc4oc(=O)[nH]c4c3)CC2)c1,CHEMBL3591527,Ki,6.47,CHEMBL3590086,2015,CHEMBL3588810,J Med Chem,Scientific Literature,Binding affinity to human dopamine D2 receptor,111,845,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2oc(=O)[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(Cn2ncc(N3CCNCC3)c(Cl)c2=O)cc1NC(=O)c1ccc(-c2ccccc2)cc1,CHEMBL991395,Ki,5.31,CHEMBL458002,2009,CHEMBL1143385,J Med Chem,Scientific Literature,Displacement of [125I]iodosulpiride from dopamine D2 receptor expressed in CHO cells,65,831,O=C(Nc1cccc(Cn2ncc(N3CCNCC3)cc2=O)c1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)cc1,CHEMBL3776608,Ki,6.2,CHEMBL3775071,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CC(O)CN3C(=O)NC(C)(c4ccc(F)cc4)C3=O)CC2)cc1C,CHEMBL3771916,Ki,5.65,CHEMBL3770110,2016,CHEMBL3769356,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells,118,240,O=C1NC(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CC3CC3c3ccccc3)CC2)c(C)c1,CHEMBL671074,IC50,7.22,CHEMBL2092961,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCC3C(=O)Nc4ccccc43)CC2)cc1C,CHEMBL4039163,Ki,5.74,CHEMBL4095082,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,126,546,O=C1Nc2ccccc2C1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCC3NC(=O)c4ccccc43)CC2)cc1C,CHEMBL5235417,Ki,5.74,CHEMBL38262,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to D2R (unknown origin) assessed as inhibition constant,150,476,O=C1NC(CCN2CCN(c3ccccc3)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCC3NC(=O)c4ccccc43)CC2)cc1C,CHEMBL672174,Ki,5.74,CHEMBL38262,1998,CHEMBL1131363,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,14,841,O=C1NC(CCN2CCN(c3ccccc3)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCCCNC(=O)c3ccc(-c4ccsc4)cc3)CC2)cc1,CHEMBL4350893,Ki,4.6,CHEMBL4545775,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",137,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCCCc3ccc(F)cc3)CC2)nc1,CHEMBL3292986,Ki,5.715,CHEMBL3289648,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCCCc3ccc(F)cc3)CC2)nc1,CHEMBL4688549,Ki,5.715,CHEMBL3289648,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,150,847,c1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324908,Ki,5.98,CHEMBL5425920,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,158,704,c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324912,IC50,5.7,CHEMBL5425920,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,158,705,c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324922,IC50,5.81,CHEMBL5425920,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,158,706,c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCCN3C(=O)CCc4ccccc43)CC2)cc1,CHEMBL5106582,Ki,5.29,CHEMBL5171439,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,154,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCCOc3ccc(F)cc3)CC2)nc1,CHEMBL3292986,Ki,5.98,CHEMBL3289646,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCCSc3ccc(F)cc3)CC2)nc1,CHEMBL3292986,Ki,5.98,CHEMBL3289647,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(SCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)cc1,CHEMBL1044430,Ki,6.0,CHEMBL564948,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,65,233,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)cc1,CHEMBL1059864,Ki,6.0,CHEMBL564948,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,65,234,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCN3CCCCCC3)C2=O)cc1,CHEMBL1106075,Ki,7.3,CHEMBL1077348,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,72,556,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)s1,CHEMBL1057875,Ki,6.3,CHEMBL552460,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,65,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CC[C@@H]3NC(=O)c4ccccc43)CC2)cc1C,CHEMBL672174,Ki,5.23,CHEMBL37170,1998,CHEMBL1131363,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,14,841,O=C1NC(CCN2CCN(c3ccccc3)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4CCCCC4)CC3)CC2)cc1C,CHEMBL671651,Ki,8.25,CHEMBL80615,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,11,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4cccs4)CC3)CC2)cc1,CHEMBL671651,Ki,7.78,CHEMBL311575,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,11,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(CC[C@H]3NC(=O)c4ccccc43)CC2)cc1C,CHEMBL672174,Ki,5.56,CHEMBL35093,1998,CHEMBL1131363,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,14,841,O=C1NC(CCN2CCN(c3ccccc3)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(C[C@@H]3C[C@@H]3c3ccccc3)CC2)c(C)c1,CHEMBL983536,Ki,6.29,CHEMBL492033,2008,CHEMBL1144236,Bioorg Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,60,848,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(C[C@@H]3C[C@H]3c3ccccc3)CC2)c(C)c1,CHEMBL671074,IC50,7.14,CHEMBL1202208,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(C[C@@H]3C[C@H]3c3ccccc3)CC2)c(C)c1,CHEMBL671376,Ki,7.21,CHEMBL1202208,2000,CHEMBL1133592,J Med Chem,Scientific Literature,Antagonism of dopamine-stimulated [35S]GTP-gamma-S binding against human Dopamine receptor D2 in CHO cells,23,849,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(C)c1,CHEMBL671074,IC50,7.35,CHEMBL1204119,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(C)c1,CHEMBL983536,Ki,6.27,CHEMBL338337,2008,CHEMBL1144236,Bioorg Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,60,848,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(C[C@H]3C[C@H]3c3ccccc3)CC2)c(C)c1,CHEMBL983536,Ki,6.03,CHEMBL523993,2008,CHEMBL1144236,Bioorg Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,60,848,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1,CHEMBL671372,Ki,6.31,CHEMBL345552,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,18,707,O=C1COc2ccc(CN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(Cc3ccc4c(c3)NC(=O)CO4)CC2)cc1C,CHEMBL671372,Ki,5.63,CHEMBL150181,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,18,707,O=C1COc2ccc(CN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(Cc3ccc4c(c3)OCC(=O)N4)CC2)cc1,CHEMBL671372,Ki,5.53,CHEMBL150173,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,18,707,O=C1COc2cc(CN3CCN(c4ccccc4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(N2CCN(Cc3ccc4c(c3)OCC(=O)N4)CC2)cc1C,CHEMBL671372,Ki,6.46,CHEMBL151533,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,18,707,O=C1COc2cc(CN3CCN(c4ccccc4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(NC(=O)C(C)C)cc1C1CCN(Cc2ccc(Oc3ccc(F)c(F)c3)cc2)CC1,CHEMBL894444,Ki,5.13,CHEMBL242004,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,55,122,c1ccc(Oc2ccc(CN3CCC(c4ccccc4)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCCNCCOc2ccc(C)cc2)cc1,CHEMBL671378,Ki,6.56,CHEMBL130370,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCCNCCOc2ccc(C)cc2)cc1,CHEMBL835389,Ki,6.56,CHEMBL130370,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCCNCCOc2ccc(Cl)cc2)cc1,CHEMBL671378,Ki,5.88,CHEMBL131484,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCCNCCOc2ccc(Cl)cc2)cc1,CHEMBL835389,Ki,5.88,CHEMBL131484,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCCNCCOc2ccccc2)cc1,CHEMBL671378,Ki,7.19,CHEMBL131299,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCCNCCOc2ccccc2)cc1,CHEMBL835389,Ki,7.19,CHEMBL131299,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCN2CCN(C(=O)c3cc4ccccc4[nH]3)CC2)cc1C,CHEMBL4406527,IC50,4.89,CHEMBL4519087,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,144,455,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccc(Br)cc2)cc1,CHEMBL671378,Ki,5.24,CHEMBL341225,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccc(Br)cc2)cc1,CHEMBL835389,Ki,5.24,CHEMBL341225,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccc(F)cc2)cc1,CHEMBL671378,Ki,6.41,CHEMBL131357,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccc(F)cc2)cc1,CHEMBL835389,Ki,6.41,CHEMBL131357,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2cccc(C)c2)cc1,CHEMBL671378,Ki,6.54,CHEMBL435598,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2cccc(C)c2)cc1,CHEMBL835389,Ki,6.53,CHEMBL435598,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccccc2)cc1,CHEMBL671378,Ki,6.57,CHEMBL128647,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccccc2)cc1,CHEMBL835389,Ki,6.57,CHEMBL128647,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccccc2)cc1C,CHEMBL671378,Ki,6.84,CHEMBL129927,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccccc2)cc1C,CHEMBL835389,Ki,6.84,CHEMBL129927,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccccc2)cc1Cl,CHEMBL671378,Ki,6.52,CHEMBL131997,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccccc2)cc1Cl,CHEMBL835389,Ki,6.52,CHEMBL131997,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccccc2C)cc1,CHEMBL671378,Ki,6.53,CHEMBL334545,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCOc2ccccc2C)cc1,CHEMBL835389,Ki,6.53,CHEMBL334545,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCCNCCCSc2ccccc2)cc1,CHEMBL671378,Ki,6.93,CHEMBL130402,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCNCCCSc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(OCc2nc(N)nc(N3CCN(C)CC3)n2)cc1,CHEMBL4366763,Ki,5.54,CHEMBL4584325,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,137,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(Oc2cccc(CN3CCC(c4cccc(NC(=O)C(C)C)c4)CC3)c2)cc1,CHEMBL894444,Ki,5.89,CHEMBL244374,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,55,122,c1ccc(Oc2cccc(CN3CCC(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(S(=O)(=O)CC2CCN(CCCc3noc4cc(F)ccc34)C2)cc1C,CHEMBL5046640,Ki,7.7,CHEMBL5092755,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,151,530,O=S(=O)(CC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(S(=O)(=O)N(CCCCCCN2CCN(c3nsc4ccccc34)CC2)c2ccccc2)cc1,CHEMBL4629186,Ki,6.97,CHEMBL4638388,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,144,764,O=S(=O)(c1ccccc1)N(CCCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1,CHEMBL911524,Ki,6.47,CHEMBL209805,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,48,194,O=S(=O)(c1ccccc1)N1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(S(=O)(=O)N[C@H]2CC[C@@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl,CHEMBL894519,Ki,7.22,CHEMBL234423,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,55,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1,CHEMBL3706129,Ki,7.23,CHEMBL3676883,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",101,55,O=S(=O)(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](CCN3CCN(c4nsc5ccccc45)CC3)CC2)cc1,CHEMBL3872755,Ki,9.38,CHEMBL3948056,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,118,114,O=S(=O)(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(S(=O)(=O)N[C@H]2CC[C@H](N3CCN(c4ccccc4OC(C)C)CC3)CC2)cc1Cl,CHEMBL894519,Ki,7.28,CHEMBL234609,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,55,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(Cc2cc[nH]n2)CC3)cc1Cl,CHEMBL1108513,Ki,6.4,CHEMBL1079311,2009,CHEMBL1154336,Bioorg Med Chem Lett,Scientific Literature,Agonist activity at dopamine D2 receptor,65,200,O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(SCCNCCCOc2ccccc2)cc1,CHEMBL671378,Ki,6.65,CHEMBL128281,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCSc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc(Sc2ccccc2N2CCN(CCc3c(C)nc4n(c3=O)CCCC4O)CC2)c(C)c1,CHEMBL4045104,IC50,6.06,CHEMBL4082150,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3ccccc3Sc3ccccc3)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c2c1,CHEMBL872394,Ki,7.97,CHEMBL198107,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C(F)(F)F)oc6c(Br)c5CC4)n3C)cccc2n1,CHEMBL948181,Ki,6.0,CHEMBL257369,2008,CHEMBL1142271,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,60,504,c1cc(-c2nnc(SCCCCN3CCc4cc5ncoc5cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C(F)(F)F)oc6c(C)c5CC4)n3C)cccc2n1,CHEMBL948181,Ki,6.2,CHEMBL271097,2008,CHEMBL1142271,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,60,504,c1cc(-c2nnc(SCCCCN3CCc4cc5ncoc5cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6nc(C)oc6c(C)c5CC4)n3C)cccc2n1,CHEMBL948181,Ki,6.8,CHEMBL256481,2008,CHEMBL1142271,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,60,504,c1cc(-c2nnc(SCCCCN3CCc4cc5ncoc5cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Br)cc5)C4)n3C)cccc2n1,CHEMBL1107668,Ki,5.4,CHEMBL1079497,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5ncccc45)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C#N)cc5)C4)n3C)cccc2n1,CHEMBL1107668,Ki,5.2,CHEMBL1079577,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5ncccc45)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(C(C)(C)C)cc5)C4)n3C)cccc2n1,CHEMBL1107668,Ki,6.1,CHEMBL1081401,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5ncccc45)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)c(Cl)c5)C4)n3C)cccc2n1,CHEMBL1107668,Ki,5.9,CHEMBL1081237,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5ncccc45)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)cc5)C4)n3C)cccc2n1,CHEMBL1107668,Ki,6.4,CHEMBL1080117,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5ncccc45)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccccc5)C4)n3C)cccc2n1,CHEMBL1107668,Ki,6.75,CHEMBL1081203,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5ncccc45)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,CHEMBL1044430,Ki,6.5,CHEMBL244946,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,65,233,c1cc(-c2nnc(SCCCN3CCc4ccc(-c5ccn[nH]5)cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,CHEMBL1059864,Ki,6.5,CHEMBL244946,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,65,234,c1cc(-c2nnc(SCCCN3CCc4ccc(-c5ccn[nH]5)cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,CHEMBL1107668,Ki,6.5,CHEMBL244946,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1cc(-c2nnc(SCCCN3CCc4ccc(-c5ccn[nH]5)cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,CHEMBL895462,Ki,6.5,CHEMBL244946,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1cc(-c2nnc(SCCCN3CCc4ccc(-c5ccn[nH]5)cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,CHEMBL895483,Ki,6.5,CHEMBL244946,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTPgammaS from human recombinant dopamine D2 receptor expressed in CHO cells after 30 mins at 10 uM,55,851,c1cc(-c2nnc(SCCCN3CCc4ccc(-c5ccn[nH]5)cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,CHEMBL895485,Ki,5.02,CHEMBL244946,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Binding affinity to human recombinant dopamine D2,55,852,c1cc(-c2nnc(SCCCN3CCc4ccc(-c5ccn[nH]5)cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)nn6C)cc5CC4)n3C)cccc2n1,CHEMBL931096,Ki,6.5,CHEMBL244946,2008,CHEMBL1143157,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,60,853,c1cc(-c2nnc(SCCCN3CCc4ccc(-c5ccn[nH]5)cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)on6)cc5CC4)n3C)cccc2n1,CHEMBL895462,Ki,6.0,CHEMBL243707,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1cc(-c2nnc(SCCCN3CCc4ccc(-c5ccon5)cc4CC3)[nH]2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(-c3nnc(SCCCN4C[C@@H]5C[C@]5(c5ccc(C(F)(F)F)cc5)C4)n3C)cccc2n1,CHEMBL1107668,Ki,6.2,CHEMBL1081685,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cccc5ncccc45)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)cccc2n1,CHEMBL674348,Ki,6.7,CHEMBL3084598,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc2ncccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)ccc(F)c2n1,CHEMBL674348,Ki,6.1,CHEMBL2113363,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc2ncccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)cccc2n1,CHEMBL674348,Ki,6.5,CHEMBL3084599,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc2ncccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(N3CCN(CCc4ccc5c(c4)NC(=O)CO5)CC3)cccc2n1,CHEMBL990622,Ki,6.5,CHEMBL490417,2008,CHEMBL1142481,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at dopamine D2 receptor,60,854,O=C1COc2ccc(CCN3CCN(c4cccc5ncccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(N3CCN(CCc4cccc(-n5cccn5)c4)CC3)cccc2n1,CHEMBL1635455,Ki,6.4,CHEMBL1631545,2010,CHEMBL1629528,J Med Chem,Scientific Literature,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,72,123,c1cc(CCN2CCN(c3cccc4ncccc34)CC2)cc(-n2cccn2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(N3CCN(CCc4cccc(N5CCNC5=O)c4)CC3)cccc2n1,CHEMBL1635455,Ki,6.3,CHEMBL1631540,2010,CHEMBL1629528,J Med Chem,Scientific Literature,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,72,123,O=C1NCCN1c1cccc(CCN2CCN(c3cccc4ncccc34)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(N3CCN(CCc4cccc(N5CCOC5=O)c4)CC3)cccc2n1,CHEMBL1635455,Ki,6.1,CHEMBL1631542,2010,CHEMBL1629528,J Med Chem,Scientific Literature,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,72,123,O=C1OCCN1c1cccc(CCN2CCN(c3cccc4ncccc34)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(N3CCN(CCc4cccc(NC(=O)Nc5ccccc5)c4)CC3)cccc2n1,CHEMBL1635455,Ki,7.1,CHEMBL1632223,2010,CHEMBL1629528,J Med Chem,Scientific Literature,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,72,123,O=C(Nc1ccccc1)Nc1cccc(CCN2CCN(c3cccc4ncccc34)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(N3CCN(CCc4cccc(NC(=O)c5ccccc5)c4)CC3)cccc2n1,CHEMBL1635455,Ki,6.4,CHEMBL1632210,2010,CHEMBL1629528,J Med Chem,Scientific Literature,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,72,123,O=C(Nc1cccc(CCN2CCN(c3cccc4ncccc34)CC2)c1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(N3CCN(CCc4cccc(NC(=O)c5cnccn5)c4)CC3)cccc2n1,CHEMBL1635455,Ki,6.7,CHEMBL1632217,2010,CHEMBL1629528,J Med Chem,Scientific Literature,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,72,123,O=C(Nc1cccc(CCN2CCN(c3cccc4ncccc34)CC2)c1)c1cnccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(N3CCN(CCc4cccc(NS(C)(=O)=O)c4)CC3)cccc2n1,CHEMBL1635455,Ki,6.4,CHEMBL1631535,2010,CHEMBL1629528,J Med Chem,Scientific Literature,Binding affinity to human recombinant dopamine D2 receptor by radioligand displacement assay,72,123,c1ccc(CCN2CCN(c3cccc4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(OCCN3CCC(Cc4cc(F)c5c(c4)NC(=O)CO5)CC3)cc(Cl)cc2n1,CHEMBL885603,Ki,5.6,CHEMBL238732,2007,CHEMBL1139046,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,55,855,O=C1COc2ccc(CC3CCN(CCOc4cccc5ncccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(Cl)cc2n1,CHEMBL885603,Ki,5.5,CHEMBL391661,2007,CHEMBL1139046,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,55,855,O=C1COc2ccc(CC3CCN(CCOc4cccc5ncccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(OCCN3CCC(Cc4cc5c(cc4F)OCC(=O)N5)CC3)cc(F)cc2n1,CHEMBL885603,Ki,5.7,CHEMBL238520,2007,CHEMBL1139046,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,55,855,O=C1COc2ccc(CC3CCN(CCOc4cccc5ncccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4)NC(=O)CO5)CC3)cccc2n1,CHEMBL885603,Ki,5.9,CHEMBL183460,2007,CHEMBL1139046,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,55,855,O=C1COc2ccc(CC3CCN(CCOc4cccc5ncccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(Cl)cc2n1,CHEMBL885603,Ki,5.9,CHEMBL238519,2007,CHEMBL1139046,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,55,855,O=C1COc2ccc(CC3CCN(CCOc4cccc5ncccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(OCCN3CCC(Cc4ccc5c(c4F)NC(=O)CO5)CC3)cc(F)cc2n1,CHEMBL885603,Ki,5.9,CHEMBL393539,2007,CHEMBL1139046,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human cloned D2 receptor expressed in CHO cells,55,855,O=C1COc2ccc(CC3CCN(CCOc4cccc5ncccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(OCCN3CCC(Cc4cccc(N5CCCS5(=O)=O)c4)CC3)cccc2n1,CHEMBL954061,Ki,6.3,CHEMBL522708,2008,CHEMBL1150291,J Med Chem,Scientific Literature,Displacement of radioligand from human cloned dopamine D2 receptor,60,856,O=S1(=O)CCCN1c1cccc(CC2CCN(CCOc3cccc4ncccc34)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(OCCN3CCC(Cc4cccc(NS(C)(=O)=O)c4)CC3)cccc2n1,CHEMBL954061,Ki,7.2,CHEMBL497963,2008,CHEMBL1150291,J Med Chem,Scientific Literature,Displacement of radioligand from human cloned dopamine D2 receptor,60,856,c1ccc(CC2CCN(CCOc3cccc4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(OCCN3CCN(Cc4cccc5cccnc45)CC3)cccc2n1,CHEMBL838639,Ki,5.5,CHEMBL425190,2005,CHEMBL1139504,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2,41,857,c1cnc2c(CN3CCN(CCOc4cccc5ncccc45)CC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)C(=O)N(CCCCCN1CC=C(c3c[nH]c4ccc(F)cc34)CC1)C2=O,CHEMBL671418,Ki,7.7,CHEMBL340220,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,35,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)C(=O)N(CCCCCN1CC=C(c3c[nH]c4ccccc34)CC1)C2=O,CHEMBL671418,Ki,7.4,CHEMBL130261,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,35,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2,CHEMBL4671577,Ki,7.2,CHEMBL4745124,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1ccccc1N2,CHEMBL4671577,Ki,6.09,CHEMBL4793813,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)C(N1CCN(C)CC1)=Nc1cccnc1N2,CHEMBL673081,Ki,5.23,CHEMBL63329,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,30,551,c1cnc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)C(N1CCN(CCc3ccccc3)CC1)=Nc1cccnc1N2,CHEMBL673081,Ki,6.2,CHEMBL422310,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,31,551,c1ccc(CCN2CCN(C3=Nc4cccnc4Nc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)C(NC1CC3CCC(C1)N3Cc1ccccc1)=Nc1cccnc1N2,CHEMBL673081,Ki,6.83,CHEMBL148694,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,31,551,c1ccc(CN2C3CCC2CC(NC2=Nc4cccnc4Nc4ccccc42)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)C(NC1CCN(C)CC1)=Nc1cccnc1N2,CHEMBL673081,Ki,5.59,CHEMBL347959,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,31,551,c1cnc2c(c1)N=C(NC1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)C(NC1CCN(Cc3ccccc3)CC1)=Nc1cccnc1N2,CHEMBL673081,Ki,6.74,CHEMBL358657,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,31,551,c1ccc(CN2CCC(NC3=Nc4cccnc4Nc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)CCN2C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,5.77,CHEMBL106998,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,31,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)N(C(=O)CN1CCN(Cc3ccc(Cl)cc3)CC1)C(C)(C)CC2C,CHEMBL872882,Ki,5.71,CHEMBL107338,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,31,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)N(C(=O)CN1CCN(Cc3ccc(Cl)cc3)CC1)CC2,CHEMBL872882,Ki,5.2,CHEMBL105595,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,31,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)N1OC(CN(C)C)CC1c1ccccc1C2,CHEMBL672501,IC50,7.26,CHEMBL85735,2002,CHEMBL1135381,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for human cloned Dopamine receptor D2L,31,520,c1ccc2c(c1)Cc1ccccc1N1OCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)N=C(C1=CCN(C)CC1)c1cc(C)ccc1N2,CHEMBL4816284,Ki,6.16,CHEMBL4865663,2021,CHEMBL4813978,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells assessed as inhibition of dopamine-induced calcium accumulation,151,449,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)N=C(C1=CCN(C)CC1)c1cc(F)ccc1N2,CHEMBL4816284,Ki,6.35,CHEMBL4873426,2021,CHEMBL4813978,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells assessed as inhibition of dopamine-induced calcium accumulation,151,449,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)N=C(C1=CCNCC1)c1cc(F)ccc1N2,CHEMBL4816284,Ki,6.07,CHEMBL4856628,2021,CHEMBL4813978,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells assessed as inhibition of dopamine-induced calcium accumulation,151,449,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)N=C(C1=C[C@H](C)N(C)CC1)c1cc(Cl)ccc1N2,CHEMBL4671577,Ki,7.01,CHEMBL4756254,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)N=C(C1=C[C@H](C)N(C)CC1)c1cc(F)ccc1N2,CHEMBL4671577,Ki,6.34,CHEMBL4776090,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)N=C(C1=C[C@H](C)N(C)CC1)c1cc(OC(F)(F)F)ccc1N2,CHEMBL4671577,Ki,5.91,CHEMBL4797375,2020,CHEMBL4665835,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,144,488,C1=C(C2=Nc3ccccc3Nc3ccccc32)CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)Oc1sc(Cl)cc1C(N1CCN(CC(C)(C)C(=O)O)CC1)=N2,CHEMBL3889270,Ki,5.56,CHEMBL3899169,2016,CHEMBL3887018,,BindingDB Patent Bioactivity Data,"Binding Assay or Functional Activity Assay: Further, the compounds of the invention may be tested in binding assays and functional activity assays by well known methods for other physiologically important receptors such as, but not limited to, the hERG channel, other serotonin receptors (specifically 5-HT1B, 5-HT1D, receptors, lack of agonist activity at 5-HT2B receptors, 5-HT2C, 5-HT5, 5-HT6, and 5-HT7 receptors), dopaminergic receptors (specifically D1, D2, and D3), GABAA receptors, adrenergic receptors and monoamine transporters.",118,858,c1ccc2c(c1)N=C(N1CCNCC1)c1ccsc1O2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2,CHEMBL1936228,Ki,6.52,CHEMBL319707,2012,CHEMBL1932931,Eur J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor,83,499,c1ccc2c(c1)CCC1NCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)c1c(n2/C=C\c2ccccc2)CCN(C)C1,CHEMBL1038007,Ki,7.46,CHEMBL605405,2010,CHEMBL1153163,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells,72,859,C(=Cn1c2c(c3ccccc31)CNCC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1,CHEMBL1038007,Ki,6.2,CHEMBL589390,2010,CHEMBL1153163,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells,72,859,c1cncc(CCn2c3c(c4ccccc42)CNCC3)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)c1c(n2CCc2ccc(C)nc2)CCN(C)C1,CHEMBL5442215,Ki,5.81,CHEMBL589390,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,c1cncc(CCn2c3c(c4ccccc42)CNCC3)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1)c1c(n2CCc2ccccc2)CCN(C)C1,CHEMBL1038007,Ki,7.07,CHEMBL592752,2010,CHEMBL1153163,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells,72,859,c1ccc(CCn2c3c(c4ccccc42)CNCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1O)-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670676,Ki,5.97,CHEMBL53510,1995,CHEMBL1128704,J Med Chem,Scientific Literature,Ability to displace [3H]raclopride binding to cloned human Dopamine receptor D2A,6,633,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(c1O)-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670885,Ki,5.97,CHEMBL53510,1996,CHEMBL1129624,J Med Chem,Scientific Literature,In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement.,9,135,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c(n1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21,CHEMBL672175,Ki,5.85,CHEMBL27117,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,18,290,c1ccc2c(c1)CCC1NCc3ncccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(Cl)cc1)CC3,CHEMBL5232011,Ki,5.93,CHEMBL89921,2021,CHEMBL5230136,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor assessed as inhibition constant,151,735,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccc(Cl)cc1)CC3,CHEMBL671369,Ki,5.93,CHEMBL89921,1997,CHEMBL1130121,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,11,586,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccccc1)CC3,CHEMBL5232011,Ki,6.11,CHEMBL92489,2021,CHEMBL5230136,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor assessed as inhibition constant,151,735,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c3c(c(=O)oc2c1)CN(Cc1ccccc1)CC3,CHEMBL671369,Ki,6.11,CHEMBL92489,1997,CHEMBL1130121,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,11,586,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c3c(ccc2n1)OC[C@H](CN1CCN(c2ccc4cc(C#N)ccc4n2)CC1)O3,CHEMBL1062991,Ki,5.88,CHEMBL551964,2009,CHEMBL1151947,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,65,860,c1ccc2nc(N3CCN(CC4COc5ccc6ncccc6c5O4)CC3)ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2c3c1-c1c(ccc(O)c1O)C[C@H]3N(C)CC2,CHEMBL2399862,Ki,7.27,CHEMBL2397380,2013,CHEMBL2396540,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,92,542,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2cc(-c3nnc(SCCCN4CCc5ccc(-c6cc(C)on6)cc5CC4)n3C)ccc2n1,CHEMBL895462,Ki,5.7,CHEMBL395741,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1cnc2ccc(-c3nnc(SCCCN4CCc5ccc(-c6ccon6)cc5CC4)[nH]3)cc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2nc(-c3ccc(OCCCCN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cn2c1,CHEMBL895394,Ki,6.83,CHEMBL231183,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,55,795,c1ccc(N2CCN(CCCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2nc(CCCN3CCC(c4ccccn4)CC3)sc2c1,CHEMBL5324908,Ki,5.16,CHEMBL5399689,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,158,704,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2nc(CCCN3CCC(c4ccccn4)CC3)sc2c1,CHEMBL5324912,IC50,6.14,CHEMBL5399689,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,158,705,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2nc(CCCN3CCC(c4ccccn4)CC3)sc2c1,CHEMBL5324922,IC50,5.56,CHEMBL5399689,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,158,706,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2nc(CCCN3CCN(c4ccccn4)CC3)sc2c1,CHEMBL5324908,Ki,4.3,CHEMBL5403610,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,158,704,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2nc(CCCN3CCN(c4ccccn4)CC3)sc2c1,CHEMBL5324912,IC50,5.44,CHEMBL5403610,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,158,705,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2nc(CCCN3CCN(c4ccccn4)CC3)sc2c1,CHEMBL5324922,IC50,4.81,CHEMBL5403610,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,158,706,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1,CHEMBL4880035,Ki,5.380000000000001,CHEMBL3480577,2021,CHEMBL4507309,,SGC Frankfurt - Donated Chemical Probes,GPCRScan assay: inhibition of D2,151,144,c1ccc(OCCCNCc2ccc3ccccc3n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2sc(S(=O)(=O)N[C@@H]3CCN(CCCc4noc5ccccc45)C3)cc2c1,CHEMBL4685403,Ki,8.76,CHEMBL4748379,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccc2sc(S(=O)(=O)N[C@H]3CCN(CCCc4noc5ccccc45)C3)cc2c1,CHEMBL4685403,Ki,7.62,CHEMBL4784414,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(-c2c(O)c(O)cc3c2CCN(C)CC3c2cccc(C)c2)c1,CHEMBL993385,Ki,6.68,CHEMBL484538,2008,CHEMBL1142503,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,60,861,c1ccc(-c2cccc3c2CCNCC3c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(-c2ccc(C(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)n1,CHEMBL3705175,IC50,5.89,CHEMBL398175,2014,CHEMBL3638880,,BindingDB Patent Bioactivity Data,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",101,759,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(-c2ccc(C(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)n1,CHEMBL895648,Ki,6.98,CHEMBL398175,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,55,126,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(-c2ccc(C(=O)NC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2)n1,CHEMBL895651,IC50,5.89,CHEMBL398175,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,55,760,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1,CHEMBL1261591,Ki,8.47,CHEMBL1259063,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,72,108,c1ccc(-c2ccc3c(c2)C(N2CCNCC2)Cc2ccccc2S3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(-c2ccc3c(c2)C(N2CCN(C)CC2)Cc2ccccc2S3)c1C,CHEMBL1261591,Ki,8.7,CHEMBL1259080,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,72,108,c1ccc(-c2ccc3c(c2)C(N2CCNCC2)Cc2ccccc2S3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(-c2cccc(CN3CCN(c4cccc5nc(O)oc45)CC3)c2)c1,CHEMBL672308,Ki,8.03,CHEMBL305834,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,25,593,c1ccc(-c2cccc(CN3CCN(c4cccc5ncoc45)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(=O)n1CCCCN1CCN(c2cc(C(F)(F)F)nc(C(C)(C)C)n2)CC1,CHEMBL862319,Ki,6.71,CHEMBL203943,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,48,141,O=c1ccccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C#N)c1-c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL673593,Ki,5.955,CHEMBL28056,2001,CHEMBL1134402,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,25,247,c1ccc(-c2cccc3c2-c2cccc4c2C(C3)NCC4)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C(=O)NCN2CCC(c3ccccc3)CC2)c1,CHEMBL910434,Ki,6.63,CHEMBL220189,2006,CHEMBL1137302,J Med Chem,Scientific Literature,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,48,635,O=C(NCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C(=O)NCN2CCC(c3ccccn3)CC2)c1,CHEMBL910422,Ki,5.46,CHEMBL216794,2006,CHEMBL1137302,J Med Chem,Scientific Literature,Agonist activity at human D2 receptor in HEK293 cells coexpressing G-alpha-qo5 by FLIPR,48,862,O=C(NCN1CCC(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C(=O)NCN2CCC(c3ccccn3)CC2)c1,CHEMBL910434,Ki,5.46,CHEMBL216794,2006,CHEMBL1137302,J Med Chem,Scientific Literature,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,48,635,O=C(NCN1CCC(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1,CHEMBL4323478,Ki,5.64,CHEMBL45244,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,137,70,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1,CHEMBL4323479,Ki,5.96,CHEMBL45244,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,137,71,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1,CHEMBL671981,Ki,5.43,CHEMBL45244,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,11,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1,CHEMBL672163,Ki,5.43,CHEMBL45244,2001,CHEMBL1133786,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2,25,863,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C(=O)NCN2CCN(c3ccccc3C#N)CC2)c1,CHEMBL835392,Ki,5.55,CHEMBL45244,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,41,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C(=O)NCN2CCN(c3ccccc3Cl)CC2)c1,CHEMBL671981,Ki,5.88,CHEMBL298166,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,11,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C(=O)NCN2CCN(c3ccccc3Cl)CC2)c1,CHEMBL835392,Ki,6.33,CHEMBL298166,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,41,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)c1,CHEMBL870468,Ki,6.29,CHEMBL213793,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,48,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C)c1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2,CHEMBL1261591,Ki,8.34,CHEMBL1259097,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,72,108,c1ccc(-c2ccc3c(c2)C(N2CCNCC2)Cc2ccccc2S3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL870468,Ki,6.54,CHEMBL213336,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,48,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL870474,Ki,6.54,CHEMBL213336,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at dopamine D2 receptor,48,566,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL911524,Ki,6.54,CHEMBL213336,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,48,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C2CN(C)CCc3c2cc(O)c(O)c3-c2ccc3ccccc3c2)c1,CHEMBL993385,Ki,7.54,CHEMBL520821,2008,CHEMBL1142503,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,60,861,c1ccc(C2CNCCc3c(-c4ccc5ccccc5c4)cccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(C2CN(CCCc3cn(CCCN4CCN(c5nsc6ccccc56)CC4)nn3)CCc3cc(O)c(O)cc32)c1,CHEMBL1041331,Ki,6.7,CHEMBL585741,2009,CHEMBL1154108,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor expressed in HEK293 cells by liquid scintillation counting,65,802,c1ccc(C2CN(CCCc3cn(CCCN4CCN(c5nsc6ccccc56)CC4)nn3)CCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(CN2CCC(CC(=O)N3c4ccccc4CC3C)CC2)c1,CHEMBL872891,Ki,6.78,CHEMBL105011,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",31,214,O=C(CC1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(CN2CCC(n3c(O)nc(-c4ccccc4)c3C)CC2)c1,CHEMBL671375,Ki,7.02,CHEMBL92859,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL870468,Ki,5.99,CHEMBL213424,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human dopamine D2 receptor expressed in CHO cells,48,262,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL870474,Ki,5.99,CHEMBL213424,2006,CHEMBL1146871,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at dopamine D2 receptor,48,566,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)n4C)CC32)c1,CHEMBL3776608,Ki,6.5,CHEMBL3775836,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCC(=O)NCc3nc4cc(F)ccc4c(=O)n3-c3ccccc3)CC2)c1C,CHEMBL920904,IC50,5.82,CHEMBL261102,2008,CHEMBL1144677,Bioorg Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,60,489,O=C(CCCN1CCN(c2ccccc2)CC1)NCc1nc2ccccc2c(=O)n1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCC(=O)NCc3nc4ccc(F)cc4c(=O)n3-c3ccccc3)CC2)c1C,CHEMBL920904,IC50,5.4,CHEMBL261434,2008,CHEMBL1144677,Bioorg Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,60,489,O=C(CCCN1CCN(c2ccccc2)CC1)NCc1nc2ccccc2c(=O)n1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCC(=O)NCc3nc4ccccc4c(=O)n3-c3ccccc3)CC2)c1C,CHEMBL920904,IC50,5.16,CHEMBL259415,2008,CHEMBL1144677,Bioorg Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,60,489,O=C(CCCN1CCN(c2ccccc2)CC1)NCc1nc2ccccc2c(=O)n1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCNC(=O)[C@H]3CCc4ccccc4N3)CC2)c1,CHEMBL3381713,Ki,5.47,CHEMBL3358506,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),101,574,O=C(NCCCCN1CCN(c2ccccc2)CC1)C1CCc2ccccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4cn3)CC2)c1,CHEMBL3381713,Ki,6.54,CHEMBL3358100,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),101,574,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2cn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1,CHEMBL3381713,Ki,6.58,CHEMBL496739,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),101,574,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1,CHEMBL959903,IC50,6.23,CHEMBL496739,2009,CHEMBL1139353,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells by [35S]GTPgammaS binding assay,65,864,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1,CHEMBL959904,IC50,5.91,CHEMBL496739,2009,CHEMBL1139353,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2S receptor expressed in CHO cells by [35S]GTPgammaS binding assay,65,865,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCNC(=O)c3cc4ccccc4o3)CC2)c1C,CHEMBL3381713,Ki,7.07,CHEMBL3358493,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),101,574,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCNC(=O)c3ccc(-c4ccsc4)cc3)CC2)c1,CHEMBL4350893,Ki,4.79,CHEMBL4438630,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",137,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)c1C,CHEMBL3762401,Ki,6.52,CHEMBL3758741,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,118,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1C,CHEMBL1225816,Ki,7.92,CHEMBL1223682,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,72,794,c1ccc(N2CCN(CCCCNc3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCOc3ccc4c(c3)NC(=O)CC4)CC2)c1C,CHEMBL2169117,Ki,8.09,CHEMBL160744,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,83,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCOc3ccc4c(n3)NC(=O)CC4)CC2)c1C,CHEMBL1776016,Ki,8.6,CHEMBL1774071,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,79,830,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCOc3ccc4c(n3)NC(=O)CC4)CC2)c1Cl,CHEMBL1776016,Ki,9.0,CHEMBL1774069,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,79,830,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCCn3c(C)cn4c5c(=O)n(C)c(=O)n(C)c5nc34)CC2)c1C,CHEMBL3423552,Ki,7.57,CHEMBL3423339,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,111,866,O=c1[nH]c(=O)c2c(nc3n(CCCCN4CCN(c5ccccc5)CC4)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCN3C(=O)CCc4ccccc43)CC2)c1,CHEMBL5106582,Ki,5.84,CHEMBL5170580,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,154,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCCNC(=O)c3cn[nH]c3C)CC2)c1,CHEMBL4137914,Ki,5.79,CHEMBL3461530,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cn[nH]c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1,CHEMBL1044430,Ki,6.6,CHEMBL560270,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,65,233,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCN(C)C[C@]34CC[C@H](CC3)C4(C)C)C2=O)c1,CHEMBL1059864,Ki,6.6,CHEMBL560270,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,65,234,O=C1N(CCNCC23CCC(CC2)C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCN3CCCCCC3)C2=O)c1,CHEMBL1106075,Ki,7.6,CHEMBL1081311,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,72,556,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4cccs4)CC3)CC2)c1,CHEMBL671651,Ki,8.2,CHEMBL80875,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,11,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)c1C,CHEMBL3073105,Ki,7.29,CHEMBL184770,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),92,427,c1ccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)c1C,CHEMBL838638,Ki,7.29,CHEMBL184770,2004,CHEMBL1137161,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2,38,598,c1ccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CCN2CCC(c3ccccn3)CC2)c1,CHEMBL4392163,Ki,5.23,CHEMBL4464861,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,137,500,O=C(CCN1CCC(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CCN2CCC(c3ccccn3)CC2)c1,CHEMBL4392168,Ki,7.09,CHEMBL4464861,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H](R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by scintillation counting method,137,503,O=C(CCN1CCC(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CCN2CCC(c3ccccn3)CC2)c1,CHEMBL4392186,IC50,5.12,CHEMBL4464861,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,137,502,O=C(CCN1CCC(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CCN2CCN(c3ccccn3)CC2)c1,CHEMBL4392163,Ki,4.92,CHEMBL4454068,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,137,500,O=C(CCN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CCN2CCN(c3ccccn3)CC2)c1,CHEMBL4392168,Ki,6.7,CHEMBL4454068,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H](R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by scintillation counting method,137,503,O=C(CCN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CCN2CCN(c3ccccn3)CC2)c1,CHEMBL4392186,IC50,5.15,CHEMBL4454068,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,137,502,O=C(CCN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CCN2CCN(c3ncccn3)CC2)c1,CHEMBL4392163,Ki,5.73,CHEMBL4588808,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,137,500,O=C(CCN1CCN(c2ncccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CCN2CCN(c3ncccn3)CC2)c1,CHEMBL4392168,Ki,5.83,CHEMBL4588808,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H](R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by scintillation counting method,137,503,O=C(CCN1CCN(c2ncccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CCN2CCN(c3ncccn3)CC2)c1,CHEMBL4392186,IC50,4.93,CHEMBL4588808,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,137,502,O=C(CCN1CCN(c2ncccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCC(c3ccc(Cl)cc3)CC2)c1,CHEMBL4392176,IC50,4.15,CHEMBL4436479,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,137,501,O=C(CN1CCC(c2ccccc2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCC(c3ccccc3)CC2)c1,CHEMBL4392163,Ki,6.09,CHEMBL216393,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,137,500,O=C(CN1CCC(c2ccccc2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCC(c3ccccc3)CC2)c1,CHEMBL4392168,Ki,6.9,CHEMBL216393,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H](R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by scintillation counting method,137,503,O=C(CN1CCC(c2ccccc2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCC(c3ccccc3)CC2)c1,CHEMBL4392176,IC50,4.78,CHEMBL216393,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,137,501,O=C(CN1CCC(c2ccccc2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCC(c3ccccc3)CC2)c1,CHEMBL4392186,IC50,5.11,CHEMBL216393,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,138,502,O=C(CN1CCC(c2ccccc2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1,CHEMBL4392163,Ki,5.2,CHEMBL375596,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,138,500,O=C(CN1CCC(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1,CHEMBL4392168,Ki,6.6,CHEMBL375596,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H](R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by scintillation counting method,138,503,O=C(CN1CCC(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1,CHEMBL4392186,IC50,5.23,CHEMBL375596,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,138,502,O=C(CN1CCC(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCC(c3ccccn3)CC2)c1,CHEMBL910434,Ki,5.54,CHEMBL375596,2006,CHEMBL1137302,J Med Chem,Scientific Literature,Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane,48,635,O=C(CN1CCC(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCN(c3ccc(Cl)cn3)CC2)c1,CHEMBL4392176,IC50,4.18,CHEMBL4572245,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,138,501,O=C(CN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCN(c3cccc4ccccc34)CC2)c1,CHEMBL4392163,Ki,5.83,CHEMBL4473652,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,138,500,O=C(CN1CCN(c2cccc3ccccc23)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCN(c3cccc4ccccc34)CC2)c1,CHEMBL4392168,Ki,6.7,CHEMBL4473652,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H](R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by scintillation counting method,138,503,O=C(CN1CCN(c2cccc3ccccc23)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCN(c3cccc4ccccc34)CC2)c1,CHEMBL4392176,IC50,4.17,CHEMBL4473652,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,138,501,O=C(CN1CCN(c2cccc3ccccc23)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCN(c3ccccn3)CC2)c1,CHEMBL4392168,Ki,5.48,CHEMBL4448320,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H](R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by scintillation counting method,138,503,O=C(CN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCN(c3ccccn3)CC2)c1,CHEMBL4392186,IC50,4.8,CHEMBL4448320,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,138,502,O=C(CN1CCN(c2ccccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCN(c3ncccn3)CC2)c1,CHEMBL4392163,Ki,5.19,CHEMBL4443054,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by scintillation counting method,138,500,O=C(CN1CCN(c2ncccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCN(c3ncccn3)CC2)c1,CHEMBL4392168,Ki,5.62,CHEMBL4443054,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Displacement of [3H](R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by scintillation counting method,138,503,O=C(CN1CCN(c2ncccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(NC(=O)CN2CCN(c3ncccn3)CC2)c1,CHEMBL4392186,IC50,4.6,CHEMBL4443054,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 90 mins by luminescence assay,138,502,O=C(CN1CCN(c2ncccn2)CC1)Nc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(O)c1-c1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL673593,Ki,5.535,CHEMBL26907,2001,CHEMBL1134402,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,25,247,c1ccc(-c2cccc3c2-c2cccc4c2C(C3)NCC4)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(OCCNCCCOc2ccccc2)c1,CHEMBL671378,Ki,7.21,CHEMBL128232,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,11,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(OCCNCCCOc2ccccc2)c1,CHEMBL835389,Ki,7.21,CHEMBL128232,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(OCCOCCN2CCN(CCc3ccccc3)CC2)c1C,CHEMBL4195136,Ki,5.92,CHEMBL4217761,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,131,717,c1ccc(CCN2CCN(CCOCCOc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(OCc2nc(N)nc(N3CCN(C)CC3)n2)c1,CHEMBL4366763,Ki,6.13,CHEMBL4532712,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,138,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)CC2CCN(CCCc3noc4cc(F)ccc34)C2)c1,CHEMBL5046640,Ki,7.03,CHEMBL5080305,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,151,530,O=S(=O)(CC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)N(C)[C@H](C)CCN2CCC(C)CC2)c1,CHEMBL670659,Ki,5.4,CHEMBL12264,1998,CHEMBL1131479,J Med Chem,Scientific Literature,The compound was tested for its binding affinity towards cloned human Dopamine receptor D2 in CHO cells using [125I]iodosulpiride.,14,867,O=S(=O)(NCCCN1CCCCC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)N(C)[C@H](C)CCN2CCC(C)CC2)c1,CHEMBL673593,Ki,5.4,CHEMBL12264,2001,CHEMBL1134402,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,25,247,O=S(=O)(NCCCN1CCCCC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)N2CCC[C@@H]2CCN2CCC(C)CC2)c1,CHEMBL674938,Ki,5.8,CHEMBL12624,2000,CHEMBL1133573,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2. (human cloned receptor) in CHO cells using [125I]iodosulpiride radioligand.,23,868,O=S(=O)(c1ccccc1)N1CCCC1CCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCCN2CC=C(c3c(C)[nH]c4ccc(Cl)cc34)CC2)c1,CHEMBL4041093,Ki,7.25,CHEMBL4099997,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,126,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCCN2CC=C(c3c[nH]c4ccc(Cl)cc34)CC2)c1,CHEMBL4041093,Ki,8.6,CHEMBL4080369,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,126,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCCN2CC=C(c3c[nH]c4ccc(F)cc34)CC2)c1,CHEMBL4041093,Ki,8.52,CHEMBL4075673,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,126,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,CHEMBL3297244,Ki,7.77,CHEMBL3289992,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,101,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCCN2CCN(c3noc4ccccc34)CC2)c1,CHEMBL3297244,Ki,7.36,CHEMBL3289968,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,101,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCCN2CCN(c3nsc4ccccc34)CC2)c1,CHEMBL3297244,Ki,8.06,CHEMBL3289944,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,101,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCN2CC=C(c3c(C)[nH]c4ccc(Cl)cc34)CC2)c1,CHEMBL4041093,Ki,7.17,CHEMBL4081987,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,126,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCN2CC=C(c3c[nH]c4ccc(Cl)cc34)CC2)c1,CHEMBL4041093,Ki,8.26,CHEMBL4077040,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,126,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCN2CC=C(c3c[nH]c4ccc(F)cc34)CC2)c1,CHEMBL4041093,Ki,7.77,CHEMBL4060649,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,126,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,CHEMBL3297244,Ki,7.8,CHEMBL3289991,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,101,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCN2CCN(c3noc4ccccc34)CC2)c1,CHEMBL3297244,Ki,5.7,CHEMBL3289967,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,101,833,O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCCN2CCN(c3nsc4ccccc34)CC2)c1,CHEMBL3297244,Ki,7.89,CHEMBL3289709,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,101,833,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCN2CC=C(c3c(C)[nH]c4ccc(Cl)cc34)CC2)c1,CHEMBL4041093,Ki,6.46,CHEMBL4104596,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,126,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCN2CC=C(c3c[nH]c4ccc(Cl)cc34)CC2)c1,CHEMBL4041093,Ki,8.48,CHEMBL4065568,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,126,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCN2CC=C(c3c[nH]c4ccc(F)cc34)CC2)c1,CHEMBL4041093,Ki,7.7,CHEMBL4078873,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,126,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,CHEMBL3297244,Ki,7.7,CHEMBL3289990,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,101,833,O=S(=O)(NCCN1CCC(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)NCCN2CCN(c3nsc4ccccc34)CC2)c1,CHEMBL3297244,Ki,7.37,CHEMBL3289708,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,101,833,O=S(=O)(NCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)N[C@@H]2CCN(CCCc3noc4ccccc34)C2)c1,CHEMBL4685403,Ki,7.5,CHEMBL4750664,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)N[C@H]2CCN(CCCc3noc4ccccc34)C2)c1,CHEMBL4685403,Ki,6.98,CHEMBL4779739,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc(S(=O)(=O)n2ccc3c(N4CCNCC4)nc4ccccc4c32)c1,CHEMBL4844536,Ki,5.67,CHEMBL4870374,2021,CHEMBL4842371,J Med Chem,Scientific Literature,Displacement of [3H]-haloperidol from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,151,869,O=S(=O)(c1ccccc1)n1ccc2c(N3CCNCC3)nc3ccccc3c21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c(C3=CCN(CCCCCN4C(=O)c5ccccc5C4=O)CC3)c[nH]c12,CHEMBL671418,Ki,7.4,CHEMBL422618,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,35,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c(CCCN3CCN(c4cccc5c4OCCO5)CC3)c[nH]c12,CHEMBL872394,Ki,7.8,CHEMBL372735,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c(CCNCc3cccc(CCNC[C@H](O)c4ccc(O)c5[nH]c(=O)sc45)c3)c[nH]c12,CHEMBL1947794,IC50,6.4,CHEMBL1945031,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,83,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCCc4c[nH]c5ccccc45)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL671731,Ki,5.31,CHEMBL423247,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,31,45,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL671732,Ki,5.3,CHEMBL423247,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL913685,Ki,5.31,CHEMBL423247,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,55,44,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL664743,Ki,6.7,CHEMBL27940,2000,CHEMBL1132996,J Med Chem,Scientific Literature,Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride,23,335,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c1-c1cccc3c1[C@@H](C2)N(C)CC3,CHEMBL670880,Ki,6.7,CHEMBL27940,1996,CHEMBL1129625,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human Dopamine receptor D2A,9,99,c1ccc2c(c1)CC1NCCc3cccc-2c31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c1C(=O)N(CCCCCN1CC=C(c3c[nH]c4ccc(F)cc34)CC1)C2=O,CHEMBL671418,Ki,7.6,CHEMBL335259,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,35,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c1C(=O)N(CCCCCN1CC=C(c3c[nH]c4ccccc34)CC1)C2=O,CHEMBL671418,Ki,7.0,CHEMBL129852,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,35,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c1CCN2C(=O)CN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872882,Ki,5.46,CHEMBL321058,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,31,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccc2c1N(C(=O)CN1CCN(Cc3ccc(Cl)cc3)CC1)CC2,CHEMBL872882,Ki,5.33,CHEMBL107229,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,31,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1-c1cc2c(=O)n(CCN3CCN(c4ccccc4Cl)CC3)c(=O)[nH]c2[nH]1,CHEMBL864519,Ki,6.2,CHEMBL200802,2006,CHEMBL1148546,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,48,688,O=c1[nH]c2[nH]c(-c3ccccc3)cc2c(=O)n1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1-c1ccc(C(=O)NCCCCN2CCc3ccc(OS(=O)(=O)C(F)(F)F)cc3C2)cc1,CHEMBL672227,Ki,5.8,CHEMBL54715,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,18,131,O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1-c1ccc2c(c1)C(N1CCN(C)CC1)Cc1ccccc1S2,CHEMBL1261591,Ki,8.8,CHEMBL1259062,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,72,108,c1ccc(-c2ccc3c(c2)C(N2CCNCC2)Cc2ccccc2S3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1C(=O)CCCN1CCC(O)(c2ccc(Cl)cc2)CC1,CHEMBL4416273,Ki,8.45,CHEMBL4475608,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1C(=O)N1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL911524,Ki,5.31,CHEMBL378543,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,48,194,O=C(c1ccccc1)N1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21,CHEMBL911524,Ki,6.76,CHEMBL379942,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,48,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1C(=O)NN1c2ccccc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21,CHEMBL911524,Ki,5.8,CHEMBL385295,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,49,194,O=C(NN1c2ccccc2N=C(N2CCNCC2)c2ccccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1CC1c2ccc(O)cc2CCN1C,CHEMBL1038853,Ki,5.57,CHEMBL594798,2009,CHEMBL1152600,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,65,639,c1ccc(CC2NCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1,CHEMBL939457,IC50,5.29,CHEMBL522460,2008,CHEMBL1152245,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor,61,870,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(Cc3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1,CHEMBL983581,IC50,5.58,CHEMBL522460,2008,CHEMBL1142444,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,61,871,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(Cc3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1CN1CCN(CC(=O)N2c3ccccc3CC2C)CC1,CHEMBL872891,Ki,5.82,CHEMBL104256,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",31,214,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1N1CCC2CN(CCCSc3nnc(-c4cnccn4)n3C)CC21,CHEMBL3776608,Ki,5.5,CHEMBL3774927,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1,CHEMBL894060,Ki,6.84,CHEMBL222755,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,55,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccsc3)cc2)CC1,CHEMBL4350893,Ki,6.72,CHEMBL4587635,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",138,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1,CHEMBL3762401,Ki,6.39,CHEMBL3758881,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,118,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1N1CCN(CCCCNc2ccccn2)CC1,CHEMBL1225816,Ki,7.5,CHEMBL1223681,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,72,794,c1ccc(N2CCN(CCCCNc3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL2169117,Ki,8.23,CHEMBL346129,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,83,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1N1CCN(CCCCOc2ccc3c(n2)NC(=O)CC3)CC1,CHEMBL1776016,Ki,8.3,CHEMBL1774070,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,79,830,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1N1CCN(CCCCc2cc(-c3ccccc3)no2)CC1,CHEMBL672182,Ki,5.19,CHEMBL558036,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,31,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1N1CCN(CCCCc2cc(-c3cccs3)no2)CC1,CHEMBL672182,Ki,5.68,CHEMBL544451,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,31,52,c1ccc(N2CCN(CCCCc3cc(-c4cccs4)no3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1N1CCN(CCCN2C(=O)CCc3ccccc32)CC1,CHEMBL5106582,Ki,6.4,CHEMBL5209074,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,154,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1N1CCN(CC[C@H]2CC[C@H](NC(=O)c3cccs3)CC2)CC1,CHEMBL671651,Ki,8.3,CHEMBL309501,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1OCCNCCCOc1ccccc1,CHEMBL671378,Ki,7.7,CHEMBL128313,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,12,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1OCCNCCCOc1ccccc1,CHEMBL835389,Ki,7.7,CHEMBL128313,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1OCc1nc(N)nc(N2CCN(C)CC2)n1,CHEMBL4366763,Ki,5.37,CHEMBL4570584,2019,CHEMBL4364280,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in human HEK293 cells incubated for 1 hr by radioligand binding assay,138,228,c1ccc(OCc2ncnc(N3CCNCC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccccc1S(=O)(=O)N1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21,CHEMBL911524,Ki,7.2,CHEMBL377452,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,49,194,O=S(=O)(c1ccccc1)N1c2ccccc2N=C(N2CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c1=O,CHEMBL862319,Ki,6.77,CHEMBL203016,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,49,141,O=c1ccccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccn2cc(-c3ccc(OCCCCN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)nc12,CHEMBL895394,Ki,6.25,CHEMBL230218,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,55,795,c1ccc(N2CCN(CCCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccn2cc(-c3ccc(OCCCN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)nc12,CHEMBL895394,Ki,6.9,CHEMBL231080,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,55,795,c1ccc(N2CCN(CCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccn2ncc(CN3CCN(c4ccc(Cl)cc4)CC3)c12,CHEMBL671731,Ki,4.89,CHEMBL156369,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,31,45,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccn2ncc(CN3CCN(c4ccc(Cl)cc4)CC3)c12,CHEMBL671732,Ki,4.92,CHEMBL156369,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccnc1-c1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL3705175,IC50,6.43,CHEMBL244773,2014,CHEMBL3638880,,BindingDB Patent Bioactivity Data,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",101,759,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccnc1-c1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL895648,Ki,7.04,CHEMBL244773,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,55,126,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccnc1-c1ccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)cc1,CHEMBL895651,IC50,6.43,CHEMBL244773,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,55,760,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccnc1C1CCN(CCCc2nc3ccccc3s2)CC1,CHEMBL5324908,Ki,4.88,CHEMBL5394387,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,158,704,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccnc1C1CCN(CCCc2nc3ccccc3s2)CC1,CHEMBL5324912,IC50,5.34,CHEMBL5394387,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,158,705,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cccnc1C1CCN(CCCc2nc3ccccc3s2)CC1,CHEMBL5324922,IC50,5.0,CHEMBL5394387,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,158,706,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)c1,CHEMBL862319,Ki,7.2,CHEMBL382773,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,49,141,O=c1ccccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)n1,CHEMBL862319,Ki,6.51,CHEMBL202253,2006,CHEMBL1146925,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human dopamine D2 receptor,49,141,O=c1ncccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)n1,CHEMBL865866,Ki,6.51,CHEMBL202253,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,49,168,O=c1ncccn1CCCCN1CCN(c2ccncn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccn(CCN2CCC(Cc3ccccc3F)CC2)n1,CHEMBL4137914,Ki,5.65,CHEMBL4161837,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1ccc(CC2CCN(CCn3cccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccn2cc(-c3ccc(OCCCCN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)nc2c1,CHEMBL895394,Ki,6.96,CHEMBL231260,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,55,795,c1ccc(N2CCN(CCCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccn2cc(-c3ccc(OCCCN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)nc2c1,CHEMBL895394,Ki,7.08,CHEMBL231079,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,55,795,c1ccc(N2CCN(CCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccnc(N2CCN(CCCc3nc4ccccc4s3)CC2)c1,CHEMBL5324908,Ki,5.8,CHEMBL5437265,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,158,704,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccnc(N2CCN(CCCc3nc4ccccc4s3)CC2)c1,CHEMBL5324912,IC50,6.2,CHEMBL5437265,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,158,705,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccnc(N2CCN(CCCc3nc4ccccc4s3)CC2)c1,CHEMBL5324922,IC50,5.19,CHEMBL5437265,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,158,706,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL1107668,Ki,6.4,CHEMBL1079639,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4ccco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ccsc1C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL671651,Ki,7.94,CHEMBL309336,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)[nH]c1=O,CHEMBL865866,Ki,6.5,CHEMBL201115,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,49,168,O=c1ccn(CCCCN2CCN(c3ccncn3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c(=O)n(C)c1=O,CHEMBL865866,Ki,6.45,CHEMBL426473,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,49,168,O=c1ccn(CCCCN2CCN(c3ccncn3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cn2c3c(=O)n(C)c(=O)n(C)c3nc2n1CCCCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1,CHEMBL3423552,Ki,7.23,CHEMBL3423340,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,111,866,O=c1[nH]c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5)CC4)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cn2c3c(=O)n(C)c(=O)n(C)c3nc2n1CCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL3423552,Ki,6.97,CHEMBL3423336,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,111,866,O=c1[nH]c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5)CC4)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cn2c3c(=O)n(C)c(=O)n(C)c3nc2n1CCCCCN1CCN(c2ccccc2O)CC1,CHEMBL3423552,Ki,6.33,CHEMBL3423331,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,111,866,O=c1[nH]c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5)CC4)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cn2c3c(=O)n(C)c(=O)n(C)c3nc2n1CCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL3423552,Ki,6.91,CHEMBL3423335,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,111,866,O=c1[nH]c(=O)c2c(nc3n(CCCCN4CCN(c5ccccc5)CC4)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cn2c3c(=O)n(C)c(=O)n(C)c3nc2n1CCCCN1CCN(c2ccccc2O)CC1,CHEMBL3423552,Ki,6.37,CHEMBL3423330,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,111,866,O=c1[nH]c(=O)c2c(nc3n(CCCCN4CCN(c5ccccc5)CC4)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cc5ccccc5[nH]4)n2C)CC3)o1,CHEMBL895462,Ki,6.0,CHEMBL397429,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1ccc2[nH]c(-c3nnc(SCCCN4CCc5ccc(-c6ncco6)cc5CC4)[nH]3)cc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc5[nH]ccc5c4)n2C)CC3)o1,CHEMBL895462,Ki,6.2,CHEMBL244276,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1coc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4ccc5[nH]ccc5c4)[nH]2)CC3)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccn4C)n2C)CC3)o1,CHEMBL895462,Ki,5.9,CHEMBL244277,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1c[nH]c(-c2nnc(SCCCN3CCc4ccc(-c5ncco5)cc4CC3)[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc(-c2ccc3c(c2)CCN(CCCSc2nnc(-c4cccs4)n2C)CC3)o1,CHEMBL895462,Ki,6.6,CHEMBL244275,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,c1csc(-c2nnc(SCCCN3CCc4ccc(-c5ncco5)cc4CC3)[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)c2)o1,CHEMBL674348,Ki,6.5,CHEMBL3084629,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2ncco2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)o1,CHEMBL674348,Ki,6.2,CHEMBL2113357,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2ncco2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)cn1,CHEMBL1107668,Ki,6.3,CHEMBL1079480,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnccn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4CCOCC4)CC3)CC2)c2c1OCC2,CHEMBL3705135,Ki,5.35,CHEMBL3642785,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc(N2CCN(CC[C@H]3CC[C@H](NC(=O)C4CCOCC4)CC3)CC2)c2ccoc12,CHEMBL3705135,Ki,5.95,CHEMBL3642781,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(NC1CCC(CCN2CCN(c3nccc4occc34)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc(N2CCN(CC[C@H]3CC[C@H](NC(=O)CC4CCOCC4)CC3)CC2)c2c1OCC2,CHEMBL3705135,Ki,5.53,CHEMBL3642786,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(CC1CCOCC1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc(N2CCN(CC[C@H]3CC[C@H](NC(=O)CC4CCOCC4)CC3)CC2)c2ccoc12,CHEMBL3705135,Ki,5.57,CHEMBL3642782,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(CC1CCOCC1)NC1CCC(CCN2CCN(c3nccc4occc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cnc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2,CHEMBL672175,Ki,4.92,CHEMBL275379,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,18,290,c1ccc2c(c1)CCC1NCc3ncccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1cncc2c1CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21,CHEMBL672175,Ki,6.4,CHEMBL282136,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,18,290,c1ccc2c(c1)CCC1NCc3ccncc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1coc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)c2)n1,CHEMBL674348,Ki,6.7,CHEMBL3084612,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2ncco2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1csc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc(Cl)c4Cl)CC3)CC2)c1,CHEMBL671651,Ki,7.72,CHEMBL312752,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1n[nH]c2ncc(C(=O)N3CCC[C@H]3c3ccc(Cl)cc3)cc12,CHEMBL5481013,IC50,5.07,CHEMBL3903492,2024,CHEMBL5465560,,EUbOPEN Chemogenomic Library Literature Data,"Selectivity interaction (CEREP panel (binding assay, receptors and ion channels)) EUB0001623a DRD2",159,872,O=C(c1cnc2[nH]ncc2c1)N1CCCC1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(-c2ccc(C(=O)N[C@H]3CC[C@H](CCN4CCC(c5cccc6c5CCO6)CC4)CC3)cc2)no1,CHEMBL3705383,Ki,5.43,CHEMBL3695422,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",101,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-c2ncon2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(-c2ccc(C(=O)N[C@H]3CC[C@H](CCN4CCC(c5coc6ccccc56)CC4)CC3)cc2)no1,CHEMBL3706129,Ki,6.64,CHEMBL3676906,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",101,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-c2ncon2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(-c2ccc(CSc3nc4ccccc4n3Cc3ccc(Cl)cc3)cc2)no1,CHEMBL671383,Ki,7.02,CHEMBL108856,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,38,133,c1ccc(Cn2c(SCc3ccc(-c4ncon4)cc3)nc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCN(c5nccc6c5CCO6)CC4)CC3)c2)no1,CHEMBL3705135,Ki,5.67,CHEMBL3642803,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1cccc(-c2ncon2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)c2)no1,CHEMBL674348,Ki,6.7,CHEMBL3084613,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2ncon2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)no1,CHEMBL674348,Ki,6.4,CHEMBL3084616,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2ncon2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)no1,CHEMBL829065,Ki,6.4,CHEMBL244083,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]iodosulpiride binding to human Dopamine D2 receptor expressed in CHO cells,41,873,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2ncon2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)no1,CHEMBL895462,Ki,6.1,CHEMBL244083,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,55,690,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2ncon2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(C(=O)NCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c(C)n1-c1ccccc1,CHEMBL1827739,IC50,5.86,CHEMBL3216098,2011,CHEMBL1821711,J Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor by competition binding assay,79,874,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cn(-c2ccccc2)cn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(C(=O)NCCN2CCN(c3cccc(Cl)c3Cl)CC2)c(C)n1-c1ccccc1,CHEMBL1827739,IC50,6.04,CHEMBL3216758,2011,CHEMBL1821711,J Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor by competition binding assay,79,874,O=C(NCCN1CCN(c2ccccc2)CC1)c1cn(-c2ccccc2)cn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(C(=O)O)ccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,5.12,CHEMBL3964649,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(C(N)=O)ccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,5.94,CHEMBL3941520,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(C(N)=O)ccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855280,Ki,5.68,CHEMBL3941520,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,118,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5cc(Cl)ccc54)C3)n2C)s1,CHEMBL1261449,Ki,6.4,CHEMBL1258948,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,72,731,c1ccc2c(c1)CCC21CCN(CCCSc2nnc(-c3cncs3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5ccc(Cl)cc54)C3)n2C)s1,CHEMBL1261449,Ki,6.5,CHEMBL1258834,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,72,731,c1ccc2c(c1)CCC21CCN(CCCSc2nnc(-c3cncs3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(C)c(-c2nnc(SCCCN3CCC4(CCc5ccc(F)cc54)C3)n2C)s1,CHEMBL1261449,Ki,6.4,CHEMBL1257214,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,72,731,c1ccc2c(c1)CCC21CCN(CCCSc2nnc(-c3cncs3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(C)c(-c2nnc(SCCCN3CCC4CC4(c4ccc(C(F)(F)F)cc4)CC3)n2C)o1,CHEMBL1261449,Ki,6.7,CHEMBL1257925,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,72,731,c1ccc(C23CCN(CCCSc4nnc(-c5cnco5)[nH]4)CCC2C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(C)c(-c2nnc(SCCCN3CCC4CC4(c4ccc(C(F)(F)F)cc4)CC3)n2C)s1,CHEMBL1261449,Ki,6.7,CHEMBL1257926,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,72,731,c1ccc(C23CCN(CCCSc4nnc(-c5cncs5)[nH]4)CCC2C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(C)c(-c2nnc(SCCCN3C[C@@H]4C[C@]4(c4ccc(C(F)(F)F)cc4)C3)n2C)s1,CHEMBL1107668,Ki,6.6,CHEMBL1081746,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cncs4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(Cl)c(Sc2ccc(Cl)cc2)c(N2CCN(C)CC2)n1,CHEMBL672311,Ki,7.21,CHEMBL14998,2001,CHEMBL1134832,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to Dopamine receptor D2 was determined,25,610,c1ccc(Sc2cncnc2N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(Cl)c(Sc2ccc(Cl)cc2)c(NC2CCN(Cc3ccccc3)CC2)n1,CHEMBL672311,Ki,7.21,CHEMBL15270,2001,CHEMBL1134832,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to Dopamine receptor D2 was determined,25,610,c1ccc(CN2CCC(Nc3ncncc3Sc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)[nH]c1-c1ccc2ccn(S(=O)(=O)c3ccccc3)c2c1,CHEMBL4354013,Ki,6.15,CHEMBL4472629,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,138,125,O=S(=O)(c1ccccc1)n1ccc2ccc(-c3cnc[nH]3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)[nH]c1-c1cn(S(=O)(=O)c2cccc3ccccc23)c2ccccc12,CHEMBL4354013,Ki,5.93,CHEMBL4471055,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,138,125,O=S(=O)(c1cccc2ccccc12)n1cc(-c2cnc[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)[nH]c1-c1cn(S(=O)(=O)c2ccccc2)c2ccccc12,CHEMBL4354013,Ki,6.1,CHEMBL4586353,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,138,125,O=S(=O)(c1ccccc1)n1cc(-c2cnc[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NC(C)c1cccc(F)c1,CHEMBL4815484,Ki,6.5,CHEMBL4875600,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,151,259,O=C(N=CNCCCc1cncs1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NC(C)c1ccco1,CHEMBL4815484,Ki,5.77,CHEMBL4846380,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,151,259,O=C(N=CNCCCc1cncs1)NCc1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)C1CCCCC1,CHEMBL4815484,Ki,6.58,CHEMBL4846638,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,151,259,O=C(N=CNCCCc1cncs1)NCCC1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)CC1CCCCC1,CHEMBL4815484,Ki,6.32,CHEMBL4857560,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,151,259,O=C(N=CNCCCc1cncs1)NCCCC1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)CCCc1ccccc1,CHEMBL4815484,Ki,6.23,CHEMBL4846201,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,151,259,O=C(N=CNCCCc1cncs1)NCCCCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCC(C)CCc1ccccc1,CHEMBL4815484,Ki,6.45,CHEMBL4865765,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,151,259,O=C(N=CNCCCc1cncs1)NCCCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)sc1CCCN/C(N)=N/C(=O)NCc1ccccc1,CHEMBL4815484,Ki,6.22,CHEMBL4856005,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,151,259,O=C(N=CNCCCc1cncs1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)sc1CCCN/C(N)=N/C(=O)N[C@@H](C)c1ccccc1,CHEMBL4815484,Ki,6.1,CHEMBL4867962,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,151,259,O=C(N=CNCCCc1cncs1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)sc1CCCN/C(N)=N/C(=O)N[C@H](C)c1ccccc1,CHEMBL4815484,Ki,6.81,CHEMBL4856059,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,151,259,O=C(N=CNCCCc1cncs1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N)sc1CCCN/C(N)=N/C(=S)N[C@H](C)c1ccccc1,CHEMBL4815484,Ki,5.93,CHEMBL4853772,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,151,259,S=C(N=CNCCCc1cncs1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(C)(C)C)n1,CHEMBL3379351,Ki,5.34,CHEMBL3323007,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,101,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)n1,CHEMBL3379351,Ki,4.6,CHEMBL3323005,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,101,163,O=C(NCCCCN1CCN(c2ccncn2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc(O)n(C2CCN(Cc3ccccc3)CC2)c1-c1ccccc1,CHEMBL671375,Ki,6.55,CHEMBL91821,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,18,496,c1ccc(CN2CCC(n3cncc3-c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2c(O)cccn2c(=O)c1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4045104,IC50,7.57,CHEMBL4102561,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4sccc34)CC2)cnc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2c(OCCNCc3ccccc3)cccc2[nH]1,CHEMBL672205,Ki,7.82,CHEMBL87067,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,18,876,c1ccc(CNCCOc2cccc3[nH]cnc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2c(o1)CC(CN1CC=C(c3c[nH]c4cc(F)ccc34)CC1)CC2=O,CHEMBL3222870,Ki,6.76,CHEMBL3220216,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=C1CC(CN2CC=C(c3c[nH]c4ccccc34)CC2)Cc2ocnc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2c(o1)CC(CN1CCC(c3c[nH]c4cc(F)ccc34)CC1)CC2=O,CHEMBL3222870,Ki,6.7,CHEMBL3220215,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=C1CC(CN2CCC(c3c[nH]c4ccccc34)CC2)Cc2ocnc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2c(o1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O,CHEMBL3222870,Ki,7.49,CHEMBL3220214,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2ocnc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2ccccn2c(=O)c1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4045104,IC50,8.48,CHEMBL4094825,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4sccc34)CC2)cnc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3cccc4sccc34)CC1)CCCC2,CHEMBL4045104,IC50,7.98,CHEMBL4078409,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCC(c3cccc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3cccc4sccc34)CC1)CCCC2O,CHEMBL4045104,IC50,7.12,CHEMBL4094926,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCC(c3cccc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL1059279,Ki,8.21,CHEMBL85,2009,CHEMBL1154195,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,65,568,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL2211561,Ki,8.57,CHEMBL85,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,83,376,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL3106891,Ki,8.21,CHEMBL85,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,101,134,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL3222870,Ki,8.21,CHEMBL85,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL3226695,Ki,8.0,CHEMBL85,2012,CHEMBL3217546,Medchemcomm,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,83,553,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL3381713,Ki,8.42,CHEMBL85,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),101,574,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL3707630,Ki,8.23,CHEMBL85,2013,CHEMBL3638417,,BindingDB Patent Bioactivity Data,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",92,575,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL4045104,IC50,8.15,CHEMBL85,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL4229838,Ki,9.22,CHEMBL85,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,131,578,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL4686240,Ki,8.45,CHEMBL85,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin),144,579,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL4729778,Ki,8.42,CHEMBL85,2020,CHEMBL4725387,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),144,100,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL4821052,Ki,8.41,CHEMBL85,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL672169,Ki,8.48,CHEMBL85,2004,CHEMBL1149193,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,38,533,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL672179,Ki,9.36,CHEMBL85,2001,CHEMBL1134342,J Med Chem,Scientific Literature,Binding affinity towards human D2 dopamine receptor.,26,534,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL672308,Ki,8.51,CHEMBL85,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,26,593,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL672525,Ki,8.85,CHEMBL85,1995,CHEMBL1128570,J Med Chem,Scientific Literature,Ability to inhibit the binding of [3H]spiperone to the Dopamine receptor D2L in COS7 cells,6,75,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL829120,Ki,8.19,CHEMBL85,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,41,536,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL895618,Ki,8.2,CHEMBL85,2007,CHEMBL1148822,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,56,452,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2,CHEMBL992743,Ki,8.66,CHEMBL85,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2(C)O,CHEMBL4045104,IC50,7.1,CHEMBL4082084,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2(F)F,CHEMBL4045104,IC50,8.3,CHEMBL4096467,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2=O,CHEMBL4045104,IC50,8.04,CHEMBL4077702,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=C1CCCn2c1ncc(CCN1CCC(c3noc4ccccc34)CC1)c2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2Cl,CHEMBL4045104,IC50,8.54,CHEMBL4090872,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2F,CHEMBL4045104,IC50,8.21,CHEMBL4062936,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2O,CHEMBL4045104,IC50,8.08,CHEMBL1621,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCC(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3CCS4)CC1)CCCC2O,CHEMBL4045104,IC50,7.93,CHEMBL4087246,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4c3CCS4)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3OC(F)(F)O4)CC1)CCCC2,CHEMBL4045104,IC50,7.44,CHEMBL4077006,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4c3OCO4)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4c3OC(F)(F)O4)CC1)CCCC2O,CHEMBL4045104,IC50,7.57,CHEMBL4100152,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4c3OCO4)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCC=C2,CHEMBL4045104,IC50,8.03,CHEMBL4074326,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4sccc34)CC2)cnc2n1CCC=C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2,CHEMBL4045104,IC50,8.58,CHEMBL4083333,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2(C)O,CHEMBL4045104,IC50,7.5,CHEMBL4065710,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2(F)F,CHEMBL4045104,IC50,8.46,CHEMBL4087132,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2=O,CHEMBL4045104,IC50,7.39,CHEMBL4103509,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=C1CCCn2c1ncc(CCN1CCN(c3cccc4sccc34)CC1)c2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2Cl,CHEMBL4045104,IC50,8.26,CHEMBL4079251,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2F,CHEMBL4045104,IC50,8.48,CHEMBL4104261,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cccc4sccc34)CC1)CCCC2O,CHEMBL4045104,IC50,8.48,CHEMBL4102670,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cccc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3cncc4sccc34)CC1)CCCC2O,CHEMBL4045104,IC50,6.02,CHEMBL4091554,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3cncc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3csc4ccsc34)CC1)CCCC2O,CHEMBL4045104,IC50,6.8,CHEMBL4067506,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3csc4ccsc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3nccc4sccc34)CC1)CCCC2,CHEMBL4045104,IC50,7.42,CHEMBL4079365,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3nccc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3nccc4sccc34)CC1)CCCC2O,CHEMBL4045104,IC50,7.7,CHEMBL4097395,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3nccc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3ncnc4sccc34)CC1)CCCC2,CHEMBL4045104,IC50,5.26,CHEMBL4063748,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3ncnc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3ncnc4sccc34)CC1)CCCC2O,CHEMBL4045104,IC50,5.18,CHEMBL4064609,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3ncnc4sccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3noc4cc(F)ccc34)CC1)CCCC2O,CHEMBL4045104,IC50,8.02,CHEMBL4098594,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3noc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2(C)O,CHEMBL4045104,IC50,8.62,CHEMBL4061068,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3nsc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2(F)F,CHEMBL4045104,IC50,8.28,CHEMBL4062992,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3nsc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2=O,CHEMBL4045104,IC50,8.12,CHEMBL4084663,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=C1CCCn2c1ncc(CCN1CCN(c3nsc4ccccc34)CC1)c2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2Cl,CHEMBL4045104,IC50,8.08,CHEMBL4101115,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3nsc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2F,CHEMBL4045104,IC50,8.11,CHEMBL4074373,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3nsc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2n(c(=O)c1CCN1CCN(c3nsc4ccccc34)CC1)CCCC2O,CHEMBL4045104,IC50,8.29,CHEMBL4060678,2017,CHEMBL4043141,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,126,850,O=c1c(CCN2CCN(c3nsc4ccccc34)CC2)cnc2n1CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL5442215,Ki,6.74,CHEMBL267777,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=c1c(CCN2CCC(=C(c3ccccc3)c3ccccc3)CC2)cnc2sccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(OS(C)(=O)=O)cc5CC4)CC3)c2)o1,CHEMBL674348,Ki,6.7,CHEMBL3084597,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2cnco2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncc(-c2cccc(C(=O)N[C@H]3CC[C@H](CCN4CCc5ccc(S(C)(=O)=O)cc5CC4)CC3)c2)o1,CHEMBL674348,Ki,6.2,CHEMBL3084602,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,35,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2cnco2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F,CHEMBL4392130,Ki,5.02,CHEMBL4572614,2019,CHEMBL4390674,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cells measured after 90 mins by microbeta scintillation counting method,138,838,c1cc2occc2c(Oc2ccc(-c3cncc4nccn34)cc2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,5.83,CHEMBL3968272,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncccc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL1107668,Ki,6.5,CHEMBL1081687,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCC(O)CN2CC[C@@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,5.76,CHEMBL3954490,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,6.01,CHEMBL3908862,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855280,Ki,5.87,CHEMBL3908862,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,118,875,c1ccc(C2CC23CCN(CCCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(C(F)(F)F)ccc3F)C2)n1C,CHEMBL1107668,Ki,6.449999999999999,CHEMBL1082111,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cc(F)cc(C(F)(F)F)c3)C2)n1C,CHEMBL1107668,Ki,7.7,CHEMBL1081868,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Br)cc3)C2)n1C,CHEMBL1107668,Ki,6.9,CHEMBL1082106,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(C)(C)C)cc3)C2)n1C,CHEMBL1107668,Ki,7.1,CHEMBL1079822,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)c(F)c3)C2)n1C,CHEMBL1107668,Ki,6.65,CHEMBL1080126,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL1107668,Ki,6.9,CHEMBL1079481,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,72,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL1211614,Ki,6.9,CHEMBL1079481,2010,CHEMBL1208692,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by FLIPR assay,72,877,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL1225698,Ki,6.9,CHEMBL1079481,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,72,93,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL1261449,Ki,6.9,CHEMBL1079481,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(C(F)(F)F)cc3F)C2)n1C,CHEMBL1107668,Ki,6.4,CHEMBL1081023,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)c(Cl)c3)C2)n1C,CHEMBL1107668,Ki,7.5,CHEMBL1080846,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3)C2)n1C,CHEMBL1107668,Ki,6.65,CHEMBL1080490,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(Cl)cc3F)C2)n1C,CHEMBL1107668,Ki,6.5,CHEMBL1081747,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)c(C(F)(F)F)c3)C2)n1C,CHEMBL1107668,Ki,7.0,CHEMBL1081587,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(F)cc3)C2)n1C,CHEMBL1107668,Ki,6.4,CHEMBL1079462,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(OC(F)(F)F)cc3)C2)n1C,CHEMBL1107668,Ki,6.4,CHEMBL1081966,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccc(S(F)(F)(F)(F)F)cc3)C2)n1C,CHEMBL1211614,Ki,6.8,CHEMBL1210552,2010,CHEMBL1208692,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by FLIPR assay,73,877,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,CHEMBL1107668,Ki,7.5,CHEMBL1081957,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,CHEMBL1211614,Ki,7.5,CHEMBL1081957,2010,CHEMBL1208692,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by FLIPR assay,73,877,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(C(F)(F)F)c3F)C2)n1C,CHEMBL1107668,Ki,6.9,CHEMBL1079938,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(Cl)c3)C2)n1C,CHEMBL1107668,Ki,7.0,CHEMBL1079461,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(F)c3)C2)n1C,CHEMBL1107668,Ki,6.75,CHEMBL1079980,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(OC(F)(F)F)c3)C2)n1C,CHEMBL1107668,Ki,7.25,CHEMBL1081934,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3cccc(S(F)(F)(F)(F)F)c3)C2)n1C,CHEMBL1211614,Ki,7.2,CHEMBL1210614,2010,CHEMBL1208692,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by FLIPR assay,73,877,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CC3(c3ccccc3)C2)n1C,CHEMBL1107668,Ki,6.7,CHEMBL1079667,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4c(F)cccc4F)C3C2)n1C,CHEMBL3776608,Ki,6.3,CHEMBL3775967,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cc(Cl)cc(Cl)c4)C3C2)n1C,CHEMBL3776608,Ki,8.0,CHEMBL3775338,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)n1C,CHEMBL3776608,Ki,6.9,CHEMBL3774540,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4F)C3C2)n1C,CHEMBL3776608,Ki,7.0,CHEMBL3775226,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4F)C3C2)n1C,CHEMBL3776848,Ki,7.3,CHEMBL3775226,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of dopamine-mediated Ca+2 stimulation pretreated for 10 mins followed by addition of dopamine by fluo-4 AM dye-based FLIPR assay,118,878,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(Cl)cc4Cl)C3C2)n1C,CHEMBL3776608,Ki,6.3,CHEMBL3775301,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)n1C,CHEMBL3776608,Ki,6.7,CHEMBL3774588,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccc(OC(F)(F)F)cc4)C3C2)n1C,CHEMBL3776608,Ki,6.2,CHEMBL3775395,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cccc(C#N)c4)C3C2)n1C,CHEMBL3776608,Ki,7.3,CHEMBL3775534,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4cccc(F)c4)C3C2)n1C,CHEMBL3776608,Ki,6.8,CHEMBL3775005,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccccc4)C3C2)n1C,CHEMBL3776608,Ki,6.6,CHEMBL3775589,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccccc4)C3C2)n1C,CHEMBL3776848,Ki,6.8,CHEMBL3775589,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of dopamine-mediated Ca+2 stimulation pretreated for 10 mins followed by addition of dopamine by fluo-4 AM dye-based FLIPR assay,118,878,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC3CCN(c4ccccc4OC(F)(F)F)C3C2)n1C,CHEMBL3776608,Ki,7.7,CHEMBL3775872,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,118,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnco5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3(CCCc4cc(Br)ccc43)C2)n1C,CHEMBL1261449,Ki,6.3,CHEMBL1258380,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc2c(c1)CCCC21CCN(CCCSc2nnc(-c3cnco3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3(CCCc4ccc(Br)cc43)C2)n1C,CHEMBL1261449,Ki,6.5,CHEMBL1258381,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc2c(c1)CCCC21CCN(CCCSc2nnc(-c3cnco3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4c(Br)cccc43)C2)n1C,CHEMBL1261449,Ki,6.6,CHEMBL1258713,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc2c(c1)CCC21CCN(CCCSc2nnc(-c3cnco3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4cc(Br)ccc43)C2)n1C,CHEMBL1261449,Ki,6.9,CHEMBL1258712,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc2c(c1)CCC21CCN(CCCSc2nnc(-c3cnco3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4cc(F)ccc43)C2)n1C,CHEMBL1261449,Ki,7.0,CHEMBL1258949,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc2c(c1)CCC21CCN(CCCSc2nnc(-c3cnco3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3(CCc4ccc(Br)cc43)C2)n1C,CHEMBL1261449,Ki,7.4,CHEMBL1258833,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc2c(c1)CCC21CCN(CCCSc2nnc(-c3cnco3)[nH]2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3(c4ccc(C(F)(F)F)cc4)CC3C2)n1C,CHEMBL1261449,Ki,6.5,CHEMBL1257686,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CCN(CCCSc4nnc(-c5cnco5)[nH]4)CC2C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3(c4cccc(C(F)(F)F)c4)CC3C2)n1C,CHEMBL1261449,Ki,5.6,CHEMBL1257808,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CCN(CCCSc4nnc(-c5cnco5)[nH]4)CC2C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3(c4ccccc4)CC3C2)n1C,CHEMBL1261449,Ki,5.5,CHEMBL1257565,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CCN(CCCSc4nnc(-c5cnco5)[nH]4)CC2C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL1261449,Ki,6.3,CHEMBL1257566,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CC2CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)CC2)n1C,CHEMBL1261449,Ki,7.0,CHEMBL1257809,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CCN(CCCSc4nnc(-c5cnco5)[nH]4)CCC2C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3cccc(C(F)(F)F)c3)C2)n1C,CHEMBL1261449,Ki,6.5,CHEMBL1257687,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CC2CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCC3CC3(c3ccccc3)C2)n1C,CHEMBL1261449,Ki,6.4,CHEMBL1257447,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CC2CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCOC(c3ccc(Br)cc3)C2)n1C,CHEMBL3768209,Ki,4.8,CHEMBL3764833,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,118,132,c1ccc(C2CN(CCCSc3nnc(-c4cnco4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3768209,Ki,4.9,CHEMBL3764557,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,118,132,c1ccc(C2CN(CCCSc3nnc(-c4cnco4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3F)C2)n1C,CHEMBL3768209,Ki,5.0,CHEMBL3764586,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,118,132,c1ccc(C2CN(CCCSc3nnc(-c4cnco4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,6.2,CHEMBL3944642,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,CHEMBL3855278,Ki,6.01,CHEMBL3901587,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,CHEMBL3855280,Ki,6.1,CHEMBL3901587,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,118,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(F)cc3)C2)n1C,CHEMBL3855278,Ki,6.1,CHEMBL3912029,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(F)cc3C(F)(F)F)C2)n1C,CHEMBL3855278,Ki,5.66,CHEMBL3966647,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccc(F)cc3F)C2)n1C,CHEMBL3855278,Ki,6.02,CHEMBL3945775,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccccc3)C2)n1C,CHEMBL3855278,Ki,6.15,CHEMBL3901211,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@@H]3c3ccccc3C(F)(F)F)C2)n1C,CHEMBL3855278,Ki,7.2,CHEMBL3975989,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,CHEMBL3855278,Ki,6.65,CHEMBL3955505,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,CHEMBL3855280,Ki,7.59,CHEMBL3955505,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,118,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3)C2)n1C,CHEMBL3855278,Ki,6.62,CHEMBL3963783,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3)C2)n1C,CHEMBL3855280,Ki,7.24,CHEMBL3963783,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,118,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3C(F)(F)F)C2)n1C,CHEMBL3855278,Ki,5.89,CHEMBL3975147,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3F)C2)n1C,CHEMBL3855278,Ki,6.59,CHEMBL3926847,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccc(F)cc3F)C2)n1C,CHEMBL3855280,Ki,7.18,CHEMBL3926847,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,118,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccccc3)C2)n1C,CHEMBL3855278,Ki,6.1,CHEMBL3983937,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@@]3(C[C@H]3c3ccccc3)C2)n1C,CHEMBL3855280,Ki,6.17,CHEMBL3983937,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,118,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3cc(Cl)cc(Cl)c3)C2)n1C,CHEMBL3855278,Ki,7.21,CHEMBL3899336,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,6.6,CHEMBL3935692,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,118,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855280,Ki,7.13,CHEMBL3935692,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,119,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,CHEMBL3855278,Ki,5.92,CHEMBL3927895,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3)C2)n1C,CHEMBL3855278,Ki,5.73,CHEMBL3922143,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3C(F)(F)F)C2)n1C,CHEMBL3855278,Ki,5.42,CHEMBL3945776,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3F)C2)n1C,CHEMBL3855278,Ki,6.53,CHEMBL3917887,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccccc3)C2)n1C,CHEMBL3855278,Ki,5.4,CHEMBL3913062,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccccc3C(F)(F)F)C2)n1C,CHEMBL3855278,Ki,5.8,CHEMBL3905196,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3cc(Cl)cc(Cl)c3)C2)n1C,CHEMBL3855278,Ki,7.18,CHEMBL3983121,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,6.115,CHEMBL3913607,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3F)C2)n1C,CHEMBL3855278,Ki,6.505,CHEMBL3935776,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(F)cc3)C2)n1C,CHEMBL3855278,Ki,5.984999999999999,CHEMBL3950264,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(F)cc3C(F)(F)F)C2)n1C,CHEMBL3855278,Ki,6.78,CHEMBL3985877,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(F)cc3F)C2)n1C,CHEMBL3855278,Ki,6.22,CHEMBL3908548,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccccc3)C2)n1C,CHEMBL3855278,Ki,6.145,CHEMBL3958494,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccccc3C(F)(F)F)C2)n1C,CHEMBL3855278,Ki,6.525,CHEMBL3914195,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2CCc3ccc4oc(C(C)(F)F)nc4c3CC2)n1C,CHEMBL931096,Ki,7.8,CHEMBL437792,2008,CHEMBL1143157,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,61,853,c1ncc(-c2nnc(SCCCN3CCc4ccc5ocnc5c4CC3)[nH]2)o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(C)(C)C)cc3)C2)n1C,CHEMBL1107668,Ki,7.1,CHEMBL1079824,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL1107668,Ki,7.0,CHEMBL1081409,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3F)C2)n1C,CHEMBL3591366,Ki,5.68,CHEMBL3590085,2015,CHEMBL3588810,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,111,726,c1ccc(C23CC2CN(CCCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2[C@@H]3CC[C@H]2C[C@@H](c2ccc(C(C)(C)C)cc2)C3)n1C,CHEMBL1261449,Ki,6.4,CHEMBL1257215,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C2CC3CCC(C2)N3CCCSc2nnc(-c3cnco3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN2[C@@H]3CC[C@H]2C[C@@H](c2ccc(C(F)(F)F)cc2)C3)n1C,CHEMBL1261449,Ki,6.4,CHEMBL1257336,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C2CC3CCC(C2)N3CCCSc2nnc(-c3cnco3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCNC2CC3CC3(c3ccccc3)C2)n1C,CHEMBL1261449,Ki,6.6,CHEMBL1257335,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CC(NCCCSc4nnc(-c5cnco5)[nH]4)CC2C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN[C@@H]2CC[C@]3(c4ccc(C(F)(F)F)cc4)CC23)n1C,CHEMBL1261449,Ki,6.3,CHEMBL1258035,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CCC(NCCCSc4nnc(-c5cnco5)[nH]4)C2C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCCN[C@@H]2CC[C@]3(c4ccc(C(F)(F)F)cc4F)CC23)n1C,CHEMBL1261449,Ki,6.7,CHEMBL1258268,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CCC(NCCCSc4nnc(-c5cnco5)[nH]4)C2C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCN2CC[C@@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,6.1,CHEMBL3953365,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,6.28,CHEMBL3936812,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855280,Ki,6.3,CHEMBL3936812,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,119,875,c1ccc(C2CC23CCN(CCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncoc1-c1nnc(SCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,6.15,CHEMBL3954568,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCSc2nnc(-c4cnco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncsc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,5.79,CHEMBL3923578,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cncs4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1ncsc1-c1nnc(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,5.91,CHEMBL3894257,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,119,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cncs4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn(-c2ccccc2)cc1CN1CCN(c2ccccc2)CC1,CHEMBL871242,Ki,7.15,CHEMBL208018,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,49,66,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn(-c2ccccc2)cc1CN1CCN(c2ccccc2)CC1,CHEMBL871243,Ki,7.37,CHEMBL208018,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,49,67,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn(-c2ccccc2)cc1CN1CCN(c2ccccc2)CC1,CHEMBL913685,Ki,7.15,CHEMBL208018,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,56,44,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn(C2CCN(Cc3cccc(C#N)c3)CC2)cc1-c1ccccc1,CHEMBL671371,Ki,7.82,CHEMBL26120,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,18,588,c1ccc(CN2CCC(n3cc(-c4ccccc4)cn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn(C2CCN(Cc3cccc(Cl)c3)CC2)cc1-c1ccccc1,CHEMBL671371,Ki,7.82,CHEMBL287412,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,18,588,c1ccc(CN2CCC(n3cc(-c4ccccc4)cn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn(C2CCN(Cc3ccccc3)CC2)cc1-c1ccccc1,CHEMBL671371,Ki,8.21,CHEMBL279247,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,18,588,c1ccc(CN2CCC(n3cc(-c4ccccc4)cn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn(C2CCN(Cc3ccccc3)CC2)cc1-c1ccccc1,CHEMBL671730,Ki,8.21,CHEMBL279247,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,35,693,c1ccc(CN2CCC(n3cc(-c4ccccc4)cn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn2c(-c3ccc(F)cc3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL671731,Ki,4.85,CHEMBL160749,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,31,45,c1ccc(-c2cccc3c(CN4CCN(c5ccccc5)CC4)cnn23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn2c(-c3ccc(F)cc3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL671732,Ki,4.8,CHEMBL160749,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(-c2cccc3c(CN4CCN(c5ccccc5)CC4)cnn23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn2c(-c3ccccc3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL671731,Ki,4.55,CHEMBL351550,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,31,45,c1ccc(-c2cccc3c(CN4CCN(c5ccccc5)CC4)cnn23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn2c(-c3ccccc3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL671732,Ki,4.62,CHEMBL351550,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(-c2cccc3c(CN4CCN(c5ccccc5)CC4)cnn23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn2c(C#N)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL671732,Ki,4.24,CHEMBL160932,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn2c(C#N)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL672909,Ki,4.23,CHEMBL160932,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,Binding affinity of compound was tested in vitro for its ability to compete with [3H]spiperone radioligand at cloned human Dopamine receptor D2L stably expressed in CHO cells,31,879,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn2c(N3CCN(Cc4ccccc4)CC3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL671731,Ki,6.52,CHEMBL160536,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,31,45,c1ccc(CN2CCN(c3cccc4c(CN5CCN(c6ccccc6)CC5)cnn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nn2c(N3CCN(Cc4ccccc4)CC3)cccc2c1CN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL671732,Ki,6.92,CHEMBL160536,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(CN2CCN(c3cccc4c(CN5CCN(c6ccccc6)CC5)cnn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nnc(-c2ccc(-c3ccc(C(=O)NCCCCN4CCc5ccc(OS(=O)(=O)C(F)(F)F)cc5C4)cc3)cc2)o1,CHEMBL672227,Ki,7.0,CHEMBL279925,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,18,131,O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccc(-c3nnco3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1nnn(C2CCN(Cc3ccccc3)CC2)c1-c1ccccc1,CHEMBL671371,Ki,5.92,CHEMBL25887,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,18,588,c1ccc(CN2CCC(n3nncc3-c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1noc(-c2ccc(CSc3nc4ccccc4n3Cc3ccc(Cl)cc3)cc2)n1,CHEMBL671383,Ki,6.51,CHEMBL264394,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,38,133,c1ccc(Cn2c(SCc3ccc(-c4ncno4)cc3)nc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1noc(C)c1-c1ccc(S(=O)(=O)Nc2ccc3c(c2)CCN(C)CC3)cc1,CHEMBL905981,Ki,7.0,CHEMBL230930,2007,CHEMBL1143778,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human recombinant dopamine D2 receptor expressed in CHO cells,56,199,O=S(=O)(Nc1ccc2c(c1)CCNCC2)c1ccc(-c2cnoc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1noc2c1C(=O)CC(CN1CCC(c3c[nH]c4cc(F)ccc34)CC1)C2,CHEMBL3222870,Ki,7.2,CHEMBL3220212,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=C1CC(CN2CCC(c3c[nH]c4ccccc34)CC2)Cc2oncc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1noc2c1C(=O)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)C2,CHEMBL3222870,Ki,6.92,CHEMBL391985,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2oncc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1oc(-c2ccc3ccccc3c2)nc1CN1CCO[C@H](CCN)C1,CHEMBL4137914,Ki,5.82,CHEMBL4160967,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1ccc2cc(-c3nc(CN4CCOCC4)co3)ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1oc(-c2ccco2)nc1CN(C)C[C@@H]1Cc2ccccc2O1,CHEMBL4137914,Ki,5.24,CHEMBL4164849,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1coc(-c2nc(CNCC3Cc4ccccc4O3)co2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1oc(-c2ccco2)nc1CN1CCN([C@@H]2CCc3ccccc3C2)CC1,CHEMBL4137914,Ki,5.91,CHEMBL4175018,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1coc(-c2nc(CN3CCN(C4CCc5ccccc5C4)CC3)co2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1oc(C)c2c1CCCc1cnn(C)c1-2,CHEMBL672165,Ki,7.55,CHEMBL433376,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,35,434,c1occ2c1CCCc1cn[nH]c1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1sc(C)c2c1CCCc1c[nH]nc1-2,CHEMBL672165,Ki,5.68,CHEMBL432579,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,35,434,c1scc2c1CCCc1c[nH]nc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1sc(C)c2c1CCCc1cn(C)nc1-2,CHEMBL672165,Ki,6.19,CHEMBL317078,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,35,434,c1scc2c1CCCc1c[nH]nc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1sc(C)c2c1CCCc1cnn(C(C)C)c1-2,CHEMBL672165,Ki,6.26,CHEMBL99649,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,35,434,c1scc2c1CCCc1cn[nH]c1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1sc(C)c2c1CCCc1cnn(C)c1-2,CHEMBL672165,Ki,6.75,CHEMBL316727,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,36,434,c1scc2c1CCCc1cn[nH]c1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1sc(C)c2c1CCc1c[nH]nc1-2,CHEMBL672165,Ki,5.38,CHEMBL329276,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,36,434,c1scc2c1CCc1c[nH]nc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1sc(C)c2c1CCc1cnn(C)c1-2,CHEMBL672165,Ki,6.33,CHEMBL98830,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,36,434,c1scc2c1CCc1cn[nH]c1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1sc(C)c2c1SCc1cnn(C)c1-2,CHEMBL672165,Ki,6.96,CHEMBL100203,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,36,434,c1n[nH]c2c1CSc1cscc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cc1sc(N)nc1-c1cn(S(=O)(=O)c2ccccc2)c2ccccc12,CHEMBL4354013,Ki,5.29,CHEMBL4468396,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,138,125,O=S(=O)(c1ccccc1)n1cc(-c2cscn2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cc(Cl)cc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1,CHEMBL671074,IC50,7.5,CHEMBL1202225,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(-c2cc(C3CCCCN3Cc3ccccc3)[nH]n2)cc1,CHEMBL672209,Ki,5.47,CHEMBL80863,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CN2CCCCC2c2cc(-c3ccccc3)n[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(-c2cc(C3CCCN(Cc4ccccc4)C3)[nH]n2)cc1,CHEMBL672209,Ki,6.02,CHEMBL80833,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CN2CCCC(c3cc(-c4ccccc4)n[nH]3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(-c2cc(C3CCN(CC4CCCCC4)CC3)[nH]n2)cc1,CHEMBL672209,Ki,6.92,CHEMBL420954,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(-c2cc(C3CCN(CC4CCCCC4)CC3)[nH]n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(-c2cc(C3CCN(CCCc4ccccc4)CC3)[nH]n2)cc1,CHEMBL672209,Ki,6.25,CHEMBL77017,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CCCN2CCC(c3cc(-c4ccccc4)n[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)[nH]n2)cc1,CHEMBL671370,Ki,6.28,CHEMBL6416,1996,CHEMBL1129307,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,9,587,c1ccc(CCN2CCC(c3cc(-c4ccccc4)n[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(-c2cc(C3CCN(CCc4ccccc4)CC3)[nH]n2)cc1,CHEMBL672209,Ki,6.28,CHEMBL6416,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CCN2CCC(c3cc(-c4ccccc4)n[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(-c2cc(C3CCN(Cc4cccc(Cl)c4)CC3)[nH]n2)cc1,CHEMBL672209,Ki,6.24,CHEMBL78287,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)n[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(-c2cc(C3CCN(Cc4ccccc4)C3)[nH]n2)cc1,CHEMBL672209,Ki,6.92,CHEMBL76355,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)n[nH]3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(-c2cc(C3CCN(Cc4ccccc4)CC3)[nH]n2)cc1,CHEMBL672209,Ki,6.9,CHEMBL76090,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)n[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(-c2cc(C3CCN(Cc4ccccc4Cl)CC3)[nH]n2)cc1,CHEMBL672209,Ki,6.16,CHEMBL312255,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)n[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(CN2CC=C(c3nc4cc(Cl)ccc4[nH]3)CC2)cc1,CHEMBL670393,Ki,6.48,CHEMBL71216,1997,CHEMBL1130515,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,12,68,C1=C(c2nc3ccccc3[nH]2)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(CN2CC=C(c3nc4cc(Cl)ccc4s3)CC2)cc1,CHEMBL670393,Ki,5.7,CHEMBL70215,1997,CHEMBL1130515,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,12,68,C1=C(c2nc3ccccc3s2)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(CN2CC=C(c3nc4ccccc4[nH]3)CC2)cc1,CHEMBL670393,Ki,6.17,CHEMBL305481,1997,CHEMBL1130515,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,12,68,C1=C(c2nc3ccccc3[nH]2)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)[nH]n3)CC2)cc1,CHEMBL671370,Ki,6.62,CHEMBL61080,1996,CHEMBL1129307,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,9,587,c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)[nH]n3)CC2)cc1,CHEMBL672209,Ki,6.62,CHEMBL61080,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)no3)CC2)cc1,CHEMBL671370,Ki,6.89,CHEMBL61195,1996,CHEMBL1129307,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,9,587,c1ccc(CN2CCC(c3cc(-c4ccccc4)no3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)no3)CC2)cc1,CHEMBL672209,Ki,6.89,CHEMBL61195,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)no3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)on3)CC2)cc1,CHEMBL671370,Ki,6.8,CHEMBL58296,1996,CHEMBL1129307,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,9,587,c1ccc(CN2CCC(c3cc(-c4ccccc4)on3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(CN2CCC(c3cc(-c4ccc(Cl)cc4)on3)CC2)cc1,CHEMBL672209,Ki,6.8,CHEMBL58296,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)on3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(Cn2c(SCc3ccccc3)nc3ccccc32)cc1,CHEMBL671383,Ki,5.17,CHEMBL110774,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,38,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CC3CC2CN3Cc2c[nH]c3ncccc23)cc1,CHEMBL1033197,Ki,7.21,CHEMBL514747,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,65,880,c1ccc(N2CC3CC2CN3Cc2c[nH]c3ncccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCCN(CCCCc3nc4ccccc4s3)CC2)cc1,CHEMBL1949469,Ki,6.59,CHEMBL1946254,2012,CHEMBL1944557,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,83,881,c1ccc(N2CCCN(CCCCc3nc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCCN(CCCCc3nc4ccccc4s3)CC2)cc1,CHEMBL2037965,Ki,6.59,CHEMBL1946254,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,c1ccc(N2CCCN(CCCCc3nc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCCN(CCCc3cc4ccccc4o3)CC2)cc1,CHEMBL3292986,Ki,5.6,CHEMBL3289655,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(N2CCCN(CCCc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL1033197,Ki,6.01,CHEMBL460223,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,65,880,c1ccc(N2CCCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCCCc3cc4ccccn4n3)CC2)cc1,CHEMBL1031082,Ki,6.8,CHEMBL561622,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,65,782,c1ccc(N2CCN(CCCCCc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCCCc3cc4ccccn4n3)CC2)cc1,CHEMBL1031088,Ki,6.66,CHEMBL561622,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,65,783,c1ccc(N2CCN(CCCCCc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCCCc3nc4ccccc4o3)CC2)cc1,CHEMBL3292986,Ki,5.51,CHEMBL3289649,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(N2CCN(CCCCCc3nc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCCNc3noc(-c4ccccc4)n3)CC2)c(Cl)c1,CHEMBL3742610,Ki,5.55,CHEMBL3740360,2016,CHEMBL3739355,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,119,883,c1ccc(-c2nc(NCCCCN3CCN(c4ccccc4)CC3)no2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCCNc3noc(-c4ccccc4)n3)CC2)cc1,CHEMBL3742610,Ki,4.1,CHEMBL3739820,2016,CHEMBL3739355,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,119,883,c1ccc(-c2nc(NCCCCN3CCN(c4ccccc4)CC3)no2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1,CHEMBL2037965,Ki,6.66,CHEMBL2037431,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1,CHEMBL3292986,Ki,6.66,CHEMBL2037431,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324908,Ki,6.08,CHEMBL5426481,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,158,704,c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324922,IC50,4.64,CHEMBL5426481,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,158,706,c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,CHEMBL3073105,Ki,6.06,CHEMBL87260,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),92,427,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,CHEMBL670391,Ki,6.06,CHEMBL87260,1995,CHEMBL1149936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,6,428,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCOc3ccccc3)CC2)cc1,CHEMBL1944110,Ki,6.35,CHEMBL1940413,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCOc3ccccc3)CC2)cc1,CHEMBL3292986,Ki,6.35,CHEMBL1940413,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCc3cc4ccccc4o3)CC2)cc1,CHEMBL3292986,Ki,5.7,CHEMBL3289653,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(N2CCN(CCCc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCc3nc4ccccc4o3)CC2)cc1,CHEMBL3292986,Ki,5.4,CHEMBL3286429,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(N2CCN(CCCc3nc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)cc1,CHEMBL2037965,Ki,5.63,CHEMBL2037430,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)cc1,CHEMBL3292986,Ki,5.63,CHEMBL2037430,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(CCc3cc4ccc[nH]c-4n3)CC2)cc1,CHEMBL671652,Ki,6.1,CHEMBL347155,1999,CHEMBL1132519,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,19,58,c1ccc(N2CCN(CCc3cc4ccc[nH]c-4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(C[C@@H]3C[C@H]3c3ccccc3)CC2)c(Cl)c1,CHEMBL671074,IC50,7.19,CHEMBL125455,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(Cl)c1,CHEMBL671074,IC50,7.11,CHEMBL1204116,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(Cl)c1,CHEMBL671376,Ki,6.74,CHEMBL1204116,2000,CHEMBL1133592,J Med Chem,Scientific Literature,Antagonism of dopamine-stimulated [35S]GTP-gamma-S binding against human Dopamine receptor D2 in CHO cells,23,849,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c(Cl)c1,CHEMBL672795,Ki,7.03,CHEMBL302075,2000,CHEMBL1132730,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,23,447,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1,CHEMBL671074,IC50,6.61,CHEMBL1202220,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1Cl,CHEMBL4039163,Ki,7.03,CHEMBL126429,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,126,546,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)cc1Cl,CHEMBL671074,IC50,6.68,CHEMBL1202212,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,CHEMBL672164,Ki,7.15,CHEMBL268799,1996,CHEMBL1129306,J Med Chem,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,9,249,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL1033197,Ki,6.02,CHEMBL267014,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,65,880,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL1061432,Ki,4.27,CHEMBL267014,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL1061433,Ki,4.42,CHEMBL267014,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL3292986,Ki,6.02,CHEMBL267014,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL4039163,Ki,6.02,CHEMBL267014,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,126,546,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL4048883,Ki,5.79,CHEMBL267014,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,131,245,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL4323478,Ki,4.33,CHEMBL267014,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,138,70,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL4323479,Ki,4.48,CHEMBL267014,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,138,71,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL5106582,Ki,5.79,CHEMBL267014,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,154,267,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL5235417,Ki,6.02,CHEMBL267014,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to D2R (unknown origin) assessed as inhibition constant,151,476,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL671073,IC50,6.44,CHEMBL555670,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,14,212,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL671372,Ki,6.04,CHEMBL267014,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,19,707,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL671652,Ki,6.02,CHEMBL267014,1999,CHEMBL1132519,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,19,58,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL671731,Ki,4.27,CHEMBL267014,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,31,45,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL671732,Ki,4.42,CHEMBL267014,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL672101,Ki,6.04,CHEMBL267014,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity was measured at the cloned human Dopamine receptor D2 using [3H]spiroperidol as radioligand.,14,255,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL672164,Ki,6.02,CHEMBL267014,1996,CHEMBL1129306,J Med Chem,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,9,249,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL672174,Ki,6.04,CHEMBL267014,1998,CHEMBL1131363,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,14,841,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL672347,Ki,6.35,CHEMBL267014,2004,CHEMBL1149162,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 using [3H]spiperone as radioligand,38,885,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL838814,Ki,6.02,CHEMBL555670,2004,CHEMBL1138643,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,38,886,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL913685,Ki,4.27,CHEMBL267014,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,56,44,c1ccc(N2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL1031082,Ki,5.47,CHEMBL310843,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in CHO cells,65,782,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL1031088,Ki,5.64,CHEMBL310843,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from wild type human cloned dopamine D2L receptor expressed in HEK293 cells,65,783,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL1031094,Ki,4.33,CHEMBL310843,2009,CHEMBL1158482,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor E181V/I183S mutant expressed in HEK293 cells,65,784,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL2423805,Ki,5.5,CHEMBL310843,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,92,493,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL4039193,Ki,5.2,CHEMBL310843,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 (short) receptor,126,887,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL5235409,Ki,5.47,CHEMBL310843,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,151,478,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL672347,Ki,5.88,CHEMBL310843,2004,CHEMBL1149162,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 using [3H]spiperone as radioligand,38,885,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL672382,Ki,5.47,CHEMBL310843,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,26,480,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL672572,Ki,5.2,CHEMBL310843,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,26,481,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL839477,Ki,5.47,CHEMBL310843,2005,CHEMBL1141881,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 long,41,457,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL913685,Ki,5.47,CHEMBL310843,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,56,44,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL931954,Ki,5.47,CHEMBL310843,2008,CHEMBL1143133,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 long receptor,61,670,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL934518,Ki,5.47,CHEMBL310843,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,61,4,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL934519,Ki,5.2,CHEMBL310843,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,61,5,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3ccc4ccnn4c3)CC2)cc1,CHEMBL672382,Ki,4.89,CHEMBL432059,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,26,480,c1ccc(N2CCN(Cc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3ccc4ccnn4c3)CC2)cc1,CHEMBL672572,Ki,4.82,CHEMBL432059,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,26,481,c1ccc(N2CCN(Cc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cccc4ccnn34)CC2)cc1,CHEMBL672382,Ki,4.51,CHEMBL88937,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,26,480,c1ccc(N2CCN(Cc3cccc4ccnn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cccc4ccnn34)CC2)cc1,CHEMBL672572,Ki,4.17,CHEMBL88937,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,26,481,c1ccc(N2CCN(Cc3cccc4ccnn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cccc4ccnn34)CC2)cc1,CHEMBL839477,Ki,4.51,CHEMBL88937,2005,CHEMBL1141881,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 long,41,457,c1ccc(N2CCN(Cc3cccc4ccnn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cccn4nccc34)CC2)cc1,CHEMBL672382,Ki,4.8,CHEMBL90374,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,26,480,c1ccc(N2CCN(Cc3cccn4nccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cccn4nccc34)CC2)cc1,CHEMBL672572,Ki,4.68,CHEMBL90374,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,26,481,c1ccc(N2CCN(Cc3cccn4nccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cccs3)CC2)cc1Cl,CHEMBL2423805,Ki,5.8,CHEMBL2420777,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,92,493,c1ccc(N2CCN(Cc3cccs3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cn4cc(Br)ccc4n3)CC2)cc1Cl,CHEMBL866799,Ki,5.46,CHEMBL210341,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cn4cc(Br)ccc4n3)CC2)cc1Cl,CHEMBL866800,Ki,5.43,CHEMBL210341,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,CHEMBL866799,Ki,4.82,CHEMBL212370,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,CHEMBL866800,Ki,4.8,CHEMBL212370,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1Cl,CHEMBL866799,Ki,5.5,CHEMBL378680,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1Cl,CHEMBL866800,Ki,5.57,CHEMBL378680,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2)cc1,CHEMBL866799,Ki,4.92,CHEMBL211135,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cn4ncccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2)cc1,CHEMBL866800,Ki,5.09,CHEMBL211135,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cn4ncccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cn4nc(N5CCCCC5)ccc4n3)CC2)cc1Cl,CHEMBL866799,Ki,5.96,CHEMBL207543,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cn4nc(N5CCCCC5)ccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cn4nc(N5CCCCC5)ccc4n3)CC2)cc1Cl,CHEMBL866800,Ki,6.15,CHEMBL207543,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cn4nc(N5CCCCC5)ccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL871242,Ki,5.54,CHEMBL210955,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,49,66,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL871243,Ki,5.72,CHEMBL210955,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,49,67,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL913685,Ki,5.54,CHEMBL210955,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,56,44,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4c(-c5ccccc5)cccc34)CC2)cc1,CHEMBL671731,Ki,5.27,CHEMBL155913,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,31,45,c1ccc(-c2cccc3c(CN4CCN(c5ccccc5)CC4)cnn23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4c(-c5ccccc5)cccc34)CC2)cc1,CHEMBL671732,Ki,5.55,CHEMBL155913,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(-c2cccc3c(CN4CCN(c5ccccc5)CC4)cnn23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4c(I)cccc34)CC2)cc1,CHEMBL913685,Ki,5.12,CHEMBL218787,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,56,44,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4c(N5CCN(Cc6ccccc6)CC5)cccc34)CC2)cc1,CHEMBL671731,Ki,6.19,CHEMBL160266,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,31,45,c1ccc(CN2CCN(c3cccc4c(CN5CCN(c6ccccc6)CC5)cnn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4c(N5CCN(Cc6ccccc6)CC5)cccc34)CC2)cc1,CHEMBL671732,Ki,6.4,CHEMBL160266,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(CN2CCN(c3cccc4c(CN5CCN(c6ccccc6)CC5)cnn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL3292986,Ki,5.5,CHEMBL7927,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,101,846,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL4039193,Ki,5.37,CHEMBL7927,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 (short) receptor,126,887,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL4039194,Ki,5.5,CHEMBL7927,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 (long) receptor (unknown origin),126,888,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL5235409,Ki,5.5,CHEMBL7927,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,151,478,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL671363,Ki,5.5,CHEMBL7927,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,31,34,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL671365,Ki,5.37,CHEMBL7927,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,31,35,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL671731,Ki,5.5,CHEMBL7927,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,31,45,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL671732,Ki,5.37,CHEMBL7927,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL672382,Ki,5.5,CHEMBL7927,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,26,480,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL672572,Ki,5.37,CHEMBL7927,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,26,481,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL839477,Ki,5.5,CHEMBL7927,2005,CHEMBL1141881,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 long,41,457,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL866799,Ki,5.5,CHEMBL7927,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL866800,Ki,5.37,CHEMBL7927,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL913685,Ki,5.55,CHEMBL7927,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,56,44,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL934518,Ki,5.54,CHEMBL7927,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,61,4,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL934519,Ki,5.66,CHEMBL7927,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,61,5,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(OCCNCCCOc2ccccc2)cc1,CHEMBL671378,Ki,6.64,CHEMBL132884,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,12,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(OCCNCCCOc2ccccc2)cc1,CHEMBL835389,Ki,6.64,CHEMBL132884,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(OCCNCCCSc2ccccc2)cc1,CHEMBL671378,Ki,6.64,CHEMBL337627,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,12,589,c1ccc(OCCNCCCSc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc(SCCNCCCOc2ccccc2)cc1,CHEMBL671378,Ki,6.45,CHEMBL130347,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,12,589,c1ccc(OCCCNCCSc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc([C@@H]2C[C@H]2NCCC2(c3ccccn3)CCOC3(CCCC3)C2)cc1,CHEMBL5363864,Ki,5.26,CHEMBL5433458,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,158,244,c1ccc(C2CC2NCCC2(c3ccccn3)CCOC3(CCCC3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc([C@@H]2C[C@H]2NCCC2(c3ccccn3)CCOCC2)cc1,CHEMBL5363864,Ki,5.39,CHEMBL5418730,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,158,244,c1ccc(C2CC2NCCC2(c3ccccn3)CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2[nH]c(C3=CCN(Cc4ccccc4)CC3)nc2c1,CHEMBL670393,Ki,6.23,CHEMBL71324,1997,CHEMBL1130515,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,12,68,C1=C(c2nc3ccccc3[nH]2)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c2c1,CHEMBL872394,Ki,7.5,CHEMBL370359,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2[nH]ccc2c1N1CCN(Cc2ccccc2)CC1,CHEMBL884862,Ki,7.09,CHEMBL311539,1998,CHEMBL1130595,Bioorg Med Chem Lett,Scientific Literature,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,14,1,c1ccc(CN2CCN(c3cccc4[nH]ccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(CCCN3CCN(c4cccc5c4OCCO5)CC3)c[nH]c2c1,CHEMBL872394,Ki,8.68,CHEMBL194240,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)C(N1CCN(C3CCCCC3)CC1)=Nc1cccnc1N2,CHEMBL673081,Ki,6.24,CHEMBL148559,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,31,551,c1cnc2c(c1)N=C(N1CCN(C3CCCCC3)CC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)C(N1CCN(CCc3ccccc3)CC1)=Nc1cccnc1N2,CHEMBL5235410,Ki,6.05,CHEMBL436274,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in Sf9 cells assessed as inhibition constant measured after 60 mins,151,889,c1ccc(CCN2CCN(C3=Nc4cccnc4Nc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)C(N1CCN(CCc3ccccc3)CC1)=Nc1cccnc1N2,CHEMBL673081,Ki,6.05,CHEMBL436274,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,31,551,c1ccc(CCN2CCN(C3=Nc4cccnc4Nc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)C(N1CCN(Cc3ccccc3)CC1)=Nc1cccnc1N2,CHEMBL673081,Ki,5.0,CHEMBL146856,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,31,551,c1ccc(CN2CCN(C3=Nc4cccnc4Nc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1S2,CHEMBL3705566,Ki,9.15,CHEMBL3646150,2014,CHEMBL3639279,,BindingDB Patent Bioactivity Data,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",101,607,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)C(NC1CC3CCC(C1)N3Cc1ccccc1)=Nc1cccnc1N2,CHEMBL673081,Ki,6.87,CHEMBL148353,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,31,551,c1ccc(CN2C3CCC2CC(NC2=Nc4cccnc4Nc4ccccc42)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)C(NC1CCN(Cc3ccccc3)CC1)=Nc1cccnc1N2,CHEMBL673081,Ki,6.74,CHEMBL342536,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,31,551,c1ccc(CN2CCC(NC3=Nc4cccnc4Nc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2,CHEMBL670398,Ki,7.5,CHEMBL291417,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)CC(CCN1CCN(c3ccccn3)CC1)C2,CHEMBL4815619,Ki,5.91,CHEMBL4866058,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,151,118,c1ccc(N2CCN(CCC3Cc4ccccc4C3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)N=C(N1CCN(Cc3ccc(OCCCN4CCCCC4)cc3)CC1)c1ccccc1N2,CHEMBL1030600,Ki,6.54,CHEMBL464811,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,65,518,c1ccc2c(c1)N=C(N1CCN(Cc3ccc(OCCCN4CCCCC4)cc3)CC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)N=C(N1CCN(Cc3ccc4c(c3)OCCO4)CC1)c1ccccc1N2,CHEMBL911524,Ki,7.54,CHEMBL213577,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,49,194,c1ccc2c(c1)N=C(N1CCN(Cc3ccc4c(c3)OCCO4)CC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)N=C(N1CCN(Cc3cccc4c3OCO4)CC1)c1ccccc1N2,CHEMBL911524,Ki,7.1,CHEMBL211915,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,49,194,c1ccc2c(c1)N=C(N1CCN(Cc3cccc4c3OCO4)CC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)N=C(N1CCN(c3ccccc3)CC1)CCN2,CHEMBL5235411,Ki,5.33,CHEMBL5286175,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2 receptor assessed as inhibition constant,151,890,c1ccc(N2CCN(C3=Nc4ccccc4NCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,CHEMBL4816284,Ki,6.31,CHEMBL845,2021,CHEMBL4813978,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells assessed as inhibition of dopamine-induced calcium accumulation,151,449,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2nc(CCCN3CCN(c4ccccn4)CC3)sc2c1,CHEMBL5324908,Ki,5.62,CHEMBL5403986,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,158,704,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2nc(CCCN3CCN(c4ccccn4)CC3)sc2c1,CHEMBL5324922,IC50,4.62,CHEMBL5403986,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,158,706,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2nc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)cn2n1,CHEMBL866799,Ki,5.96,CHEMBL209034,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cn4ncccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2nc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)cn2n1,CHEMBL866800,Ki,6.17,CHEMBL209034,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cn4ncccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2sc(CCCCN3CCC4CCCCC4C3)nc2c1,CHEMBL3863657,Ki,5.96,CHEMBL3941795,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,119,59,c1ccc2sc(CCCCN3CCC4CCCCC4C3)nc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2sc(CCCCN3CCc4c(Cl)cccc4C3)nc2c1,CHEMBL3863657,Ki,6.07,CHEMBL3971383,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,119,59,c1ccc2c(c1)CCN(CCCCc1nc3ccccc3s1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2sc(CCCCN3CCc4ccccc4C3)nc2c1,CHEMBL3863657,Ki,6.86,CHEMBL3970299,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,119,59,c1ccc2c(c1)CCN(CCCCc1nc3ccccc3s1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2sc(CCCN3CCN(c4ccccn4)CC3)nc2c1,CHEMBL5324908,Ki,4.85,CHEMBL5400983,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,158,704,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccc2sc(CCCN3CCN(c4ccccn4)CC3)nc2c1,CHEMBL5324912,IC50,4.94,CHEMBL5400983,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,158,705,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(C(OC2CC3CCC(C2)N3CCCc2ccccc2)c2ccccc2)c1,CHEMBL671385,Ki,7.23,CHEMBL106660,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,c1ccc(CCCN2C3CCC2CC(OC(c2ccccc2)c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL2169117,Ki,7.38,CHEMBL2165137,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,84,205,c1ccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL3887359,Ki,7.38,CHEMBL2165137,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",111,117,c1ccc(C2CCN(CCCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL2169117,Ki,7.12,CHEMBL2165138,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,84,205,c1ccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL3887359,Ki,7.12,CHEMBL2165138,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",111,117,c1ccc(C2CCN(CCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(CN2CC=C(c3nc4ccccc4s3)CC2)c1,CHEMBL670393,Ki,6.47,CHEMBL307869,1997,CHEMBL1130515,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor in CHO cells,12,68,C1=C(c2nc3ccccc3s2)CCN(Cc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL2169117,Ki,7.75,CHEMBL2165114,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,84,205,c1ccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL3887359,Ki,7.75,CHEMBL2165114,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",111,117,c1ccc(N2CCCN(CCCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL2169117,Ki,7.7,CHEMBL2165140,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,84,205,c1ccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL3887359,Ki,7.7,CHEMBL2165140,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",111,117,c1ccc(N2CCCN(CCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCC3(c4ccccn4)CCOCC3)CC2)c1Cl,CHEMBL5363864,Ki,6.92,CHEMBL5399270,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,158,244,c1ccc(N2CCN(CCC3(c4ccccn4)CCOCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCN3CCc4ncsc4CC3)CC2)c1Cl,CHEMBL4334858,Ki,7.74,CHEMBL4439577,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,138,774,c1ccc(N2CCN(CCCCN3CCc4ncsc4CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCNCCC3(c4ccccn4)CCOCC3)CC2)c1Cl,CHEMBL5363864,Ki,6.02,CHEMBL5407747,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,158,244,c1ccc(N2CCN(CCCCNCCC3(c4ccccn4)CCOCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1Cl,CHEMBL1225816,Ki,9.26,CHEMBL1223856,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,73,794,c1ccc(-c2ccnc(NCCCCN3CCN(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1Cl,CHEMBL1225816,Ki,9.23,CHEMBL1223800,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,73,794,c1ccc(-c2ccc(NCCCCN3CCN(c4ccccc4)CC3)nc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1Cl,CHEMBL1225816,Ki,9.22,CHEMBL1223683,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,73,794,c1ccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1Cl,CHEMBL1225816,Ki,9.4,CHEMBL1223616,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,73,794,c1ccc(N2CCN(CCCCNc3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1Cl,CHEMBL1225816,Ki,8.51,CHEMBL1223749,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,73,794,c1ccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3cc4ccccn4n3)CC2)c1Cl,CHEMBL3295080,Ki,8.03,CHEMBL3287394,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,101,391,c1ccc(N2CCN(CCCCOc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3cc4ccccn4n3)CC2)c1Cl,CHEMBL3295081,Ki,8.0,CHEMBL3287394,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,101,392,c1ccc(N2CCN(CCCCOc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)c1Cl,CHEMBL895394,Ki,7.17,CHEMBL387784,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,56,795,c1ccc(N2CCN(CCCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)c1Cl,CHEMBL3295080,Ki,8.38,CHEMBL3287392,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,101,391,c1ccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)c1Cl,CHEMBL3295081,Ki,8.68,CHEMBL3287392,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,101,392,c1ccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,CHEMBL2169117,Ki,7.18,CHEMBL2165134,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,84,205,c1ccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,CHEMBL3887359,Ki,7.18,CHEMBL2165134,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",111,117,c1ccc(N2CCN(CCCCOc3ccc4cn[nH]c4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL2169117,Ki,7.77,CHEMBL2165136,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,84,205,c1ccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL3887359,Ki,7.77,CHEMBL2165136,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",111,117,c1ccc(N2CCN(CCCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3cccc4ccnn34)CC2)c1Cl,CHEMBL3295080,Ki,7.19,CHEMBL3287393,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,101,391,c1ccc(N2CCN(CCCCOc3cccc4ccnn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3cccc4ccnn34)CC2)c1Cl,CHEMBL3295081,Ki,7.8,CHEMBL3287393,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,101,392,c1ccc(N2CCN(CCCCOc3cccc4ccnn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3cccn4nccc34)CC2)c1Cl,CHEMBL3295080,Ki,7.6,CHEMBL3287391,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,101,391,c1ccc(N2CCN(CCCCOc3cccn4nccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3cccn4nccc34)CC2)c1Cl,CHEMBL3295081,Ki,7.52,CHEMBL3287391,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,101,392,c1ccc(N2CCN(CCCCOc3cccn4nccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl,CHEMBL3295080,Ki,7.47,CHEMBL3287390,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,101,391,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c1Cl,CHEMBL3295081,Ki,7.41,CHEMBL3287390,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,101,392,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCc3cn(-c4ccc5[nH]ccc5c4)nn3)CC2)c1Cl,CHEMBL3591124,Ki,7.33,CHEMBL3588919,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,111,753,c1ccc(N2CCN(CCCCc3cn(-c4ccc5[nH]ccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCc3cn(-c4ccc5c(c4)Cc4ccccc4-5)nn3)CC2)c1Cl,CHEMBL3591124,Ki,6.37,CHEMBL3588918,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,112,753,c1ccc(N2CCN(CCCCc3cn(-c4ccc5c(c4)Cc4ccccc4-5)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCc3cn(-c4ccc5ccccc5c4)nn3)CC2)c1Cl,CHEMBL3591124,Ki,7.09,CHEMBL3588917,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,112,753,c1ccc(N2CCN(CCCCc3cn(-c4ccc5ccccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,CHEMBL3614290,Ki,7.64,CHEMBL3613880,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,112,431,c1ccc(N2CCN(CCCCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,CHEMBL3614291,Ki,8.14,CHEMBL3613880,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,112,801,c1ccc(N2CCN(CCCCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCn3cc(-c4ccc(-c5ccccc5)cc4)nn3)CC2)c1Cl,CHEMBL3591124,Ki,5.59,CHEMBL3588988,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,112,753,c1ccc(-c2ccc(-c3cn(CCCCN4CCN(c5ccccc5)CC4)nn3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCn3cc(-c4ccc5[nH]ccc5c4)nn3)CC2)c1Cl,CHEMBL3591124,Ki,7.25,CHEMBL3588986,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,112,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5[nH]ccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCn3cc(-c4ccc5c(c4)Cc4ccccc4-5)nn3)CC2)c1Cl,CHEMBL3591124,Ki,6.05,CHEMBL3588985,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,112,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5c(c4)Cc4ccccc4-5)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCn3cc(-c4ccc5ccccc5c4)nn3)CC2)c1Cl,CHEMBL3591124,Ki,6.99,CHEMBL3588984,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,112,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5ccccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCCn3cc(-c4ccc5ncccc5c4)nn3)CC2)c1Cl,CHEMBL3591124,Ki,7.27,CHEMBL3588987,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,112,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5ncccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCOC3(c4ccccn4)CCOCC3)CC2)c1Cl,CHEMBL5363864,Ki,7.23,CHEMBL5425944,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,158,244,c1ccc(N2CCN(CCCOC3(c4ccccn4)CCOCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)c1Cl,CHEMBL895394,Ki,7.36,CHEMBL230971,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,56,795,c1ccc(N2CCN(CCCOc3ccc(-c4cn5ccccc5n4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)c1,CHEMBL3073105,Ki,5.85,CHEMBL84819,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),92,427,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)c1,CHEMBL670391,Ki,5.85,CHEMBL84819,1995,CHEMBL1149936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,6,428,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,CHEMBL2169117,Ki,6.98,CHEMBL2165116,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,84,205,c1ccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)c1Cl,CHEMBL3887359,Ki,6.98,CHEMBL2165116,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",112,117,c1ccc(N2CCN(CCCOc3ccc4cn[nH]c4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL2169117,Ki,7.52,CHEMBL2165139,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,84,205,c1ccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)c1Cl,CHEMBL3887359,Ki,7.52,CHEMBL2165139,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",112,117,c1ccc(N2CCN(CCCOc3ccc4scnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,CHEMBL3614290,Ki,6.89,CHEMBL3613879,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,112,431,c1ccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,CHEMBL3614291,Ki,7.27,CHEMBL3613879,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,112,801,c1ccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)c1Cl,CHEMBL672206,Ki,7.96,CHEMBL350352,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,14,62,c1ccc(N2CCN(CCC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,CHEMBL3614290,Ki,7.66,CHEMBL3613878,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,112,431,c1ccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl,CHEMBL3614291,Ki,8.0,CHEMBL3613878,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,112,801,c1ccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1,CHEMBL671074,IC50,6.84,CHEMBL1202221,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(C[C@H]3C[C@@H]3c3ccccc3)CC2)c1Cl,CHEMBL671074,IC50,8.7,CHEMBL1202213,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)c1Cl,CHEMBL2423805,Ki,6.3,CHEMBL2420895,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,92,493,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(Cc3cccc4ccccc34)CC2)c1Cl,CHEMBL2423805,Ki,6.46,CHEMBL2420782,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,92,493,c1ccc(N2CCN(Cc3cccc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(Cc3ccccc3)CC2)c1Cl,CHEMBL2423805,Ki,6.62,CHEMBL2420893,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,92,493,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(Cc3cccnc3)CC2)c1Cl,CHEMBL2423805,Ki,6.49,CHEMBL2420780,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,92,493,c1ccc(N2CCN(Cc3cccnc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(Cc3cccs3)CC2)c1Cl,CHEMBL2423805,Ki,5.81,CHEMBL2420772,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,92,493,c1ccc(N2CCN(Cc3cccs3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCN(Cc3csc4ccccc34)CC2)c1Cl,CHEMBL2423805,Ki,6.42,CHEMBL2420891,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,92,493,c1ccc(N2CCN(Cc3csc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCNCC2)c1Cl,CHEMBL2168000,Ki,6.86,CHEMBL1424807,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,84,254,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(N2CCNCC2)c1Cl,CHEMBL3300162,Ki,5.94,CHEMBL1424807,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,101,146,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(Nc2nc(Cc3ccccc3)nc3c2CCNCC3)c1,CHEMBL2396124,IC50,7.07,CHEMBL2393245,2013,CHEMBL2390866,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,92,743,c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(OCCNCCCOc2ccccc2)c1,CHEMBL671378,Ki,7.66,CHEMBL129534,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,12,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc(OCCNCCCOc2ccccc2)c1,CHEMBL835389,Ki,7.66,CHEMBL129534,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c12,CHEMBL872394,Ki,7.62,CHEMBL365605,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc2c(CCCN3CCN(c4cccc5c4OCCO5)CC3)c[nH]c12,CHEMBL872394,Ki,7.81,CHEMBL194510,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc2c1CN(CCCCc1nc3ccccc3s1)CC2,CHEMBL3863657,Ki,6.57,CHEMBL3899099,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,119,59,c1ccc2c(c1)CCN(CCCCc1nc3ccccc3s1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc2sc(CCCN3CCN(c4ccccn4)CC3)nc12,CHEMBL5324908,Ki,5.19,CHEMBL5422150,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,158,704,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cccc2sc(CCCN3CCN(c4ccccn4)CC3)nc12,CHEMBL5324912,IC50,5.52,CHEMBL5422150,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,158,705,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1,CHEMBL3073105,Ki,6.9,CHEMBL88058,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),92,427,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccccc1N1CCN(CCCOc2ccc(-c3nc4ccccc4[nH]3)cc2)CC1,CHEMBL670391,Ki,6.9,CHEMBL88058,1995,CHEMBL1149936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,6,428,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccccc1N1CCN(C[C@H]2C[C@@H]2c2ccccc2)CC1,CHEMBL671074,IC50,8.3,CHEMBL1202215,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccccc1N1CCN(Cc2cccs2)CC1,CHEMBL2423805,Ki,5.66,CHEMBL2420771,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,92,493,c1ccc(N2CCN(Cc3cccs3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccccc1OCCNCCCOc1ccccc1,CHEMBL671378,Ki,6.95,CHEMBL131396,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,12,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1ccccc1OCCNCCCOc1ccccc1,CHEMBL835389,Ki,6.95,CHEMBL131396,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cncc(NCCCCN2CCN(c3ccccc3)CC2)n1,CHEMBL4137914,Ki,7.28,CHEMBL4171171,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1ccc(N2CCN(CCCCNc3cnccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1cncc(NCCCN2CCN(c3ccccc3)CC2)n1,CHEMBL4137914,Ki,5.66,CHEMBL4176490,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1ccc(N2CCN(CCCNc3cnccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1nccc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12,CHEMBL1061432,Ki,5.58,CHEMBL559868,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,c1ccc(N2CCN(Cc3c[nH]c4cnccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1nccc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12,CHEMBL1061433,Ki,5.54,CHEMBL559868,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,c1ccc(N2CCN(Cc3c[nH]c4cnccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Clc1sc(Cl)c2c1CCCc1c[nH]nc1-2,CHEMBL672165,Ki,6.27,CHEMBL317770,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,36,434,c1scc2c1CCCc1c[nH]nc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(-c2ccccc2)cn(C2CCN(Cc3ccccc3)CC2)c1=O,CHEMBL671375,Ki,7.96,CHEMBL91669,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,19,496,O=c1[nH]c(-c2ccccc2)cn1C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccc(Cl)cc5)CC4)c(-c4ccccc4)cn23)n(C)c1=O,CHEMBL3423552,Ki,8.05,CHEMBL3423338,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,112,866,O=c1[nH]c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5)CC4)c(-c4ccccc4)cn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccc(Cl)cc5)CC4)c(=O)ccn23)n(C)c1=O,CHEMBL3423552,Ki,6.67,CHEMBL3423379,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,112,866,O=c1[nH]c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5)CC4)c(=O)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccc(Cl)cc5)CC4)ccn23)n(C)c1=O,CHEMBL3423552,Ki,6.59,CHEMBL3423334,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,112,866,O=c1[nH]c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5)CC4)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5O)CC4)c(-c4ccccc4)cn23)n(C)c1=O,CHEMBL3423552,Ki,7.62,CHEMBL3423333,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,112,866,O=c1[nH]c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5)CC4)c(-c4ccccc4)cn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5O)CC4)c(=O)ccn23)n(C)c1=O,CHEMBL3423552,Ki,6.47,CHEMBL3423377,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,112,866,O=c1[nH]c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5)CC4)c(=O)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5O)CC4)ccn23)n(C)c1=O,CHEMBL3423552,Ki,6.58,CHEMBL3423329,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,112,866,O=c1[nH]c(=O)c2c(nc3n(CCCCCN4CCN(c5ccccc5)CC4)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(nc3n(CCCCN4CCN(c5ccc(Cl)cc5)CC4)c(-c4ccccc4)cn23)n(C)c1=O,CHEMBL3423552,Ki,7.64,CHEMBL3423337,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,112,866,O=c1[nH]c(=O)c2c(nc3n(CCCCN4CCN(c5ccccc5)CC4)c(-c4ccccc4)cn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(nc3n(CCCCN4CCN(c5ccc(Cl)cc5)CC4)c(=O)ccn23)n(C)c1=O,CHEMBL3423552,Ki,7.17,CHEMBL3423378,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,112,866,O=c1[nH]c(=O)c2c(nc3n(CCCCN4CCN(c5ccccc5)CC4)c(=O)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(nc3n(CCCCN4CCN(c5ccccc5O)CC4)c(-c4ccccc4)cn23)n(C)c1=O,CHEMBL3423552,Ki,8.4,CHEMBL3423332,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,112,866,O=c1[nH]c(=O)c2c(nc3n(CCCCN4CCN(c5ccccc5)CC4)c(-c4ccccc4)cn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(nc3n(CCCCN4CCN(c5ccccc5O)CC4)ccn23)n(C)c1=O,CHEMBL3423552,Ki,6.16,CHEMBL3423328,2015,CHEMBL3421538,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by microbeta plate reader based method,112,866,O=c1[nH]c(=O)c2c(nc3n(CCCCN4CCN(c5ccccc5)CC4)ccn23)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(ncn2CCCN2CCC(C(c3ccccc3)c3ccccc3)CC2)n(C)c1=O,CHEMBL671744,IC50,7.39,CHEMBL338611,1995,CHEMBL1128457,J Med Chem,Scientific Literature,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,6,164,O=c1[nH]c(=O)c2c(ncn2CCCN2CCC(C(c3ccccc3)c3ccccc3)CC2)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)c2c(ncn2CCCN2CCN(C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)n(C)c1=O,CHEMBL671744,IC50,7.37,CHEMBL553331,1995,CHEMBL1128457,J Med Chem,Scientific Literature,Compound is evaluated for in vitro receptor binding affinity against Dopamine receptor D2,6,164,O=c1[nH]c(=O)c2c(ncn2CCCN2CCN(C(c3ccccc3)c3ccccc3)CC2)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)ccc2cc(/C=C/C(=O)NCCCCN3CCc4ccc(OS(=O)(=O)C(F)(F)F)cc4C3)ccc21,CHEMBL672227,Ki,6.5,CHEMBL292577,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,19,131,O=C(C=Cc1ccc2[nH]c(=O)ccc2c1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)ccn(CCCCN2CCN(c3cc(C(F)(F)F)nc(C(C)(C)C)n3)CC2)c1=O,CHEMBL865866,Ki,6.21,CHEMBL200026,2006,CHEMBL1149389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,49,168,O=c1ccn(CCCCN2CCN(c3ccncn3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)cnn(CCCCN2CCN(c3cccc4ccc(O[11CH3])cc34)CC2)c1=O,CHEMBL868787,Ki,7.66,CHEMBL199824,2006,CHEMBL1148600,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor,49,891,O=c1cnn(CCCCN2CCN(c3cccc4ccccc34)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)cnn(CCCCN2CCN(c3ccccc3OCCF)CC2)c1=O,CHEMBL2416736,Ki,7.43,CHEMBL2413153,2013,CHEMBL2413016,Bioorg Med Chem,Scientific Literature,Binding affinity to dopamine 2 receptor (unknown origin),92,892,O=c1cnn(CCCCN2CCN(c3ccccc3)CC2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(=O)oc2c(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)cccc21,CHEMBL672308,Ki,8.0,CHEMBL306634,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,26,593,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(C(N)=O)ccc1-c1cccc(OC(=O)NCCN2CCN(c3ccccc3)CC2)c1,CHEMBL4409079,Ki,7.25,CHEMBL4517296,2019,CHEMBL4406846,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,138,837,O=C(NCCN1CCN(c2ccccc2)CC1)Oc1cccc(-c2ccc[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc(-c2ccccc2)c1C(=O)NC(C)(C)C,CHEMBL5236927,IC50,6.79,CHEMBL5274672,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,151,142,c1ccc(-c2c[nH]c(CCCN3CCN(c4ccccc4)CC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc(-c2ccccc2)c1C(=O)NC1CCCCC1,CHEMBL5236927,IC50,5.76,CHEMBL5281787,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,151,142,O=C(NC1CCCCC1)c1[nH]c(CCCN2CCN(c3ccccc3)CC2)nc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc(-c2ccccc2)c1C(=O)NCc1ccccc1,CHEMBL5236927,IC50,8.3,CHEMBL5281830,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,151,142,O=C(NCc1ccccc1)c1[nH]c(CCCN2CCN(c3ccccc3)CC2)nc1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CN2CCC(c3ccc(C(F)(F)F)cc3)CC2)nc2ccccc21,CHEMBL1071924,Ki,6.6,CHEMBL593745,2010,CHEMBL1153221,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,73,893,c1ccc(C2CCN(Cc3nc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CN2CCC(c3ccc(Cl)cc3)CC2)nc2ccccc21,CHEMBL1071924,Ki,7.8,CHEMBL593744,2010,CHEMBL1153221,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,73,893,c1ccc(C2CCN(Cc3nc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CN2CCC(c3cccc(C(F)(F)F)c3)CC2)nc2ccccc21,CHEMBL1071924,Ki,6.9,CHEMBL604993,2010,CHEMBL1153221,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,73,893,c1ccc(C2CCN(Cc3nc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CN2CCC(c3cccc(Cl)c3)CC2)nc2ccccc21,CHEMBL1071924,Ki,7.4,CHEMBL608103,2010,CHEMBL1153221,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,73,893,c1ccc(C2CCN(Cc3nc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CN2CCC(c3ccccc3)CC2)nc2ccccc21,CHEMBL1071924,Ki,7.6,CHEMBL593196,2010,CHEMBL1153221,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,73,893,c1ccc(C2CCN(Cc3nc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CN2CCC(c3ccccc3F)CC2)nc2ccccc21,CHEMBL1071924,Ki,7.4,CHEMBL607689,2010,CHEMBL1153221,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,73,893,c1ccc(C2CCN(Cc3nc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CN2CCC(c3nc4ccccc4s3)CC2)nc2ccccc21,CHEMBL1071924,Ki,6.4,CHEMBL605831,2010,CHEMBL1153221,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,73,893,c1ccc2[nH]c(CN3CCC(c4nc5ccccc5s4)CC3)nc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CN2CCC(c3ncc(C(F)(F)F)cc3Cl)CC2)nc2ccccc21,CHEMBL1071924,Ki,6.1,CHEMBL593056,2010,CHEMBL1153221,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,73,893,c1ccc(C2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CN2CCC(c3nsc4ccccc34)CC2)nc2ccccc21,CHEMBL1071924,Ki,7.1,CHEMBL596527,2010,CHEMBL1153221,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,73,893,c1ccc2[nH]c(CN3CCC(c4nsc5ccccc45)CC3)nc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(CN2CCN(c3ncc(C(F)(F)F)cc3Cl)CC2)nc2ccccc21,CHEMBL1071924,Ki,5.3,CHEMBL605836,2010,CHEMBL1153221,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells co-expressing G0 by [35S]GTPgammaS binding assay,73,893,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)c[nH]c2c1=O,CHEMBL1061432,Ki,6.24,CHEMBL564688,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,O=c1[nH]c(N2CCCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)c[nH]c2c1=O,CHEMBL1061433,Ki,6.42,CHEMBL564688,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,O=c1[nH]c(N2CCCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccc(F)cc4)CC3)c[nH]c2c1=O,CHEMBL1061432,Ki,6.08,CHEMBL559399,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,O=c1[nH]c(N2CCCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccc(F)cc4)CC3)c[nH]c2c1=O,CHEMBL1061433,Ki,6.4,CHEMBL559399,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,O=c1[nH]c(N2CCCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c2c1=O,CHEMBL1061432,Ki,6.41,CHEMBL556288,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,O=c1[nH]c(N2CCCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c2c1=O,CHEMBL1061433,Ki,6.75,CHEMBL556288,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,O=c1[nH]c(N2CCCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccccn4)CC3)c[nH]c2c1=O,CHEMBL1061432,Ki,6.57,CHEMBL551199,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,O=c1[nH]c(N2CCCC2)nc2c(CN3CCN(c4ccccn4)CC3)c[nH]c12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(N2CCCC2)nc2c(CN3CCN(c4ccccn4)CC3)c[nH]c2c1=O,CHEMBL1061433,Ki,6.82,CHEMBL551199,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,O=c1[nH]c(N2CCCC2)nc2c(CN3CCN(c4ccccn4)CC3)c[nH]c12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(N2CCOCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c2c1=O,CHEMBL1061432,Ki,5.96,CHEMBL561123,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2 long receptor expressed in CHO cells,65,569,O=c1[nH]c(N2CCOCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(N2CCOCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c2c1=O,CHEMBL1061433,Ki,6.14,CHEMBL561123,2009,CHEMBL1152959,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2 short receptor expressed in CHO cells,65,570,O=c1[nH]c(N2CCOCC2)nc2c(CN3CCN(c4ccccc4)CC3)c[nH]c12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4c(F)cc(F)cc4F)C3C2)nnc1-c1ccn(C)c(=O)c1,CHEMBL3776608,Ki,5.9,CHEMBL3775350,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,O=c1cc(-c2nnc(SCCCN3CC4CCN(c5ccccc5)C4C3)[nH]2)cc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4c(F)cc(F)cc4F)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,6.2,CHEMBL3774519,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4c(F)cccc4C(F)(F)F)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,6.4,CHEMBL3775946,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4c(F)cccc4F)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,6.2,CHEMBL3775771,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C#N)cc4)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,5.2,CHEMBL3775097,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cc[nH]c(=O)c1,CHEMBL3776608,Ki,6.2,CHEMBL3774411,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,O=c1cc(-c2nnc(SCCCN3CC4CCN(c5ccccc5)C4C3)[nH]2)cc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccc(=O)[nH]c1,CHEMBL3776608,Ki,6.4,CHEMBL3775718,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,O=c1ccc(-c2nnc(SCCCN3CC4CCN(c5ccccc5)C4C3)[nH]2)c[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccc(=O)n(C)c1,CHEMBL3776608,Ki,6.2,CHEMBL3774769,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,O=c1ccc(-c2nnc(SCCCN3CC4CCN(c5ccccc5)C4C3)[nH]2)c[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccccn1,CHEMBL3776608,Ki,6.4,CHEMBL3775554,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5ccccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cccnc1,CHEMBL3776608,Ki,6.1,CHEMBL3775604,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cccnc5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cccnn1,CHEMBL3776608,Ki,6.5,CHEMBL3775583,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cccnn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccncc1,CHEMBL3776608,Ki,6.4,CHEMBL3774490,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5ccncc5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccncn1,CHEMBL3776608,Ki,6.8,CHEMBL3775810,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5ccncn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1ccnnc1,CHEMBL3776608,Ki,6.2,CHEMBL3774534,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5ccnnc5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,6.6,CHEMBL3774683,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1cncnc1,CHEMBL3776608,Ki,5.9,CHEMBL3775572,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cncnc5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1-c1nccs1,CHEMBL3776608,Ki,6.8,CHEMBL3775256,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5nccs5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1C1CCCC1,CHEMBL3776608,Ki,6.7,CHEMBL3774462,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(C5CCCC5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1C1CCCCC1,CHEMBL3776608,Ki,5.2,CHEMBL3774463,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(C5CCCCC5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(C(F)(F)F)cc4)C3C2)nnc1N1CCOCC1,CHEMBL3776608,Ki,6.7,CHEMBL3775243,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(N5CCOCC5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1-c1cc[nH]c(=O)c1,CHEMBL3776608,Ki,6.2,CHEMBL3775033,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,O=c1cc(-c2nnc(SCCCN3CC4CCN(c5ccccc5)C4C3)[nH]2)cc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1-c1ccn(C)c(=O)c1,CHEMBL3776608,Ki,6.4,CHEMBL3774569,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,O=c1cc(-c2nnc(SCCCN3CC4CCN(c5ccccc5)C4C3)[nH]2)cc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,6.7,CHEMBL3774996,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCCCC1,CHEMBL3776608,Ki,6.4,CHEMBL3774431,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(C5CCCCC5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4)C3C2)nnc1C1CCOCC1,CHEMBL3776608,Ki,6.6,CHEMBL3775737,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(C5CCOCC5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4C(F)(F)F)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,5.9,CHEMBL3774911,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(F)cc4F)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,6.4,CHEMBL3774591,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccc(OC(F)(F)F)cc4)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,6.5,CHEMBL3775386,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4cccc(C#N)c4)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,7.0,CHEMBL3775667,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4cccc(C(F)(F)F)c4)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,7.5,CHEMBL3774425,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4cccc(F)c4)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,6.6,CHEMBL3774869,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4cccc(OC(F)(F)F)c4)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,7.0,CHEMBL3774895,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccccc4)C3C2)nnc1C1CCOCC1,CHEMBL3776608,Ki,6.6,CHEMBL3774649,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(C5CCOCC5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccccc4C#N)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,6.7,CHEMBL3775631,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1ccccn1,CHEMBL3776608,Ki,6.5,CHEMBL3775408,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5ccccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cccnc1,CHEMBL3776608,Ki,6.1,CHEMBL3775197,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cccnc5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1ccncc1,CHEMBL3776608,Ki,6.6,CHEMBL3775214,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,119,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5ccncc5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccccc4C(F)(F)F)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,6.5,CHEMBL3774783,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,120,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccccc4F)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,6.4,CHEMBL3775294,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,120,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC3CCN(c4ccccc4OC(F)(F)F)C3C2)nnc1-c1cnccn1,CHEMBL3776608,Ki,7.5,CHEMBL3774621,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,120,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cnccn5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCC(C)(C)CC2)nnc1-c1ccccc1,CHEMBL4397357,Ki,4.22,CHEMBL4555952,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,138,279,c1ccc(-c2nnc(SCCCN3CCCCC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCC3(CC2)CCN(c2ccc(C(F)(F)F)cc2F)CC3)nnc1-c1ccccc1,CHEMBL4397357,Ki,4.67,CHEMBL4435765,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,138,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCC3(CC2)CCN(c2ccc(F)cc2)CC3)nnc1-c1ccccc1,CHEMBL4032441,Ki,5.01,CHEMBL4073927,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,126,714,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCC3(CC2)CCN(c2ccc(F)cc2)CC3)nnc1-c1ccccc1,CHEMBL4397357,Ki,5.01,CHEMBL4073927,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,138,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCC3(CC2)CCN(c2cccc(C#N)c2)CC3)nnc1-c1ccccc1,CHEMBL4032441,Ki,4.24,CHEMBL4076086,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,126,714,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCC3(CC2)CCN(c2cccc(Cl)c2Cl)CC3)nnc1-c1ccccc1,CHEMBL4032441,Ki,5.12,CHEMBL4101993,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,126,714,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCC3(CC2)CCN(c2ccccc2F)CC3)nnc1-c1ccccc1,CHEMBL4397357,Ki,4.58,CHEMBL4555876,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,138,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCC3(CC2)CCN(c2ccccc2O)CC3)nnc1-c1ccccc1,CHEMBL4397357,Ki,4.75,CHEMBL4591835,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,138,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCC3(CC2)CCN(c2ccccc2OCCF)CC3)nnc1-c1ccccc1,CHEMBL4397357,Ki,5.2,CHEMBL4471201,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,138,279,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccc3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCC3(CC2)CCN(c2ccccn2)CC3)nnc1-c1ccccc1,CHEMBL4032441,Ki,4.08,CHEMBL4076527,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,126,714,c1ccc(-c2nnc(SCCCN3CCC4(CC3)CCN(c3ccccn3)CC4)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCC3CC3(c3ccc(C(F)(F)F)cc3)CC2)nnc1-c1ccnnc1,CHEMBL1261449,Ki,6.4,CHEMBL1258034,2010,CHEMBL1255216,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells assessed as inhibition of quinelorane-induced [35S]GTPgammaS binding,73,731,c1ccc(C23CCN(CCCSc4nnc(-c5ccnnc5)[nH]4)CCC2C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCCCC2)nnc1-c1ccccc1,CHEMBL4397357,Ki,4.01,CHEMBL4473583,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,138,279,c1ccc(-c2nnc(SCCCN3CCCCC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCNCC2)nnc1-c1ccccc1,CHEMBL4397357,Ki,4.13,CHEMBL4591203,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,138,279,c1ccc(-c2nnc(SCCCN3CCNCC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1,CHEMBL3768209,Ki,5.3,CHEMBL3764143,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(C2CN(CCCSc3nnc(-c4ccc(-c5ncco5)cc4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2nnco2)cc1,CHEMBL3768209,Ki,4.9,CHEMBL3765285,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(C2CN(CCCSc3nnc(-c4ccc(-c5nnco5)cc4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-n2cnnc2)cc1,CHEMBL3768209,Ki,5.0,CHEMBL3765072,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(C2CN(CCCSc3nnc(-c4ccc(-n5cnnc5)cc4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C#N)cc1,CHEMBL3768209,Ki,5.0,CHEMBL3764639,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(-c2nnc(SCCCN3CCOC(c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)cc1,CHEMBL3768209,Ki,4.95,CHEMBL3765426,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(-c2nnc(SCCCN3CCOC(c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)nc1,CHEMBL3768209,Ki,4.6,CHEMBL3764306,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(C2CN(CCCSc3nnc(-c4cccnc4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(C(N)=O)c1,CHEMBL3768209,Ki,4.8,CHEMBL3764212,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(-c2nnc(SCCCN3CCOC(c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnc1,CHEMBL3768209,Ki,4.8,CHEMBL3764612,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(C2CN(CCCSc3nnc(-c4cccnc4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncc1,CHEMBL3768209,Ki,4.9,CHEMBL3763200,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(C2CN(CCCSc3nnc(-c4ccncc4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccsc1,CHEMBL3768209,Ki,5.1,CHEMBL3764191,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(C2CN(CCCSc3nnc(-c4ccsc4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cncc(C(N)=O)c1,CHEMBL3768209,Ki,4.8,CHEMBL3765422,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(C2CN(CCCSc3nnc(-c4cccnc4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cnccn1,CHEMBL3768209,Ki,5.0,CHEMBL3765169,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(C2CN(CCCSc3nnc(-c4cnccn4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1nccs1,CHEMBL3768209,Ki,5.1,CHEMBL3764884,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(C2CN(CCCSc3nnc(-c4nccs4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCCCC1,CHEMBL3768209,Ki,5.1,CHEMBL3764245,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(C2CN(CCCSc3nnc(C4CCCCC4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3F)C2)nnc1-c1ccc(C(N)=O)cc1,CHEMBL3768209,Ki,4.8,CHEMBL3764597,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,120,132,c1ccc(-c2nnc(SCCCN3CCOC(c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1,CHEMBL3855278,Ki,6.44,CHEMBL3941818,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccc(-c5ncco5)cc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(-c2ncco2)cc1,CHEMBL3855280,Ki,6.17,CHEMBL3941818,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccc(-c5ncco5)cc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(=O)n(C)c1,CHEMBL3855278,Ki,6.06,CHEMBL3922838,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,O=c1ccc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)c[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C#N)cc1,CHEMBL3855278,Ki,6.46,CHEMBL3950540,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C#N)nc1,CHEMBL3855278,Ki,6.16,CHEMBL3922535,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)cc1,CHEMBL3855278,Ki,6.45,CHEMBL3899125,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)cc1,CHEMBL3855280,Ki,6.37,CHEMBL3899125,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)nc1,CHEMBL3855278,Ki,6.26,CHEMBL3950254,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(C(N)=O)nc1,CHEMBL3855280,Ki,6.32,CHEMBL3950254,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(CC(N)=O)cc1,CHEMBL3855278,Ki,6.33,CHEMBL3981856,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccc(S(N)(=O)=O)cc1,CHEMBL3855278,Ki,6.66,CHEMBL3959240,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(-c2ncco2)c1,CHEMBL3855278,Ki,6.3,CHEMBL3920167,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccc(-c5ncco5)c4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(-c2ncco2)c1,CHEMBL3855280,Ki,5.93,CHEMBL3920167,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccc(-c5ncco5)c4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(C(N)=O)c1,CHEMBL3855278,Ki,6.2,CHEMBL3970323,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccc(C(N)=O)c1,CHEMBL3855280,Ki,6.47,CHEMBL3970323,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccc1C(N)=O,CHEMBL3855278,Ki,7.4,CHEMBL3890178,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccn1,CHEMBL3855278,Ki,6.28,CHEMBL3946901,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccccn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccn1,CHEMBL3855280,Ki,6.97,CHEMBL3946901,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccccn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnc1,CHEMBL3855278,Ki,6.05,CHEMBL3938107,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnc1C(F)(F)F,CHEMBL3855278,Ki,6.02,CHEMBL3946313,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnn1,CHEMBL3855278,Ki,5.86,CHEMBL3969386,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccco1,CHEMBL3855278,Ki,6.32,CHEMBL3967806,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccco4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccs1,CHEMBL3855278,Ki,6.46,CHEMBL3976319,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccs4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccs1,CHEMBL3855280,Ki,6.79,CHEMBL3976319,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccs4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccn(C)c(=O)c1,CHEMBL3855278,Ki,5.65,CHEMBL3894853,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,O=c1cc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)cc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccn(C)c(=O)c1,CHEMBL3855280,Ki,5.73,CHEMBL3894853,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,O=c1cc(-c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)cc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncc1,CHEMBL3855278,Ki,6.21,CHEMBL3929083,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccncc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncn1,CHEMBL3855278,Ki,6.53,CHEMBL3958309,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccncn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccnnc1,CHEMBL3855278,Ki,5.81,CHEMBL3940897,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccnnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccoc1,CHEMBL3855278,Ki,6.3,CHEMBL3985419,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccoc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccsc1,CHEMBL3855278,Ki,6.48,CHEMBL3896638,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccsc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cnccn1,CHEMBL3855278,Ki,6.33,CHEMBL3955608,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnccn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1csnn1,CHEMBL3855278,Ki,6.89,CHEMBL3905582,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4csnn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1csnn1,CHEMBL3855280,Ki,6.21,CHEMBL3905582,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4csnn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1nccs1,CHEMBL3855278,Ki,6.37,CHEMBL3914556,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4nccs4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1=CC=NC(=O)C1,CHEMBL3855278,Ki,5.84,CHEMBL3897772,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,O=C1CC(c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)=CC=N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1=CCC(=O)N=C1,CHEMBL3855278,Ki,6.295,CHEMBL3964512,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,O=C1CC=C(c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)C=N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CC2CCC(C1)O2,CHEMBL3855278,Ki,6.13,CHEMBL3903779,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(C4CC5CCC(C4)O5)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CC2CCC(C1)O2,CHEMBL3855280,Ki,6.27,CHEMBL3903779,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(C2CC23CCN(CCCSc2nnc(C4CC5CCC(C4)O5)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCCCC1,CHEMBL3855278,Ki,6.23,CHEMBL3958201,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(C4CCCCC4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCCCC1,CHEMBL3855280,Ki,6.91,CHEMBL3958201,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(C2CC23CCN(CCCSc2nnc(C4CCCCC4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCN(C(N)=O)CC1,CHEMBL3855278,Ki,6.0,CHEMBL3963243,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(C4CCNCC4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCN(C(N)=O)CC1,CHEMBL3855280,Ki,5.93,CHEMBL3963243,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(C2CC23CCN(CCCSc2nnc(C4CCNCC4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCNC(=O)C1,CHEMBL3855278,Ki,5.87,CHEMBL3913849,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,O=C1CC(c2nnc(SCCCN3CCC4(CC4c4ccccc4)C3)[nH]2)CCN1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCOCC1,CHEMBL3855278,Ki,6.09,CHEMBL3948167,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,120,105,c1ccc(C2CC23CCN(CCCSc2nnc(C4CCOCC4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1C1CCOCC1,CHEMBL3855280,Ki,6.16,CHEMBL3948167,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,120,875,c1ccc(C2CC23CCN(CCCSc2nnc(C4CCOCC4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3F)C2)nnc1-c1cccnc1,CHEMBL3855278,Ki,6.14,CHEMBL3949662,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3)C2)nnc1-c1cccnc1,CHEMBL3855278,Ki,6.18,CHEMBL3897134,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3F)C2)nnc1-c1cccnc1,CHEMBL3855278,Ki,6.28,CHEMBL3921885,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccc(F)cc3F)C2)nnc1-c1cccnc1,CHEMBL3855280,Ki,6.41,CHEMBL3921885,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2L receptor expressed in CHO cells coexpressing Galpha16 assessed as inhibition of dopamine-induced Ca2+ stimulation pre-incubated for 10 mins followed by dopamine challenge by Fluo-4AM based fluorometric analysis,121,875,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@@H]3c3ccccc3)C2)nnc1-c1cccnc1,CHEMBL3855278,Ki,5.48,CHEMBL3912897,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccn1,CHEMBL3855278,Ki,6.2,CHEMBL3967683,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccccn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnc1,CHEMBL3855278,Ki,5.87,CHEMBL3956612,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cccnn1,CHEMBL3855278,Ki,5.75,CHEMBL3930825,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cccnn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncc1,CHEMBL3855278,Ki,6.06,CHEMBL3947961,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccncc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccncn1,CHEMBL3855278,Ki,6.36,CHEMBL3984236,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccncn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccnnc1,CHEMBL3855278,Ki,5.59,CHEMBL3939830,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccnnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1cnccn1,CHEMBL3855278,Ki,5.84,CHEMBL3976192,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cnccn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1csnn1,CHEMBL3855278,Ki,6.93,CHEMBL3984387,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4csnn4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2CC[C@]3(C[C@H]3c3ccc(C(F)(F)F)cc3)C2)nnc1-c1nccs1,CHEMBL3855278,Ki,6.33,CHEMBL3895585,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4nccs4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccccc1,CHEMBL1107668,Ki,6.8,CHEMBL1081686,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(-c2nnc(SCCCN3CC4CC4(c4ccccc4)C3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCN2C[C@@H]3C[C@]3(c3ccc(C(F)(F)F)cc3)C2)nnc1-c1ccnnc1,CHEMBL1107668,Ki,6.7,CHEMBL1081867,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,73,703,c1ccc(C23CC2CN(CCCSc2nnc(-c4ccnnc4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1c(SCCCNCC2CC2c2cc(F)ccc2OCCF)nnc1-c1ccccc1,CHEMBL4406061,Ki,5.82,CHEMBL4546749,2020,CHEMBL4402598,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cell membranes measured after 90 mins by microbeta scintillation counting method,144,357,c1ccc(-c2nnc(SCCCNCC3CC3c3ccccc3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1,CHEMBL1261591,Ki,6.51,CHEMBL328187,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,73,108,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccc(-c4c[nH]nn4)cc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)nn1,CHEMBL2327488,Ki,6.51,CHEMBL328187,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,92,552,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccc(-c4c[nH]nn4)cc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cc(-c2nnc(SCCCN3CC4CCN(c5ccc(C(F)(F)F)cc5)C4C3)n2C)cn1,CHEMBL3776608,Ki,6.7,CHEMBL3775036,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,121,203,c1ccc(N2CCC3CN(CCCSc4nnc(-c5cn[nH]c5)[nH]4)CC32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cc(-c2nnc(SCCCN3CC[C@]4(C[C@@H]4c4ccc(C(F)(F)F)cc4)C3)n2C)cn1,CHEMBL3855278,Ki,6.27,CHEMBL3956758,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4cn[nH]c4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cc(CN2CCC(O)(c3ccc(Cl)cc3)CC2)c2ccccc21,CHEMBL902495,Ki,7.53,CHEMBL400827,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,56,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cc(CN2CCc3cc4nc(N)sc4cc3CC2)cn1,CHEMBL2328744,IC50,6.06,CHEMBL2326472,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,92,466,c1nc2cc3c(cc2s1)CCN(Cc1cn[nH]c1)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cc(CN2CCc3cc4nc(N)sc4cc3CC2)cn1,CHEMBL2328745,Ki,7.82,CHEMBL2326472,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,92,467,c1nc2cc3c(cc2s1)CCN(Cc1cn[nH]c1)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cc(S(=O)(=O)N(CC2CC2)C2CCN(CCOc3ccccc3-c3ccccc3)CC2)cn1,CHEMBL3750144,Ki,7.8,CHEMBL3747240,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,121,167,O=S(=O)(c1cn[nH]c1)N(CC1CC1)C1CCN(CCOc2ccccc2-c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cc(S(=O)(=O)N(CC2CC2)C2CCN(CCOc3ccccc3C(C)(C)C)CC2)cn1,CHEMBL3750144,Ki,6.64,CHEMBL3746493,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,121,167,O=S(=O)(c1cn[nH]c1)N(CC1CC1)C1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)n1,CHEMBL2328744,IC50,5.36,CHEMBL2326473,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,92,466,c1cc(CN2CCc3cc4ncsc4cc3CC2)n[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1ccc(CN2CCc3cc4nc(N)sc4cc3CC2)n1,CHEMBL2328745,Ki,6.46,CHEMBL2326473,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,92,467,c1cc(CN2CCc3cc4ncsc4cc3CC2)n[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1ccc2c(N3CCN(CCCCOc4ccc5c(c4)NC(=O)CC5)CC3)cccc21,CHEMBL5236912,Ki,7.92,CHEMBL4445841,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor assessed as inhibition constant,151,251,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5[nH]ccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1ccc2c(S(=O)(=O)N[C@@H]3CCN(CCCc4noc5ccccc45)C3)cccc21,CHEMBL4685403,Ki,8.04,CHEMBL4742856,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cccc2[nH]ccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1ccc2c(S(=O)(=O)N[C@H]3CCN(CCCc4noc5ccccc45)C3)cccc21,CHEMBL4685403,Ki,7.42,CHEMBL4749824,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cccc2[nH]ccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1ccc2cc(S(=O)(=O)N[C@@H]3CCN(CCCc4noc5ccccc45)C3)ccc21,CHEMBL4685403,Ki,9.03,CHEMBL4759492,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccc2[nH]ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1ccc2cc(S(=O)(=O)N[C@H]3CCN(CCCc4noc5ccccc45)C3)ccc21,CHEMBL4685403,Ki,7.91,CHEMBL4785434,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccc2[nH]ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cccc1-c1nnc(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3768209,Ki,5.2,CHEMBL3764739,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,121,132,c1ccc(C2CN(CCCSc3nnc(-c4ccc[nH]4)[nH]3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cnc(S(=O)(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)c1,CHEMBL3707825,Ki,6.94,CHEMBL3664884,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,111,O=S(=O)(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1c[nH]cn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cnc(S(=O)(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)c1,CHEMBL3707837,Ki,7.26,CHEMBL3698019,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",101,112,O=S(=O)(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1c[nH]cn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cncc1-c1c[nH]c2ccc(Br)cc12,CHEMBL4394035,Ki,5.73,CHEMBL4526012,2019,CHEMBL4393658,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,138,505,c1ccc2c(-c3cnc[nH]3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1cncc1-c1c[nH]c2ccc(C(N)=O)cc12,CHEMBL4369114,Ki,5.25,CHEMBL4474827,2018,CHEMBL4368858,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2LR receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,131,506,c1ccc2c(-c3cnc[nH]3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1nc(C(=O)N2CCN(CCN3CCN(c4cccc(Cl)c4Cl)CC3)CC2)c2ccccc21,CHEMBL5145822,Ki,6.89,CHEMBL5200023,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C(c1n[nH]c2ccccc12)N1CCN(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1nc(S(=O)(=O)c2cccc3ccccc23)c2cc(N3CCNCC3)ccc21,CHEMBL1286377,Ki,5.65,CHEMBL1277565,2010,CHEMBL1275334,J Med Chem,Scientific Literature,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,73,192,O=S(=O)(c1cccc2ccccc12)c1n[nH]c2ccc(N3CCNCC3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1ncc2c1-c1c(Cl)sc(Cl)c1CCC2,CHEMBL672165,Ki,6.38,CHEMBL98946,2003,CHEMBL1136188,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 was determined,36,434,c1scc2c1CCCc1cn[nH]c1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1nccc1-c1cccc(C(=O)N[C@H]2CC[C@H](CCN3CCc4ccc(S(C)(=O)=O)cc4CC3)CC2)c1,CHEMBL674348,Ki,6.3,CHEMBL3084605,2003,CHEMBL1145891,J Med Chem,Scientific Literature,Binding affinity against human Dopamine receptor D2 expressed in CHO cells by using [125I]iodosulpiride as radioligand,36,694,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc(-c2ccn[nH]2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1nccc1-c1nnc(SCCCN2CC[C@]3(C[C@@H]3c3ccc(C(F)(F)F)cc3)C2)n1C,CHEMBL3855278,Ki,6.07,CHEMBL3908174,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,c1ccc(C2CC23CCN(CCCSc2nnc(-c4ccn[nH]4)[nH]2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1,CHEMBL1261591,Ki,6.85,CHEMBL319352,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,73,108,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccc(-c4nn[nH]n4)cc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1nnc(-c2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1,CHEMBL2327488,Ki,6.85,CHEMBL319352,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,92,552,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccc(-c4nn[nH]n4)cc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Cn1nnc(Cc2ccc3c(c2)c(C2CCN(CCN4CCNC4=O)CC2)cn3-c2ccc(F)cc2)n1,CHEMBL1261591,Ki,8.57,CHEMBL1259188,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,73,108,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccc(Cc4nn[nH]n4)cc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(CCNCc1ccc2c(c1)Cc1ccccc1-2)CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL1777183,Ki,5.28,CHEMBL1774550,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,c1ccc(N2CCN(CCCCNCc3ccc4c(c3)Cc3ccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)Oc1ccc(CN2CCOC(CCc3ccccc3)C2)cc1,CHEMBL3383656,Ki,5.26,CHEMBL3335538,2014,CHEMBL3352711,ACS Med Chem Lett,Scientific Literature,Inhibition of human dopamine D2L receptor,101,711,c1ccc(CCC2CN(Cc3ccccc3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)Oc1ccc(CN2CCO[C@H](CCc3ccccc3)C2)cc1,CHEMBL3383656,Ki,5.26,CHEMBL3335554,2014,CHEMBL3352711,ACS Med Chem Lett,Scientific Literature,Inhibition of human dopamine D2L receptor,101,711,c1ccc(CCC2CN(Cc3ccccc3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)Oc1cccc(CN2CCN(C3=Nc4cc(Cl)ccc4Nc4ccccc43)CC2)c1,CHEMBL911524,Ki,8.47,CHEMBL215669,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,49,194,c1ccc(CN2CCN(C3=Nc4ccccc4Nc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12,CHEMBL4392130,Ki,5.06,CHEMBL4466483,2019,CHEMBL4390674,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cells measured after 90 mins by microbeta scintillation counting method,138,838,c1cc(-c2ccc(Oc3nccc4ccsc34)cc2)n2ccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12,CHEMBL4392130,Ki,5.12,CHEMBL4469848,2019,CHEMBL4390674,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from recombinant human D2 receptor stably expressed in fibroblast cells measured after 90 mins by microbeta scintillation counting method,138,838,c1cc(-c2ccc(Oc3nccc4occc34)cc2)n2ccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1ccc(/C=C/COCC2CCN(Cc3ccccc3)CC2)cc1,CHEMBL878132,Ki,5.36,CHEMBL430444,1994,CHEMBL1127981,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,4,50,C(=Cc1ccccc1)COCC1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,5.58,CHEMBL110431,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,38,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL3292986,Ki,5.96,CHEMBL3289645,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCC3(c4ccccn4)CCOC4(CCCC4)C3)CC2)n1,CHEMBL5363864,Ki,5.26,CHEMBL5413807,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,158,244,c1ccc(N2CCN(CCC3(c4ccccn4)CCOC4(CCCC4)C3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCC3(c4ccccn4)CCOCC3)CC2)n1,CHEMBL5363864,Ki,5.13,CHEMBL5429207,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,158,244,c1ccc(N2CCN(CCC3(c4ccccn4)CCOCC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCCCNc3cc(-c4ccccc4)ccn3)CC2)c1,CHEMBL1225816,Ki,9.12,CHEMBL1223857,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,73,794,c1ccc(-c2ccnc(NCCCCN3CCN(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc(-c4ccccc4)cn3)CC2)c1,CHEMBL1225816,Ki,8.96,CHEMBL1223801,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,73,794,c1ccc(-c2ccc(NCCCCN3CCN(c4ccccc4)CC3)nc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)c1,CHEMBL1225816,Ki,8.8,CHEMBL1223747,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,73,794,c1ccc(N2CCN(CCCCNc3ccc4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCCCNc3ccccn3)CC2)c1,CHEMBL1225816,Ki,7.77,CHEMBL1223617,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,73,794,c1ccc(N2CCN(CCCCNc3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCCCNc3nc(-c4ccccc4)cs3)CC2)c1,CHEMBL1225816,Ki,7.89,CHEMBL1223859,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,73,794,c1ccc(-c2csc(NCCCCN3CCN(c4ccccc4)CC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCCCNc3ncc(-c4ccccc4)o3)CC2)c1,CHEMBL1225816,Ki,8.02,CHEMBL1223858,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,74,794,c1ccc(-c2cnc(NCCCCN3CCN(c4ccccc4)CC3)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)c1,CHEMBL1225816,Ki,9.0,CHEMBL1223750,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,74,794,c1ccc(N2CCN(CCCCNc3nccc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCCOC3(c4ccccn4)CCOC4(CCCC4)C3)CC2)n1,CHEMBL5363864,Ki,5.88,CHEMBL5423250,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,158,244,c1ccc(N2CCN(CCCOC3(c4ccccn4)CCOC4(CCCC4)C3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCCOC3(c4ccccn4)CCOCC3)CC2)n1,CHEMBL5363864,Ki,5.77,CHEMBL5400356,2023,CHEMBL5360615,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane assessed as inhibition constant incubated for 60 mins by MicroBeta scintillation counting method,158,244,c1ccc(N2CCN(CCCOC3(c4ccccn4)CCOCC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCCc3ccc4[nH]c(=S)[nH]c4c3)CC2)c1,CHEMBL3073105,Ki,8.24,CHEMBL2298819,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),92,427,S=c1[nH]c2ccc(CCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CCOc3ccc4[nH]c(=S)[nH]c4c3)CC2)c1,CHEMBL3073105,Ki,8.23,CHEMBL2298828,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),92,427,S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1cccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)c1,CHEMBL672206,Ki,8.22,CHEMBL165056,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,14,62,c1ccc(N2CCN(CCC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1nc2c(N3CCN(Cc4ccccc4)CC3)cccc2[nH]1,CHEMBL884862,Ki,8.39,CHEMBL88289,1998,CHEMBL1130595,Bioorg Med Chem Lett,Scientific Literature,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,14,1,c1ccc(CN2CCN(c3cccc4[nH]cnc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1nc2c(OCCNCc3ccccc3)cc(Cl)cc2[nH]1,CHEMBL672205,Ki,7.49,CHEMBL86504,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,19,876,c1ccc(CNCCOc2cccc3[nH]cnc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1nc2c(OCCNCc3ccccc3)cccc2[nH]1,CHEMBL672205,Ki,8.76,CHEMBL87192,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,19,876,c1ccc(CNCCOc2cccc3[nH]cnc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC(F)(F)c1nc2c3c(ccc2[nH]1)CCC(CNCc1ccccc1)O3,CHEMBL670555,Ki,6.88,CHEMBL313851,2002,CHEMBL1135019,Bioorg Med Chem Lett,Scientific Literature,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,31,894,c1ccc(CNCC2CCc3ccc4[nH]cnc4c3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC1(F)Oc2cccc(CN3CCN(C4=Nc5cc(Cl)ccc5Nc5ccccc54)CC3)c2O1,CHEMBL911524,Ki,8.1,CHEMBL384634,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,49,194,c1ccc2c(c1)N=C(N1CCN(Cc3cccc4c3OCO4)CC1)c1ccccc1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.92,CHEMBL394065,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,56,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCCOc1cccc(CN2CCN(Cc3cc4ccccc4o3)CC2)c1,CHEMBL1219344,Ki,5.54,CHEMBL1214960,2010,CHEMBL1212881,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,74,426,c1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCOc1ccc(CN2CCN(c3ccc(Cl)cc3)CC2)cc1,CHEMBL931954,Ki,5.96,CHEMBL272073,2008,CHEMBL1143133,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 long receptor,61,670,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCOc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL934518,Ki,4.52,CHEMBL272853,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,61,4,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCOc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,CHEMBL934519,Ki,4.3,CHEMBL272853,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,61,5,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCOc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL934518,Ki,4.18,CHEMBL272873,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,61,4,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCOc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL934519,Ki,4.1,CHEMBL272873,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,61,5,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCOc1cccc(CN2CCN(Cc3cc4ccccc4o3)CC2)c1,CHEMBL1219344,Ki,5.64,CHEMBL1214958,2010,CHEMBL1212881,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,74,426,c1ccc(CN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCOc1cccc(CN2CCN(c3ccc(Cl)cc3)CC2)c1,CHEMBL931954,Ki,6.23,CHEMBL255163,2008,CHEMBL1143133,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 long receptor,61,670,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCOc1ccccc1N1CCN(Cc2cc3ccccn3n2)CC1,CHEMBL934518,Ki,7.34,CHEMBL405260,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,61,4,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCOc1ccccc1N1CCN(Cc2cc3ccccn3n2)CC1,CHEMBL934519,Ki,7.1,CHEMBL405260,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,61,5,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCOc1ccccc1N1CCN(Cc2cnn3ccccc23)CC1,CHEMBL934518,Ki,6.82,CHEMBL411437,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,61,4,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
FCCOc1ccccc1N1CCN(Cc2cnn3ccccc23)CC1,CHEMBL934519,Ki,6.75,CHEMBL411437,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,61,5,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2[nH]c3cc(F)ccc3c2C2CCCNC2)cc1,CHEMBL671367,Ki,7.55,CHEMBL296512,2001,CHEMBL1134475,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,26,554,c1ccc(-c2[nH]c3ccccc3c2C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2[nH]c3cc(F)ccc3c2[C@@H]2CNCC[C@H]2F)cc1,CHEMBL671367,Ki,6.05,CHEMBL523245,2001,CHEMBL1134475,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,26,554,c1ccc(-c2[nH]c3ccccc3c2C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)cc1,CHEMBL672182,Ki,5.83,CHEMBL539999,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,31,52,c1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,CHEMBL672182,Ki,5.6,CHEMBL539235,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,31,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2ccc(CN3CCN(c4cccc5ccoc45)CC3)[nH]2)cc1,CHEMBL672308,Ki,9.38,CHEMBL292187,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,26,593,c1ccc(-c2ccc(CN3CCN(c4cccc5ccoc45)CC3)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1,CHEMBL671073,IC50,7.31,CHEMBL59942,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,14,212,c1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cccc3c(CN4CCN(c5ccc(Cl)cc5)CC4)cnn23)cc1,CHEMBL671731,Ki,4.82,CHEMBL156198,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,31,45,c1ccc(-c2cccc3c(CN4CCN(c5ccccc5)CC4)cnn23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cccc3c(CN4CCN(c5ccc(Cl)cc5)CC4)cnn23)cc1,CHEMBL671732,Ki,4.82,CHEMBL156198,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(-c2cccc3c(CN4CCN(c5ccccc5)CC4)cnn23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cncc(CN3CCN(c4ccc(F)cc4)CC3)c2)cc1,CHEMBL671073,IC50,7.16,CHEMBL291824,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,14,212,c1ccc(-c2cncc(CN3CCN(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cncc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1,CHEMBL4686239,Ki,8.4,CHEMBL4751170,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2S receptor expressed in CHO cell membrane measured after 60 mins by scintillation counting method,144,895,c1ccc(-c2cncc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cncc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1,CHEMBL895618,Ki,8.4,CHEMBL221692,2007,CHEMBL1148822,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,56,452,c1ccc(-c2cncc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cncc(CN3CCN(c4ccccc4)CC3)c2)cc1,CHEMBL671073,IC50,7.64,CHEMBL302904,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,14,212,c1ccc(-c2cncc(CN3CCN(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cncc(CN3CCN(c4ccccc4F)CC3)c2)cc1,CHEMBL671073,IC50,7.6,CHEMBL61682,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,14,212,c1ccc(-c2cncc(CN3CCN(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cncc(CN3CCN(c4ccccn4)CC3)c2)cc1,CHEMBL671073,IC50,7.22,CHEMBL61657,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,14,212,c1ccc(-c2cncc(CN3CCN(c4ccccn4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cncc(CN3CCN(c4cnccn4)CC3)c2)cc1,CHEMBL671073,IC50,6.35,CHEMBL60957,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,15,212,c1ccc(-c2cncc(CN3CCN(c4cnccn4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(-c2cncc(CN3CCN(c4ncccn4)CC3)c2)cc1,CHEMBL671073,IC50,6.92,CHEMBL302183,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,15,212,c1ccc(-c2cncc(CN3CCN(c4ncccn4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(/C=C/COCC2CCN(Cc3ccccc3)CC2)cc1,CHEMBL878132,Ki,5.66,CHEMBL80968,1994,CHEMBL1127981,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,4,50,C(=Cc1ccccc1)COCC1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(C#CCOCCC2CCN(CCc3ccccc3)CC2)cc1,CHEMBL878132,Ki,5.97,CHEMBL308098,1994,CHEMBL1127981,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,4,50,C(#Cc1ccccc1)COCCC1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(C(OC2CC3CCC(C2)N3Cc2cc3ccccc3[nH]2)c2ccc(F)cc2)cc1,CHEMBL671385,Ki,6.66,CHEMBL109299,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,c1ccc(C(OC2CC3CCC(C2)N3Cc2cc3ccccc3[nH]2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(C(OC2CC3CCC(C2)N3Cc2ccc(Cl)c(Cl)c2)c2ccc(F)cc2)cc1,CHEMBL671385,Ki,6.2,CHEMBL267562,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,c1ccc(CN2C3CCC2CC(OC(c2ccccc2)c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(C(OC2CC3CCC(C2)N3Cc2cccc3ccccc23)c2ccc(F)cc2)cc1,CHEMBL671385,Ki,6.42,CHEMBL12004,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,c1ccc(C(OC2CC3CCC(C2)N3Cc2cccc3ccccc23)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(C(OC2CC3CCC(C2)N3Cc2ccccc2)c2ccc(F)cc2)cc1,CHEMBL671385,Ki,6.88,CHEMBL12375,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,c1ccc(CN2C3CCC2CC(OC(c2ccccc2)c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(C(OCCN2C3CCC2CC(OC(c2ccc(F)cc2)c2ccc(F)cc2)C3)c2ccc(F)cc2)cc1,CHEMBL671385,Ki,6.03,CHEMBL323997,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,c1ccc(C(OCCN2C3CCC2CC(OC(c2ccccc2)c2ccccc2)C3)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(C(OCCOC2CC3CCC(C2)N3)c2ccc(F)cc2)cc1,CHEMBL671385,Ki,5.95,CHEMBL110435,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,c1ccc(C(OCCOC2CC3CCC(C2)N3)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(C(O[C@H]2C[C@H]3CC[C@@H](C2)N3CCCCc2ccccc2)c2ccc(F)cc2)cc1,CHEMBL671385,Ki,7.09,CHEMBL2308105,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,c1ccc(CCCCN2C3CCC2CC(OC(c2ccccc2)c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(C(SCCNCCCc2ccccc2)c2ccc(F)cc2)cc1,CHEMBL3863990,Ki,6.64,CHEMBL3126735,2016,CHEMBL3862037,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,121,226,c1ccc(CCCNCCSC(c2ccccc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(C(SCCNCCCc2ccccc2)c2ccc(F)cc2)cc1,CHEMBL3863997,IC50,5.7,CHEMBL3126735,2016,CHEMBL3862037,J Med Chem,Scientific Literature,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,121,896,c1ccc(CCCNCCSC(c2ccccc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(C(c2ccc(F)cc2)N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1,CHEMBL3820048,Ki,6.71,CHEMBL3818799,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,121,897,c1ccc(C(c2ccccc2)N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCCN(c3ccc(Cl)cc3)CC2)cc1,CHEMBL1949469,Ki,6.86,CHEMBL1946253,2012,CHEMBL1944557,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,84,881,c1ccc(CCCCN2CCCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1,CHEMBL1944110,Ki,6.55,CHEMBL1940408,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(CCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1,CHEMBL3292986,Ki,6.55,CHEMBL1940408,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(CCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCN(c3ccc(Cl)cn3)CC2)cc1,CHEMBL4688549,Ki,6.71,CHEMBL4462108,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,151,847,c1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCN(c3cccc(-c4ccccc4)n3)CC2)cc1,CHEMBL4688549,Ki,6.19,CHEMBL4743284,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,151,847,c1ccc(CCCCN2CCN(c3cccc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL1944110,Ki,6.91,CHEMBL1940418,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL3292986,Ki,6.91,CHEMBL1940418,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL4688544,Ki,6.91,CHEMBL1940418,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from dopamine D2 receptor (unknown origin) expressed in HEK293T cells measured after 15 mins by GloSensor cAMP assay,151,898,c1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL4815619,Ki,6.91,CHEMBL1940418,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,151,118,c1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCN(c3ncccn3)CC2)cc1,CHEMBL1944110,Ki,6.57,CHEMBL1940415,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(CCCCN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCN(c3ncccn3)CC2)cc1,CHEMBL3292986,Ki,6.57,CHEMBL1940415,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(CCCCN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCCCN2CCc3ccccc3C2)cc1,CHEMBL3821452,Ki,6.5,CHEMBL3818128,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,121,698,c1ccc(CCCCN2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCN2CCC(CCOCC#Cc3ccccc3)CC2)cc1,CHEMBL878132,Ki,5.74,CHEMBL76927,1994,CHEMBL1127981,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,4,50,C(#Cc1ccccc1)COCCC1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCN2CCC3(C=Cc4cc(F)ccc4O3)CC2)c(F)c1,CHEMBL697295,Ki,6.19,CHEMBL359270,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,31,732,C1=CC2(CCN(CCc3ccccc3)CC2)Oc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCN2CCC3(CCc4c(F)cccc4O3)CC2)c(F)c1,CHEMBL697295,Ki,6.15,CHEMBL147164,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,31,732,c1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCN2CCC3(CCc4ccc(F)cc4O3)CC2)c(F)c1,CHEMBL697295,Ki,6.31,CHEMBL148348,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,31,732,c1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCN2CCC3(CCc4cccc(F)c4O3)CC2)c(F)c1,CHEMBL697295,Ki,6.08,CHEMBL149423,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,31,732,c1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCN2CCC3(CCc4ccccc4C3)CC2)c(F)c1,CHEMBL697295,Ki,6.0,CHEMBL150210,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,31,732,c1ccc(CCN2CCC3(CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)c(F)c1,CHEMBL697295,Ki,6.12,CHEMBL147431,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,31,732,c1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CN2CCC(NCCSC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1,CHEMBL4711026,Ki,5.54,CHEMBL4794406,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,144,140,c1ccc(CN2CCC(NCCSC(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CN2CCC(Nc3ccc(C(F)(F)F)nn3)CC2)cc1F,CHEMBL3239709,Ki,6.8,CHEMBL3234237,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,102,448,c1ccc(CN2CCC(Nc3cccnn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CN2CCN(C3=Nc4cc(Cl)ccc4Nc4ccccc43)CC2)c(F)c1,CHEMBL911524,Ki,6.75,CHEMBL213200,2006,CHEMBL1146903,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from dopamine D2 receptor expressed in CHO cells,49,194,c1ccc(CN2CCN(C3=Nc4ccccc4Nc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cc1,CHEMBL1926041,Ki,5.12,CHEMBL1923292,2011,CHEMBL1921774,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,79,671,c1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cc1,CHEMBL1926042,Ki,5.24,CHEMBL1923292,2011,CHEMBL1921774,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,79,672,c1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cn1,CHEMBL1926041,Ki,4.54,CHEMBL1923416,2011,CHEMBL1921774,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,79,671,c1cncc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cn1,CHEMBL1926042,Ki,4.35,CHEMBL1923416,2011,CHEMBL1921774,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,79,672,c1cncc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,CHEMBL4039163,Ki,6.7,CHEMBL81330,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,126,546,c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,CHEMBL5235409,Ki,6.7,CHEMBL81330,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,151,478,c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(CCNc3cncc(Cl)n3)CC2)cc1,CHEMBL4137914,Ki,5.47,CHEMBL4174330,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1ccc(N2CCN(CCNc3cnccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1,CHEMBL670114,IC50,7.1,CHEMBL349034,1998,CHEMBL1131565,J Med Chem,Scientific Literature,The in vitro intrinsic activity was measured at DA D2 receptor by measuring its ability to increase [3H]thymidine uptake in CHO-K1 cells transfected with the Dopamine receptor D2,15,806,c1ccc(N2CCN(CCC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1,CHEMBL672206,Ki,8.07,CHEMBL349034,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,c1ccc(N2CCN(CCC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,CHEMBL866799,Ki,4.68,CHEMBL380054,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,CHEMBL866800,Ki,4.72,CHEMBL380054,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cn4ccccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(Cc3cn4cccnc4n3)CC2)cc1,CHEMBL866799,Ki,4.26,CHEMBL425064,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cn4cccnc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(Cc3cn4cccnc4n3)CC2)cc1,CHEMBL866800,Ki,4.31,CHEMBL425064,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cn4cccnc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(Cc3cn4ccncc4n3)CC2)cc1,CHEMBL866799,Ki,4.19,CHEMBL377542,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cn4ccncc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(Cc3cn4ccncc4n3)CC2)cc1,CHEMBL866800,Ki,4.17,CHEMBL377542,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cn4ccncc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2)cc1,CHEMBL866799,Ki,5.0,CHEMBL207488,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cn4ncccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(Cc3cn4nc(Cl)ccc4n3)CC2)cc1,CHEMBL866800,Ki,4.92,CHEMBL207488,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cn4ncccc4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL871242,Ki,6.35,CHEMBL437490,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,49,66,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL871243,Ki,6.4,CHEMBL437490,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,49,67,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL913685,Ki,6.35,CHEMBL437490,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,56,44,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCN2CCC(c3ccc(Cl)cc3)CC2)cc1,CHEMBL1944110,Ki,7.39,CHEMBL1940406,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(OCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCN2CCC(c3ccc(Cl)cc3)CC2)cc1,CHEMBL3292986,Ki,7.39,CHEMBL1940406,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(OCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCN2CCCN(c3ccc(Cl)cc3)CC2)cc1,CHEMBL1949469,Ki,6.76,CHEMBL1946126,2012,CHEMBL1944557,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,84,881,c1ccc(OCCCN2CCCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1,CHEMBL1944110,Ki,6.41,CHEMBL1940411,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1,CHEMBL3292986,Ki,6.41,CHEMBL1940411,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,CHEMBL1944110,Ki,7.43,CHEMBL1940412,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL1944110,Ki,6.73,CHEMBL1940420,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL3292986,Ki,6.73,CHEMBL1940420,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCN2CCN(c3ncccn3)CC2)cc1,CHEMBL1944110,Ki,6.2,CHEMBL1940417,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(OCCCN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCN2CCN(c3ncccn3)CC2)cc1,CHEMBL3292986,Ki,6.2,CHEMBL1940417,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(OCCCN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCN2CCc3ccccc3C2)cc1,CHEMBL3821452,Ki,6.78,CHEMBL3819366,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,121,698,c1ccc(OCCCN2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCNCCOc2ccc(Cl)cc2)cc1,CHEMBL671378,Ki,6.61,CHEMBL129757,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,12,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OCCCNCCOc2ccc(Cl)cc2)cc1,CHEMBL835389,Ki,6.61,CHEMBL129757,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,41,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OC[C@@H]2CC[C@@H]3CN(c4ncc(F)cn4)CCN3C2)cc1,CHEMBL670394,Ki,6.01,CHEMBL349699,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OC[C@@H]2CC[C@H]3CN(c4ccc(Cl)cn4)CCN3C2)cc1,CHEMBL670394,Ki,5.73,CHEMBL161982,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,c1ccc(OCC2CCC3CN(c4ccccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OC[C@@H]2CC[C@H]3CN(c4ccc(F)cc4)CCN3C2)cc1,CHEMBL670394,Ki,6.69,CHEMBL166321,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,c1ccc(OCC2CCC3CN(c4ccccc4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1,CHEMBL670394,Ki,5.92,CHEMBL159903,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OC[C@H]2CC[C@@H]3CN(c4ncc(F)cn4)CCN3C2)cc1,CHEMBL670394,Ki,6.71,CHEMBL162873,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(OC[C@H]2CC[C@H]3CN(c4ncc(F)cn4)CCN3C2)cc1,CHEMBL670394,Ki,7.17,CHEMBL163009,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(SCCCN2CCC(c3ccc(Cl)cc3)CC2)cc1,CHEMBL1944110,Ki,6.73,CHEMBL1940405,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(SCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(SCCCN2CCCN(c3ccc(Cl)cc3)CC2)cc1,CHEMBL1949469,Ki,6.12,CHEMBL1946125,2012,CHEMBL1944557,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,84,881,c1ccc(SCCCN2CCCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(SCCCN2CCN(c3ccc(C(F)(F)F)cc3)CC2)cc1,CHEMBL1944110,Ki,5.32,CHEMBL1940410,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(SCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(SCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1,CHEMBL1944110,Ki,6.68,CHEMBL1940409,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(SCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(SCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1,CHEMBL3292986,Ki,6.68,CHEMBL1940409,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(SCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(SCCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL1944110,Ki,6.74,CHEMBL1940419,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(SCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(SCCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL3292986,Ki,6.74,CHEMBL1940419,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(SCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(SCCCN2CCN(c3ncccn3)CC2)cc1,CHEMBL1944110,Ki,6.37,CHEMBL1940416,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,c1ccc(SCCCN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(SCCCN2CCN(c3ncccn3)CC2)cc1,CHEMBL3292986,Ki,6.37,CHEMBL1940416,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(SCCCN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc(SCCCN2CCc3ccccc3C2)cc1,CHEMBL3821452,Ki,6.91,CHEMBL3819556,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,121,698,c1ccc(SCCCN2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccc(Cl)cc3)CC2)cc1,CHEMBL671074,IC50,6.7,CHEMBL1202222,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc([C@H]2C[C@@H]2CN2CCN(c3cccc(Cl)c3)CC2)cc1,CHEMBL671074,IC50,7.25,CHEMBL1202223,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccccc3Cl)CC2)cc1,CHEMBL671074,IC50,7.89,CHEMBL1202219,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",23,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc([Si]2(c3ccc(F)cc3)CCC(N3CCN(c4ccccc4)CC3)C2)cc1,CHEMBL666192,IC50,6.925,CHEMBL134423,1994,CHEMBL1127235,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor,4,899,c1ccc(N2CCN(C3CC[Si](c4ccccc4)(c4ccccc4)C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2[nH]c(CN3CCN(c4ccccn4)CC3)cc2c1,CHEMBL672168,Ki,6.92,CHEMBL77395,2004,CHEMBL1148372,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,38,900,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c2c1,CHEMBL872394,Ki,7.72,CHEMBL193501,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1,CHEMBL4821052,Ki,8.7,CHEMBL4856753,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CCN5CCCCC5)cc4)CC3)noc2c1,CHEMBL4821052,Ki,8.01,CHEMBL4861311,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CCN5CCCCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CCN5CCOCC5)cc4)CC3)noc2c1,CHEMBL4821052,Ki,7.98,CHEMBL4867978,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CCN5CCOCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CCN5CCOCC5)cc4)CC3)noc2c1,CHEMBL4821086,IC50,7.95,CHEMBL4867978,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin),151,901,c1ccc2c(C3CCN(CCCOc4ccc(CCN5CCOCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCCC5)cc4)CC3)noc2c1,CHEMBL4821052,Ki,7.91,CHEMBL4852663,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCCC5)cc4Cl)CC3)noc2c1,CHEMBL4821052,Ki,7.85,CHEMBL4879054,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCCCC5)c(F)c4)CC3)noc2c1,CHEMBL4821052,Ki,7.94,CHEMBL4876719,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCCCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCCCC5)cc4)CC3)noc2c1,CHEMBL4821052,Ki,7.97,CHEMBL4865735,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCCCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCCCC5)cc4F)CC3)noc2c1,CHEMBL4821052,Ki,7.99,CHEMBL4859348,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCCCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)c(Cl)c4)CC3)noc2c1,CHEMBL4821052,Ki,8.27,CHEMBL4863980,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)c(F)c4)CC3)noc2c1,CHEMBL4821052,Ki,8.7,CHEMBL4878271,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1,CHEMBL4821052,Ki,8.82,CHEMBL4870716,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4Cl)CC3)noc2c1,CHEMBL4821052,Ki,8.6,CHEMBL4853342,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4F)CC3)noc2c1,CHEMBL4821052,Ki,8.72,CHEMBL4860828,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),151,248,c1ccc2c(C3CCN(CCCOc4ccc(CN5CCOCC5)cc4)CC3)noc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(CCCN3CCN(c4cccc5c4OCCO5)CC3)c[nH]c2c1,CHEMBL872394,Ki,7.84,CHEMBL369984,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(CCNCc3cccc(OCC(F)(F)C(F)F)c3)c[nH]c2c1,CHEMBL4316415,Ki,5.92,CHEMBL3286580,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,144,544,c1ccc(CNCCc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccc4ccccc4c3)[nH]c2c1,CHEMBL671367,Ki,6.3,CHEMBL496860,2001,CHEMBL1134475,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,26,554,c1ccc2cc(-c3[nH]c4ccccc4c3C3CCCNC3)ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3cccc4ccccc34)[nH]c2c1,CHEMBL671367,Ki,5.85,CHEMBL496687,2001,CHEMBL1134475,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,26,554,c1ccc2c(-c3[nH]c4ccccc4c3C3CCCNC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c([C@@H]3CNCC[C@H]3F)c(-c3ccsc3)[nH]c2c1,CHEMBL671367,Ki,5.8,CHEMBL497054,2001,CHEMBL1134475,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,26,554,c1ccc2c(C3CCCNC3)c(-c3ccsc3)[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1S2,CHEMBL3705566,Ki,7.96,CHEMBL3646149,2014,CHEMBL3639279,,BindingDB Patent Bioactivity Data,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",102,607,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2,CHEMBL670398,Ki,7.6,CHEMBL303979,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(c1)CC(CCN1CCCN(c3ccccn3)CC1)C2,CHEMBL4688549,Ki,6.22,CHEMBL4474014,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,151,847,c1ccc(N2CCCN(CCC3Cc4ccccc4C3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(c1)CC(CCN1CCN(c3ccc(Cl)cc3)CC1)C2,CHEMBL3292986,Ki,5.85,CHEMBL3289644,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,102,846,c1ccc(N2CCN(CCC3Cc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(c1)CC(CCN1CCc3ccccc3C1)C2,CHEMBL3821452,Ki,5.94,CHEMBL3819082,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,121,698,c1ccc2c(c1)CCN(CCC1Cc3ccccc3C1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2c(c1)CCC1(CCN(C3CCc4ccccc4C3)CC1)O2,CHEMBL697295,Ki,5.75,CHEMBL423206,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,31,732,c1ccc2c(c1)CCC(N1CCC3(CCc4ccccc4O3)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2cccc(N3CCN(CCCCOc4ccc5c(c4)CNC5)CC3)c2c1,CHEMBL1260558,Ki,7.09,CHEMBL1258532,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,74,832,c1ccc2c(N3CCN(CCCCOc4ccc5c(c4)CNC5)CC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccc2cccc(N3CCN(CCCOc4ccc5c(c4)CNC5)CC3)c2c1,CHEMBL1260558,Ki,7.61,CHEMBL1258426,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,74,832,c1ccc2c(N3CCN(CCCOc4ccc5c(c4)CNC5)CC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1cccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)c1,CHEMBL671073,IC50,7.09,CHEMBL62829,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,15,212,c1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1cccc(CCCN2CCCC2)c1,CHEMBL2033368,Ki,5.0,CHEMBL2030637,2012,CHEMBL2029272,Bioorg Med Chem Lett,Scientific Literature,Inhibition of D2 dopamine receptor,84,902,c1ccc(CCCN2CCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1cccc(N2CCN(Cc3cc4ccccn4n3)CC2)n1,CHEMBL934518,Ki,5.47,CHEMBL405292,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,61,4,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1cccc(N2CCN(Cc3cc4ccccn4n3)CC2)n1,CHEMBL934519,Ki,5.77,CHEMBL405292,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,61,5,c1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1cccc(N2CCN(Cc3cnn4ccccc34)CC2)n1,CHEMBL934518,Ki,6.48,CHEMBL270056,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,61,4,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1cccc(N2CCN(Cc3cnn4ccccc34)CC2)n1,CHEMBL934519,Ki,6.66,CHEMBL270056,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,61,5,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1cccc(Nc2nc(Cc3ccccc3)nc3c2CCNCC3)c1,CHEMBL2396124,IC50,7.2,CHEMBL2393244,2013,CHEMBL2390866,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,92,743,c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1cccc2[nH]cc(CCCN3CCN(c4cccc5c4OCCO5)CC3)c12,CHEMBL872394,Ki,8.09,CHEMBL193854,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1cccc2c(CCCN3CCN(c4cccc5c4OCCO5)CC3)c[nH]c12,CHEMBL872394,Ki,7.97,CHEMBL196893,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1cccc2c1CC[C@@H](NCc1ccccc1)C2,CHEMBL672183,Ki,6.11,CHEMBL141537,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,9,197,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1cccc2c1CC[C@@H](NCc1ccccc1)C2,CHEMBL672184,Ki,5.55,CHEMBL141537,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,9,198,c1ccc(CNC2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccccc1-c1cccc(CN2CCN(c3ncccn3)CC2)c1,CHEMBL671073,IC50,6.6,CHEMBL291380,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,15,212,c1ccc(-c2cccc(CN3CCN(c4ncccn4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccccc1N1CCN(CCCCNc2cc(-c3ccccc3)ccn2)CC1,CHEMBL1225816,Ki,8.82,CHEMBL1223802,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,74,794,c1ccc(-c2ccnc(NCCCCN3CCN(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccccc1N1CCN(CCCCNc2ccc(-c3ccccc3)cn2)CC1,CHEMBL1225816,Ki,8.6,CHEMBL1223799,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,74,794,c1ccc(-c2ccc(NCCCCN3CCN(c4ccccc4)CC3)nc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccccc1N1CCN(CCCCNc2ccccn2)CC1,CHEMBL1225816,Ki,7.96,CHEMBL1223680,2010,CHEMBL1221353,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK293 cells,74,794,c1ccc(N2CCN(CCCCNc3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccccc1N1CCN(CCCCc2cc(/C=C/c3ccccc3)no2)CC1,CHEMBL672182,Ki,6.23,CHEMBL554016,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,31,52,C(=Cc1cc(CCCCN2CCN(c3ccccc3)CC2)on1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccccc1N1CCN(CCCNc2cncc(Cl)n2)CC1,CHEMBL4137914,Ki,7.43,CHEMBL4163265,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1ccc(N2CCN(CCCNc3cnccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1,CHEMBL871242,Ki,7.2,CHEMBL210717,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,49,66,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1,CHEMBL871243,Ki,7.43,CHEMBL210717,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,49,67,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Fc1ccccc1N1CCN(Cc2cnn(-c3ccccc3)c2)CC1,CHEMBL913685,Ki,7.2,CHEMBL210717,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,56,44,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Ic1cccn1C1CCN(Cc2ccccc2)CC1,CHEMBL672580,Ki,5.28,CHEMBL106635,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,19,47,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Ic1cccn1C1CCN(Cc2ccccc2)CC1,CHEMBL673074,Ki,5.07,CHEMBL106635,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,19,48,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1[nH]ccc1CN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL670553,Ki,4.82,CHEMBL300553,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,19,583,c1ccc(N2CCN(Cc3cc[nH]c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1[nH]ccc1CN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL872499,Ki,5.05,CHEMBL300553,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,19,602,c1ccc(N2CCN(Cc3cc[nH]c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1[nH]ccc1CN1CCN(c2ccccc2)CC1,CHEMBL670553,Ki,4.89,CHEMBL440120,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,19,583,c1ccc(N2CCN(Cc3cc[nH]c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1[nH]ccc1CN1CCN(c2ccccc2)CC1,CHEMBL872499,Ki,5.4,CHEMBL440120,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,19,602,c1ccc(N2CCN(Cc3cc[nH]c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1cc(CN2CCN(c3ccc(Cl)cc3)CC2)c[nH]1,CHEMBL670553,Ki,4.99,CHEMBL294458,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,19,583,c1ccc(N2CCN(Cc3cc[nH]c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1cc(CN2CCN(c3ccc(Cl)cc3)CC2)c[nH]1,CHEMBL872499,Ki,5.13,CHEMBL294458,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,19,602,c1ccc(N2CCN(Cc3cc[nH]c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1cc(CN2CCN(c3ccccc3)CC2)c[nH]1,CHEMBL670553,Ki,6.01,CHEMBL294459,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,19,583,c1ccc(N2CCN(Cc3cc[nH]c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1cc(CN2CCN(c3ccccc3)CC2)c[nH]1,CHEMBL872499,Ki,5.73,CHEMBL294459,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,19,602,c1ccc(N2CCN(Cc3cc[nH]c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1ccc(CN2CCN(c3ccc(Cl)cc3)CC2)[nH]1,CHEMBL670553,Ki,4.23,CHEMBL303538,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2S stably expressed in Chinese hamster ovary (CHO) cells was determined.,19,583,c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1ccc(CN2CCN(c3ccc(Cl)cc3)CC2)[nH]1,CHEMBL872499,Ki,4.31,CHEMBL303538,1999,CHEMBL1131791,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from the cloned human Dopamine receptor D2L stably expressed in Chinese hamster ovary (CHO) cells was determined.,19,602,c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1cccn1C1CCN(Cc2ccccc2)CC1,CHEMBL672580,Ki,5.11,CHEMBL326864,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,19,47,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1cccn1C1CCN(Cc2ccccc2)CC1,CHEMBL673074,Ki,4.96,CHEMBL326864,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,19,48,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1ccn(C2CCN(Cc3ccccc3)CC2)c1,CHEMBL672580,Ki,4.75,CHEMBL104201,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,19,47,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(C#N)=Cc1ccn(C2CCN(Cc3ccccc3)CC2)c1,CHEMBL673074,Ki,4.89,CHEMBL104201,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,19,48,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(CCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,5.58,CHEMBL5079903,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,151,253,c1ccc(C(CCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(CCNCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,6.04,CHEMBL5073904,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,151,253,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(CCNCCCCC(=O)N1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,5.71,CHEMBL5077104,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,151,253,O=C(CCCCNCCC(c1ccccc1)c1ccccc1)N1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(CCNCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,6.83,CHEMBL5089655,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,151,253,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(CCNCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)(c1ccccc1)c1ccccc1,CHEMBL5046490,Ki,7.44,CHEMBL5089655,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,151,474,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC(CCNCCc1ccccc1)(c1ccccc1)c1ccccc1,CHEMBL5046486,Ki,4.75,CHEMBL5090346,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,151,253,c1ccc(CCNCCC(c2ccccc2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.7,CHEMBL246230,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,56,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.86,CHEMBL3695408,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.69,CHEMBL3664833,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CCC(=O)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.38,CHEMBL3676868,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.12,CHEMBL3697964,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",102,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.15,CHEMBL3642736,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CCCCN(CCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1,CHEMBL670524,Ki,6.21,CHEMBL346512,2002,CHEMBL1135449,Bioorg Med Chem Lett,Scientific Literature,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,31,27,c1ccc(N2CCN(CCCNC3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#CCO/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,CHEMBL863653,Ki,6.85,CHEMBL376955,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,49,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1[nH]c2ccccc2c1CN1CCN(c2ccccc2)CC1,CHEMBL5235409,Ki,5.31,CHEMBL5278853,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,151,478,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1c(CN2CCN(CCc3ccccc3)CC2)cn2ccccc12,CHEMBL4137914,Ki,5.74,CHEMBL4168691,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1ccc(CCN2CCN(Cc3cc4ccccn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1,CHEMBL671363,Ki,5.43,CHEMBL56118,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,31,34,c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1c[nH]c(CN2CCN(c3ccccc3)CC2)c1,CHEMBL671365,Ki,5.1,CHEMBL56118,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,31,35,c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cc(CN2CCN(c3ccccc3)CC2)c[nH]1,CHEMBL671363,Ki,5.62,CHEMBL2113718,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,31,34,c1ccc(N2CCN(Cc3cc[nH]c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cc(CN2CCN(c3ccccc3)CC2)c[nH]1,CHEMBL671365,Ki,5.47,CHEMBL2113718,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,31,35,c1ccc(N2CCN(Cc3cc[nH]c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)cc(C(F)(F)F)c1,CHEMBL3379351,Ki,6.72,CHEMBL3322996,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,102,163,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)ccc1F,CHEMBL1057875,Ki,6.0,CHEMBL554073,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,65,166,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cc(N2CCN(CCN3Cc4ccccc4C3)C2=O)ccc1F,CHEMBL1057875,Ki,6.1,CHEMBL562176,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,65,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cc(N2CCN(CC[C@H]3CC[C@H](NC(=O)CN)CC3)CC2)cc(C(F)(F)F)c1,CHEMBL3387258,Ki,8.27,CHEMBL3335471,2014,CHEMBL3352435,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2long receptor expressed in HEK293Galpha15 cells after 120 mins by scintillation counting analysis,102,903,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cc(N2CCN(CC[C@H]3CC[C@H](NC(N)=O)CC3)CC2)cc(C(F)(F)F)c1,CHEMBL3387258,Ki,7.52,CHEMBL3335470,2014,CHEMBL3352435,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2long receptor expressed in HEK293Galpha15 cells after 120 mins by scintillation counting analysis,102,903,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cc(N2CCN(CC[C@H]3CC[C@H](NS(N)(=O)=O)CC3)CC2)cc(C(F)(F)F)c1,CHEMBL3387258,Ki,7.43,CHEMBL3335472,2014,CHEMBL3352435,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2long receptor expressed in HEK293Galpha15 cells after 120 mins by scintillation counting analysis,102,903,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3,CHEMBL672490,Ki,8.82,CHEMBL101535,1992,CHEMBL1125523,J Med Chem,Scientific Literature,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",0,286,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccc4[nH]ccc4c3O1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,CHEMBL3295080,Ki,8.05,CHEMBL3287406,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,102,391,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,CHEMBL3295081,Ki,8.17,CHEMBL3287406,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,102,392,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(C(=O)CCCN2CCc3ccccc3C2)cc1,CHEMBL3821452,Ki,5.84,CHEMBL3818200,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,121,698,O=C(CCCN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(C(=O)NCc2ccccc2CN2CCc3cc(O)c(O)cc3C2)cc1,CHEMBL4822008,Ki,7.08,CHEMBL4860225,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),151,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4CCO5)CC3)CC2)cc1,CHEMBL3705383,Ki,6.72,CHEMBL3695398,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4cccc5c4OCO5)CC3)CC2)cc1,CHEMBL3707825,Ki,6.82,CHEMBL3664827,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",92,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCC(c4coc5ccccc45)CC3)CC2)cc1,CHEMBL3706129,Ki,7.82,CHEMBL3676915,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4cccc5c4OCO5)CC3)CC2)cc1,CHEMBL3707837,Ki,7.0,CHEMBL3698009,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",102,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(C(=O)N[C@H]2CC[C@H](CCN3CCN(c4nccc5c4CCO5)CC3)CC2)cc1,CHEMBL3705135,Ki,6.42,CHEMBL3642793,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CCOC(=O)N2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1,CHEMBL671072,IC50,5.65,CHEMBL326263,2001,CHEMBL1134625,J Med Chem,Scientific Literature,Inhibition of human dopamine receptor D2,26,486,O=C(OCCc1ccccc1)N1CCN(CCCC(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CCOC(=O)NC2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1,CHEMBL671072,IC50,6.26,CHEMBL116463,2001,CHEMBL1134625,J Med Chem,Scientific Literature,Inhibition of human dopamine receptor D2,26,486,O=C(NC1CCN(CCCC(c2ccccc2)c2ccccc2)CC1)OCCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccc(F)cc3-c3ccc(C#N)cc3)CC2)cc1,CHEMBL3857974,Ki,5.86,CHEMBL3910730,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,121,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1,CHEMBL1034994,Ki,6.85,CHEMBL522691,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,61,216,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1,CHEMBL3857980,Ki,6.62,CHEMBL522691,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),121,904,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CNC(=O)CCCCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1,CHEMBL4369149,Ki,6.85,CHEMBL522691,2018,CHEMBL4368858,Medchemcomm,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in cell membrane measured after 1.5 hrs by scintillation counting method,131,905,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CNC(=O)CCOCCN2CCN(c3ccccc3-c3ccccc3)CC2)cc1,CHEMBL3857974,Ki,6.2,CHEMBL3914155,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,121,537,O=C(CCOCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CNC(=O)CCOCCN2CCN(c3cccnc3-c3ccc(F)cc3)CC2)cc1,CHEMBL3857974,Ki,5.71,CHEMBL3947670,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,121,537,O=C(CCOCCN1CCN(c2cccnc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CNC(=O)CCOCCN2CCN(c3cccnc3-c3ccccc3)CC2)cc1,CHEMBL3857974,Ki,5.36,CHEMBL3913100,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,121,537,O=C(CCOCCN1CCN(c2cccnc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CNC(=O)CCOCCN2CCN(c3ncccc3-c3ccc(F)cc3)CC2)cc1,CHEMBL3857974,Ki,6.16,CHEMBL3922670,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,121,537,O=C(CCOCCN1CCN(c2ncccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CNC(=O)CCOCCN2CCN(c3ncccc3-c3ccccc3)CC2)cc1,CHEMBL3857974,Ki,6.27,CHEMBL3904094,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,121,537,O=C(CCOCCN1CCN(c2ncccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,5.38,CHEMBL111006,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,38,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(S(=O)(=O)C2(F)CCN(CCc3ccc(F)cc3F)CC2)cc1,CHEMBL830303,Ki,6.06,CHEMBL368816,2005,CHEMBL1142766,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2,41,745,O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc(S(=O)(=O)N(CCCN2CCC(c3noc4cc(F)ccc34)CC2)C2COC2)cc1,CHEMBL4686220,IC50,8.44,CHEMBL4747208,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,144,193,O=S(=O)(c1ccccc1)N(CCCN1CCC(c2noc3ccccc23)CC1)C1COC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)cc2c1,CHEMBL672383,Ki,4.37,CHEMBL140006,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,23,594,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)cc2c1,CHEMBL672577,Ki,4.44,CHEMBL140006,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,23,906,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccc(Cl)cc4)CC3)cc2c1,CHEMBL672383,Ki,5.1,CHEMBL140594,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,23,594,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccc(Cl)cc4)CC3)cc2c1,CHEMBL672577,Ki,5.12,CHEMBL140594,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,23,906,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccc(F)cc4)CC3)cc2c1,CHEMBL5235409,Ki,4.55,CHEMBL143761,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,151,478,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccc(F)cc4)CC3)cc2c1,CHEMBL672383,Ki,4.55,CHEMBL143761,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,23,594,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccc(F)cc4)CC3)cc2c1,CHEMBL672577,Ki,4.72,CHEMBL143761,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,23,906,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccc(F)cc4)CC3)cc2c1,CHEMBL866799,Ki,4.55,CHEMBL143761,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccc(F)cc4)CC3)cc2c1,CHEMBL866800,Ki,4.72,CHEMBL143761,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4)CC3)cc2c1,CHEMBL5235409,Ki,5.51,CHEMBL140099,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,151,478,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4)CC3)cc2c1,CHEMBL672383,Ki,5.51,CHEMBL140099,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,23,594,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4)CC3)cc2c1,CHEMBL672577,Ki,6.54,CHEMBL140099,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,23,906,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4)CC3)cc2c1,CHEMBL866799,Ki,5.51,CHEMBL140099,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(long) in CHO cell membrane,49,599,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4)CC3)cc2c1,CHEMBL866800,Ki,6.54,CHEMBL140099,2006,CHEMBL1138042,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine receptor D2(short) in CHO cell membrane,49,600,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4Cl)CC3)cc2c1,CHEMBL672383,Ki,5.64,CHEMBL141035,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,23,594,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]c(CN3CCN(c4ccccc4Cl)CC3)cc2c1,CHEMBL672577,Ki,6.02,CHEMBL141035,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,23,906,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,CHEMBL2037965,Ki,6.18,CHEMBL439849,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,c1ccc2c(CCCCN3CCN(c4ccc5occc5c4)CC3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc5oc(C(N)=O)cc5c4)CC3)c2c1,CHEMBL5442215,Ki,6.26,CHEMBL1615374,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,c1ccc2c(CCCCN3CCN(c4ccc5occc5c4)CC3)c[nH]c2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)c2c1,CHEMBL672383,Ki,6.1,CHEMBL344270,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,23,594,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)c2c1,CHEMBL672577,Ki,6.32,CHEMBL344270,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,23,906,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(Cl)cc4)CC3)c2c1,CHEMBL672383,Ki,5.37,CHEMBL342001,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,23,594,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(Cl)cc4)CC3)c2c1,CHEMBL672577,Ki,5.58,CHEMBL342001,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,23,906,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(F)cc4)CC3)c2c1,CHEMBL672383,Ki,5.62,CHEMBL140165,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,23,594,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CN3CCN(c4ccc(F)cc4)CC3)c2c1,CHEMBL672577,Ki,5.75,CHEMBL140165,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,23,906,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CN3CCN(c4ccccc4)CC3)c2c1,CHEMBL672383,Ki,4.47,CHEMBL142217,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,23,594,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CN3CCN(c4ccccc4)CC3)c2c1,CHEMBL672577,Ki,5.46,CHEMBL142217,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,23,906,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CN3CCN(c4ccccc4Cl)CC3)c2c1,CHEMBL672383,Ki,5.85,CHEMBL143355,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,23,594,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2[nH]cc(CN3CCN(c4ccccc4Cl)CC3)c2c1,CHEMBL672577,Ki,6.27,CHEMBL143355,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,23,906,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)C1CN(CCCCNC(=O)c3ccc(-c4ccccc4)cc3)CC1CO2,CHEMBL670398,Ki,7.1,CHEMBL277790,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,O=C(NCCCCN1CC2COc3ccccc3C2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)C1CN(Cc3ccc(F)cc3)CC1CO2,CHEMBL670398,Ki,7.1,CHEMBL64721,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CC2,CHEMBL670398,Ki,8.0,CHEMBL305392,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,c1ccc(CN2CC3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)C1CN(Cc3ccccc3)CC1CO2,CHEMBL670398,Ki,7.05,CHEMBL302416,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)C2,CHEMBL673026,Ki,6.7,CHEMBL2368611,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,24,817,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)CC2,CHEMBL674940,Ki,6.4,CHEMBL314050,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,24,121,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3cccc(F)c3)CC1)CC2,CHEMBL674940,Ki,6.4,CHEMBL420789,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,24,121,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3)CC1)C2,CHEMBL673026,Ki,6.7,CHEMBL2368612,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,24,817,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3F)CC1)CC2,CHEMBL674940,Ki,6.2,CHEMBL315209,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,24,121,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cc4ccccc4[nH]3)CC1)C2,CHEMBL673026,Ki,6.1,CHEMBL2113349,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,24,817,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cc4ccccc4[nH]3)CC1)CC2,CHEMBL674940,Ki,6.5,CHEMBL82864,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,24,121,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccc4c(c3)NC(=O)CO4)CC1)CC2,CHEMBL674940,Ki,6.1,CHEMBL86032,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,24,121,O=C1COc2ccc(C(=O)NC3CCC(CCN4CCc5ccccc5CC4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccc4ccc(O)nc4c3)CC1)CC2,CHEMBL674940,Ki,6.3,CHEMBL87753,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,24,121,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1ccc2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccc4ccccc4c3)CC1)C2,CHEMBL673026,Ki,5.8,CHEMBL2113348,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,24,817,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccc4ccccc4c3)CC1)CC2,CHEMBL674940,Ki,5.5,CHEMBL86402,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,24,121,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ccccc34)CC1)C2,CHEMBL673026,Ki,6.4,CHEMBL2113351,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,24,817,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ccccc34)CC1)CC2,CHEMBL674940,Ki,5.9,CHEMBL85711,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,24,121,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3cccc4ncccc34)CC1)CC2,CHEMBL674940,Ki,5.7,CHEMBL86127,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,24,121,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1cccc2ncccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL1044430,Ki,6.4,CHEMBL85606,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,65,233,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL1059864,Ki,6.4,CHEMBL85606,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,66,234,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL1107668,Ki,6.4,CHEMBL85606,2010,CHEMBL1153718,J Med Chem,Scientific Literature,Antagonist activity at human Dopamine D2 receptor expressed in CHO cell by GTPgammaS binding assay,74,703,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL3768209,Ki,6.3,CHEMBL85606,2016,CHEMBL3763143,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]-7-OH-PIPAT from rat brain dopamine D2 receptor after 45 mins by microplate scintillation counting analysis,121,132,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL3776608,Ki,6.3,CHEMBL85606,2016,CHEMBL3774368,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes after 120 mins by liquid scintillation counter method,121,203,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL3855278,Ki,6.31,CHEMBL85606,2016,CHEMBL3853329,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2 receptor expressed in CHO-K1 cell membranes coexpressing Galpha16 after 120 mins by liquid scintillation counting,121,105,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL4053560,Ki,5.29,CHEMBL85606,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,126,265,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL672225,Ki,6.0,CHEMBL85606,2001,CHEMBL1134827,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,26,733,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL673026,Ki,6.0,CHEMBL2110366,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,24,817,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL674940,Ki,6.0,CHEMBL85606,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,24,121,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL876379,Ki,5.98,CHEMBL85606,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]iodosulpiride binding to human Dopamine D2L receptor expressed in CHO cells,41,907,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL895462,Ki,6.4,CHEMBL85606,2007,CHEMBL1148818,J Med Chem,Scientific Literature,Displacement of [35S]GTP-gamma-S from human cloned dopamine D2 receptor expressed in CHO cells after 30 mins,56,690,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL931096,Ki,6.4,CHEMBL85606,2008,CHEMBL1143157,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,61,853,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL948181,Ki,6.4,CHEMBL85606,2008,CHEMBL1142271,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,61,504,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)CC2,CHEMBL674940,Ki,5.9,CHEMBL445111,2000,CHEMBL1133070,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 by displacement of [125I]iodosulpiride expressed in CHO cells,24,121,O=C(NC1CCC(CCN2CCc3ccccc3CC2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCN(C[C@@H]1C[C@H]1CNC(=O)c1ccnc3ccccc13)C2,CHEMBL4053560,Ki,5.02,CHEMBL4087513,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,126,265,O=C(NCC1CC1CN1CCc2ccccc2C1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CCNC2,CHEMBL4053560,Ki,4.27,CHEMBL4076796,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,126,265,c1ccc2c(c1)CCNC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(CCCCNC(=O)/C=C/c1c[nH]c3ccccc13)CC2,CHEMBL673026,Ki,6.1,CHEMBL553591,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,24,817,O=C(C=Cc1c[nH]c2ccccc12)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(CC[C@@H]1C[C@H]1CNC(=O)c1cc3ccccc3[nH]1)CC2,CHEMBL4053560,Ki,6.32,CHEMBL4097669,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,126,265,O=C(NCC1CC1CCN1CCc2ccccc2C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(CC[C@@H]1C[C@H]1CNC(=O)c1cc3cccnc3[nH]1)CC2,CHEMBL4053560,Ki,6.72,CHEMBL4079637,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,126,265,O=C(NCC1CC1CCN1CCc2ccccc2C1)c1cc2cccnc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3c[nH]c4ccccc34)CC1)CC2,CHEMBL673026,Ki,6.9,CHEMBL2112078,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,24,817,O=C(C=Cc1c[nH]c2ccccc12)NC1CCC(CCN2CCc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccc(F)cc3)CC1)C2,CHEMBL672225,Ki,6.2,CHEMBL162193,2001,CHEMBL1134827,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,26,733,O=C(C=Cc1ccccc1)NC1CCC(CCN2Cc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)/C=C/c3ccccc3)CC1)CC2,CHEMBL673026,Ki,6.8,CHEMBL2113350,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,24,817,O=C(C=Cc1ccccc1)NC1CCC(CCN2CCc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)c3cc4ccccc4[nH]3)CC1)C2,CHEMBL672225,Ki,5.6,CHEMBL160998,2001,CHEMBL1134827,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,26,733,O=C(NC1CCC(CCN2Cc3ccccc3C2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)c3cc4ccccc4[nH]3)CC1)CC2,CHEMBL4053560,Ki,6.31,CHEMBL2219578,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,126,265,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)c3cc4ccccc4[nH]3)CC1)CC2,CHEMBL673026,Ki,7.0,CHEMBL2113347,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,24,817,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(CC[C@H]1CC[C@H](NC(=O)c3ccnc4ccccc34)CC1)C2,CHEMBL672225,Ki,5.6,CHEMBL351722,2001,CHEMBL1134827,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,26,733,O=C(NC1CCC(CCN2Cc3ccccc3C2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(C[C@@H]1C[C@H]1CCNC(=O)c1cc3ccccc3[nH]1)CC2,CHEMBL4053560,Ki,6.74,CHEMBL4089939,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,126,265,O=C(NCCC1CC1CN1CCc2ccccc2C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(C[C@@H]1C[C@H]1CCNC(=O)c1cc3cccnc3[nH]1)CC2,CHEMBL4053560,Ki,7.84,CHEMBL4068843,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,127,265,O=C(NCCC1CC1CN1CCc2ccccc2C1)c1cc2cccnc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(C[C@@H]1C[C@H]1CNC(=O)c1cc3ccccc3[nH]1)CC2,CHEMBL4053560,Ki,6.16,CHEMBL4095216,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,127,265,O=C(NCC1CC1CN1CCc2ccccc2C1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CN(C[C@@H]1C[C@H]1CNC(=O)c1ccnc3ccccc13)CC2,CHEMBL4053560,Ki,5.84,CHEMBL4067792,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,127,265,O=C(NCC1CC1CN1CCc2ccccc2C1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)CNCC2,CHEMBL4053560,Ki,4.94,CHEMBL27162,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,127,265,c1ccc2c(c1)CCNC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)OCC1CN(Cc3ccccc3)CC21,CHEMBL670398,Ki,6.3,CHEMBL292485,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)[C@@H]1CN(CCCCNC(=O)c3ccc(-c4ccccc4)cc3)C[C@H]1CO2,CHEMBL670398,Ki,7.3,CHEMBL66080,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,O=C(NCCCCN1CC2COc3ccccc3C2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)[C@@H]1CN(Cc3ccc(F)cc3)C[C@H]1CO2,CHEMBL670398,Ki,7.4,CHEMBL65122,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)[C@@H]1CN(Cc3ccccc3)C[C@H]1CO2,CHEMBL670398,Ki,7.5,CHEMBL294515,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)[C@H]1CN(CCCCNC(=O)c3ccc(-c4ccc(N)cc4)cc3)C[C@@H]1CO2,CHEMBL670398,Ki,7.7,CHEMBL2112210,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,O=C(NCCCCN1CC2COc3ccccc3C2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)[C@H]1CN(CCCCNC(=O)c3ccc(-c4ccccc4)cc3)C[C@@H]1CO2,CHEMBL670398,Ki,7.5,CHEMBL65280,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,O=C(NCCCCN1CC2COc3ccccc3C2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)[C@H]1CN(Cc3ccc(F)cc3)C[C@@H]1CO2,CHEMBL670398,Ki,7.6,CHEMBL64157,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2c(c1)[C@H]1CN(Cc3ccccc3)C[C@@H]1CO2,CHEMBL670398,Ki,7.7,CHEMBL293159,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,19,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2cc(C(=O)NCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)[nH]c2c1,CHEMBL913685,Ki,6.47,CHEMBL218151,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,56,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2cc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)[nH]c2c1,CHEMBL672383,Ki,5.7,CHEMBL344602,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,24,594,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2cc(CN3CCN(c4ccc(Cl)c(Cl)c4)CC3)[nH]c2c1,CHEMBL672577,Ki,5.85,CHEMBL344602,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,24,906,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2cc(CN3CCN(c4ccccc4)CC3)[nH]c2c1,CHEMBL672383,Ki,5.25,CHEMBL343880,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,24,594,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2cc(CN3CCN(c4ccccc4)CC3)[nH]c2c1,CHEMBL672577,Ki,5.6,CHEMBL343880,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,24,906,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2cc(CN3CCN(c4ccccc4Cl)CC3)[nH]c2c1,CHEMBL672383,Ki,6.3,CHEMBL140258,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,24,594,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2cc(CN3CCN(c4ccccc4Cl)CC3)[nH]c2c1,CHEMBL672577,Ki,6.66,CHEMBL140258,2000,CHEMBL1133533,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,24,906,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n2c1,CHEMBL4619928,IC50,8.99,CHEMBL4644391,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,144,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc(-c2cccc(CN3CCN(c4cccc5nc(O)oc45)CC3)c2)c1,CHEMBL672308,Ki,8.22,CHEMBL80156,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,26,593,c1ccc(-c2cccc(CN3CCN(c4cccc5ncoc45)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc(C(=O)NCc2ccccc2CN2CCc3cc(O)c(O)cc3C2)c1,CHEMBL4822008,Ki,6.05,CHEMBL4849499,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),151,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc(N2CCN(CCCCNC(=O)c3ccc(-c4ccsc4)cc3)CC2)c1,CHEMBL4350893,Ki,6.13,CHEMBL4437341,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",138,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,CHEMBL1043568,Ki,6.8,CHEMBL552373,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human DRD2 receptor by filtration binding assay,66,908,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,CHEMBL1057875,Ki,7.0,CHEMBL552373,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,CHEMBL1057891,Ki,6.8,CHEMBL552373,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor by filtration binding assay,66,909,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc(N2CCN(CCN3Cc4ccccc4C3)C2=O)c1,CHEMBL1057875,Ki,7.0,CHEMBL559856,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc(N2CCN(C[C@@H]3C[C@H]3CNC(=O)c3ccnc4ccccc34)CC2)c1,CHEMBL4053560,Ki,5.64,CHEMBL4105375,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,127,265,O=C(NCC1CC1CN1CCN(c2ccccc2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc(N2CCNCC2)c1,CHEMBL4053560,Ki,5.31,CHEMBL4099491,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,127,265,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc([C@@H]2CCCN(CC3CC3)C2)c1,CHEMBL679938,Ki,6.29,CHEMBL328894,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",4,30,c1ccc(C2CCCN(CC3CC3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc([C@@H]2CCCN(CCCc3ccccc3)C2)c1,CHEMBL678343,Ki,7.22,CHEMBL94811,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",4,257,c1ccc(CCCN2CCCC(c3ccccc3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc([C@@H]2CCCN(CCCc3ccccc3)C2)c1,CHEMBL679938,Ki,7.54,CHEMBL94811,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",4,30,c1ccc(CCCN2CCCC(c3ccccc3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc([C@@H]2CCCN(CCc3ccccc3)C2)c1,CHEMBL679938,Ki,7.66,CHEMBL93646,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",4,30,c1ccc(CCN2CCCC(c3ccccc3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc([C@@H]2CCCNC2)c1,CHEMBL679938,Ki,6.5,CHEMBL93682,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"In vitro binding affinity against cloned mammalian dopamine D2 autoreceptor, expressed in CHO-K1 cells, using [3H]U-86170 as radioligand",4,30,c1ccc(C2CCCNC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL5235409,Ki,4.36,CHEMBL160626,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,151,478,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL671732,Ki,4.35,CHEMBL160626,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,31,46,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL672909,Ki,4.36,CHEMBL160626,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,Binding affinity of compound was tested in vitro for its ability to compete with [3H]spiperone radioligand at cloned human Dopamine receptor D2L stably expressed in CHO cells,31,879,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccc2nn(CCCCN3CCN(c4cccc5sccc45)CC3)c(=O)n12,CHEMBL4619928,IC50,7.37,CHEMBL4644742,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,144,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1-c1cccc(CN2CCN(c3cccc4nc(O)oc34)CC2)c1,CHEMBL672308,Ki,8.7,CHEMBL420016,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,26,593,c1ccc(-c2cccc(CN3CCN(c4cccc5ncoc45)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1N1CCN(CC(O)CN2C(=O)NC(c3ccccc3)(c3ccccc3)C2=O)CC1,CHEMBL4148417,Ki,6.27,CHEMBL4162548,2018,CHEMBL4145534,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes after 1 hr by Microbeta scintillation counting method,131,239,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1N1CCN(CCCCCC(=O)NC2CCCc3ccccc32)CC1,CHEMBL894060,Ki,6.58,CHEMBL221513,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,56,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1N1CCN(CCCCNC(=O)c2ccc(-c3ccsc3)cc2)CC1,CHEMBL4350893,Ki,7.03,CHEMBL4571568,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",138,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL2169117,Ki,8.54,CHEMBL160921,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,84,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1N1CCN(CCCN2C(=O)CCc3ccccc32)CC1,CHEMBL5106582,Ki,6.45,CHEMBL5191299,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,154,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1N1CCN(CNC(=O)c2ccc(Cl)cc2)CC1,CHEMBL671981,Ki,6.03,CHEMBL49876,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,12,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1N1CCN(CNC(=O)c2ccc(Cl)cc2)CC1,CHEMBL835392,Ki,6.22,CHEMBL49876,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,41,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1N1CCN(CNC(=O)c2cccc(Cl)c2)CC1,CHEMBL671981,Ki,6.05,CHEMBL49502,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,12,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1N1CCN(CNC(=O)c2cccc(Cl)c2)CC1,CHEMBL835392,Ki,5.64,CHEMBL49502,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,41,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1N1CCN(CNC(=O)c2ccccc2)CC1,CHEMBL671981,Ki,5.38,CHEMBL423659,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,12,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1N1CCN(CNC(=O)c2ccccc2)CC1,CHEMBL835392,Ki,5.52,CHEMBL423659,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,41,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccccc1S(=O)(=O)C1CCN(CCc2ccc(F)cc2F)CC1,CHEMBL697295,Ki,6.17,CHEMBL146998,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,31,732,O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc12,CHEMBL4619928,IC50,8.82,CHEMBL4638430,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,144,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccnc1N1CCN(CCCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL5145822,Ki,5.68,CHEMBL5201798,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C1CCc2ccc(OCCCCN3CCN(c4ccccn4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccnc1N1CCN(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5145822,Ki,8.0,CHEMBL5190788,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,c1ccc(N2CCN(CCCN3CCN(c4ccccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccnc1N1CCN(CCCN2CCN(c3ccccc3)CC2)CC1,CHEMBL5145822,Ki,6.11,CHEMBL5176374,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,c1ccc(N2CCN(CCCN3CCN(c4ccccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccnc1N1CCN(CCCOc2ccc3c(c2)NC(=O)CC3)CC1,CHEMBL5145822,Ki,7.09,CHEMBL5170927,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C1CCc2ccc(OCCCN3CCN(c4ccccn4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cccnc1N1CCN(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5145822,Ki,6.68,CHEMBL5205697,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,c1ccc(N2CCN(CCN3CCN(c4ccccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1ccn2c(=O)n(CCCCN3CCN(c4cccc5sccc45)CC3)nc2c1,CHEMBL4619928,IC50,6.84,CHEMBL4648979,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,144,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL4010153,Ki,9.28,CHEMBL4091064,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,127,360,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL4010156,Ki,9.04,CHEMBL4091064,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,127,361,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL3295080,Ki,9.24,CHEMBL3287405,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,102,391,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL3295081,Ki,9.49,CHEMBL3287405,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,102,392,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#[11C]c1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,CHEMBL1291989,Ki,7.38,CHEMBL567286,2010,CHEMBL1287708,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,74,776,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N#[11C]c1cccc(N2CCN(CCN3CCC(C(F)(F)F)CC3)C2=O)c1,CHEMBL1291990,Ki,6.92,CHEMBL567286,2010,CHEMBL1287708,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,74,775,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N/C(=N\C(=O)NCCCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1)NCCCc1nnc(N)s1,CHEMBL5151464,Ki,6.02,CHEMBL5176229,2021,CHEMBL5149991,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,151,223,O=C(N=CNCCCc1nncs1)NCCCCCCNC(=O)N=CNCCCc1nncs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N/C(=N\C(=O)NCc1ccccc1)NC1CCc2nc(N)sc2C1,CHEMBL4815484,Ki,6.26,CHEMBL4878215,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,152,259,O=C(N=CNC1CCc2ncsc2C1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N/C(=N\C(=O)NCc1ccccc1)NCCCc1cnc(N)s1,CHEMBL5151464,Ki,5.34,CHEMBL5178472,2021,CHEMBL5149991,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,152,223,O=C(N=CNCCCc1cncs1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1,CHEMBL5151464,Ki,5.2,CHEMBL5206565,2021,CHEMBL5149991,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 long receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 140 mins by radioligand competition binding based assay,152,223,O=C(N=CNCCCc1nncs1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1,CHEMBL1810621,IC50,4.6,CHEMBL1346,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,79,487,c1ccc(C(c2ccccc2)C2CCN(CCc3ccc4c(c3)CCO4)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)C1CCC(CN2CCC(=C(c3ccccc3)c3ccc(F)cc3)CC2)O1,CHEMBL670684,Ki,7.0,CHEMBL282927,2001,CHEMBL1134798,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity for Dopamine receptor D2,26,585,c1ccc(C(=C2CCN(CC3CCCO3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL665376,Ki,10.51,CHEMBL156164,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),19,181,O=C(C1CCCN1)N1CCCC12CC1SCCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL665377,Ki,9.91,CHEMBL156164,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,19,182,O=C(C1CCCN1)N1CCCC12CC1SCCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL666180,Ki,10.19,CHEMBL156164,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p (pretreatment with 100 nM of compound),19,183,O=C(C1CCCN1)N1CCCC12CC1SCCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL666181,Ki,6.71,CHEMBL156164,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,19,184,O=C(C1CCCN1)N1CCCC12CC1SCCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL666182,Ki,6.78,CHEMBL156164,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),19,185,O=C(C1CCCN1)N1CCCC12CC1SCCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL666183,Ki,6.655,CHEMBL156164,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,19,186,O=C(C1CCCN1)N1CCCC12CC1SCCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)C1CCS[C@@H]2C[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL670962,Ki,10.15,CHEMBL156164,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,19,187,O=C(C1CCCN1)N1CCCC12CC1SCCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)C[S@@+]([O-])C(c1ccccc1)c1ccccc1,CHEMBL3863997,IC50,8.68,CHEMBL1201192,2016,CHEMBL3862037,J Med Chem,Scientific Literature,Antagonist activity at DRD2 (unknown origin) expressed in HEK293T cells transfected with Galphai1-RLuc8 and gamma2-GFP10 assessed as inhibition of quinpirole-induced Gi1 activation pre-incubated with quinpirole for 10 mins before compound incubation for 10 mins by BRET assay,121,896,c1ccc(Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)N1CCN(c2cccc(Cl)c2)CC1,CHEMBL5163611,Ki,3.935916564036404,CHEMBL5191370,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,154,910,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)NCCCCCCN1CCN(c2cccc(Cl)c2)CC1,CHEMBL5163611,Ki,6.63,CHEMBL5201464,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,154,910,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5381008,Ki,8.83,CHEMBL5417351,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,158,147,c1ccc(N2CCN(CCC3CCCCC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL665376,Ki,10.3,CHEMBL156651,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),19,181,O=C(C1CCCN1)N1CCCC12CCC1SCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL665377,Ki,9.71,CHEMBL156651,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,19,182,O=C(C1CCCN1)N1CCCC12CCC1SCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL666180,Ki,10.05,CHEMBL156651,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p (pretreatment with 100 nM of compound),19,183,O=C(C1CCCN1)N1CCCC12CCC1SCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL666181,Ki,6.72,CHEMBL156651,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,19,184,O=C(C1CCCN1)N1CCCC12CCC1SCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL666182,Ki,6.73,CHEMBL156651,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p (pretreatment with 100 nM of compound),19,185,O=C(C1CCCN1)N1CCCC12CCC1SCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL666183,Ki,6.63,CHEMBL156651,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for low affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in presence of Gpp(NH)p,19,186,O=C(C1CCCN1)N1CCCC12CCC1SCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)[C@H]1CS[C@@H]2CC[C@]3(CCCN3C(=O)[C@@H]3CCCN3)C(=O)N12,CHEMBL670962,Ki,10.17,CHEMBL156651,1999,CHEMBL1132286,J Med Chem,Scientific Literature,Inhibitor constant of compound for high affinity component of [3H]spiroperidol/N-propylnorapomorphine binding to Dopamine receptor D2 in absence of Gpp(NH)p,19,187,O=C(C1CCCN1)N1CCCC12CCC1SCCN1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,CHEMBL4187998,IC50,7.37,CHEMBL4217986,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,131,471,c1ccc2c(N3CCN(CCCCOc4ccncc4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3,CHEMBL672490,Ki,8.74,CHEMBL320880,1992,CHEMBL1125523,J Med Chem,Scientific Literature,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",0,286,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccc4[nH]ccc4c3O1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccc(C(=O)CCCN2CCc3ccccc3C2)cc1,CHEMBL3821452,Ki,6.66,CHEMBL3819427,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,121,698,O=C(CCCN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)cc1,CHEMBL697295,Ki,6.0,CHEMBL148058,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,31,732,O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccc2c(c1)CCOC2CCN1CC=C(c2c[nH]c3cc(F)ccc23)CC1,CHEMBL881219,Ki,8.33,CHEMBL83617,2005,CHEMBL1140446,J Med Chem,Scientific Literature,Inhibition constant against dopamine receptor D2,41,820,C1=C(c2c[nH]c3ccccc23)CCN(CCC2OCCc3ccccc32)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1cccc(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL3806800,IC50,7.26,CHEMBL3806169,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,121,124,c1ccc(OCCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1cccc(S(=O)(=O)C2CCN(CCc3ccc(F)cc3F)CC2)c1,CHEMBL697295,Ki,6.19,CHEMBL146485,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,31,732,O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,CHEMBL3413541,Ki,7.11,CHEMBL3409257,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCOc4ccccc4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCN1CC=C(c2cn(Cc3ccccc3)c3ccccc23)CC1,CHEMBL3413541,Ki,7.51,CHEMBL3409243,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,C1=C(c2cn(Cc3ccccc3)c3ccccc23)CCN(CCCOc2ccccc2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCN1CC=C(c2cn(S(=O)(=O)c3ccccc3)c3ccccc23)CC1,CHEMBL3413541,Ki,6.8,CHEMBL3409244,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,O=S(=O)(c1ccccc1)n1cc(C2=CCN(CCCOc3ccccc3)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCN1CCC(c2cn(Cc3ccccc3)c3ccccc23)CC1,CHEMBL3413541,Ki,7.54,CHEMBL3409245,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,c1ccc(Cn2cc(C3CCN(CCCOc4ccccc4)CC3)c3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCN1CCC(c2cn(S(=O)(=O)c3ccccc3)c3ccccc23)CC1,CHEMBL3413541,Ki,7.21,CHEMBL3409246,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,O=S(=O)(c1ccccc1)n1cc(C2CCN(CCCOc3ccccc3)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3Cc2ccc(F)cc2)CC1,CHEMBL3413541,Ki,7.36,CHEMBL3409252,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,c1ccc(Cn2ccc3c(N4CCN(CCCOc5ccccc5)CC4)cccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3Cc2cccc(Cl)c2)CC1,CHEMBL3413541,Ki,7.12,CHEMBL3409253,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,c1ccc(Cn2ccc3c(N4CCN(CCCOc5ccccc5)CC4)cccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3Cc2cccc(F)c2)CC1,CHEMBL3413541,Ki,7.35,CHEMBL3409251,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,c1ccc(Cn2ccc3c(N4CCN(CCCOc5ccccc5)CC4)cccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3Cc2ccccc2)CC1,CHEMBL3413541,Ki,7.02,CHEMBL3409249,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,c1ccc(Cn2ccc3c(N4CCN(CCCOc5ccccc5)CC4)cccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3Cc2ccccc2F)CC1,CHEMBL3413541,Ki,7.68,CHEMBL3409250,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,c1ccc(Cn2ccc3c(N4CCN(CCCOc5ccccc5)CC4)cccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,CHEMBL3413541,Ki,8.2,CHEMBL3409256,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccccc4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCN1CCN(c2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1,CHEMBL3413553,Ki,8.2,CHEMBL3409256,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2S receptor expressed in HEK293 cells,112,160,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccccc4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCNCCc1cn(Cc2ccccc2)c2ccccc12,CHEMBL3413541,Ki,6.57,CHEMBL3409247,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,c1ccc(Cn2cc(CCNCCCOc3ccccc3)c3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccccc1OCCCNCCc1cn(S(=O)(=O)c2ccccc2)c2ccccc12,CHEMBL3413541,Ki,6.75,CHEMBL3409248,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,O=S(=O)(c1ccccc1)n1cc(CCNCCCOc2ccccc2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccn(-c2cccc(OC(=O)NCCCN3CCN(c4ccccc4)CC3)c2)c1,CHEMBL4409079,Ki,7.18,CHEMBL4554053,2019,CHEMBL4406846,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,138,837,O=C(NCCCN1CCN(c2ccccc2)CC1)Oc1cccc(-n2cccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(=O)c1ccn(-c2cccc(OC(=O)NCCN3CCN(c4ccccc4)CC3)c2)c1,CHEMBL4409079,Ki,6.73,CHEMBL4473519,2019,CHEMBL4406846,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2 receptor expressed in CHO cells co-expressing Galpha16 incubated for 120 mins by liquid scintillation counting method,138,837,O=C(NCCN1CCN(c2ccccc2)CC1)Oc1cccc(-n2cccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC(N)=NC(=O)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL3095674,Ki,5.85,CHEMBL3092753,2013,CHEMBL3091369,Bioorg Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),93,550,c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.74,CHEMBL430198,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,56,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC1CCc2c(O)cccc2C1,CHEMBL670536,Ki,5.83,CHEMBL441092,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,9,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21,CHEMBL945767,Ki,7.68,CHEMBL404000,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,c1ccc2c(N3CCN(CCc4ccc5c(c4)CCC5)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC1CCc2ccc(O)cc2C1,CHEMBL670173,Ki,8.48,CHEMBL133830,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]N-0437 binding on Dopamine receptor D2L of CHO K-1 cells,9,302,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC1CCc2ccc(O)cc2C1,CHEMBL670536,Ki,7.11,CHEMBL133830,1996,CHEMBL1129692,J Med Chem,Scientific Literature,Binding affinity was evaluated by calculating competition for [3H]spiperone binding on Dopamine receptor D2L of CHO K-1 cells.,9,285,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1,CHEMBL4189962,Ki,5.09,CHEMBL4216870,2018,CHEMBL4184336,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293T cell membranes after 90 mins by scintillation counting method,131,911,c1ccc(-c2ccc3c(-c4ccc(C5CCN(CCCCc6c[nH]nn6)CC5)cc4)cccc3c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCCCN(C[C@H]1Cc2ccccc2CN1)[C@H]1CCCc2cccnc21,CHEMBL5048805,IC50,5.24,CHEMBL3091687,2022,CHEMBL5046278,J Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),154,912,c1ccc2c(c1)CNC(CNC1CCCc3cccnc31)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCCCN(C[C@H]1Cc2cccnc2CN1)[C@H]1CCCc2cccnc21,CHEMBL5048805,IC50,5.0,CHEMBL5076569,2022,CHEMBL5046278,J Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),154,912,c1cnc2c(c1)CC(CNC1CCCc3cccnc31)NC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCCCN(C[C@H]1Cc2ncccc2CN1)[C@H]1CCCc2cccnc21,CHEMBL5048805,IC50,5.03,CHEMBL5070958,2022,CHEMBL5046278,J Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),154,912,c1cnc2c(c1)CNC(CNC1CCCc3cccnc31)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]1CCCc2cccnc21,CHEMBL5048805,IC50,5.39,CHEMBL518924,2022,CHEMBL5046278,J Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),154,912,c1cnc2c(c1)CCCC2NCc1nc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1c[nH]c2ccc(O)cc12,CHEMBL671063,IC50,12.522878745280337,CHEMBL39,1985,CHEMBL1122967,J Med Chem,Scientific Literature,Agonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]-Spiperone,0,913,c1ccc2[nH]ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL1066831,Ki,5.68,CHEMBL59,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,74,380,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL1066832,Ki,8.54,CHEMBL59,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,74,381,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL2066740,Ki,5.68,CHEMBL59,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,84,442,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL2182832,Ki,6.38,CHEMBL59,2012,CHEMBL2177058,J Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,84,272,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL2346426,Ki,6.96,CHEMBL59,2013,CHEMBL2331212,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,93,914,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL2346428,Ki,6.72,CHEMBL59,2013,CHEMBL2331212,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,93,915,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL2399862,Ki,5.68,CHEMBL59,2013,CHEMBL2396540,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis,93,542,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3089791,Ki,8.1,CHEMBL59,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-NPA from dopamine D2L receptor (unknown origin) expressed in CHO cell membranes,93,916,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3117737,Ki,6.05,CHEMBL1557,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,102,273,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3117738,IC50,4.0,CHEMBL1557,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,102,274,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3117738,Ki,5.095000000000001,CHEMBL1557,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,102,274,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3117739,IC50,6.0,CHEMBL1557,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,102,275,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3117739,Ki,6.805,CHEMBL1557,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,102,275,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3119986,Ki,7.66,CHEMBL1557,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]-iodosulpiride from cloned human dopamine D2S receptor expressed in CHO cells,102,917,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3119988,Ki,7.25,CHEMBL1557,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]-iodosulpiride from recombinant high-affinity state of human dopamine D2L receptor,102,918,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3119990,Ki,8.7,CHEMBL1557,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from high-affinity state of human dopamine D2L receptor (443 amino acids) expressed in LTK deficient mouse fibroblasts after 60 mins by liquid scintillation counting analysis,102,919,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3801477,Ki,7.32,CHEMBL59,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,121,196,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3801662,Ki,5.43,CHEMBL59,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,121,291,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL3801665,Ki,8.06,CHEMBL59,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,121,292,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL4011211,Ki,7.8,CHEMBL59,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,127,342,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL669147,Ki,8.72,CHEMBL59,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,19,331,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL669148,Ki,6.12,CHEMBL59,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,19,332,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL670556,Ki,5.96,CHEMBL59,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity of Compound of Dopamine receptor D2S,24,7,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL670557,Ki,4.82,CHEMBL59,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2S,24,8,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL670558,Ki,7.77,CHEMBL59,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity on High Affinity Site of Dopamine receptor D2S,24,9,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL671063,IC50,14.096910013008056,CHEMBL59,1985,CHEMBL1122967,J Med Chem,Scientific Literature,Agonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]-Spiperone,0,913,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL671379,Ki,6.58,CHEMBL59,1995,CHEMBL1128531,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,6,432,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL671447,Ki,7.38,CHEMBL59,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2L,24,920,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL672183,Ki,8.72,CHEMBL59,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,9,197,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL672184,Ki,6.24,CHEMBL59,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,9,198,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL672210,Ki,5.1,CHEMBL59,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,15,87,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL672526,Ki,4.82,CHEMBL59,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was determined in the presence of 100 micro M Gpp(NH)p for decoupling of the ternary complex of Compound to Dopamine receptor D2L,24,10,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL672527,Ki,7.7,CHEMBL59,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding affinity on High Affinity Site of Dopamine receptor D2L,24,6,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL672528,Ki,5.72,CHEMBL59,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was tested on low Affinity Site of Dopamine receptor D2L,24,11,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL872880,Ki,7.47,CHEMBL59,2000,CHEMBL1133710,J Med Chem,Scientific Literature,Binding Affinity was tested on relative proportion of High Affinity Site of Dopamine receptor D2S,24,15,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL995087,Ki,6.35,CHEMBL59,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cells,61,16,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)c(O)c1,CHEMBL995088,Ki,6.44,CHEMBL59,2008,CHEMBL1142495,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,61,17,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1ccc(O)cc1,CHEMBL672210,Ki,3.795880017344075,CHEMBL11608,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,15,87,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCCc1cccc(O)c1,CHEMBL672210,Ki,4.7,CHEMBL145584,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,15,87,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC[C@@H]1O[C@H](C23CC4CC(CC(C4)C2)C3)Cc2c1ccc(O)c2O,CHEMBL671379,Ki,5.81,CHEMBL291143,1995,CHEMBL1128531,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,6,432,c1ccc2c(c1)COC(C13CC4CC(CC(C4)C1)C3)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC[C@H](O)c1ccc(O)c(O)c1,CHEMBL3801477,Ki,5.89,CHEMBL1437,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,121,196,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NC[C@H](O)c1ccc(O)c(O)c1,CHEMBL671063,IC50,13.096910013008056,CHEMBL1437,1985,CHEMBL1122967,J Med Chem,Scientific Literature,Agonist required to inhibit Dopamine receptor D2 photoinactivation by 50% with Iodazidoclebopride using [3H]-Spiperone,0,913,c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NCc1ccc2c(c1)c(C1CCN(CCN3CCNC3=O)CC1)cn2-c1ccc(F)cc1,CHEMBL1261591,Ki,7.43,CHEMBL1259172,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,74,108,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NS(=O)(=O)NCCCCCCN1CCN(c2cccc(Cl)c2)CC1,CHEMBL5163611,Ki,6.64,CHEMBL5181868,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,154,910,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NS(=O)(=O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,5.92,CHEMBL108297,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,38,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NS(=O)(=O)c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,CHEMBL5235417,Ki,5.29,CHEMBL146246,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to D2R (unknown origin) assessed as inhibition constant,152,476,c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
NS(=O)(=O)c1ccc(N2CCN(CC[C@@H]3OCCc4ccccc43)CC2)cc1,CHEMBL4039163,Ki,5.29,CHEMBL69759,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,127,546,c1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N[C@@H]1CCN(c2ccc3[nH]nc(S(=O)(=O)c4cccc5ccccc45)c3c2)C1,CHEMBL1073463,Ki,5.54,CHEMBL604102,2010,CHEMBL1157614,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor,74,921,O=S(=O)(c1cccc2ccccc12)c1n[nH]c2ccc(N3CCCC3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N[C@@H]1CCc2c(F)cccc2C1,CHEMBL672183,Ki,6.23,CHEMBL138792,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,9,197,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N[C@@H]1CCc2c(F)cccc2C1,CHEMBL672184,Ki,6.06,CHEMBL138792,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,9,198,c1ccc2c(c1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801662,Ki,4.92,CHEMBL3799271,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,121,291,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N[C@@H]1Cc2cccc3[nH]c(=O)n(c23)C1,CHEMBL3801665,Ki,6.94,CHEMBL3799271,2016,CHEMBL3797097,J Med Chem,Scientific Literature,Displacement of [3H]7-OH-DPAT from human D2 receptor transfected in HEK293 cells measured after 60 mins by liquid scintillation counter,121,292,O=c1[nH]c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N[C@H]1CCCC[C@@H]1NC(=O)c1c2c(c3c4c(ncnc14)-c1ccccc1C3=O)N[C@@H]1CCCC[C@H]1N2,CHEMBL671655,Ki,5.5,CHEMBL2112936,1999,CHEMBL1132065,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against dopamine D2 receptor,19,922,O=C(NC1CCCCC1)c1c2c(c3c4c(ncnc14)-c1ccccc1C3=O)NC1CCCCC1N2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,8.34,CHEMBL3891773,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,121,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1c(F)cccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,7.85,CHEMBL165126,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(Br)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,8.33,CHEMBL352182,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(Cl)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,8.64,CHEMBL424384,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(F)ccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCC3,CHEMBL672312,Ki,7.54,CHEMBL163904,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCC3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(F)ccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCCC3,CHEMBL672312,Ki,7.72,CHEMBL165897,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCC3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(F)ccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,8.33,CHEMBL349151,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(F)ccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCO3,CHEMBL672312,Ki,7.8,CHEMBL349057,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCO3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(F)ccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCS3,CHEMBL672312,Ki,7.85,CHEMBL351247,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCC3,CHEMBL672312,Ki,8.28,CHEMBL351592,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCC3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCC3,CHEMBL672312,Ki,8.46,CHEMBL349683,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCC3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,8.48,CHEMBL166310,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCO3,CHEMBL672312,Ki,8.64,CHEMBL165780,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCO3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCS3,CHEMBL672312,Ki,8.4,CHEMBL354005,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cc(O)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,7.3,CHEMBL164909,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccc(C(=O)CCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL4815619,Ki,5.96,CHEMBL4861794,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,152,118,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,CHEMBL4815619,Ki,6.17,CHEMBL4845741,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,152,118,c1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccc(F)cc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,7.82,CHEMBL165723,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccc2c(N3CCN(CC[C@H]4CC[C@H](NC(=O)c5ccco5)CC4)CC3)nsc2c1,CHEMBL3872755,Ki,7.85,CHEMBL3941190,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,121,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccc2c(c1)C(=O)C(CCN1CCC(C(=O)c3ccc(F)cc3O)CC1)CC2,CHEMBL3106891,Ki,6.95,CHEMBL3104515,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,102,134,O=C(c1ccccc1)C1CCN(CCC2CCc3ccccc3C2=O)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccc2c(c1)C(=O)C(CCN1CCC(c3noc4cc(F)ccc34)CC1)CC2,CHEMBL3106891,Ki,7.33,CHEMBL3104647,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,102,134,O=C1c2ccccc2CCC1CCN1CCC(c2noc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccc2c(c1)C(O)C(CCN1CCC(C(=O)c3ccc(F)cc3O)CC1)CC2,CHEMBL3106891,Ki,6.19,CHEMBL3104523,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,102,134,O=C(c1ccccc1)C1CCN(CCC2CCc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccc2c(c1)C(O)C(CCN1CCC(c3noc4cc(F)ccc34)CC1)CC2,CHEMBL3106891,Ki,7.06,CHEMBL3104522,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,102,134,c1ccc2c(c1)CCC(CCN1CCC(c3noc4ccccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccc2c(c1)N(CCCCN1CCN(c3cccc4sccc34)CC1)S(=O)(=O)CC2,CHEMBL4708967,IC50,7.17,CHEMBL4751542,2020,CHEMBL4706522,Eur J Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,144,548,O=S1(=O)CCc2ccccc2N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccc2oc(=O)c(CN3CCCC3)cc2c1,CHEMBL3117964,IC50,4.79,CHEMBL3113644,2014,CHEMBL3112537,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK cells co-expressing Gqi5 assessed as inhibition of dopamine-induced effect by FLIPR assay,102,923,O=c1oc2ccccc2cc1CN1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cccc(-c2ccc(C(=O)NC3CCN(Cc4ccccc4)C3)cc2)c1,CHEMBL839650,Ki,5.3,CHEMBL424808,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cccc(-c2ccc(CCN3CCN(c4cccc5cccnc45)CC3)cc2)n1,CHEMBL671377,Ki,7.96,CHEMBL87187,1999,CHEMBL1131962,Bioorg Med Chem Lett,Scientific Literature,Binding ability of compound to human Dopamine receptor D2,19,924,c1ccc(-c2ccc(CCN3CCN(c4cccc5cccnc45)CC3)cc2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1cccc(C(=O)NC/C=C/CN2CCN(c3cccc(Cl)c3Cl)CC2)c1,CHEMBL838683,Ki,7.54,CHEMBL191855,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,41,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCC3,CHEMBL672312,Ki,7.2,CHEMBL352686,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCC3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCCC3,CHEMBL672312,Ki,7.7,CHEMBL163261,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCC3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,8.23,CHEMBL444342,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCO3,CHEMBL672312,Ki,7.22,CHEMBL166366,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCO3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccccc1C(=O)CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CCS3,CHEMBL672312,Ki,7.72,CHEMBL351459,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCC3,CHEMBL672312,Ki,7.17,CHEMBL348977,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCC3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCC3,CHEMBL672312,Ki,7.96,CHEMBL352194,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCC3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,8.02,CHEMBL164185,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCO3,CHEMBL672312,Ki,7.64,CHEMBL351708,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCO3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCS3,CHEMBL672312,Ki,7.39,CHEMBL163742,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ccccc1C(=O)NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL838683,Ki,7.74,CHEMBL426994,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,41,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(-c2ccc(Cl)cc2)cc(C2CCN(Cc3ccccc3)CC2)n1,CHEMBL672209,Ki,8.07,CHEMBL78923,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)ncn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCCN3CCCC3)ccc1C2,CHEMBL5032915,Ki,5.9,CHEMBL5088622,2021,CHEMBL5032500,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2S receptor expressed in CHO cells by liquid scintillation counting analysis,152,925,c1ccc(-c2ncnc3c2Cc2ccc(OCCCN4CCCC4)cc2-3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(-c2ccccc2)c2c(n1)-c1cc(OCCCN3CCCCC3)ccc1C2=O,CHEMBL5032915,Ki,5.8,CHEMBL5082650,2021,CHEMBL5032500,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2S receptor expressed in CHO cells by liquid scintillation counting analysis,152,925,O=C1c2ccc(OCCCN3CCCCC3)cc2-c2ncnc(-c3ccccc3)c21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(N)nc(NCCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)n1,CHEMBL5121178,Ki,8.3,CHEMBL5194270,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCCCNc3ncncn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(N)nc(NCCCCCCN2CCN(c3ccccc3)CC2)n1,CHEMBL5121178,Ki,6.0,CHEMBL5205324,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCCCNc3ncncn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(N)nc(NCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)n1,CHEMBL5121178,Ki,8.1,CHEMBL5191557,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCCNc3ncncn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(N)nc(NCCCCCN2CCN(c3ccccc3)CC2)n1,CHEMBL5121178,Ki,5.98,CHEMBL5202120,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCCNc3ncncn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(N)nc(NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)n1,CHEMBL5121178,Ki,8.15,CHEMBL5170808,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCNc3ncncn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(N)nc(NCCCCN2CCN(c3ccccc3)CC2)n1,CHEMBL5121178,Ki,6.44,CHEMBL5186821,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCNc3ncncn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(NCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc(NCCc2c[nH]c3ccccc23)n1,CHEMBL5121178,Ki,7.41,CHEMBL5194614,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCNc3ncnc(NCCc4c[nH]c5ccccc45)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(NCCCCN2CCN(c3ccccc3)CC2)nc(NCCc2c[nH]c3ccccc23)n1,CHEMBL5121178,Ki,7.28,CHEMBL5189648,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCCCNc3ncnc(NCCc4c[nH]c5ccccc45)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(NCCNc2cccc(Cl)c2Cl)nc(NCCc2c[nH]c3ccccc23)n1,CHEMBL5121178,Ki,5.3,CHEMBL5171734,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(NCCNc2ncnc(NCCc3c[nH]c4ccccc34)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(NCCNc2ccccc2)nc(NCCc2c[nH]c3ccccc23)n1,CHEMBL5121178,Ki,5.06,CHEMBL5178499,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(NCCNc2ncnc(NCCc3c[nH]c4ccccc34)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(NCCOc2cccc(Cl)c2Cl)nc(NCCc2c[nH]c3ccccc23)n1,CHEMBL5121178,Ki,5.36,CHEMBL5197266,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(OCCNc2ncnc(NCCc3c[nH]c4ccccc34)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(NCCc2c[nH]c3ccccc23)nc(N2CCN(c3cccc(Cl)c3Cl)CC2)n1,CHEMBL5121178,Ki,5.49,CHEMBL5201719,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(c3ncnc(NCCc4c[nH]c5ccccc45)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(NCCc2c[nH]c3ccccc23)nc(N2CCN(c3ccccc3)CC2)n1,CHEMBL5121178,Ki,5.08,CHEMBL5194826,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(c3ncnc(NCCc4c[nH]c5ccccc45)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(NCCc2c[nH]c3ccccc23)nc(NCCN2CCN(c3ccccc3)CC2)n1,CHEMBL5121178,Ki,6.38,CHEMBL5199820,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(N2CCN(CCNc3ncnc(NCCc4c[nH]c5ccccc45)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc(NCCc2cccc(Cl)c2Cl)nc(NCCc2c[nH]c3ccccc23)n1,CHEMBL5121178,Ki,5.51,CHEMBL5177186,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader analysis,154,756,c1ccc(CCNc2ncnc(NCCc3c[nH]c4ccccc34)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2c(s1)CCN(CCCCN1CCN(c3cccc(Cl)c3Cl)CC1)CC2,CHEMBL4334858,Ki,7.65,CHEMBL4572887,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,138,774,c1ccc(N2CCN(CCCCN3CCc4ncsc4CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2c(s1)CCN(CCCCN1CCN(c3ncccn3)CC1)CC2,CHEMBL4334858,Ki,5.56,CHEMBL4435367,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,138,774,c1cnc(N2CCN(CCCCN3CCc4ncsc4CC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(C(=O)c1ccccc1)CC3,CHEMBL2328744,IC50,5.0,CHEMBL2326475,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,O=C(c1ccccc1)N1CCc2cc3ncsc3cc2CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(C(=O)c1ccccc1)CC3,CHEMBL2328745,Ki,5.37,CHEMBL2326475,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,O=C(c1ccccc1)N1CCc2cc3ncsc3cc2CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(C1CC1)CC3,CHEMBL2328744,IC50,5.35,CHEMBL2326490,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1nc2cc3c(cc2s1)CCN(C1CC1)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(C1CC1)CC3,CHEMBL2328745,Ki,5.96,CHEMBL2326490,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1nc2cc3c(cc2s1)CCN(C1CC1)CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(CC(F)(F)F)CC3,CHEMBL2328744,IC50,4.52,CHEMBL2326491,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(CC(F)(F)F)CC3,CHEMBL2328745,Ki,5.3,CHEMBL2326491,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(CCO)CC3,CHEMBL2328744,IC50,5.0,CHEMBL2326474,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(CCO)CC3,CHEMBL2328745,Ki,6.1,CHEMBL2326474,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1ccc(F)cc1)CC3,CHEMBL2328744,IC50,6.22,CHEMBL2326477,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1ccc(F)cc1)CC3,CHEMBL2328745,Ki,7.12,CHEMBL2326477,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1cccc(F)c1)CC3,CHEMBL2328744,IC50,6.4,CHEMBL2326478,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1cccc(F)c1)CC3,CHEMBL2328745,Ki,7.38,CHEMBL2326478,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1ccccc1)CC3,CHEMBL2328744,IC50,5.54,CHEMBL2326476,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1ccccc1)CC3,CHEMBL2328745,Ki,7.1,CHEMBL2326476,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1ccc(CN2CCc3cc4ncsc4cc3CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1ccccn1)CC3,CHEMBL2328744,IC50,5.1,CHEMBL2326483,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1ccc(CN2CCc3cc4ncsc4cc3CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1ccccn1)CC3,CHEMBL2328745,Ki,5.3,CHEMBL2326483,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1ccc(CN2CCc3cc4ncsc4cc3CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1cccnc1)CC3,CHEMBL2328744,IC50,5.77,CHEMBL2326484,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1cncc(CN2CCc3cc4ncsc4cc3CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1cccnc1)CC3,CHEMBL2328745,Ki,6.7,CHEMBL2326484,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1cncc(CN2CCc3cc4ncsc4cc3CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1ccncc1)CC3,CHEMBL2328744,IC50,5.35,CHEMBL2326485,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1cc(CN2CCc3cc4ncsc4cc3CC2)ccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1ccncc1)CC3,CHEMBL2328745,Ki,7.42,CHEMBL2326485,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1cc(CN2CCc3cc4ncsc4cc3CC2)ccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1cnc[nH]1)CC3,CHEMBL2328744,IC50,5.82,CHEMBL2326470,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1ncc(CN2CCc3cc4ncsc4cc3CC2)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1cnc[nH]1)CC3,CHEMBL2328745,Ki,6.24,CHEMBL2326470,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1ncc(CN2CCc3cc4ncsc4cc3CC2)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1cnco1)CC3,CHEMBL2328744,IC50,5.6,CHEMBL2326468,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1ncc(CN2CCc3cc4ncsc4cc3CC2)o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1cnco1)CC3,CHEMBL2328745,Ki,6.5,CHEMBL2326468,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1ncc(CN2CCc3cc4ncsc4cc3CC2)o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1cscn1)CC3,CHEMBL2328744,IC50,5.92,CHEMBL2326469,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1nc(CN2CCc3cc4ncsc4cc3CC2)cs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1cscn1)CC3,CHEMBL2328745,Ki,6.31,CHEMBL2326469,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1nc(CN2CCc3cc4ncsc4cc3CC2)cs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1ncon1)CC3,CHEMBL2328744,IC50,5.0,CHEMBL2326471,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1nc(CN2CCc3cc4ncsc4cc3CC2)no1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCN(Cc1ncon1)CC3,CHEMBL2328745,Ki,5.3,CHEMBL2326471,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1nc(CN2CCc3cc4ncsc4cc3CC2)no1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCNCC3,CHEMBL2328744,IC50,5.12,CHEMBL2326487,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,93,466,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1nc2cc3c(cc2s1)CCNCC3,CHEMBL2328745,Ki,5.41,CHEMBL2326487,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,93,467,c1nc2cc3c(cc2s1)CCNCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ncc(-c2cccc3c2ccn3S(=O)(=O)c2ccccc2)[nH]1,CHEMBL4354013,Ki,5.4,CHEMBL4450907,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,138,125,O=S(=O)(c1ccccc1)n1ccc2c(-c3cnc[nH]3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Nc1ncc(-c2cn(S(=O)(=O)c3ccccc3)c3ccccc23)[nH]1,CHEMBL4354013,Ki,7.06,CHEMBL4441060,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,138,125,O=S(=O)(c1ccccc1)n1cc(-c2cnc[nH]2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O/N=C(\CCN1CCN(c2ccccn2)CC1)c1ccccc1,CHEMBL863653,Ki,6.59,CHEMBL214314,2006,CHEMBL1145336,J Med Chem,Scientific Literature,Displacement of [3H]PIPAT from human recombinant D2L receptor expressed in HEK293 cells,49,472,N=C(CCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O/N=C/c1c(CN2CCN(c3ccccc3)CC2)[nH]c2ccccc12,CHEMBL5235409,Ki,5.06,CHEMBL5285358,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,152,478,c1ccc(N2CCN(Cc3cc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O/N=C/c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,CHEMBL3295080,Ki,8.48,CHEMBL3287404,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,102,391,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O/N=C/c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,CHEMBL3295081,Ki,8.64,CHEMBL3287404,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,102,392,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O/N=C/c1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12,CHEMBL4046973,Ki,8.155,CHEMBL4085752,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,127,385,c1cc2c(c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O/N=C/c1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12,CHEMBL4046974,Ki,8.38,CHEMBL4085752,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,127,386,c1cc2c(c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL3293231,IC50,8.42,CHEMBL3287403,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,102,509,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL3295080,Ki,9.254999999999999,CHEMBL3287403,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,102,391,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL3295081,Ki,9.184999999999999,CHEMBL3287403,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,102,392,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C(\O)c1ccc(Cl)cc1)C1CCN(Cc2ccccc2)CC1,CHEMBL672209,Ki,6.92,CHEMBL2112285,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,O=C(C=Cc1ccccc1)C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1c[nH]c2ccccc12)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,CHEMBL672227,Ki,6.2,CHEMBL301475,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,19,131,O=C(C=Cc1c[nH]c2ccccc12)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1c[nH]c2ccccc12)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,CHEMBL673026,Ki,6.2,CHEMBL552599,2000,CHEMBL1132939,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO cells,24,817,O=C(C=Cc1c[nH]c2ccccc12)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccc(Cl)c(Cl)c1)NCCCCCN1CCC(c2c[nH]c3ccc(O)cc23)CC1,CHEMBL670679,Ki,7.8,CHEMBL432713,2001,CHEMBL1133914,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for Dopamine receptor D2 was determined,26,926,O=C(C=Cc1ccccc1)NCCCCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccc(Cl)c(Cl)c1)N[C@H]1CC[C@@H](CN2[C@@H]3CC[C@H]2C[C@H](c2c[nH]c4ccc(O)cc24)C3)CC1,CHEMBL670089,Ki,5.9,CHEMBL71707,2001,CHEMBL1133914,Bioorg Med Chem Lett,Scientific Literature,Binding affinity relative to indolopiperidine (compound 1) for Dopamine receptor D2 was determined,26,927,O=C(C=Cc1ccccc1)NC1CCC(CN2C3CCC2CC(c2c[nH]c4ccccc24)C3)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccc(F)cc1)N[C@H]1CC[C@H](CCN2Cc3ccc(Br)cc3C2)CC1,CHEMBL672225,Ki,7.0,CHEMBL351300,2001,CHEMBL1134827,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,26,733,O=C(C=Cc1ccccc1)NC1CCC(CCN2Cc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccc(F)cc1)N[C@H]1CC[C@H](CCN2Cc3ccc(C(F)(F)F)cc3C2)CC1,CHEMBL672225,Ki,6.4,CHEMBL161126,2001,CHEMBL1134827,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,26,733,O=C(C=Cc1ccccc1)NC1CCC(CCN2Cc3ccccc3C2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccc2[nH]ccc2c1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,CHEMBL672227,Ki,6.7,CHEMBL291545,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,19,131,O=C(C=Cc1ccc2[nH]ccc2c1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccc2ccccc2c1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,CHEMBL672227,Ki,6.0,CHEMBL55840,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,19,131,O=C(C=Cc1ccc2ccccc2c1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccc2ccccc2n1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,CHEMBL672227,Ki,6.4,CHEMBL55090,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,19,131,O=C(C=Cc1ccc2ccccc2n1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccc2nc(O)ccc2c1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,CHEMBL672227,Ki,6.8,CHEMBL52466,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,19,131,O=C(C=Cc1ccc2ncccc2c1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccc2ncccc2c1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,CHEMBL672227,Ki,6.6,CHEMBL52468,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,19,131,O=C(C=Cc1ccc2ncccc2c1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccccc1)N(Cc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1)Cc1cccnc1,CHEMBL840226,Ki,5.9,CHEMBL187928,2005,CHEMBL1142810,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 expressed in CHO cells using the radioligand [125I]iodosulpiride,41,532,O=C(C=Cc1ccccc1)N(Cc1ccc(-c2ccc(CNCCc3ccccc3)cc2)cc1)Cc1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccccc1)NC1CCN(Cc2ccccc2)CC1,CHEMBL667743,IC50,5.33,CHEMBL116233,1994,CHEMBL1127992,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from dopamine D2 receptor,4,49,O=C(C=Cc1ccccc1)NC1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccccc1)NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1,CHEMBL897619,Ki,6.79,CHEMBL401223,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(C=Cc1ccccc1)NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccccc1)NCCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,CHEMBL897619,Ki,6.02,CHEMBL241455,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(C=Cc1ccccc1)NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccccc1)NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,CHEMBL897619,Ki,6.19,CHEMBL241026,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(C=Cc1ccccc1)NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccccc1)NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1,CHEMBL897619,Ki,6.37,CHEMBL239065,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(C=Cc1ccccc1)NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccccc1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,CHEMBL672227,Ki,6.5,CHEMBL55276,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,19,131,O=C(C=Cc1ccccc1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1ccccc1)NCCCCN1CCc2ccccc2C1,CHEMBL897619,Ki,5.9,CHEMBL240589,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(C=Cc1ccccc1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C/c1cnc2ccccc2c1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,CHEMBL672227,Ki,6.5,CHEMBL52901,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,19,131,O=C(C=Cc1cnc2ccccc2c1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(/C=C\c1ccccc1)NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1,CHEMBL672227,Ki,6.5,CHEMBL55524,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,19,131,O=C(C=Cc1ccccc1)NCCCCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C#Cc1ccccc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1,CHEMBL667743,IC50,5.82,CHEMBL112170,1994,CHEMBL1127992,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from dopamine D2 receptor,4,49,O=C(C#Cc1ccccc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C#Cc1ccccc1)NC1CCN(Cc2ccccc2)CC1,CHEMBL667743,IC50,5.6,CHEMBL113449,1994,CHEMBL1127992,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from dopamine D2 receptor,4,49,O=C(C#Cc1ccccc1)NC1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.46,CHEMBL3695371,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.68,CHEMBL3664823,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.37,CHEMBL3676857,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.04,CHEMBL3697966,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",102,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.16,CHEMBL3642737,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1(O)CCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.58,CHEMBL3664857,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,111,O=C(CC1CCC1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1(O)CCC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.02,CHEMBL3697978,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",102,112,O=C(CC1CCC1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1(O)CCC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.39,CHEMBL3642817,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,O=C(CC1CCC1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1(O)CCCCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.44,CHEMBL3664834,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,111,O=C(CC1CCCCC1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1(O)CCCCC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.8,CHEMBL3697965,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",102,112,O=C(CC1CCCCC1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1(O)CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.51,CHEMBL3664844,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,111,O=C(CC1CCOCC1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.57,CHEMBL3695383,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,54,O=C(CC1CC1)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.52,CHEMBL3664821,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,111,O=C(CC1CC1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.47,CHEMBL3676870,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,55,O=C(CC1CC1)NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.85,CHEMBL3697958,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",102,112,O=C(CC1CC1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.23,CHEMBL3642728,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,O=C(CC1CC1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.52,CHEMBL3695413,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,54,O=C(CC1CCC1)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCC1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.24,CHEMBL3676893,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,55,O=C(CC1CCC1)NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.22,CHEMBL3642750,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,O=C(CC1CCC1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.28,CHEMBL3664835,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,111,O=C(CC1CCCCO1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.42,CHEMBL3695378,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,54,O=C(CC1CCCO1)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.41,CHEMBL3664819,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,111,O=C(CC1CCCO1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.28,CHEMBL3676874,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,55,O=C(CC1CCCO1)NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.72,CHEMBL3697956,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",102,112,O=C(CC1CCCO1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.9,CHEMBL3642741,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,O=C(CC1CCCO1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCN(CC2CC2)CC1)c1ccc(F)cc1,CHEMBL673013,Ki,5.79,CHEMBL543412,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C(CC1CCN(CC2CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3ccc(F)c4occc34)CC2)CC1,CHEMBL3705383,Ki,6.21,CHEMBL3695419,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,54,O=C(CC1CCOCC1)NC1CCC(CCN2CCC(c3cccc4occc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.19,CHEMBL3695361,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,54,O=C(CC1CCOCC1)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.45,CHEMBL3664865,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,111,O=C(CC1CCOCC1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1,CHEMBL3705383,Ki,6.66,CHEMBL3695357,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,54,O=C(CC1CCOCC1)NC1CCC(CCN2CCC(c3cccc4occc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.11,CHEMBL3676849,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",102,55,O=C(CC1CCOCC1)NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.86,CHEMBL3698003,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",102,112,O=C(CC1CCOCC1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.06,CHEMBL3642711,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,O=C(CC1CCOCC1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,6.17,CHEMBL3642688,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,O=C(CC1CCOCC1)NC1CCC(CCN2CCN(c3nccc4occc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1CCOCC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1,CHEMBL3705135,Ki,6.84,CHEMBL3642701,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,O=C(CC1CCOCC1)NC1CCC(CCN2CCN(c3nccc4sccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.71,CHEMBL3695433,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",103,54,O=C(CC1COC1)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.59,CHEMBL3664842,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,111,O=C(CC1COC1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.47,CHEMBL3676921,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",103,55,O=C(CC1COC1)NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.97,CHEMBL3697972,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",103,112,O=C(CC1COC1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1COC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.12,CHEMBL3642754,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,O=C(CC1COC1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.14,CHEMBL3695369,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",103,54,O=C(CC1COCCO1)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.28,CHEMBL3664816,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,111,O=C(CC1COCCO1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1,CHEMBL3705383,Ki,6.66,CHEMBL3695365,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",103,54,O=C(CC1COCCO1)NC1CCC(CCN2CCC(c3cccc4occc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.07,CHEMBL3676853,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",103,55,O=C(CC1COCCO1)NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.7,CHEMBL3697953,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",103,112,O=C(CC1COCCO1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.83,CHEMBL3642714,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,O=C(CC1COCCO1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CC1C[C@H](O)CO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.03,CHEMBL3642768,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,O=C(CC1CCCO1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCC(=O)N1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3369121,Ki,6.07,CHEMBL3318852,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCC(=O)N1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCC(=O)N1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3369122,Ki,6.33,CHEMBL3318852,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCC(=O)N1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.17,CHEMBL3318831,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.27,CHEMBL3318831,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.6,CHEMBL3695427,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",103,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.39,CHEMBL3664824,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCC(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.21,CHEMBL3676889,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",103,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCC(F)(F)F)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.9,CHEMBL3642772,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",93,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,7.92,CHEMBL3318832,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,7.92,CHEMBL3318832,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020816,IC50,7.06,CHEMBL2016626,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,84,268,O=C(CCCCC(=O)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020817,Ki,8.469999999999999,CHEMBL2016626,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,84,269,O=C(CCCCC(=O)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.52,CHEMBL3318833,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.64,CHEMBL3318833,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.48,CHEMBL3318834,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.59,CHEMBL3318834,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020816,IC50,7.635,CHEMBL2016627,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,84,268,O=C(CCCCCCC(=O)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020817,Ki,8.86,CHEMBL2016627,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,84,269,O=C(CCCCCCC(=O)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.6,CHEMBL3318835,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.54,CHEMBL3318835,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.25,CHEMBL3318836,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.19,CHEMBL3318836,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020816,IC50,7.355,CHEMBL2016628,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,84,268,O=C(CCCCCCCCC(=O)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020817,Ki,8.89,CHEMBL2016628,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,84,269,O=C(CCCCCCCCC(=O)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,7.82,CHEMBL3318837,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,7.51,CHEMBL3318837,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020816,IC50,5.955,CHEMBL2016629,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,84,268,O=C(CCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,7.18,CHEMBL3318838,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,7.34,CHEMBL3318838,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020816,IC50,4.965,CHEMBL2016630,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,84,268,O=C(CCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,6.92,CHEMBL3318839,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,7.21,CHEMBL3318839,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,6.85,CHEMBL3318840,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCCCCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,6.55,CHEMBL3318840,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCCCCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020816,IC50,5.11,CHEMBL2016631,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Inhibition of human dopamine D2L receptor expressed in intact CHO FlpIn cells assessed as inhibition of receptor-mediated mediated ERK1/2 phosphorylation by Alpha-Screen plate-based assay,84,268,O=C(CCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,CHEMBL2020817,Ki,6.59,CHEMBL2016631,2012,CHEMBL2016514,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO FlpIn cell membrane measured after 60 mins by topcount scintillation counting,84,269,O=C(CCCCCCCCCCCCCCCCC(=O)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1)NCCCN1CCN(C2=Nc3ccccc3Nc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,6.8,CHEMBL3318841,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCCCCCCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,6.82,CHEMBL3318841,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCCCCCCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,7.6,CHEMBL3318842,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,7.57,CHEMBL3318842,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,6.51,CHEMBL3318843,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,6.55,CHEMBL3318843,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCCCCCCCCCCCCCCCCCCC(=O)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,CHEMBL894060,Ki,6.0,CHEMBL222188,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,56,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)N1CCc2ccccc2C1,CHEMBL1034994,Ki,6.44,CHEMBL492480,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,61,216,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)N1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)N1Cc2ccccc2C1,CHEMBL1034994,Ki,7.03,CHEMBL494118,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,61,216,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)N1Cc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NC1CCCc2ccccc21,CHEMBL894060,Ki,6.65,CHEMBL243954,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,56,138,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccc(OCCCN2CCOCC2)cc1,CHEMBL3857974,Ki,7.19,CHEMBL3906408,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,121,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccc(OCCCN2CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccc(OCCN2CCOCC2)cc1,CHEMBL3857974,Ki,6.87,CHEMBL3977072,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,121,537,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccc(OCCN2CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,CHEMBL1034994,Ki,6.3,CHEMBL492871,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,61,216,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccncc1,CHEMBL1034994,Ki,6.73,CHEMBL494709,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,61,216,O=C(CCCCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccncc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2Cl)CC1)NC1CCCc2ccccc21,CHEMBL894060,Ki,7.29,CHEMBL222477,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,56,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2F)CC1)NC1CCCc2ccccc21,CHEMBL894060,Ki,6.54,CHEMBL244577,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,56,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2O)CC1)NC1CCCc2ccccc21,CHEMBL894060,Ki,6.01,CHEMBL225512,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,56,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2ccccc2[N+](=O)[O-])CC1)NC1CCCc2ccccc21,CHEMBL894060,Ki,6.17,CHEMBL225571,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,56,138,O=C(CCCCCN1CCN(c2ccccc2)CC1)NC1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCCN1CCN(c2noc3ccccc23)CC1)c1ccccc1O,CHEMBL672386,Ki,6.61,CHEMBL160817,2003,CHEMBL1145970,J Med Chem,Scientific Literature,Binding affinity of compound was tested for Dopamine receptor D2L,36,754,O=C(CCCCCN1CCN(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1nc2ccccc2s1,CHEMBL3820048,Ki,6.745,CHEMBL3818881,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,121,897,O=C(CCCCN1C2CCC1CC(c1ccccc1)C2)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,7.92,CHEMBL4450047,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCC(c2ccccc2)CC1)c1nc2ccccc2s1,CHEMBL2037965,Ki,6.19,CHEMBL2037531,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,O=C(CCCCN1CCC(c2ccccc2)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2,CHEMBL4276601,IC50,8.04,CHEMBL4293999,2018,CHEMBL4270672,J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor long isoform (unknown origin) expressed in HEK293 cells assessed as inhibition of dopamine-induced calcium flux after 15 mins by calcium 4-dye based FLIPR assay,131,617,O=C(CCCCN1CCC(c2noc3ccccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2,CHEMBL4709830,Ki,8.54,CHEMBL4293999,2020,CHEMBL4706549,Eur J Med Chem,Scientific Literature,Binding affinity to D2 receptor (unknown origin),144,928,O=C(CCCCN1CCC(c2noc3ccccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1nc2ccccc2s1,CHEMBL2037965,Ki,6.66,CHEMBL2037520,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,O=C(CCCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1nc2ccccc2s1,CHEMBL3820048,Ki,6.66,CHEMBL2037520,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,121,897,O=C(CCCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1nc2ccccc2s1,CHEMBL2037965,Ki,7.6,CHEMBL2037526,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,O=C(CCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1nc2ccccc2s1,CHEMBL3820048,Ki,7.595,CHEMBL2037526,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,121,897,O=C(CCCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCCN(c2ccc(Cl)cc2)CC1)c1nc2ccccc2s1,CHEMBL1949469,Ki,5.7,CHEMBL1946257,2012,CHEMBL1944557,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,84,881,O=C(CCCCN1CCCN(c2ccccc2)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCCN(c2ccc(Cl)cc2)CC1)c1nc2ccccc2s1,CHEMBL2037965,Ki,5.7,CHEMBL1946257,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,O=C(CCCCN1CCCN(c2ccccc2)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCN(C(c2ccc(F)cc2)c2ccc(F)cc2)CC1)c1nc2ccccc2s1,CHEMBL3820048,Ki,6.8,CHEMBL3819403,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,121,897,O=C(CCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCN(c2ccc(Cl)cc2)CC1)c1nc2ccccc2s1,CHEMBL2037965,Ki,5.32,CHEMBL2037528,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,O=C(CCCCN1CCN(c2ccccc2)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)Nc1nc2ccccc2s1,CHEMBL3608115,Ki,5.25,CHEMBL3605327,2015,CHEMBL3603825,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,112,738,O=C(CCCCN1CCN(c2ccccc2)CC1)Nc1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)Nc1nc2ccccc2s1,CHEMBL4259825,Ki,5.25,CHEMBL3605327,2018,CHEMBL4257542,Medchemcomm,Scientific Literature,Displacement of [3H]-sulpiride from human D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting method,131,929,O=C(CCCCN1CCN(c2ccccc2)CC1)Nc1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCN(c2ccccc2)CC1)c1nc2ccccc2s1,CHEMBL2037965,Ki,6.7,CHEMBL2037530,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,O=C(CCCCN1CCN(c2ccccc2)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCN(c2ccccc2F)CC1)Nc1nc2ccccc2s1,CHEMBL3608115,Ki,6.76,CHEMBL3605331,2015,CHEMBL3603825,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-sulpiride from human dopamine D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting,112,738,O=C(CCCCN1CCN(c2ccccc2)CC1)Nc1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCN(c2ccccc2F)CC1)Nc1nc2ccccc2s1,CHEMBL4259825,Ki,6.76,CHEMBL3605331,2018,CHEMBL4257542,Medchemcomm,Scientific Literature,Displacement of [3H]-sulpiride from human D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting method,131,929,O=C(CCCCN1CCN(c2ccccc2)CC1)Nc1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1CCN(c2ncccn2)CC1)c1nc2ccccc2s1,CHEMBL2037965,Ki,6.3,CHEMBL2037529,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,O=C(CCCCN1CCN(c2ncccn2)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1Cc2ccccc2C1)c1nc2ccccc2s1,CHEMBL2037965,Ki,5.53,CHEMBL2037527,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,O=C(CCCCN1Cc2ccccc2C1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCCN1[C@@H]2CC[C@H]1CC(O)(c1ccc(Cl)cc1)C2)c1nc2ccccc2s1,CHEMBL1949469,Ki,6.75,CHEMBL1946744,2012,CHEMBL1944557,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,84,881,O=C(CCCCN1C2CCC1CC(c1ccccc1)C2)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2C3C4CC5C6C4C2C6C1(O)C53)c1ccc(F)cc1,CHEMBL1781414,Ki,5.76,CHEMBL1779058,2011,CHEMBL1777734,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,79,683,O=C(CCCN1C2C3C4CC5C6C4C2C6C1C53)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,CHEMBL1033197,Ki,8.8,CHEMBL210578,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,66,880,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,CHEMBL3366156,Ki,9.51,CHEMBL210578,2014,CHEMBL3352364,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,103,840,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,CHEMBL671416,Ki,9.51,CHEMBL210578,2003,CHEMBL1136328,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to inhibit the binding of [3H]spiperone to cloned human Dopamine receptor D2 using apomorphine induced climbing test in male Swiss mice,36,590,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,CHEMBL674342,Ki,9.51,CHEMBL210578,2003,CHEMBL1136328,Bioorg Med Chem Lett,Scientific Literature,Cataleptogenic effect against cloned human Dopamine receptor D2 in male Sprague-Dawley rats in a bar test,36,597,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,CHEMBL868244,Ki,8.8,CHEMBL210578,2006,CHEMBL1148503,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor by radioligand binding assay,49,930,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,CHEMBL992743,Ki,8.8,CHEMBL210578,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CC(O)(c1ccccc1)C2)c1ccc(F)cc1,CHEMBL838814,Ki,8.64,CHEMBL553327,2004,CHEMBL1138643,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,38,886,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CC(O)(c1ccccc1)C2)c1ccc(F)cc1,CHEMBL992743,Ki,8.64,CHEMBL478617,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CC(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,CHEMBL838814,Ki,6.72,CHEMBL537182,2004,CHEMBL1138643,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,38,886,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccc(F)cc1,CHEMBL838814,Ki,6.91,CHEMBL553417,2004,CHEMBL1138643,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,38,886,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccc(F)cc1,CHEMBL992743,Ki,6.91,CHEMBL340816,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CN(c1ccc(Cl)cc1)CC2)c1ccc(F)cc1,CHEMBL992743,Ki,6.75,CHEMBL476109,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=C(CCCN1C2CCC1CN(c1ccccc1)CC2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1C2CCC1CN(c1ccc(Cl)cn1)C2)c1ccc(F)cc1,CHEMBL4688549,Ki,5.9,CHEMBL4789472,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,152,847,O=C(CCCN1C2CCC1CN(c1ccccn1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CC2CC1CN2c1ccc(Cl)cc1)c1ccc(F)cc1,CHEMBL992743,Ki,6.77,CHEMBL476934,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=C(CCCN1CC2CC1CN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CC2CC1N(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,CHEMBL1033197,Ki,6.77,CHEMBL514591,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,66,880,O=C(CCCN1CC2CC1N(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CC2CCC(C1)N2c1ccccc1)c1ccc(F)cc1,CHEMBL992743,Ki,6.81,CHEMBL476933,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=C(CCCN1CC2CCC(C1)N2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CC=C(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,8.0,CHEMBL3544895,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CC=C(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(CCc2c[nH]c3ccccc23)CC1)c1ccc(F)cc1,CHEMBL671418,Ki,7.4,CHEMBL423706,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C(CCCN1CCC(CCc2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2c(Cl)cccc2Cl)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,8.83,CHEMBL4453290,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2cc(Cl)cc(Cl)c2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,9.35,CHEMBL4436241,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2cc(Cl)ccc2Cl)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,8.99,CHEMBL4529368,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL1261459,Ki,6.85,CHEMBL1256169,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,74,777,O=C(CCCN1CCC(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL1261460,Ki,6.7,CHEMBL1256169,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,74,778,O=C(CCCN1CCC(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccc(F)cc1,CHEMBL1261459,Ki,8.32,CHEMBL1257688,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,74,777,O=C(CCCN1CCC(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccc(F)cc1,CHEMBL1261460,Ki,8.44,CHEMBL1257688,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,74,778,O=C(CCCN1CCC(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(C(F)(F)F)cc2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,9.49,CHEMBL4436610,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)c(Cl)c2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,9.81,CHEMBL4544491,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1,CHEMBL1033197,Ki,7.48,CHEMBL150161,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,66,880,O=C(CCCN1CCC(c2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1,CHEMBL868244,Ki,6.8,CHEMBL150161,2006,CHEMBL1148503,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor by radioligand binding assay,49,930,O=C(CCCN1CCC(c2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)C1)c1ccc(F)cc1,CHEMBL992743,Ki,6.8,CHEMBL150161,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=C(CCCN1CCC(c2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1c(F)cccc1F,CHEMBL4416273,Ki,7.2,CHEMBL4576998,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cc(F)cc(F)c1,CHEMBL4416273,Ki,6.77,CHEMBL4465318,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cc(F)ccc1F,CHEMBL4416273,Ki,6.95,CHEMBL4482896,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL1261459,Ki,7.68,CHEMBL1257810,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,74,777,O=C(CCCN1CCC(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL1261460,Ki,7.89,CHEMBL1257810,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,74,778,O=C(CCCN1CCC(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(Cl)cc1,CHEMBL4416273,Ki,8.3,CHEMBL363548,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(Cl)cc1,CHEMBL894444,Ki,6.72,CHEMBL363548,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,56,122,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)c(F)c1,CHEMBL4416273,Ki,8.11,CHEMBL4463187,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1027240,Ki,9.22,CHEMBL54,2008,CHEMBL1140101,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,61,482,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1033197,Ki,8.96,CHEMBL54,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,66,880,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1034994,Ki,8.38,CHEMBL54,2008,CHEMBL1140136,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor expressed in rat C6 cells,61,216,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1040200,Ki,8.52,CHEMBL54,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,66,931,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1059279,Ki,9.22,CHEMBL54,2009,CHEMBL1154195,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,66,568,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1066831,Ki,8.72,CHEMBL54,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,74,380,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1066832,Ki,9.0,CHEMBL54,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,74,381,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1110025,Ki,8.52,CHEMBL54,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,74,815,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1176478,Ki,8.96,CHEMBL54,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,74,641,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1261459,Ki,8.96,CHEMBL54,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,74,777,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1261460,Ki,9.06,CHEMBL54,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,74,778,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1781414,Ki,9.0,CHEMBL54,2011,CHEMBL1777734,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in HEK cells,79,683,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1803210,Ki,8.82,CHEMBL54,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]SCH23390 from human D2long receptor expressed in CHO cells,79,293,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1803211,Ki,8.96,CHEMBL54,2011,CHEMBL1799971,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cells,79,294,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1920023,Ki,8.82,CHEMBL54,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 Long receptor expressed in chinese hamster CHO cells by radioligand binding assay,79,295,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1920024,Ki,8.96,CHEMBL54,2011,CHEMBL1914371,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human DRD2 short receptor expressed in chinese hamster CHO cells by radioligand binding assay,79,296,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL2060138,Ki,8.52,CHEMBL54,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,84,932,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL2208721,Ki,8.55,CHEMBL54,2011,CHEMBL2203023,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,79,933,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL2342830,IC50,6.26,CHEMBL54,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in HEK293 cells assessed as inhibition of [35S]GTPgammaS binding by scintillation proximity assay,93,662,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3106129,Ki,8.455,CHEMBL54,2014,CHEMBL3102773,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-Methylspiperone from dopamine D2 receptor (unknown origin),103,613,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3106891,Ki,9.22,CHEMBL54,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,103,134,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3222870,Ki,9.22,CHEMBL54,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3239709,Ki,8.85,CHEMBL54,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,103,448,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3265956,Ki,9.07,CHEMBL54,2014,CHEMBL3259715,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK cells,103,82,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3293231,IC50,9.15,CHEMBL54,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,103,509,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3297244,Ki,8.4,CHEMBL54,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,103,833,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3366156,Ki,9.05,CHEMBL54,2014,CHEMBL3352364,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,103,840,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3369121,Ki,9.09,CHEMBL54,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3369122,Ki,9.07,CHEMBL54,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3372144,IC50,9.8,CHEMBL54,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,103,169,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3387745,IC50,6.39,CHEMBL54,2014,CHEMBL3351714,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) after 40 mins by [35S]GTP-gammaS binding assay in presence of quinpirole,103,288,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3413541,Ki,8.4,CHEMBL54,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,112,210,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3626473,Ki,9.02,CHEMBL54,2015,CHEMBL3621057,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells,112,0,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3707630,Ki,9.15,CHEMBL54,2013,CHEMBL3638417,,BindingDB Patent Bioactivity Data,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",93,575,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3783165,Ki,8.02,CHEMBL54,2016,CHEMBL3779868,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,121,278,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4041093,Ki,8.85,CHEMBL54,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,127,826,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4044352,Ki,9.38,CHEMBL54,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,127,668,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4044353,Ki,9.6,CHEMBL54,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,127,669,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4195136,Ki,8.23,CHEMBL54,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperonee from recombinant human D2 receptor expressed in HEK293 cells cell membranes after 60 mins by liquid scintillation counting method,131,717,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4229838,Ki,8.7,CHEMBL54,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,131,578,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4344297,Ki,8.21,CHEMBL54,2020,CHEMBL4342460,J Nat Prod,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO-K1 cells by radioligand competitive binding analysis,144,621,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4368000,Ki,8.35,CHEMBL54,2019,CHEMBL4364313,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,138,528,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4368222,Ki,8.49,CHEMBL54,2019,CHEMBL4364325,Eur J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human D2S receptor expressed in CHOK1 cell membranes measured after 120 mins,138,60,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4397362,IC50,9.8,CHEMBL54,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Antagonist activity at recombinant human D2 receptor expressed in CHOK1 cells assessed as inhibition of quinpirole-induced beta arrestin2 recruitment preincubated for 30 mins followed by quinpirole addition and measured after 90 mins by coelenterazine-based beta-galactosidase reporter gene assay,138,758,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4401065,Ki,8.35,CHEMBL54,2019,CHEMBL4400523,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,138,529,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,9.33,CHEMBL54,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4625240,Ki,8.25,CHEMBL54,2020,CHEMBL4622940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),144,91,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4625526,Ki,8.25,CHEMBL54,2020,CHEMBL4622954,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-Methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells incubated for 90 mins by microbeta counting method,144,629,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4628381,Ki,8.71,CHEMBL54,2020,CHEMBL4627308,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human D2 receptor,144,31,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4685403,Ki,8.73,CHEMBL54,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,144,736,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4686240,Ki,9.13,CHEMBL54,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin),144,579,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4723517,Ki,9.92,CHEMBL54,2020,CHEMBL4715859,J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin),144,934,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4815484,Ki,9.58,CHEMBL54,2021,CHEMBL4813951,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cells co-expressing CRE-Luc incubated for 60 mins by microbeta scintillation counting method,152,259,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4842092,Ki,8.2,CHEMBL54,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,152,362,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL5046486,Ki,8.45,CHEMBL54,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,152,253,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL5046640,Ki,8.73,CHEMBL54,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,152,530,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL5133886,Ki,8.58,CHEMBL54,2022,CHEMBL5131451,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2S receptor (unknown origin) by radioligand displacement assay,154,497,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL5335368,Ki,8.02,CHEMBL54,2023,CHEMBL5331137,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor assessed as inhibition constant,159,276,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL5362774,Ki,8.13,CHEMBL54,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL651364,Ki,9.36,CHEMBL54,1993,CHEMBL1126960,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,2,935,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL669147,Ki,9.8,CHEMBL54,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]quinpirole from human dopamine D2A receptors expressed in LtK cells,20,331,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL669148,Ki,9.36,CHEMBL54,1999,CHEMBL1131815,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2A receptors expressed in LtK cells,20,332,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL670113,IC50,8.39,CHEMBL54,1998,CHEMBL1131412,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2 by [3H]spiroperidol displacement.,15,582,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL670394,Ki,9.08,CHEMBL54,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL670395,Ki,8.44,CHEMBL54,1997,CHEMBL1129926,Bioorg Med Chem Lett,Scientific Literature,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,12,153,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL670400,Ki,9.0,CHEMBL54,1995,CHEMBL1128113,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,6,721,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL670681,Ki,9.22,CHEMBL54,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,38,584,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL670684,Ki,9.1,CHEMBL54,2001,CHEMBL1134798,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity for Dopamine receptor D2,26,585,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL671074,IC50,8.4,CHEMBL54,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",24,461,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL671075,IC50,8.31,CHEMBL54,1999,CHEMBL1132638,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,20,567,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL671369,Ki,8.8,CHEMBL54,1997,CHEMBL1130121,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,12,586,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL671370,Ki,8.85,CHEMBL54,1996,CHEMBL1129307,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,9,587,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL671376,Ki,8.15,CHEMBL54,2000,CHEMBL1133592,J Med Chem,Scientific Literature,Antagonism of dopamine-stimulated [35S]GTP-gamma-S binding against human Dopamine receptor D2 in CHO cells,24,849,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL671378,Ki,8.8,CHEMBL54,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,12,589,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL671416,Ki,9.05,CHEMBL54,2003,CHEMBL1136328,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to inhibit the binding of [3H]spiperone to cloned human Dopamine receptor D2 using apomorphine induced climbing test in male Swiss mice,36,590,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL671418,Ki,8.52,CHEMBL54,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL672100,Ki,8.43,CHEMBL54,2004,CHEMBL1139457,J Med Chem,Scientific Literature,In vitro binding affinity towards Dopamine receptor D2 in human using [3H]-spiperone as radioligand,38,565,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL672164,Ki,8.85,CHEMBL54,1996,CHEMBL1129306,J Med Chem,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,9,249,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL672169,Ki,8.85,CHEMBL54,2004,CHEMBL1149193,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,38,533,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL672170,Ki,9.92,CHEMBL54,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,32,653,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL672173,Ki,8.32,CHEMBL54,1997,CHEMBL1130009,J Med Chem,Scientific Literature,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,12,591,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL672182,Ki,7.75,CHEMBL54,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,32,52,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL672183,Ki,9.8,CHEMBL54,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,9,197,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL672184,Ki,9.18,CHEMBL54,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,9,198,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL672209,Ki,8.85,CHEMBL54,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,12,230,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL672308,Ki,8.85,CHEMBL54,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,26,593,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL672310,Ki,8.82,CHEMBL54,2000,CHEMBL1133417,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,24,280,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL673081,Ki,8.07,CHEMBL54,2002,CHEMBL1135647,J Med Chem,Scientific Literature,In vitro binding affinity at human cloned Dopamine receptor D2L expressed in Sf9 cell membranes,32,551,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL673082,Ki,8.25,CHEMBL54,2000,CHEMBL1133667,J Med Chem,Scientific Literature,"In vitro binding affinity towards Dopamine receptor D2L, using [3H]spiroperidol radioligand in Sf9 baculovirus expression.",24,596,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL673248,Ki,9.3,CHEMBL54,1994,CHEMBL1127372,J Med Chem,Scientific Literature,Tested for binding affinity towards human D2L receptor using [3H]spiperone as radioligand,4,65,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL674342,Ki,9.05,CHEMBL54,2003,CHEMBL1136328,Bioorg Med Chem Lett,Scientific Literature,Cataleptogenic effect against cloned human Dopamine receptor D2 in male Sprague-Dawley rats in a bar test,36,597,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL675680,Ki,9.0,CHEMBL54,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,32,96,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL829120,Ki,8.6,CHEMBL54,2005,CHEMBL1142715,J Med Chem,Scientific Literature,Inhibition of [3H]-spiperone binding to human Dopamine receptor D2,41,536,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL839477,Ki,8.89,CHEMBL54,2005,CHEMBL1141881,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 long,41,457,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL839543,Ki,8.66,CHEMBL54,2004,CHEMBL1138672,J Med Chem,Scientific Literature,Binding affinity for human recombinant dopamine D2 receptor,38,936,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL872394,Ki,8.7,CHEMBL54,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,41,238,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL892631,Ki,8.48,CHEMBL54,2007,CHEMBL1147208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cells,56,492,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL894060,Ki,8.7,CHEMBL54,2007,CHEMBL1148718,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human recombinant Dopamine D2 long receptor,56,138,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL895394,Ki,8.59,CHEMBL54,2007,CHEMBL1148812,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor,56,795,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL895618,Ki,8.3,CHEMBL54,2007,CHEMBL1148822,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,56,452,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL913685,Ki,8.95,CHEMBL54,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,56,44,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL923071,Ki,9.22,CHEMBL54,2007,CHEMBL1140677,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone human cloned dopamine D2 receptor,56,603,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL938581,Ki,5.19,CHEMBL54,2008,CHEMBL1140844,J Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopaminergic D2 receptor expressed in rat C6 cells,61,739,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL938625,Ki,8.38,CHEMBL54,2009,CHEMBL1140855,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,66,673,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL983536,Ki,8.29,CHEMBL54,2008,CHEMBL1144236,Bioorg Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2S receptor in membrane suspensions by liquid scintillation counter,61,848,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL992743,Ki,8.85,CHEMBL54,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1F,CHEMBL4416273,Ki,7.08,CHEMBL4468416,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(OCCSSCCO)cc1,CHEMBL4044352,Ki,6.62,CHEMBL4086894,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,127,668,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(OCCSSCCO)cc1,CHEMBL4044353,Ki,7.14,CHEMBL4086894,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,127,669,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cccc(F)c1,CHEMBL4416273,Ki,7.42,CHEMBL611991,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,138,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1cccc(F)c1F,CHEMBL4416273,Ki,7.33,CHEMBL4590085,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccccc1,CHEMBL4416273,Ki,8.75,CHEMBL199226,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccccc1Cl,CHEMBL4416273,Ki,8.45,CHEMBL4472585,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccccc1F,CHEMBL4416273,Ki,8.1,CHEMBL4514517,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(Cl)cc2Cl)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,8.58,CHEMBL4444768,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(F)cc2)CC1)c1ccc(Cl)cc1,CHEMBL4416273,Ki,7.75,CHEMBL4556173,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccc(F)cc2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,8.48,CHEMBL4461948,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2cccc(Cl)c2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,9.0,CHEMBL4455788,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,9.92,CHEMBL4570273,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccccc2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,8.12,CHEMBL54206,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccccc2)CC1)c1ccccc1,CHEMBL4416273,Ki,7.49,CHEMBL4446597,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccccc2-c2ccccc2Cl)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,8.61,CHEMBL4472206,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2-c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(O)(c2ccccc2Cl)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,8.67,CHEMBL4540679,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(S(=O)(=O)c2ccccc2)CC1)c1ccc(F)cc1,CHEMBL697295,Ki,5.96,CHEMBL343411,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,32,732,O=C(CCCN1CCC(S(=O)(=O)c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL1261459,Ki,7.77,CHEMBL1256170,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,74,777,O=C(CCCN1CCC(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL1261460,Ki,7.52,CHEMBL1256170,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,74,778,O=C(CCCN1CCC(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,8.76,CHEMBL147830,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(c2ccccc2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,8.11,CHEMBL56843,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(c2ccccc2)CC1)c1nc2ccccc2s1,CHEMBL2037965,Ki,6.28,CHEMBL2037518,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,O=C(CCCN1CCC(c2ccccc2)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2,CHEMBL4821052,Ki,8.54,CHEMBL4289498,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),152,248,O=C(CCCN1CCC(c2noc3ccccc23)CC1)c1cc2c3c(c1)CCN3C(=O)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1,CHEMBL3820059,Ki,10.57,CHEMBL297302,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Binding affinity to human dopamine D2 receptor by radioligand displacement assay,121,937,O=C(CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)N(CCc1ccc(Nc3ccc([N+](=O)[O-])c4nonc34)cc1)CN2c1ccccc1)c1ccc(F)cc1,CHEMBL671034,Ki,9.18,CHEMBL92649,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,366,O=C(CCCN1CCC2(CC1)C(=O)N(CCc1ccc(Nc3cccc4nonc34)cc1)CN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL1013927,Ki,10.0,CHEMBL267930,1993,CHEMBL1147348,J Nat Prod,Scientific Literature,Displacement of [3H]sulpiride from dopamine D2 receptor,2,938,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL2060922,IC50,8.9,CHEMBL267930,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,84,676,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL2060922,Ki,9.55,CHEMBL267930,2012,CHEMBL2057072,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiprone from human dopamine D2 receptor expressed in HEK293 cells,84,676,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL2343279,Ki,8.92,CHEMBL267930,2013,CHEMBL2331343,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,93,663,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL2395274,IC50,9.6,CHEMBL267930,2013,CHEMBL2390918,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells after 2 hrs,93,939,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL2395274,Ki,10.05,CHEMBL267930,2013,CHEMBL2390918,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human recombinant dopamine D2S receptor expressed in CHO cells after 2 hrs,93,939,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL3610650,Ki,8.97,CHEMBL267930,2015,CHEMBL3608303,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from dopamine D2 receptor (unknown origin) expressed in HEK293 cell membranes incubated for 15 mins by liquid scintillation spectrometry,112,940,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL3888598,IC50,8.59,CHEMBL267930,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",121,677,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL3888598,Ki,9.3,CHEMBL267930,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",121,677,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL4032441,Ki,10.22,CHEMBL267930,2017,CHEMBL4028897,J Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cell membranes after 60 mins by scintillation counting method,127,714,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL4397357,Ki,10.22,CHEMBL267930,2019,CHEMBL4396871,J Med Chem,Scientific Literature,Displacement of [125I]IABN from recombinant human D2 long receptor stably expressed in HEK293 cell membranes measured after 60 mins by scintillation counting analysis,139,279,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL5324912,IC50,9.23,CHEMBL267930,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,159,705,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL5324922,IC50,8.92,CHEMBL267930,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,159,706,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL671033,Ki,10.22,CHEMBL267930,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,365,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL673098,Ki,9.7,CHEMBL267930,1993,CHEMBL1126779,J Med Chem,Scientific Literature,Tested for binding affinity against dopamine receptor D2,2,941,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL839477,Ki,9.92,CHEMBL267930,2005,CHEMBL1141881,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 long,42,457,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1,CHEMBL937845,Ki,9.36,CHEMBL267930,2008,CHEMBL1155028,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells,61,615,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CC1)OC=C(c1ccccc1)C2=O)c1ccc(F)cc1,CHEMBL671745,Ki,7.16,CHEMBL540799,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C(CCCN1CCC2(CC1)OC=C(c1ccccc1)C2=O)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(CCc3ccccc3C2=O)CC1)c1ccc(F)cc1,CHEMBL673013,Ki,7.6,CHEMBL553311,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C(CCCN1CCC2(CCc3ccccc3C2=O)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCC2(c3ccc(Cl)cc3)CC2C1)c1ccc(F)cc1,CHEMBL4416273,Ki,9.8,CHEMBL4528835,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCC2(c3ccccc3)CC2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCCC2(C1)OC(c1ccccc1)=CC2=O)c1ccc(F)cc1,CHEMBL671745,Ki,6.82,CHEMBL539521,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C(CCCN1CCCC2(C1)OC(c1ccccc1)=CC2=O)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL992743,Ki,7.36,CHEMBL476108,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=C(CCCN1CCCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCCN(c2ccc(Cl)cn2)CC1)c1ccc(F)cc1,CHEMBL4688549,Ki,7.39,CHEMBL4574793,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,152,847,O=C(CCCN1CCCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCCN(c2ccccn2)CC1)c1ccc(F)cc1,CHEMBL4688549,Ki,6.720000000000001,CHEMBL4533305,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,152,847,O=C(CCCN1CCCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCCc2ccccc2C1)c1ccc(Cl)cc1,CHEMBL3863657,Ki,5.45,CHEMBL3924565,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,121,59,O=C(CCCN1CCCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccc(F)cc1,CHEMBL1261459,Ki,7.72,CHEMBL1258036,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,74,777,O=C(CCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccc(F)cc1,CHEMBL1261460,Ki,7.66,CHEMBL1258036,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,74,778,O=C(CCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL1261459,Ki,6.21,CHEMBL1258154,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,74,777,O=C(CCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL1261460,Ki,6.36,CHEMBL1258154,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,74,778,O=C(CCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1033197,Ki,6.59,CHEMBL476935,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,66,880,O=C(CCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1261459,Ki,7.2,CHEMBL476935,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,74,777,O=C(CCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1261460,Ki,7.21,CHEMBL476935,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,74,778,O=C(CCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3292986,Ki,6.6,CHEMBL476935,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,103,846,O=C(CCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,7.53,CHEMBL476935,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL838814,Ki,6.6,CHEMBL558392,2004,CHEMBL1138643,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,38,886,O=C(CCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL992743,Ki,6.6,CHEMBL476935,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=C(CCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccc(Cl)cc2)CC1)c1nc2ccccc2s1,CHEMBL2037965,Ki,5.08,CHEMBL2037524,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,O=C(CCCN1CCN(c2ccccc2)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccc(Cl)cn2)CC1)c1ccc(F)cc1,CHEMBL4688549,Ki,6.54,CHEMBL4573441,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,152,847,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)NCc1nc2cc(F)ccc2c(=O)n1-c1ccccc1,CHEMBL920904,IC50,5.18,CHEMBL261019,2008,CHEMBL1144677,Bioorg Med Chem,Scientific Literature,Binding affinity at dopamine D2 receptor,61,489,O=C(CCCN1CCN(c2ccccc2)CC1)NCc1nc2ccccc2c(=O)n1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)N1C=CN(C2CCCCC2)C(=O)C1,CHEMBL5236927,IC50,6.96,CHEMBL5280677,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,152,142,O=C(CCCN1CCN(c2ccccc2)CC1)N1C=CN(C2CCCCC2)C(=O)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)N1C=CN(Cc2ccccc2)C(=O)C1,CHEMBL5236927,IC50,5.86,CHEMBL5266395,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,152,142,O=C(CCCN1CCN(c2ccccc2)CC1)N1C=CN(Cc2ccccc2)C(=O)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2ncc(/C=N\O)c2c1,CHEMBL4010153,Ki,9.3,CHEMBL4069091,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,127,360,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2ncc(/C=N\O)c2c1,CHEMBL4010156,Ki,9.24,CHEMBL4069091,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,127,361,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2nccc2c1,CHEMBL4010153,Ki,8.11,CHEMBL4091155,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,127,360,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2nccc2c1,CHEMBL4010156,Ki,8.09,CHEMBL4091155,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,127,361,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CHEMBL4688549,Ki,6.64,CHEMBL340211,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,152,847,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CHEMBL4815619,Ki,6.64,CHEMBL340211,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,152,118,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CHEMBL651364,Ki,7.28,CHEMBL340211,1993,CHEMBL1126960,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,2,935,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc2c(c1)CCC2,CHEMBL4815619,Ki,6.16,CHEMBL4874069,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,152,118,O=C(CCCN1CCN(c2ccccn2)CC1)c1ccc2c(c1)CCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2cccnc2)CC1)c1ccc(F)cc1,CHEMBL4688549,Ki,5.93,CHEMBL4793296,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,152,847,O=C(CCCN1CCN(c2cccnc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ncccn2)CC1)c1ccc(F)cc1,CHEMBL1944110,Ki,7.01,CHEMBL140872,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,884,O=C(CCCN1CCN(c2ncccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ncccn2)CC1)c1ccc(F)cc1,CHEMBL992743,Ki,7.01,CHEMBL140872,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,61,604,O=C(CCCN1CCN(c2ncccn2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCN(c2ncccn2)CC1)c1nc2ccccc2s1,CHEMBL2037965,Ki,5.82,CHEMBL2037519,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,84,882,O=C(CCCN1CCN(c2ncccn2)CC1)c1nc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3)c1ccc(F)cc1,CHEMBL672312,Ki,8.06,CHEMBL352648,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3)c1ccccc1,CHEMBL672312,Ki,7.77,CHEMBL350567,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CC[Si](O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL2208721,Ki,9.26,CHEMBL2204343,2011,CHEMBL2203023,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,79,933,O=C(CCCN1CC[SiH](c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCc2ccccc2C1)c1ccc(Cl)cc1,CHEMBL3821452,Ki,6.9,CHEMBL3818047,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,121,698,O=C(CCCN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCc2ccccc2C1)c1ccc(F)cc1,CHEMBL3821452,Ki,7.31,CHEMBL3818994,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,121,698,O=C(CCCN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCc2ccccc2C1)c1ccc(O)cc1,CHEMBL3821452,Ki,6.44,CHEMBL3818056,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,121,698,O=C(CCCN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCc2ccccc2C1)c1ccccc1,CHEMBL3821452,Ki,6.19,CHEMBL3818989,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,122,698,O=C(CCCN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1CCc2ccccc2CC1)c1ccc(Cl)cc1,CHEMBL3863657,Ki,5.93,CHEMBL3952251,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,122,59,O=C(CCCN1CCc2ccccc2CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCN1[C@@H]2CC[C@H]1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,CHEMBL4416273,Ki,10.28,CHEMBL4451384,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCCN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCc1cn(-c2ccc([N+](=O)[O-])cc2)nn1)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL1044860,Ki,7.28,CHEMBL572379,2009,CHEMBL1154112,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,66,691,O=C(CCCc1cn(-c2ccccc2)nn1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCCc1cn(-c2ccc([N+](=O)[O-])cc2)nn1)NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL1044861,Ki,7.36,CHEMBL572379,2009,CHEMBL1154112,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,66,692,O=C(CCCc1cn(-c2ccccc2)nn1)NCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,6.88,CHEMBL94371,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,139,541,O=C(CCN1CCC(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCN1CCN(CCC(=O)OC2(c3ccc(Cl)cc3)CCN(CCCC(=O)c3ccc(F)cc3)CC2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.6,CHEMBL3318846,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCN1CCN(CCC(=O)OC2(c3ccccc3)CCN(CCCC(=O)c3ccccc3)CC2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCN1CCN(CCC(=O)OC2(c3ccc(Cl)cc3)CCN(CCCC(=O)c3ccc(F)cc3)CC2)CC1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.96,CHEMBL3318846,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCN1CCN(CCC(=O)OC2(c3ccccc3)CCN(CCCC(=O)c3ccccc3)CC2)CC1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccccc21,CHEMBL872891,Ki,5.23,CHEMBL104498,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",32,214,O=C(CCN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCO)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.46,CHEMBL3695380,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",103,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCO)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.2,CHEMBL3676866,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",103,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCO)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.13,CHEMBL3642718,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCO)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,6.02,CHEMBL3642684,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCOCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccc(C(F)(F)F)cc1,CHEMBL3857974,Ki,6.46,CHEMBL3895172,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,122,537,O=C(CCOCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCOCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccncc1,CHEMBL3857974,Ki,5.61,CHEMBL3923145,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,122,537,O=C(CCOCCN1CCN(c2ccccc2-c2ccccc2)CC1)NCc1ccncc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCOCCN1CCN(c2cccnc2-c2ccc(F)cc2)CC1)NCc1ccc(C(F)(F)F)cc1,CHEMBL3857974,Ki,5.46,CHEMBL3976948,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,122,537,O=C(CCOCCN1CCN(c2cccnc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCOCCN1CCN(c2cccnc2-c2ccccc2)CC1)NCc1ccc(C(F)(F)F)cc1,CHEMBL3857974,Ki,5.56,CHEMBL3941102,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,122,537,O=C(CCOCCN1CCN(c2cccnc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCOCCN1CCN(c2ncccc2-c2ccc(F)cc2)CC1)NCc1ccc(C(F)(F)F)cc1,CHEMBL3857974,Ki,6.41,CHEMBL3894679,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,122,537,O=C(CCOCCN1CCN(c2ncccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCOCCN1CCN(c2ncccc2-c2ccccc2)CC1)NCc1ccc(C(F)(F)F)cc1,CHEMBL3857974,Ki,6.57,CHEMBL3950020,2016,CHEMBL3856221,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting analysis,122,537,O=C(CCOCCN1CCN(c2ncccc2-c2ccccc2)CC1)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21,CHEMBL945767,Ki,7.48,CHEMBL252201,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,O=C(CCc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCc1cn(CCCCCCCCCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.31,CHEMBL3318850,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCc1cn(CCCCCCCCCCn2cc(CCC(=O)OC3(c4ccccc4)CCN(CCCC(=O)c4ccccc4)CC3)nn2)nn1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCc1cn(CCCCCCCCCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.27,CHEMBL3318850,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCc1cn(CCCCCCCCCCn2cc(CCC(=O)OC3(c4ccccc4)CCN(CCCC(=O)c4ccccc4)CC3)nn2)nn1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCc1cn(CCCCCCCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.89,CHEMBL3318849,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCc1cn(CCCCCCCCn2cc(CCC(=O)OC3(c4ccccc4)CCN(CCCC(=O)c4ccccc4)CC3)nn2)nn1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCc1cn(CCCCCCCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.8,CHEMBL3318849,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCc1cn(CCCCCCCCn2cc(CCC(=O)OC3(c4ccccc4)CCN(CCCC(=O)c4ccccc4)CC3)nn2)nn1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCc1cn(CCOCCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,8.8,CHEMBL3318851,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCc1cn(CCOCCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccccc4)CCN(CCCC(=O)c4ccccc4)CC3)nn2)nn1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCc1cn(CCOCCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.42,CHEMBL3318851,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCc1cn(CCOCCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccccc4)CCN(CCCC(=O)c4ccccc4)CC3)nn2)nn1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCc1cn(CCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369121,Ki,9.0,CHEMBL3317465,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor stably expressed in CHO cell membranes by competitive binding assay,103,127,O=C(CCc1cn(CCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccccc4)CCN(CCCC(=O)c4ccccc4)CC3)nn2)nn1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CCc1cn(CCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccc(Cl)cc4)CCN(CCCC(=O)c4ccc(F)cc4)CC3)nn2)nn1)OC1(c2ccc(Cl)cc2)CCN(CCCC(=O)c2ccc(F)cc2)CC1,CHEMBL3369122,Ki,8.52,CHEMBL3317465,2014,CHEMBL3352709,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor stably expressed in CHO cell membranes by competitive binding assay,103,128,O=C(CCc1cn(CCOCCOCCOCCn2cc(CCC(=O)OC3(c4ccccc4)CCN(CCCC(=O)c4ccccc4)CC3)nn2)nn1)OC1(c2ccccc2)CCN(CCCC(=O)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CF)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.64,CHEMBL3664888,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CF)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.91,CHEMBL3698022,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",103,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,CHEMBL1033197,Ki,5.91,CHEMBL456429,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,66,880,O=C(CN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1C2CCC1CC(O)(c1ccc(Cl)cc1)C2)c1ccc(F)cc1,CHEMBL838814,Ki,5.91,CHEMBL556361,2004,CHEMBL1138643,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,38,886,O=C(CN1C2CCC1CC(c1ccccc1)C2)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(CCCc2c[nH]c3ccc(F)cc23)CC1)N(c1ccccc1)C1CCCCC1,CHEMBL4686220,Ki,5.67,CHEMBL4790303,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,144,193,O=C(CN1CCN(CCCc2c[nH]c3ccccc23)CC1)N(c1ccccc1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCCC2CCCCC21,CHEMBL872882,Ki,5.23,CHEMBL107755,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,32,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCCC2CCCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCCc2ccccc21,CHEMBL872882,Ki,5.58,CHEMBL323537,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,32,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCOc2ccccc21,CHEMBL872882,Ki,5.58,CHEMBL104196,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,32,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCOc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2c(Cl)cccc21,CHEMBL872882,Ki,5.67,CHEMBL106598,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,32,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccc(Cl)cc21,CHEMBL672176,Ki,6.22,CHEMBL318739,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity toward Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as the competitive ligand,32,942,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccc(F)cc21,CHEMBL872882,Ki,5.59,CHEMBL317266,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,32,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccc([N+](=O)[O-])cc21,CHEMBL872882,Ki,6.35,CHEMBL105625,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,32,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccccc21,CHEMBL672162,Ki,6.16,CHEMBL69584,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,36,236,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccccc21,CHEMBL672795,Ki,6.16,CHEMBL69584,2000,CHEMBL1132730,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,24,447,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccccc21,CHEMBL872217,IC50,6.16,CHEMBL69584,2005,CHEMBL1140446,J Med Chem,Scientific Literature,Inhibitory concentration against dopamine receptor D2,42,601,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1CCc2ccccc21,CHEMBL872882,Ki,6.16,CHEMBL69584,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,32,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1c2ccccc2CC12CCCC2,CHEMBL872882,Ki,6.73,CHEMBL441274,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,32,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1c2ccccc2CC12CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1c2ccccc2CC12CCCCC2,CHEMBL872882,Ki,5.48,CHEMBL107962,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,32,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1c2ccccc2CC12CCCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1c2ccccc2C[C@H]1CF,CHEMBL675680,Ki,5.96,CHEMBL320721,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,32,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1c2ccccc2C[C@H]1CO,CHEMBL675680,Ki,5.52,CHEMBL107151,2002,CHEMBL1134937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine type 2 receptor was determined by displacement assays using [3H]-YM 09151 as the competitive ligand,32,96,O=C(CN1CCN(Cc2ccccc2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)N1c2ccccc2[C@H]2CCCC[C@H]21,CHEMBL872882,Ki,6.42,CHEMBL323213,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human Dopamine receptor D2 was determined via standard competitive displacement assay using [3H]-YM 09151 as radioligand,32,177,O=C(CN1CCN(Cc2ccccc2)CC1)N1c2ccccc2C2CCCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(c2ccc(Cl)cn2)CC1)Nc1cccnc1,CHEMBL4392176,IC50,4.06,CHEMBL4591118,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,139,501,O=C(CN1CCN(c2ccccn2)CC1)Nc1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(c2ccc(Cl)cn2)CC1)Nc1cncnc1,CHEMBL4392176,IC50,4.14,CHEMBL4456754,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,139,501,O=C(CN1CCN(c2ccccn2)CC1)Nc1cncnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CN1CCN(c2ccccn2)CC1)Nc1cncnc1,CHEMBL4392176,IC50,4.03,CHEMBL4453069,2019,CHEMBL4390675,J Med Chem,Scientific Literature,Antagonist activity at human D2L receptor expressed in CHOK1 cells assessed as suppression of dopamine-induced inhibition of forskolin-stimulated cAMP accumulation measured after 30 mins by Eu-cAMP tracer based TR-FRET assay,139,501,O=C(CN1CCN(c2ccccn2)CC1)Nc1cncnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CO)NC[C@H]1CCN(Cc2csc(-c3ccccc3)n2)C1,CHEMBL4137914,Ki,5.31,CHEMBL4166178,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,131,220,c1ccc(-c2nc(CN3CCCC3)cs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CO)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.24,CHEMBL3695373,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CO)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.53,CHEMBL3664877,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CO)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.33,CHEMBL3676856,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CO)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.74,CHEMBL3697960,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",104,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CO)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.8,CHEMBL3642717,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CO)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,5.87,CHEMBL3642685,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,c1cc2occc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(CO)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1,CHEMBL3705135,Ki,6.66,CHEMBL3642704,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,c1cc2sccc2c(N2CCN(CCC3CCCCC3)CC2)n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H](O)C(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.62,CHEMBL3695389,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H](O)C(F)(F)F)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.3,CHEMBL3676880,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H](O)C(F)(F)F)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.14,CHEMBL3642765,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H]1CCCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.38,CHEMBL3664853,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(CC1CCCCO1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H]1CCCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.66,CHEMBL3697980,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",104,112,O=C(CC1CCCCO1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.25,CHEMBL3695385,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(CC1CCCO1)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.28,CHEMBL3664830,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(CC1CCCO1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.07,CHEMBL3642746,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(CC1CCCO1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H]1CCCOC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.49,CHEMBL3664855,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(CC1CCCOC1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H]1CCCOC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.86,CHEMBL3697982,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",104,112,O=C(CC1CCCOC1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.38,CHEMBL3695374,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(CC1COCCO1)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.48,CHEMBL3664818,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(CC1COCCO1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.76,CHEMBL3697955,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",104,112,O=C(CC1COCCO1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.95,CHEMBL3642738,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(CC1COCCO1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1CCCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.31,CHEMBL3664854,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(CC1CCCCO1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1CCCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.51,CHEMBL3697981,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",104,112,O=C(CC1CCCCO1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.29,CHEMBL3695384,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(CC1CCCO1)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.64,CHEMBL3664829,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(CC1CCCO1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1CCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.04,CHEMBL3642745,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(CC1CCCO1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1CCCOC1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.39,CHEMBL3639637,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(CC1CCCOC1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1CCCOC1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.74,CHEMBL3697983,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",104,112,O=C(CC1CCCOC1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1CC[C@H](O)CC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1,CHEMBL3705135,Ki,5.81,CHEMBL3642681,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(CC1CCCCC1)NC1CCC(CCN2CCN(c3nccc4occc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1CC[C@H](O)CC1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1,CHEMBL3705135,Ki,6.41,CHEMBL3642705,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(CC1CCCCC1)NC1CCC(CCN2CCN(c3nccc4sccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.16,CHEMBL3695375,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(CC1COCCO1)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.33,CHEMBL3664817,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(CC1COCCO1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.52,CHEMBL3697954,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",104,112,O=C(CC1COCCO1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1COCCO1)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.83,CHEMBL3642744,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(CC1COCCO1)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(C[C@H]1C[C@H](CO)C1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.93,CHEMBL3698023,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",104,112,O=C(CC1CCC1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccc2c(c1)OCO2)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.14,CHEMBL3639943,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(Cc1ccc2c(c1)OCO2)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccc2c(c1)OCO2)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,6.49,CHEMBL3664871,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(Cc1ccc2c(c1)OCO2)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccc2c(c1)OCO2)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.03,CHEMBL3676919,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,55,O=C(Cc1ccc2c(c1)OCO2)NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccc2c(c1)OCO2)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.17,CHEMBL3698001,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",104,112,O=C(Cc1ccc2c(c1)OCO2)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccc2c(c1)OCO2)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.52,CHEMBL3642798,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(Cc1ccc2c(c1)OCO2)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1,CHEMBL4000277,Ki,6.08,CHEMBL1242923,2015,CHEMBL4000143,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,112,796,O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21,CHEMBL945767,Ki,7.58,CHEMBL253878,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,O=C(Cc1ccccc1)NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccccc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,CHEMBL2032826,Ki,5.38,CHEMBL2029915,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,84,943,O=C(Cc1ccccc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccccc1)Nc1cccc(C2CCN(CCCC(=O)c3ccc(Cl)cc3)CC2)c1,CHEMBL894444,Ki,6.11,CHEMBL244372,2007,CHEMBL1148741,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2 receptor,56,122,O=C(Cc1ccccc1)Nc1cccc(C2CCN(CCCC(=O)c3ccccc3)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccccc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,CHEMBL2032826,Ki,5.45,CHEMBL2029923,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,84,943,O=C(Cc1ccccc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccccn1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,CHEMBL2032826,Ki,7.15,CHEMBL2029916,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,84,943,O=C(Cc1ccccn1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccccn1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,CHEMBL2032826,Ki,6.56,CHEMBL2029924,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Cc1ccccn1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1cccnc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,CHEMBL2032826,Ki,7.16,CHEMBL2029917,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Cc1cccnc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1cccnc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,CHEMBL2032826,Ki,7.08,CHEMBL2029925,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Cc1cccnc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccncc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,CHEMBL2032826,Ki,7.31,CHEMBL2029918,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Cc1ccncc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1ccncc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,CHEMBL2032826,Ki,6.7,CHEMBL2029926,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Cc1ccncc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1noc2ccccc12)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.61,CHEMBL3695446,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(Cc1noc2ccccc12)NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1noc2ccccc12)N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,6.61,CHEMBL3676930,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,55,O=C(Cc1noc2ccccc12)NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cc1noc2ccccc12)N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,5.88,CHEMBL3642805,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(Cc1noc2ccccc12)NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2cc(Br)c(Br)cc21)NC1CCCCC1,CHEMBL5236927,IC50,5.42,CHEMBL5275349,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,152,142,O=C(Cn1c(CCCN2CCN(c3ccccc3)CC2)nc2ccccc21)NC1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2cc(Br)c(Br)cc21)NCc1ccccc1,CHEMBL5236927,IC50,8.66,CHEMBL5278601,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,152,142,O=C(Cn1c(CCCN2CCN(c3ccccc3)CC2)nc2ccccc21)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2ccccc21)NC1CCCCC1,CHEMBL5236927,IC50,5.04,CHEMBL5280979,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,152,142,O=C(Cn1c(CCCN2CCN(c3ccccc3)CC2)nc2ccccc21)NC1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Cn1c(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2ccccc21)NCc1ccccc1,CHEMBL5236927,IC50,4.87,CHEMBL5288557,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,152,142,O=C(Cn1c(CCCN2CCN(c3ccccc3)CC2)nc2ccccc21)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL827419,IC50,6.96,CHEMBL366904,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,42,699,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL828890,Ki,6.88,CHEMBL366904,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,42,700,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL828891,Ki,7.12,CHEMBL366904,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL838683,Ki,7.12,CHEMBL366904,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL827419,IC50,6.59,CHEMBL175734,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,42,699,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL828890,Ki,6.61,CHEMBL175734,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,42,700,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL828891,Ki,6.83,CHEMBL175734,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL838683,Ki,6.83,CHEMBL175734,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1,CHEMBL3705175,IC50,7.39,CHEMBL244562,2014,CHEMBL3638880,,BindingDB Patent Bioactivity Data,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",104,759,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1,CHEMBL895648,Ki,7.63,CHEMBL244562,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,56,126,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1,CHEMBL895651,IC50,7.39,CHEMBL244562,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,56,760,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2cccc(=O)[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc[n+]2[O-])cc1,CHEMBL3705175,IC50,7.64,CHEMBL244774,2014,CHEMBL3638880,,BindingDB Patent Bioactivity Data,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",104,759,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2cccc[nH+]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc[n+]2[O-])cc1,CHEMBL895648,Ki,7.59,CHEMBL244774,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,56,126,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2cccc[nH+]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccc[n+]2[O-])cc1,CHEMBL895651,IC50,7.64,CHEMBL244774,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,56,760,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2cccc[nH+]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL1777183,Ki,7.03,CHEMBL180010,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL3591366,Ki,7.13,CHEMBL180010,2015,CHEMBL3588810,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,112,726,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL827419,IC50,7.09,CHEMBL180010,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,42,699,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL828890,Ki,6.97,CHEMBL180010,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,42,700,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL828891,Ki,7.03,CHEMBL180010,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL838683,Ki,7.03,CHEMBL180010,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL895648,Ki,7.03,CHEMBL180010,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,56,126,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL895651,IC50,7.09,CHEMBL180010,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,56,760,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccnc2)cc1,CHEMBL827140,Ki,7.26,CHEMBL414838,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,944,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2cccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccncc2)cc1,CHEMBL838683,Ki,7.36,CHEMBL425143,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccncc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ncc[nH]2)cc1,CHEMBL838683,Ki,8.1,CHEMBL179351,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ncc[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ncccn2)cc1,CHEMBL838683,Ki,7.34,CHEMBL368961,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ncccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(Cl)cc1,CHEMBL838683,Ki,7.76,CHEMBL175466,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1,CHEMBL838683,Ki,8.21,CHEMBL366900,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,CHEMBL827419,IC50,6.79,CHEMBL180060,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,42,699,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,CHEMBL828890,Ki,6.72,CHEMBL180060,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,42,700,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,CHEMBL828891,Ki,7.45,CHEMBL180060,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,CHEMBL838683,Ki,7.45,CHEMBL180060,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(O)cc1,CHEMBL827419,IC50,8.08,CHEMBL195057,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,42,699,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(O)cc1,CHEMBL828890,Ki,7.18,CHEMBL195057,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,42,700,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(O)cc1,CHEMBL828891,Ki,7.86,CHEMBL195057,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(O)cc1,CHEMBL838683,Ki,7.86,CHEMBL195057,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1,CHEMBL827419,IC50,7.86,CHEMBL194493,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,42,699,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1,CHEMBL828890,Ki,7.51,CHEMBL194493,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,42,700,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1,CHEMBL828891,Ki,7.71,CHEMBL194493,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc([N+](=O)[O-])cc1,CHEMBL838683,Ki,7.71,CHEMBL194493,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL2388819,Ki,6.7,CHEMBL304605,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,94,97,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL828891,Ki,6.78,CHEMBL304605,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL838683,Ki,6.78,CHEMBL304605,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL895648,Ki,6.78,CHEMBL304605,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,56,126,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(Cl)c1,CHEMBL838683,Ki,7.82,CHEMBL176884,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(F)c1,CHEMBL838683,Ki,8.06,CHEMBL175677,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(I)c1,CHEMBL838683,Ki,7.55,CHEMBL179053,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc([N+](=O)[O-])c1,CHEMBL838683,Ki,7.66,CHEMBL364759,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2,CHEMBL828891,Ki,7.2,CHEMBL69571,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,CHEMBL827419,IC50,7.79,CHEMBL71327,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,42,699,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,CHEMBL828890,Ki,7.63,CHEMBL71327,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,42,700,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,CHEMBL828891,Ki,8.54,CHEMBL71327,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,CHEMBL838683,Ki,8.54,CHEMBL71327,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1Cl,CHEMBL838683,Ki,7.99,CHEMBL179003,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1F,CHEMBL838683,Ki,8.0,CHEMBL177398,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1I,CHEMBL838683,Ki,7.97,CHEMBL176212,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1O,CHEMBL838683,Ki,8.18,CHEMBL372022,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1[N+](=O)[O-],CHEMBL838683,Ki,8.13,CHEMBL191795,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccn1,CHEMBL838683,Ki,7.77,CHEMBL179025,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccnc1,CHEMBL838683,Ki,7.71,CHEMBL175838,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccncc1,CHEMBL838683,Ki,7.51,CHEMBL367720,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccncc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1,CHEMBL838683,Ki,7.18,CHEMBL175462,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1cc2cc(O)ccc2[nH]1,CHEMBL3136930,Ki,7.47,CHEMBL3133864,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,94,725,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1cc2ccccc2[nH]1,CHEMBL3136930,Ki,7.39,CHEMBL3133863,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,94,725,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL1694505,Ki,7.15,CHEMBL1689012,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1ccc(CCF)cc1,CHEMBL1694505,Ki,7.75,CHEMBL1689009,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1ccc(OCCF)cc1,CHEMBL1694505,Ki,7.42,CHEMBL1689010,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/CN1CCN(c2ccccc2OCCF)CC1)c1ccc(OCCOCCF)cc1,CHEMBL1694505,Ki,7.19,CHEMBL1689011,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C/C[N+]1([O-])CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL895648,Ki,5.94,CHEMBL244775,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,56,126,O=C(NCC=CC[NH+]1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C\CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,CHEMBL827419,IC50,8.13,CHEMBL71865,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,42,699,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C\CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,CHEMBL828890,Ki,7.82,CHEMBL71865,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,42,700,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC/C=C\CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccccc1,CHEMBL828891,Ki,8.6,CHEMBL71865,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCC=CCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CC1)c1cc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)ccn1,CHEMBL4187998,IC50,7.27,CHEMBL4212622,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,131,471,O=C(NC1CC1)c1cc(OCCCCN2CCC(c3noc4ccccc34)CC2)ccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CC1)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,CHEMBL4187998,IC50,7.19,CHEMBL4202871,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,131,471,O=C(NC1CC1)c1cc(OCCCCN2CCN(c3nsc4ccccc34)CC2)ccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CC1)c1ccnc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,CHEMBL4187998,IC50,7.29,CHEMBL4210128,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,131,471,O=C(NC1CC1)c1ccnc(OCCCCN2CCC(c3noc4ccccc34)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CC1)c1cncc(OCCCCN2CCC(c3noc4cc(F)ccc34)CC2)c1,CHEMBL4187998,IC50,7.37,CHEMBL4217039,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,131,471,O=C(NC1CC1)c1cncc(OCCCCN2CCC(c3noc4ccccc34)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc2ncccc2c1,CHEMBL3705383,Ki,5.49,CHEMBL3976966,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc2ncccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc2ncccc2c1,CHEMBL3706129,Ki,6.99,CHEMBL3953892,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc2ncccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccccc1,CHEMBL671651,Ki,7.38,CHEMBL310158,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1cccs1,CHEMBL671651,Ki,7.75,CHEMBL78655,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,CHEMBL671651,Ki,7.0,CHEMBL80571,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,CHEMBL671651,Ki,7.4,CHEMBL311772,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc2ccccc2n1,CHEMBL2162846,Ki,7.62,CHEMBL2159469,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,85,218,O=C(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1cccc(F)c1F,CHEMBL2162846,Ki,7.82,CHEMBL2159467,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,85,218,O=C(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1,CHEMBL839650,Ki,5.1,CHEMBL187804,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccc(Cl)cc2)cc1,CHEMBL839650,Ki,5.58,CHEMBL366043,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccc(F)cc2)cc1,CHEMBL839650,Ki,6.92,CHEMBL184388,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccc(F)c2)cc1,CHEMBL839650,Ki,5.4,CHEMBL183160,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccccc2)cc1,CHEMBL839650,Ki,6.22,CHEMBL185156,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,CHEMBL839650,Ki,6.08,CHEMBL187236,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccsc2)cc1,CHEMBL839650,Ki,5.92,CHEMBL187122,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCN(Cc2ccccc2)C1)c1cccc(-c2ccccc2)c1,CHEMBL839650,Ki,6.82,CHEMBL360394,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1cccc(-c2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)C(F)(F)F,CHEMBL945767,Ki,8.1,CHEMBL398711,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,c1ccc2c(N3CCN(CCc4ccc5c(c4)CCC5)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1ccc(F)cc1,CHEMBL945767,Ki,8.0,CHEMBL252429,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1cccnc1,CHEMBL945767,Ki,8.3,CHEMBL252430,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,O=C(NC1CCc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc21)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C(F)(F)F,CHEMBL945767,Ki,8.0,CHEMBL252816,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,c1ccc2c(N3CCN(CCc4ccc5c(c4)CCC5)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C1CC1,CHEMBL945767,Ki,7.68,CHEMBL253024,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(Cl)cc1,CHEMBL945767,Ki,8.3,CHEMBL253439,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccc(F)cc1,CHEMBL945767,Ki,8.22,CHEMBL442290,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1,CHEMBL945767,Ki,7.66,CHEMBL253233,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1cccnc1,CHEMBL945767,Ki,8.22,CHEMBL398619,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccco1,CHEMBL945767,Ki,8.3,CHEMBL398744,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccno1,CHEMBL945767,Ki,8.52,CHEMBL251834,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,61,106,O=C(NC1CCc2ccc(CCN3CCN(c4nsc5ccccc45)CC3)cc21)c1ccno1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC(O)CCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL3705175,IC50,7.05,CHEMBL390253,2014,CHEMBL3638880,,BindingDB Patent Bioactivity Data,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",104,759,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC(O)CCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL895648,Ki,7.55,CHEMBL390253,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,56,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC(O)CCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL895651,IC50,7.05,CHEMBL390253,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,56,760,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC(O)CCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL895648,Ki,7.08,CHEMBL394862,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,56,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(CF)N1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL3291797,Ki,5.13,CHEMBL3287281,2014,CHEMBL3286326,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,104,945,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL1777183,Ki,6.28,CHEMBL1774535,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL1777183,Ki,4.84,CHEMBL1774386,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL1777239,Ki,5.04,CHEMBL1774386,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from wild type human dopamine D2 receptor expressed in HEK293 cells,79,946,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL3291797,Ki,6.02,CHEMBL1774386,2014,CHEMBL3286326,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,104,945,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL1777183,Ki,6.33,CHEMBL1774539,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL1777183,Ki,6.42,CHEMBL1774384,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL1777183,Ki,5.37,CHEMBL1774537,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1,CHEMBL1777183,Ki,6.71,CHEMBL1774542,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(F)ccc2[nH]1,CHEMBL3599873,Ki,6.48,CHEMBL1627310,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,112,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL3270692,Ki,6.13,CHEMBL1627305,2014,CHEMBL3259695,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by liquid scintillation counting analysis,104,152,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL3291797,Ki,6.12,CHEMBL1627305,2014,CHEMBL3286326,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,104,945,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL3591124,Ki,6.13,CHEMBL1627305,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,112,753,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL3599873,Ki,6.13,CHEMBL1627305,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,112,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL3599945,IC50,5.36,CHEMBL1627305,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,112,659,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL3705175,IC50,7.8,CHEMBL244990,2014,CHEMBL3638880,,BindingDB Patent Bioactivity Data,"Functional Assay: To measure D2 and D3 stimulation of mitogenesis (agonist assay) or D2 and D3 inhibition of quinpirole stimulation of mitogenesis (antagonist assay), CHOp-cells (human receptor) were seeded in a 96-well plate at a concentration of 5,000 cells/well. The cells were incubated at 37C. in alpha -MEM with 10% FBS, 0.05% penicillin-streptomycin, and 200 ug/mL of G418. After 48 hours, the cells were rinsed twice with serum-free alpha -MEM and incubated for 24 hours at 37 C. In the functional assay for agonism, the medium was removed and replaced with 90 ul of serum-free alpha -MEM and 10 ul of test compound in sterile water; in the antagonist assay, the test compound was diluted in sterile water plus 30 nM quinpirole. After another 24-hour incubation at 37 C., 0.25 uCi of [3H]thymidine was added to each well and the plates were further incubated for 2 hours at 37 C. The cells were then trypsinized, and the plates were filtered and counted as usual in the art.",104,759,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL895648,Ki,6.57,CHEMBL244990,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,56,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)-c1ccccc1C2,CHEMBL3591124,Ki,7.26,CHEMBL3589652,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,112,753,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)-c1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL895648,Ki,6.5,CHEMBL396024,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,56,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccc(F)cc2c1,CHEMBL3599873,Ki,6.08,CHEMBL3597640,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,112,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1,CHEMBL3591124,Ki,6.49,CHEMBL3589651,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,112,753,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1,CHEMBL4052936,Ki,6.57,CHEMBL3589651,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,127,282,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1,CHEMBL3599873,Ki,6.59,CHEMBL3597636,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,112,656,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCC(O)CN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1,CHEMBL3599945,IC50,6.14,CHEMBL3597636,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,112,659,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,CHEMBL4629186,Ki,7.85,CHEMBL4645793,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,144,764,O=C(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCCCn1nc2ccccn2c1=O)N1CCN(c2cccc(Cl)c2)CC1,CHEMBL5163611,Ki,5.71,CHEMBL5204274,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,154,910,O=C(NCCCCCCn1nc2ccccn2c1=O)N1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,CHEMBL671385,Ki,8.3,CHEMBL68720,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCCCN1CCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN(CCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1)c1ccccc1,CHEMBL670524,Ki,6.11,CHEMBL156816,2002,CHEMBL1135449,Bioorg Med Chem Lett,Scientific Literature,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,32,27,O=C(NCCCCN(CCCN1CCN(c2ccccc2)CC1)C1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1)c1cc2ccccc2s1,CHEMBL897619,Ki,6.07,CHEMBL239706,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(NCCCCN1CCC(=C2c3ccccc3CCc3cccnc32)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1)c1ccc2ccccc2c1,CHEMBL897619,Ki,6.6,CHEMBL239493,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(NCCCCN1CCC(=C2c3ccccc3CCc3cccnc32)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCC(N(Cc2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1,CHEMBL897619,Ki,5.8,CHEMBL392579,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(NCCCCN1CCC(N(Cc2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCC(N(Cc2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1,CHEMBL897619,Ki,6.15,CHEMBL239923,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(NCCCCN1CCC(N(Cc2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1,CHEMBL897619,Ki,6.2,CHEMBL401224,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1,CHEMBL897619,Ki,6.87,CHEMBL394189,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1)c1cccs1,CHEMBL897619,Ki,6.18,CHEMBL436998,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(NCCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCC[C@@H]2c3cccc(O)c3CC[C@H]21)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.2,CHEMBL419706,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,15,750,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCC[C@@H]2c3ccccc3CC[C@@H]21)c1ccc(-c2ccccc2)cc1,CHEMBL670662,Ki,6.1,CHEMBL97840,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]iodosulpiride from Dopamine receptor D2 expressed in CHO cells,15,947,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCC[C@@H]2c3ccccc3CC[C@H]21)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.3,CHEMBL95743,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,15,750,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCC[C@H]2c3ccc(O)cc3CC[C@@H]21)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.3,CHEMBL95759,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,15,750,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCC[C@H]2c3cccc(O)c3CC[C@@H]21)c1ccc(-c2ccccc2)cc1,CHEMBL671730,Ki,7.6,CHEMBL99198,2003,CHEMBL1144878,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 by displacing [125I]iodosulpiride expressed in CHO cells,36,693,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCC[C@H]2c3cccc(O)c3CC[C@@H]21)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,7.6,CHEMBL99198,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,15,750,O=C(NCCCCN1CCCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)C1CCCCC1,CHEMBL897619,Ki,6.72,CHEMBL239539,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)c1cc2ccccc2s1,CHEMBL897619,Ki,6.0,CHEMBL241659,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)c1ccc2ccccc2c1,CHEMBL897619,Ki,6.23,CHEMBL394019,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1)c1cccs1,CHEMBL897619,Ki,6.8,CHEMBL241660,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,56,755,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)C1CCCCC1,CHEMBL897619,Ki,6.36,CHEMBL429462,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1,CHEMBL897619,Ki,6.23,CHEMBL391057,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1,CHEMBL897619,Ki,6.34,CHEMBL240588,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1cccs1,CHEMBL897619,Ki,6.21,CHEMBL241027,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C(NCCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cc(C(F)(F)F)nc3ccccc23)CC1)c1cn2ccccc2n1,CHEMBL3379351,Ki,4.87,CHEMBL3322999,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,104,163,O=C(NCCCCN1CCN(c2ccnc3ccccc23)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cc(Cl)cc(Cl)c2)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,5.69,CHEMBL4583609,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL1261459,Ki,7.5,CHEMBL1256171,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,74,777,O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL1261460,Ki,7.32,CHEMBL1256171,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,74,778,O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccccc2s1,CHEMBL1261459,Ki,7.08,CHEMBL1258382,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells,74,777,O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccccc2s1,CHEMBL1261460,Ki,6.82,CHEMBL1258382,2010,CHEMBL1255217,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells,74,778,O=C(NCCCCN1CCN(c2cc3ccc2CCc2ccc(cc2)CC3)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)C12CC3CC(CC(C3)C1)C2,CHEMBL670172,Ki,6.2,CHEMBL21119,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",9,107,O=C(NCCCCN1CCN(c2ccccc2)CC1)C12CC3CC(CC(C3)C1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,4.56,CHEMBL4442321,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc2ccccc2c1,CHEMBL3762401,Ki,4.92,CHEMBL3758920,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,122,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccccc1,CHEMBL670172,Ki,6.4,CHEMBL21205,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",9,107,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccc(Cl)cc2Cl)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,6.12,CHEMBL4438037,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccc(F)cc2)CC1)c1n[nH]c2ccccc12,CHEMBL5362774,Ki,6.22,CHEMBL5431642,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccc(O)cc2)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,5.32,CHEMBL4565997,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccc3ccccc3n2)CC1)c1cn2ccccc2n1,CHEMBL3379351,Ki,5.81,CHEMBL3323002,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,104,163,O=C(NCCCCN1CCN(c2ccc3ccccc3n2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc2ccccc2[nH]1,CHEMBL3381713,Ki,7.28,CHEMBL3358104,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),104,574,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,7.0,CHEMBL4590192,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccc2ccccc2c1,CHEMBL3762401,Ki,5.81,CHEMBL3758711,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,122,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cn2ccccc2n1,CHEMBL3372144,IC50,7.22,CHEMBL3322995,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,104,169,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cn2ccccc2n1,CHEMBL3379351,Ki,6.79,CHEMBL3322995,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,104,163,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1n[nH]c2ccccc12,CHEMBL5362774,Ki,6.96,CHEMBL5435580,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,4.92,CHEMBL4446350,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2)CC1)c1ccc2ccccc2c1,CHEMBL3762401,Ki,5.48,CHEMBL3759513,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,122,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)C1c2ccccc2-c2ccccc21,CHEMBL671385,Ki,8.0,CHEMBL307800,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCCN1CCN(c2ccccc2)CC1)C1c2ccccc2-c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1[nH]nc2ccccc12,CHEMBL672170,Ki,6.97,CHEMBL152010,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,32,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1[nH]nc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1c[nH]c2ccccc12,CHEMBL672170,Ki,7.2,CHEMBL152262,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,32,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1c[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(Br)ccc2[nH]1,CHEMBL913685,Ki,5.64,CHEMBL218150,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,57,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(Br)ccc2o1,CHEMBL913685,Ki,5.0,CHEMBL376445,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,57,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(F)ccc2[nH]1,CHEMBL3599873,Ki,7.43,CHEMBL68740,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,112,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(F)ccc2[nH]1,CHEMBL3599945,IC50,6.25,CHEMBL68740,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,112,659,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(I)ccc2o1,CHEMBL828760,Ki,6.37,CHEMBL184383,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,38,779,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(I)ccc2o1,CHEMBL828883,Ki,5.5,CHEMBL184383,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,38,780,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(I)ccc2s1,CHEMBL828760,Ki,6.85,CHEMBL183871,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,38,779,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(I)ccc2s1,CHEMBL828883,Ki,6.35,CHEMBL183871,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,38,780,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL860506,Ki,6.66,CHEMBL210461,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,49,657,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL860507,Ki,6.85,CHEMBL210461,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,49,658,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL2167045,Ki,6.99,CHEMBL346692,2012,CHEMBL2163217,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from D2 receptor,85,781,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL2168000,Ki,6.99,CHEMBL346692,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,85,254,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL3614290,Ki,6.12,CHEMBL346692,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,112,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL4052936,Ki,6.99,CHEMBL346692,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,127,282,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL4259825,Ki,6.69,CHEMBL4285942,2018,CHEMBL4257542,Medchemcomm,Scientific Literature,Displacement of [3H]-sulpiride from human D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting method,131,929,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL672170,Ki,6.87,CHEMBL346692,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,32,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL913685,Ki,5.51,CHEMBL346692,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,57,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[te]1,CHEMBL672384,Ki,7.04,CHEMBL337531,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,32,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[te]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[te]1,CHEMBL672573,Ki,7.32,CHEMBL337531,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,32,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[te]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL1777183,Ki,7.35,CHEMBL139926,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL3614290,Ki,7.09,CHEMBL139926,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,112,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL672170,Ki,5.24,CHEMBL2112911,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,32,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL672384,Ki,6.5,CHEMBL139926,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,32,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL672573,Ki,7.1,CHEMBL139926,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,32,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL827419,IC50,6.93,CHEMBL139926,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,42,699,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL828890,Ki,6.92,CHEMBL139926,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,42,700,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL828891,Ki,7.35,CHEMBL139926,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL838683,Ki,7.35,CHEMBL139926,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL913685,Ki,6.49,CHEMBL139926,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,57,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL2388819,Ki,5.44,CHEMBL59725,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,94,97,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL3614290,Ki,6.0,CHEMBL59725,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,112,431,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL672170,Ki,6.77,CHEMBL2112910,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,32,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL672384,Ki,5.44,CHEMBL59725,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (long) by [3H]- spiperone displacement.,32,769,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL672573,Ki,5.58,CHEMBL59725,2002,CHEMBL1135974,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 (short) by [3H]- spiperone displacement.,32,770,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL827419,IC50,7.02,CHEMBL59725,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,42,699,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL828760,Ki,5.58,CHEMBL59725,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,38,779,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL828883,Ki,5.44,CHEMBL59725,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,38,780,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL828890,Ki,7.37,CHEMBL59725,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,42,700,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL828891,Ki,7.19,CHEMBL59725,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,42,701,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL838683,Ki,7.19,CHEMBL59725,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,42,702,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL839477,Ki,5.44,CHEMBL59725,2005,CHEMBL1141881,J Med Chem,Scientific Literature,Binding affinity for human dopamine receptor D2 long,42,457,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL884780,Ki,5.44,CHEMBL59725,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,43,787,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL884781,Ki,5.58,CHEMBL59725,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,43,788,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1,CHEMBL913685,Ki,5.44,CHEMBL59725,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,57,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL827419,IC50,7.04,CHEMBL69451,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,43,699,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL828890,Ki,7.21,CHEMBL69451,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,43,700,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL828891,Ki,7.61,CHEMBL69451,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,43,701,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL838683,Ki,7.61,CHEMBL69451,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,43,702,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL895648,Ki,7.61,CHEMBL69451,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,57,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2cccnc2)cc1,CHEMBL838683,Ki,7.74,CHEMBL179960,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,43,702,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2cccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,7.2,CHEMBL4535174,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(C#Cc2ccccc2)cc1,CHEMBL898785,Ki,6.11,CHEMBL241641,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,57,40,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(C#Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(C#Cc2ccccc2)cc1,CHEMBL898786,Ki,6.08,CHEMBL241641,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,57,41,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(C#Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1,CHEMBL884780,Ki,7.77,CHEMBL196744,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,43,787,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1,CHEMBL884781,Ki,7.75,CHEMBL196744,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,43,788,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)nc1,CHEMBL884780,Ki,7.68,CHEMBL197162,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,43,787,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)nc1,CHEMBL884781,Ki,7.54,CHEMBL197162,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,43,788,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,CHEMBL827419,IC50,7.26,CHEMBL302374,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,43,699,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,CHEMBL828890,Ki,7.29,CHEMBL302374,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,43,700,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,CHEMBL828891,Ki,7.41,CHEMBL302374,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,43,701,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)cc1,CHEMBL838683,Ki,7.41,CHEMBL302374,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,43,702,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)s1,CHEMBL828760,Ki,7.5,CHEMBL362101,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 short receptor using [3H]spiperone expressed in CHO cells,38,779,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(I)s1,CHEMBL828883,Ki,7.05,CHEMBL362101,2004,CHEMBL1137095,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human D2 long receptor using [3H]spiperone expressed in CHO cells,38,780,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)-c1ccccc1-2,CHEMBL671385,Ki,6.58,CHEMBL419505,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)-c1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)-c1ccccc1-2,CHEMBL872490,Ki,6.58,CHEMBL419505,1998,CHEMBL1130602,Bioorg Med Chem Lett,Scientific Literature,Compound was evaluated for binding affinity against Dopamine receptor D2 subtype from primate,15,948,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)-c1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)-c1ccccc1C2,CHEMBL671385,Ki,6.66,CHEMBL110411,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)-c1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)C(=O)c1ccccc1-2,CHEMBL2388819,Ki,7.05,CHEMBL2386603,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,94,97,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)C(=O)c1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL1777183,Ki,6.95,CHEMBL300780,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL2388819,Ki,6.95,CHEMBL300780,2013,CHEMBL2385020,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,94,97,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL3591366,Ki,7.26,CHEMBL300780,2015,CHEMBL3588810,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,112,726,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL827419,IC50,5.89,CHEMBL300780,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,43,699,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL828890,Ki,6.16,CHEMBL300780,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,43,700,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL828891,Ki,6.95,CHEMBL300780,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,43,701,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL838683,Ki,6.95,CHEMBL300780,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,43,702,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL872490,Ki,6.66,CHEMBL300780,1998,CHEMBL1130602,Bioorg Med Chem Lett,Scientific Literature,Compound was evaluated for binding affinity against Dopamine receptor D2 subtype from primate,15,948,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL895648,Ki,6.95,CHEMBL300780,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,57,126,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL895651,IC50,5.89,CHEMBL300780,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,57,760,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1,CHEMBL3762401,Ki,5.94,CHEMBL154508,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,122,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2ccccc2c1,CHEMBL672170,Ki,5.28,CHEMBL154508,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,32,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(C#Cc2ccccc2)c1,CHEMBL898785,Ki,6.68,CHEMBL241436,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,57,40,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc(C#Cc2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(C#Cc2ccccc2)c1,CHEMBL898786,Ki,6.62,CHEMBL241436,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,57,41,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc(C#Cc2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(F)n1,CHEMBL884780,Ki,7.36,CHEMBL197195,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,43,787,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(F)n1,CHEMBL884781,Ki,7.24,CHEMBL197195,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,43,788,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,CHEMBL671385,Ki,7.05,CHEMBL301242,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,CHEMBL827419,IC50,7.645,CHEMBL301242,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,43,699,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,CHEMBL828890,Ki,7.71,CHEMBL301242,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,43,700,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,CHEMBL828891,Ki,7.15,CHEMBL301242,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,43,701,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccnc2ccccc12,CHEMBL672170,Ki,6.37,CHEMBL152304,2002,CHEMBL1136013,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2 using [3H]spiroperidol as radioligand,32,653,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn(-c2ccc([N+](=O)[O-])cc2)nn1,CHEMBL1044860,Ki,6.09,CHEMBL573792,2009,CHEMBL1154112,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2-long expressed in CHO cells,66,691,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(-c2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn(-c2ccc([N+](=O)[O-])cc2)nn1,CHEMBL1044861,Ki,7.77,CHEMBL573792,2009,CHEMBL1154112,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2-short expressed in CHO cells,66,692,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn(-c2ccccc2)nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1,CHEMBL3372144,IC50,7.04,CHEMBL3322994,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,104,169,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1,CHEMBL3372150,IC50,8.96,CHEMBL3322994,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHO cells assessed as inhibition of dopamine-induced [35S]GTPgammaS binding by dopamine potency shift assay,104,172,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1,CHEMBL3379351,Ki,7.92,CHEMBL3322994,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,104,163,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cn2ccccc2n1,CHEMBL3379904,IC50,7.26,CHEMBL3322994,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2R expressed in CHO cells assessed as inhibition of quinpirole-induced mitogenesis after 24 hrs by [3H]thymidine uptake assay,104,175,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccc(F)cc2c1,CHEMBL3599873,Ki,7.41,CHEMBL3597639,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,112,656,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1,CHEMBL4052936,Ki,8.0,CHEMBL4093656,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,127,282,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1,CHEMBL827419,IC50,7.12,CHEMBL262724,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Mitogenic stimulation or antagonism of 30 nM quinpirole-stimulated mitogenesis in CHO cells expressing human dopamine D2 receptor,43,699,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1,CHEMBL828890,Ki,7.23,CHEMBL262724,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [3H]YM-09151-2 binding to human Dopamine D2L receptor expressed in CHO cells,43,700,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1,CHEMBL828891,Ki,7.53,CHEMBL262724,2005,CHEMBL1139520,J Med Chem,Scientific Literature,Inhibition of [125I]IABN binding to human Dopamine D2L receptor expressed in HEK 293 cells,43,701,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2n1,CHEMBL838683,Ki,7.53,CHEMBL262724,2005,CHEMBL1145183,J Med Chem,Scientific Literature,Binding affinity for human dopamine D2 receptor,43,702,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1csc2ccccc12,CHEMBL1777183,Ki,7.19,CHEMBL1774552,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,79,354,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1csc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(F)c2)CC1)c1cc2ccccc2cn1,CHEMBL3381713,Ki,6.8,CHEMBL3358498,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),104,574,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2cn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(F)c2)CC1)c1n[nH]c2ccccc12,CHEMBL5362774,Ki,7.12,CHEMBL5411002,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(F)c2F)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL860506,Ki,6.92,CHEMBL426863,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 long receptor expressed in CHO cells,49,657,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(F)c2F)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,CHEMBL860507,Ki,7.46,CHEMBL426863,2006,CHEMBL1148643,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 short receptor expressed in CHO cells,49,658,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccc1CCc1ccc(cc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(O)c2)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,6.85,CHEMBL4579251,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(O)c2)CC1)c1ccc2ccccc2c1,CHEMBL3762401,Ki,6.43,CHEMBL3759491,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,122,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc(OCCF)c2)CC1)c1ccc(-n2ccnc2)cc1,CHEMBL938625,Ki,6.71,CHEMBL458758,2009,CHEMBL1140855,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,66,673,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-n2ccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc3[nH]c(=O)[nH]c23)CC1)c1ccc2ccccc2c1,CHEMBL3762401,Ki,6.88,CHEMBL3760110,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,122,477,O=C(NCCCCN1CCN(c2cccc3[nH]c(=O)[nH]c23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc3[nH]ccc23)CC1)c1ccc2ccccc2c1,CHEMBL3762401,Ki,7.02,CHEMBL3759865,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,122,477,O=C(NCCCCN1CCN(c2cccc3[nH]ccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2[nH]1,CHEMBL3599873,Ki,7.89,CHEMBL3597643,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,112,656,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2[nH]1,CHEMBL3599945,IC50,7.06,CHEMBL3597643,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,112,659,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2o1,CHEMBL3599873,Ki,7.83,CHEMBL3596212,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,113,656,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2s1,CHEMBL3599873,Ki,8.08,CHEMBL3597645,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,113,656,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1ccccc1,CHEMBL3381713,Ki,7.24,CHEMBL3358512,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),104,574,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1,CHEMBL3599873,Ki,7.8,CHEMBL3597635,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor (unknown origin) expressed in HEK293 cells after 1 hr by liquid scintillation counting,113,656,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1,CHEMBL3599945,IC50,7.54,CHEMBL3597635,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of quinpirole-stimulated mitogenesis,113,659,O=C(NCCCCN1CCN(c2cccc3ccccc23)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,5.07,CHEMBL4586531,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(Br)cc1,CHEMBL670400,Ki,6.4,CHEMBL71894,1995,CHEMBL1128113,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards mouse LtK- cells transfected with human D2 receptor using [3H]spiperone,6,721,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,CHEMBL3379351,Ki,6.75,CHEMBL3322992,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,104,163,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,CHEMBL5362774,Ki,7.16,CHEMBL5398291,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2C(F)(F)F)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,6.58,CHEMBL4476605,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2C(F)(F)F)CC1)c1n[nH]c2ccccc12,CHEMBL5362774,Ki,8.07,CHEMBL5424052,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc(-c2ccccc2)cc1,CHEMBL913685,Ki,6.89,CHEMBL374749,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,57,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,6.77,CHEMBL4450777,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc(Cl)cc1,CHEMBL913685,Ki,6.33,CHEMBL219274,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,57,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc2ccccc2c1,CHEMBL3762401,Ki,6.62,CHEMBL218203,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,122,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1ccc2ccccc2c1,CHEMBL913685,Ki,6.34,CHEMBL218203,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,57,44,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2Cl)CC1)c1n[nH]c2ccccc12,CHEMBL5362774,Ki,7.93,CHEMBL5422196,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1cc2ccccc2o1,CHEMBL3381713,Ki,7.12,CHEMBL3358105,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),104,574,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1ccc2ccccc2c1,CHEMBL3762401,Ki,6.51,CHEMBL3759607,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,122,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2F)CC1)c1n[nH]c2ccccc12,CHEMBL5362774,Ki,7.58,CHEMBL5429491,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2O)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,5.46,CHEMBL4459381,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2O)CC1)c1ccc2ccccc2c1,CHEMBL3762401,Ki,5.3,CHEMBL3758330,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,122,477,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1c[nH]c2ccccc12,CHEMBL3136930,Ki,8.29,CHEMBL3133870,2013,CHEMBL3132749,Medchemcomm,Scientific Literature,Displacement of [125I]ABN from human D2 receptor transfected in HEK-293 cell membrane after 60 mins by filtration binding assay,94,725,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1c[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1cc2ccccn2n1,CHEMBL4054777,Ki,7.41,CHEMBL4064974,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,127,170,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1cc2ccccn2n1,CHEMBL4054778,Ki,7.68,CHEMBL4064974,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,127,171,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL1694505,Ki,7.56,CHEMBL1689006,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(-c2ccsc2)cc1,CHEMBL4350893,Ki,9.77,CHEMBL1739963,2019,CHEMBL4346764,Bioorg Med Chem Lett,Scientific Literature,"Displacement of 2,3-dimethoxy-5-[125I]-iodo-N-[9-benzyl-9-azabicyclo[3.3.1]nonan-3beta-yl]benzamide from human dopamine D2L receptor expressed in HEK293 cells measured after 60 mins by gamma counting analysis",139,283,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(-n2ccnc2)cc1,CHEMBL938625,Ki,8.23,CHEMBL456233,2009,CHEMBL1140855,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,66,673,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc(-n2ccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(CCF)cc1,CHEMBL1694505,Ki,7.67,CHEMBL1689003,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(OCCF)cc1,CHEMBL1694505,Ki,7.82,CHEMBL1689004,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(OCCOCCF)cc1,CHEMBL1694505,Ki,7.85,CHEMBL1689005,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc(OCCOCCOCCF)cc1,CHEMBL1694505,Ki,7.5,CHEMBL1689007,2011,CHEMBL1687933,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human D2 receptor transfected in human HEK 293 cells by gamma-counting,79,540,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1ccc2nonc2c1,CHEMBL938625,Ki,7.75,CHEMBL515535,2009,CHEMBL1140855,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiroperidol from human cloned dopamine D2L receptor by liquid scintillation counting,66,673,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2nonc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccn2)CC1)c1cc2ccccc2cn1,CHEMBL3381713,Ki,5.25,CHEMBL3358098,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),104,574,O=C(NCCCCN1CCN(c2ccccn2)CC1)c1cc2ccccc2cn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccccn2)CC1)c1n[nH]c2ccccc12,CHEMBL5362774,Ki,6.62,CHEMBL5395668,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(NCCCCN1CCN(c2ccccn2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cccnc2)CC1)c1n[nH]c2ccccc12,CHEMBL5362774,Ki,6.25,CHEMBL5420627,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(NCCCCN1CCN(c2cccnc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccnc3cc(C(F)(F)F)ccc23)CC1)c1cn2ccccc2n1,CHEMBL3379351,Ki,5.3,CHEMBL3323000,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,104,163,O=C(NCCCCN1CCN(c2ccnc3ccccc23)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccnc3cc(Cl)ccc23)CC1)c1cn2ccccc2n1,CHEMBL3379351,Ki,5.72,CHEMBL3323001,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,104,163,O=C(NCCCCN1CCN(c2ccnc3ccccc23)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccnc3ccccc23)CC1)c1cn2ccccc2n1,CHEMBL3372144,IC50,6.79,CHEMBL3322998,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,104,169,O=C(NCCCCN1CCN(c2ccnc3ccccc23)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ccnc3ccccc23)CC1)c1cn2ccccc2n1,CHEMBL3379351,Ki,6.24,CHEMBL3322998,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,104,163,O=C(NCCCCN1CCN(c2ccnc3ccccc23)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2cnc3ccccc3c2)CC1)c1ccccc1,CHEMBL3381713,Ki,9.0,CHEMBL3358513,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),104,574,O=C(NCCCCN1CCN(c2cnc3ccccc3c2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ncccn2)CC1)c1n[nH]c2ccccc12,CHEMBL5362774,Ki,6.58,CHEMBL5439203,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(NCCCCN1CCN(c2ncccn2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ncnc3ccccc23)CC1)c1cn2ccccc2n1,CHEMBL3372144,IC50,6.61,CHEMBL3323003,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Antagonist activity against human D2LR expressed in CHOK1 cells assessed as inhibition of pergolide-induced beta-arrestin translocation by beta-galactosidase based beta-arrestin recruitment assay,104,169,O=C(NCCCCN1CCN(c2ncnc3ccccc23)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN(c2ncnc3ccccc23)CC1)c1cn2ccccc2n1,CHEMBL3379351,Ki,5.95,CHEMBL3323003,2014,CHEMBL3351252,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2LR expressed in HEK293 cell membranes by gamma counting method,104,163,O=C(NCCCCN1CCN(c2ncnc3ccccc23)CC1)c1cn2ccccc2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)C1CCCCC1,CHEMBL897619,Ki,6.59,CHEMBL239067,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)c1cc2ccccc2s1,CHEMBL897619,Ki,5.31,CHEMBL393774,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)c1ccc2ccccc2c1,CHEMBL897619,Ki,5.88,CHEMBL238859,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)c1cccs1,CHEMBL897619,Ki,6.3,CHEMBL239066,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C(NCCCCN1CCN2c3ccccc3Cc3ccccc3C2C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3cc(O)ccc3OC[C@@H]21)c1cc2ccccc2[nH]1,CHEMBL4731081,Ki,5.03,CHEMBL4791884,2020,CHEMBL4725442,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,144,406,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)C1CCCCC1,CHEMBL4825013,Ki,6.14,CHEMBL4869668,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1cc2ccccc2[nH]1,CHEMBL4825013,Ki,6.11,CHEMBL4875008,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccc(-c2ccccc2)cc1,CHEMBL4825013,Ki,5.99,CHEMBL4854126,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccc(Br)cc1,CHEMBL4825013,Ki,6.05,CHEMBL4845838,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccc(Cl)cc1,CHEMBL4825013,Ki,6.33,CHEMBL4878826,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccc([N+](=O)[O-])cc1,CHEMBL4825013,Ki,6.02,CHEMBL4869122,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccc2ccccc2c1,CHEMBL4825013,Ki,6.14,CHEMBL4878501,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1cccc(Cl)c1,CHEMBL4825013,Ki,6.18,CHEMBL4878577,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1cccc2ccccc12,CHEMBL4825013,Ki,6.25,CHEMBL4862399,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccccc1,CHEMBL4825013,Ki,6.11,CHEMBL4848199,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1ccco1,CHEMBL4825013,Ki,6.07,CHEMBL4848907,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@@H]2c3ccccc3OC[C@H]21)c1cccs1,CHEMBL4825013,Ki,6.38,CHEMBL4855711,2021,CHEMBL4823295,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor transfected in HEK293 cell membrane measured after 50 mins by competitive radioligand binding analysis,152,407,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCO[C@H]2c3cc(O)ccc3OC[C@@H]21)c1cc2ccccc2[nH]1,CHEMBL4731081,Ki,5.23,CHEMBL4778398,2020,CHEMBL4725442,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human D2L receptor expressed in HEK293 cells after 90 mins by microbeta counting based assay,144,406,O=C(NCCCCN1CCOC2c3ccccc3OCC21)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CC[C@@H]2c3ccccc3CC[C@@H]21)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.3,CHEMBL97107,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,15,750,O=C(NCCCCN1CCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CC[C@H]2c3ccc(O)cc3CC[C@@H]21)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.5,CHEMBL97856,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,15,750,O=C(NCCCCN1CCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CC[C@H]2c3cccc(O)c3CC[C@@H]21)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,7.2,CHEMBL319116,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,15,750,O=C(NCCCCN1CCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CC[C@H]2c3ccccc3CC[C@@H]21)c1ccc(-c2ccccc2)cc1,CHEMBL674943,Ki,6.3,CHEMBL98452,1998,CHEMBL1130629,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at Dopamine receptor D2 expressed in CHO cells by [125I]iodosulpiride displacement.,15,750,O=C(NCCCCN1CCC2c3ccccc3CCC21)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CC[C@]2(c3cccc(O)c3)CCC[C@H]1[C@@H]2O)c1cc2ccccc2[nH]1,CHEMBL5046486,Ki,5.34,CHEMBL5075014,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,152,253,O=C(NCCCCN1CCC2(c3ccccc3)CCCC1C2)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CC[C@]2(c3cccc(O)c3)CCC[C@H]1[C@H]2O)c1cc2ccccc2[nH]1,CHEMBL5046486,Ki,5.88,CHEMBL5072449,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,152,253,O=C(NCCCCN1CCC2(c3ccccc3)CCCC1C2)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CC[N+]2(CCOc3ccccc32)CC1)c1cc2ccccn2n1,CHEMBL4054777,Ki,5.2,CHEMBL4060837,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-long receptor expressed in CHO cell membranes,127,170,O=C(NCCCCN1CC[N+]2(CCOc3ccccc32)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CC[N+]2(CCOc3ccccc32)CC1)c1cc2ccccn2n1,CHEMBL4054778,Ki,5.35,CHEMBL4060837,2017,CHEMBL4052643,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2-short receptor expressed in CHO cell membranes,127,171,O=C(NCCCCN1CC[N+]2(CCOc3ccccc32)CC1)c1cc2ccccn2n1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1)c1ccc(-c2ccc(N3CCCC3=O)cc2)cc1,CHEMBL672227,Ki,6.9,CHEMBL297960,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,20,131,O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccc(N3CCCC3=O)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1)c1ccc(-c2ccccc2)cc1,CHEMBL672227,Ki,6.3,CHEMBL299038,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,20,131,O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCc2ccc(OS(=O)(=O)C(F)(F)F)cc2C1)c1cccc(-c2ccccc2)c1,CHEMBL672227,Ki,6.3,CHEMBL52770,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,20,131,O=C(NCCCCN1CCc2ccccc2C1)c1cccc(-c2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,CHEMBL672227,Ki,6.3,CHEMBL53833,1999,CHEMBL1132014,Bioorg Med Chem Lett,Scientific Literature,Displacement [125I]iodosulpiride from human Dopamine receptor D2 expressed in CHO cells,20,131,O=C(NCCCCN1CCc2ccccc2C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCN1CCc2ncsc2CC1)C12CC3CC(CC(C3)C1)C2,CHEMBL4334858,Ki,5.26,CHEMBL4460592,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,139,774,O=C(NCCCCN1CCc2ncsc2CC1)C12CC3CC(CC(C3)C1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCCNC1COc2ccc(O)cc2C1=O)c1cc2ccccc2[nH]1,CHEMBL4361371,Ki,6.225,CHEMBL4467736,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,139,352,O=C(NCCCCNC1COc2ccccc2C1=O)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1,CHEMBL4323478,Ki,6.1,CHEMBL4439728,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,139,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1,CHEMBL4323479,Ki,6.21,CHEMBL4439728,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,139,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323478,Ki,6.14,CHEMBL4476278,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,139,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323479,Ki,6.28,CHEMBL4476278,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,139,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccc(Cl)cc2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1,CHEMBL4323478,Ki,6.3,CHEMBL4589982,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,139,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccc(Cl)cc2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1,CHEMBL4323479,Ki,6.42,CHEMBL4589982,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,139,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccc(Cl)cc2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323478,Ki,6.19,CHEMBL4587645,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,139,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccc(Cl)cc2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323479,Ki,6.39,CHEMBL4587645,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,139,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccc(I)cc2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323478,Ki,6.16,CHEMBL4572646,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,139,70,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccc(I)cc2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323479,Ki,6.17,CHEMBL4572646,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,139,71,O=C(NCCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1n[nH]c2ccccc12,CHEMBL5362774,Ki,6.94,CHEMBL5432478,2023,CHEMBL5360565,Eur J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human D2s receptor expressed in CHO-K1 cells membrane incubated for 1 hr by microbeta liquid scintillation counting analysis,159,491,O=C(NCCCN1CCN(c2ccccc2)CC1)c1n[nH]c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)C1c2ccccc2-c2ccccc21,CHEMBL671385,Ki,6.38,CHEMBL68860,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCN1CCN(c2ccccc2)CC1)C1c2ccccc2-c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL671385,Ki,5.59,CHEMBL67750,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1-c1ccccc1C2=O,CHEMBL671385,Ki,6.29,CHEMBL309118,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc2c1Cc1ccccc1-2,CHEMBL671385,Ki,5.78,CHEMBL108527,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cccc2c1Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccccc2)CC1)C1c2ccccc2-c2ccccc21,CHEMBL671385,Ki,6.22,CHEMBL302796,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCN1CCN(c2ccccc2)CC1)C1c2ccccc2-c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,CHEMBL671385,Ki,6.08,CHEMBL108637,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCN1CCN(c2ccccc2)CC1)c1ccc2c(c1)Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2=O,CHEMBL671385,Ki,6.11,CHEMBL322179,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cccc2c1-c1ccccc1C2=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ccccc2)CC1)c1cccc2c1Cc1ccccc1-2,CHEMBL671385,Ki,6.33,CHEMBL110349,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,26,547,O=C(NCCCN1CCN(c2ccccc2)CC1)c1cccc2c1Cc1ccccc1-2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1,CHEMBL4323478,Ki,6.37,CHEMBL4567758,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,139,70,O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccc(F)cc1)c1ccccc1,CHEMBL4323479,Ki,6.51,CHEMBL4567758,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,139,71,O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323478,Ki,6.24,CHEMBL4443944,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,139,70,O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323479,Ki,6.36,CHEMBL4443944,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,139,71,O=C(NCCCN1CCN(c2ncccn2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCCc1ccccc1)c1cc2c3c(ccc2[nH]1)OCC(CNCCCc1ccccc1)O3,CHEMBL672490,Ki,7.39,CHEMBL103983,1992,CHEMBL1125523,J Med Chem,Scientific Literature,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",0,286,O=C(NCCCc1ccccc1)c1cc2c3c(ccc2[nH]1)OCC(CNCCCc1ccccc1)O3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN(CCCN1CCN(c2ccccc2)CC1)C1CCc2ccc(O)cc2C1)c1ccccc1,CHEMBL670524,Ki,6.45,CHEMBL422883,2002,CHEMBL1135449,Bioorg Med Chem Lett,Scientific Literature,Tested for the binding constant against cloned human Dopamine receptor D2L in HEK cells by displacing [3H]spiperone,32,27,O=C(NCCN(CCCN1CCN(c2ccccc2)CC1)C1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCC(O)(c2ccc(Cl)cc2)CC1)NCCN1C(=O)C=CC1=O,CHEMBL4044352,Ki,5.66,CHEMBL4071729,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,127,668,O=C(NCCN1CCC(c2ccccc2)CC1)NCCN1C(=O)C=CC1=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCC(O)(c2ccc(Cl)cc2)CC1)NCCN1C(=O)C=CC1=O,CHEMBL4044353,Ki,5.82,CHEMBL4071729,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,127,669,O=C(NCCN1CCC(c2ccccc2)CC1)NCCN1C(=O)C=CC1=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1)c1ccc(F)cc1,CHEMBL2330406,IC50,8.15,CHEMBL245621,2013,CHEMBL2321744,J Med Chem,Scientific Literature,Inhibition of dopamine receptor D2 (unknown origin),94,949,O=C(NCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323478,Ki,6.41,CHEMBL4536530,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,139,70,O=C(NCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2ccc(Br)cc2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323479,Ki,6.37,CHEMBL4536530,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,139,71,O=C(NCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1)c1ccccn1,CHEMBL4179172,Ki,6.6,CHEMBL4208744,2017,CHEMBL4177580,Bioorg Med Chem,Scientific Literature,Displacement of [3H]methyl-spiperone from human recombinant dopamine D2 receptor expressed in HEK293 cells,127,950,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2ccc(Cl)cc2)CC1)C12CC3CC(CC(C3)C1)C2,CHEMBL670172,Ki,6.4,CHEMBL21168,1996,CHEMBL1129089,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity at cloned human Dopamine receptor D2 expressed in CHO cells, using [125I]iodosulpiride as radioligand",9,107,O=C(NCCN1CCN(c2ccccc2)CC1)C12CC3CC(CC(C3)C1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccncc1,CHEMBL4179172,Ki,5.64,CHEMBL3763633,2017,CHEMBL4177580,Bioorg Med Chem,Scientific Literature,Displacement of [3H]methyl-spiperone from human recombinant dopamine D2 receptor expressed in HEK293 cells,127,950,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccncc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2ccc(I)cc2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323478,Ki,6.31,CHEMBL4466114,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2L receptor expressed in CHO cells by competitive radioligand binding assay,139,70,O=C(NCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2ccc(I)cc2)CC1)NN(Cc1ccccc1)c1ccccc1,CHEMBL4323479,Ki,6.29,CHEMBL4466114,2019,CHEMBL4321823,J Med Chem,Scientific Literature,Displacement of [3H] Spiperone from human D2S receptor expressed in CHO cells by competitive radioligand binding assay,139,71,O=C(NCCN1CCN(c2ccccc2)CC1)NN(Cc1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(C#Cc2ccccc2)cc1,CHEMBL898785,Ki,5.33,CHEMBL241210,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,57,40,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc(C#Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(C#Cc2ccccc2)cc1,CHEMBL898786,Ki,5.0,CHEMBL241210,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,57,41,O=C(NCCN1CCN(c2ccccc2)CC1)c1ccc(C#Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(C#Cc2ccccc2)c1,CHEMBL898785,Ki,5.92,CHEMBL241211,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 long expressed in CHO cell membranes,57,40,O=C(NCCN1CCN(c2ccccc2)CC1)c1cccc(C#Cc2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cccc(C#Cc2ccccc2)c1,CHEMBL898786,Ki,5.85,CHEMBL241211,2007,CHEMBL1137491,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine receptor D2 short expressed in CHO cell membranes,57,41,O=C(NCCN1CCN(c2ccccc2)CC1)c1cccc(C#Cc2ccccc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCCN1CCN(c2cccc3nc(O)oc23)CC1)c1ccc(F)cc1,CHEMBL672308,Ki,8.34,CHEMBL78058,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,26,593,O=C(NCCN1CCN(c2cccc3ncoc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC[C@@H](F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL3291797,Ki,6.1,CHEMBL3287279,2014,CHEMBL3286326,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,104,945,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL3291797,Ki,6.52,CHEMBL1627306,2014,CHEMBL3286326,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,104,945,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL3599871,Ki,6.53,CHEMBL1627306,2015,CHEMBL3596172,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),113,951,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL4052936,Ki,6.36,CHEMBL1627306,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,127,282,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC[C@@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1,CHEMBL4052936,Ki,6.7,CHEMBL4081424,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,127,282,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC[C@H](F)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1,CHEMBL3291797,Ki,5.6,CHEMBL3287280,2014,CHEMBL3286326,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,104,945,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC[C@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL3291797,Ki,6.1,CHEMBL1627307,2014,CHEMBL3286326,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in human HEK293 cell membrane for 1 hr by liquid scintillation counting analysis,104,945,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC[C@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL4052936,Ki,6.15,CHEMBL1627307,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,127,282,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCC[C@H](O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1,CHEMBL4052936,Ki,6.5,CHEMBL4105681,2017,CHEMBL4052584,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells after 1 hr by MicroBeta microplate counting method,127,282,O=C(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCN1CCN(c2ccccc2Cl)CC1)c1ccc(Cl)cc1,CHEMBL671981,Ki,6.3,CHEMBL296953,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,12,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCN1CCN(c2ccccc2Cl)CC1)c1ccc(Cl)cc1,CHEMBL835392,Ki,7.18,CHEMBL296953,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,43,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCN1CCN(c2ccccc2Cl)CC1)c1cccc(Cl)c1,CHEMBL671981,Ki,5.62,CHEMBL295094,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,12,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCN1CCN(c2ccccc2Cl)CC1)c1cccc(Cl)c1,CHEMBL835392,Ki,6.44,CHEMBL295094,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,43,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCN1CCN(c2ccccc2Cl)CC1)c1ccccc1,CHEMBL671981,Ki,5.82,CHEMBL298763,1997,CHEMBL1130052,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2 expressed in CHO K1 transfected cells using [3H]spiperone as radioligand,12,808,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCN1CCN(c2ccccc2Cl)CC1)c1ccccc1,CHEMBL835392,Ki,6.75,CHEMBL298763,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human dopamine receptor D2 was determined by using [3H]spiperone as radioligand,43,809,O=C(NCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC[C@@H]1C[C@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1,CHEMBL4053560,Ki,8.07,CHEMBL4077536,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,127,265,O=C(NCC1CC1CN1CCN(c2ccccc2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC[C@@H]1C[C@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccnc2ccccc12,CHEMBL4053560,Ki,7.7,CHEMBL4083903,2017,CHEMBL4052607,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,127,265,O=C(NCC1CC1CN1CCN(c2ccccc2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC[C@H]1CC[C@H](CN2CCN(c3nsc4cc(Cl)ccc34)CC2)CC1)c1ccco1,CHEMBL3872755,Ki,8.68,CHEMBL3932186,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NCC1CCC(CN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC[C@H]1CC[C@H](CN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,CHEMBL3872755,Ki,8.05,CHEMBL3959698,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NCC1CCC(CN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC[C@H]1C[C@@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL895648,Ki,7.27,CHEMBL231156,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,57,126,O=C(NCC1CC1CN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC[C@H]1C[C@@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL895651,IC50,6.17,CHEMBL231156,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in HEK293 cells by mitogenesis assay,57,760,O=C(NCC1CC1CN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NC[C@H]1C[C@H]1CN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(-c2ccccn2)cc1,CHEMBL895648,Ki,5.98,CHEMBL394863,2007,CHEMBL1148745,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 receptor expressed in HEK293 cells,57,126,O=C(NCC1CC1CN1CCN(c2ccccc2)CC1)c1ccc(-c2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCc1ccccc1)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,8.85,CHEMBL3940712,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NCc1ccccc1)NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NCc1ccccc1CN1CCc2cc(O)c(O)cc2C1)c1cccc(Br)c1,CHEMBL4822008,Ki,7.25,CHEMBL4876260,2021,CHEMBL4819092,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from dopamine D2 receptor (unknown origin),152,646,O=C(NCc1ccccc1CN1CCc2ccccc2C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1,CHEMBL4880035,Ki,6.405,CHEMBL4456585,2021,CHEMBL4507321,,SGC Frankfurt - Donated Chemical Probes,GPCRScan assay: inhibition of D2,152,144,O=C(NNS(=O)(=O)c1ccccc1)c1cccc(-c2ccccn2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(NNS(=O)(=O)c1ccccc1F)c1cc(F)cc(-c2ccccn2)c1,CHEMBL5214067,Ki,6.4,CHEMBL4456585,2023,CHEMBL5212743,,EUbOPEN Chemogenomic Library Literature Data,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000329a DRD2,159,952,O=C(NNS(=O)(=O)c1ccccc1)c1cccc(-c2ccccn2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@@H]1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,CHEMBL839650,Ki,5.82,CHEMBL186558,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@@H]1CCN(Cc2ccccc2)C1)c1ccc(-c2ccsc2)cc1,CHEMBL839650,Ki,6.05,CHEMBL366304,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@@H]1CCN(Cc2ccccc2)C1)c1cccc(-c2ccsc2)c1,CHEMBL839650,Ki,7.03,CHEMBL187113,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1cccc(-c2ccsc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccc(C(F)(F)F)cc2)C1)c1cccc(-c2cccs2)c1,CHEMBL860444,Ki,5.89,CHEMBL370652,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,43,740,O=C(NC1CCN(Cc2ccccc2)C1)c1cccc(-c2cccs2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccc(Cl)c(Cl)c2)C1)c1ccc(-c2cccs2)cc1,CHEMBL860444,Ki,4.54,CHEMBL199186,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,43,740,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccc(Cl)cc2)C1)c1cccc(-c2cccs2)c1,CHEMBL860444,Ki,6.64,CHEMBL197381,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,43,740,O=C(NC1CCN(Cc2ccccc2)C1)c1cccc(-c2cccs2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccc(F)c(F)c2)C1)c1ccc(-c2cccs2)cc1,CHEMBL860444,Ki,4.75,CHEMBL198580,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,43,740,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccc(F)cc2)C1)c1ccc(-c2cccs2)cc1,CHEMBL860444,Ki,5.82,CHEMBL370823,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,43,740,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccc(OC(F)(F)F)cc2)C1)c1cccc(-c2cccs2)c1,CHEMBL860444,Ki,6.3,CHEMBL373032,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,43,740,O=C(NC1CCN(Cc2ccccc2)C1)c1cccc(-c2cccs2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccc(OC3CCNCC3)c(Br)c2)C1)c1ccc(Cl)c(Cl)c1,CHEMBL1009492,Ki,7.0,CHEMBL495075,2008,CHEMBL1155072,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,62,953,O=C(NC1CCN(Cc2ccc(OC3CCNCC3)cc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccc3c(c2)OCO3)C1)c1ccc(-c2cccs2)cc1,CHEMBL860444,Ki,5.75,CHEMBL197225,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,43,740,O=C(NC1CCN(Cc2ccc3c(c2)OCO3)C1)c1ccc(-c2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,CHEMBL839650,Ki,6.01,CHEMBL360424,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,CHEMBL860444,Ki,6.01,CHEMBL360424,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,43,740,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1ccc(-c2ccsc2)cc1,CHEMBL839650,Ki,6.0,CHEMBL364782,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccsc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1cccc(-c2cccs2)c1,CHEMBL839650,Ki,7.22,CHEMBL361035,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1cccc(-c2cccs2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1cccc(-c2cccs2)c1,CHEMBL860444,Ki,7.22,CHEMBL361035,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,43,740,O=C(NC1CCN(Cc2ccccc2)C1)c1cccc(-c2cccs2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccccc2)C1)c1cccc(-c2ccsc2)c1,CHEMBL839650,Ki,7.16,CHEMBL426062,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1cccc(-c2ccsc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CCN(Cc2ccccc2F)C1)c1ccc(-c2cccs2)cc1,CHEMBL860444,Ki,4.42,CHEMBL196866,2005,CHEMBL1141940,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2(short) receptor in rat pituitary GH4C1 cells,43,740,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2cccs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,CHEMBL3872755,Ki,8.2,CHEMBL3950977,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3ccc(F)c4occc34)CC2)CC1)C1CCOCC1,CHEMBL3705383,Ki,6.44,CHEMBL3695418,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(NC1CCC(CCN2CCC(c3cccc4occc34)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C(F)(F)F,CHEMBL3705383,Ki,6.54,CHEMBL3695396,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C(O)C(F)(F)F,CHEMBL3705383,Ki,6.62,CHEMBL3695390,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1(O)CC1,CHEMBL3705383,Ki,6.53,CHEMBL3695381,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1(O)CCC1,CHEMBL3705383,Ki,6.51,CHEMBL3695392,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CC1,CHEMBL3705383,Ki,6.82,CHEMBL3695382,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CC1(F)F,CHEMBL3705383,Ki,6.63,CHEMBL3695414,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCC1,CHEMBL3705383,Ki,6.84,CHEMBL3695379,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",104,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCCO1,CHEMBL3705383,Ki,6.43,CHEMBL3695406,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCCO1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCCOC1,CHEMBL3705383,Ki,6.2,CHEMBL3695407,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCCOC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCOC1,CHEMBL3705383,Ki,6.87,CHEMBL3695405,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCOC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCOCC1,CHEMBL3705383,Ki,6.14,CHEMBL3695360,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-c2ccccc2)cc1,CHEMBL3705383,Ki,6.3,CHEMBL3695444,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-c2cccnc2)cc1,CHEMBL3705383,Ki,7.0,CHEMBL3695445,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-c2cccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-n2cccc2)cc1,CHEMBL3705383,Ki,7.07,CHEMBL3695443,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-n2cccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-n2cccn2)cc1,CHEMBL3705383,Ki,5.77,CHEMBL3695421,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(-n2cccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(C(F)(F)F)cc1,CHEMBL3705383,Ki,5.83,CHEMBL3695410,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(Cl)cc1,CHEMBL3705383,Ki,7.14,CHEMBL3695387,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(Cl)cc1Cl,CHEMBL3705383,Ki,6.63,CHEMBL3695442,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(F)cc1,CHEMBL3705383,Ki,7.13,CHEMBL3695388,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCCCC2)cc1,CHEMBL3705383,Ki,5.64,CHEMBL3695409,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1,CHEMBL3705383,Ki,6.89,CHEMBL3695386,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)nc1,CHEMBL3705383,Ki,6.04,CHEMBL3695399,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCS(=O)(=O)CC2)cc1,CHEMBL3705383,Ki,6.48,CHEMBL3695430,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(N2CCS(=O)(=O)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc2c(c1)OCO2,CHEMBL3705383,Ki,6.09,CHEMBL3695432,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1,CHEMBL3705383,Ki,6.5,CHEMBL3695370,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccnc2ccccc12,CHEMBL3705383,Ki,6.25,CHEMBL3695393,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C(F)(F)F,CHEMBL3707825,Ki,6.46,CHEMBL3664885,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C(O)C(F)(F)F,CHEMBL3707825,Ki,6.63,CHEMBL3664825,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1(C(F)(F)F)CC1,CHEMBL3707825,Ki,6.61,CHEMBL3664862,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1(O)CC1,CHEMBL3707825,Ki,6.61,CHEMBL3664861,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1(O)CCCCC1,CHEMBL3707825,Ki,6.66,CHEMBL3664878,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CC(Cl)C1,CHEMBL3707825,Ki,6.52,CHEMBL3664841,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CC1(F)F,CHEMBL3707825,Ki,6.71,CHEMBL3664839,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCC1,CHEMBL3707825,Ki,7.0,CHEMBL3664866,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCCO1,CHEMBL3707825,Ki,6.33,CHEMBL3664858,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCCO1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCOC1,CHEMBL3707825,Ki,6.78,CHEMBL3664859,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCOC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCOCC1,CHEMBL3707825,Ki,6.74,CHEMBL3664860,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCS(=O)(=O)C1,CHEMBL3707825,Ki,6.89,CHEMBL3664864,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1CCS(=O)(=O)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1COc2ccccc2C1,CHEMBL3707825,Ki,5.98,CHEMBL3664872,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)C1COc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)N1CCc2ccccc21,CHEMBL3707825,Ki,6.64,CHEMBL3664886,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)[C@@H](O)C(F)(F)F,CHEMBL3707825,Ki,6.55,CHEMBL3664852,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)[C@H](O)C(F)(F)F,CHEMBL3707825,Ki,6.68,CHEMBL3664851,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc(Cl)cc1,CHEMBL3707825,Ki,6.83,CHEMBL3664849,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc(F)cc1,CHEMBL3707825,Ki,6.63,CHEMBL3664850,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1,CHEMBL3707825,Ki,6.23,CHEMBL3664868,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc2c(c1)OCCO2,CHEMBL3707825,Ki,6.46,CHEMBL3664870,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc2c(c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,CHEMBL3707825,Ki,6.92,CHEMBL3664822,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccnc2ccccc12,CHEMBL3707825,Ki,6.43,CHEMBL3664869,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,111,O=C(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3cccc4occc34)CC2)CC1)C1CCOCC1,CHEMBL3705383,Ki,6.52,CHEMBL3695356,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,54,O=C(NC1CCC(CCN2CCC(c3cccc4occc34)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C(F)(F)F,CHEMBL3706129,Ki,7.43,CHEMBL3676884,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C(O)C(F)(F)F,CHEMBL3706129,Ki,7.33,CHEMBL3676877,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1(O)CC1,CHEMBL3706129,Ki,7.32,CHEMBL3676867,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C12CC3CC(CC(C3)C1)C2,CHEMBL3706129,Ki,6.89,CHEMBL3676923,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)C12CC3CC(CC(C3)C1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CC1,CHEMBL3706129,Ki,7.64,CHEMBL3676872,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CC1(F)F,CHEMBL3706129,Ki,7.55,CHEMBL3676875,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCC(C(F)(F)F)CC1,CHEMBL3706129,Ki,7.14,CHEMBL3676924,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCC1,CHEMBL3706129,Ki,7.42,CHEMBL3676865,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCCO1,CHEMBL3706129,Ki,7.09,CHEMBL3676863,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCCO1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCCOC1,CHEMBL3706129,Ki,7.43,CHEMBL3676871,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCCOC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCOC1,CHEMBL3706129,Ki,7.28,CHEMBL3676862,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCOC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCOCC1,CHEMBL3706129,Ki,7.43,CHEMBL3676848,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-c2ccccc2)cc1,CHEMBL3706129,Ki,7.66,CHEMBL3676908,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-c2cccnc2)cc1,CHEMBL3706129,Ki,7.78,CHEMBL3676909,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-c2cccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-n2cccc2)cc1,CHEMBL3706129,Ki,7.46,CHEMBL3676913,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-n2cccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-n2cccn2)cc1,CHEMBL3706129,Ki,7.33,CHEMBL3676904,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(-n2cccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(C(F)(F)F)cc1,CHEMBL3706129,Ki,6.82,CHEMBL3676895,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(C2CC2)cc1,CHEMBL3706129,Ki,6.45,CHEMBL3676929,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(C2CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(Cl)cc1,CHEMBL3706129,Ki,7.59,CHEMBL3676894,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(Cl)cc1Cl,CHEMBL3706129,Ki,7.42,CHEMBL3676932,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(F)cc1,CHEMBL3706129,Ki,7.16,CHEMBL3676869,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCCCC2)cc1,CHEMBL3706129,Ki,6.46,CHEMBL3676896,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCOCC2)cc1,CHEMBL3706129,Ki,6.39,CHEMBL3676858,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCOCC2)nc1,CHEMBL3706129,Ki,7.29,CHEMBL3676910,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCOCC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCS(=O)(=O)CC2)cc1,CHEMBL3706129,Ki,7.72,CHEMBL3676911,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc(N2CCS(=O)(=O)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc2c(c1)OCO2,CHEMBL3706129,Ki,7.54,CHEMBL3676903,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,CHEMBL3706129,Ki,7.49,CHEMBL3676854,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccnc2ccccc12,CHEMBL3706129,Ki,7.01,CHEMBL3676864,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1)c1cnc(N2CCOCC2)cn1,CHEMBL3706129,Ki,6.98,CHEMBL3676912,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",105,55,O=C(NC1CCC(CCN2CCC(c3coc4ccccc34)CC2)CC1)c1cnc(N2CCOCC2)cn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccc(Cl)cc3)CC2)CC1)C1CCCCC1,CHEMBL671651,Ki,7.09,CHEMBL310680,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccc(Cl)cc3)CC2)CC1)c1cccs1,CHEMBL671651,Ki,7.47,CHEMBL309459,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(C(F)(F)F)n3)CC2)CC1)c1ccnc2ccccc12,CHEMBL5381008,Ki,6.79,CHEMBL5436641,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,159,147,O=C(NC1CCC(CCN2CCN(c3ccccn3)CC2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3)CC2)CC1)C1CCCCC1,CHEMBL671651,Ki,7.43,CHEMBL310401,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3)CC2)CC1)c1cccs1,CHEMBL671651,Ki,8.19,CHEMBL78368,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)C12CC3CC(CC(C3)C1)C2,CHEMBL671651,Ki,6.47,CHEMBL77411,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C12CC3CC(CC(C3)C1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)C1=CC2C=CC=CC2N1,CHEMBL5381008,Ki,8.19,CHEMBL5395965,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,159,147,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1=CC2C=CC=CC2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)C1CCCC1,CHEMBL671651,Ki,8.77,CHEMBL78617,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)C1CCCCC1,CHEMBL671651,Ki,8.13,CHEMBL309979,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)C1CCCCCC1,CHEMBL671651,Ki,7.92,CHEMBL78195,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)N1CCc2ncccc2C1,CHEMBL5381008,Ki,8.73,CHEMBL5398100,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,159,147,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)N1CCc2ncccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccc(-c2cccnc2)cc1,CHEMBL5381008,Ki,8.43,CHEMBL5429048,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,159,147,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1ccc(-c2cccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccccc1,CHEMBL671651,Ki,8.35,CHEMBL430439,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccco1,CHEMBL671651,Ki,8.52,CHEMBL312430,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1cccs1,CHEMBL671651,Ki,9.22,CHEMBL80919,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccnc2ccccc12,CHEMBL5381008,Ki,7.54,CHEMBL5429826,2023,CHEMBL5380776,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor in HEK293 cell membranes measured after 60 mins by scintillation counting method,159,147,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1)c1ccsc1,CHEMBL671651,Ki,8.3,CHEMBL309727,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1ccsc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C(F)(F)F,CHEMBL3707837,Ki,6.95,CHEMBL3698020,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1(O)CC1,CHEMBL3707837,Ki,7.21,CHEMBL3697979,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1(O)CCC1,CHEMBL3707837,Ki,7.07,CHEMBL3697985,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1(O)CCCC1,CHEMBL3707837,Ki,6.91,CHEMBL3697986,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1(O)CCCCC1,CHEMBL3707837,Ki,6.76,CHEMBL3697987,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CC(Cl)C1,CHEMBL3707837,Ki,7.09,CHEMBL3698010,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CC1(F)F,CHEMBL3707837,Ki,6.84,CHEMBL3697970,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCC1,CHEMBL3707837,Ki,7.04,CHEMBL3698004,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCCO1,CHEMBL3707837,Ki,6.93,CHEMBL3697994,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCCO1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCOCC1,CHEMBL3707837,Ki,6.66,CHEMBL3697993,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCS(=O)(=O)C1,CHEMBL3707837,Ki,7.23,CHEMBL3698002,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1CCS(=O)(=O)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1COc2ccccc2C1,CHEMBL3707837,Ki,6.24,CHEMBL3698000,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)C1COc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)N1CCc2ccccc21,CHEMBL3707837,Ki,6.62,CHEMBL3639968,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)N1CCc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccc(F)cc1,CHEMBL3707837,Ki,7.08,CHEMBL3697996,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",105,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1,CHEMBL3707837,Ki,5.82,CHEMBL3697995,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",106,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccc2c(c1)OCCO2,CHEMBL3707837,Ki,5.32,CHEMBL3697999,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",106,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccc2c(c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,CHEMBL3707837,Ki,6.57,CHEMBL3697961,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",106,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1cccnc1,CHEMBL3707837,Ki,7.05,CHEMBL3697998,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",106,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccnc2ccccc12,CHEMBL3707837,Ki,6.29,CHEMBL3697997,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",106,112,O=C(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,CHEMBL671651,Ki,7.42,CHEMBL309623,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,CHEMBL672206,Ki,7.42,CHEMBL309623,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,CHEMBL671651,Ki,8.47,CHEMBL78791,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,CHEMBL672206,Ki,8.47,CHEMBL78791,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3Cl)CC2)CC1)C1CCCCC1,CHEMBL671651,Ki,7.82,CHEMBL310204,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccc3Cl)CC2)CC1)c1cccs1,CHEMBL671651,Ki,9.0,CHEMBL78800,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccc3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3ccccn3)CC2)CC1)c1cccs1,CHEMBL671651,Ki,7.15,CHEMBL78406,1997,CHEMBL1151542,Bioorg Med Chem Lett,Scientific Literature,Ability to displace radioligand [3H]N-0437 from human dopamine D2 receptor transfected chinese hamster ovary cell membranes.,12,113,O=C(NC1CCC(CCN2CCN(c3ccccn3)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C(F)(F)F,CHEMBL3705135,Ki,6.11,CHEMBL3642756,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C(O)C(F)(F)F,CHEMBL3705135,Ki,6.07,CHEMBL3642788,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1(O)CC1,CHEMBL3705135,Ki,6.23,CHEMBL3642735,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1(O)CCC1,CHEMBL3705135,Ki,6.02,CHEMBL3642799,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CC1,CHEMBL3705135,Ki,6.31,CHEMBL3642740,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CC1(F)F,CHEMBL3705135,Ki,6.36,CHEMBL3642751,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCC1,CHEMBL3705135,Ki,6.26,CHEMBL3642729,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCCO1,CHEMBL3705135,Ki,5.98,CHEMBL3642720,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCCO1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCCOC1,CHEMBL3705135,Ki,6.12,CHEMBL3642730,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",94,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCCOC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCOC1,CHEMBL3705135,Ki,6.21,CHEMBL3642719,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCOC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCOCC1,CHEMBL3705135,Ki,6.3,CHEMBL3642710,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-c2ccccc2)cc1,CHEMBL3705135,Ki,5.95,CHEMBL3642810,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-c2cccnc2)cc1,CHEMBL3705135,Ki,6.65,CHEMBL3642796,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-c2cccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-n2cccc2)cc1,CHEMBL3705135,Ki,6.79,CHEMBL3642809,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-n2cccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-n2cccn2)cc1,CHEMBL3705135,Ki,6.32,CHEMBL3642802,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(-n2cccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(C(F)(F)F)cc1,CHEMBL3705135,Ki,6.06,CHEMBL3642724,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(Cl)cc1,CHEMBL3705135,Ki,6.54,CHEMBL3642723,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(Cl)cc1Cl,CHEMBL3705135,Ki,6.29,CHEMBL3642808,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(F)cc1,CHEMBL3705135,Ki,6.47,CHEMBL3642722,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCCCC2)cc1,CHEMBL3705135,Ki,5.27,CHEMBL3642733,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1,CHEMBL3705135,Ki,6.06,CHEMBL3642734,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)nc1,CHEMBL3705135,Ki,6.0,CHEMBL3642795,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCOCC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCS(=O)(=O)CC2)cc1,CHEMBL3705135,Ki,6.93,CHEMBL3642801,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(N2CCS(=O)(=O)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc2c(c1)OCO2,CHEMBL3705135,Ki,5.47,CHEMBL3642797,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc2ncccc2c1,CHEMBL3705135,Ki,6.3,CHEMBL3642804,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc2ncccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,CHEMBL3705135,Ki,6.32,CHEMBL3642721,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccnc2ccccc12,CHEMBL3705135,Ki,6.26,CHEMBL3642739,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1cnc(N2CCOCC2)cn1,CHEMBL3705135,Ki,6.3,CHEMBL3642806,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1cnc(N2CCOCC2)cn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1)C1CC1,CHEMBL3705135,Ki,6.58,CHEMBL3642691,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4occc34)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1)C1CCOCC1,CHEMBL3705135,Ki,6.29,CHEMBL3642689,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4occc34)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4occc34)CC2)CC1)c1ccnc2ccccc12,CHEMBL3705135,Ki,6.34,CHEMBL3642706,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4occc34)CC2)CC1)c1ccnc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nccc4sccc34)CC2)CC1)C1CCOCC1,CHEMBL3705135,Ki,6.0,CHEMBL3642702,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=C(NC1CCC(CCN2CCN(c3nccc4sccc34)CC2)CC1)C1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4cc([N+](=O)[O-])ccc34)CC2)CC1)c1ccco1,CHEMBL3872755,Ki,7.58,CHEMBL3970746,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)C(F)(F)F,CHEMBL3872755,Ki,8.77,CHEMBL3913691,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,c1ccc2c(N3CCN(CCC4CCCCC4)CC3)nsc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)C1CC1,CHEMBL3872755,Ki,9.07,CHEMBL3956720,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)C1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)C1CCCCC1,CHEMBL3872755,Ki,9.03,CHEMBL3929168,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)C1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)N1CCOCC1,CHEMBL3872755,Ki,8.66,CHEMBL3909821,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)N1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cc2ccccc2[nH]1,CHEMBL3872755,Ki,9.37,CHEMBL3905247,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cc2ccccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccc[nH]1,CHEMBL3872755,Ki,9.68,CHEMBL3938210,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccc[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccccc1,CHEMBL3872755,Ki,9.48,CHEMBL3920252,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccnc1,CHEMBL3872755,Ki,9.07,CHEMBL3967779,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,CHEMBL3872755,Ki,8.54,CHEMBL3946995,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,CHEMBL3872774,IC50,7.21,CHEMBL3946995,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Antagonistic activity at D2 receptor (unknown origin) expressed in CHOK1 cells co-expressing G-alpha 15 assessed as inhibition of dopamine-induced calcium flux by fluo-4 dye based FLIPR assay,122,450,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1ccco1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccs1,CHEMBL3872755,Ki,9.72,CHEMBL3976282,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(N[C@H]1CC[C@H](CCN2CCc3ccccc3C2)CC1)Oc1ccccc1,CHEMBL3089794,Ki,6.04,CHEMBL3088214,2013,CHEMBL3085627,J Med Chem,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2L receptor expressed in CHO cell membranes after 3 hrs by liquid scintillation counting analysis,95,115,O=C(NC1CCC(CCN2CCc3ccccc3C2)CC1)Oc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1)Nc1ccccn1,CHEMBL2032826,Ki,7.85,CHEMBL2029920,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1)Nc1ccccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1)Nc1cccnc1,CHEMBL2032826,Ki,8.09,CHEMBL2029921,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1)Nc1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccc(Cl)cc1)N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707825,Ki,5.57,CHEMBL3664889,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,111,O=C(Nc1ccccc1)NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccc(Cl)cc1)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,6.8,CHEMBL3698024,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",106,112,O=C(Nc1ccccc1)NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccc2[nH]cc(C3CCN(CCCCCCCN4CCC(c5c[nH]c6ccc(NC(=O)c7ccc(F)cc7)cc56)CC4)CC3)c2c1)c1ccc(F)cc1,CHEMBL965249,IC50,6.16,CHEMBL503468,2008,CHEMBL1150432,J Med Chem,Scientific Literature,Binding affinity to human dopamine D2 receptor,62,954,O=C(Nc1ccc2[nH]cc(C3CCN(CCCCCCCN4CCC(c5c[nH]c6ccc(NC(=O)c7ccccc7)cc56)CC4)CC3)c2c1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1)Nc1ccccn1,CHEMBL2032826,Ki,6.44,CHEMBL2029928,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1)Nc1ccccn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1cccc(Cn2ncc(N3CCNCC3)c(Cl)c2=O)c1)c1ccc(-c2ccccc2)cc1,CHEMBL991395,Ki,5.28,CHEMBL458001,2009,CHEMBL1143385,J Med Chem,Scientific Literature,Displacement of [125I]iodosulpiride from dopamine D2 receptor expressed in CHO cells,66,831,O=C(Nc1cccc(Cn2ncc(N3CCNCC3)cc2=O)c1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1cccc(SC(F)(F)F)c1)N1CCC(N2CCC(n3c(=O)[nH]c4c(F)cccc43)CC2)CC1,CHEMBL939457,IC50,5.96,CHEMBL487788,2008,CHEMBL1152245,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor,62,870,O=C(Nc1ccccc1)N1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1cccc(SC(F)(F)F)c1)N1CCC(N2CCC(n3c(=O)[nH]c4ccc(F)cc43)CC2)CC1,CHEMBL939457,IC50,5.72,CHEMBL487985,2008,CHEMBL1152245,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor,62,870,O=C(Nc1ccccc1)N1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccccc1)NC1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,7.07,CHEMBL91621,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,20,496,O=C(Nc1ccccc1)NC1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccccc1)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,9.2,CHEMBL3918755,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(Nc1ccccc1)NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccccc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,CHEMBL2032826,Ki,6.32,CHEMBL2029919,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Nc1ccccc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccccc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,CHEMBL2032826,Ki,5.49,CHEMBL2029927,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Nc1ccccc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccccn1)NC1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,6.72,CHEMBL91272,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,20,496,O=C(Nc1ccccn1)NC1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1cccnc1)N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,9.29,CHEMBL3896937,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(Nc1cccnc1)NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1cccnc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,CHEMBL2032826,Ki,7.53,CHEMBL2029929,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Nc1cccnc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccncc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,CHEMBL2032826,Ki,8.44,CHEMBL2029922,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Nc1ccncc1)Nc1ccc(CCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1ccncc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,CHEMBL2032826,Ki,7.31,CHEMBL2029930,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,85,943,O=C(Nc1ccncc1)Nc1cccc(CCN2CCN(c3ccccc3)CC2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(Nc1nccc2ccccc12)NC1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,6.82,CHEMBL328667,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,20,496,O=C(Nc1nccc2ccccc12)NC1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(O)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3,CHEMBL672490,Ki,7.24,CHEMBL106283,1992,CHEMBL1125523,J Med Chem,Scientific Literature,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",0,286,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccc4[nH]ccc4c3O1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(O)c1ccc(CSc2nc3ccccc3n2Cc2ccc(Cl)cc2)cc1,CHEMBL671383,Ki,5.46,CHEMBL109179,2004,CHEMBL1146646,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human recombinant dopamine receptor D2 was determined using radioligand competition binding assay,38,133,c1ccc(CSc2nc3ccccc3n2Cc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(OCC1CCN(Cc2ccccc2)CC1)c1ccc(Cl)cc1,CHEMBL672215,Ki,5.7,CHEMBL299479,1996,CHEMBL1129308,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 (long) using [125I]iodosulpiride as radioligand,9,685,O=C(OCC1CCN(Cc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1)c1ccc(OCCCN2CCCCC2)cc1,CHEMBL1030600,Ki,7.33,CHEMBL455288,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,66,518,O=C(OCCN1CCN(CCCN2c3ccccc3Sc3ccccc32)CC1)c1ccc(OCCCN2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(OCCc1ccc(F)cc1)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL671072,IC50,5.58,CHEMBL325516,2001,CHEMBL1134625,J Med Chem,Scientific Literature,Inhibition of human dopamine receptor D2,26,486,O=C(OCCc1ccccc1)N1CCN(CCCC(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(OCc1ccccc1)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3,CHEMBL672490,Ki,8.24,CHEMBL318166,1992,CHEMBL1125523,J Med Chem,Scientific Literature,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",0,286,O=C(OCc1ccccc1)c1cc2c3c(ccc2[nH]1)OCC(CN1CCC2(CC1)C(=O)NCN2c1ccccc1)O3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccc(F)cc2)CC1,CHEMBL4406527,IC50,5.01,CHEMBL4456795,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,144,455,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccc3[nH]ccc3c2)CC1,CHEMBL4406527,IC50,6.36,CHEMBL4550539,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,144,455,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccc3[nH]ccc3c2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccccc2)CC1,CHEMBL4406527,IC50,6.27,CHEMBL4574338,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,144,455,O=C(c1cc2ccccc2[nH]1)N1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1cc2ccccc2s1)N1CCN(CCOc2cccnc2)CC1,CHEMBL4406527,IC50,5.68,CHEMBL4470996,2020,CHEMBL4402608,J Med Chem,Scientific Literature,Antagonist activity at human D2R expressed in CHOK1 cells assessed as inhibition of dopamine-induced beta-arrestin recruitment measured after 120 mins by beta-galactosidase based PathHunter assay,145,455,O=C(c1cc2ccccc2s1)N1CCN(CCOc2cccnc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccc(Cl)c(Cl)c1)N1CCC(F)(CNCCOc2cccc3c2OCCO3)CC1,CHEMBL4670399,Ki,6.04,CHEMBL4756322,2020,CHEMBL4665789,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2 receptor stably expressed in CHO-K1 cell membranes measured after 60 mins by Microbeta2 scintillation counting method,145,235,O=C(c1ccccc1)N1CCC(CNCCOc2cccc3c2OCCO3)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccc(Cl)c(Cl)c1)N1CCC(F)(CNCCOc2cccc3cccnc23)CC1,CHEMBL4670399,Ki,6.36,CHEMBL4743868,2020,CHEMBL4665789,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2 receptor stably expressed in CHO-K1 cell membranes measured after 60 mins by Microbeta2 scintillation counting method,145,235,O=C(c1ccccc1)N1CCC(CNCCOc2cccc3cccnc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccc(F)cc1)C1CCN(CCC2CCc3occc3C2=O)CC1,CHEMBL1027240,Ki,6.14,CHEMBL159929,2008,CHEMBL1140101,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,62,482,O=C(c1ccccc1)C1CCN(CCC2CCc3occc3C2=O)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,CHEMBL672310,Ki,6.62,CHEMBL51,2000,CHEMBL1133417,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for Dopamine receptor D2 by displacement of [3H]-spiperone,24,280,O=C(c1ccccc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1,CHEMBL961033,Ki,7.21,CHEMBL62919,2009,CHEMBL1153452,Bioorg Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor by competitive binding experiment,66,746,O=C(c1ccccc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccc(F)cc1)C1CCN([C@H]2CCN(Cc3ccc(F)cc3)C[C@@H]2O)CC1,CHEMBL1827958,Ki,5.87,CHEMBL1822386,2011,CHEMBL1821670,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,79,697,O=C(c1ccccc1)C1CCN(C2CCN(Cc3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccc(F)cc1)N1CCC(NCCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4711026,Ki,5.05,CHEMBL4741279,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,145,140,O=C(c1ccccc1)N1CCC(NCCSC(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccc(F)cc1)N1CCC(NCC[S+]([O-])C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4711026,Ki,3.806875401645539,CHEMBL4777080,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,145,140,O=C(c1ccccc1)N1CCC(NCC[SH+]C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccc(F)cc1F)N1CCC(NCCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4711026,Ki,5.13,CHEMBL4791063,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,145,140,O=C(c1ccccc1)N1CCC(NCCSC(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1cccc(CN2CCc3c([nH]c4ccccc34)C2)c1)N1CCCCC1,CHEMBL670744,Ki,6.43,CHEMBL423632,1997,CHEMBL1129884,Bioorg Med Chem Lett,Scientific Literature,Compound was measured in vivo for its binding affinity at Dopamine receptor D2 using [3H]spiperone as radioligand.,12,208,O=C(c1cccc(CN2CCc3c([nH]c4ccccc34)C2)c1)N1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccccc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C1COC1,CHEMBL4686220,IC50,6.81,CHEMBL4749144,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,145,193,O=C(c1ccccc1)N(CCCN1CCC(c2noc3ccccc23)CC1)C1COC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccccc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)CC1CC1,CHEMBL4686220,IC50,7.97,CHEMBL4751911,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,145,193,O=C(c1ccccc1)N(CCCN1CCC(c2noc3ccccc23)CC1)CC1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccccc1)N(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)C1COC1,CHEMBL4686220,IC50,5.73,CHEMBL4800286,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,145,193,O=C(c1ccccc1)N(CCCN1CCN(c2ccccc2)CC1)C1COC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccccc1)N(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)CC1CC1,CHEMBL4686220,IC50,6.34,CHEMBL4777207,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,145,193,O=C(c1ccccc1)N(CCCN1CCN(c2ccccc2)CC1)CC1CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccccc1)N1CCC(NCCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4711026,Ki,5.54,CHEMBL4744824,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,145,140,O=C(c1ccccc1)N1CCC(NCCSC(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccccc1)N1CCN(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5145822,Ki,6.92,CHEMBL5195091,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C(c1ccccc1)N1CCN(CCCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccccc1)N1CCN(CCCN2CCN(c3ccccc3)CC2)CC1,CHEMBL5145822,Ki,5.68,CHEMBL5173564,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C(c1ccccc1)N1CCN(CCCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccccc1)N1CCN(CCN2CCc3ncsc3CC2)CC1,CHEMBL4334858,Ki,4.38,CHEMBL4437202,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,139,774,O=C(c1ccccc1)N1CCN(CCN2CCc3ncsc3CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccccc1)c1ccccc1OCCN1CCCC1,CHEMBL838569,Ki,5.27,CHEMBL364586,2004,CHEMBL1138672,J Med Chem,Scientific Literature,Binding affinity for human recombinant dopamine receptor D2L,38,440,O=C(c1ccccc1)c1ccccc1OCCN1CCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccccn1)N1CCN(CCCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL5145822,Ki,7.09,CHEMBL5188923,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C(c1ccccn1)N1CCN(CCCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C(c1ccco1)N1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1,CHEMBL3872755,Ki,7.82,CHEMBL3942236,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=C(c1ccco1)N1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(=O)N(CCN2CCN(Cc3ccc(Cl)cc3)CC2)c2ccccc21,CHEMBL872891,Ki,5.91,CHEMBL322567,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",32,214,O=C1C(=O)N(CCN2CCN(Cc3ccccc3)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(N2CCN(Cc3ccc(Cl)cc3)CC2)CCc2cccc3c2N1CC3,CHEMBL672162,Ki,6.94,CHEMBL352207,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-YM 09151 from D2 receptor,36,236,O=C1C(N2CCN(Cc3ccccc3)CC2)CCc2cccc3c2N1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(N2CCN(Cc3ccc(Cl)cc3)CC2)CCc2cccc3c2N1CC3,CHEMBL673092,Ki,7.21,CHEMBL352207,2003,CHEMBL1136593,Bioorg Med Chem Lett,Scientific Literature,"D2 receptor functional activity was measured through reversal of quinpirole inhibited, forskolin stimulated cAMP production from whole cells",36,955,O=C1C(N2CCN(Cc3ccccc3)CC2)CCc2cccc3c2N1CC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccc(F)cc2)=COC12CCN(CC1CCCCC1)CC2,CHEMBL671745,Ki,6.02,CHEMBL542398,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(CC1CCCCC1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccc(F)cc2)=COC12CCN(CCc1ccccc1)CC2,CHEMBL671745,Ki,6.66,CHEMBL545693,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(CCc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccc(F)cc2)=COC12CCN(Cc1ccc(F)cc1)CC2,CHEMBL671745,Ki,5.78,CHEMBL545695,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccc(F)cc2)=COC12CCN(Cc1ccccc1)CC2,CHEMBL671745,Ki,5.85,CHEMBL554415,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccc(F)cc2)COC12CCN(Cc1ccccc1)CC2,CHEMBL671745,Ki,7.33,CHEMBL543344,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)COC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccc(F)cc2)COC12CCN(Cc1ccccc1)CC2,CHEMBL672710,Ki,7.33,CHEMBL543344,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,956,O=C1C(c2ccccc2)COC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccc3ccccc3c2)=COC12CCN(CCc1ccccc1)CC2,CHEMBL671745,Ki,5.5,CHEMBL543343,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccc3ccccc3c2)=COC12CCN(CCc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccccc2)=COC12CCN(CC1CCCCC1)CC2,CHEMBL671745,Ki,6.19,CHEMBL544996,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(CC1CCCCC1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccccc2)=COC12CCN(CCc1ccccc1)CC2,CHEMBL671745,Ki,6.26,CHEMBL553372,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(CCc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccccc2)=COC12CCN(CCc1ccsc1)CC2,CHEMBL671745,Ki,6.82,CHEMBL556831,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(CCc1ccsc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccccc2)=COC12CCN(Cc1ccc(F)cc1)CC2,CHEMBL671745,Ki,5.62,CHEMBL542395,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccccc2)=COC12CCN(Cc1cccc(Cl)c1)CC2,CHEMBL671745,Ki,5.68,CHEMBL538248,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccccc2)=COC12CCN(Cc1ccccc1)C2,CHEMBL671745,Ki,4.7,CHEMBL542877,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(Cc1ccccc1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccccc2)=COC12CCN(Cc1ccccc1)CC2,CHEMBL671745,Ki,5.62,CHEMBL552687,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccccc2)=COC12CCN(Cc1ccco1)CC2,CHEMBL671745,Ki,5.12,CHEMBL559021,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCN(Cc1ccco1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C(c2ccccc2)=COC12CCNCC2,CHEMBL671745,Ki,5.0,CHEMBL541817,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C(c2ccccc2)=COC12CCNCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(c2nsc3ccccc23)CC1,CHEMBL5215982,Ki,8.77,CHEMBL5219924,2021,CHEMBL5214911,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2R (unknown origin) assessed as inhibition constant,152,456,O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C2CC(O)C(O)CC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,8.03,CHEMBL4280084,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,131,130,O=C1C2CCCCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C2CC=CCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,8.07,CHEMBL4287980,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,131,130,O=C1C2CC=CCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C2CCCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,7.89,CHEMBL4291387,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,131,130,O=C1C2CCCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C2CCCCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,8.37,CHEMBL4283546,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,131,130,O=C1C2CCCCC2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C=C(c2ccc(F)cc2)OC12CCN(CCc1ccccc1)CC2,CHEMBL671745,Ki,5.27,CHEMBL553784,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C=C(c2ccccc2)OC12CCN(CCc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C=C(c2ccccc2)OC12CCN(CCc1ccccc1)CC2,CHEMBL671745,Ki,5.14,CHEMBL545222,1993,CHEMBL1127181,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 in guinea pig striatal membrane using radiolabeled ligand [3H]spiperone,2,29,O=C1C=C(c2ccccc2)OC12CCN(CCc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C=C(c2ccccc2)OC2(CCN(CCc3ccccc3)CC2)C1,CHEMBL672709,Ki,5.38,CHEMBL539526,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,519,O=C1C=C(c2ccccc2)OC2(CCN(CCc3ccccc3)CC2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C=C(c2ccco2)OC2(CCN(CCc3ccccc3)CC2)C1,CHEMBL672709,Ki,5.12,CHEMBL542647,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,519,O=C1C=C(c2ccco2)OC2(CCN(CCc3ccccc3)CC2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CC=C(c3c[nH]c4cc(F)ccc34)CC2)Cc2nc(N3CCCC3)sc21,CHEMBL3222870,Ki,7.26,CHEMBL3220220,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=C1CC(CN2CC=C(c3c[nH]c4ccccc34)CC2)Cc2nc(N3CCCC3)sc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2[nH]ncc21,CHEMBL3222870,Ki,6.4,CHEMBL397543,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=C1CC(CN2CCC(C(=O)c3ccccc3)CC2)Cc2[nH]ncc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2ccccc21,CHEMBL670681,Ki,6.65,CHEMBL308480,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,38,584,O=C1CC(CN2CCC(C(=O)c3ccccc3)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2ncncc21,CHEMBL1059279,Ki,6.2,CHEMBL575760,2009,CHEMBL1154195,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,66,568,O=C1CC(CN2CCC(C(=O)c3ccccc3)CC2)Cc2ncncc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(C(=O)c3ccc(F)cc3)CC2)Cc2occc21,CHEMBL1027240,Ki,6.82,CHEMBL143022,2008,CHEMBL1140101,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,62,482,O=C1CC(CN2CCC(C(=O)c3ccccc3)CC2)Cc2occc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(c3c[nH]c4cc(F)ccc34)CC2)Cc2nc(N3CCCC3)sc21,CHEMBL3222870,Ki,6.8,CHEMBL3220219,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=C1CC(CN2CCC(c3c[nH]c4ccccc34)CC2)Cc2nc(N3CCCC3)sc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2[nH]ncc21,CHEMBL3222870,Ki,6.95,CHEMBL246484,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2[nH]ncc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2cc(-c3ccccc3)ccc21,CHEMBL3106891,Ki,7.76,CHEMBL3104517,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,106,134,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2cc(-c3ccccc3)ccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2ccccc21,CHEMBL670681,Ki,7.19,CHEMBL155486,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,38,584,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2nc(-c3ccccc3)ncc21,CHEMBL1059279,Ki,7.47,CHEMBL575788,2009,CHEMBL1154195,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,66,568,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2nc(-c3ccccc3)ncc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2nc(N3CCCC3)sc21,CHEMBL3222870,Ki,6.7,CHEMBL3220218,2011,CHEMBL3217716,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human cloned D2 receptor by in vitro binding assay,79,571,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2nc(N3CCCC3)sc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2ncncc21,CHEMBL1059279,Ki,6.8,CHEMBL572708,2009,CHEMBL1154195,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,66,568,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2ncncc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2oc(-c3ccccc3)cc21,CHEMBL1027240,Ki,7.92,CHEMBL516809,2008,CHEMBL1140101,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,62,482,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2oc(-c3ccccc3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2occc21,CHEMBL1027240,Ki,7.79,CHEMBL143027,2008,CHEMBL1140101,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,62,482,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2occc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(CN2CCN(c3ccccn3)CC2)Cc2ccccc21,CHEMBL670681,Ki,6.4,CHEMBL155124,2004,CHEMBL1149215,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2,38,584,O=C1CC(CN2CCN(c3ccccn3)CC2)Cc2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(c2c[nH]c3ccc(F)cc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccc(F)cc23)CC1,CHEMBL4314365,Ki,7.72,CHEMBL4515160,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,139,512,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(c2c[nH]c3ccc(F)cc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1,CHEMBL4314365,Ki,6.72,CHEMBL4571862,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,139,512,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccc(F)cc23)CC1,CHEMBL2379237,Ki,7.85,CHEMBL2377590,2013,CHEMBL2375249,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr,95,728,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccc(F)cc23)CC1,CHEMBL4314365,Ki,7.85,CHEMBL2377590,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,139,512,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCCCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCN1CCC(c2c[nH]c3ccc(F)cc23)CC1,CHEMBL2379237,Ki,7.1,CHEMBL2377445,2013,CHEMBL2375249,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr,95,728,O=C1CC(c2c[nH]c3ccccc23)C(=O)N1CCN1CCC(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC(c2ccccc2)c2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c2N1,CHEMBL872392,Ki,7.82,CHEMBL438980,2005,CHEMBL1140391,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2 expressed in CHO cells,43,103,O=C1CC(c2ccccc2)c2cccc(CCN3CCN(c4nsc5ccccc45)CC3)c2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,7.61,CHEMBL4294617,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,131,130,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,CHEMBL4037101,Ki,6.32,CHEMBL49,2018,CHEMBL4033775,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2 receptor expressed in HEK cells,131,231,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,CHEMBL4308339,Ki,6.32,CHEMBL49,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human D2 receptor expressed in HEK-GIRK-M4 cell membrane by radioligand binding assay,139,957,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,CHEMBL663159,Ki,7.05,CHEMBL49,1993,CHEMBL1126894,J Med Chem,Scientific Literature,Binding affinity for DA2 receptor,2,958,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,CHEMBL670667,Ki,7.89,CHEMBL49,1993,CHEMBL1126741,J Med Chem,Scientific Literature,Displacement of [3H]U-86170 from human D2-dopamine receptor expressed in CHO K1 cells,2,306,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,CHEMBL670781,Ki,6.0,CHEMBL49,1997,CHEMBL1129976,J Med Chem,Scientific Literature,Binding affinity against Dopamine receptor D2,12,316,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,CHEMBL870200,Ki,7.89,CHEMBL49,2006,CHEMBL1147799,J Med Chem,Scientific Literature,Binding affinity to D2 receptor by radioligand binding assay,49,232,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2C1,CHEMBL670073,IC50,7.17,CHEMBL11425,1996,CHEMBL1129704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 by displacement of [3H]-Raclopride.,9,329,O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCCCN[C@@H]1CCc2c(F)cccc2C1,CHEMBL672183,Ki,7.43,CHEMBL139089,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Displacement of [3H]quinpirole from Dopamine receptor D2,9,197,O=C1CC2(CCCC2)CC(=O)N1CCCCNC1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCCCN[C@@H]1CCc2c(F)cccc2C1,CHEMBL672794,Ki,7.17,CHEMBL139089,1996,CHEMBL1129381,J Med Chem,Scientific Literature,Inhibition of [3H]raclopride binding to Dopamine receptor D2,9,353,O=C1CC2(CCCC2)CC(=O)N1CCCCNC1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)c(F)cc2F)CC1,CHEMBL826339,Ki,6.16,CHEMBL193620,2005,CHEMBL1143615,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2,43,804,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2cc(F)ccc2F)CC1,CHEMBL826339,Ki,6.92,CHEMBL556313,2005,CHEMBL1143615,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2,43,804,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)c(F)c2)CC1,CHEMBL826339,Ki,5.66,CHEMBL192099,2005,CHEMBL1143615,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2,43,804,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccc(F)cc2)CC1,CHEMBL826339,Ki,5.66,CHEMBL57546,2005,CHEMBL1143615,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2,43,804,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2F)CC1,CHEMBL826339,Ki,6.85,CHEMBL299691,2005,CHEMBL1143615,J Med Chem,Scientific Literature,Binding affinity for human Dopamine receptor D2,43,804,O=C1CC2(CCCC2)CC(=O)N1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,7.96,CHEMBL4295055,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,131,130,O=C1CC2(CCCCC2)CC(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCCN(Cc3ccccc3)C2)OC=C1c1ccc(F)cc1,CHEMBL672710,Ki,5.06,CHEMBL553864,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,956,O=C1CC2(CCCN(Cc3ccccc3)C2)OC=C1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1ccc(F)cc1,CHEMBL672710,Ki,5.54,CHEMBL543822,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,956,O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1ccccc1,CHEMBL672710,Ki,5.69,CHEMBL538755,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,956,O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1ccccc1F,CHEMBL672710,Ki,5.63,CHEMBL542400,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,956,O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1cccs1,CHEMBL672709,Ki,5.97,CHEMBL543823,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,519,O=C1CC2(CCN(CCc3ccccc3)CC2)OC=C1c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCN(CCc3ccccc3)CC2)OCC1c1ccc(F)cc1,CHEMBL672710,Ki,5.82,CHEMBL539007,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,956,O=C1CC2(CCN(CCc3ccccc3)CC2)OCC1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CC2(CCN(Cc3ccccc3)CC2)OC=C1c1ccccc1,CHEMBL672709,Ki,5.84,CHEMBL544533,1993,CHEMBL1127001,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine D2 receptor using radiolabeled ligand [3H]spiperone,2,519,O=C1CC2(CCN(Cc3ccccc3)CC2)OC=C1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2c(F)cccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,CHEMBL2060138,Ki,7.22,CHEMBL2059317,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1CCc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,CHEMBL872394,Ki,7.94,CHEMBL383396,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,43,238,O=C1CCc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2cc(CCCCN3CCN(c4ccccn4)CC3)ccc2N1,CHEMBL4815619,Ki,6.29,CHEMBL4857597,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,152,118,O=C1CCc2cc(CCCCN3CCN(c4ccccn4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2cc(F)ccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,CHEMBL2060138,Ki,8.19,CHEMBL2059318,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1CCc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2cc(OCCCCCCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,CHEMBL4629186,Ki,7.41,CHEMBL4644906,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=C1CCc2cc(OCCCCCCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2cc(OCCCN3CCCN(c4ccccn4)CC3)ccc2N1,CHEMBL4815619,Ki,5.55,CHEMBL4859722,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,152,118,O=C1CCc2cc(OCCCN3CCCN(c4ccccn4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc2N1,CHEMBL4815619,Ki,5.57,CHEMBL4865591,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,152,118,O=C1CCc2cc(OCCCN3CCN(c4ccccn4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(CC3C4CCC3CN(C[C@@H]3COc5c(ccc6c5CC(=O)N6)O3)C4)cc2N1,CHEMBL1110025,Ki,8.2,CHEMBL1087817,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,74,815,O=C1CCc2ccc(CC3C4CCC3CN(CC3COc5c(ccc6c5CC(=O)N6)O3)C4)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(CC3CC4CCC(C3)N4C[C@@H]3COc4c(ccc5c4CC(=O)N5)O3)cc2N1,CHEMBL1110025,Ki,7.8,CHEMBL1088000,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,74,815,O=C1CCc2ccc(CC3CC4CCC(C3)N4CC3COc4c(ccc5c4CC(=O)N5)O3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(CC3CCN(C[C@@H]4COc5c(ccc6c5CC(=O)N6)O4)CC3)cc2N1,CHEMBL1110025,Ki,8.1,CHEMBL1087455,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,74,815,O=C1CCc2ccc(CC3CCN(CC4COc5c(ccc6c5CC(=O)N6)O4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(CCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2N1,CHEMBL1776016,Ki,8.59,CHEMBL1774062,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(CCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(CO[C@@H]3C[C@H]3CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL2169117,Ki,6.63,CHEMBL2165130,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(COC3CC3CN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(F)cc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,CHEMBL2060138,Ki,7.05,CHEMBL2059319,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1CCc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OC/C=C/CN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3887359,Ki,7.82,CHEMBL3896746,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(OCC=CCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OC3CCN(C[C@@H]4COc5c(ccc6c5CC(=O)N6)O4)CC3)cc2N1,CHEMBL1110025,Ki,8.6,CHEMBL1087744,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,74,815,O=C1CCc2ccc(OC3CCN(CC4COc5c(ccc6c5CC(=O)N6)O4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCC#CCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL2169117,Ki,6.0,CHEMBL2165129,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCC#CCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCC#CCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3887359,Ki,6.0,CHEMBL2165129,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(OCC#CCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCC3CCC(CN4CCN(c5cccc(Cl)c5Cl)CC4)CC3)cc2N1,CHEMBL3887359,Ki,6.84,CHEMBL3903542,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(OCC3CCC(CN4CCN(c5ccccc5)CC4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CC=C(c4cn(Cc5ccccc5)c5ccccc45)CC3)cc2N1,CHEMBL3413541,Ki,7.14,CHEMBL3409232,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCN3CC=C(c4cn(Cc5ccccc5)c5ccccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CC=C(c4cn(S(=O)(=O)c5ccccc5)c5ccccc45)CC3)cc2N1,CHEMBL3413541,Ki,7.4,CHEMBL3409233,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCN3CC=C(c4cn(S(=O)(=O)c5ccccc5)c5ccccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCC(O)(c4ccc(Cl)cc4)CC3)cc2N1,CHEMBL1815674,Ki,5.58,CHEMBL1813586,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,80,640,O=C1CCc2ccc(OCCCCN3CCC(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL2169117,Ki,7.96,CHEMBL2165125,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCCCCN3CCC(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCC(c4cn(Cc5ccccc5)c5ccccc45)CC3)cc2N1,CHEMBL3413541,Ki,8.32,CHEMBL3409234,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCN3CCC(c4cn(Cc5ccccc5)c5ccccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCC(c4cn(S(=O)(=O)c5ccccc5)c5ccccc45)CC3)cc2N1,CHEMBL3413541,Ki,7.85,CHEMBL3407518,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCN3CCC(c4cn(S(=O)(=O)c5ccccc5)c5ccccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCC(n4c(=O)[nH]c5cc(Cl)ccc54)CC3)cc2N1,CHEMBL1815674,Ki,6.51,CHEMBL1813588,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,80,640,O=C1CCc2ccc(OCCCCN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2N1,CHEMBL1815674,Ki,6.84,CHEMBL1813587,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,80,640,O=C1CCc2ccc(OCCCCN3CCC(n4c(=O)[nH]c5ccccc54)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1,CHEMBL4015806,Ki,8.8,CHEMBL4102628,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,127,297,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc5[nH]c(=O)ccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1,CHEMBL4015807,Ki,9.09,CHEMBL4102628,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,127,298,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc5[nH]c(=O)ccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1,CHEMBL4015806,Ki,8.8,CHEMBL4064742,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,127,297,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc5c4OCC(=O)N5)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1,CHEMBL4015807,Ki,8.8,CHEMBL4064742,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,127,298,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc5c4OCC(=O)N5)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5oc(=O)ccc45)CC3)cc2N1,CHEMBL4015806,Ki,7.0,CHEMBL4084690,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,127,297,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc5oc(=O)ccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5oc(=O)ccc45)CC3)cc2N1,CHEMBL4015807,Ki,7.43,CHEMBL4084690,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,127,298,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc5oc(=O)ccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL2169117,Ki,8.44,CHEMBL2165126,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3887359,Ki,8.370000000000001,CHEMBL2165126,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4015806,Ki,9.28,CHEMBL2165126,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,127,297,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4015807,Ki,9.7,CHEMBL2165126,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,127,298,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)nc2N1,CHEMBL2169117,Ki,8.92,CHEMBL2165119,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)nc2N1,CHEMBL3887359,Ki,8.754999999999999,CHEMBL2165119,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(C(=O)c4ccccn4)CC3)cc2N1,CHEMBL5145822,Ki,8.05,CHEMBL5172819,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C1CCc2ccc(OCCCCN3CCN(C(=O)c4ccccn4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4c(F)ccc5ccccc45)CC3)nc2N1,CHEMBL1776016,Ki,8.8,CHEMBL1774081,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cc(F)cc5ccccc45)CC3)nc2N1,CHEMBL1776016,Ki,8.96,CHEMBL1774082,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccc(F)c5ccccc45)CC3)nc2N1,CHEMBL1776016,Ki,8.7,CHEMBL1774083,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1,CHEMBL4015806,Ki,9.05,CHEMBL4083239,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,127,297,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5[nH]c(=O)ccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1,CHEMBL4015807,Ki,9.0,CHEMBL4083239,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,127,298,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5[nH]c(=O)ccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1,CHEMBL4015806,Ki,9.06,CHEMBL4072780,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,127,297,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCC(=O)N5)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1,CHEMBL4015807,Ki,9.17,CHEMBL4072780,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,127,298,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCC(=O)N5)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc2N1,CHEMBL4015806,Ki,8.54,CHEMBL4091933,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,127,297,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc2N1,CHEMBL4015807,Ki,8.66,CHEMBL4091933,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,127,298,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5ncccc45)CC3)cc2N1,CHEMBL4015806,Ki,8.47,CHEMBL4064186,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,127,297,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ncccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5ncccc45)CC3)cc2N1,CHEMBL4015807,Ki,8.82,CHEMBL4064186,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,127,298,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ncccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5oc(=O)ccc45)CC3)cc2N1,CHEMBL4015806,Ki,8.32,CHEMBL4099666,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,127,297,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5oc(=O)ccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5oc(=O)ccc45)CC3)cc2N1,CHEMBL4015807,Ki,8.7,CHEMBL4099666,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,127,298,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5oc(=O)ccc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(C(F)(F)F)c4Cl)CC3)nc2N1,CHEMBL1776016,Ki,9.0,CHEMBL1774074,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4C(F)(F)F)CC3)nc2N1,CHEMBL1776016,Ki,8.52,CHEMBL1774075,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL1066831,Ki,8.59,CHEMBL1112,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,74,380,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL1066832,Ki,8.55,CHEMBL1112,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,74,381,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL1260558,Ki,8.4,CHEMBL1112,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,74,832,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL1776016,Ki,8.74,CHEMBL1112,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL1815674,Ki,8.51,CHEMBL1112,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,80,640,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL2169117,Ki,8.41,CHEMBL1112,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL2321509,Ki,9.1,CHEMBL1112,2013,CHEMBL2311489,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,95,959,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL2328744,IC50,8.12,CHEMBL1112,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,95,466,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL2328745,Ki,9.7,CHEMBL1112,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,95,467,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3293231,IC50,7.955,CHEMBL1112,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,106,509,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3295080,Ki,9.27,CHEMBL1112,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,106,391,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3295081,Ki,9.35,CHEMBL1112,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,106,392,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3381713,Ki,9.1,CHEMBL1112,2014,CHEMBL3351528,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),106,574,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3591366,Ki,9.46,CHEMBL1112,2015,CHEMBL3588810,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cells,113,726,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3614290,Ki,9.32,CHEMBL1112,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,113,431,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3707630,Ki,8.8,CHEMBL1112,2013,CHEMBL3638417,,BindingDB Patent Bioactivity Data,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",95,575,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3806800,IC50,7.76,CHEMBL1112,2016,CHEMBL3804825,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Ultra Lance cAMP assay,122,124,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3821452,Ki,8.48,CHEMBL1112,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,122,698,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3887359,Ki,8.1,CHEMBL1112,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4010153,Ki,9.35,CHEMBL1112,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,127,360,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4010156,Ki,9.28,CHEMBL1112,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,127,361,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4011211,Ki,9.32,CHEMBL1112,2017,CHEMBL4007493,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes after 90 mins by micro beta scintillation counting analysis,127,342,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4015806,Ki,9.28,CHEMBL1112,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,127,297,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4015807,Ki,9.42,CHEMBL1112,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,127,298,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4046973,Ki,9.28,CHEMBL1112,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,127,385,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4046974,Ki,9.42,CHEMBL1112,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,127,386,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4187998,IC50,7.5,CHEMBL1112,2018,CHEMBL4184238,Bioorg Med Chem Lett,Scientific Literature,Antagonistic activity at human dopamine D2 receptor measured after 60 mins by Lance Ultra cAMP assay,131,471,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4229838,Ki,9.1,CHEMBL1112,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,131,578,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4308344,Ki,8.48,CHEMBL1112,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]methylspiperone from human D2 receptor by radio ligand binding assay,139,960,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4314365,Ki,9.47,CHEMBL1112,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,139,512,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4688549,Ki,8.48,CHEMBL1112,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,152,847,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4815619,Ki,8.48,CHEMBL1112,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,152,118,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4821052,Ki,8.01,CHEMBL1112,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),152,248,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4828545,Ki,9.16,CHEMBL1112,2021,CHEMBL4825766,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by MicroBeta scintillation counting method,152,373,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL4842092,Ki,8.67,CHEMBL1112,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,152,362,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL5121188,Ki,8.48,CHEMBL1112,2022,CHEMBL5120748,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2 receptor incubated for 1 hr by liquid scintillation counting method,154,961,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL5145822,Ki,8.35,CHEMBL1112,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells measured after 1 hr by Microbeta plate reader method,154,581,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL5145883,Ki,9.52,CHEMBL1112,2022,CHEMBL5143593,Eur J Med Chem,Scientific Literature,Modulation of human D2L receptor,154,513,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL5236912,Ki,9.47,CHEMBL1112,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor assessed as inhibition constant,152,251,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL5236927,IC50,7.42,CHEMBL1112,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,152,142,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL5236933,IC50,9.0,CHEMBL1112,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as beta-arrestin recruitment preincubated for 10 mins with coelenterazine followed by compound addition and measured after 10 mins by BRET assay,152,962,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL5385535,Ki,5.66,CHEMBL1112,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,159,201,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL895618,Ki,8.3,CHEMBL1112,2007,CHEMBL1148822,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,57,452,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL913685,Ki,8.74,CHEMBL1112,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,57,44,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2N1,CHEMBL1776016,Ki,9.0,CHEMBL1774063,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2N1,CHEMBL2169117,Ki,8.47,CHEMBL1774063,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4F)CC3)nc2N1,CHEMBL1776016,Ki,9.0,CHEMBL1774073,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(F)c4Cl)CC3)nc2N1,CHEMBL1776016,Ki,8.6,CHEMBL1774068,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5[nH]c(=O)oc45)CC3)cc2N1,CHEMBL1110025,Ki,8.08,CHEMBL1087454,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,74,815,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5[nH]c(=O)oc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c(F)cccc45)CC3)nc2N1,CHEMBL1776016,Ki,8.22,CHEMBL1774084,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4CCC5)CC3)nc2N1,CHEMBL1776016,Ki,9.0,CHEMBL1774076,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4CCC5)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4CCCC5)CC3)nc2N1,CHEMBL1776016,Ki,8.85,CHEMBL1774077,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4CCCC5)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4CCCO5)CC3)nc2N1,CHEMBL1776016,Ki,9.0,CHEMBL1774078,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4CCCO5)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCC(=O)N5)CC3)cc2N1,CHEMBL3887359,Ki,9.33,CHEMBL3983588,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCC(=O)N5)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCC5)CC3)nc2N1,CHEMBL1776016,Ki,9.15,CHEMBL1774079,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCC5)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2N1,CHEMBL3887359,Ki,9.52,CHEMBL3982360,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)nc2N1,CHEMBL3887359,Ki,9.35,CHEMBL3912435,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4ccc(F)cc4)CC3)cc2N1,CHEMBL3413541,Ki,7.92,CHEMBL3409241,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4cccc(Cl)c4)CC3)cc2N1,CHEMBL3413541,Ki,8.89,CHEMBL3409242,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4cccc(F)c4)CC3)cc2N1,CHEMBL3413541,Ki,8.21,CHEMBL3409240,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4ccccc4)CC3)cc2N1,CHEMBL3413541,Ki,7.7,CHEMBL3409237,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4ccccc4F)CC3)cc2N1,CHEMBL3413541,Ki,7.96,CHEMBL3409239,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5Cc4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5S(=O)(=O)c4ccccc4)CC3)cc2N1,CHEMBL3413541,Ki,8.89,CHEMBL3409238,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5c4ccn5S(=O)(=O)c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5cc(F)ccc45)CC3)nc2N1,CHEMBL1776016,Ki,9.0,CHEMBL1774085,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccc(F)cc45)CC3)nc2N1,CHEMBL1776016,Ki,8.92,CHEMBL1774086,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)nc2N1,CHEMBL1776016,Ki,8.77,CHEMBL1774087,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1,CHEMBL1776016,Ki,9.09,CHEMBL1774080,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,CHEMBL2169117,Ki,8.37,CHEMBL160357,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4C(F)(F)F)CC3)cc2N1,CHEMBL2169117,Ki,8.38,CHEMBL2165122,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4Cl)CC3)cc2N1,CHEMBL2169117,Ki,8.43,CHEMBL157923,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4Cl)CC3)nc2N1,CHEMBL1776016,Ki,8.24,CHEMBL1774067,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4F)CC3)cc2N1,CHEMBL2169117,Ki,8.26,CHEMBL160630,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4OCCF)CC3)cc2N1,CHEMBL1815674,Ki,9.59,CHEMBL1813591,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,80,640,O=C1CCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCN3CCO[C@@H]4c5cc(O)ccc5OC[C@H]43)cc2N1,CHEMBL4361371,Ki,5.2,CHEMBL4474048,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,140,352,O=C1CCc2ccc(OCCCCN3CCOC4c5ccccc5OCC43)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2N1,CHEMBL4842092,Ki,6.61,CHEMBL4871833,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,152,362,O=C1CCc2ccc(OCCCCNCC3CC3c3ccccc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2N1,CHEMBL4842092,Ki,6.42,CHEMBL4854391,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,152,362,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2N1,CHEMBL4842092,Ki,6.52,CHEMBL4863636,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,152,362,O=C1CCc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCNCCc3cn(Cc4ccccc4)c4ccccc34)cc2N1,CHEMBL3413541,Ki,7.16,CHEMBL3409235,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCNCCc3cn(Cc4ccccc4)c4ccccc34)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCNCCc3cn(S(=O)(=O)c4ccccc4)c4ccccc34)cc2N1,CHEMBL3413541,Ki,6.92,CHEMBL3409236,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCCNCCc3cn(S(=O)(=O)c4ccccc4)c4ccccc34)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCCNCc3cc4ccccc4o3)cc2N1,CHEMBL5385535,Ki,6.235,CHEMBL5414943,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,159,201,O=C1CCc2ccc(OCCCCNCc3cc4ccccc4o3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL3887359,Ki,8.08,CHEMBL3918805,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(OCCCN3CCCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1,CHEMBL2169117,Ki,7.68,CHEMBL2165127,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCN3CCN(c4cccc5[nH]c(=O)oc45)CC3)cc2N1,CHEMBL1110025,Ki,8.07,CHEMBL1087453,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,74,815,O=C1CCc2ccc(OCCCN3CCN(c4cccc5[nH]c(=O)oc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCCN3CCN(c4cccc5c4ccn5S(=O)(=O)c4ccccc4)CC3)cc2N1,CHEMBL3413541,Ki,7.64,CHEMBL3409254,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=C1CCc2ccc(OCCCN3CCN(c4cccc5c4ccn5S(=O)(=O)c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OCCN3CCN(c4cccc5[nH]c(=O)oc45)CC3)cc2N1,CHEMBL1110025,Ki,8.07,CHEMBL1087452,2010,CHEMBL1157886,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone form human dopamine D2 receptor by liquid scintillation counting,74,815,O=C1CCc2ccc(OCCN3CCN(c4cccc5[nH]c(=O)oc45)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(OC[C@H]3CC[C@H](CN4CCN(c5cccc(Cl)c5Cl)CC4)CC3)cc2N1,CHEMBL2169117,Ki,6.84,CHEMBL2165128,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(OCC3CCC(CN4CCN(c5ccccc5)CC4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(Oc3ccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cc2N1,CHEMBL2169117,Ki,6.97,CHEMBL2165132,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(Oc3ccc(CN4CCN(c5ccccc5)CC4)cc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(Oc3ccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)cc3)cc2N1,CHEMBL3887359,Ki,6.97,CHEMBL2165132,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(Oc3ccc(CN4CCN(c5ccccc5)CC4)cc3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(Oc3cccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)c3)cc2N1,CHEMBL2169117,Ki,6.95,CHEMBL2165131,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1CCc2ccc(Oc3cccc(CN4CCN(c5ccccc5)CC4)c3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccc(Oc3cccc(CN4CCN(c5cccc(Cl)c5Cl)CC4)c3)cc2N1,CHEMBL3887359,Ki,6.95,CHEMBL2165131,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1CCc2ccc(Oc3cccc(CN4CCN(c5ccccc5)CC4)c3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2cccc(F)c2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,CHEMBL2060138,Ki,7.02,CHEMBL2059320,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1CCc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCCCN1CCN(c2ccccc2)CC1,CHEMBL5106582,Ki,6.55,CHEMBL5188796,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,154,267,O=C1CCc2ccccc2N1CCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,CHEMBL5106582,Ki,5.95,CHEMBL5199358,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,154,267,O=C1CCc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCC(CCCCCCCO)CC1,CHEMBL4048883,Ki,6.03,CHEMBL3354074,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,132,245,O=C1CCc2ccccc2N1CCCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCC(CCCCCO)CC1,CHEMBL4048883,Ki,5.93,CHEMBL3354073,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,132,245,O=C1CCc2ccccc2N1CCCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCC(CCCO)CC1,CHEMBL4048883,Ki,6.18,CHEMBL3354072,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,132,245,O=C1CCc2ccccc2N1CCCN1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCC(CCc2ccccc2)CC1,CHEMBL4048883,Ki,6.54,CHEMBL4093527,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,132,245,O=C1CCc2ccccc2N1CCCN1CCC(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1,CHEMBL4048883,Ki,6.04,CHEMBL4072818,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,132,245,O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCC(c2ccc3[nH]ccc3c2)CC1,CHEMBL2060138,Ki,7.38,CHEMBL2059305,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1CCc2ccccc2N1CCCN1CCC(c2ccc3[nH]ccc3c2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCC(c2ccccc2)CC1,CHEMBL4048883,Ki,6.34,CHEMBL4091231,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,132,245,O=C1CCc2ccccc2N1CCCN1CCC(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,CHEMBL2060138,Ki,8.02,CHEMBL2059306,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1CCc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(CCc2ccccc2)CC1,CHEMBL4048883,Ki,5.24,CHEMBL4063176,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,132,245,O=C1CCc2ccccc2N1CCCN1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(Cc2ccccc2)CC1,CHEMBL4048883,Ki,5.42,CHEMBL4091058,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,132,245,O=C1CCc2ccccc2N1CCCN1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1,CHEMBL5106582,Ki,6.02,CHEMBL5175054,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL5106582,Ki,5.26,CHEMBL5196870,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2ccc(Cl)cc2Cl)CC1,CHEMBL5106582,Ki,6.26,CHEMBL5179930,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2ccc([N+](=O)[O-])cc2)CC1,CHEMBL5106582,Ki,4.62,CHEMBL5175009,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2cccc(Cl)c2)CC1,CHEMBL5106582,Ki,6.12,CHEMBL5204418,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL5106582,Ki,7.26,CHEMBL5177462,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2cccc([N+](=O)[O-])c2)CC1,CHEMBL5106582,Ki,5.6,CHEMBL5176100,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,CHEMBL4048883,Ki,5.96,CHEMBL4085780,2018,CHEMBL4043296,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by scintillation counting method,132,245,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,CHEMBL5106582,Ki,5.96,CHEMBL4085780,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2Cl)CC1,CHEMBL5106582,Ki,6.86,CHEMBL5172201,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2[N+](=O)[O-])CC1,CHEMBL5106582,Ki,6.88,CHEMBL5198170,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2ccccn2)CC1,CHEMBL5106582,Ki,5.56,CHEMBL5196873,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCCN1CCN(c2ncccn2)CC1,CHEMBL5106582,Ki,5.4,CHEMBL5172871,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1CCN1CCN(c2ccccc2)CC1,CHEMBL5106582,Ki,4.89,CHEMBL5171721,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,O=C1CCc2ccccc2N1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ccccc2N1OCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,CHEMBL2060138,Ki,7.26,CHEMBL2059312,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1CCc2ccccc2N1OCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2cccnc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,CHEMBL2060138,Ki,6.22,CHEMBL2059310,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1CCc2cccnc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2cnccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,CHEMBL2060138,Ki,5.96,CHEMBL2059308,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1CCc2cnccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1CCc2ncccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,CHEMBL2060138,Ki,5.66,CHEMBL2059307,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1CCc2ncccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2c(N3CCCNCC3)ccc(O)c2N1,CHEMBL4046973,Ki,4.85,CHEMBL4072785,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,128,385,O=C1COc2c(cccc2N2CCCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2c(N3CCCNCC3)ccc(O)c2N1,CHEMBL4046974,Ki,5.05,CHEMBL4072785,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,128,386,O=C1COc2c(cccc2N2CCCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2N1,CHEMBL4046973,Ki,9.024999999999999,CHEMBL4063145,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,128,385,O=C1COc2c(cccc2N2CCN(CCCCOc3ccn4nccc4c3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2N1,CHEMBL4046974,Ki,9.094999999999999,CHEMBL4063145,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,128,386,O=C1COc2c(cccc2N2CCN(CCCCOc3ccn4nccc4c3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2N1,CHEMBL4015806,Ki,8.7,CHEMBL4100183,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,128,297,O=C1COc2c(cccc2N2CCN(CCCCOc3ccn4nccc4c3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2N1,CHEMBL4015807,Ki,9.07,CHEMBL4100183,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,128,298,O=C1COc2c(cccc2N2CCN(CCCCOc3ccn4nccc4c3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2c(N3CCNCC3)ccc(O)c2N1,CHEMBL4046973,Ki,5.08,CHEMBL4093493,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,128,385,O=C1COc2c(cccc2N2CCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2c(N3CCNCC3)ccc(O)c2N1,CHEMBL4046974,Ki,5.75,CHEMBL4093493,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,128,386,O=C1COc2c(cccc2N2CCNCC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,CHEMBL872394,Ki,8.37,CHEMBL198069,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,43,238,O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2c(cccc2N2CCN(Cc3cccc(-c4ccccc4)c3)CC2)N1,CHEMBL672308,Ki,9.0,CHEMBL305920,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,26,593,O=C1COc2c(cccc2N2CCN(Cc3cccc(-c4ccccc4)c3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1,CHEMBL4039163,Ki,6.38,CHEMBL346389,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,128,546,O=C1COc2cc(CN3CCN(c4ccccc4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1,CHEMBL5235409,Ki,6.38,CHEMBL346389,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,152,478,O=C1COc2cc(CN3CCN(c4ccccc4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2cc(CN3CCN(c4ccc(Cl)cc4)CC3)ccc2N1,CHEMBL671372,Ki,6.38,CHEMBL346389,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,20,707,O=C1COc2cc(CN3CCN(c4ccccc4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2cc(CN3CCN(c4ccccc4)CC3)ccc2N1,CHEMBL671372,Ki,6.89,CHEMBL149233,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,20,707,O=C1COc2cc(CN3CCN(c4ccccc4)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccc(CN3CCN(c4ccccc4)CC3)cc2N1,CHEMBL671372,Ki,5.66,CHEMBL147130,1999,CHEMBL1132537,J Med Chem,Scientific Literature,Binding affinity at Dopamine receptor D2 in CHO cells by radioligand displacement.,20,707,O=C1COc2ccc(CN3CCN(c4ccccc4)CC3)cc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4708967,IC50,6.67,CHEMBL4741908,2020,CHEMBL4706522,Eur J Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,145,548,O=C1COc2ccccc2N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL4000277,Ki,8.49,CHEMBL4062602,2015,CHEMBL4000143,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,113,796,O=C1COc2ccccc2N1CCCN1CCC(c2noc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3c(F)cccc32)CC1,CHEMBL2060138,Ki,7.82,CHEMBL2059324,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cc(F)ccc32)CC1,CHEMBL2060138,Ki,8.6,CHEMBL2059323,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccc(F)cc32)CC1,CHEMBL2060138,Ki,7.85,CHEMBL2059322,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cccc(F)c32)CC1,CHEMBL2060138,Ki,7.39,CHEMBL2059321,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,CHEMBL2060138,Ki,7.8,CHEMBL2059311,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cccnc32)CC1,CHEMBL2060138,Ki,5.9,CHEMBL2059313,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cccnc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cnccc32)CC1,CHEMBL2060138,Ki,5.87,CHEMBL2059315,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3cnccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ncccc32)CC1,CHEMBL2060138,Ki,6.19,CHEMBL2059316,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,85,932,O=C1COc2ccccc2N1CCCN1CCC(n2c(=O)[nH]c3ncccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4000277,Ki,6.56,CHEMBL4093980,2015,CHEMBL4000143,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,113,796,O=C1COc2ccccc2N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCN(c2cccc3[nH]c(=O)oc23)CC1,CHEMBL4000277,Ki,8.765,CHEMBL4104013,2015,CHEMBL4000143,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,113,796,O=C1COc2ccccc2N1CCCN1CCN(c2cccc3[nH]c(=O)oc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1COc2ccccc2N1CCCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4000277,Ki,7.75,CHEMBL4090568,2015,CHEMBL4000143,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in F1pIn CHO cells after 60 mins by scintillation counting analysis,113,796,O=C1COc2ccccc2N1CCCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C[C@@H](CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2occc21,CHEMBL1027240,Ki,7.38,CHEMBL492689,2008,CHEMBL1140101,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,62,482,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2occc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C[C@@H](CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1,CHEMBL672098,Ki,4.75,CHEMBL168541,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,36,397,O=C1CC(CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C[C@@H](CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1,CHEMBL672099,Ki,5.19,CHEMBL168541,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,36,398,O=C1CC(CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C[C@H](CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2occc21,CHEMBL1027240,Ki,7.8,CHEMBL523680,2008,CHEMBL1140101,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,62,482,O=C1CC(CN2CCC(c3noc4ccccc34)CC2)Cc2occc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C[C@H](CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1,CHEMBL672098,Ki,5.14,CHEMBL168571,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,36,397,O=C1CC(CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1C[C@H](CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1,CHEMBL672099,Ki,5.55,CHEMBL168571,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,36,398,O=C1CC(CN2CCN(c3ccccc3)CC2)N=C(c2ccccc2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(ccc(Cl)c2N2CCN(Cc3ccccc3)CC2)N1,CHEMBL884862,Ki,6.27,CHEMBL330108,1998,CHEMBL1130595,Bioorg Med Chem Lett,Scientific Literature,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,15,1,O=C1Cc2c(cccc2N2CCN(Cc3ccccc3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(ccc3c2OC[C@H](CNCC2CCc4[nH]c5ccc(F)cc5c4C2)O3)N1,CHEMBL1040200,Ki,8.52,CHEMBL569251,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,66,931,O=C1Cc2c(ccc3c2OCC(CNCC2CCc4[nH]c5ccccc5c4C2)O3)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(ccc3c2OC[C@H](CNCC2CCc4c([nH]c5ccc(F)cc45)C2)O3)N1,CHEMBL1040200,Ki,7.0,CHEMBL565935,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,66,931,O=C1Cc2c(ccc3c2OCC(CNCC2CCc4c([nH]c5ccccc45)C2)O3)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(ccc3c2OC[C@H](CNCCC2CCc4[nH]c5ccc(F)cc5c4C2)O3)N1,CHEMBL1040200,Ki,7.62,CHEMBL1237165,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,66,931,O=C1Cc2c(ccc3c2OCC(CNCCC2CCc4[nH]c5ccccc5c4C2)O3)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(ccc3c2OC[C@H](CNCCC2CCc4c([nH]c5ccc(F)cc45)C2)O3)N1,CHEMBL1040200,Ki,7.44,CHEMBL566155,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,66,931,O=C1Cc2c(ccc3c2OCC(CNCCC2CCc4c([nH]c5ccccc45)C2)O3)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(ccc3c2OC[C@H](CNCCCC2CCc4c([nH]c5ccc(F)cc45)C2)O3)N1,CHEMBL1040200,Ki,7.324999999999999,CHEMBL566379,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,66,931,O=C1Cc2c(ccc3c2OCC(CNCCCC2CCc4c([nH]c5ccccc45)C2)O3)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(ccc3c2O[C@@H](CNCc2ccccc2)CC3)N1,CHEMBL670555,Ki,8.03,CHEMBL303556,2002,CHEMBL1135019,Bioorg Med Chem Lett,Scientific Literature,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,32,894,O=C1Cc2c(ccc3c2OC(CNCc2ccccc2)CC3)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(cccc2N2CCN(CC3CCc4[nH]c5ccc(F)cc5c4C3)CC2)N1,CHEMBL1040200,Ki,7.82,CHEMBL571464,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,66,931,O=C1Cc2c(cccc2N2CCN(CC3CCc4[nH]c5ccccc5c4C3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(cccc2N2CCN(CCC3CCc4[nH]c5ccc(F)cc5c4C3)CC2)N1,CHEMBL1040200,Ki,7.82,CHEMBL2094011,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,66,931,O=C1Cc2c(cccc2N2CCN(CCC3CCc4[nH]c5ccccc5c4C3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(cccc2N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)N1,CHEMBL3762401,Ki,7.28,CHEMBL3759441,2016,CHEMBL3758127,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-spiperone from human dopamine D2S receptor expressed in HEK293 cell membranes,122,477,O=C1Cc2c(cccc2N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(cccc2N2CCN(Cc3ccccc3)CC2)N1,CHEMBL884862,Ki,8.1,CHEMBL314952,1998,CHEMBL1130595,Bioorg Med Chem Lett,Scientific Literature,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,15,1,O=C1Cc2c(cccc2N2CCN(Cc3ccccc3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2c(cccc2OCCNCc2ccccc2)N1,CHEMBL672205,Ki,8.37,CHEMBL59752,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,20,876,O=C1Cc2c(cccc2OCCNCc2ccccc2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(C(=O)CCCN3CCc4ccccc4C3)ccc2N1,CHEMBL3863657,Ki,5.27,CHEMBL3986927,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,122,59,O=C1Cc2cc(C(=O)CCCN3CCc4ccccc4C3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4cccc5ccccc45)CC3)ccc2N1,CHEMBL872217,IC50,7.36,CHEMBL54786,2005,CHEMBL1140446,J Med Chem,Scientific Literature,Inhibitory concentration against dopamine receptor D2,43,601,O=C1Cc2cc(CCN3CCN(c4cccc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL2211561,Ki,8.07,CHEMBL708,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,85,376,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL3090831,Ki,8.32,CHEMBL708,2013,CHEMBL3085767,J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) by radioligand binding assay,95,224,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL3707630,Ki,8.3,CHEMBL708,2013,CHEMBL3638417,,BindingDB Patent Bioactivity Data,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",95,575,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL3997508,Ki,8.68,CHEMBL708,2017,CHEMBL3994665,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),128,438,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL4229838,Ki,9.1,CHEMBL708,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL4316415,Ki,8.68,CHEMBL708,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,145,544,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL4354013,Ki,9.06,CHEMBL708,2019,CHEMBL4351001,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 long receptor expressed in HEK293 cells measured after 1 hr by liquid scintillation counter method,140,125,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL4394035,Ki,9.05,CHEMBL708,2019,CHEMBL4393658,Eur J Med Chem,Scientific Literature,Displacement of [3H] raclopride from human recombinant D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting method,140,505,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL672169,Ki,8.01,CHEMBL708,2004,CHEMBL1149193,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,38,533,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL672179,Ki,8.55,CHEMBL708,2001,CHEMBL1134342,J Med Chem,Scientific Literature,Binding affinity towards human D2 dopamine receptor.,26,534,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL872217,IC50,8.3,CHEMBL708,2005,CHEMBL1140446,J Med Chem,Scientific Literature,Inhibitory concentration against dopamine receptor D2,43,601,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL895618,Ki,7.9,CHEMBL708,2007,CHEMBL1148822,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,57,452,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL945767,Ki,8.3,CHEMBL708,2008,CHEMBL1140829,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in CHO cells,62,106,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1,CHEMBL992743,Ki,8.51,CHEMBL708,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,62,604,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)ccc2N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2ccccc2C(=C2CCN(CCCCN3C(=O)c4ccccc4C3=O)CC2)c2ccsc21,CHEMBL897619,Ki,5.94,CHEMBL393775,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C1Cc2ccccc2C(=C2CCN(CCCCN3C(=O)c4ccccc4C3=O)CC2)c2ccsc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2ccccc2N1CCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL898619,Ki,5.76,CHEMBL239917,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,57,772,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2ccccc2N1CCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL898624,Ki,6.43,CHEMBL239917,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,57,773,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2ccccc2N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL898619,Ki,6.49,CHEMBL268371,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,57,772,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2ccccc2N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL898624,Ki,6.38,CHEMBL268371,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,57,773,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,CHEMBL898619,Ki,6.79,CHEMBL395933,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,57,772,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,CHEMBL898624,Ki,6.82,CHEMBL395933,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,57,773,O=C1Cc2ccccc2N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Cc2ccccc2N1CCN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872891,Ki,5.79,CHEMBL322326,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",32,214,O=C1Cc2ccccc2N1CCN1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CC2CCCCN2)CCN1c1cccc(C(F)(F)F)c1,CHEMBL1106075,Ki,7.7,CHEMBL1085903,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CC2CCCCN2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CC2CCCCN2)CCN1c1cccc(Cl)c1,CHEMBL1106075,Ki,7.1,CHEMBL1085672,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CC2CCCCN2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CC2CCCNC2)CCN1c1cccc(Cl)c1,CHEMBL1106075,Ki,6.2,CHEMBL1085673,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CC2CCCNC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CC2CCNCC2)CCN1c1cccc(Cl)c1,CHEMBL1106075,Ki,6.2,CHEMBL1085674,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CC2CCNCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCF)CN(c2ccccc2)C12CCN(Cc1coc3ccccc13)CC2,CHEMBL1176478,Ki,8.1,CHEMBL1170085,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,74,641,O=C1NCN(c2ccccc2)C12CCN(Cc1coc3ccccc13)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(Cl)c1,CHEMBL1057875,Ki,7.0,CHEMBL562624,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(I)c1,CHEMBL1057875,Ki,7.9,CHEMBL560574,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(O)c1,CHEMBL1057875,Ki,7.4,CHEMBL569846,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCC(C(F)(F)F)CC2)CCN1c1cccc(OC(F)(F)F)c1,CHEMBL1057875,Ki,6.8,CHEMBL559919,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2CCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCC(c3ccc(Cl)cc3)CC2)CCN1c1cccc(Cl)c1,CHEMBL1044430,Ki,6.6,CHEMBL561128,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,66,233,O=C1N(CCN2CCC(c3ccccc3)CC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCC(c3ccc(Cl)cc3)CC2)CCN1c1cccc(Cl)c1,CHEMBL1059864,Ki,6.6,CHEMBL561128,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,66,234,O=C1N(CCN2CCC(c3ccccc3)CC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCC(c3nnc(-c4ccccc4)o3)CC2)CCN1c1cccc(Cl)c1,CHEMBL1044430,Ki,6.3,CHEMBL561326,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,66,233,O=C1N(CCN2CCC(c3nnc(-c4ccccc4)o3)CC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCC(c3nnc(-c4ccccc4)o3)CC2)CCN1c1cccc(Cl)c1,CHEMBL1059864,Ki,6.3,CHEMBL561326,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,66,234,O=C1N(CCN2CCC(c3nnc(-c4ccccc4)o3)CC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCC(OCc3ccccc3)C2)CCN1c1cccc(Cl)c1,CHEMBL1044430,Ki,7.1,CHEMBL557110,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,66,233,O=C1N(CCN2CCCC(OCc3ccccc3)C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCC(OCc3ccccc3)C2)CCN1c1cccc(Cl)c1,CHEMBL1059864,Ki,7.1,CHEMBL557110,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,66,234,O=C1N(CCN2CCCC(OCc3ccccc3)C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCCCC2)CCN1c1cc(Cl)cc(Cl)c1,CHEMBL1106075,Ki,9.2,CHEMBL1081309,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCCCC2)CCN1c1ccc(Cl)cc1,CHEMBL1106075,Ki,7.0,CHEMBL1079191,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCCCC2)CCN1c1ccc(F)c(Cl)c1,CHEMBL1106075,Ki,7.8,CHEMBL1083813,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCCCC2)CCN1c1ccc(F)cc1,CHEMBL1106075,Ki,7.2,CHEMBL1081491,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCCCC2)CCN1c1cccc(C(F)(F)F)c1,CHEMBL1106075,Ki,8.8,CHEMBL1081488,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCCCC2)CCN1c1cccc(Cl)c1,CHEMBL1106075,Ki,8.0,CHEMBL1077344,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCCCC2)CCN1c1cccc(F)c1,CHEMBL1106075,Ki,8.6,CHEMBL1081490,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,CHEMBL1106075,Ki,8.1,CHEMBL1081489,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,74,556,O=C1N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCCCC2)CCN1c1cccnc1,CHEMBL1106075,Ki,7.0,CHEMBL1083814,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,75,556,O=C1N(CCN2CCCCCC2)CCN1c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCCCC2)CCN1c1ccncc1,CHEMBL1106075,Ki,6.2,CHEMBL1083815,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,75,556,O=C1N(CCN2CCCCCC2)CCN1c1ccncc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCc3sccc3C2)CCN1c1cccc(Cl)c1,CHEMBL1044430,Ki,8.5,CHEMBL559873,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,66,233,O=C1N(CCN2CCCc3sccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2CCCc3sccc3C2)CCN1c1cccc(Cl)c1,CHEMBL1059864,Ki,8.5,CHEMBL559873,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,66,234,O=C1N(CCN2CCCc3sccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2C[C@@H]3CC[C@H]2Cc2ccccc2C3)CCN1c1cccc(Cl)c1,CHEMBL1044430,Ki,7.6,CHEMBL562464,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,66,233,O=C1N(CCN2CC3CCC2Cc2ccccc2C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2C[C@@H]3CC[C@H]2Cc2ccccc2C3)CCN1c1cccc(Cl)c1,CHEMBL1059864,Ki,7.6,CHEMBL562464,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,66,234,O=C1N(CCN2CC3CCC2Cc2ccccc2C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2C[C@H]3CC[C@@H]2C3)CCN1c1cccc(Cl)c1,CHEMBL1044430,Ki,8.4,CHEMBL563860,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,66,233,O=C1N(CCN2CC3CCC2C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2C[C@H]3CC[C@@H]2C3)CCN1c1cccc(Cl)c1,CHEMBL1059864,Ki,8.4,CHEMBL563860,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,66,234,O=C1N(CCN2CC3CCC2C3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2C[C@H]3CC[C@H](CC3)C2)CCN1c1cccc(Cl)c1,CHEMBL1044430,Ki,7.6,CHEMBL565075,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,66,233,O=C1N(CCN2CC3CCC(CC3)C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2C[C@H]3CC[C@H](CC3)C2)CCN1c1cccc(Cl)c1,CHEMBL1059864,Ki,7.6,CHEMBL565075,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,66,234,O=C1N(CCN2CC3CCC(CC3)C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cc(Cl)ccc1Cl,CHEMBL1057875,Ki,6.1,CHEMBL552367,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cccc(C(F)(F)F)c1,CHEMBL1057875,Ki,6.6,CHEMBL552366,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1cccc(Cl)c1,CHEMBL1057875,Ki,6.3,CHEMBL571229,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1ccccc1Cl,CHEMBL1057875,Ki,6.4,CHEMBL551386,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1Cc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(Cl)cc(Cl)c1,CHEMBL1057875,Ki,8.2,CHEMBL561512,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(Cl)ccc1F,CHEMBL1057875,Ki,6.8,CHEMBL565031,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1cc(F)cc(Cl)c1,CHEMBL1057875,Ki,7.5,CHEMBL556272,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc(Cl)c(Cl)c1,CHEMBL1057875,Ki,6.6,CHEMBL550502,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc(F)c(Cl)c1,CHEMBL1057875,Ki,6.8,CHEMBL562983,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc2occc2c1,CHEMBL1057875,Ki,6.0,CHEMBL559004,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc2occc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc2sccc2c1,CHEMBL1057875,Ki,6.6,CHEMBL556478,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccc2sccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(C(F)(F)F)c1,CHEMBL1057875,Ki,7.3,CHEMBL559029,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,66,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(Cl)c1,CHEMBL1044430,Ki,7.0,CHEMBL560177,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,67,233,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(Cl)c1,CHEMBL1057875,Ki,7.0,CHEMBL560177,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,67,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(Cl)c1,CHEMBL1059864,Ki,7.0,CHEMBL560177,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,67,234,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1cccc(OC(F)(F)F)c1,CHEMBL1057875,Ki,7.4,CHEMBL565017,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,67,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2Cc3ccccc3C2)CCN1c1csc2ccccc12,CHEMBL1057875,Ki,5.9,CHEMBL563247,2009,CHEMBL1152393,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHO cells by [35S]GTP-gamma-S-based scintillation spectrometry,67,166,O=C1N(CCN2Cc3ccccc3C2)CCN1c1csc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2[C@@H]3CCC[C@H]2CC3)CCN1c1cccc(Cl)c1,CHEMBL1044430,Ki,8.3,CHEMBL563580,2009,CHEMBL1155321,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human DRD2 receptor by GTPgammaS binding assay,67,233,O=C1N(CCN2C3CCCC2CC3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(CCN2[C@@H]3CCC[C@H]2CC3)CCN1c1cccc(Cl)c1,CHEMBL1059864,Ki,8.3,CHEMBL563580,2009,CHEMBL1153053,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 receptor expressed in CHO cells by [35S]GTPgammaS binding assay,67,234,O=C1N(CCN2C3CCCC2CC3)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1N(Cc2cn(CCF)nn2)CN(c2ccccc2)C12CCN(Cc1coc3ccccc13)CC2,CHEMBL1176478,Ki,8.7,CHEMBL1171630,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,75,641,O=C1N(Cc2c[nH]nn2)CN(c2ccccc2)C12CCN(Cc1coc3ccccc13)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)c2cc(F)ccc21,CHEMBL4708967,IC50,7.46,CHEMBL4763837,2020,CHEMBL4706522,Eur J Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,145,548,O=C1NCC(=O)N(CCCCN2CCN(c3cccc4sccc34)CC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C1C(=O)NC1CCCCC1,CHEMBL5236927,IC50,5.48,CHEMBL5269858,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,152,142,O=C1NCCN(C(=O)CCCN2CCN(c3ccccc3)CC2)C1C(=O)NC1CCCCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCN(C(=O)CCCN2CCN(c3cccc(Cl)c3Cl)CC2)C1C(=O)NCc1ccccc1,CHEMBL5236927,IC50,8.94,CHEMBL5283891,2021,CHEMBL5236546,J Med Chem,Scientific Literature,Partial agonist activity at human D2 receptor expressed in HEK293T cells assessed as inhibition of forskolin-induced cAMP production incubated for 1 hr by HTRF analysis,152,142,O=C1NCCN(C(=O)CCCN2CCN(c3ccccc3)CC2)C1C(=O)NCc1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CHEMBL1261591,Ki,9.35,CHEMBL12713,2010,CHEMBL1255222,J Med Chem,Scientific Literature,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,75,108,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CHEMBL2327488,Ki,9.35,CHEMBL12713,2013,CHEMBL2321719,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells after 30 mins by scintillation counting analysis,95,552,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CHEMBL5346625,Ki,9.42,CHEMBL12713,2024,CHEMBL5344475,RSC Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) assessed as inhibition constant,159,189,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1,CHEMBL672169,Ki,8.13,CHEMBL12713,2004,CHEMBL1149193,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,38,533,O=C1NCCN1CCN1CCC(c2cn(-c3ccccc3)c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCc2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc21,CHEMBL3887359,Ki,7.7,CHEMBL3898054,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1NCCc2ccc(OCCCCN3CCC(c4ccccc4)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,CHEMBL3887359,Ki,8.34,CHEMBL3943838,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1NCCc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,CHEMBL2169117,Ki,7.75,CHEMBL2165133,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1NCCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,CHEMBL3887359,Ki,7.75,CHEMBL2165133,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1NCCc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,CHEMBL2169117,Ki,8.24,CHEMBL2165118,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1NCCc2ccc(OCCCN3CCCN(c4ccccc4)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc21,CHEMBL3887359,Ki,8.24,CHEMBL2165118,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1NCCc2ccc(OCCCN3CCCN(c4ccccc4)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,CHEMBL2169117,Ki,7.75,CHEMBL2165117,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,85,205,O=C1NCCc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCCc2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc21,CHEMBL3887359,Ki,7.75,CHEMBL2165117,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=C1NCCc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccc4[nH]c(CO)cc4c3O1)CC2,CHEMBL672490,Ki,8.7,CHEMBL323088,1992,CHEMBL1125523,J Med Chem,Scientific Literature,"Binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",0,286,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccc4[nH]ccc4c3O1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccc4[nH]ccc4c3O1)CC2,CHEMBL670743,Ki,9.7,CHEMBL317433,1992,CHEMBL1125523,J Med Chem,Scientific Literature,"Compound was evaluated for the binding affinity towards Dopamine receptor D2 from mammalian clones expressed in CHO cell membranes using 2 (86.1 Ci/mmol,1.7nanoM)as radioligand",0,963,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccc4[nH]ccc4c3O1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccccc3O1)CC2,CHEMBL5442215,Ki,8.17,CHEMBL300555,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=C1NCN(c2ccccc2)C12CCN(CC1COc3ccccc3O1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(CCCCc1c[nH]c3ccccc13)CC2,CHEMBL3820048,Ki,7.655,CHEMBL3818478,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,122,897,O=C1NCN(c2ccccc2)C12CCN(CCCCc1c[nH]c3ccccc13)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3cc(Cl)ccc3s1)CC2,CHEMBL3820048,Ki,7.745,CHEMBL3818124,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,122,897,O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3ccccc3s1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3ccccc3o1)CC2,CHEMBL3820048,Ki,7.995,CHEMBL3818935,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,122,897,O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3ccccc3o1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3ccccc3s1)CC2,CHEMBL3820048,Ki,7.62,CHEMBL3819567,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,122,897,O=C1NCN(c2ccccc2)C12CCN(CCCCc1nc3ccccc3s1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccc(F)cc1)CC2,CHEMBL5442215,Ki,8.02,CHEMBL79834,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccc(F)cc1)CC2,CHEMBL673098,Ki,8.52,CHEMBL79834,1993,CHEMBL1126779,J Med Chem,Scientific Literature,Tested for binding affinity against dopamine receptor D2,2,941,O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(Cc1ccc3c(c1)OCO3)CC2,CHEMBL671072,IC50,6.25,CHEMBL326962,2001,CHEMBL1134625,J Med Chem,Scientific Literature,Inhibition of human dopamine receptor D2,26,486,O=C1NCN(c2ccccc2)C12CCN(Cc1ccc3c(c1)OCO3)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(Cc1ccc3nsnc3c1)CC2,CHEMBL671072,IC50,6.91,CHEMBL325750,2001,CHEMBL1134625,J Med Chem,Scientific Literature,Inhibition of human dopamine receptor D2,26,486,O=C1NCN(c2ccccc2)C12CCN(Cc1ccc3nsnc3c1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCN(c2ccccc2)C12CCN(Cc1cccc(Oc3ccccc3)c1)CC2,CHEMBL671072,IC50,6.27,CHEMBL115280,2001,CHEMBL1134625,J Med Chem,Scientific Literature,Inhibition of human dopamine receptor D2,26,486,O=C1NCN(c2ccccc2)C12CCN(Cc1cccc(Oc3ccccc3)c1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(Cl)c(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21,CHEMBL1260558,Ki,8.23,CHEMBL1257385,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(Cl)c(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,CHEMBL1260558,Ki,8.03,CHEMBL1257264,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(Cl)c(OCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21,CHEMBL1260558,Ki,7.61,CHEMBL1257384,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(Cl)c(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,CHEMBL1260558,Ki,7.29,CHEMBL1257263,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(F)c(OCCCCN3CCN(c4cccc5cc(F)ccc45)CC3)cc21,CHEMBL1260558,Ki,9.05,CHEMBL1258881,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(F)c(OCCCCN3CCN(c4cccc5ccc(F)cc45)CC3)cc21,CHEMBL1260558,Ki,7.95,CHEMBL1258762,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(F)c(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21,CHEMBL1260558,Ki,8.85,CHEMBL1258649,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(F)c(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,CHEMBL1260558,Ki,9.06,CHEMBL1258534,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(F)c(OCCCN3CCN(c4cccc5cc(F)ccc45)CC3)cc21,CHEMBL1260558,Ki,8.73,CHEMBL1258763,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(F)c(OCCCN3CCN(c4cccc5ccc(F)cc45)CC3)cc21,CHEMBL1260558,Ki,8.24,CHEMBL1258650,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(F)c(OCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21,CHEMBL1260558,Ki,8.02,CHEMBL1258535,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2cc(F)c(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,CHEMBL1260558,Ki,8.05,CHEMBL1258428,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCC5)CC3)cc21,CHEMBL1260558,Ki,10.24,CHEMBL1257382,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCC5)CC3)cc21,CHEMBL3790456,Ki,10.24,CHEMBL1257382,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCCC5)CC3)cc21,CHEMBL1260558,Ki,8.81,CHEMBL1257614,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCCC5)CC3)cc21,CHEMBL3790456,Ki,8.81,CHEMBL1257614,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCO5)CC3)cc21,CHEMBL1260558,Ki,8.68,CHEMBL1257492,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCO5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCO5)CC3)cc21,CHEMBL3790456,Ki,8.68,CHEMBL1257492,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCO5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCOC5)CC3)cc21,CHEMBL1260558,Ki,7.94,CHEMBL1257968,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCOC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCOC5)CC3)cc21,CHEMBL3790456,Ki,7.94,CHEMBL1257968,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4CCOC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COC5)CC3)cc21,CHEMBL1260558,Ki,9.24,CHEMBL1257493,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COC5)CC3)cc21,CHEMBL3790456,Ki,9.24,CHEMBL1257493,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COCC5)CC3)cc21,CHEMBL1260558,Ki,7.65,CHEMBL1257857,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COCC5)CC3)cc21,CHEMBL3790456,Ki,7.65,CHEMBL1257857,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4COCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4OCCC5)CC3)cc21,CHEMBL1260558,Ki,9.24,CHEMBL1257735,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4OCCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4OCCC5)CC3)cc21,CHEMBL3790456,Ki,9.24,CHEMBL1257735,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5c4OCCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cc(F)c(F)cc45)CC3)cc21,CHEMBL1260558,Ki,8.09,CHEMBL1257261,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cc(F)ccc45)CC3)c(F)c21,CHEMBL1260558,Ki,7.8,CHEMBL1258427,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cc(F)ccc45)CC3)c(F)c21,CHEMBL3790456,Ki,7.8,CHEMBL1258427,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cc(F)ccc45)CC3)cc21,CHEMBL1260558,Ki,7.24,CHEMBL1257144,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccc(F)cc45)CC3)c(F)c21,CHEMBL1260558,Ki,8.24,CHEMBL1258313,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccc(F)cc45)CC3)c(F)c21,CHEMBL3790456,Ki,8.24,CHEMBL1258313,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccc(F)cc45)CC3)cc21,CHEMBL1260558,Ki,7.47,CHEMBL1258760,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)c(Cl)c21,CHEMBL1260558,Ki,8.01,CHEMBL1257147,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)c(F)c21,CHEMBL1260558,Ki,7.45,CHEMBL1258199,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)c(F)c21,CHEMBL3790456,Ki,7.45,CHEMBL1258199,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21,CHEMBL1260558,Ki,8.5,CHEMBL1258879,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)c(F)c21,CHEMBL1260558,Ki,7.65,CHEMBL1258084,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)c(F)c21,CHEMBL3790456,Ki,7.65,CHEMBL1258084,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,CHEMBL1260558,Ki,8.13,CHEMBL1258647,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,CHEMBL3790456,Ki,8.13,CHEMBL1258647,2016,CHEMBL3784936,Medchemcomm,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),122,964,O=C1NCc2ccc(OCCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4CCC5)CC3)cc21,CHEMBL1260558,Ki,9.52,CHEMBL1257262,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4CCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4CCCC5)CC3)cc21,CHEMBL1260558,Ki,8.58,CHEMBL1257613,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4CCCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4CCO5)CC3)cc21,CHEMBL1260558,Ki,7.92,CHEMBL1257383,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4CCO5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4COCC5)CC3)cc21,CHEMBL1260558,Ki,6.54,CHEMBL1257856,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4COCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4OCCC5)CC3)cc21,CHEMBL1260558,Ki,8.35,CHEMBL1257734,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5c4OCCC5)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5cc(F)c(F)cc45)CC3)cc21,CHEMBL1260558,Ki,7.99,CHEMBL1257145,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5cc(F)ccc45)CC3)c(F)c21,CHEMBL1260558,Ki,8.07,CHEMBL1258314,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5cc(F)ccc45)CC3)cc21,CHEMBL1260558,Ki,7.35,CHEMBL1258880,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccc(F)cc45)CC3)c(F)c21,CHEMBL1260558,Ki,7.99,CHEMBL1258200,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccc(F)cc45)CC3)cc21,CHEMBL1260558,Ki,7.56,CHEMBL1258648,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5cccc(F)c45)CC3)c(Cl)c21,CHEMBL1260558,Ki,8.04,CHEMBL1257146,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5cccc(F)c45)CC3)c(F)c21,CHEMBL1260558,Ki,8.26,CHEMBL1258085,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5cccc(F)c45)CC3)cc21,CHEMBL1260558,Ki,7.87,CHEMBL1258761,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)c(Cl)c21,CHEMBL1260558,Ki,7.97,CHEMBL1258882,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)c(F)c21,CHEMBL1260558,Ki,7.86,CHEMBL1257969,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,CHEMBL1260558,Ki,7.79,CHEMBL1258533,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,75,832,O=C1NCc2ccc(OCCCN3CCN(c4cccc5ccccc45)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Nc2ccc(F)cc2C1CCCCN1CCN(c2ccccc2)CC1,CHEMBL927100,Ki,6.48,CHEMBL411663,2008,CHEMBL1144747,J Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor,62,261,O=C1Nc2ccccc2C1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Nc2cccc3c2[C@]1(CCCCN1CC=C(c2ccccc2)CC1)CCC3,CHEMBL673593,Ki,6.98,CHEMBL25815,2001,CHEMBL1134402,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells,26,247,O=C1Nc2cccc3c2C1(CCCCN1CC=C(c2ccccc2)CC1)CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Nc2ccccc2C1CCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL927100,Ki,6.02,CHEMBL260994,2008,CHEMBL1144747,J Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor,62,261,O=C1Nc2ccccc2C1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1Nc2ccccc2CC1N1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL672795,Ki,5.86,CHEMBL67222,2000,CHEMBL1132730,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at human Dopamine receptor D2 by [3H]- YM 09151 displacement.,24,447,O=C1Nc2ccccc2CC1N1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@@H]3C[C@@H]([C@@H](O)[C@H]3O)[C@@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,7.85,CHEMBL4279645,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3CCC(C3)C2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H](C(=O)N1CCCCCN1CCN(c3cccc4sccc34)CC1)[C@H]1C=C[C@@H]2C1,CHEMBL4254801,IC50,7.55,CHEMBL4282051,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3C=CC(C3)C2C(=O)N1CCCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4c3OC(F)(F)O4)CC1)[C@H]1C=C[C@@H]2C1,CHEMBL4254801,IC50,8.7,CHEMBL4293718,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3C=CC(C3)C2C(=O)N1CCCCN1CCN(c2cccc3c2OCO3)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4c3OCCO4)CC1)[C@H]1C=C[C@@H]2C1,CHEMBL4254801,IC50,8.01,CHEMBL4285839,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3C=CC(C3)C2C(=O)N1CCCCN1CCN(c2cccc3c2OCCO3)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4ccsc34)CC1)[C@H]1C=C[C@@H]2C1,CHEMBL4254801,IC50,8.28,CHEMBL4278581,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3C=CC(C3)C2C(=O)N1CCCCN1CCN(c2cccc3ccsc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4sc(F)cc34)CC1)[C@H]1C=C[C@@H]2C1,CHEMBL4254801,IC50,8.6,CHEMBL4289238,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3C=CC(C3)C2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4sccc34)CC1)[C@H]1C=C[C@@H]2C1,CHEMBL4254801,IC50,8.19,CHEMBL4277101,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3C=CC(C3)C2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3cccc4scnc34)CC1)[C@H]1C=C[C@@H]2C1,CHEMBL4254801,IC50,8.02,CHEMBL4287752,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3C=CC(C3)C2C(=O)N1CCCCN1CCN(c2cccc3scnc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H](C(=O)N1CCCCN1CCN(c3nsc4ccccc34)CC1)[C@H]1C=C[C@@H]2C1,CHEMBL4254801,IC50,8.38,CHEMBL4277532,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3C=CC(C3)C2C(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H](C(=O)N1CCCN1CCN(c3cccc4sccc34)CC1)[C@H]1C=C[C@@H]2C1,CHEMBL4254801,IC50,7.49,CHEMBL4292655,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3C=CC(C3)C2C(=O)N1CCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H](C(=O)N1CCN1CCN(c3cccc4sccc34)CC1)[C@H]1C=C[C@@H]2C1,CHEMBL4254801,IC50,6.92,CHEMBL4285479,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3C=CC(C3)C2C(=O)N1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL4629186,Ki,6.43,CHEMBL4632519,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=C1C2C3CCC(C3)C2C(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL4629186,Ki,6.78,CHEMBL4636435,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=C1C2C3CCC(C3)C2C(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2cccc(Cl)c2)CC1,CHEMBL4629186,Ki,6.65,CHEMBL4635363,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=C1C2C3CCC(C3)C2C(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4629186,Ki,7.26,CHEMBL4639203,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=C1C2C3CCC(C3)C2C(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2ccccc2Cl)CC1,CHEMBL4629186,Ki,7.46,CHEMBL4645308,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=C1C2C3CCC(C3)C2C(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4629186,Ki,9.0,CHEMBL4641609,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=C1C2C3CCC(C3)C2C(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL4254801,IC50,8.32,CHEMBL4280940,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3CCC(C3)C2C(=O)N1CCCCN1CCC(c2noc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2ccc3ccsc3c2)CC1,CHEMBL4254801,IC50,7.1,CHEMBL4292250,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3CCC(C3)C2C(=O)N1CCCCN1CCN(c2ccc3ccsc3c2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,8.21,CHEMBL4284346,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1C2C3CCC(C3)C2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1,CHEMBL663159,Ki,7.55,CHEMBL1628275,1993,CHEMBL1126894,J Med Chem,Scientific Literature,Binding affinity for DA2 receptor,2,958,O=C1C2C3CCC(C3)C2C(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN1CCN(c2ncccn2)CC1,CHEMBL672311,Ki,6.34,CHEMBL274047,2001,CHEMBL1134832,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to Dopamine receptor D2 was determined,26,610,O=C1C2C3CCC(C3)C2C(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1C[C@@H]1CCCC[C@H]1CN1CCN(c2nsc3ccccc23)CC1,CHEMBL4314365,Ki,8.77,CHEMBL1237021,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,140,512,O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2c(F)cc(F)cc2CCC12CCN(CCc1ccccc1)CC2,CHEMBL673013,Ki,6.29,CHEMBL122165,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC12CCN(CCc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cc(Cl)c(Cl)cc2CC1CCN1CCN(c2ccccn2)CC1,CHEMBL4815619,Ki,5.51,CHEMBL4854456,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,152,118,O=C1c2ccccc2CC1CCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cc(Cl)ccc2CC1CCN1CCN(c2ccccn2)CC1,CHEMBL4815619,Ki,5.35,CHEMBL4876297,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,153,118,O=C1c2ccccc2CC1CCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cc([N+](=O)[O-])ccc2CCC1CCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL3106891,Ki,7.43,CHEMBL3104524,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,106,134,O=C1c2ccccc2CCC1CCN1CCC(c2noc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(Cl)cc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,6.26,CHEMBL4283369,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(Cl)cc2CC1CCCCN1CCN(c2ccccn2)CC1,CHEMBL4815619,Ki,5.98,CHEMBL4857665,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,153,118,O=C1c2ccccc2CC1CCCCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(Cl)cc2CC1CCN1CCc2ccccc2C1,CHEMBL3863657,Ki,6.02,CHEMBL3898250,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,122,59,O=C1c2ccccc2CC1CCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(Cl)cc2CCC12CCN(CCc1ccccc1)CC2,CHEMBL697295,Ki,5.96,CHEMBL122761,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,32,732,O=C1c2ccccc2CCC12CCN(CCc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(Cl)cc2CCC1C1CCN(CCc2ccccc2)CC1,CHEMBL673013,Ki,6.9,CHEMBL545058,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(F)cc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1,CHEMBL671418,Ki,8.0,CHEMBL336771,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(F)cc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,CHEMBL671418,Ki,7.4,CHEMBL421902,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(F)cc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,6.67,CHEMBL4277751,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(F)cc2CC1CCN1CCCN(c2ccc(Cl)cc2)CC1,CHEMBL1949469,Ki,5.99,CHEMBL1946124,2012,CHEMBL1944557,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,85,881,O=C1c2ccccc2CC1CCN1CCCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(F)cc2CC1CCN1CCCN(c2ccc(Cl)cc2)CC1,CHEMBL4688549,Ki,5.99,CHEMBL1946124,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,153,847,O=C1c2ccccc2CC1CCN1CCCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(F)cc2CC1CCN1CCCN(c2ccc(Cl)cn2)CC1,CHEMBL4688549,Ki,6.44,CHEMBL4558031,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,153,847,O=C1c2ccccc2CC1CCN1CCCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(F)cc2CC1CCN1CCCN(c2ccccn2)CC1,CHEMBL4688549,Ki,6.19,CHEMBL4570411,2021,CHEMBL4680313,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,153,847,O=C1c2ccccc2CC1CCN1CCCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(F)cc2CC1CCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL3292986,Ki,5.81,CHEMBL3289642,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,106,846,O=C1c2ccccc2CC1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(F)cc2CC1CCN1CCc2ccccc2C1,CHEMBL3863657,Ki,6.12,CHEMBL3958215,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,122,59,O=C1c2ccccc2CC1CCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(F)cc2CCC1C1CCN(CCc2ccccc2)CC1,CHEMBL673013,Ki,6.46,CHEMBL331470,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccc(F)cc2CCC1C1CCN(Cc2ccccc2)CC1,CHEMBL673013,Ki,7.21,CHEMBL122538,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc(Cl)c2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,7.52,CHEMBL4288388,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc(F)c2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1,CHEMBL671418,Ki,7.92,CHEMBL335844,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc(F)c2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,CHEMBL671418,Ki,7.6,CHEMBL339098,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc(F)c2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,7.42,CHEMBL4286905,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc(F)c2CCC1C1CCN(CCc2ccccc2)CC1,CHEMBL673013,Ki,6.7,CHEMBL543889,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2ccccc2[N+](=O)[O-])CC1,CHEMBL4390409,Ki,6.85,CHEMBL4469539,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,140,490,O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2ccccn2)CC1,CHEMBL4390409,Ki,5.88,CHEMBL4564093,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,140,490,O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4629186,Ki,7.23,CHEMBL4646868,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=C1c2cccc3cccc(c23)C(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(Br)cc2)CC1,CHEMBL4390419,Ki,6.69,CHEMBL4442062,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(C(F)(F)F)cc2)CC1,CHEMBL4390419,Ki,6.03,CHEMBL4545270,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1,CHEMBL4390419,Ki,6.61,CHEMBL4592962,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL4390419,Ki,6.71,CHEMBL4548353,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL4390419,Ki,6.3,CHEMBL4447594,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(Cl)c2)CC1,CHEMBL4390419,Ki,7.12,CHEMBL4519312,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4390419,Ki,7.03,CHEMBL4546775,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc3cccnc23)CC1,CHEMBL4390409,Ki,7.09,CHEMBL4458938,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,140,490,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc3cccnc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2C(F)(F)F)CC1,CHEMBL4390419,Ki,6.79,CHEMBL4585051,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2Cl)CC1,CHEMBL4390419,Ki,7.24,CHEMBL4567345,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2F)CC1,CHEMBL4390419,Ki,6.5,CHEMBL4541606,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2[N+](=O)[O-])CC1,CHEMBL4390409,Ki,6.37,CHEMBL4468036,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,140,490,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccn2)CC1,CHEMBL4390409,Ki,6.06,CHEMBL4442385,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,140,490,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ncccn2)CC1,CHEMBL4390409,Ki,6.73,CHEMBL4470304,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,140,490,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4629186,Ki,7.25,CHEMBL4637294,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=C1c2cccc3cccc(c23)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2/C=C\c2ccccc2N1CCCN1CCOCC1,CHEMBL4669829,Ki,4.72,CHEMBL4778076,2020,CHEMBL4665756,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),145,523,O=C1c2ccccc2C=Cc2ccccc2N1CCCN1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1,CHEMBL671418,Ki,7.6,CHEMBL338270,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C1c2ccccc2C(=O)N1CCCCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4629186,Ki,8.0,CHEMBL38409,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=C1c2ccccc2C(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1,CHEMBL671418,Ki,7.7,CHEMBL129979,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1,CHEMBL671418,Ki,8.3,CHEMBL133524,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,CHEMBL671418,Ki,7.6,CHEMBL414433,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C1c2ccccc2C(=O)N1CCCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL671385,Ki,7.96,CHEMBL306672,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,27,547,O=C1c2ccccc2C(=O)N1CCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1,CHEMBL671418,Ki,7.8,CHEMBL131495,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C1c2ccccc2C(=O)N1CCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1,CHEMBL895618,Ki,8.5,CHEMBL131495,2007,CHEMBL1148822,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor short form expressed in CHO cells,57,452,O=C1c2ccccc2C(=O)N1CCCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCN1CCC(N(Cc2ccccc2)c2ccccc2)CC1,CHEMBL897619,Ki,6.89,CHEMBL239708,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C1c2ccccc2C(=O)N1CCCCN1CCC(N(Cc2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCN1CCCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,CHEMBL897619,Ki,6.65,CHEMBL240587,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C1c2ccccc2C(=O)N1CCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1,CHEMBL897619,Ki,5.93,CHEMBL240379,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C1c2ccccc2C(=O)N1CCCCN1CCCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,CHEMBL897619,Ki,6.25,CHEMBL240378,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C1c2ccccc2C(=O)N1CCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,CHEMBL897619,Ki,6.22,CHEMBL240377,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C1c2ccccc2C(=O)N1CCCCN1CCN(C(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL671385,Ki,6.92,CHEMBL69717,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,27,547,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc(F)c2F)CC1,CHEMBL4259825,Ki,5.67,CHEMBL4294744,2018,CHEMBL4257542,Medchemcomm,Scientific Literature,Displacement of [3H]-sulpiride from human D2 receptor expressed in HEK293 cells after 150 mins by liquid scintillation counting method,132,929,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4254801,IC50,6.88,CHEMBL4294797,2018,CHEMBL4251643,Eur J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) after 60 mins by Ultra lance cAMP assay,132,130,O=C1c2ccccc2C(=O)N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCCN1CCN2c3ccccc3Cc3ccccc3C2C1,CHEMBL897619,Ki,6.09,CHEMBL238858,2007,CHEMBL1137479,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in HEK cells,57,755,O=C1c2ccccc2C(=O)N1CCCCN1CCN2c3ccccc3Cc3ccccc3C2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2C(=O)N1CCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1,CHEMBL671418,Ki,7.7,CHEMBL334956,2003,CHEMBL1136546,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]spiperone displacement.,36,61,O=C1c2ccccc2C(=O)N1CCCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CC1CCN1CCc2ccccc2C1,CHEMBL3863657,Ki,5.59,CHEMBL3978642,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,122,59,O=C1c2ccccc2CC1CCN1CCc2ccccc2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCC12CCN(CC1CCCCC1)CC2,CHEMBL673013,Ki,5.93,CHEMBL554437,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC12CCN(CC1CCCCC1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCC12CCN(CCc1ccccc1)CC2,CHEMBL673013,Ki,5.66,CHEMBL554873,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC12CCN(CCc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCC12CCN(Cc1ccc(C(F)(F)F)cc1)CC2,CHEMBL673013,Ki,5.66,CHEMBL123488,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCC12CCN(Cc1ccc(F)cc1)CC2,CHEMBL673013,Ki,5.94,CHEMBL545285,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCC12CCN(Cc1ccc([N+](=O)[O-])cc1)CC2,CHEMBL673013,Ki,5.71,CHEMBL544123,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCC12CCN(Cc1ccccc1)CC2,CHEMBL673013,Ki,5.46,CHEMBL554874,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC12CCN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCC1C1CCN(CC2CC2)CC1,CHEMBL673013,Ki,5.97,CHEMBL543176,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(CC2CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCC1C1CCN(CCc2ccccc2)CC1,CHEMBL673013,Ki,6.22,CHEMBL539288,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCC1C1CCN(Cc2ccc(C(F)(F)F)cc2)CC1,CHEMBL673013,Ki,6.24,CHEMBL552572,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCC1C1CCN(Cc2ccc(F)cc2)CC1,CHEMBL673013,Ki,7.21,CHEMBL545287,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCC1C1CCN(Cc2ccccc2)CC1,CHEMBL673013,Ki,6.0,CHEMBL544594,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,O=C1c2ccccc2CCC1C1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCCN1CCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL993531,Ki,7.44,CHEMBL476394,2009,CHEMBL1153914,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,67,741,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCCN1CCCCN1CCN(c2ccccn2)CC1,CHEMBL993531,Ki,6.64,CHEMBL476185,2009,CHEMBL1153914,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,67,741,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCCN1CCCCN1CCN(c2ncccn2)CC1,CHEMBL993531,Ki,6.82,CHEMBL476393,2009,CHEMBL1153914,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,67,741,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCCN1CCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL993531,Ki,6.66,CHEMBL477055,2009,CHEMBL1153914,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,67,741,O=C1c2ccccc2CCCN1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCCN1CCN1CCC(n2c(O)nc3cc(F)ccc32)CC1,CHEMBL672229,Ki,6.63,CHEMBL273921,2003,CHEMBL1136643,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human dopamine D2 receptor was determined,36,966,O=C1c2ccccc2CCCN1CCN1CCC(n2cnc3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCN1CCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL993531,Ki,7.94,CHEMBL477646,2009,CHEMBL1153914,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,67,741,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2Cl)CC1,CHEMBL993531,Ki,7.45,CHEMBL514382,2009,CHEMBL1153914,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,67,741,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CN1CCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL898619,Ki,6.12,CHEMBL240995,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,57,772,O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CN1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL898619,Ki,6.41,CHEMBL240996,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,57,772,O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CN1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL898624,Ki,7.58,CHEMBL240996,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,57,773,O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1,CHEMBL898619,Ki,6.72,CHEMBL240774,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,57,772,O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1,CHEMBL898624,Ki,7.22,CHEMBL240774,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,57,773,O=C1c2ccccc2CN1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1,CHEMBL4308346,Ki,6.98,CHEMBL4465181,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL4308346,Ki,7.55,CHEMBL4439795,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL4308346,Ki,8.15,CHEMBL4463030,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc(Cl)c2)CC1,CHEMBL4308346,Ki,7.41,CHEMBL4464512,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4308346,Ki,6.88,CHEMBL4569757,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc3ccccc23)CC1,CHEMBL4308346,Ki,8.1,CHEMBL4454105,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc3cccnc23)CC1,CHEMBL4308346,Ki,7.82,CHEMBL4434735,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2cccc3cccnc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,CHEMBL4308346,Ki,7.32,CHEMBL4540404,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2C(F)(F)F)CC1,CHEMBL4308346,Ki,7.57,CHEMBL4462839,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2Cl)CC1,CHEMBL4308346,Ki,7.35,CHEMBL4457109,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2F)CC1,CHEMBL4308346,Ki,7.62,CHEMBL4473026,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccn2)CC1,CHEMBL4308346,Ki,6.62,CHEMBL4592941,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ncccn2)CC1,CHEMBL4308346,Ki,7.29,CHEMBL4470487,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ncccn2)CC1,CHEMBL4821476,Ki,7.29,CHEMBL4470487,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4308346,Ki,8.05,CHEMBL4440695,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from full length human cloned D2L receptor expressed in HEK293 cells incubated for 1 hr by radioligand displacement assay,140,716,O=C1c2ccccc2S(=O)(=O)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL4821476,Ki,6.59,CHEMBL4867109,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL4821476,Ki,7.47,CHEMBL4874914,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4821476,Ki,7.77,CHEMBL4869198,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2cccc3ccccc23)CC1,CHEMBL4821476,Ki,7.7,CHEMBL4866981,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2cccc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccccc2)CC1,CHEMBL4821476,Ki,6.78,CHEMBL4872713,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccccn2)CC1,CHEMBL4821476,Ki,7.04,CHEMBL4853700,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ncccn2)CC1,CHEMBL4821476,Ki,6.02,CHEMBL4873100,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL4821476,Ki,6.75,CHEMBL238915,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL898619,Ki,6.75,CHEMBL238915,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,57,772,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL4821476,Ki,6.95,CHEMBL238916,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL898619,Ki,6.95,CHEMBL238916,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,57,772,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4821476,Ki,7.58,CHEMBL4860626,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,CHEMBL4821476,Ki,7.42,CHEMBL394110,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,CHEMBL898619,Ki,7.42,CHEMBL394110,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,57,772,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,CHEMBL898624,Ki,8.39,CHEMBL394110,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Antagonist activity at human Dopamine receptor D2 isoform long expressed in HEK293 cells assessed as change in quinpirole-induced intracellular calcium response,57,773,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1,CHEMBL4308338,Ki,5.91,CHEMBL8412,2019,CHEMBL4304820,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human cloned D2 receptor expressed in HEK293 cells by radioligand binding assay,140,967,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1,CHEMBL4821476,Ki,5.91,CHEMBL8412,2021,CHEMBL4819072,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in human HEK293 cells,153,765,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1,CHEMBL870200,Ki,6.96,CHEMBL8412,2006,CHEMBL1147799,J Med Chem,Scientific Literature,Binding affinity to D2 receptor by radioligand binding assay,49,232,O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=C1c2ccoc2CCC1CCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL1027240,Ki,7.34,CHEMBL164471,2008,CHEMBL1140101,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2 receptor,62,482,O=C1c2ccoc2CCC1CCN1CCC(c2noc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=CC1=Cc2cn(S(=O)(=O)c3cccc4ccccc34)c3cccc(c23)O1,CHEMBL3997508,Ki,5.29,CHEMBL4079631,2017,CHEMBL3994665,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),128,438,O=S(=O)(c1cccc2ccccc12)n1cc2c3c(cccc31)OC=C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=CN[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1,CHEMBL3705383,Ki,6.78,CHEMBL3695440,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",106,54,c1cc2c(c(C3CCN(CCC4CCCCC4)CC3)c1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=CN[C@H]1CC[C@H](CCN2CCC(c3coc4ccccc34)CC2)CC1,CHEMBL3706129,Ki,7.41,CHEMBL3676901,2014,CHEMBL3639297,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: liquots of membrane preparations were thawed at RT, resuspended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KC1, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein / well (D2, D3) and 15 ug protein / well (5-HT2A), respectively.The binding affinity (IQ) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ulÂ with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H] -spiperone for D2, 0.5 nM [3H] -spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10uM - 0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",106,55,c1ccc2c(C3CCN(CCC4CCCCC4)CC3)coc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=CN[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1,CHEMBL3705135,Ki,6.08,CHEMBL3642760,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)n1)CCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=CNc1cc(F)ccc1C(=O)CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCCS3,CHEMBL672312,Ki,8.11,CHEMBL164744,2003,CHEMBL1144968,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards DA D2 receptor using [3H]N-methyl-spiperone as radioligand.,36,116,O=C(CCCN1CCC2C(C1)c1cccc3c1N2CCCS3)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nn2ccccc12,CHEMBL3295080,Ki,8.0,CHEMBL3287401,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,106,391,c1ccc(N2CCN(CCCCOc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1c(OCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nn2ccccc12,CHEMBL3295081,Ki,7.85,CHEMBL3287401,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,106,392,c1ccc(N2CCN(CCCCOc3cc4ccccn4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,CHEMBL3293231,IC50,7.6,CHEMBL3287402,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,106,509,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,CHEMBL3295080,Ki,7.85,CHEMBL3287402,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,106,391,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,CHEMBL3295081,Ki,7.85,CHEMBL3287402,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,106,392,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1ccc(-c2ccc(C(=O)NC3CCN(Cc4ccccc4)C3)cc2)cc1,CHEMBL839650,Ki,5.43,CHEMBL427522,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1ccc(-c2ccccc2OCF)cc1,CHEMBL5119252,Ki,8.26,CHEMBL5187578,2022,CHEMBL5113516,J Med Chem,Scientific Literature,Competitive binding affinity to human D2R in transfected cells,155,968,c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL671731,Ki,5.02,CHEMBL346805,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,32,45,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn12,CHEMBL671732,Ki,5.04,CHEMBL346805,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,32,46,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1ccccc1-c1ccc(C(=O)NC2CCN(Cc3ccccc3)C2)cc1,CHEMBL839650,Ki,5.51,CHEMBL184551,2004,CHEMBL1137866,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from human Dopamine receptor D2S stably transfected in GH4C1 (rat pituitary) cells,38,818,O=C(NC1CCN(Cc2ccccc2)C1)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cccn1C1CCN(Cc2ccccc2)CC1,CHEMBL672580,Ki,5.82,CHEMBL109173,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,20,47,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cccn1C1CCN(Cc2ccccc2)CC1,CHEMBL673074,Ki,5.85,CHEMBL109173,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,20,48,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1ccn(C2CCN(Cc3ccccc3)CC2)c1,CHEMBL672580,Ki,4.19,CHEMBL422959,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,20,47,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1ccn(C2CCN(Cc3ccccc3)CC2)c1,CHEMBL673074,Ki,4.31,CHEMBL422959,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,20,48,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2c(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cccc12,CHEMBL3295080,Ki,7.29,CHEMBL3287400,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,106,391,c1ccc(N2CCN(CCCCOc3cccc4ccnn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2c(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cccc12,CHEMBL3295081,Ki,7.82,CHEMBL3287400,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,106,392,c1ccc(N2CCN(CCCCOc3cccc4ccnn34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccc12,CHEMBL3295080,Ki,8.21,CHEMBL3287399,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,106,391,c1ccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccc12,CHEMBL3295081,Ki,8.09,CHEMBL3287399,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,106,392,c1ccc(N2CCN(CCCCOc3ccc4ccnn4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(-n3cc(CCCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,CHEMBL3614290,Ki,6.96,CHEMBL3613875,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,113,431,c1ccc(N2CCN(CCCCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(-n3cc(CCCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,CHEMBL3614291,Ki,7.29,CHEMBL3613875,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,113,801,c1ccc(N2CCN(CCCCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(-n3cc(CCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,CHEMBL3614290,Ki,8.17,CHEMBL3613874,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,113,431,c1ccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(-n3cc(CCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,CHEMBL3614291,Ki,8.42,CHEMBL3613874,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,113,801,c1ccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(-n3cc(CCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,CHEMBL3614290,Ki,7.96,CHEMBL3613876,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cell membranes by radioligand competition binding assay,113,431,c1ccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(-n3cc(CCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12,CHEMBL3614291,Ki,8.1,CHEMBL3613876,2015,CHEMBL3612016,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO cell membranes by radioligand competition binding assay,113,801,c1ccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL4010153,Ki,9.39,CHEMBL4060403,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2S receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,128,360,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL4010156,Ki,9.52,CHEMBL4060403,2017,CHEMBL4007455,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human Dopamine D2L receptor expressed in CHO cell membranes after 2 hrs by scintillation counting analysis,128,361,O=C(CCCN1CCN(c2ccccc2)CC1)Nc1ccn2nccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc12,CHEMBL4046973,Ki,9.0,CHEMBL4103639,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,128,385,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc12,CHEMBL4046974,Ki,9.24,CHEMBL4103639,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,128,386,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc12,CHEMBL4046973,Ki,8.96,CHEMBL4079375,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,128,385,O=C1COc2c(cccc2N2CCN(CCCCOc3ccn4nccc4c3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc12,CHEMBL4046974,Ki,9.14,CHEMBL4079375,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,128,386,O=C1COc2c(cccc2N2CCN(CCCCOc3ccn4nccc4c3)CC2)N1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12,CHEMBL4046973,Ki,8.24,CHEMBL4095881,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,128,385,c1cc2c(c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12,CHEMBL4046974,Ki,8.54,CHEMBL4095881,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,128,386,c1cc2c(c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL3293231,IC50,6.44,CHEMBL3287397,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells assessed as inhibition of beta-arrestin recruitment after 6 hrs by chemiluminescence assay,106,509,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL3295080,Ki,8.34,CHEMBL3287397,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,106,391,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12,CHEMBL3295081,Ki,8.49,CHEMBL3287397,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,106,392,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2cccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c12,CHEMBL3295080,Ki,7.54,CHEMBL3287398,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,106,391,c1ccc(N2CCN(CCCCOc3cccn4nccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=Cc1cnn2cccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)c12,CHEMBL3295081,Ki,7.62,CHEMBL3287398,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,106,392,c1ccc(N2CCN(CCCCOc3cccn4nccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(CC(F)(F)F)N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1,CHEMBL3707837,Ki,7.13,CHEMBL3698016,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",106,112,c1cc2c(c(N3CCN(CCC4CCCCC4)CC3)c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc(C(F)(F)F)cc1,CHEMBL5046640,Ki,7.02,CHEMBL5089348,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,153,530,O=S(=O)(CC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc(Cl)c(Cl)c1,CHEMBL5046640,Ki,7.3,CHEMBL5077755,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,153,530,O=S(=O)(CC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc(F)c(Cl)c1,CHEMBL5046640,Ki,6.87,CHEMBL5080955,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,153,530,O=S(=O)(CC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc(F)c(F)c1,CHEMBL5046640,Ki,6.37,CHEMBL5093250,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,153,530,O=S(=O)(CC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc(F)cc1,CHEMBL5046640,Ki,6.59,CHEMBL5077178,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,153,530,O=S(=O)(CC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1ccc2ccccc2c1,CHEMBL5046640,Ki,8.28,CHEMBL5084167,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,153,530,O=S(=O)(CC1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1cccc(C(F)(F)F)c1,CHEMBL5046640,Ki,6.52,CHEMBL5082267,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,153,530,O=S(=O)(CC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1cccc(Cl)c1,CHEMBL5046640,Ki,6.79,CHEMBL5082182,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,153,530,O=S(=O)(CC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(CC1CCN(CCCc2noc3cc(F)ccc23)C1)c1cccc(F)c1,CHEMBL5046640,Ki,6.19,CHEMBL5083505,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,153,530,O=S(=O)(CC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(CCCOCCc1ccccc1)CCNCCc1ccc(O)c2nc(O)sc12,CHEMBL1810621,IC50,7.0,CHEMBL82663,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=S(=O)(CCCOCCc1ccccc1)CCNCCc1cccc2ncsc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CC2CCC(C1)N2CCOc1cccc(-c2ccccc2)c1)c1cccc(Cl)c1,CHEMBL3762073,Ki,7.03,CHEMBL3759819,2016,CHEMBL3758131,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,122,215,O=S(=O)(NC1CC2CCC(C1)N2CCOc1cccc(-c2ccccc2)c1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CC(O)COc2ccccc2-c2ccccc2)CC1)c1cccc(Cl)c1,CHEMBL4178665,Ki,6.46,CHEMBL4212199,2017,CHEMBL4177556,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 or CHO-K1 cells after 1 hr by microbeta counting analysis,128,217,O=S(=O)(NC1CCN(CCCOc2ccccc2-c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2cc(Cl)ccc2Cl)C1)c1ccc(Cl)s1,CHEMBL2162846,Ki,7.11,CHEMBL2159475,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,85,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2cccc(Cl)c2Cl)C1)c1ccc(Cl)s1,CHEMBL2162846,Ki,7.17,CHEMBL2159474,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,85,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2cccc(F)c2)C1)c1ccc(F)c(F)c1,CHEMBL2162846,Ki,6.28,CHEMBL2159482,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,85,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2cccc(F)c2)C1)c1cccs1,CHEMBL2162846,Ki,6.14,CHEMBL2159473,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,85,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2cccc3c2CCCC3)C1)c1cc(F)ccc1F,CHEMBL2162846,Ki,7.22,CHEMBL2159484,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,85,218,O=S(=O)(NC1CCN(CCOc2cccc3c2CCCC3)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2cccc3c2CCCC3)C1)c1ccc(F)cc1,CHEMBL2162846,Ki,7.14,CHEMBL2159480,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,85,218,O=S(=O)(NC1CCN(CCOc2cccc3c2CCCC3)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2cccc3c2CCCC3)C1)c1cccs1,CHEMBL2162846,Ki,7.14,CHEMBL2159472,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,85,218,O=S(=O)(NC1CCN(CCOc2cccc3c2CCCC3)C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1ccc(Cl)s1,CHEMBL2162846,Ki,6.5,CHEMBL2159476,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,85,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1ccc(F)cc1,CHEMBL2162846,Ki,7.96,CHEMBL2159479,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NC1CCN(CCOc2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1cccs1,CHEMBL2162846,Ki,7.08,CHEMBL2159464,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NC1CCN(CCOc2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1cc(F)ccc1F,CHEMBL2162846,Ki,7.75,CHEMBL2159483,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc(F)c(F)c1,CHEMBL2162846,Ki,7.62,CHEMBL2159481,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1cccs1,CHEMBL2162846,Ki,7.8,CHEMBL2159471,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccc(F)c(F)c1,CHEMBL2162846,Ki,7.2,CHEMBL2159466,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccc(F)c(F)c1,CHEMBL3744663,Ki,7.2,CHEMBL2159466,2015,CHEMBL3739404,Medchemcomm,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,113,219,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1cccc(Cl)c1,CHEMBL3744663,Ki,7.07,CHEMBL3740055,2015,CHEMBL3739404,Medchemcomm,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,113,219,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NC1CCN(CCOc2ccccc2C2CCCC2)CC1)c1cccc(F)c1,CHEMBL3762073,Ki,6.49,CHEMBL3758591,2016,CHEMBL3758131,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells after 1 hr,122,215,O=S(=O)(NC1CCN(CCOc2ccccc2C2CCCC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCC1CCN(CCOc2cccc(F)c2)CC1)c1ccc(F)cc1,CHEMBL2162846,Ki,6.08,CHEMBL2159459,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NCC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCC1CCN(CCOc2cccc(F)c2)CC1)c1cccc(Cl)c1,CHEMBL2162846,Ki,6.25,CHEMBL2159462,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NCC1CCN(CCOc2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCC1CCN(CCOc2cccc(F)c2)CC1)c1cccs1,CHEMBL2162846,Ki,5.97,CHEMBL2159456,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NCC1CCN(CCOc2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccc(Cl)s1,CHEMBL2162846,Ki,7.5,CHEMBL2159455,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NCC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccc(F)cc1,CHEMBL2162846,Ki,7.34,CHEMBL2159458,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NCC1CCN(CCOc2ccccc2-c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1,CHEMBL4629186,Ki,7.57,CHEMBL4645525,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=S(=O)(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1cccc2ccccc12,CHEMBL4629186,Ki,7.51,CHEMBL4636031,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=S(=O)(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,CHEMBL4629186,Ki,7.51,CHEMBL4641296,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=S(=O)(NCCCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(Cl)cc1,CHEMBL4041093,Ki,8.35,CHEMBL4070715,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(F)cc1,CHEMBL4041093,Ki,8.36,CHEMBL4095979,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc2ccccc2c1,CHEMBL4041093,Ki,8.59,CHEMBL4074195,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(Cl)c1,CHEMBL4041093,Ki,9.0,CHEMBL4070254,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(F)c1,CHEMBL4041093,Ki,8.74,CHEMBL4087852,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(O)c1,CHEMBL4041093,Ki,8.6,CHEMBL4066971,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc2ccccc12,CHEMBL4041093,Ki,8.64,CHEMBL4096479,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1)c1ccc2ccccc2c1,CHEMBL4041093,Ki,9.52,CHEMBL4062817,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccc(Cl)cc2s1,CHEMBL3297244,Ki,8.92,CHEMBL3290014,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1,CHEMBL3297244,Ki,8.7,CHEMBL3290012,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1,CHEMBL3297335,Ki,8.74,CHEMBL3290012,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human recombinant D2S receptor expressed in HEK293 cells,106,159,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(Cl)c(Cl)c1,CHEMBL3297244,Ki,7.82,CHEMBL3289994,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(F)c(Cl)c1,CHEMBL3297244,Ki,7.58,CHEMBL3289996,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(OC(F)(F)F)cc1,CHEMBL3297244,Ki,7.19,CHEMBL3289998,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc2cc(Cl)ccc2c1,CHEMBL3297244,Ki,9.0,CHEMBL3290008,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc2ccccc2c1,CHEMBL3297244,Ki,8.96,CHEMBL3290006,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cccc2ccccc12,CHEMBL3297244,Ki,8.52,CHEMBL3290003,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cccc2scnc12,CHEMBL3297244,Ki,7.6,CHEMBL3290021,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1cccc2scnc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1csc2ccccc12,CHEMBL3297244,Ki,7.66,CHEMBL3290010,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCC(c2noc3ccccc23)CC1)c1csc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2cn1,CHEMBL2321509,Ki,7.77,CHEMBL2312639,2013,CHEMBL2311489,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,95,959,O=S(=O)(NCCCCN1CCN(c2ccccc2)CC1)c1cc2ccccc2cn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1,CHEMBL884780,Ki,7.41,CHEMBL195247,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2L receptor using CHO cell line and [3H]spiperone as radioligand ,43,787,O=S(=O)(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc(F)cc1,CHEMBL884781,Ki,7.31,CHEMBL195247,2005,CHEMBL1143473,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine D2S receptor using CHO cell line and [3H]spiperone as radioligand ,43,788,O=S(=O)(NCCCCN1CCN(c2ccccc2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2cccnc2c1,CHEMBL2321509,Ki,7.96,CHEMBL2312637,2013,CHEMBL2311489,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,95,959,O=S(=O)(NCCCCN1CCN(c2ccccc2)CC1)c1ccc2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cnc2ccccc2c1,CHEMBL2321509,Ki,8.05,CHEMBL2312935,2013,CHEMBL2311489,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,95,959,O=S(=O)(NCCCCN1CCN(c2ccccc2)CC1)c1cnc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cncc2ccccc12,CHEMBL2321509,Ki,8.1,CHEMBL2312640,2013,CHEMBL2311489,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,95,959,O=S(=O)(NCCCCN1CCN(c2ccccc2)CC1)c1cncc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccc(Cl)cc2s1,CHEMBL3297244,Ki,7.27,CHEMBL3289984,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccccc2s1,CHEMBL3297244,Ki,5.89,CHEMBL3289982,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc(Cl)c(Cl)c1,CHEMBL3297244,Ki,7.24,CHEMBL3289970,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc(F)c(Cl)c1,CHEMBL3297244,Ki,7.11,CHEMBL3289972,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc(OC(F)(F)F)cc1,CHEMBL3297244,Ki,6.4,CHEMBL3289974,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc2cc(Cl)ccc2c1,CHEMBL3297244,Ki,7.29,CHEMBL3289980,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc2ccccc2c1,CHEMBL3297244,Ki,7.82,CHEMBL3289978,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cccc2scnc12,CHEMBL3297244,Ki,6.77,CHEMBL3289989,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cccc2scnc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cccs1,CHEMBL3297244,Ki,8.28,CHEMBL3289976,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cnc2ccccn12,CHEMBL3297244,Ki,7.0,CHEMBL3289987,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2noc3ccccc23)CC1)c1cnc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cc2ccc(Cl)cc2s1,CHEMBL3297244,Ki,7.35,CHEMBL3289960,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cc2ccccc2s1,CHEMBL3297244,Ki,7.82,CHEMBL3289958,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(Cl)c(Cl)c1,CHEMBL3297244,Ki,7.57,CHEMBL3289946,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(F)c(Cl)c1,CHEMBL3297244,Ki,7.41,CHEMBL3286432,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(OC(F)(F)F)cc1,CHEMBL3297244,Ki,7.32,CHEMBL3289949,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2cc(Cl)ccc2c1,CHEMBL3297244,Ki,7.31,CHEMBL3289956,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1,CHEMBL3297244,Ki,9.05,CHEMBL3289954,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cccc2scnc12,CHEMBL3297244,Ki,7.8,CHEMBL3289966,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cccc2scnc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cccs1,CHEMBL3297244,Ki,8.49,CHEMBL3289951,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cnc2ccccn12,CHEMBL3297244,Ki,7.34,CHEMBL3289964,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCCN1CCN(c2nsc3ccccc23)CC1)c1cnc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(Cl)cc1,CHEMBL4041093,Ki,8.57,CHEMBL4103725,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(F)cc1,CHEMBL4041093,Ki,8.46,CHEMBL4077937,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc2ccccc2c1,CHEMBL4041093,Ki,8.43,CHEMBL4100951,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(Cl)c1,CHEMBL4041093,Ki,8.25,CHEMBL4091193,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(F)c1,CHEMBL4041093,Ki,8.77,CHEMBL4075144,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(O)c1,CHEMBL4041093,Ki,8.59,CHEMBL4080399,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc2ccccc12,CHEMBL4041093,Ki,8.55,CHEMBL4069237,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1)c1ccc2ccccc2c1,CHEMBL4041093,Ki,9.15,CHEMBL4092243,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccc(Cl)cc2s1,CHEMBL3297244,Ki,7.57,CHEMBL3290013,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1,CHEMBL3297244,Ki,7.96,CHEMBL3290011,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(Cl)c(Cl)c1,CHEMBL3297244,Ki,7.85,CHEMBL3289993,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,106,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(F)c(Cl)c1,CHEMBL3297244,Ki,8.43,CHEMBL3289995,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc(OC(F)(F)F)cc1,CHEMBL3297244,Ki,7.48,CHEMBL3289997,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc2cc(Cl)ccc2c1,CHEMBL3297244,Ki,7.64,CHEMBL3290007,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc2ccccc2c1,CHEMBL3297244,Ki,9.0,CHEMBL3290005,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cccc2ccccc12,CHEMBL3297244,Ki,8.4,CHEMBL3290002,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cccs1,CHEMBL3297244,Ki,8.06,CHEMBL3289999,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cnc2ccccn12,CHEMBL3297244,Ki,7.82,CHEMBL3290018,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1cnc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1csc2ccccc12,CHEMBL3297244,Ki,7.44,CHEMBL3290009,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCC(c2noc3ccccc23)CC1)c1csc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1ccc2cccnc2c1,CHEMBL2321509,Ki,7.8,CHEMBL2312934,2013,CHEMBL2311489,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human dopamine D2L receptor expressed in HEK293 after 1 hr,95,959,O=S(=O)(NCCCN1CCN(c2ccccc2)CC1)c1ccc2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccc(Cl)cc2s1,CHEMBL3297244,Ki,7.52,CHEMBL3289983,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccccc2s1,CHEMBL3297244,Ki,7.82,CHEMBL3289981,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1ccc(OC(F)(F)F)cc1,CHEMBL3297244,Ki,7.2,CHEMBL3289973,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1ccc2ccccc2c1,CHEMBL3297244,Ki,5.14,CHEMBL3289977,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1cccs1,CHEMBL3297244,Ki,7.26,CHEMBL3289975,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2noc3ccccc23)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cc2ccccc2s1,CHEMBL3297244,Ki,7.32,CHEMBL3289957,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(Cl)c(Cl)c1,CHEMBL3297244,Ki,8.11,CHEMBL3289945,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(F)c(Cl)c1,CHEMBL3297244,Ki,7.43,CHEMBL3289947,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc(OC(F)(F)F)cc1,CHEMBL3297244,Ki,7.57,CHEMBL3289948,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2cc(Cl)ccc2c1,CHEMBL3297244,Ki,8.22,CHEMBL3289955,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1,CHEMBL3297244,Ki,8.66,CHEMBL3289953,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cccc2scnc12,CHEMBL3297244,Ki,7.57,CHEMBL3289965,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cccc2scnc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cccs1,CHEMBL3297244,Ki,7.25,CHEMBL3289950,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cnc2ccccn12,CHEMBL3297244,Ki,7.58,CHEMBL3289963,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCCN1CCN(c2nsc3ccccc23)CC1)c1cnc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(Cl)cc1,CHEMBL4041093,Ki,7.96,CHEMBL4085802,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc(F)cc1,CHEMBL4041093,Ki,8.0,CHEMBL4088249,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1ccc2ccccc2c1,CHEMBL4041093,Ki,7.36,CHEMBL4084492,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(Cl)c1,CHEMBL4041093,Ki,7.64,CHEMBL4066532,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(F)c1,CHEMBL4041093,Ki,8.62,CHEMBL4095555,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc(O)c1,CHEMBL4041093,Ki,8.82,CHEMBL4104622,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1)c1cccc2ccccc12,CHEMBL4041093,Ki,7.43,CHEMBL4104216,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCN1CC=C(c2c[nH]c3ccc(F)cc23)CC1)c1ccc2ccccc2c1,CHEMBL4041093,Ki,7.85,CHEMBL4071451,2017,CHEMBL4038339,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor expressed in CHO-K1 cells after 60 mins by scintillation counting,128,826,O=S(=O)(NCCN1CC=C(c2c[nH]c3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCN1CCC(c2noc3cc(F)ccc23)CC1)c1ccc2ccccc2c1,CHEMBL3297244,Ki,8.28,CHEMBL3290004,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCN1CCC(c2noc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cccc2ccccc12,CHEMBL3297244,Ki,8.04,CHEMBL3290001,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCN1CCC(c2noc3ccccc23)CC1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(NCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1,CHEMBL3297244,Ki,7.75,CHEMBL3289952,2014,CHEMBL3286108,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant D2 receptor expressed in CHO-K1 cell membrane after 60 mins by liquid scintillation counting analysis,107,833,O=S(=O)(NCCN1CCN(c2nsc3ccccc23)CC1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccc(Cl)cc2s1,CHEMBL4685403,Ki,8.08,CHEMBL4751063,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccc(F)cc2s1,CHEMBL4685403,Ki,8.85,CHEMBL4754193,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2o1,CHEMBL4685403,Ki,8.91,CHEMBL4764006,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,CHEMBL4685403,Ki,9.35,CHEMBL4795995,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc(F)c(Cl)c1,CHEMBL4685403,Ki,7.25,CHEMBL4775997,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc(F)cc1,CHEMBL4685403,Ki,7.02,CHEMBL4758402,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc2cc(Cl)ccc2c1,CHEMBL4685403,Ki,8.59,CHEMBL4760655,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1,CHEMBL4685403,Ki,9.7,CHEMBL4747225,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cccc(Cl)c1,CHEMBL4685403,Ki,7.25,CHEMBL4784228,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1cccc2ccccc12,CHEMBL4685403,Ki,7.69,CHEMBL4754138,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCCc2noc3ccccc23)C1)c1csc2ccccc12,CHEMBL4685403,Ki,7.7,CHEMBL4793608,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1csc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc(Cl)s1,CHEMBL2162846,Ki,7.41,CHEMBL2159488,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@@H]1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc(F)cc1,CHEMBL2162846,Ki,7.8,CHEMBL2159489,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccc(Cl)cc2s1,CHEMBL4685403,Ki,7.46,CHEMBL4763106,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccc(F)cc2s1,CHEMBL4685403,Ki,7.75,CHEMBL4762226,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2o1,CHEMBL4685403,Ki,8.25,CHEMBL4753094,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,CHEMBL4685403,Ki,7.79,CHEMBL4764468,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cc2ccccc2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc(F)c(Cl)c1,CHEMBL4685403,Ki,6.77,CHEMBL4750587,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc(F)cc1,CHEMBL4685403,Ki,6.49,CHEMBL4796647,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc2cc(Cl)ccc2c1,CHEMBL4685403,Ki,6.99,CHEMBL4748107,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1,CHEMBL4685403,Ki,7.85,CHEMBL4763085,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccc2ccccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cccc(Cl)c1,CHEMBL4685403,Ki,7.0,CHEMBL4741142,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1cccc2ccccc12,CHEMBL4685403,Ki,7.49,CHEMBL4776225,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1cccc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCCc2noc3ccccc23)C1)c1csc2ccccc12,CHEMBL4685403,Ki,7.36,CHEMBL4782149,2020,CHEMBL4680205,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from recombinant human D2 receptor expressed in CHOK1 cell membranes measured after 60 mins by microbeta counting method,145,736,O=S(=O)(NC1CCN(CCCc2noc3ccccc23)C1)c1csc2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc(Cl)s1,CHEMBL2162846,Ki,8.1,CHEMBL2159491,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccc(F)cc1,CHEMBL2162846,Ki,8.0,CHEMBL2159492,2012,CHEMBL2157986,Eur J Med Chem,Scientific Literature,Binding affinity to human dopamine D2L receptor expressed in HEK293 cells after 1 hr,86,218,O=S(=O)(NC1CCN(CCOc2ccccc2-c2ccccc2)C1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F,CHEMBL889238,Ki,6.73,CHEMBL228280,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,57,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2,CHEMBL889238,Ki,7.18,CHEMBL389104,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,57,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F,CHEMBL889238,Ki,7.11,CHEMBL228445,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,57,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1,CHEMBL889238,Ki,6.81,CHEMBL387832,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,57,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2,CHEMBL889238,Ki,7.24,CHEMBL439197,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,57,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccc2c(c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1,CHEMBL889238,Ki,7.07,CHEMBL228496,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,57,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@@H](N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1cc(Cl)ccc1F,CHEMBL894519,Ki,6.37,CHEMBL234476,2007,CHEMBL1148021,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human dopamine D2 receptor,57,209,O=S(=O)(NC1CCC(N2CCN(c3ccccc3OCC3CC3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccc(F)cc1,CHEMBL3705383,Ki,6.98,CHEMBL3695403,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",107,54,O=S(=O)(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1,CHEMBL3705383,Ki,6.86,CHEMBL3695402,2014,CHEMBL3638568,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 ug protein/well (D2, D3) and 15 ug protein/well (5-HT2A), respectively.The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 ul with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 uM-0.1 nM for 1 h at RT. At the end of the incubation, the reaction mixtures were filtered on to unifilter 96-well white microplates with bonded GF/C filters.",107,54,O=S(=O)(NC1CCC(CCN2CCC(c3cccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)N1CCOCC1,CHEMBL3707825,Ki,6.64,CHEMBL3664891,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,111,O=S(=O)(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)N1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccc(F)cc1,CHEMBL3707825,Ki,6.98,CHEMBL3664883,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,111,O=S(=O)(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,CHEMBL3707825,Ki,7.2,CHEMBL3664882,2013,CHEMBL3638396,,BindingDB Patent Bioactivity Data,"Biochemical Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,111,O=S(=O)(NC1CCC(CCN2CCC(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)N1CCOCC1,CHEMBL3707837,Ki,7.2,CHEMBL3698026,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",107,112,O=S(=O)(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)N1CCOCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccc(F)cc1,CHEMBL3707837,Ki,7.34,CHEMBL3698018,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",107,112,O=S(=O)(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,CHEMBL3707837,Ki,7.14,CHEMBL3698017,2014,CHEMBL3639169,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Aliquots of membrane preparations were thawed at RT, resupended in assay buffer (D2, D3: 50 mM Tris-HCl, 120 mM NaCl, 5 mM MgCl2, 1 mM EDTA, 5 mM KCl, 1.5 mM CaCl2, pH=7.4; 5-HT2A: 50 mM Tris-HCl, 10 mM MgCl2, 1 mM EGTA, pH=7.4), homogenized with a Polytron for 20-30 sec at 12.000 rpm and adjusted to a final concentration of approximately 7.5 μg protein/well (D2, D3) and 15 μg protein/well (5-HT2A), respectively. The binding affinity (Ki) of the compounds was determined using radioligand binding. Membranes were incubated in a total volume of 200 μl with a fixed concentration of radioligand (final concentration approximately 0.7 nM [3H]-spiperone for D2, 0.5 nM [3H]-spiperone for D3, and 1.1 nM [3H]-ketanserin for 5-HT2A) and ten concentrations of test compound in ranging between 10 μM-0.1 nM for 1 h at RT.",107,112,O=S(=O)(NC1CCC(CCN2CCN(c3cccc4c3OCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccc(F)cc1,CHEMBL3705135,Ki,6.62,CHEMBL3642727,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=S(=O)(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,CHEMBL3705135,Ki,6.62,CHEMBL3642814,2013,CHEMBL3639183,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The ability of the compounds to bind to the 5-HT2A, D3 and D2 receptors was determined using radioligand binding to cloned receptors selectively expressed in HEK-293 EBNA cells.",95,56,O=S(=O)(NC1CCC(CCN2CCN(c3nccc4c3CCO4)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccnc1,CHEMBL3872755,Ki,9.46,CHEMBL3933256,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=S(=O)(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccnc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccs1,CHEMBL3872755,Ki,9.37,CHEMBL3966842,2016,CHEMBL3872208,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from recombinant human D2L receptor expressed in CHO cell membranes after 60 mins by scintillation counting method,122,114,O=S(=O)(NC1CCC(CCN2CCN(c3nsc4ccccc34)CC2)CC1)c1cccs1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1cc(Cl)ccc1F,CHEMBL889238,Ki,6.8,CHEMBL228332,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,57,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2,CHEMBL889238,Ki,7.15,CHEMBL228333,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,58,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3OC3CC3)CC2)CC1)c1ccc2c(c1)OCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cc(Cl)ccc1F,CHEMBL889238,Ki,7.43,CHEMBL228494,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,58,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc(OC(F)F)cc1,CHEMBL889238,Ki,6.98,CHEMBL228554,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,58,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1ccc2c(c1)OCCO2,CHEMBL889238,Ki,7.64,CHEMBL228390,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,58,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccc2c(c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(N[C@H]1CC[C@H](N2CCC(c3ccccc3OCC(F)(F)F)CC2)CC1)c1cccc(OC(F)F)c1,CHEMBL889238,Ki,6.89,CHEMBL228553,2007,CHEMBL1145372,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,58,202,O=S(=O)(NC1CCC(N2CCC(c3ccccc3)CC2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(Nc1ccc([C@]23CNC[C@H]2C3)cc1)c1ccc(OC(F)(F)F)cc1,CHEMBL1225698,Ki,6.0,CHEMBL1224701,2010,CHEMBL1221332,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor by GTPgammaS binding assay,75,93,O=S(=O)(Nc1ccc(C23CNCC2C3)cc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccc(-c2ccccc2)cc1,CHEMBL1108513,Ki,6.2,CHEMBL1078207,2009,CHEMBL1154336,Bioorg Med Chem Lett,Scientific Literature,Agonist activity at dopamine D2 receptor,67,200,O=S(=O)(Nc1ccc2c(c1)CCN(Cc1cc[nH]n1)CC2)c1ccc(-c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(Oc1cccc([C@@H]2CCCN(CCc3ccccc3)C2)c1)C(F)(F)F,CHEMBL678343,Ki,7.14,CHEMBL328119,1994,CHEMBL1127438,J Med Chem,Scientific Literature,"Affinity against recombinant dopamine receptor (DA) D2 expressed in CHO-K1 cells, using [3H]-spiperone as radioligand",4,257,c1ccc(CCN2CCCC(c3ccccc3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccc(C(F)(F)F)cc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C1COC1,CHEMBL4686220,IC50,8.64,CHEMBL4746981,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,145,193,O=S(=O)(c1ccccc1)N(CCCN1CCC(c2noc3ccccc23)CC1)C1COC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccc(Cl)cc1)C1CCN(CCc2ccc(F)cc2F)CC1,CHEMBL697295,Ki,5.96,CHEMBL149429,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,32,732,O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccc(Cl)cc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C1COC1,CHEMBL4686220,IC50,8.7,CHEMBL4759817,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,145,193,O=S(=O)(c1ccccc1)N(CCCN1CCC(c2noc3ccccc23)CC1)C1COC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccc(F)cc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1,CHEMBL830303,Ki,6.5,CHEMBL175832,2005,CHEMBL1142766,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2,43,745,O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccc(F)cc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1,CHEMBL886666,Ki,6.51,CHEMBL175832,2007,CHEMBL1139157,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,58,969,O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccc(F)cc1)N(CC1CC1)C1CCN(CCOc2ccccc2-c2ccccc2)CC1,CHEMBL3750144,Ki,7.43,CHEMBL3745853,2016,CHEMBL3745654,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr,123,167,O=S(=O)(c1ccccc1)N(CC1CC1)C1CCN(CCOc2ccccc2-c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccc(F)cc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C1COC1,CHEMBL4686220,IC50,8.52,CHEMBL4787495,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,145,193,O=S(=O)(c1ccccc1)N(CCCN1CCC(c2noc3ccccc23)CC1)C1COC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccc(N2CCC2)cc1)C1(F)CCN(CCc2ccc(F)cc2F)CC1,CHEMBL830303,Ki,5.7,CHEMBL176109,2005,CHEMBL1142766,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2,43,745,O=S(=O)(c1ccc(N2CCC2)cc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccc2cccnc2c1)n1cc(C2=CCNCC2)c2cc(Cl)ccc21,CHEMBL4426355,Ki,5.93,CHEMBL4572158,2016,CHEMBL4425120,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells by microbeta liquid scintillation counting,123,734,O=S(=O)(c1ccc2cccnc2c1)n1cc(C2=CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccc2ncccc2c1)n1cc(C2=CCNCC2)c2ccccc21,CHEMBL4426355,Ki,5.85,CHEMBL4442456,2016,CHEMBL4425120,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-Raclopride from human D2L receptor expressed in HEK293 cells by microbeta liquid scintillation counting,123,734,O=S(=O)(c1ccc2ncccc2c1)n1cc(C2=CCNCC2)c2ccccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc(Cl)c1)n1c(-c2ccccc2)nc2c(N3CCNCC3)nccc21,CHEMBL4736131,Ki,6.13,CHEMBL4799851,2021,CHEMBL4732141,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L expressed in CHO-K1 cell membranes incubated for 1 hr by micro-beta plate reader based analysis,153,222,O=S(=O)(c1ccccc1)n1c(-c2ccccc2)nc2c(N3CCNCC3)nccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc(Cl)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21,CHEMBL4844536,Ki,5.87,CHEMBL4846153,2021,CHEMBL4842371,J Med Chem,Scientific Literature,Displacement of [3H]-haloperidol from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,153,869,O=S(=O)(c1ccccc1)n1ccc2c(N3CCNCC3)nc3ccccc3c21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc(Cl)c1)n1cnc2c(N3CCNCC3)nccc21,CHEMBL4736131,Ki,6.34,CHEMBL4777550,2021,CHEMBL4732141,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L expressed in CHO-K1 cell membranes incubated for 1 hr by micro-beta plate reader based analysis,153,222,O=S(=O)(c1ccccc1)n1cnc2c(N3CCNCC3)nccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc(F)c1)C1(F)CCN(CCc2ccc(F)cc2F)CC1,CHEMBL830303,Ki,6.1,CHEMBL177401,2005,CHEMBL1142766,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2,43,745,O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc(F)c1)n1ccc2c(N3CCNCC3)nc3ccccc3c21,CHEMBL4844536,Ki,5.36,CHEMBL4867565,2021,CHEMBL4842371,J Med Chem,Scientific Literature,Displacement of [3H]-haloperidol from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,153,869,O=S(=O)(c1ccccc1)n1ccc2c(N3CCNCC3)nc3ccccc3c21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ccccc12)c1nn(Cc2ccccc2)c2ccc(N3CCNCC3)cc12,CHEMBL1286377,Ki,6.22,CHEMBL1278001,2010,CHEMBL1275334,J Med Chem,Scientific Literature,Displacement of [3H]LSD from human cloned dopamine D2 receptor expressed in human HeLa cells,75,192,O=S(=O)(c1cccc2ccccc12)c1nn(Cc2ccccc2)c2ccc(N3CCNCC3)cc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ccccc12)n1cc2c3c(cccc31)OC(CO)=C2,CHEMBL3997508,Ki,5.37,CHEMBL4068850,2017,CHEMBL3994665,ACS Med Chem Lett,Scientific Literature,Displacement of [3H]-Raclopride from D2L receptor (unknown origin),128,438,O=S(=O)(c1cccc2ccccc12)n1cc2c3c(cccc31)OC=C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2cnccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,8.3,CHEMBL4238479,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2cnccc12)N1CCCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2cnccc12)N1CCC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,9.52,CHEMBL4239091,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2cnccc12)N1CCCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2cnccc12)N1CCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,8.3,CHEMBL4244691,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2cnccc12)N1CCCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2cnccc12)N1CCC[C@H]1CCN1CCN(c2noc3ccccc23)CC1,CHEMBL4229838,Ki,8.52,CHEMBL4243579,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2cnccc12)N1CCCC1CCN1CCN(c2noc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2cnccc12)N1CCC[C@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,9.3,CHEMBL4242392,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2cnccc12)N1CCCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccc(Cl)c(Cl)c3)CC2)CC1,CHEMBL4036228,Ki,6.92,CHEMBL4066426,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccc(Cl)cc3)CC2)CC1,CHEMBL4036228,Ki,6.85,CHEMBL4080398,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccc(F)cc3)CC2)CC1,CHEMBL4036228,Ki,6.65,CHEMBL4076525,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)CC1,CHEMBL4036228,Ki,6.83,CHEMBL4081383,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3cccc(Cl)c3)CC2)CC1,CHEMBL4036228,Ki,7.12,CHEMBL4076408,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL4036228,Ki,7.44,CHEMBL4082456,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3cccc(F)c3)CC2)CC1,CHEMBL4036228,Ki,5.74,CHEMBL4077538,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,CHEMBL4036228,Ki,5.91,CHEMBL4076903,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cccc2ncccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCCCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,8.0,CHEMBL4241497,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCCCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCCCC[C@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,8.4,CHEMBL4240162,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCCCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCCC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,7.68,CHEMBL4248544,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCCC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,8.15,CHEMBL4241081,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1,CHEMBL4229838,Ki,7.82,CHEMBL4245622,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL4229838,Ki,8.7,CHEMBL4250475,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CCC(c2noc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3[nH]ccc23)CC1,CHEMBL4229838,Ki,8.1,CHEMBL4248597,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CCN(c2cccc3[nH]ccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3c2OCCO3)CC1,CHEMBL4229838,Ki,7.92,CHEMBL4238124,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CCN(c2cccc3c2OCCO3)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,8.4,CHEMBL4243848,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,9.15,CHEMBL4242858,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1,CHEMBL4229838,Ki,7.96,CHEMBL4249426,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL4229838,Ki,8.77,CHEMBL4241050,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CCC(c2noc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCN(c2cccc3[nH]ccc23)CC1,CHEMBL4229838,Ki,7.38,CHEMBL4238029,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CCN(c2cccc3[nH]ccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCN(c2cccc3c2OCCO3)CC1,CHEMBL4229838,Ki,7.89,CHEMBL4241830,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CCN(c2cccc3c2OCCO3)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,7.8,CHEMBL4240954,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCN(c2noc3ccccc23)CC1,CHEMBL4229838,Ki,8.4,CHEMBL4249179,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CCN(c2noc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CCC[C@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,9.0,CHEMBL4246202,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,7.62,CHEMBL4243932,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cccc2ncccc12)N1CC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,7.96,CHEMBL4238897,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cccc2ncccc12)N1CCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)C1CCN(CCc2ccc(F)cc2F)CC1,CHEMBL697295,Ki,5.85,CHEMBL145939,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,32,732,O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)N(CCCCCCN1CCN(c2nsc3ccccc23)CC1)c1cccc(C(F)(F)F)c1,CHEMBL4629186,Ki,6.79,CHEMBL4648390,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=S(=O)(c1ccccc1)N(CCCCCCN1CCN(c2nsc3ccccc23)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)N(CCCN1CCC(c2noc3cc(F)ccc23)CC1)C1COC1,CHEMBL4686220,IC50,8.72,CHEMBL4776840,2020,CHEMBL4680230,Eur J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor expressed in HEK293 cells incubated for 60 mins by Eu-cAMP tracer based LANCE ultra cAMP assay,145,193,O=S(=O)(c1ccccc1)N(CCCN1CCC(c2noc3ccccc23)CC1)C1COC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)N1CCc2c(C3CCN(C4CCC4)CC3)cccc21,CHEMBL4479923,Ki,5.98,CHEMBL4566363,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,123,378,O=S(=O)(c1ccccc1)N1CCc2c(C3CCN(C4CCC4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)N1CCc2c(N3CCN(C4CCC4)CC3)cccc21,CHEMBL4479923,Ki,6.45,CHEMBL4525992,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,123,378,O=S(=O)(c1ccccc1)N1CCc2c(N3CCN(C4CCC4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)N1CCc2ccc(N3CCN(C4CCC4)CC3)cc21,CHEMBL4479923,Ki,6.39,CHEMBL4483496,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,123,378,O=S(=O)(c1ccccc1)N1CCc2ccc(N3CCN(C4CCC4)CC3)cc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)N1Cc2cccc(C3CCN(C4CCC4)CC3)c2C1,CHEMBL4479923,Ki,5.74,CHEMBL4550561,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,123,378,O=S(=O)(c1ccccc1)N1Cc2cccc(C3CCN(C4CCC4)CC3)c2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)N1Cc2cccc(N3CCN(C4CCC4)CC3)c2C1,CHEMBL4479923,Ki,5.8,CHEMBL4520580,2016,CHEMBL4477255,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human recombinant dopamine D2 long receptor expressed in CHO-K1 cells incubated for 120 mins by scintillation counting analysis,123,378,O=S(=O)(c1ccccc1)N1Cc2cccc(N3CCN(C4CCC4)CC3)c2C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1,CHEMBL4146376,Ki,6.0,CHEMBL1083390,2018,CHEMBL4145461,Eur J Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta counting method,132,221,O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1,CHEMBL4736131,Ki,6.0,CHEMBL1083390,2021,CHEMBL4732141,J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L expressed in CHO-K1 cell membranes incubated for 1 hr by micro-beta plate reader based analysis,153,222,O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCOc4ccc(F)cc4)CC3)cccc21,CHEMBL3413541,Ki,7.33,CHEMBL3409263,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCOc4ccccc4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCOc4ccccc4)CC3)cccc21,CHEMBL3413541,Ki,7.21,CHEMBL3409261,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCCOc4ccccc4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccc(F)cc4)CC3)cccc21,CHEMBL3413541,Ki,7.17,CHEMBL3409262,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccccc4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccc5ccoc5c4)CC3)cccc21,CHEMBL3413541,Ki,6.66,CHEMBL3409255,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccc5ccoc5c4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccccc4)CC3)cccc21,CHEMBL3413541,Ki,6.54,CHEMBL3409260,2015,CHEMBL3407464,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor expressed in CHOK1 cells incubated for 60 mins by scintillation counting method,113,210,O=S(=O)(c1ccccc1)n1ccc2c(N3CCN(CCCOc4ccccc4)CC3)cccc21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1)n1ccc2c3c(ccc21)[C@H]1CCNCC[C@@H]31,CHEMBL3872136,Ki,6.1,CHEMBL3889852,2017,CHEMBL3871306,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-methyl-spiperone from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by radioligand binding assay,128,119,O=S(=O)(c1ccccc1)n1ccc2c3c(ccc21)C1CCNCCC31,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccccc1F)C1(F)CCN(CCc2ccc(F)cc2F)CC1,CHEMBL830303,Ki,6.58,CHEMBL177416,2005,CHEMBL1142766,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against human Dopamine receptor D2,43,745,O=S(=O)(c1ccccc1)C1CCN(CCc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccnc2ccccc12)N1CCCCC[C@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,8.52,CHEMBL4250274,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1ccnc2ccccc12)N1CCCCCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1ccnc2ccccc12)N1CCCC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,8.3,CHEMBL4240642,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1ccnc2ccccc12)N1CCCCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccc(Cl)c(Cl)c3)CC2)CC1,CHEMBL4036228,Ki,6.84,CHEMBL4086211,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccc(F)cc3)CC2)CC1,CHEMBL4036228,Ki,6.38,CHEMBL4089427,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3cccc(C(F)(F)F)c3)CC2)CC1,CHEMBL4036228,Ki,6.83,CHEMBL4100470,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3cccc(Cl)c3)CC2)CC1,CHEMBL4036228,Ki,7.43,CHEMBL4096866,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1,CHEMBL4036228,Ki,7.52,CHEMBL4093971,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3cccc(F)c3)CC2)CC1,CHEMBL4036228,Ki,6.0,CHEMBL4061131,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,CHEMBL4036228,Ki,5.91,CHEMBL4075422,2017,CHEMBL4033716,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-Raclopride from human dopamine D2L receptor expressed in HEK293 cell membranes after 1 hr by microbeta liquid scintillation counting analysis,128,970,O=S(=O)(c1cncc2ccccc12)N1CCC(CCN2CCN(c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCCCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,8.22,CHEMBL4245607,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cncc2ccccc12)N1CCCCCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCCC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,7.64,CHEMBL4244280,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cncc2ccccc12)N1CCCCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@@H]1CCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1,CHEMBL4229838,Ki,7.92,CHEMBL4246630,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3[nH]ccc23)CC1,CHEMBL4229838,Ki,8.52,CHEMBL4245997,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CCN(c2cccc3[nH]ccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3c2OCCO3)CC1,CHEMBL4229838,Ki,7.66,CHEMBL4242268,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CCN(c2cccc3c2OCCO3)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,8.22,CHEMBL4248491,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,9.05,CHEMBL4238679,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,132,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CC=C(c2c[nH]c3ccc(Cl)cc23)CC1,CHEMBL4229838,Ki,7.89,CHEMBL4250244,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CC=C(c2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCC(c2noc3cc(F)ccc23)CC1,CHEMBL4229838,Ki,10.0,CHEMBL4245263,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CCC(c2noc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2cccc3[nH]ccc23)CC1,CHEMBL4229838,Ki,7.43,CHEMBL4242170,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CCN(c2cccc3[nH]ccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2cccc3c2OCCO3)CC1,CHEMBL4229838,Ki,7.72,CHEMBL4247770,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CCN(c2cccc3c2OCCO3)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,7.96,CHEMBL4239823,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229953,Ki,7.96,CHEMBL4239823,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]methyl-spiperone from recombinant human dopamine D2 receptor after 60 mins by scintillation counting method,133,971,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2noc3ccccc23)CC1,CHEMBL4229838,Ki,8.52,CHEMBL4249640,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CCN(c2noc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CCC[C@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,9.85,CHEMBL4246655,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=S(=O)(c1cncc2ccccc12)N1CCCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CC[C@@H]1CCN1CCN(c2cccc3sccc23)CC1,CHEMBL4229838,Ki,7.54,CHEMBL4239705,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=S(=O)(c1cncc2ccccc12)N1CCC1CCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S(=O)(c1cncc2ccccc12)N1CC[C@@H]1CCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4229838,Ki,8.0,CHEMBL4243497,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=S(=O)(c1cncc2ccccc12)N1CCC1CCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)CCc2ccc(O)cc2N1CCCCN1CCN(c2cccc3sccc23)CC1,CHEMBL4708967,IC50,7.7,CHEMBL4759331,2020,CHEMBL4706522,Eur J Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,145,548,O=S1(=O)CCc2ccccc2N1CCCCN1CCN(c2cccc3sccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)Cc2ccccc2N1CCCN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872891,Ki,6.01,CHEMBL104380,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",32,214,O=S1(=O)Cc2ccccc2N1CCCN1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)N(CCCCCCN2CCN(c3cccc(Cl)c3)CC2)c2cccc3c2N1CCC3,CHEMBL5163611,Ki,6.6,CHEMBL5204088,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,155,910,O=S1(=O)N(CCCCCCN2CCN(c3ccccc3)CC2)c2cccc3c2N1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)N(CCN2CCCCCC2)CCN1c1cccc(Cl)c1,CHEMBL1106075,Ki,6.7,CHEMBL1084121,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,75,556,O=S1(=O)N(CCN2CCCCCC2)CCN1c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(C(F)(F)F)cc2)CC1,CHEMBL4390419,Ki,6.03,CHEMBL4464370,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1,CHEMBL4390419,Ki,6.59,CHEMBL4528793,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL4390419,Ki,6.47,CHEMBL4436319,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL4390419,Ki,6.52,CHEMBL4447659,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(Cl)c2)CC1,CHEMBL4390419,Ki,6.92,CHEMBL4453687,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL4390419,Ki,6.66,CHEMBL4449590,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2Cl)CC1,CHEMBL4390419,Ki,6.85,CHEMBL4455845,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2F)CC1,CHEMBL4390419,Ki,7.05,CHEMBL4530770,2019,CHEMBL4387769,Bioorg Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells incubated for 1 hr by microbeta plate reader method,140,965,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccn2)CC1,CHEMBL4390409,Ki,6.93,CHEMBL4571077,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,140,490,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccn2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4629186,Ki,7.75,CHEMBL4642594,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccc(F)cc2)CC1,CHEMBL697295,Ki,6.75,CHEMBL83894,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,32,732,O=S1(=O)c2cccc3cccc(c23)N1CCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=S1(=O)c2ccccc2CCC12CCN(CCc1ccc(F)cc1F)CC2,CHEMBL697295,Ki,5.82,CHEMBL146595,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,32,732,O=S1(=O)c2ccccc2CCC12CCN(CCc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=[N+]([O-])c1ccc(CCN2CCN(c3ccccc3)CC2)cc1[N+](=O)[O-],CHEMBL3073105,Ki,7.29,CHEMBL2298799,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),95,427,c1ccc(CCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=[N+]([O-])c1ccc(OCCNCCCOc2ccccc2)cc1,CHEMBL671378,Ki,5.85,CHEMBL132455,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,13,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=[N+]([O-])c1ccc(OCCNCCCOc2ccccc2)cc1,CHEMBL835389,Ki,5.85,CHEMBL132455,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,43,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=[N+]([O-])c1ccc2c(c1)C(O)C(CCN1CCC(c3noc4cc(F)ccc34)CC1)CC2,CHEMBL3106891,Ki,6.92,CHEMBL3104519,2014,CHEMBL3102756,Eur J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2 receptor,107,134,c1ccc2c(c1)CCC(CCN1CCC(c3noc4ccccc34)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=[N+]([O-])c1cccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)c1,CHEMBL672182,Ki,5.82,CHEMBL553810,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,32,52,c1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=[N+]([O-])c1cccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)c1,CHEMBL672182,Ki,5.83,CHEMBL538977,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,32,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=[N+]([O-])c1ccccc1N1CCN(CCCCCCN2c3cccc4cccc(c34)S2(=O)=O)CC1,CHEMBL4390409,Ki,6.58,CHEMBL4449148,2019,CHEMBL4387768,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2L receptor expressed in HEK293 cells measured after 1 hr by microbeta counting method,140,490,O=S1(=O)c2cccc3cccc(c23)N1CCCCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=[N+]([O-])c1ccccc1S(=O)(=O)NC[C@H]1CC[C@H](CNCC2CCc3ccccc3C2)CC1,CHEMBL672346,Ki,7.2,CHEMBL299879,2002,CHEMBL1135171,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 was evaluated,32,972,O=S(=O)(NCC1CCC(CNCC2CCc3ccccc3C2)CC1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c(=O)n(CCCCN2CCN(c3cccc4sccc34)CC2)c2ccccc12,CHEMBL4708967,IC50,7.54,CHEMBL4777475,2020,CHEMBL4706522,Eur J Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) preincubated for 60 mins followed by addition of Eu-cAMP and measured after 60 mins by plate reader method,145,548,O=c1[nH]c(=O)n(CCCCN2CCN(c3cccc4sccc34)CC2)c2ccccc12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2[nH]c(-c3ccc(Cl)cc3)cc2c(=O)n1CCN1CCN(c2ccccc2Cl)CC1,CHEMBL864519,Ki,5.62,CHEMBL199876,2006,CHEMBL1148546,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,49,688,O=c1[nH]c2[nH]c(-c3ccccc3)cc2c(=O)n1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2[nH]c(-c3ccccc3)cc2c(=O)n1CCN1CCN(c2ccccc2Cl)CC1,CHEMBL864519,Ki,6.86,CHEMBL203362,2006,CHEMBL1148546,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,49,688,O=c1[nH]c2[nH]c(-c3ccccc3)cc2c(=O)n1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2[nH]c(-c3ccccc3Cl)cc2c(=O)n1CCN1CCN(c2ccccc2Cl)CC1,CHEMBL864519,Ki,6.45,CHEMBL443567,2006,CHEMBL1148546,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,49,688,O=c1[nH]c2[nH]c(-c3ccccc3)cc2c(=O)n1CCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(N3CCN(CC[C@@H]4CCCN4S(=O)(=O)c4cccc5ncccc45)CC3)cccc2o1,CHEMBL4229838,Ki,8.05,CHEMBL4240910,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=c1[nH]c2c(N3CCN(CCC4CCCN4S(=O)(=O)c4cccc5ncccc45)CC3)cccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(N3CCN(CC[C@@H]4CCCN4S(=O)(=O)c4cncc5ccccc45)CC3)cccc2o1,CHEMBL4229838,Ki,8.3,CHEMBL4247275,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=c1[nH]c2c(N3CCN(CCC4CCCN4S(=O)(=O)c4cncc5ccccc45)CC3)cccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(N3CCN(CC[C@H]4CCCN4S(=O)(=O)c4cncc5ccccc45)CC3)cccc2o1,CHEMBL4229838,Ki,7.92,CHEMBL4243036,2018,CHEMBL4229332,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2LR expressed in HEK293 cell membranes after 1 hr at 37 degC by microbeta counting method,133,578,O=c1[nH]c2c(N3CCN(CCC4CCCN4S(=O)(=O)c4cncc5ccccc45)CC3)cccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCNCCc3cccc(Cl)c3Cl)c2s1,CHEMBL1810621,IC50,5.7,CHEMBL1807873,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCCOCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCOCCOCCc3ccccc3)c2s1,CHEMBL1810621,IC50,6.1,CHEMBL1807821,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCCOCCOCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCCOCCc3ccccc3)c2s1,CHEMBL1810621,IC50,6.2,CHEMBL1807819,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCCSCCCOCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3)c2s1,CHEMBL1810621,IC50,5.8,CHEMBL1807869,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCCSCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3cccc(Cl)c3Cl)c2s1,CHEMBL1810621,IC50,6.0,CHEMBL1807871,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCCSCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCNCCc3ccccc3Cl)c2s1,CHEMBL1810621,IC50,6.0,CHEMBL1807870,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCCSCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCSCCOCCc3cccc4ccccc34)c2s1,CHEMBL1810621,IC50,6.7,CHEMBL1807820,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCCSCCOCCc3cccc4ccccc34)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1,CHEMBL1947794,IC50,7.1,CHEMBL1945296,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCCc3cccc(CNCCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOCCCNCCc3cccc(Cl)c3)c2s1,CHEMBL1810621,IC50,5.5,CHEMBL1807832,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCOCCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCOc3cccc(CNCCc4ccccc4F)c3)c2s1,CHEMBL1947794,IC50,6.4,CHEMBL1945298,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCOc3cccc(CNCCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCS(=O)(=O)CCCNCCc3cccc(Cl)c3)c2s1,CHEMBL1810621,IC50,6.1,CHEMBL1807831,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCS(=O)(=O)CCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(C(F)(F)F)c3)c2s1,CHEMBL1810621,IC50,6.3,CHEMBL1807826,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCSCCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3cccc(Cl)c3Cl)c2s1,CHEMBL1810621,IC50,6.4,CHEMBL1807829,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCSCCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3)c2s1,CHEMBL1810621,IC50,5.4,CHEMBL1807823,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCSCCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCSCCCNCCc3ccccc3Cl)c2s1,CHEMBL1810621,IC50,5.8,CHEMBL1807828,2011,CHEMBL1806408,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine 2 receptor,80,487,O=c1[nH]c2cccc(CCNCCSCCCNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4c(Cl)cccc4Cl)cc3)c2s1,CHEMBL1947794,IC50,6.0,CHEMBL1944689,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3ccc(CNCCc4ccccc4)cc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4)cc3)c2s1,CHEMBL1947794,IC50,5.7,CHEMBL1944695,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3ccc(CNCCc4ccccc4)cc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccc4F)cc3)c2s1,CHEMBL1947794,IC50,5.7,CHEMBL1944692,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3ccc(CNCCc4ccccc4)cc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccc(CNCCc4ccccn4)cc3)c2s1,CHEMBL1947794,IC50,5.6,CHEMBL1945034,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3ccc(CNCCc4ccccn4)cc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CN4CCCC4)c3)c2s1,CHEMBL1947794,IC50,5.5,CHEMBL1945294,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3cccc(CN4CCCC4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCCc4ccccc4)c3)c2s1,CHEMBL1947794,IC50,6.5,CHEMBL1945037,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCCCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4c(Cl)cccc4Cl)c3)c2s1,CHEMBL1947794,IC50,6.6,CHEMBL1947157,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4Cl)c3)c2s1,CHEMBL1947794,IC50,6.2,CHEMBL1944690,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccc4F)c3)c2s1,CHEMBL1947794,IC50,6.4,CHEMBL1944691,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCCc4ccccn4)c3)c2s1,CHEMBL1947794,IC50,5.8,CHEMBL1945033,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCCc4ccccn4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4Cl)c3)c2s1,CHEMBL1947794,IC50,6.6,CHEMBL1945041,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccc4F)c3)c2s1,CHEMBL1947794,IC50,6.2,CHEMBL1945042,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCc4ccccc4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3cccc(CNCc4ccccn4)c3)c2s1,CHEMBL1947794,IC50,5.3,CHEMBL1945043,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3cccc(CNCc4ccccn4)c3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2c(O)ccc([C@@H](O)CNCCc3ccccc3CNCCc3ccccc3F)c2s1,CHEMBL1947794,IC50,6.1,CHEMBL1945035,2012,CHEMBL1944599,Bioorg Med Chem Lett,Scientific Literature,Displacement of radiolabeled spiperone from dopamine D2 receptor,86,225,O=c1[nH]c2cccc(CCNCCc3ccccc3CNCCc3ccccc3)c2s1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cc(Br)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,CHEMBL939457,IC50,5.57,CHEMBL487984,2008,CHEMBL1152245,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor,62,870,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cc(Cl)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,CHEMBL939457,IC50,5.64,CHEMBL521030,2008,CHEMBL1152245,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor,62,870,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CCCCc2c[nH]c3ccccc23)CC1,CHEMBL3820048,Ki,6.87,CHEMBL3818805,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,123,897,O=c1[nH]c2ccccc2n1C1CCN(CCCCc2c[nH]c3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CCCCc2nc3ccccc3o2)CC1,CHEMBL3820048,Ki,7.02,CHEMBL3819153,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,123,897,O=c1[nH]c2ccccc2n1C1CCN(CCCCc2nc3ccccc3o2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cc(Cl)ccc2n1C1CCN(CCCCc2nc3ccccc3s2)CC1,CHEMBL3820048,Ki,6.67,CHEMBL3818398,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,123,897,O=c1[nH]c2ccccc2n1C1CCN(CCCCc2nc3ccccc3s2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cc(F)ccc2n1C1CCN(C2CCN(Cc3ccccc3C(F)(F)F)CC2)CC1,CHEMBL983581,IC50,5.57,CHEMBL489576,2008,CHEMBL1142444,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,62,871,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(Cc3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cc(F)ccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,CHEMBL939457,IC50,5.44,CHEMBL485755,2008,CHEMBL1152245,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at dopamine D2 receptor,62,870,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(S(=O)(=O)c3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2[nH]c1=O,CHEMBL3073105,Ki,7.55,CHEMBL2298807,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),95,427,O=c1[nH]c2ccc(CCN3CCN(c4ccccc4)CC3)cc2[nH]c1=O,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,CHEMBL2169117,Ki,7.96,CHEMBL2165115,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,86,205,O=c1[nH]c2ccc(OCCCCN3CCC(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccc(OCCCCN3CCC(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,CHEMBL3887359,Ki,7.96,CHEMBL2165115,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=c1[nH]c2ccc(OCCCCN3CCC(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,CHEMBL2169117,Ki,7.82,CHEMBL2165135,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,86,205,O=c1[nH]c2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,CHEMBL3887359,Ki,7.82,CHEMBL2165135,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=c1[nH]c2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,CHEMBL3887359,Ki,8.35,CHEMBL3915863,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=c1[nH]c2ccc(OCCCN3CCCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccc(OCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,CHEMBL3887359,Ki,7.6,CHEMBL3934712,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=c1[nH]c2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccc(OCCN3CCN(c4cccc(C(F)(F)F)c4)CC3)cc2[nH]1,CHEMBL3073105,Ki,7.58,CHEMBL2299001,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),95,427,O=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccc(OCCN3CCN(c4cccc(Cl)c4)CC3)cc2[nH]1,CHEMBL3073105,Ki,7.34,CHEMBL2298801,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),95,427,O=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,CHEMBL3073105,Ki,8.12,CHEMBL2299000,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),95,427,O=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(CN3CCN(CC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1,CHEMBL1040200,Ki,6.92,CHEMBL566172,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,67,931,O=c1[nH]c2cccc(CN3CCN(CC4CCc5[nH]c6ccccc6c5C4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(N3CCN(CC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1,CHEMBL1040200,Ki,7.494999999999999,CHEMBL569513,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,67,931,O=c1[nH]c2cccc(N3CCN(CC4CCc5[nH]c6ccccc6c5C4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(N3CCN(CC4CCc5c([nH]c6ccc(F)cc56)C4)CC3)c2o1,CHEMBL1040200,Ki,6.66,CHEMBL566380,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,67,931,O=c1[nH]c2cccc(N3CCN(CC4CCc5c([nH]c6ccccc56)C4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(N3CCN(CCCC4CCc5c([nH]c6ccc(F)cc56)C4)CC3)c2o1,CHEMBL1040200,Ki,7.3,CHEMBL568103,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,67,931,O=c1[nH]c2cccc(N3CCN(CCCC4CCc5c([nH]c6ccccc56)C4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,CHEMBL1066831,Ki,10.0,CHEMBL218166,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,75,380,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,CHEMBL1066832,Ki,10.4,CHEMBL218166,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,75,381,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,CHEMBL1067765,Ki,8.66,CHEMBL218166,2010,CHEMBL1157588,Bioorg Med Chem,Scientific Literature,Agonist activity at dopamine D2 receptor,75,973,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,CHEMBL2328744,IC50,8.54,CHEMBL218166,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at human D2 dopamine receptor expressed in CHO cell membrane by GTPgammaS-binding assay,95,466,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,CHEMBL2328745,Ki,9.22,CHEMBL218166,2013,CHEMBL2321835,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2 dopamine receptor expressed in CHO cell membranes,95,467,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,CHEMBL3294603,Ki,8.64,CHEMBL218166,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]nemonapride from dopamine D2L receptor (unknown origin) expressed in African green monkey COS7 cells,107,974,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,CHEMBL672308,Ki,8.66,CHEMBL218166,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,O=c1[nH]c2cccc(N3CCN(Cc4cccc(-c5ccccc5)c4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(N3C[C@H]4C[C@@H]3CN4CC3CCc4[nH]c5ccc(F)cc5c4C3)c2o1,CHEMBL1040200,Ki,7.885,CHEMBL566356,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,67,931,O=c1[nH]c2cccc(N3CC4CC3CN4CC3CCc4[nH]c5ccccc5c4C3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(OC3CCN(CC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1,CHEMBL1040200,Ki,6.85,CHEMBL567454,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,67,931,O=c1[nH]c2cccc(OC3CCN(CC4CCc5[nH]c6ccccc6c5C4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(OC3CCN(CCC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1,CHEMBL1040200,Ki,6.51,CHEMBL565553,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,67,931,O=c1[nH]c2cccc(OC3CCN(CCC4CCc5[nH]c6ccccc6c5C4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(OCC3CCN(CC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1,CHEMBL1040200,Ki,7.55,CHEMBL566396,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,67,931,O=c1[nH]c2cccc(OCC3CCN(CC4CCc5[nH]c6ccccc6c5C4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2cccc(OCC3CCN(CCC4CCc5[nH]c6ccc(F)cc6c5C4)CC3)c2o1,CHEMBL1040200,Ki,6.14,CHEMBL569476,2009,CHEMBL1156031,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from D2 receptor,67,931,O=c1[nH]c2cccc(OCC3CCN(CCC4CCc5[nH]c6ccccc6c5C4)CC3)c2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccccc2n1C1CCN(C2CCN(Cc3ccccc3Cl)CC2)CC1,CHEMBL983581,IC50,5.69,CHEMBL477821,2008,CHEMBL1142444,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,62,871,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(Cc3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccccc2n1C1CCN(C2CCN(Cc3ccccc3[N+](=O)[O-])CC2)CC1,CHEMBL983581,IC50,5.95,CHEMBL478034,2008,CHEMBL1142444,Bioorg Med Chem Lett,Scientific Literature,Inhibition of dopamine D2 receptor,62,871,O=c1[nH]c2ccccc2n1C1CCN(C2CCN(Cc3ccccc3)CC2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL2211561,Ki,7.93,CHEMBL1423,2012,CHEMBL2203152,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human low affinity Dopamine D2S receptor by competition binding assay,86,376,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL5353627,Ki,8.85,CHEMBL1423,2022,CHEMBL5352414,Eur J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) assessed as inhibition constant,155,975,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL671484,Ki,7.92,CHEMBL1423,2003,CHEMBL1145042,J Med Chem,Scientific Literature,Binding affinity towards Dopamine receptor D2,36,819,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccccc2)c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccccc2n1C1CCN(CCCOc2ccc(F)cc2)CC1,CHEMBL2149602,Ki,9.3,CHEMBL1802360,2010,CHEMBL2146410,ACS Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor,75,976,O=c1[nH]c2ccccc2n1C1CCN(CCCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccccc2n1C1CCN(CCOc2ccccc2)CC1,CHEMBL2060138,Ki,8.26,CHEMBL2059304,2012,CHEMBL2057071,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in CHO cells after 60 mins by scintillation proximity assay,86,932,O=c1[nH]c2ccccc2n1C1CCN(CCOc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccccc2n1C1CCN(Cc2coc3ccccc23)CC1,CHEMBL1176478,Ki,7.87,CHEMBL1172214,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,75,641,O=c1[nH]c2ccccc2n1C1CCN(Cc2coc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccccc2n1C1CCN(Cc2csc3ccccc23)CC1,CHEMBL1176478,Ki,7.42,CHEMBL1169895,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,75,641,O=c1[nH]c2ccccc2n1C1CCN(Cc2csc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccccc2n1CCCCCCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4629186,Ki,7.8,CHEMBL4638308,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=c1[nH]c2ccccc2n1CCCCCCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1,CHEMBL3887246,Ki,8.89,CHEMBL219916,2015,CHEMBL3886237,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: The pharmacological profile of metopimazine, metopimazine acid (MPZA), domperidone, and metoclopramide were assessed by radioligand binding and by a functional antagonist assay. For the radioligand binding assay, cell membranes of dopamine D2 receptor expressing cells were incubated with [3H]spiperone and competing drugs in buffer. The assay was terminated by rapid filtration, and the bound radioactive signal was determined by liquid scintillation counting.",113,439,O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1c(-c2ccc(Cl)cc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2,CHEMBL4368000,Ki,5.78,CHEMBL4469633,2019,CHEMBL4364313,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,140,528,O=c1c(-c2ccccc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1c(-c2ccc(F)cc2)c2ccccn2c(=O)n1CCCCN1CCCC(c2c[nH]c3ccccc23)C1,CHEMBL4401065,Ki,6.02,CHEMBL4462139,2019,CHEMBL4400523,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,140,529,O=c1c(-c2ccccc2)c2ccccn2c(=O)n1CCCCN1CCCC(c2c[nH]c3ccccc23)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1c(-c2ccc(F)cc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccc(F)cc34)C1)CCCC2,CHEMBL4368000,Ki,5.98,CHEMBL4582567,2019,CHEMBL4364313,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,140,528,O=c1c(-c2ccccc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1c(-c2ccc(F)cc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2,CHEMBL4368000,Ki,5.7,CHEMBL4469537,2019,CHEMBL4364313,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,140,528,O=c1c(-c2ccccc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1c(-c2ccccc2)c2ccccn2c(=O)n1CCCCN1CCCC(c2c[nH]c3ccccc23)C1,CHEMBL4401065,Ki,4.75,CHEMBL4451231,2019,CHEMBL4400523,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from recombinant human D2 receptor expressed in HEK293 cells measured after 1 hr by microbeta scintillation counting analysis,140,529,O=c1c(-c2ccccc2)c2ccccn2c(=O)n1CCCCN1CCCC(c2c[nH]c3ccccc23)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1c(-c2ccccc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2,CHEMBL4368000,Ki,5.63,CHEMBL4476164,2019,CHEMBL4364313,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,140,528,O=c1c(-c2ccccc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1c(-c2ccccc2Cl)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2,CHEMBL4368000,Ki,6.05,CHEMBL4455658,2019,CHEMBL4364313,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2 receptor expressed in HEK cells incubated for 1 hr by Cheng-Prusoff analysis based microbeta scintillation counting method,140,528,O=c1c(-c2ccccc2)c2n(c(=O)n1CCCCN1CCCC(c3c[nH]c4ccccc34)C1)CCCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1c2ccccc2ncn1CCCCN1CCN(c2ccc(Cl)cc2)CC1,CHEMBL898619,Ki,6.85,CHEMBL238718,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,58,772,O=c1c2ccccc2ncn1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1c2ccccc2ncn1CCCCN1CCN(c2cccc(C(F)(F)F)c2)CC1,CHEMBL898619,Ki,7.14,CHEMBL398813,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,58,772,O=c1c2ccccc2ncn1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1c2ccccc2ncn1CCCCN1CCN(c2ccccc2)CC1,CHEMBL898619,Ki,7.34,CHEMBL238717,2007,CHEMBL1149628,Bioorg Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human Dopamine receptor D2 isoform long expressed in HEK293 cells,58,772,O=c1c2ccccc2ncn1CCCCN1CCN(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc(OCCCN2CCC(c3noc4cc(F)ccc34)CC2)nn1-c1c(F)cccc1F,CHEMBL4821052,Ki,8.3,CHEMBL3883955,2021,CHEMBL4819047,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),153,248,O=c1ccc(OCCCN2CCC(c3noc4ccccc34)CC2)nn1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2c(N3CCCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1,CHEMBL4015806,Ki,7.11,CHEMBL4091507,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,128,297,O=c1ccc2c(N3CCCN(CCCCOc4ccn5nccc5c4)CC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2c(N3CCCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1,CHEMBL4015807,Ki,7.34,CHEMBL4091507,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,128,298,O=c1ccc2c(N3CCCN(CCCCOc4ccn5nccc5c4)CC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2[nH]1,CHEMBL4046973,Ki,8.635000000000002,CHEMBL4068561,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,128,385,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2[nH]1,CHEMBL4046974,Ki,9.08,CHEMBL4068561,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,129,386,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1,CHEMBL4015806,Ki,8.08,CHEMBL4092441,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,129,297,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1,CHEMBL4015807,Ki,8.43,CHEMBL4092441,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,129,298,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2o1,CHEMBL4015806,Ki,7.4,CHEMBL4073330,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,129,297,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)cccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2o1,CHEMBL4015807,Ki,7.72,CHEMBL4073330,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,129,298,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)cccc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2c(N3CCNCC3)ccc(O)c2[nH]1,CHEMBL4046973,Ki,5.28,CHEMBL4064191,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,129,385,O=c1ccc2c(N3CCNCC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2c(N3CCNCC3)ccc(O)c2[nH]1,CHEMBL4046974,Ki,5.92,CHEMBL4064191,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,129,386,O=c1ccc2c(N3CCNCC3)cccc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,CHEMBL2169117,Ki,8.47,CHEMBL2165120,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,86,205,O=c1ccc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,CHEMBL3887359,Ki,8.47,CHEMBL2165120,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=c1ccc2ccc(OCCCCN3CCCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2[nH]1,CHEMBL1776016,Ki,9.0,CHEMBL1774064,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=c1ccc2ccc(OCCCCN3CCN(c4ccccc4)CC3)nc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2[nH]1,CHEMBL3887359,Ki,9.4,CHEMBL3966956,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5c4OCCO5)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,CHEMBL4314365,Ki,9.52,CHEMBL2105760,2019,CHEMBL4311986,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cells incubated for 1 hr by liquid scintillation counting method,140,512,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,CHEMBL4709838,Ki,9.52,CHEMBL2105760,2020,CHEMBL4706549,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2 long receptor expressed in CHO cells measured after 60 mins,145,977,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,CHEMBL4842092,Ki,9.29,CHEMBL2105760,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,153,362,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,CHEMBL5442215,Ki,8.22,CHEMBL2105760,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCN3CCN(c4ccccc4OCCF)CC3)cc2[nH]1,CHEMBL1815674,Ki,10.15,CHEMBL1813595,2011,CHEMBL1811837,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human recombinant D2L receptor expressed in HEK cells after 60 mins by gamma counter,80,640,O=c1ccc2ccc(OCCCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCNCC3CC3c3cccc(Cl)c3Cl)cc2[nH]1,CHEMBL4842092,Ki,6.89,CHEMBL4859080,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,153,362,O=c1ccc2ccc(OCCCCNCC3CC3c3ccccc3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2[nH]1,CHEMBL4842092,Ki,6.75,CHEMBL4859567,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,153,362,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4c3OCCO4)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2[nH]1,CHEMBL4842092,Ki,7.01,CHEMBL4848451,2021,CHEMBL4840367,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from D2 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,153,362,O=c1ccc2ccc(OCCCCNCC3CC3c3cccc4ccccc34)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCCNCc3cc4ccccc4o3)cc2[nH]1,CHEMBL5385535,Ki,6.62,CHEMBL5438499,2023,CHEMBL5380874,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from Dopamine D2 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,159,201,O=c1ccc2ccc(OCCCCNCc3cc4ccccc4o3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,CHEMBL3887359,Ki,8.47,CHEMBL3916047,2015,CHEMBL3886292,,BindingDB Patent Bioactivity Data,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",113,117,O=c1ccc2ccc(OCCCN3CCCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2o1,CHEMBL670879,Ki,7.8,CHEMBL120590,1998,CHEMBL1130712,Bioorg Med Chem Lett,Scientific Literature,Compound was measured for the binding affinity in homogenated mouse fibroblast (LTK) cells transfected with human Dopamine receptor D2A using [3H]raclopride as radioligand.,15,829,O=c1ccc2ccc(OCCCN3CCN(c4ccccc4)CC3)cc2o1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2cnc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2[nH]1,CHEMBL1776016,Ki,8.7,CHEMBL1774065,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=c1ccc2cnc(OCCCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccc2cnc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)nc2[nH]1,CHEMBL1776016,Ki,9.0,CHEMBL1774066,2011,CHEMBL1773056,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2L receptor expressed in CHO cells,80,830,O=c1ccc2cnc(OCCCCN3CCN(c4ccccc4)CC3)nc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1ccn([C@@H]2O[C@H](COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])O)[C@@H](O)[C@H]2O)c(=O)[nH]1,CHEMBL5442215,Ki,5.42,CHEMBL5077459,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,O=c1ccn(C2CCCO2)c(=O)[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CC2CCC(CN3CCN(c4cccc(Cl)c4)CC3)CC2)nc2ccccn12,CHEMBL5163611,Ki,6.25,CHEMBL5190996,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,155,910,O=c1n(CC2CCC(CN3CCN(c4ccccc4)CC3)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCCCN2CCN(c3cccc(C(F)(F)F)c3)CC2)nc2ccccn12,CHEMBL5163611,Ki,7.21,CHEMBL5193103,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,155,910,O=c1n(CCCCCCN2CCN(c3ccccc3)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCCCN2CCN(c3cccc(Cl)c3)CC2)c2cccc3c2n1CCC3,CHEMBL5163611,Ki,7.75,CHEMBL5201984,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,155,910,O=c1n(CCCCCCN2CCN(c3ccccc3)CC2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,CHEMBL5163622,Ki,6.86,CHEMBL5202054,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Binding affinity to D2L receptor (unknown origin) assessed as inhibition constant,155,978,O=c1n(CCCCCCN2CCN(c3ccccc3)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCCCN2CCN(c3cccc(Cl)c3Cl)CC2)nc2ccccn12,CHEMBL5163611,Ki,8.05,CHEMBL5199228,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,155,910,O=c1n(CCCCCCN2CCN(c3ccccc3)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCCCN2CCN(c3cccc4c3OCCO4)CC2)nc2ccccn12,CHEMBL5163611,Ki,7.22,CHEMBL5189101,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,155,910,O=c1n(CCCCCCN2CCN(c3cccc4c3OCCO4)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCCCN2CCN(c3cccc4ccccc34)CC2)nc2ccccn12,CHEMBL5163611,Ki,7.5,CHEMBL5185787,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,155,910,O=c1n(CCCCCCN2CCN(c3cccc4ccccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCCCN2CCN(c3cccc4cccnc34)CC2)nc2ccccn12,CHEMBL5163611,Ki,6.84,CHEMBL5172673,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,155,910,O=c1n(CCCCCCN2CCN(c3cccc4cccnc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCCCN2CCN(c3nsc4ccccc34)CC2)c2cccc3c2n1CCC3,CHEMBL4629186,Ki,9.0,CHEMBL4642981,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=c1n(CCCCCCN2CCN(c3nsc4ccccc34)CC2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCCCN2CCN(c3nsc4ccccc34)CC2)nc2ccccn12,CHEMBL4629186,Ki,8.05,CHEMBL4648581,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,145,764,O=c1n(CCCCCCN2CCN(c3nsc4ccccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCC(c3cc(F)cc4oncc34)CC2)nc2ccccn12,CHEMBL4619928,IC50,7.39,CHEMBL4636764,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,145,752,O=c1n(CCCCN2CCC(c3cccc4oncc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCN(c3cccc4sc(F)cc34)CC2)nc2c(F)cccn12,CHEMBL4619928,IC50,7.96,CHEMBL4649106,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,145,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Br)cccn12,CHEMBL4619928,IC50,6.98,CHEMBL4640409,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,146,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Cl)cc(Cl)cn12,CHEMBL4619928,IC50,6.39,CHEMBL4648027,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,146,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(Cl)cccn12,CHEMBL4619928,IC50,7.02,CHEMBL4636321,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,146,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(F)cc(F)cn12,CHEMBL4619928,IC50,7.2,CHEMBL4635414,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,146,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2c(F)cccn12,CHEMBL4619928,IC50,7.52,CHEMBL4644352,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,146,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccc(Cl)cn12,CHEMBL4619928,IC50,6.87,CHEMBL4633978,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,146,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccc(F)cn12,CHEMBL4619928,IC50,7.58,CHEMBL4647011,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,146,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,CHEMBL4619928,IC50,7.91,CHEMBL4638599,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,146,752,O=c1n(CCCCN2CCN(c3cccc4sccc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCN(c3cccc4scnc34)CC2)nc2c(F)cccn12,CHEMBL4619928,IC50,8.15,CHEMBL4633397,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,146,752,O=c1n(CCCCN2CCN(c3cccc4scnc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCCN2CCN(c3cccc4scnc34)CC2)nc2ccccn12,CHEMBL4619928,IC50,6.93,CHEMBL4635890,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,146,752,O=c1n(CCCCN2CCN(c3cccc4scnc34)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCN2CCCCCC2)ccn1-c1cccc(Cl)c1,CHEMBL1106075,Ki,6.2,CHEMBL1086395,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,75,556,O=c1n(CCCN2CCCCCC2)ccn1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12,CHEMBL4619928,IC50,5.35,CHEMBL621,2020,CHEMBL4619707,Bioorg Med Chem Lett,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) by HTRF cAMP assay,146,752,O=c1n(CCCN2CCN(c3ccccc3)CC2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(CCN2CCCCCC2)ccn1-c1cccc(Cl)c1,CHEMBL1106075,Ki,6.4,CHEMBL1083816,2010,CHEMBL1155385,Bioorg Med Chem Lett,Scientific Literature,Partial agonistic activity at human dopamine D2 receptor expressed in CHO cells by assay [35S]GTPgamma assay with scintillation proximity affinity assay,75,556,O=c1n(CCN2CCCCCC2)ccn1-c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(Cc2ccc(CN3CCN(c4ccc(Cl)cc4)CC3)cc2)nc2ccccn12,CHEMBL5163611,Ki,5.86,CHEMBL5177716,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,155,910,O=c1n(Cc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1n(Cc2ccc(CN3CCN(c4cccc(Cl)c4)CC3)cc2)nc2ccccn12,CHEMBL5163611,Ki,6.83,CHEMBL5186688,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,155,910,O=c1n(Cc2ccc(CN3CCN(c4ccccc4)CC3)cc2)nc2ccccn12,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1oc2cc(O)ccc2c2c1CN(Cc1ccc(Cl)cc1)CC2,CHEMBL5232011,Ki,5.56,CHEMBL314095,2021,CHEMBL5230136,Eur J Med Chem,Scientific Literature,Binding affinity to human D2 receptor assessed as inhibition constant,153,735,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1oc2cc(O)ccc2c2c1CN(Cc1ccc(Cl)cc1)CC2,CHEMBL671369,Ki,5.56,CHEMBL314095,1997,CHEMBL1130121,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human cloned Dopamine receptor D2 expressed in CHO K-1 cells in vitro.,13,586,O=c1oc2ccccc2c2c1CN(Cc1ccccc1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1oc2ccccc2n1CCCCCCN1CCN(c2nsc3ccccc23)CC1,CHEMBL4629186,Ki,7.8,CHEMBL4643450,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,146,764,O=c1oc2ccccc2n1CCCCCCN1CCN(c2nsc3ccccc23)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1oc2ccccc2n1CCN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872891,Ki,5.09,CHEMBL104063,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",32,214,O=c1oc2ccccc2n1CCN1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O=c1sc2ccccc2n1CCN1CCN(Cc2ccc(Cl)cc2)CC1,CHEMBL872891,Ki,5.92,CHEMBL108157,2002,CHEMBL1134936,Bioorg Med Chem Lett,Scientific Literature,"Binding affinity towards human dopamine D2 receptor, using [3H]YM-09151 as a radioligand",32,214,O=c1sc2ccccc2n1CCN1CCN(Cc2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL4416273,Ki,7.04,CHEMBL1036,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,140,541,c1ccc(CCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(CCCN1CCN(c2ncc(F)cn2)CC1)c1ccc(F)cc1,CHEMBL651364,Ki,5.47,CHEMBL60859,1993,CHEMBL1126960,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,2,935,c1ccc(CCCCN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(CCNCc1ccc2c(c1)Cc1ccccc1-2)CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL1777183,Ki,5.68,CHEMBL1774549,2011,CHEMBL1772985,J Med Chem,Scientific Literature,Displacement of [125I]-IABN from human dopamine D2L receptor expressed in HEK293 cells after 60 mins by gamma counting,80,354,c1ccc(N2CCN(CCCCNCc3ccc4c(c3)Cc3ccccc3-4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(CCc1ccccc1)CN1CCC2(CCc3cc(F)ccc3O2)CC1,CHEMBL697295,Ki,5.96,CHEMBL149510,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,32,732,c1ccc(CCCCN2CCC3(CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(CCn1cc(-c2ccc(-c3ccccc3)cc2)nn1)CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL3591124,Ki,4.82,CHEMBL3588996,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,113,753,c1ccc(-c2ccc(-c3cn(CCCCN4CCN(c5ccccc5)CC4)nn3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(CCn1cc(-c2ccc3[nH]ccc3c2)nn1)CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL3591124,Ki,6.02,CHEMBL3588998,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,114,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5[nH]ccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(CCn1cc(-c2ccc3ccccc3c2)nn1)CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL3591124,Ki,4.73,CHEMBL3588995,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,114,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5ccccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(CCn1cc(-c2ccc3ncccc3c2)nn1)CN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL3591124,Ki,6.61,CHEMBL3589650,2015,CHEMBL3588746,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting analysis,114,753,c1ccc(N2CCN(CCCCn3cc(-c4ccc5ncccc5c4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(CNC1CCN(CCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1)Cc1ccccc1,CHEMBL4711026,Ki,5.64,CHEMBL4798638,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,146,140,c1ccc(CCCNC2CCN(CCSC(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(COc1cccc2ccccc12)CN1CCC(Cc2ccccc2)CC1,CHEMBL671653,Ki,5.84,CHEMBL418758,1997,CHEMBL1130437,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,13,979,c1ccc(CC2CCN(CCCOc3cccc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(COc1cccc2ccccc12)CN1CCC(Oc2ccccc2)CC1,CHEMBL671653,Ki,5.63,CHEMBL286177,1997,CHEMBL1130437,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,13,979,c1ccc(OC2CCN(CCCOc3cccc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(COc1ccccc1)CN1CCC(Oc2ccccc2)CC1,CHEMBL671653,Ki,6.04,CHEMBL32402,1997,CHEMBL1130437,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,13,979,c1ccc(OCCCN2CCC(Oc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(Cc1ccccc1)CN1CCC(NCCSC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4711026,Ki,5.4,CHEMBL4750607,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,146,140,c1ccc(CCCN2CCC(NCCSC(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC(c1ccccc1)c1ccccc1OCCN1CCCC1,CHEMBL838569,Ki,5.2,CHEMBL185875,2004,CHEMBL1138672,J Med Chem,Scientific Literature,Binding affinity for human recombinant dopamine receptor D2L,38,440,c1ccc(Cc2ccccc2OCCN2CCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(Cc2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,5.54,CHEMBL245815,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(CC2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(-c3ccccc3)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,7.01,CHEMBL245615,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(-c2ccc(C3CCN(Cc4c[nH]c5ccccc45)CC3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Br)cc2)CCN(Cc2c[nH]c3ccc(OCCF)cc23)CC1,CHEMBL1176478,Ki,7.86,CHEMBL1173366,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,75,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Br)cc2)CCN(Cc2c[nH]c3cccc(OCCF)c23)CC1,CHEMBL1176478,Ki,7.56,CHEMBL1173711,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,75,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Br)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL1176478,Ki,8.32,CHEMBL1170683,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,75,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Br)cc2)CCN(Cc2c[nH]c3ncccc23)CC1,CHEMBL1176478,Ki,6.67,CHEMBL1170879,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,75,641,c1ccc(C2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Br)cc2)CCN(Cc2cc3ccccc3o2)CC1,CHEMBL1176478,Ki,7.76,CHEMBL1172210,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,76,641,c1ccc(C2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Br)cc2)CCN(Cc2coc3ccccc23)CC1,CHEMBL1176478,Ki,8.18,CHEMBL1172213,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,76,641,c1ccc(C2CCN(Cc3coc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4260833,Ki,6.8,CHEMBL47050,2018,CHEMBL4257579,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,133,713,c1ccc(C2CCN(CCCC(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccccc2)c2ccccc2)CC1,CHEMBL4260833,Ki,7.42,CHEMBL1644980,2018,CHEMBL4257579,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,133,713,c1ccc(C2CCN(CCCC(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4260833,Ki,6.5,CHEMBL4287623,2018,CHEMBL4257579,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,133,713,C(CCCN1CCC(c2ccccc2)CC1)=C(c1ccccc1)c1ccccc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4260833,Ki,6.71,CHEMBL1644978,2018,CHEMBL4257579,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,133,713,c1ccc(C2CCN(CCCCC(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCCCc2ccc(F)cc2)CC1,CHEMBL4260833,Ki,6.34,CHEMBL4282702,2018,CHEMBL4257579,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,133,713,c1ccc(CCCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCCN(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4260833,Ki,6.26,CHEMBL4278465,2018,CHEMBL4257579,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,133,713,c1ccc(C2CCN(CCCCN(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCN(c2ccc(F)cc2)c2ccc(F)cc2)CC1,CHEMBL4260833,Ki,6.83,CHEMBL4291048,2018,CHEMBL4257579,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor expressed in stable fibroblast cells by radioligand binding assay,133,713,c1ccc(C2CCN(CCCN(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)c(Cl)c2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL1033058,Ki,8.16,CHEMBL246637,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)c(Cl)c2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,8.16,CHEMBL246637,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)c(Cl)c2)CCN(Cc2coc3ccccc23)CC1,CHEMBL902495,Ki,7.68,CHEMBL246643,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3coc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)c(Cl)c2)CCN(Cc2n[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.36,CHEMBL246642,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3n[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCCc1ccc(F)cc1,CHEMBL3366156,Ki,7.48,CHEMBL3321788,2014,CHEMBL3352364,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,107,840,c1ccc(CCCCN2C3CCC2CC(c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCCc1nc2ccccc2s1,CHEMBL3820048,Ki,7.355,CHEMBL3819434,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,123,897,c1ccc(C2CC3CCC(C2)N3CCCCc2nc3ccccc3s2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCOc1ccc(F)cc1,CHEMBL3366156,Ki,7.66,CHEMBL3321789,2014,CHEMBL3352364,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,107,840,c1ccc(OCCCN2C3CCC2CC(c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCSc1ccc(F)cc1,CHEMBL3366156,Ki,8.54,CHEMBL3321790,2014,CHEMBL3352364,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,107,840,c1ccc(SCCCN2C3CCC2CC(c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCSc1cccc(F)c1,CHEMBL3366156,Ki,7.57,CHEMBL3321791,2014,CHEMBL3352364,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,107,840,c1ccc(SCCCN2C3CCC2CC(c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCSc1ccccc1F,CHEMBL3366156,Ki,8.32,CHEMBL3321792,2014,CHEMBL3352364,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,107,840,c1ccc(SCCCN2C3CCC2CC(c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCc1c[nH]c2ccccc12,CHEMBL1033197,Ki,7.28,CHEMBL460854,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,67,880,c1ccc(C2CC3CCC(C2)N3CCc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2Cc1c[nH]c2ncccc12,CHEMBL1033197,Ki,6.23,CHEMBL514590,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,67,880,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ncccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2Cc1ccc(F)cc1,CHEMBL1033197,Ki,5.98,CHEMBL456430,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,67,880,c1ccc(CN2C3CCC2CC(c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2Cc1ccc(F)cc1,CHEMBL838814,Ki,5.98,CHEMBL537183,2004,CHEMBL1138643,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine D2 receptor,38,886,c1ccc(CN2C3CCC2CC(c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCCN(Cc2c[nH]c3ccccc23)C1,CHEMBL902495,Ki,5.37,CHEMBL245816,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCCN(Cc3c[nH]c4ccccc34)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.7,CHEMBL393027,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CC#Cc2ccc(F)cc2)CC1,CHEMBL4416273,Ki,6.55,CHEMBL4584060,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,140,541,C(#Cc1ccccc1)CN1CCC(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CC/C=C/c2ccc(F)cc2)CC1,CHEMBL4416273,Ki,7.95,CHEMBL4474020,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,140,541,C(=Cc1ccccc1)CCN1CCC(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CC/C=C\c2ccc(F)cc2)CC1,CHEMBL4416273,Ki,7.53,CHEMBL4440708,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,140,541,C(=Cc1ccccc1)CCN1CCC(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCC#Cc2ccc(F)cc2)CC1,CHEMBL4416273,Ki,7.13,CHEMBL4475451,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,140,541,C(#Cc1ccccc1)CCN1CCC(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCC#Cc2ccc(F)cc2)CC1,CHEMBL4416273,Ki,7.72,CHEMBL4470321,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,140,541,C(#Cc1ccccc1)CCCN1CCC(c2ccccc2)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCCCc2ccc(F)cc2)CC1,CHEMBL4416273,Ki,7.66,CHEMBL4519420,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,140,541,c1ccc(CCCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccc(F)cc2)CC1,CHEMBL1944110,Ki,7.62,CHEMBL1940402,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,86,884,c1ccc(CCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccc(F)cc2)CC1,CHEMBL3366156,Ki,7.62,CHEMBL1940402,2014,CHEMBL3352364,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,107,840,c1ccc(CCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccc(F)cc2)CC1,CHEMBL4416273,Ki,8.27,CHEMBL1940402,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,140,541,c1ccc(CCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCCc2nc3ccccc3o2)CC1,CHEMBL3820048,Ki,6.36,CHEMBL3818940,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,123,897,c1ccc(C2CCN(CCCCc3nc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCCc2nc3ccccc3s2)CC1,CHEMBL2037965,Ki,6.7,CHEMBL2037432,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,86,882,c1ccc(C2CCN(CCCCc3nc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCCc2nc3ccccc3s2)CC1,CHEMBL3820048,Ki,6.7,CHEMBL2037432,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,123,897,c1ccc(C2CCN(CCCCc3nc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCOc2ccc(F)cc2)CC1,CHEMBL1944110,Ki,8.28,CHEMBL1940404,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,86,884,c1ccc(OCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCOc2ccc(F)cc2)CC1,CHEMBL3366156,Ki,8.06,CHEMBL1940404,2014,CHEMBL3352364,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,107,840,c1ccc(OCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCOc2ccc(F)cc2)CC1,CHEMBL4416273,Ki,8.97,CHEMBL1940404,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,140,541,c1ccc(OCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCSc2ccc(F)cc2)CC1,CHEMBL1944110,Ki,8.06,CHEMBL1940403,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,86,884,c1ccc(SCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCSc2ccc(F)cc2)CC1,CHEMBL3366156,Ki,8.28,CHEMBL1940403,2014,CHEMBL3352364,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,107,840,c1ccc(SCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCSc2ccc(F)cc2)CC1,CHEMBL4416273,Ki,8.68,CHEMBL1940403,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,140,541,c1ccc(SCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCc2ccc(F)cc2)CC1,CHEMBL4416273,Ki,7.21,CHEMBL4579971,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,140,541,c1ccc(CCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CCCc2nc3ccccc3s2)CC1,CHEMBL3820048,Ki,6.12,CHEMBL3819642,2016,CHEMBL3817845,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human recombinant dopamine D2 receptor incubated for 1.5 hrs by microbeta scintillation counting method,123,897,c1ccc(C2CCN(CCCc3nc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CC[C@H]2C[C@@H]2c2ccc(F)cc2)CC1,CHEMBL4416273,Ki,8.82,CHEMBL4472382,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,141,541,c1ccc(C2CCN(CCC3CC3c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(CC[C@H]2C[C@H]2c2ccc(F)cc2)CC1,CHEMBL4416273,Ki,7.53,CHEMBL4537230,2019,CHEMBL4414605,J Med Chem,Scientific Literature,Displacement of PPHT-red from SNAP-tagged human D2LR expressed in CHOK1 cell membranes by TR-FRET assay,141,541,c1ccc(C2CCN(CCC3CC3c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL1033058,Ki,7.95,CHEMBL445102,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL1033065,IC50,8.35,CHEMBL445102,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,62,980,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL1033197,Ki,7.95,CHEMBL445102,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,67,880,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL1176478,Ki,8.0,CHEMBL445102,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,76,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL3239709,Ki,8.12,CHEMBL445102,2014,CHEMBL3232915,J Med Chem,Scientific Literature,Displacement of [3H]methylspiperone from human D2L receptor expressed in HEK cell membrane after 90 mins by scintillation counting analysis,107,448,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL5442215,Ki,7.06,CHEMBL445102,2024,CHEMBL5442175,,EUbOPEN Chemogenomic Library,"PDSP Secondary Binding target: DRD2 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",159,139,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL672164,Ki,8.62,CHEMBL445102,1996,CHEMBL1129306,J Med Chem,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,9,249,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,7.95,CHEMBL445102,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(Cc2coc3ccccc23)CC1,CHEMBL902495,Ki,7.68,CHEMBL246644,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3coc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCN(Cc2n[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.26,CHEMBL394066,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3n[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)CCNCC1,CHEMBL3300162,Ki,5.04,CHEMBL3298755,2014,CHEMBL3297649,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2L receptor expressed in FlpIn CHO cell membrane after 3 hrs by liquid scintillation counting analysis,107,146,c1ccc(C2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2CCCCc1ccc(F)cc1,CHEMBL1949469,Ki,7.48,CHEMBL1946123,2012,CHEMBL1944557,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,86,881,c1ccc(CCCCN2C3CCC2CC(c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2CCCCc1nc2ccccc2s1,CHEMBL1949469,Ki,7.36,CHEMBL1946745,2012,CHEMBL1944557,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,86,881,c1ccc(C2CC3CCC(C2)N3CCCCc2nc3ccccc3s2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2CCCOc1ccc(F)cc1,CHEMBL1949469,Ki,7.66,CHEMBL1946122,2012,CHEMBL1944557,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from dopamine D2 receptor expressed in human MES-23.5 cells,86,881,c1ccc(OCCCN2C3CCC2CC(c2ccccc2)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(F)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.9,CHEMBL246849,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(I)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL1176478,Ki,8.42,CHEMBL1173285,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,76,641,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(I)cc2)CCN(Cc2c[nH]c3ncccc23)CC1,CHEMBL1176478,Ki,7.21,CHEMBL1172208,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,76,641,c1ccc(C2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(I)cc2)CCN(Cc2cc3ccccc3o2)CC1,CHEMBL1176478,Ki,7.84,CHEMBL1170456,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,76,641,c1ccc(C2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccc(I)cc2)CCN(Cc2coc3ccccc23)CC1,CHEMBL1176478,Ki,8.62,CHEMBL1171249,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,76,641,c1ccc(C2CCN(Cc3coc4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2cccc(C(F)(F)F)c2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.97,CHEMBL246848,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2cccc(Cl)c2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.89,CHEMBL396092,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2cccc(Cl)c2Cl)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,7.58,CHEMBL397770,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccccc2)CCN(Cc2cc3ccccc3s2)CC1,CHEMBL1176478,Ki,7.33,CHEMBL1172212,2010,CHEMBL1177670,Bioorg Med Chem,Scientific Literature,Displacement of [125I]ABN from human dopamine D2 long receptor expressed in HEK293 cells after 60 mins by gamma counting,76,641,c1ccc(C2CCN(Cc3cc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1(c2ccccc2Cl)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,6.42,CHEMBL392822,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC12C3C4CC5C6C4C1C6C(C53)N2CC1CCCCC1,CHEMBL2210352,Ki,5.55,CHEMBL2205831,2012,CHEMBL2203059,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 dopamine receptor,86,981,C1CCC(CN2C3C4C5CC6C7C5C3C7C2C64)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC12C3C4CC5C6C4C1C6C(C53)N2CC1CCCCC1,CHEMBL2432454,Ki,5.55,CHEMBL2205831,2013,CHEMBL2429832,Bioorg Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,95,69,C1CCC(CN2C3C4C5CC6C7C5C3C7C2C64)CC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1CCc2c(c3ccccc3n2CCCN2CCN(c3ccccc3)CC2)C1,CHEMBL671385,Ki,6.75,CHEMBL110120,2001,CHEMBL1134599,J Med Chem,Scientific Literature,Binding affinity at human dopamine receptor D2,27,547,c1ccc(N2CCN(CCCn3c4c(c5ccccc53)CCCC4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1c2ccc(F)cc2CC1CCN1CCN(c2ccccn2)CC1,CHEMBL4815619,Ki,6.29,CHEMBL4866053,2021,CHEMBL4813955,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor incubated for 1 hr by liquid scintillation counting method,153,118,c1ccc(N2CCN(CCC3Cc4ccccc4C3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC1c2ccccc2CCC12CCN(CCc1ccccc1)CC2,CHEMBL697295,Ki,5.77,CHEMBL146144,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,32,732,c1ccc(CCN2CCC3(CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1,CHEMBL902495,Ki,5.62,CHEMBL246437,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1,CHEMBL1030600,Ki,8.84,CHEMBL726,2009,CHEMBL1149085,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor expressed in CHO cells,67,518,c1ccc2c(c1)Sc1ccccc1N2CCCN1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1,CHEMBL2390217,IC50,9.52,CHEMBL567,2013,CHEMBL2385071,J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor (unknown origin) expressed in CHOK1 cells coexpressing Galpha15 assessed as inhibition of agonist-induced response incubated for 60 mins in incubator followed by 15 mins at room temperature by FLIPR assay,95,834,c1ccc2c(c1)Sc1ccccc1N2CCCN1CCNCC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCN1CCN(c2cccc(Cl)c2Cl)CC1,CHEMBL2168000,Ki,7.2,CHEMBL2165675,2012,CHEMBL2163237,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human D2L receptor expressed in HEK293 cells after 60 mins by gamma counting analysis,86,254,c1ccc(N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1,CHEMBL4195122,Ki,6.42,CHEMBL896,2018,CHEMBL4190389,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to D2 receptor (unknown origin),133,982,c1ccc(C(c2ccccc2)N2CCNCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,CHEMBL3226695,Ki,6.0,CHEMBL716,2012,CHEMBL3217546,Medchemcomm,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin) by PDSP assay,86,553,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,CHEMBL3707630,Ki,6.4,CHEMBL716,2013,CHEMBL3638417,,BindingDB Patent Bioactivity Data,"Binding Assay: Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.",95,575,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,CHEMBL4718597,Ki,6.85,CHEMBL716,2016,CHEMBL4715748,Bioorg Med Chem,Scientific Literature,Binding affinity to human dopamine D2 receptor,123,580,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,CHEMBL5046640,Ki,6.51,CHEMBL716,2021,CHEMBL5046222,J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from human D2 receptor transfected in CHO-K1 cells measured after 60 mins by scintillation counting method,153,530,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,CHEMBL670684,Ki,7.2,CHEMBL716,2001,CHEMBL1134798,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity for Dopamine receptor D2,27,585,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,CHEMBL672169,Ki,6.51,CHEMBL716,2004,CHEMBL1149193,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2,39,533,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,CHEMBL672179,Ki,7.16,CHEMBL716,2001,CHEMBL1134342,J Med Chem,Scientific Literature,Binding affinity towards human D2 dopamine receptor.,27,534,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1,CHEMBL992743,Ki,6.75,CHEMBL716,2008,CHEMBL1155799,Bioorg Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,62,604,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC[C@@H]1[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccccc3)[C@@H]2[C@H]1N1CCCC1,CHEMBL2066740,Ki,6.6,CHEMBL2062851,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,86,442,c1ccc(CN2CC3CC(N4CCCC4)C3C2c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC[C@@H]1[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccccc3)[C@@H]2[C@H]1N1CCCCC1,CHEMBL2066740,Ki,5.7,CHEMBL2062861,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,86,442,c1ccc(CN2CC3CC(N4CCCCC4)C3C2c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC[C@H]1O[C@H](Oc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)[C@H](O)[C@H](O)[C@H]1O,CHEMBL670395,Ki,4.94,CHEMBL2303762,1997,CHEMBL1129926,Bioorg Med Chem Lett,Scientific Literature,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,13,153,c1ccc2c(c1)CCNC2Cc1ccc(OC2CCCCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC[C@H]1O[C@H](Oc2ccc(CC3NCCc4cc(O)c(O)cc43)cc2)[C@H](O)[C@H](O)[C@H]1O,CHEMBL671650,IC50,5.62,CHEMBL2303762,1997,CHEMBL1129926,Bioorg Med Chem Lett,Scientific Literature,Inhibitory concentration against binding of [3H]spiperone to human D2 dopaminergic receptor,13,983,c1ccc2c(c1)CCNC2Cc1ccc(OC2CCCCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC[C@H]1[C@H]2CN(Cc3ccccc3)[C@H](c3ccccc3)[C@H]2[C@@H]1N1CCCC1,CHEMBL2066740,Ki,5.13,CHEMBL2062850,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,86,442,c1ccc(CN2CC3CC(N4CCCC4)C3C2c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OC[C@H]1[C@H]2CN(Cc3ccccc3)[C@H](c3ccccc3)[C@H]2[C@@H]1N1CCCCC1,CHEMBL2066740,Ki,5.16,CHEMBL2062860,2012,CHEMBL2062374,Eur J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells,86,442,c1ccc(CN2CC3CC(N4CCCCC4)C3C2c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCc1[nH]c2ccccc2c1CN1CCN(c2ccccc2)CC1,CHEMBL5235409,Ki,5.68,CHEMBL5272162,2021,CHEMBL5233263,Eur J Med Chem,Scientific Literature,Binding affinity to human D2R assessed as inhibition constant,153,478,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCc1cc(C(O)CNCCCCCCOCCCCc2ccccc2)ccc1O,CHEMBL3801477,Ki,4.5,CHEMBL1263,2016,CHEMBL3797035,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2S receptor expressed in CHO cells,123,196,c1ccc(CCCCOCCCCCCNCCc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,CHEMBL3295080,Ki,8.51,CHEMBL3287396,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 long receptor expressed in CHO cells by competitive binding assay,107,391,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1,CHEMBL3295081,Ki,8.64,CHEMBL3287396,2014,CHEMBL3286313,J Med Chem,Scientific Literature,Displacement of [3H]Spiperone from human dopamine D2 short receptor expressed in CHO cells by competitive binding assay,107,392,c1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCc1ccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn2c1,CHEMBL671731,Ki,4.55,CHEMBL345357,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,32,45,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCc1ccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn2c1,CHEMBL671732,Ki,4.66,CHEMBL345357,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,32,46,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCc1ccc2c(CN3CCN(c4ccc(Cl)cc4)CC3)cnn2c1,CHEMBL913685,Ki,4.56,CHEMBL345357,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,58,44,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCc1cccn2ncc(CN3CCN(c4ccc(Cl)cc4)CC3)c12,CHEMBL671731,Ki,4.25,CHEMBL160396,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (long) stably expressed in CHO cells by [3H]-Spiperone displacement.,32,45,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCc1cccn2ncc(CN3CCN(c4ccc(Cl)cc4)CC3)c12,CHEMBL671732,Ki,4.1,CHEMBL160396,2002,CHEMBL1135071,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity at human cloned dopamine receptor D2 (short) stably expressed in CHO cells by [3H]spiperone displacement.,32,46,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCc1cnn2cccc(CN3CCN(c4ccc(Cl)cc4)CC3)c12,CHEMBL672382,Ki,4.41,CHEMBL328925,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2L using radioligand [3H]-spiperone,27,480,c1ccc(N2CCN(Cc3cccn4nccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
OCc1cnn2cccc(CN3CCN(c4ccc(Cl)cc4)CC3)c12,CHEMBL672572,Ki,4.28,CHEMBL328925,2001,CHEMBL1134560,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2S using radioligand [3H]spiperone,27,481,c1ccc(N2CCN(Cc3cccn4nccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@H](CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL651364,Ki,7.14,CHEMBL129237,1993,CHEMBL1126960,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,2,935,c1ccc(CCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@H](CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CHEMBL651364,Ki,7.0,CHEMBL339963,1993,CHEMBL1126960,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,2,935,c1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@H](COC[C@@H]1CCCO1)CN1CCN(c2ccccc2F)CC1,CHEMBL4137914,Ki,5.11,CHEMBL4176800,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,133,220,c1ccc(N2CCN(CCCOCC3CCCO3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@H](COc1ccccc1)CN1CCC(Oc2ccccc2)CC1,CHEMBL671653,Ki,6.61,CHEMBL31991,1997,CHEMBL1130437,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,13,979,c1ccc(OCCCN2CCC(Oc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Br)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12,CHEMBL1033058,Ki,8.82,CHEMBL3084519,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2coc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)c(Cl)c2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12,CHEMBL1033058,Ki,7.45,CHEMBL3084503,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)c(Cl)c2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12,CHEMBL1033065,IC50,6.68,CHEMBL3084503,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,62,980,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)c(Cl)c2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccc(F)cc12,CHEMBL1033058,Ki,8.85,CHEMBL3084524,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2coc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)c(Cl)c2)C[C@H]2CC[C@@H](C1)N2Cc1csc2ccccc12,CHEMBL1033058,Ki,7.53,CHEMBL3084513,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2csc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2c1ccc1ccccc12,CHEMBL1033058,Ki,8.25,CHEMBL3084523,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2coc3c2ccc2ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccc(F)cc12,CHEMBL1033058,Ki,8.92,CHEMBL3084521,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2coc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccc3ccccc3c12,CHEMBL1033058,Ki,7.93,CHEMBL3084522,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2coc3ccc4ccccc4c23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12,CHEMBL1033058,Ki,8.97,CHEMBL3084515,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2coc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12,CHEMBL1033065,IC50,8.72,CHEMBL3084515,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,62,980,c1ccc(C2CC3CCC(C2)N3Cc2coc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1csc2ccccc12,CHEMBL1033058,Ki,7.89,CHEMBL3084512,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2csc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1csc2ccccc12,CHEMBL1033065,IC50,7.58,CHEMBL3084512,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,62,980,c1ccc(C2CC3CCC(C2)N3Cc2csc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1n[nH]c2ccccc12,CHEMBL1033058,Ki,6.65,CHEMBL3084509,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2n[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(F)cc2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12,CHEMBL1033058,Ki,7.38,CHEMBL3084505,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc(F)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12,CHEMBL1033058,Ki,8.31,CHEMBL3084518,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2coc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2ccc3ccccc3c2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12,CHEMBL1033058,Ki,6.71,CHEMBL3084506,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc2cc(C3CC4CCC(C3)N4Cc3c[nH]c4ccccc34)ccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2cccc(Cl)c2Cl)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12,CHEMBL1033058,Ki,6.26,CHEMBL3084504,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2cccc(Cl)c2Cl)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12,CHEMBL1033058,Ki,7.4,CHEMBL3084517,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2coc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@@]1(c2cccc(Cl)c2Cl)C[C@H]2CC[C@@H](C1)N2Cc1csc2ccccc12,CHEMBL1033058,Ki,6.55,CHEMBL3084514,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2csc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@H](CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL651364,Ki,6.55,CHEMBL129159,1993,CHEMBL1126960,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,2,935,c1ccc(CCCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@H](CCCN1CCN(c2ccccn2)CC1)c1ccc(F)cc1,CHEMBL651364,Ki,6.39,CHEMBL339033,1993,CHEMBL1126960,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from CHO-K1 cell membranes expressing human dopamine receptor D2,2,935,c1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@H](COc1ccccc1)CN1CCC(Oc2ccccc2)CC1,CHEMBL671653,Ki,6.15,CHEMBL282323,1997,CHEMBL1130437,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against cloned human D2 receptor transfected in CHO-K1 cells using [3H]- spiperone as radioligand.,13,979,c1ccc(OCCCN2CCC(Oc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@]1(c2ccc(Cl)c(Cl)c2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12,CHEMBL1033058,Ki,8.77,CHEMBL3084516,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2coc3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12,CHEMBL1033058,Ki,7.48,CHEMBL3084502,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,62,729,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12,CHEMBL1033065,IC50,7.32,CHEMBL3084502,2008,CHEMBL1140093,J Med Chem,Scientific Literature,Antagonist activity at dopamine D2 receptor,62,980,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
O[C@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12,CHEMBL1033197,Ki,6.79,CHEMBL3084502,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,67,880,c1ccc(C2CC3CCC(C2)N3Cc2c[nH]c3ccccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)ccc1F,CHEMBL1926041,Ki,5.05,CHEMBL1923415,2011,CHEMBL1921774,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,80,671,c1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)ccc1F,CHEMBL1926042,Ki,5.21,CHEMBL1923415,2011,CHEMBL1921774,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,80,672,c1ccc(CN2CCN(c3ccc4c(c3)OCCO4)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(c(Br)c1O)CCNCC2c1ccccc1,CHEMBL669942,Ki,7.41,CHEMBL541559,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at high affinity state.,0,88,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(c(Br)c1O)CCNCC2c1ccccc1,CHEMBL669944,Ki,5.7,CHEMBL541559,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at low affinity state.,0,984,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1,CHEMBL669945,Ki,6.51,CHEMBL553503,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards dopamine receptor D2 at high affinity state.,0,85,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1,CHEMBL669946,Ki,5.1,CHEMBL553503,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards dopamine receptor D2 at low affinity state.,0,86,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(c(Cl)c1O)CCNC[C@@H]2c1ccccc1,CHEMBL672210,Ki,5.1,CHEMBL1160787,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,15,87,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1Br)CCNCC2c1ccccc1,CHEMBL672777,Ki,5.24,CHEMBL557799,1992,CHEMBL1126025,J Med Chem,Scientific Literature,In vitro ability to inhibit [3H]spiperone binding to Dopamine receptor D2,0,90,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1Cl)CCC(CNCc1ccccc1)O2,CHEMBL671729,Ki,8.28,CHEMBL337228,1997,CHEMBL1130268,J Med Chem,Scientific Literature,Binding affinity in humans to Dopamine receptor D2 expressed in CHO cells was determined using the agonist [3H]-spiperone.,13,985,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1Cl)CCNCC2c1ccccc1,CHEMBL672778,Ki,5.86,CHEMBL540857,1992,CHEMBL1126025,J Med Chem,Scientific Literature,In vitro ability to inhibit [3H]spiperone binding to Dopamine receptor D2 from pig anterior pituitary tissue,0,986,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1Cl)CCN[C@H]2c1ccccc1,CHEMBL670683,Ki,5.43,CHEMBL65397,1989,CHEMBL1124647,J Med Chem,Scientific Literature,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,0,409,c1ccc(C2NCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1Cl)CC[C@@H](CNCc1ccccc1)O2,CHEMBL671384,Ki,7.11,CHEMBL134343,1997,CHEMBL1130268,J Med Chem,Scientific Literature,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,13,987,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1Cl)CC[C@H](CNCc1ccccc1)O2,CHEMBL671384,Ki,8.15,CHEMBL135357,1997,CHEMBL1130268,J Med Chem,Scientific Literature,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,13,987,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1Cl)CNC[C@H]2c1ccccc1,CHEMBL670682,Ki,5.74,CHEMBL59603,1989,CHEMBL1124647,J Med Chem,Scientific Literature,Binding potency of compound for Dopamine receptor D2 by displacement of [3H]spiperone,0,988,c1ccc(C2CNCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)C(c1ccccc1)CNCC2,CHEMBL1041332,Ki,3.142667503568732,CHEMBL286080,2009,CHEMBL1154108,Bioorg Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor,67,989,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)C(c1ccccc1)CNCC2,CHEMBL669941,Ki,6.8,CHEMBL542700,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at high affinity state,0,990,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)C(c1ccccc1)CNCC2,CHEMBL669943,Ki,5.06,CHEMBL542700,1991,CHEMBL1125221,J Med Chem,Scientific Literature,The compound was evaluated for the binding affinity towards Dopamine receptor D2 at low affinity state,0,89,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2,CHEMBL911249,Ki,5.43,CHEMBL217299,2006,CHEMBL1137342,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,49,417,c1ccc2c(c1)CNC1COc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2,CHEMBL912418,Ki,5.72,CHEMBL217299,2006,CHEMBL1137342,J Med Chem,Scientific Literature,Binding affinity to human cloned dopamine D2 receptor,50,991,c1ccc2c(c1)CNC1COc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2,CHEMBL671033,Ki,5.19,CHEMBL24077,1991,CHEMBL1125791,J Med Chem,Scientific Literature,Binding affinity against dopamine receptor D2 by using [3H]spiperone as radioligand in caudate-putamen of monkey,0,365,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2,CHEMBL671379,Ki,5.33,CHEMBL24077,1995,CHEMBL1128531,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,6,432,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2,CHEMBL672210,Ki,5.02,CHEMBL24077,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,15,87,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@@H]1c3ccccc3CN[C@H]1CO2,CHEMBL911249,Ki,5.17,CHEMBL384046,2006,CHEMBL1137342,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,50,417,c1ccc2c(c1)CNC1COc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3cc4c(nc3CN[C@@H]1CC2)CCCC4,CHEMBL672175,Ki,5.44,CHEMBL287513,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,20,290,c1ccc2c(c1)CCC1NCc3nc4c(cc3C21)CCCC4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3ccc(F)nc3CN[C@@H]1CC2,CHEMBL672175,Ki,5.66,CHEMBL27101,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,20,290,c1ccc2c(c1)CCC1NCc3ncccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2,CHEMBL1038853,Ki,5.58,CHEMBL25856,2009,CHEMBL1152600,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,67,639,c1ccc2c(c1)CCC1NCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2,CHEMBL1936228,Ki,7.24,CHEMBL25856,2012,CHEMBL1932931,Eur J Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor,86,499,c1ccc2c(c1)CCC1NCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2,CHEMBL671379,Ki,5.82,CHEMBL25856,1995,CHEMBL1128531,J Med Chem,Scientific Literature,Binding affinity against cloned human Dopamine receptor D2 using [3H]spiperone as radioligand transfected in HEK cells,6,432,c1ccc2c(c1)CCC1NCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2,CHEMBL672175,Ki,5.82,CHEMBL25856,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,20,290,c1ccc2c(c1)CCC1NCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2,CHEMBL672210,Ki,5.77,CHEMBL25856,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,15,87,c1ccc2c(c1)CCC1NCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2,CHEMBL911249,Ki,6.62,CHEMBL25856,2006,CHEMBL1137342,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,50,417,c1ccc2c(c1)CCC1NCc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CO2,CHEMBL911249,Ki,5.6,CHEMBL387250,2006,CHEMBL1137342,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from dopamine D2-like receptor in porcine striata homogenate,50,417,c1ccc2c(c1)CNC1COc3ccccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3cccnc3CN[C@@H]1CC2,CHEMBL672175,Ki,5.6,CHEMBL281932,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,20,290,c1ccc2c(c1)CCC1NCc3ncccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3ccncc3CN[C@@H]1CC2,CHEMBL672175,Ki,5.36,CHEMBL284644,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,20,290,c1ccc2c(c1)CCC1NCc3cnccc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3cncc(F)c3CN[C@@H]1CC2,CHEMBL672175,Ki,6.05,CHEMBL26365,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,20,290,c1ccc2c(c1)CCC1NCc3ccncc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cc2c(cc1O)[C@H]1c3cnccc3CN[C@@H]1CC2,CHEMBL672175,Ki,5.89,CHEMBL28054,1999,CHEMBL1131704,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to human Dopamine receptor D2 by using radioligand [3H]spiperone in LTK cells,20,290,c1ccc2c(c1)CCC1NCc3ccncc3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(-c2ccc(CNCCc3c[nH]c4cc(F)ccc34)o2)cc1,CHEMBL4316415,Ki,6.35,CHEMBL4584504,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,146,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(-c2ccc(CNCCc3c[nH]c4ccc(F)cc34)o2)cc1,CHEMBL4316415,Ki,6.42,CHEMBL4437523,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,146,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,CHEMBL4316415,Ki,6.12,CHEMBL4465414,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,146,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(-c2ccc(CNCCc3c[nH]c4ncc(F)cc34)o2)cc1,CHEMBL4316415,Ki,6.3,CHEMBL4442855,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,146,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ncccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)co1,CHEMBL672579,Ki,5.36,CHEMBL62996,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,24,463,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)co2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(Br)cc1-c1nc(CN2CCN(c3ccccc3)CC2)co1,CHEMBL673073,Ki,5.18,CHEMBL62996,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,24,464,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)co2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(C2(O)CCN(Cc3c[nH]c4ccccc34)CC2)cc1,CHEMBL902495,Ki,5.27,CHEMBL392823,2007,CHEMBL1138415,Bioorg Med Chem Lett,Scientific Literature,Displacement of [125I]IABN from human dopamine D2L receptor expressed in HEK293 cells,58,94,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(C2=CCC[C@@H](CN3CC=C(c4ccccc4)CC3)C2)cc1,CHEMBL672910,Ki,9.7,CHEMBL357416,1995,CHEMBL1128721,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,6,63,C1=C(c2ccccc2)CCN(CC2CCC=C(c3ccccc3)C2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(C2=CCC[C@@H](CN3CC=C(c4ccccc4)CC3)C2)cc1,CHEMBL672911,Ki,8.46,CHEMBL357416,1995,CHEMBL1128721,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,6,64,C1=C(c2ccccc2)CCN(CC2CCC=C(c3ccccc3)C2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(C2=CCN(C[C@@H]3CCC=C(c4ccc(O)cc4)C3)CC2)cc1,CHEMBL672910,Ki,8.66,CHEMBL147159,1995,CHEMBL1128721,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,6,63,C1=C(c2ccccc2)CCN(CC2CCC=C(c3ccccc3)C2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(C2=CCN(C[C@@H]3CCC=C(c4ccc(O)cc4)C3)CC2)cc1,CHEMBL672911,Ki,7.99,CHEMBL147159,1995,CHEMBL1128721,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,6,64,C1=C(c2ccccc2)CCN(CC2CCC=C(c3ccccc3)C2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(C2=CCN(C[C@@H]3CCC=C(c4ccccc4)C3)CC2)cc1,CHEMBL672910,Ki,8.24,CHEMBL356269,1995,CHEMBL1128721,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]N-0437,6,63,C1=C(c2ccccc2)CCN(CC2CCC=C(c3ccccc3)C2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(C2=CCN(C[C@@H]3CCC=C(c4ccccc4)C3)CC2)cc1,CHEMBL672911,Ki,7.03,CHEMBL356269,1995,CHEMBL1128721,J Med Chem,Scientific Literature,Binding affinity towards human Dopamine receptor D2L evaluated using [3H]spiperone,6,64,C1=C(c2ccccc2)CCN(CC2CCC=C(c3ccccc3)C2)C1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1,CHEMBL672210,Ki,6.09,CHEMBL588,1998,CHEMBL1131163,J Med Chem,Scientific Literature,Affinity towards Dopamine receptor D2,15,87,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1,CHEMBL670395,Ki,5.41,CHEMBL19344,1997,CHEMBL1129926,Bioorg Med Chem Lett,Scientific Literature,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,13,153,c1ccc(CC2NCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(CC2NCCc3cc(O)c(O)cc32)cc1O,CHEMBL670395,Ki,5.47,CHEMBL19068,1997,CHEMBL1129926,Bioorg Med Chem Lett,Scientific Literature,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,13,153,c1ccc(CC2NCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(CN2CCO[C@H](CCc3ccccc3)C2)cc1,CHEMBL3383656,IC50,4.78,CHEMBL3335555,2014,CHEMBL3352711,ACS Med Chem Lett,Scientific Literature,Inhibition of human dopamine D2L receptor,107,711,c1ccc(CCC2CN(Cc3ccccc3)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2c1OCCO2,CHEMBL4015806,Ki,6.96,CHEMBL4083727,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,129,297,c1cc2c(c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2c1OCCO2,CHEMBL4015807,Ki,7.17,CHEMBL4083727,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,129,298,c1cc2c(c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2cccnc12,CHEMBL4015806,Ki,7.48,CHEMBL4061986,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes by radioligand binding assay,129,297,c1cc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2cccnc12,CHEMBL4015807,Ki,7.6,CHEMBL4061986,2017,CHEMBL4014323,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes by radioligand binding assay,129,298,c1cc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2cccnc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(N2CCN(Cc3cccs3)CC2)cc1,CHEMBL2423805,Ki,5.66,CHEMBL2420778,2013,CHEMBL2417399,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor,95,493,c1ccc(N2CCN(Cc3cccs3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL934518,Ki,5.21,CHEMBL407818,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,62,4,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,CHEMBL934519,Ki,4.06,CHEMBL407818,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,62,5,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(N2CCNCC2)c2c1OCCO2,CHEMBL4046973,Ki,5.16,CHEMBL4066916,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2LR expressed in CHO cell membranes,129,385,c1cc2c(c(N3CCNCC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(N2CCNCC2)c2c1OCCO2,CHEMBL4046974,Ki,5.22,CHEMBL4066916,2017,CHEMBL4043213,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2SR expressed in CHO cell membranes,129,386,c1cc2c(c(N3CCNCC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(OCCNCCCOc2ccccc2)cc1,CHEMBL671378,Ki,6.25,CHEMBL22892,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,13,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc(OCCNCCCOc2ccccc2)cc1,CHEMBL835389,Ki,6.25,CHEMBL22892,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,43,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc([C@H]2CN[C@@H]3CCc4cc(O)c(O)cc4[C@H]3C2)cc1,CHEMBL2162509,Ki,6.31,CHEMBL2158636,2012,CHEMBL2157876,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,86,315,c1ccc(C2CNC3CCc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc([C@H]2C[C@@H]2CN2CCN(c3ccc(Cl)cc3Cl)CC2)cc1,CHEMBL671074,IC50,7.92,CHEMBL1202202,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",24,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)C(c1ccccc1)CNCC2,CHEMBL672777,Ki,5.36,CHEMBL543472,1992,CHEMBL1126025,J Med Chem,Scientific Literature,In vitro ability to inhibit [3H]spiperone binding to Dopamine receptor D2,1,90,c1ccc(C2CNCCc3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)C1OCCN(CCc3cccs3)C1CC2,CHEMBL671417,Ki,5.43,CHEMBL102414,2002,CHEMBL1135499,J Med Chem,Scientific Literature,In vitro binding affinity at human Dopamine receptor D2 expressed in CHO K1 cells was measured by its ability to displace [3H]- N-0437,32,318,c1csc(CCN2CCOC3c4ccccc4CCC32)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)CC(N(CCc1cccs1)CCN1CCN(c3ccccc3)CC1)CC2,CHEMBL926379,Ki,7.61,CHEMBL254199,2008,CHEMBL1140704,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2L receptor expressed in HEK293 cells,62,28,c1ccc(N2CCN(CCN(CCc3cccs3)C3CCc4ccccc4C3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)CCCNCCc1ccccc1C2,CHEMBL895724,Ki,6.07,CHEMBL396950,2007,CHEMBL1148752,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in HEK293 cells,58,563,c1ccc2c(c1)CCCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)CCN1Cc3ccccc3CC21,CHEMBL1038853,Ki,6.31,CHEMBL593897,2009,CHEMBL1152600,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2L receptor expressed in CHO cells by scintillation counting,67,639,c1ccc2c(c1)CC1c3ccccc3CCN1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)CCN2,CHEMBL670395,Ki,5.03,CHEMBL19331,1997,CHEMBL1129926,Bioorg Med Chem Lett,Scientific Literature,Potency was measured by the displacement of [3H]spiperone binding to human D2 dopaminergic receptor,13,153,c1ccc2c(c1)CCN2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)CCN2,CHEMBL671650,IC50,5.99,CHEMBL19331,1997,CHEMBL1129926,Bioorg Med Chem Lett,Scientific Literature,Inhibitory concentration against binding of [3H]spiperone to human D2 dopaminergic receptor,13,983,c1ccc2c(c1)CCN2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)CCNCCc1ccccc1C2,CHEMBL982103,Ki,6.41,CHEMBL459871,2008,CHEMBL1157471,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]SCH23390 from human cloned dopamine D2L receptor,62,470,c1ccc2c(c1)CCNCCc1ccccc1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)CN1CCc3cc4c(cc3C1C2)OCO4,CHEMBL4339971,IC50,6.3,CHEMBL4476383,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,141,618,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)OC(CN1CCc3ccccc3C1)CC2,CHEMBL672799,Ki,8.37,CHEMBL134808,1997,CHEMBL1130268,J Med Chem,Scientific Literature,"Compound was tested to inhibit Dopa accumulation in to Dopamine receptor D2 at 10 mg/kg, sc",13,992,c1ccc2c(c1)CCN(CC1CCc3ccccc3O1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)OC(CNCc1ccccc1)CC2,CHEMBL671384,Ki,8.01,CHEMBL135395,1997,CHEMBL1130268,J Med Chem,Scientific Literature,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,13,987,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CN1CCc3ccccc3C1)CC2,CHEMBL671384,Ki,8.6,CHEMBL135044,1997,CHEMBL1130268,J Med Chem,Scientific Literature,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,13,987,c1ccc2c(c1)CCN(CC1CCc3ccccc3O1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(I)cc3)CC1)CC2,CHEMBL3117737,Ki,6.949999999999999,CHEMBL3115578,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,273,c1ccc(N2CCN(CCNCC3CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(I)cc3)CC1)CC2,CHEMBL3117738,Ki,7.135,CHEMBL3115578,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,274,c1ccc(N2CCN(CCNCC3CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2,CHEMBL3117737,Ki,6.615,CHEMBL3115582,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,273,c1ccc(N2CCN(CCNCC3CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2,CHEMBL3117738,Ki,6.645,CHEMBL3115582,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,274,c1ccc(N2CCN(CCNCC3CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(OCCF)cc3)CC1)CC2,CHEMBL3117739,Ki,8.24,CHEMBL3115582,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,275,c1ccc(N2CCN(CCNCC3CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2,CHEMBL3117737,Ki,6.97,CHEMBL3115574,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,273,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2,CHEMBL3117738,Ki,7.37,CHEMBL3115574,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,274,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2,CHEMBL3117739,Ki,8.555,CHEMBL3115574,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,275,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2,CHEMBL3117737,Ki,7.035,CHEMBL3115579,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,273,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2,CHEMBL3117738,Ki,7.15,CHEMBL3115579,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,274,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2,CHEMBL3117739,Ki,8.254999999999999,CHEMBL3115579,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,275,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2,CHEMBL3117737,Ki,7.525,CHEMBL3115575,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,273,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2,CHEMBL3117738,Ki,7.305,CHEMBL3115575,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,274,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2,CHEMBL3117739,Ki,8.84,CHEMBL3115575,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,275,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2,CHEMBL3117737,Ki,6.43,CHEMBL134807,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,273,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2,CHEMBL3117738,Ki,7.275,CHEMBL134807,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,274,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2,CHEMBL3117739,Ki,8.719999999999999,CHEMBL134807,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,275,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2,CHEMBL670555,Ki,7.98,CHEMBL64553,2002,CHEMBL1135019,Bioorg Med Chem Lett,Scientific Literature,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,32,894,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2,CHEMBL671384,Ki,7.98,CHEMBL134807,1997,CHEMBL1130268,J Med Chem,Scientific Literature,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,13,987,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2,CHEMBL671654,Ki,7.98,CHEMBL64553,1998,CHEMBL1131356,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,15,816,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CO2,CHEMBL671384,Ki,8.14,CHEMBL423890,1997,CHEMBL1130268,J Med Chem,Scientific Literature,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,13,987,c1ccc(CNCC2COc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CO2,CHEMBL671654,Ki,8.14,CHEMBL300571,1998,CHEMBL1131356,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,15,816,c1ccc(CNCC2COc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1I)CC2,CHEMBL3117737,Ki,6.93,CHEMBL3115576,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,273,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1I)CC2,CHEMBL3117738,Ki,7.41,CHEMBL3115576,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,107,274,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1I)CC2,CHEMBL3117739,Ki,9.48,CHEMBL3115576,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from high-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,108,275,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1OCCCCF)CC2,CHEMBL3117737,Ki,6.395,CHEMBL3115580,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2S receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,108,273,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1OCCCCF)CC2,CHEMBL3117738,Ki,6.824999999999999,CHEMBL3115580,2014,CHEMBL3112461,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from low-affinity state of human dopamine D2L receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,108,274,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@H](CN1CCc3ccccc3C1)CC2,CHEMBL671384,Ki,7.13,CHEMBL135725,1997,CHEMBL1130268,J Med Chem,Scientific Literature,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,13,987,c1ccc2c(c1)CCN(CC1CCc3ccccc3O1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)O[C@H](CNCc1ccccc1)CC2,CHEMBL671384,Ki,6.64,CHEMBL138016,1997,CHEMBL1130268,J Med Chem,Scientific Literature,Binding affinity at human Dopamine receptor D2 (hD2) using [3H]spiperone radioligand.,13,987,c1ccc(CNCC2CCc3ccccc3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1)[C@H]1OCCN[C@@H]1CO2,CHEMBL4361371,Ki,5.37,CHEMBL4565132,2019,CHEMBL4359839,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)-7-OH-DPAT from recombinant human D2L receptor expressed in HEK293 cell membranes measured after 90 mins by microbeta scintillation counting analysis,141,352,c1ccc2c(c1)OCC1NCCOC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21,CHEMBL1225589,Ki,3.1249387366083,CHEMBL1224527,2010,CHEMBL1221364,Bioorg Med Chem,Scientific Literature,Binding affinity to dopamine D2 receptor,76,993,c1ccc(C2Cc3ccccc3C3CNCCC23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21,CHEMBL2162509,Ki,6.64,CHEMBL1224527,2012,CHEMBL2157876,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2long receptor expressed in HEK293 cells after 30 mins by scintillation counting,86,315,c1ccc(C2Cc3ccccc3C3CNCCC23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2n1,CHEMBL2169117,Ki,8.14,CHEMBL161792,2012,CHEMBL2163335,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in CHO cells after 1.5 hrs by microbeta counting method,86,205,c1ccc(N2CCN(CCCCOc3ccc4cccnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2cccc(O)c2)c1,CHEMBL5046486,Ki,6.01,CHEMBL5087504,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,153,253,c1ccc(C(CCNCCCCN2CCN(c3ccccc3)CC2)c2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(C2CCN(Cc3ccccc3)CC2)c1,CHEMBL1066831,Ki,6.54,CHEMBL592377,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,76,380,c1ccc(CN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(C2CCN(Cc3ccccc3)CC2)c1,CHEMBL1066832,Ki,7.46,CHEMBL592377,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,76,381,c1ccc(CN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(C2NCCc3c2[nH]c2ccccc32)c1,CHEMBL886705,Ki,4.06,CHEMBL392401,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,58,129,c1ccc(C2NCCc3c2[nH]c2ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(CCN(CCc2ccccc2)CC2CC2)c1,CHEMBL2182832,Ki,6.93,CHEMBL2180638,2012,CHEMBL2177058,J Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,86,272,c1ccc(CCN(CCc2ccccc2)CC2CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(CCN(CCc2ccccc2)CC2CCC2)c1,CHEMBL2182829,IC50,5.78,CHEMBL2180639,2012,CHEMBL2177058,J Med Chem,Scientific Literature,Antagonist activity at human dopamine D2 receptor expressed in CHOp cells assessed as inhibition of quinpirol-induced mitogenesis incubated for 24 hrs by [3H]thymidine incorporation assay,86,271,c1ccc(CCN(CCc2ccccc2)CC2CCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(CCN(CCc2ccccc2)CC2CCC2)c1,CHEMBL2182832,Ki,6.35,CHEMBL2180639,2012,CHEMBL2177058,J Med Chem,Scientific Literature,Displacement of [3H]YM-09151-2 from human dopamine D2 receptor expressed in CHOp cells,86,272,c1ccc(CCN(CCc2ccccc2)CC2CCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(N2CCN(Cc3ccccc3)CC2)c1,CHEMBL1066831,Ki,6.94,CHEMBL88365,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells,76,380,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(N2CCN(Cc3ccccc3)CC2)c1,CHEMBL1066832,Ki,8.34,CHEMBL88365,2010,CHEMBL1157594,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells,76,381,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(N2CCN(Cc3ccccc3)CC2)c1,CHEMBL671654,Ki,6.61,CHEMBL88365,1998,CHEMBL1131356,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,15,816,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(N2CCN(Cc3ccccc3)CC2)c1,CHEMBL884862,Ki,6.61,CHEMBL88365,1998,CHEMBL1130595,Bioorg Med Chem Lett,Scientific Literature,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,15,1,c1ccc(CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(OCCNCc2ccccc2)c1,CHEMBL671654,Ki,7.12,CHEMBL64508,1998,CHEMBL1131356,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,15,816,c1ccc(CNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc(OCCNCc2ccccc2)c1,CHEMBL672205,Ki,7.12,CHEMBL64508,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,20,876,c1ccc(CNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc([C@@]23CCC[C@@H]([C@H]2O)N(C/C=C/c2ccccc2)CC3)c1,CHEMBL5046486,Ki,5.13,CHEMBL5077645,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 60 mins by microbeta scintillation counting analysis,153,253,C(=Cc1ccccc1)CN1CCC2(c3ccccc3)CCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc([C@@]23CCC[C@@H]([C@H]2O)N(C/C=C/c2ccccc2)CC3)c1,CHEMBL5046490,Ki,5.55,CHEMBL5077645,2021,CHEMBL5046218,J Med Chem,Scientific Literature,Displacement of [3H]-(R)-(+)7-OH-DPAT from human dopamine D2 receptor expressed in HEK293 cell membranes incubated for 90 mins by microbeta scintillation counting analysis,153,474,C(=Cc1ccccc1)CN1CCC2(c3ccccc3)CCCC1C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc2c1CC1c3cc4c(cc3CCN1C2)OCO4,CHEMBL4339971,IC50,6.72,CHEMBL4582377,2019,CHEMBL4339211,Bioorg Med Chem,Scientific Literature,Antagonist activity at D2 receptor (unknown origin) expressed in CHOK1 cells assessed as inhibition of dopamine-induced calcium flux preincubated for 60 mins at 37 degC followed by 15 mins incubation under room temperature and subsequent dopamine addition measured after 20 secs for 100 secs by calcium-4 dye based FLIPR assay,141,618,c1ccc2c(c1)CC1c3cc4c(cc3CCN1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1cccc2c1CC[C@@H]1NCCC[C@@H]21,CHEMBL673016,Ki,7.96,CHEMBL56519,1993,CHEMBL1126679,J Med Chem,Scientific Literature,"Compound was tested for agonistic activity against D2 receptor from cloned CHO cells, used [3H]U-86170 as radioligand",2,77,c1ccc2c(c1)CCC1NCCCC21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccccc1N1CCN(Cc2cnn3ccccc23)CC1,CHEMBL934518,Ki,5.35,CHEMBL272602,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2L receptor expressed in CHO cells,62,4,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccccc1N1CCN(Cc2cnn3ccccc23)CC1,CHEMBL934519,Ki,5.33,CHEMBL272602,2008,CHEMBL1143102,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from cloned human dopamine D2S receptor expressed in CHO cells,62,5,c1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccccc1OCCNCC1COCC(c2ccccc2)(c2ccccc2)O1,CHEMBL4041731,Ki,7.81,CHEMBL4082195,2017,CHEMBL4041469,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from recombinant human D2 receptor expressed in HEK293 cell membranes after 1 hr by liquid scintillation counting method,129,651,c1ccc(OCCNCC2COCC(c3ccccc3)(c3ccccc3)O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1ccccc1OCCNCc1ccccc1,CHEMBL671654,Ki,6.34,CHEMBL101285,1998,CHEMBL1131356,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards human cloned dopamine (hD2s) receptors expressed in CHO cell membranes using [3H]spiperone,15,816,c1ccc(CNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc(-c2ccccc2)cn1C1CCN(Cc2ccccc2)CC1,CHEMBL671375,Ki,7.09,CHEMBL93958,1999,CHEMBL1132306,J Med Chem,Scientific Literature,Affinity to displace [3H]spiperone from cloned human Dopamine receptor D2 stably expressed in CHO cell lines,20,496,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2c(N3CCN(Cc4ccccc4)CC3)cccc2[nH]1,CHEMBL884862,Ki,7.06,CHEMBL315864,1998,CHEMBL1130595,Bioorg Med Chem Lett,Scientific Literature,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,15,1,c1ccc(CN2CCN(c3cccc4[nH]cnc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2c(OCCNCc3ccccc3)cc(Cl)cc2[nH]1,CHEMBL672205,Ki,8.59,CHEMBL329398,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,20,876,c1ccc(CNCCOc2cccc3[nH]cnc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2c(OCCNCc3ccccc3)cccc2[nH]1,CHEMBL672205,Ki,8.41,CHEMBL314174,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,20,876,c1ccc(CNCCOc2cccc3[nH]cnc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2c3c(ccc2[nH]1)CCC(CNCc1ccccc1)O3,CHEMBL670555,Ki,8.3,CHEMBL93779,2002,CHEMBL1135019,Bioorg Med Chem Lett,Scientific Literature,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,32,894,c1ccc(CNCC2CCc3ccc4[nH]cnc4c3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2c3c(ccc2[nH]1)CC[C@@H](CNCc1ccccc1)O3,CHEMBL670555,Ki,7.17,CHEMBL93753,2002,CHEMBL1135019,Bioorg Med Chem Lett,Scientific Literature,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,32,894,c1ccc(CNCC2CCc3ccc4[nH]cnc4c3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2c3c(ccc2[nH]1)CC[C@H](CNCc1ccccc1)O3,CHEMBL670555,Ki,8.52,CHEMBL420986,2002,CHEMBL1135019,Bioorg Med Chem Lett,Scientific Literature,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,32,894,c1ccc(CNCC2CCc3ccc4[nH]cnc4c3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2cc(CCN3CCN(c4cccc(C(F)(F)F)c4)CC3)ccc2[nH]1,CHEMBL838638,Ki,7.55,CHEMBL181898,2004,CHEMBL1137161,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2,39,598,c1ccc(N2CCN(CCc3ccc4[nH]cnc4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2cccc(N3CCN(Cc4cc(-c5ccc(F)cc5)ccn4)CC3)c2o1,CHEMBL672308,Ki,9.33,CHEMBL308345,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2ccnc(CN3CCN(c4cccc5ncoc45)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2cccc(N3CCN(Cc4cc(-c5ccccc5)ccc4F)CC3)c2o1,CHEMBL672308,Ki,7.92,CHEMBL77334,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cccc(CN3CCN(c4cccc5ncoc45)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2cccc(N3CCN(Cc4ccc(O)c(-c5ccccc5)c4)CC3)c2o1,CHEMBL672308,Ki,9.39,CHEMBL80230,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cccc(CN3CCN(c4cccc5ncoc45)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2cccc(N3CCN(Cc4cccc(-c5ccc(F)cc5)c4)CC3)c2o1,CHEMBL672308,Ki,8.09,CHEMBL306830,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cccc(CN3CCN(c4cccc5ncoc45)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2cccc(N3CCN(Cc4cccc(-c5ccc(F)cc5)n4)CC3)c2o1,CHEMBL672308,Ki,8.52,CHEMBL419275,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cccc(CN3CCN(c4cccc5ncoc45)CC3)n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2cccc(N3CCN(Cc4cccc(-c5cccc(Cl)c5)c4)CC3)c2o1,CHEMBL672308,Ki,7.75,CHEMBL77934,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cccc(CN3CCN(c4cccc5ncoc45)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2cccc(N3CCN(Cc4cccc(-c5cccs5)c4)CC3)c2o1,CHEMBL672308,Ki,8.66,CHEMBL75621,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1cc(CN2CCN(c3cccc4ncoc34)CC2)cc(-c2cccs2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2cccc(N3CCN(Cc4cccc(-c5ccsc5)c4)CC3)c2o1,CHEMBL672308,Ki,8.89,CHEMBL310045,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1cc(CN2CCN(c3cccc4ncoc34)CC2)cc(-c2ccsc2)c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2cccc(N3CCN(Cc4ccnc(-c5ccc(F)cc5)c4)CC3)c2o1,CHEMBL672308,Ki,8.54,CHEMBL74805,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cc(CN3CCN(c4cccc5ncoc45)CC3)ccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Oc1nc2cccc(N3CCN(Cc4cncc(-c5ccccc5)c4)CC3)c2o1,CHEMBL672308,Ki,8.74,CHEMBL76990,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cncc(CN3CCN(c4cccc5ncoc45)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
S=c1[nH]c2ccc(CCCN3CCN(c4ccc(Cl)cc4)CC3)cc2[nH]1,CHEMBL3073105,Ki,7.7,CHEMBL2298820,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),95,427,S=c1[nH]c2ccc(CCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
S=c1[nH]c2ccc(CCCN3CCN(c4ccccc4)CC3)cc2[nH]1,CHEMBL3073105,Ki,8.52,CHEMBL2298818,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),95,427,S=c1[nH]c2ccc(CCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
S=c1[nH]c2ccc(OCCN3CCN(c4cccc(Cl)c4)CC3)cc2[nH]1,CHEMBL3073105,Ki,8.15,CHEMBL2298833,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),95,427,S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,CHEMBL3073105,Ki,9.17,CHEMBL2298827,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),95,427,S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4Cl)CC3)cc2[nH]1,CHEMBL3073105,Ki,8.56,CHEMBL2298832,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),95,427,S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4)CC3)cc2[nH]1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
S=c1n(CCCCCCN2CCN(c3cccc(Cl)c3)CC2)c2cccc3c2n1CCC3,CHEMBL5163611,Ki,7.07,CHEMBL5182383,2022,CHEMBL5154833,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human full length D2L receptor expressed in HEK293 cells by radioligand binding assay,155,910,S=c1n(CCCCCCN2CCN(c3ccccc3)CC2)c2cccc3c2n1CCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Sc1nc2c(OCCNCc3ccccc3)cc(Cl)cc2[nH]1,CHEMBL672205,Ki,8.19,CHEMBL89037,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,20,876,c1ccc(CNCCOc2cccc3[nH]cnc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
Sc1nc2c(OCCNCc3ccccc3)cccc2[nH]1,CHEMBL672205,Ki,8.52,CHEMBL327782,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,20,876,c1ccc(CNCCOc2cccc3[nH]cnc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
[2H]c1c([2H])c([2H])c([C@@H]2C[C@@H](N3CCN(C([2H])([2H])[2H])C(C)(C)C3)c3cc(Cl)ccc32)c([2H])c1[2H],CHEMBL5117893,Ki,8.39,CHEMBL5191141,2022,CHEMBL5113485,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]7-OH-DPAT from recombinant human D2S receptor measured after 60 mins by scintillation counting analysis,155,994,c1ccc(C2CC(N3CCNCC3)c3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
[2H]c1c([2H])c([2H])c([C@@H]2C[C@@H](N3CCNC(C)(C)C3)c3cc(Cl)ccc32)c([2H])c1[2H],CHEMBL5117893,Ki,7.96,CHEMBL5201983,2022,CHEMBL5113485,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]7-OH-DPAT from recombinant human D2S receptor measured after 60 mins by scintillation counting analysis,155,994,c1ccc(C2CC(N3CCNCC3)c3ccccc32)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
[N-]=[N+]=NCCSSCCn1cc(C(=O)CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)nn1,CHEMBL4044352,Ki,6.58,CHEMBL4100263,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2long receptor expressed in CHO cell membranes by radioligand binding assay,129,668,O=C(CCCN1CCC(c2ccccc2)CC1)c1c[nH]nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
[N-]=[N+]=NCCSSCCn1cc(C(=O)CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)nn1,CHEMBL4044353,Ki,6.85,CHEMBL4100263,2017,CHEMBL4043101,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human D2short receptor expressed in CHO cell membranes by radioligand binding assay,129,669,O=C(CCCN1CCC(c2ccccc2)CC1)c1c[nH]nn1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
[O-][S+](CCCN1CCC(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL1944110,Ki,6.0,CHEMBL1940407,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,86,884,c1ccc([SH+]CCCN2CCC(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
[O-][S+](CCCN1CCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1,CHEMBL3292986,Ki,6.2,CHEMBL3289383,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,108,846,c1ccc([SH+]CCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
[O-][S+](CCCN1CCc2ccccc2C1)c1ccc(F)cc1,CHEMBL3821452,Ki,6.375,CHEMBL3818710,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,123,698,c1ccc([SH+]CCCN2CCc3ccccc3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
[O-][S+](CCN1CCN(CC(O)Cc2ccccc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1,CHEMBL3863990,Ki,7.11,CHEMBL3918282,2016,CHEMBL3862037,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2R expressed in HEK293 cell membranes incubated for 1 hr by radioligand binding assay,123,226,c1ccc(CCCN2CCN(CC[SH+]C(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
[O-][S+](CCN1CCN(CC(O)Cc2ccccc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1,CHEMBL4711026,Ki,7.11,CHEMBL3918282,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,146,140,c1ccc(CCCN2CCN(CC[SH+]C(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
[O-][S+](CCNC1CCN(CC(O)Cc2ccccc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1,CHEMBL4711026,Ki,5.18,CHEMBL4758774,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,146,140,c1ccc(CCCN2CCC(NCC[SH+]C(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
[O-][S+](CCNC1CCN(Cc2ccc(F)cc2)CC1)C(c1ccc(F)cc1)c1ccc(F)cc1,CHEMBL4711026,Ki,4.91,CHEMBL4750660,2020,CHEMBL4706586,Eur J Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human D2L receptor expressed in HEK293 cell membranes measured after 60 mins by microbeta scintillation counting method,146,140,c1ccc(CN2CCC(NCC[SH+]C(c3ccccc3)c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1c2c(cc3c1CC[C@@H]1[C@@H]3OCCN1CC1CC1)OCC2,CHEMBL674942,Ki,5.6,CHEMBL171672,1997,CHEMBL1129892,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,13,179,c1c2c(cc3c1CCC1C3OCCN1CC1CC1)OCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1c2c(cc3c1CC[C@H]1NCCO[C@H]31)OCC2,CHEMBL674942,Ki,6.0,CHEMBL171825,1997,CHEMBL1129892,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [125 I]iodosulpiride binding to human Dopamine receptor D2 expressed in CHO cell membranes,13,179,c1c2c(cc3c1CCC1NCCOC31)OCC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,CHEMBL3888598,IC50,5.91,CHEMBL3903297,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",123,677,c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3C1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4,CHEMBL3888598,Ki,6.62,CHEMBL3903297,2016,CHEMBL3886775,,BindingDB Patent Bioactivity Data,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",123,677,c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3C1C2)OCO4,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1c[nH]c2nc(CN3CCc4ccccc4C3)cc-2c1,CHEMBL671652,Ki,6.22,CHEMBL156896,1999,CHEMBL1132519,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,20,58,c1c[nH]c2nc(CN3CCc4ccccc4C3)cc-2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cc2c(c(N3CCN(CCCCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,CHEMBL872394,Ki,8.04,CHEMBL263329,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,43,238,c1cc2c(c(N3CCN(CCCCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cc2c(c(N3CCN(CCCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,CHEMBL872394,Ki,8.29,CHEMBL194844,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,43,238,c1cc2c(c(N3CCN(CCCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)CCCN2,CHEMBL872394,Ki,7.95,CHEMBL198040,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,43,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)CCCN2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)CCCO2,CHEMBL872394,Ki,7.69,CHEMBL198812,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,43,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)CCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCN2,CHEMBL872394,Ki,7.75,CHEMBL197665,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,44,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCN2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,CHEMBL872394,Ki,7.68,CHEMBL196171,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,44,238,c1cc2c(c(N3CCN(CCCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cc2c(c(N3CCN(CCc4c[nH]c5ccccc45)CC3)c1)OCCO2,CHEMBL872394,Ki,7.35,CHEMBL196505,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,44,238,c1cc2c(c(N3CCN(CCc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cc2c(c(N3CCN(Cc4c[nH]c5ccccc45)CC3)c1)OCCO2,CHEMBL872394,Ki,7.21,CHEMBL195015,2005,CHEMBL1140372,J Med Chem,Scientific Literature,In vitro inhibitory constant against [3H]spiperone binding to human dopamine D2 receptor expressed in CHO cells,44,238,c1cc2c(c(N3CCN(Cc4c[nH]c5ccccc45)CC3)c1)OCCO2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cc2c3c(c[nH]c3c1)CC1CN(CC3CCCCC3)CCN21,CHEMBL3294601,Ki,7.27,CHEMBL3286575,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,108,178,c1cc2c3c(c[nH]c3c1)CC1CN(CC3CCCCC3)CCN21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cc2c3c(c[nH]c3c1)CC1CNCCN21,CHEMBL3294601,Ki,5.68,CHEMBL3286567,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,108,178,c1cc2c3c(c[nH]c3c1)CC1CNCCN21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2[nH]c3ccccc3c2C2CNCCO2)cc1,CHEMBL671367,Ki,5.8,CHEMBL40284,2001,CHEMBL1134475,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,27,554,c1ccc(-c2[nH]c3ccccc3c2C2CNCCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2[nH]c3ccccc3c2CCN2CCCCC2)cc1,CHEMBL671361,Ki,6.05,CHEMBL91205,2000,CHEMBL1132836,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from CHO cells expressing human Dopamine receptor D2.,24,435,c1ccc(-c2[nH]c3ccccc3c2CCN2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2[nH]c3ccccc3c2CCN2CCCCC2)cc1,CHEMBL671362,Ki,6.05,CHEMBL91205,2000,CHEMBL1132835,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]-spiperone from CHO cells expressing human Dopamine receptor D2 was determined,24,744,c1ccc(-c2[nH]c3ccccc3c2CCN2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1,CHEMBL671363,Ki,6.64,CHEMBL60815,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,32,34,c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1,CHEMBL671365,Ki,6.77,CHEMBL60815,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,32,35,c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1,CHEMBL871242,Ki,6.64,CHEMBL60815,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,50,66,c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1,CHEMBL871243,Ki,6.77,CHEMBL60815,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,50,67,c1ccc(-c2c[nH]c(CN3CCN(c4ccccc4)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)cc1,CHEMBL672182,Ki,6.31,CHEMBL541524,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,32,52,c1ccc(-c2cc(CCCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,CHEMBL672182,Ki,5.47,CHEMBL538474,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,33,52,c1ccc(-c2cc(CCCCN3CCN(c4ccccc4)CC3)on2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2ccc(CN3CCN4c5cccc6[nH]cc(c56)CC4C3)cc2)cc1,CHEMBL3294601,Ki,6.885,CHEMBL3286579,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,108,178,c1ccc(-c2ccc(CN3CCN4c5cccc6[nH]cc(c56)CC4C3)cc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,CHEMBL4316415,Ki,6.17,CHEMBL4462814,2020,CHEMBL4312034,Eur J Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2R expressed in HEK293 cells after 1 hr by microbeta plate reader analysis,146,544,c1ccc(-c2ccc(CNCCc3c[nH]c4ccccc34)o2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2cccc(CN3CCN(c4cccc5c4CCCN5)CC3)c2)cc1,CHEMBL672308,Ki,8.4,CHEMBL308476,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cccc(CN3CCN(c4cccc5c4CCCN5)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2cccc(CN3CCN(c4cccc5c4OCCN5)CC3)c2)cc1,CHEMBL672308,Ki,9.03,CHEMBL310048,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cccc(CN3CCN(c4cccc5c4OCCN5)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2cccc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1,CHEMBL672308,Ki,8.77,CHEMBL77472,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cccc(CN3CCN(c4cccc5c4OCCO5)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2cccc(CN3CCN(c4cccc5c4OCO5)CC3)c2)cc1,CHEMBL672308,Ki,8.0,CHEMBL78241,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cccc(CN3CCN(c4cccc5c4OCO5)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2cccc(CN3CCN(c4cccc5ccoc45)CC3)c2)cc1,CHEMBL672308,Ki,8.09,CHEMBL308875,2001,CHEMBL1133937,Bioorg Med Chem Lett,Scientific Literature,Binding affinity for dopamine receptor D2 determined using [3H]spiperone,27,593,c1ccc(-c2cccc(CN3CCN(c4cccc5ccoc45)CC3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2cccc(CN3CCN4c5cccc6[nH]cc(c56)CC4C3)c2)cc1,CHEMBL3294601,Ki,9.415,CHEMBL3286578,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,108,178,c1ccc(-c2cccc(CN3CCN4c5cccc6[nH]cc(c56)CC4C3)c2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2ccccc2CN2CCN3c4cccc5[nH]cc(c45)CC3C2)cc1,CHEMBL3294601,Ki,6.525,CHEMBL3286577,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,108,178,c1ccc(-c2ccccc2CN2CCN3c4cccc5[nH]cc(c45)CC3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc(CN3CCCN(c4nccs4)CC3)co2)cc1,CHEMBL4137914,Ki,5.49,CHEMBL4161436,2018,CHEMBL4130639,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human DRD2 after 90 mins by scintillation counting method,133,220,c1ccc(-c2nc(CN3CCCN(c4nccs4)CC3)co2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)c[nH]2)cc1,CHEMBL672173,Ki,6.59,CHEMBL103871,1997,CHEMBL1130009,J Med Chem,Scientific Literature,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,13,591,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)c[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)co2)cc1,CHEMBL672579,Ki,5.76,CHEMBL294780,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,24,463,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)co2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)co2)cc1,CHEMBL673073,Ki,5.52,CHEMBL294780,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,24,464,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)co2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)cs2)cc1,CHEMBL672579,Ki,5.97,CHEMBL64376,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,24,463,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)cs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)cs2)cc1,CHEMBL673073,Ki,5.64,CHEMBL64376,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,24,464,c1ccc(-c2nc(CN3CCN(c4ccccc4)CC3)cs2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc(CN3CCN(c4ccccn4)CC3)c[nH]2)cc1,CHEMBL672173,Ki,5.66,CHEMBL99967,1997,CHEMBL1130009,J Med Chem,Scientific Literature,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,13,591,c1ccc(-c2nc(CN3CCN(c4ccccn4)CC3)c[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc(CN3CCN(c4cccnc4)CC3)c[nH]2)cc1,CHEMBL672173,Ki,6.53,CHEMBL321513,1997,CHEMBL1130009,J Med Chem,Scientific Literature,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,13,591,c1ccc(-c2nc(CN3CCN(c4cccnc4)CC3)c[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc(CN3CCN(c4ncccn4)CC3)c[nH]2)cc1,CHEMBL4039163,Ki,5.65,CHEMBL103772,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,129,546,c1ccc(-c2nc(CN3CCN(c4ncccn4)CC3)c[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc(CN3CCN(c4ncccn4)CC3)c[nH]2)cc1,CHEMBL672173,Ki,5.65,CHEMBL103772,1997,CHEMBL1130009,J Med Chem,Scientific Literature,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,13,591,c1ccc(-c2nc(CN3CCN(c4ncccn4)CC3)c[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc3cc(CCN4CCN(c5ccccc5)CC4)ccc3[nH]2)cc1,CHEMBL3073105,Ki,7.5,CHEMBL185436,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),95,427,c1ccc(-c2nc3cc(CCN4CCN(c5ccccc5)CC4)ccc3[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-c2nc3cc(CCN4CCN(c5ccccc5)CC4)ccc3[nH]2)cc1,CHEMBL838638,Ki,7.5,CHEMBL185436,2004,CHEMBL1137161,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2,39,598,c1ccc(-c2nc3cc(CCN4CCN(c5ccccc5)CC4)ccc3[nH]2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-n2cc(CN3CCN(c4cc5ccc4CCc4ccc(cc4)CC5)CC3)cn2)cc1,CHEMBL2346426,Ki,7.55,CHEMBL2336893,2013,CHEMBL2331212,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,95,914,c1ccc(-n2cc(CN3CCN(c4cc5ccc4CCc4ccc(cc4)CC5)CC3)cn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-n2cc(CN3CCN(c4cc5ccc4CCc4ccc(cc4)CC5)CC3)cn2)cc1,CHEMBL2346428,Ki,7.41,CHEMBL2336893,2013,CHEMBL2331212,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,96,915,c1ccc(-n2cc(CN3CCN(c4cc5ccc4CCc4ccc(cc4)CC5)CC3)cn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-n2cc(CN3CCN(c4ncccn4)CC3)cn2)cc1,CHEMBL871242,Ki,5.22,CHEMBL209832,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,50,66,c1ccc(-n2cc(CN3CCN(c4ncccn4)CC3)cn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(-n2cc(CN3CCN(c4ncccn4)CC3)cn2)cc1,CHEMBL871243,Ki,4.85,CHEMBL209832,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,50,67,c1ccc(-n2cc(CN3CCN(c4ncccn4)CC3)cn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C(c2ccccc2)N2CCN(CCCCc3cc(-c4cccs4)no3)CC2)cc1,CHEMBL672182,Ki,6.21,CHEMBL543040,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,33,52,c1ccc(C(c2ccccc2)N2CCN(CCCCc3cc(-c4cccs4)no3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NCC[C@@H](CN3CCN(c4ccccc4)CC3)N2)cc1,CHEMBL672102,Ki,4.54,CHEMBL169459,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,36,995,c1ccc(C2=NCCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NCC[C@@H](CN3CCN(c4ccccc4)CC3)N2)cc1,CHEMBL672103,Ki,4.52,CHEMBL169459,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 short in CHO cells,37,996,c1ccc(C2=NCCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NCC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1,CHEMBL671415,Ki,4.5,CHEMBL352925,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to displace [3H]spiperone from the cloned human dopamine D2 short receptor expressed in CHO cells,37,997,c1ccc(C2=NCCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NCC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1,CHEMBL672801,Ki,4.6,CHEMBL352925,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro ability to displace [3H]spiperone from the cloned human dopamine D2 long receptor expressed in CHO cells,37,998,c1ccc(C2=NCCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NC[C@@H](N3CCN(c4ccccc4)CC3)CCN2)cc1,CHEMBL672098,Ki,4.72,CHEMBL354748,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,37,397,c1ccc(C2=NCC(N3CCN(c4ccccc4)CC3)CCN2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NC[C@@H](N3CCN(c4ccccc4)CC3)CCN2)cc1,CHEMBL672099,Ki,4.85,CHEMBL354748,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,37,398,c1ccc(C2=NCC(N3CCN(c4ccccc4)CC3)CCN2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1,CHEMBL665385,Ki,5.0,CHEMBL540039,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,27,695,c1ccc(C2=NCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1,CHEMBL671178,Ki,4.85,CHEMBL540039,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,27,696,c1ccc(C2=NCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1,CHEMBL673085,Ki,5.0,CHEMBL540039,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human Dopamine receptor D2L expressed in CHO cells,27,999,c1ccc(C2=NCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NC[C@H](CN3CCN(c4ccccc4)CC3)N2)cc1,CHEMBL675128,Ki,4.96,CHEMBL540039,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,27,1000,c1ccc(C2=NCC(CN3CCN(c4ccccc4)CC3)N2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NC[C@H](N3CCN(c4ccccc4)CC3)CCN2)cc1,CHEMBL672098,Ki,5.0,CHEMBL169562,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]spiperone from the cloned human dopamine receptor D2 long in CHO cells,37,397,c1ccc(C2=NCC(N3CCN(c4ccccc4)CC3)CCN2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=NC[C@H](N3CCN(c4ccccc4)CC3)CCN2)cc1,CHEMBL672099,Ki,5.38,CHEMBL169562,2003,CHEMBL1136617,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity to displace [3H]-spiperone from the cloned human dopamine receptor D2 short in CHO cells,37,398,c1ccc(C2=NCC(N3CCN(c4ccccc4)CC3)CCN2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CO2)cc1,CHEMBL665385,Ki,6.220000000000001,CHEMBL86060,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,27,695,c1ccc(C2=NC(CN3CCN(c4ccccc4)CC3)CO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CO2)cc1,CHEMBL671178,Ki,5.965,CHEMBL86060,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,27,696,c1ccc(C2=NC(CN3CCN(c4ccccc4)CC3)CO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CS2)cc1,CHEMBL665385,Ki,6.05,CHEMBL82527,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 short receptor expressed in CHO cells,27,695,c1ccc(C2=NC(CN3CCN(c4ccccc4)CC3)CS2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2=N[C@@H](CN3CCN(c4ccccc4)CC3)CS2)cc1,CHEMBL671178,Ki,5.890000000000001,CHEMBL82527,2001,CHEMBL1134812,Bioorg Med Chem Lett,Scientific Literature,In vitro for its ability to displace [3H]- spiperone from cloned human dopamine D2 long receptor expressed in CHO cells,27,696,c1ccc(C2=NC(CN3CCN(c4ccccc4)CC3)CS2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,CHEMBL672164,Ki,6.96,CHEMBL59103,1996,CHEMBL1129306,J Med Chem,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,9,249,c1ccc(C2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,CHEMBL913685,Ki,6.66,CHEMBL221814,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,58,44,c1ccc(C2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(C2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL913685,Ki,7.42,CHEMBL221600,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,58,44,c1ccc(C2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCC2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,CHEMBL671652,Ki,5.96,CHEMBL155207,1999,CHEMBL1132519,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,20,58,c1ccc(CCC2CCN(Cc3c[nH]c4ncccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCC2CCN(Cc3cc4ccc[nH]c-4n3)CC2)cc1,CHEMBL671652,Ki,6.7,CHEMBL156732,1999,CHEMBL1132519,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,20,58,c1ccc(CCC2CCN(Cc3cc4ccc[nH]c-4n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCC2CN(Cc3c[nH]c4ccccc34)CCO2)cc1,CHEMBL4039163,Ki,5.89,CHEMBL4069306,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,129,546,c1ccc(CCC2CN(Cc3c[nH]c4ccccc34)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1,CHEMBL1839313,Ki,7.05,CHEMBL1834258,2011,CHEMBL1833923,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,80,708,c1ccc(CCCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1,CHEMBL1839313,Ki,5.99,CHEMBL1834255,2011,CHEMBL1833923,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]N-methylspiperone from D2 after 1.5 hrs by liquid scintillation counting,80,708,c1ccc(CCCN2CCN(Cc3cc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCCNCCCOc2ccccc2)cc1,CHEMBL671378,Ki,6.29,CHEMBL129931,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,13,589,c1ccc(CCCNCCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCCOCC2CCN(Cc3ccccc3)CC2)cc1,CHEMBL878132,Ki,6.26,CHEMBL80656,1994,CHEMBL1127981,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards Dopamine receptor D2 using [3H]spiperone as radioligand,4,50,c1ccc(CCCOCC2CCN(Cc3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN2CCC(c3c(-c4ccccc4)[nH]c4ccccc34)CC2)cc1,CHEMBL671367,Ki,6.46,CHEMBL40584,2001,CHEMBL1134475,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,27,554,c1ccc(CCN2CCC(c3c(-c4ccccc4)[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN2CCC(c3cc(-c4ccccn4)[nH]n3)CC2)cc1,CHEMBL672209,Ki,6.07,CHEMBL310819,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,13,230,c1ccc(CCN2CCC(c3cc(-c4ccccn4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN2CCC(c3cc(-c4cccnc4)[nH]n3)CC2)cc1,CHEMBL672209,Ki,6.05,CHEMBL309460,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,13,230,c1ccc(CCN2CCC(c3cc(-c4cccnc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN2CCC(c3cc(-c4cccs4)[nH]n3)CC2)cc1,CHEMBL672209,Ki,7.19,CHEMBL77743,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,13,230,c1ccc(CCN2CCC(c3cc(-c4cccs4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN2CCC(c3cc(-c4ccncc4)[nH]n3)CC2)cc1,CHEMBL672209,Ki,5.89,CHEMBL79098,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,13,230,c1ccc(CCN2CCC(c3cc(-c4ccncc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN2CCC(c3cc(C4CCCCC4)n[nH]3)CC2)cc1,CHEMBL672209,Ki,7.21,CHEMBL77744,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,13,230,c1ccc(CCN2CCC(c3cc(C4CCCCC4)n[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN2CCC3(CCc4c3n[nH]c4-c3ccccc3)CC2)cc1,CHEMBL672209,Ki,6.16,CHEMBL311832,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,13,230,c1ccc(CCN2CCC3(CCc4c3n[nH]c4-c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)cc1,CHEMBL697295,Ki,6.28,CHEMBL148418,2002,CHEMBL1135811,J Med Chem,Scientific Literature,Binding affinity for displacement of [3H]spiperone to human dopamine D2 (hD2) receptors stably expressed in CHO cells,33,732,c1ccc(CCN2CCC3(CCc4ccccc4O3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)cc1,CHEMBL671367,Ki,6.3,CHEMBL44310,2001,CHEMBL1134475,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,27,554,c1ccc(CCN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN2CCN(c3ccccc3)CC2)cc1,CHEMBL2032826,Ki,6.32,CHEMBL2029931,2012,CHEMBL2029251,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human D2 DA receptor expressed in CHO cell membrane after 60 mins by liquid scintillation counting,86,943,c1ccc(CCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN2[C@@H]3CC[C@H]2CC(c2c(-c4ccccc4)[nH]c4ccccc24)C3)cc1,CHEMBL671367,Ki,6.0,CHEMBL2113667,2001,CHEMBL1134475,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,27,554,c1ccc(CCN2C3CCC2CC(c2c(-c4ccccc4)[nH]c4ccccc24)C3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)nc1,CHEMBL2432454,Ki,5.0,CHEMBL2432049,2013,CHEMBL2429832,Bioorg Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin) by PDSP assay,96,69,c1ccc(CCNC2C3C4CC5C6C4CC3C6C52)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCc2ccccc2OCc2ccccc2)cc1,CHEMBL907725,Ki,5.3,CHEMBL215010,2006,CHEMBL1137322,J Med Chem,Scientific Literature,Binding affinity to D2 receptor,50,72,c1ccc(CCc2ccccc2OCc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCc2ccccc2OCc2ccccn2)cc1,CHEMBL907725,Ki,5.3,CHEMBL216198,2006,CHEMBL1137322,J Med Chem,Scientific Literature,Binding affinity to D2 receptor,50,72,c1ccc(CCc2ccccc2OCc2ccccn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CCc2ccccc2OCc2cccnc2)cc1,CHEMBL907725,Ki,5.3,CHEMBL217425,2006,CHEMBL1137322,J Med Chem,Scientific Literature,Binding affinity to D2 receptor,50,72,c1ccc(CCc2ccccc2OCc2cccnc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CC3COc4ccccc4C3C2)cc1,CHEMBL670398,Ki,6.5,CHEMBL304856,1999,CHEMBL1131803,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [125I]iodosulpiride from human dopamine D2 (hD2) receptor transfected into CHO cells.,20,3,c1ccc(CN2CC3COc4ccccc4C3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)CC2)cc1,CHEMBL672579,Ki,5.06,CHEMBL59702,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,24,463,c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)CC2)cc1,CHEMBL673073,Ki,4.85,CHEMBL59702,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,24,464,c1ccc(CN2CCC(NCc3coc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(NCc3csc(-c4ccccc4)n3)CC2)cc1,CHEMBL672579,Ki,4.87,CHEMBL302186,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,24,463,c1ccc(CN2CCC(NCc3csc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(NCc3csc(-c4ccccc4)n3)CC2)cc1,CHEMBL673073,Ki,4.64,CHEMBL302186,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,24,464,c1ccc(CN2CCC(NCc3csc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,CHEMBL671371,Ki,7.18,CHEMBL25938,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,20,588,c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,CHEMBL672209,Ki,7.18,CHEMBL25938,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,13,230,c1ccc(CN2CCC(c3cc(-c4ccccc4)[nH]n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(n3cc(-c4ccccc4)nn3)CC2)cc1,CHEMBL671371,Ki,6.34,CHEMBL24170,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,20,588,c1ccc(CN2CCC(n3cc(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(n3ccc(-c4cnco4)c3)CC2)cc1,CHEMBL672580,Ki,5.5,CHEMBL107529,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,20,47,c1ccc(CN2CCC(n3ccc(-c4cnco4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(n3ccc(-c4cnco4)c3)CC2)cc1,CHEMBL673074,Ki,5.47,CHEMBL107529,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,20,48,c1ccc(CN2CCC(n3ccc(-c4cnco4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(n3cccc3)CC2)cc1,CHEMBL672580,Ki,5.01,CHEMBL326877,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,20,47,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(n3cccc3)CC2)cc1,CHEMBL673074,Ki,5.07,CHEMBL326877,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,20,48,c1ccc(CN2CCC(n3cccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(n3cccc3-c3cnco3)CC2)cc1,CHEMBL672580,Ki,6.5,CHEMBL104453,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2S expressed in CHO cells,20,47,c1ccc(CN2CCC(n3cccc3-c3cnco3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(n3cccc3-c3cnco3)CC2)cc1,CHEMBL673074,Ki,6.21,CHEMBL104453,1999,CHEMBL1131871,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2L expressed in CHO cells,20,48,c1ccc(CN2CCC(n3cccc3-c3cnco3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,CHEMBL671371,Ki,6.35,CHEMBL287217,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,20,588,c1ccc(CN2CCC(n3cnc(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(n3nccc3-c3ccccc3)CC2)cc1,CHEMBL671371,Ki,6.29,CHEMBL23537,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,20,588,c1ccc(CN2CCC(n3nccc3-c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC(n3nnc(-c4ccccc4)n3)CC2)cc1,CHEMBL671371,Ki,5.96,CHEMBL24539,1999,CHEMBL1132043,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human Dopamine receptor D2 expressed in CHO cells,20,588,c1ccc(CN2CCC(n3nnc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCC3(CCCc4ccccc43)CC2)cc1,CHEMBL673013,Ki,6.19,CHEMBL303336,1994,CHEMBL1127316,J Med Chem,Scientific Literature,Binding affinity for dopamine D2 receptor using [3H]spiperone in guinea pig striatum,4,165,c1ccc(CN2CCC3(CCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)cc1,CHEMBL671367,Ki,5.8,CHEMBL46523,2001,CHEMBL1134475,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone binding to CHO cells stably expressing dopamine receptor D2,27,554,c1ccc(CN2CCCC(c3c(-c4ccccc4)[nH]c4ccccc34)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCN(Cc3coc(-c4ccccc4)n3)CC2)cc1,CHEMBL672579,Ki,4.67,CHEMBL62703,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,24,463,c1ccc(CN2CCN(Cc3coc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCN(Cc3coc(-c4ccccc4)n3)CC2)cc1,CHEMBL673073,Ki,4.56,CHEMBL62703,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,24,464,c1ccc(CN2CCN(Cc3coc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCN(Cc3csc(-c4ccccc4)n3)CC2)cc1,CHEMBL672579,Ki,4.71,CHEMBL64043,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,24,463,c1ccc(CN2CCN(Cc3csc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCN(Cc3csc(-c4ccccc4)n3)CC2)cc1,CHEMBL673073,Ki,4.55,CHEMBL64043,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,24,464,c1ccc(CN2CCN(Cc3csc(-c4ccccc4)n3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCN(c3cccc4[nH]ccc34)CC2)cc1,CHEMBL884862,Ki,7.28,CHEMBL328051,1998,CHEMBL1130595,Bioorg Med Chem Lett,Scientific Literature,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,15,1,c1ccc(CN2CCN(c3cccc4[nH]ccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCN(c3cccc4[nH]cnc34)CC2)cc1,CHEMBL884862,Ki,6.59,CHEMBL88837,1998,CHEMBL1130595,Bioorg Med Chem Lett,Scientific Literature,Affinity towards human Dopamine receptor D2 expressed in CHO cells using [3H]spiperone,15,1,c1ccc(CN2CCN(c3cccc4[nH]cnc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CCN3c4cccc5[nH]cc(c45)CC3C2)cc1,CHEMBL3294601,Ki,6.89,CHEMBL3286576,2014,CHEMBL3286112,J Med Chem,Scientific Literature,Displacement of [3H]raclopride from human dopamine D2L receptor expressed in CHOK1a cell membrane after 180 mins by scintillation counting analysis,108,178,c1ccc(CN2CCN3c4cccc5[nH]cc(c45)CC3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CC[C@@H](CNCc3csc(-c4ccccc4)n3)C2)cc1,CHEMBL672579,Ki,5.245,CHEMBL59749,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2 short form expressed in CHO cells,24,463,c1ccc(CN2CCC(CNCc3csc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CN2CC[C@@H](CNCc3csc(-c4ccccc4)n3)C2)cc1,CHEMBL673073,Ki,5.1,CHEMBL59749,2000,CHEMBL1133305,Bioorg Med Chem Lett,Scientific Literature,In vitro displacement of [3H]spiperone from the recombinant human dopamine receptor D2L stably expressed in CHO cells,24,464,c1ccc(CN2CCC(CNCc3csc(-c4ccccc4)n3)C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CNCCOc2cccc3[nH]ccc23)cc1,CHEMBL672205,Ki,7.09,CHEMBL64283,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,20,876,c1ccc(CNCCOc2cccc3[nH]ccc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CNCCOc2cccc3[nH]cnc23)cc1,CHEMBL672205,Ki,7.07,CHEMBL89420,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,20,876,c1ccc(CNCCOc2cccc3[nH]cnc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CNCCOc2cccc3[nH]ncc23)cc1,CHEMBL672205,Ki,7.1,CHEMBL87137,1999,CHEMBL1132669,Bioorg Med Chem Lett,Scientific Literature,Inhibition of [3H]spiperone binding to human Dopamine receptor D2 in CHO cell membranes,20,876,c1ccc(CNCCOc2cccc3[nH]ncc23)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(CNC[C@H]2CCc3ccc4[nH]ccc4c3O2)cc1,CHEMBL670555,Ki,6.97,CHEMBL60185,2002,CHEMBL1135019,Bioorg Med Chem Lett,Scientific Literature,Affinity for the Dopamine receptor D2S was determined using membranes from CHO cells labeled with [3H]spiperone,33,894,c1ccc(CNCC2CCc3ccc4[nH]ccc4c3O2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(Cc2cc(C3CCN(Cc4ccccc4)CC3)[nH]n2)cc1,CHEMBL672209,Ki,6.51,CHEMBL77148,1997,CHEMBL1130098,J Med Chem,Scientific Literature,Ability to displace [3H]spiperone from human dopamine receptor D2 stably expressed in CHO cells.,13,230,c1ccc(Cc2cc(C3CCN(Cc4ccccc4)CC3)[nH]n2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(Cc2ccccc2OCCCN2CCCC2)cc1,CHEMBL838569,Ki,6.0,CHEMBL187367,2004,CHEMBL1138672,J Med Chem,Scientific Literature,Binding affinity for human recombinant dopamine receptor D2L,39,440,c1ccc(Cc2ccccc2OCCCN2CCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(Cc2ccccc2OCCN2CCCCC2)cc1,CHEMBL838569,Ki,5.99,CHEMBL364565,2004,CHEMBL1138672,J Med Chem,Scientific Literature,Binding affinity for human recombinant dopamine receptor D2L,39,440,c1ccc(Cc2ccccc2OCCN2CCCCC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(Cc2ccccc2OCCN2CCN(c3ccccc3)CC2)cc1,CHEMBL838569,Ki,5.38,CHEMBL184073,2004,CHEMBL1138672,J Med Chem,Scientific Literature,Binding affinity for human recombinant dopamine receptor D2L,39,440,c1ccc(Cc2ccccc2OCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(Cc2cn(C3CCN(Cc4ccccc4)CC3)nn2)cc1,CHEMBL5116835,Ki,5.2,CHEMBL4434865,2022,CHEMBL5113450,Bioorg Med Chem,Scientific Literature,Displacement of [3H]methyl-spiperone from recombinant human D2S receptor measured after 60 mins by scintillation counting analysis,155,1001,c1ccc(Cc2cn(C3CCN(Cc4ccccc4)CC3)nn2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1,CHEMBL2396124,IC50,6.83,CHEMBL2393243,2013,CHEMBL2390866,Eur J Med Chem,Scientific Literature,Displacement of [3H]-methylspiperone from dopamine D2L receptor (unknown origin) after 60 mins,96,743,c1ccc(Cc2nc3c(c(Nc4ccccc4)n2)CCNCC3)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(C3CCC(Nc4ncccn4)CC3)CC2)cc1,CHEMBL672206,Ki,6.65,CHEMBL2110308,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,c1ccc(N2CCN(C3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCCCNC3=Nc4ccccc4OC3)CC2)cc1,CHEMBL670396,Ki,7.03,CHEMBL541826,1997,CHEMBL1130531,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,13,797,c1ccc(N2CCN(CCCCCNC3=Nc4ccccc4OC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCCCNC3=Nc4ccccc4OC3)CC2)nc1,CHEMBL670396,Ki,6.26,CHEMBL80627,1997,CHEMBL1130531,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,13,797,c1ccc(N2CCN(CCCCCNC3=Nc4ccccc4OC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCCNC3=Nc4ccccc4OC3)CC2)cc1,CHEMBL670396,Ki,5.56,CHEMBL309858,1997,CHEMBL1130531,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,13,797,c1ccc(N2CCN(CCCCNC3=Nc4ccccc4OC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCCc3cc(-c4cccs4)no3)CC2)cc1,CHEMBL672182,Ki,5.38,CHEMBL542324,2002,CHEMBL1135103,Bioorg Med Chem Lett,Scientific Literature,Displacement of the radioligand [3H]spiperone from the cloned human Dopamine receptor D2 long expressed in CHO cells,33,52,c1ccc(N2CCN(CCCCc3cc(-c4cccs4)no3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324908,Ki,6.39,CHEMBL5436702,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,159,704,c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324922,IC50,6.07,CHEMBL5436702,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,159,706,c1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCN3CCCc4ccccc43)CC2)cc1,CHEMBL5106582,Ki,6.15,CHEMBL5169993,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,c1ccc(N2CCN(CCCN3CCCc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCNC3=Nc4ccccc4OC3)CC2)cc1,CHEMBL670396,Ki,5.7,CHEMBL412665,1997,CHEMBL1130531,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,13,797,c1ccc(N2CCN(CCCNC3=Nc4ccccc4OC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,CHEMBL3073105,Ki,6.39,CHEMBL85441,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),96,427,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,CHEMBL670391,Ki,6.39,CHEMBL85441,1995,CHEMBL1149936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,6,428,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1,CHEMBL3073105,Ki,7.16,CHEMBL314983,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),96,427,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1,CHEMBL670391,Ki,7.16,CHEMBL314983,1995,CHEMBL1149936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,6,428,c1ccc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1,CHEMBL672206,Ki,8.13,CHEMBL165140,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,c1ccc(N2CCN(CCCC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCc3ccc4nc[nH]c4c3)CC2)cc1,CHEMBL3073105,Ki,6.89,CHEMBL2298813,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),96,427,c1ccc(N2CCN(CCCc3ccc4nc[nH]c4c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCc3nc4ccccc4[nH]3)CC2)cc1,CHEMBL5106582,Ki,5.21,CHEMBL5203856,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,c1ccc(N2CCN(CCCc3nc4ccccc4[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCc3nc4ccccc4o3)CC2)cc1,CHEMBL5106582,Ki,5.77,CHEMBL5179879,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,c1ccc(N2CCN(CCCc3nc4ccccc4o3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)cc1,CHEMBL5106582,Ki,5.75,CHEMBL5200816,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324908,Ki,5.53,CHEMBL5400876,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,159,704,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324912,IC50,5.17,CHEMBL5400876,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,159,705,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324922,IC50,5.0,CHEMBL5400876,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,159,706,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCn3ccc4ccccc43)CC2)cc1,CHEMBL5106582,Ki,6.14,CHEMBL5205590,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,c1ccc(N2CCN(CCCn3ccc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CCCn3cnc4ccccc43)CC2)cc1,CHEMBL5106582,Ki,4.92,CHEMBL5207313,2022,CHEMBL5104176,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2L receptor expressed in HEK293T cell membrane incubated for 1 hr by MicroBeta scintillation counting method,155,267,c1ccc(N2CCN(CCCn3cnc4ccccc43)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CC[C@H]3CC[C@@H](Nc4ncccn4)CC3)CC2)cc1,CHEMBL672206,Ki,7.55,CHEMBL3084971,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,c1ccc(N2CCN(CCC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1,CHEMBL672206,Ki,8.28,CHEMBL165679,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,c1ccc(N2CCN(CCC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)nc1,CHEMBL672206,Ki,7.92,CHEMBL355371,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,c1ccc(N2CCN(CCC3CCC(Nc4ncccn4)CC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(CC[C@H]3CC[C@H](Nc4ncnc5ccccc45)CC3)CC2)cc1,CHEMBL672206,Ki,8.49,CHEMBL349426,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,c1ccc(N2CCN(CCC3CCC(Nc4ncnc5ccccc45)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(C[C@H]3CC[C@H](Nc4ncccn4)CC3)CC2)cc1,CHEMBL672206,Ki,8.24,CHEMBL165664,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,c1ccc(N2CCN(CC3CCC(Nc4ncccn4)CC3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,CHEMBL672164,Ki,6.92,CHEMBL59324,1996,CHEMBL1129306,J Med Chem,Scientific Literature,Binding affinity towards cloned human Dopamine receptor D2 stably expressed in CHO cells was evaluated using [3H]spiperone as radioligand,9,249,c1ccc(N2CCN(Cc3c[nH]c4ccccc34)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3ccc(-n4cccn4)cc3)CC2)cc1,CHEMBL871242,Ki,5.52,CHEMBL210318,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,50,66,c1ccc(N2CCN(Cc3ccc(-n4cccn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3ccc(-n4cccn4)cc3)CC2)cc1,CHEMBL871243,Ki,5.62,CHEMBL210318,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,50,67,c1ccc(N2CCN(Cc3ccc(-n4cccn4)cc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1,CHEMBL671363,Ki,5.51,CHEMBL294394,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]SCH-23390 radioligand from cloned human Dopamine receptor D2 in CHO cells,33,34,c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1,CHEMBL671365,Ki,5.52,CHEMBL294394,2002,CHEMBL1135184,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone radioligand from cloned human Dopamine receptor D2 in CHO cells,33,35,c1ccc(N2CCN(Cc3ccc[nH]3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,CHEMBL871242,Ki,5.82,CHEMBL211026,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,50,66,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,CHEMBL871243,Ki,6.07,CHEMBL211026,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,50,67,c1ccc(N2CCN(Cc3cn(-c4ccccc4)nn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cnn(-c4cc5ccc4CCc4ccc(cc4)CC5)c3)CC2)cc1,CHEMBL2346426,Ki,7.050000000000001,CHEMBL2336892,2013,CHEMBL2331212,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,96,914,c1ccc(N2CCN(Cc3cnn(-c4cc5ccc4CCc4ccc(cc4)CC5)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cnn(-c4cc5ccc4CCc4ccc(cc4)CC5)c3)CC2)cc1,CHEMBL2346428,Ki,6.859999999999999,CHEMBL2336892,2013,CHEMBL2331212,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,96,915,c1ccc(N2CCN(Cc3cnn(-c4cc5ccc4CCc4ccc(cc4)CC5)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL2346426,Ki,7.12,CHEMBL210405,2013,CHEMBL2331212,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2short receptor expressed in CHO cells,96,914,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL2346428,Ki,6.85,CHEMBL210405,2013,CHEMBL2331212,Bioorg Med Chem,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2long receptor expressed in CHO cells,96,915,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL871242,Ki,6.85,CHEMBL210405,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,50,66,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL871243,Ki,7.12,CHEMBL210405,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,50,67,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,CHEMBL913685,Ki,6.85,CHEMBL210405,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,58,44,c1ccc(N2CCN(Cc3cnn(-c4ccccc4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1,CHEMBL871242,Ki,6.47,CHEMBL425057,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(long) receptor expressed in CHO cells,50,66,c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1,CHEMBL871243,Ki,6.72,CHEMBL425057,2006,CHEMBL1147793,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from human cloned dopamine D2(short) receptor expressed in CHO cells,50,67,c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1,CHEMBL913685,Ki,6.47,CHEMBL425057,2007,CHEMBL1141401,J Med Chem,Scientific Literature,Binding affinity to dopamine D2,58,44,c1ccc(N2CCN(Cc3cnn(-c4ccccn4)c3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,CHEMBL672095,Ki,6.8,CHEMBL440687,2004,CHEMBL1148372,J Med Chem,Scientific Literature,In vitro binding affinity tested on human Dopamine receptor D2 using [3H]spiperon as a radioligand,39,1002,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,CHEMBL672096,Ki,4.82,CHEMBL440687,2004,CHEMBL1148372,J Med Chem,Scientific Literature,In vitro binding affinity tested on human Dopamine receptor D2 (long) using [3H]spiperon as a radioligand,39,1003,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,CHEMBL672097,Ki,4.29,CHEMBL440687,2004,CHEMBL1148372,J Med Chem,Scientific Literature,In vitro binding affinity tested on human Dopamine receptor D2 (short) using [3H]spiperone as a radioligand,39,1004,c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,CHEMBL670394,Ki,6.73,CHEMBL162265,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(OCC2CN(Cc3c[nH]c4ccccc34)CCO2)cc1,CHEMBL4039163,Ki,6.4,CHEMBL4104272,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,129,546,c1ccc(OCC2CN(Cc3c[nH]c4ccccc34)CCO2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,CHEMBL1944110,Ki,6.92,CHEMBL1940414,2012,CHEMBL1938349,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,86,884,c1ccc(OCCCN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(OCCCNCCOc2ccccc2)cc1,CHEMBL671378,Ki,6.6,CHEMBL128524,1997,CHEMBL1130257,J Med Chem,Scientific Literature,Binding affinity against cloned human dopamine receptor D2 expressed in Chinese hamster ovary (CHO) K-1 cells by displacement of [3H]spiperone.,13,589,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(OCCCNCCOc2ccccc2)cc1,CHEMBL835389,Ki,6.6,CHEMBL128524,2005,CHEMBL1143544,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to displace [3H]spiperone from cloned human dopamine receptor D2 was determined,44,722,c1ccc(OCCCNCCOc2ccccc2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(OC[C@@H]2CC[C@H]3CN(c4ccccc4)CCN3C2)cc1,CHEMBL670394,Ki,7.36,CHEMBL351611,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,c1ccc(OCC2CCC3CN(c4ccccc4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(OC[C@@H]2CC[C@H]3CN(c4ccccn4)CCN3C2)cc1,CHEMBL670394,Ki,6.73,CHEMBL350160,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,c1ccc(OCC2CCC3CN(c4ccccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(OC[C@@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1,CHEMBL670394,Ki,5.94,CHEMBL166269,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc(OC[C@H]2CC[C@H]3CN(c4ncccn4)CCN3C2)cc1,CHEMBL670394,Ki,7.3,CHEMBL165504,1998,CHEMBL1131659,Bioorg Med Chem Lett,Scientific Literature,In vitro binding affinity against human D2 dopamine receptor in CHO cells by [3H]spiperone displacement.,15,120,c1ccc(OCC2CCC3CN(c4ncccn4)CCN3C2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc([C@H]2C[C@@H]2CN2CCN(c3ccccc3)CC2)cc1,CHEMBL671074,IC50,7.43,CHEMBL341497,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",24,461,c1ccc(C2CC2CN2CCN(c3ccccc3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc([C@H]2C[C@@H]2CN2CCN(c3ccccn3)CC2)cc1,CHEMBL671074,IC50,6.58,CHEMBL1203260,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",24,461,c1ccc(C2CC2CN2CCN(c3ccccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc([C@H]2C[C@@H]2CN2CCN(c3ncccn3)CC2)cc1,CHEMBL671074,IC50,6.12,CHEMBL1203257,2000,CHEMBL1133592,J Med Chem,Scientific Literature,"Binding affinity to dopamine receptor D2 cloned from human, using [3H]- YM09151 as competitive ligand",25,461,c1ccc(C2CC2CN2CCN(c3ncccn3)CC2)cc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(N3CCN(CCCCOc4ccc5c(c4)CNC5)CC3)cccc2c1,CHEMBL1260558,Ki,7.39,CHEMBL1258425,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,76,832,c1ccc2c(N3CCN(CCCCOc4ccc5c(c4)CNC5)CC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(N3CCN(CCCOc4ccc5c(c4)CNC5)CC3)cccc2c1,CHEMBL1260558,Ki,7.47,CHEMBL1258312,2010,CHEMBL1255556,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]-Spiperone from human dopamine D2L receptor expressed in CHO cells,76,832,c1ccc2c(N3CCN(CCCOc4ccc5c(c4)CNC5)CC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(N3CCN(CCc4ccc5[nH]cnc5c4)CC3)cccc2c1,CHEMBL3073105,Ki,8.78,CHEMBL2298806,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),96,427,c1ccc2c(N3CCN(CCc4ccc5[nH]cnc5c4)CC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(N3CCN(CCc4ccc5[nH]nnc5c4)CC3)cccc2c1,CHEMBL3073105,Ki,7.62,CHEMBL363124,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),96,427,c1ccc2c(N3CCN(CCc4ccc5[nH]nnc5c4)CC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(N3CCN(CCc4ccc5[nH]nnc5c4)CC3)cccc2c1,CHEMBL838638,Ki,7.62,CHEMBL363124,2004,CHEMBL1137161,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2,39,598,c1ccc2c(N3CCN(CCc4ccc5[nH]nnc5c4)CC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(N3CCN(CCc4ccc5c(c4)NCN5)CC3)cccc2c1,CHEMBL838638,Ki,8.78,CHEMBL182721,2004,CHEMBL1137161,Bioorg Med Chem Lett,Scientific Literature,Binding affinity against Dopamine receptor D2,39,598,c1ccc2c(N3CCN(CCc4ccc5c(c4)NCN5)CC3)cccc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(c1)CC(CN1CCN(c3ccc4c(c3)OCCO4)CC1)C2,CHEMBL4039163,Ki,6.13,CHEMBL146556,2017,CHEMBL4038300,J Med Chem,Scientific Literature,Inhibition of human dopamine D2 receptor,129,546,c1ccc2c(c1)CC(CN1CCN(c3ccc4c(c3)OCCO4)CC1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(c1)CCN(CCCCc1c[nH]c3ccccc13)C2,CHEMBL3821452,Ki,6.785,CHEMBL3819494,2016,CHEMBL3817758,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor expressed in cell membranes after 1 hr by liquid scintillation counting,123,698,c1ccc2c(c1)CCN(CCCCc1c[nH]c3ccccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(c1)CCN(CCCCc1nc3ccccc3s1)C2,CHEMBL2037965,Ki,7.51,CHEMBL2037522,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,86,882,c1ccc2c(c1)CCN(CCCCc1nc3ccccc3s1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(c1)CCN(CCCc1nc3ccccc3[nH]1)C2,CHEMBL3863657,Ki,6.0649999999999995,CHEMBL3959209,2016,CHEMBL3862017,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting method,123,59,c1ccc2c(c1)CCN(CCCc1nc3ccccc3[nH]1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(c1)CCN(Cc1c[nH]c3ncccc13)C2,CHEMBL671652,Ki,6.19,CHEMBL154286,1999,CHEMBL1132519,Bioorg Med Chem Lett,Scientific Literature,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,20,58,c1ccc2c(c1)CCN(Cc1c[nH]c3ncccc13)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(c1)CCN1CCc3[nH]c4ccccc4c3C21,CHEMBL1105125,Ki,5.83,CHEMBL1086789,2010,CHEMBL1155427,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,76,638,c1ccc2c(c1)CCN1CCc3[nH]c4ccccc4c3C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(c1)CCN1CCc3cccc4[nH]cc(c34)C21,CHEMBL1105125,Ki,5.35,CHEMBL1086790,2010,CHEMBL1155427,J Med Chem,Scientific Literature,Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in HEK293 cells by microplate scintillation counting,76,638,c1ccc2c(c1)CCN1CCc3cccc4[nH]cc(c34)C21,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(c1)CN(CCCCc1nc3ccccc3s1)C2,CHEMBL2037965,Ki,6.0,CHEMBL2037523,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,86,882,c1ccc2c(c1)CN(CCCCc1nc3ccccc3s1)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(c1)Cc1ccccc1C21CCNC1,CHEMBL672315,Ki,5.3,CHEMBL307956,2004,CHEMBL1148436,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards dopamine receptor D2 using [3H]spiperone as radioligand,39,524,c1ccc2c(c1)Cc1ccccc1C21CCNC1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,CHEMBL3705566,Ki,7.43,CHEMBL3526391,2014,CHEMBL3639279,,BindingDB Patent Bioactivity Data,"Binding Assay: The ability of test compounds to displace 3H-raclopride at the D2s receptor can be determined on membranes from D2s-transfected CHO cells (Bmax 13 pmol/mg protein). An assay can use a standard 96-well glass-fiber filter plate to retain radioligand bound by the receptor. Retained 3H can be determined in a TopCount scintillation plate counter following the addition of a liquid scintillant to each well. Compounds can be evaluated for their potency using competition curve analysis, resulting in calculated Ki values.",108,607,c1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1S2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2c3c([nH]c2c1)C(Cc1ccc2c(c1)OCO2)NCC3,CHEMBL886705,Ki,5.34,CHEMBL328476,2007,CHEMBL1139165,Bioorg Med Chem Lett,Scientific Literature,Displacement of [3H]spiperone from dopamine D2 receptor,58,129,c1ccc2c3c([nH]c2c1)C(Cc1ccc2c(c1)OCO2)NCC3,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1ccc2oc(SCCCCCCN3CCN(c4nsc5ccccc45)CC3)nc2c1,CHEMBL4629186,Ki,7.48,CHEMBL4635603,2020,CHEMBL4627360,Bioorg Med Chem,Scientific Literature,Displacement of [3H]-raclopride from human D2L receptor expressed in HEK293 cell membranes measured after 1 hr by microbeta counting method,146,764,c1ccc2oc(SCCCCCCN3CCN(c4nsc5ccccc45)CC3)nc2c1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(CCCCCNC3=Nc4ccccc4OC3)CC2)nc1,CHEMBL670396,Ki,5.59,CHEMBL80645,1997,CHEMBL1130531,Bioorg Med Chem Lett,Scientific Literature,Binding affinity at cloned human D2 dopamine receptor in CHO cells using [3H]-YM 09151 as radioligand,13,797,c1cnc(N2CCN(CCCCCNC3=Nc4ccccc4OC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(CCCCN3CCc4ncsc4CC3)CC2)nc1,CHEMBL4334858,Ki,5.6,CHEMBL4438968,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,141,774,c1cnc(N2CCN(CCCCN3CCc4ncsc4CC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL2037965,Ki,7.58,CHEMBL2037521,2012,CHEMBL2034919,Eur J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,86,882,c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL3292986,Ki,7.58,CHEMBL2037521,2014,CHEMBL3286287,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by PDSP assay,108,846,c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324908,Ki,6.9,CHEMBL2037521,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,159,704,c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324912,IC50,6.45,CHEMBL2037521,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as inhibition of forskolin stimulated cAMP production incubated for 30 mins by Lance ultra cAMP assay,159,705,c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324922,IC50,6.62,CHEMBL2037521,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,159,706,c1cnc(N2CCN(CCCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1,CHEMBL3073105,Ki,6.57,CHEMBL85972,2013,CHEMBL3046886,Med Chem Res,Scientific Literature,Binding affinity to dopamine D2 receptor (unknown origin),96,427,c1cnc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1,CHEMBL670391,Ki,6.57,CHEMBL85972,1995,CHEMBL1149936,Bioorg Med Chem Lett,Scientific Literature,Binding affinity towards cloned human Dopamine D2 receptor in CHO cells using [3H]spiperone as radioligand,6,428,c1cnc(N2CCN(CCCOc3ccc(-c4nc5ccccc5[nH]4)cc3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324908,Ki,5.2,CHEMBL3289656,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human D2 receptor stably expressed in HEK293 cell membrane assessed as inhibition constant incubated for 1 hr by MicroBeta scintillation counting method,159,704,c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,CHEMBL5324922,IC50,4.99,CHEMBL3289656,2023,CHEMBL5321291,J Med Chem,Scientific Literature,Antagonist activity at human D2 receptor stably expressed in CHO-K1 cells assessed as beta arrestin recruitment preincubated for 90 mins by tropix-gal screen substrate based luminescence analysis,159,706,c1cnc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(Cc3c[nH]c4ncccc34)CC2)nc1,CHEMBL1033197,Ki,5.93,CHEMBL460644,2009,CHEMBL1152692,Bioorg Med Chem,Scientific Literature,Displacement of [3H]N-methylspiperone from human dopamine D2 receptor by liquid scintillation counting,67,880,c1cnc(N2CCN(Cc3c[nH]c4ncccc34)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(Cc3cccc(-c4ccsc4)c3)CC2)nc1,CHEMBL671073,IC50,6.52,CHEMBL64597,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,15,212,c1cnc(N2CCN(Cc3cccc(-c4ccsc4)c3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(Cc3cccc4c3-c3ccccc3C4)CC2)nc1,CHEMBL671073,IC50,5.64,CHEMBL304692,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,15,212,c1cnc(N2CCN(Cc3cccc4c3-c3ccccc3C4)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N2CCN(Cc3cccc4c3Cc3ccccc3-4)CC2)nc1,CHEMBL671073,IC50,5.01,CHEMBL303519,1998,CHEMBL1130912,Bioorg Med Chem Lett,Scientific Literature,Binding affinity to cloned human Dopamine receptor D2 expressed in A9L cells by [3H]spiperone displacement.,15,212,c1cnc(N2CCN(Cc3cccc4c3Cc3ccccc3-4)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N[C@H]2CC[C@H](CCN3CCN(c4cccnc4)CC3)CC2)nc1,CHEMBL672206,Ki,7.6,CHEMBL164723,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,c1cnc(NC2CCC(CCN3CCN(c4cccnc4)CC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N[C@H]2CC[C@H](CCN3CCN(c4ccncc4)CC3)CC2)nc1,CHEMBL672206,Ki,5.32,CHEMBL166151,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,15,62,c1cnc(NC2CCC(CCN3CCN(c4ccncc4)CC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N[C@H]2CC[C@H](CCN3CCN(c4cnccn4)CC3)CC2)nc1,CHEMBL672206,Ki,6.75,CHEMBL165689,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,16,62,c1cnc(NC2CCC(CCN3CCN(c4cnccn4)CC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N[C@H]2CC[C@H](CCN3CCN(c4ncccn4)CC3)CC2)nc1,CHEMBL672206,Ki,6.62,CHEMBL349980,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,16,62,c1cnc(NC2CCC(CCN3CCN(c4ncccn4)CC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N[C@H]2CC[C@H](CCN3CCN(c4nccs4)CC3)CC2)nc1,CHEMBL672206,Ki,7.34,CHEMBL166252,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,16,62,c1cnc(NC2CCC(CCN3CCN(c4nccs4)CC3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc(N[C@H]2CC[C@H](CCN3CCc4ccccc4C3)CC2)nc1,CHEMBL672206,Ki,6.96,CHEMBL165440,1998,CHEMBL1131565,J Med Chem,Scientific Literature,Binding affinity determined by measuring its ability to displace [3H]N-0437 radioligand in CHO-K1 cells on Cloned Human Dopamine receptor D2,16,62,c1cnc(NC2CCC(CCN3CCc4ccccc4C3)CC2)nc1,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1cnc2c(c1)CN[C@@H](CN(CCCC1CCNCC1)[C@H]1CCCc3cccnc31)C2,CHEMBL5048805,IC50,5.01,CHEMBL5081505,2022,CHEMBL5046278,J Med Chem,Scientific Literature,Inhibition of dopamine D2 receptor (unknown origin),155,912,c1cnc2c(c1)CNC(CN(CCCC1CCNCC1)C1CCCc3cccnc31)C2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
c1nc2c(s1)CCN(CCCCN1CCc3ncsc3CC1)CC2,CHEMBL4334858,Ki,5.2,CHEMBL4472043,2019,CHEMBL4334436,Medchemcomm,Scientific Literature,Displacement of [3H]spiperone from human dopamine D2S receptor expressed in CHO-K1 cell membrane incubated for 2 hrs by MicroBeta Trilux scintillation counting method,141,774,c1nc2c(s1)CCN(CCCCN1CCc3ncsc3CC1)CC2,DRD2,CHEMBL217,Dopamine D2 receptor,gpcr
